Citrus Sinensis ID: 012637
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 459 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LEU7 | 445 | CBL-interacting serine/th | yes | no | 0.967 | 0.997 | 0.716 | 0.0 | |
| Q8W1D5 | 488 | CBL-interacting serine/th | no | no | 0.952 | 0.895 | 0.713 | 0.0 | |
| Q9SEZ7 | 469 | CBL-interacting serine/th | no | no | 0.934 | 0.914 | 0.646 | 1e-162 | |
| Q6ERS4 | 456 | CBL-interacting protein k | yes | no | 0.928 | 0.934 | 0.598 | 1e-157 | |
| Q9LWM4 | 461 | CBL-interacting protein k | yes | no | 0.949 | 0.945 | 0.561 | 1e-145 | |
| Q7X996 | 443 | CBL-interacting protein k | no | no | 0.934 | 0.968 | 0.567 | 1e-141 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | no | no | 0.917 | 0.958 | 0.563 | 1e-140 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.949 | 0.954 | 0.562 | 1e-138 | |
| Q9C562 | 479 | CBL-interacting serine/th | no | no | 0.947 | 0.908 | 0.542 | 1e-137 | |
| Q10LQ2 | 451 | CBL-interacting protein k | no | no | 0.945 | 0.962 | 0.552 | 1e-136 |
| >sp|Q9LEU7|CIPK5_ARATH CBL-interacting serine/threonine-protein kinase 5 OS=Arabidopsis thaliana GN=CIPK5 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/448 (71%), Positives = 373/448 (83%), Gaps = 4/448 (0%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQ-LKKEFMMEQIKR 59
MEEER VLFGKYEMGRLLGKGTFAKVYYGK+++ GE VAIKVINKDQ +K+ MMEQIKR
Sbjct: 1 MEEERRVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKR 60
Query: 60 EISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLI 119
EIS+M+LVRHPN+VEL+EVMATK KIF ME+VKGGELF K+++G+L ED AR+YFQQLI
Sbjct: 61 EISIMKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISKGKLHEDAARRYFQQLI 120
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179
SAVD+CHSRGVSHRDLKPENLLLDEN DLKISDFGLSALPEQ+ DGLLHTQCGTPAYVA
Sbjct: 121 SAVDYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVA 180
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDA 239
PEVL+KKGYDG+KAD+WSCGV+LYVLLAG LPFQDEN+MNMYRK+F+A+F +PPW S +A
Sbjct: 181 PEVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEA 240
Query: 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDR 299
+RLISKLLV DP+RRI+I +IMR PW RK FT P+AF I + E+ + D
Sbjct: 241 RRLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEEDGDC 300
Query: 300 HNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVA 359
N E SPKFFNAFEFISSMSSGFDLS+LFE+K+K S+FTSR SA +MEKIE V
Sbjct: 301 ENQTEP--ISPKFFNAFEFISSMSSGFDLSSLFESKRKVQSVFTSRSSATEVMEKIETVT 358
Query: 360 KGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFC 419
K MN KV + KDFK+++ G +EGRKG LS+ AEVFEVAPE++VVEF KS+GDTLEY +
Sbjct: 359 KEMNMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYDRLY 418
Query: 420 EEDVRPALKDIVWTWQGDNINKVEGEDC 447
EE+VRPAL DIVW+W GDN N EDC
Sbjct: 419 EEEVRPALNDIVWSWHGDN-NNTSSEDC 445
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8W1D5|CIPKP_ARATH CBL-interacting serine/threonine-protein kinase 25 OS=Arabidopsis thaliana GN=CIPK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 659 bits (1700), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/443 (71%), Positives = 366/443 (82%), Gaps = 6/443 (1%)
Query: 1 MEEERH---VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQI 57
MEEE+ VLF KYEMGRLLGKGTF KVYYGK++ TGESVAIK+INKDQ+K+E MMEQI
Sbjct: 29 MEEEQQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQI 88
Query: 58 KREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQ 117
KREIS+MRLVRHPN+VEL+EVMATK KIF MEYVKGGELF+K+ +G+L+ED ARKYFQQ
Sbjct: 89 KREISIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQ 148
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY 177
LISAVDFCHSRGVSHRDLKPENLL+DEN DLK+SDFGLSALPEQ+ DGLLHTQCGTPAY
Sbjct: 149 LISAVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAY 208
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWIST 237
VAPEVLRKKGYDG+K D+WSCG+ILYVLLAGFLPFQDEN+M MYRK+FK+EF YPPW S
Sbjct: 209 VAPEVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSP 268
Query: 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTEN 297
++KRLISKLLV DP +RI+I +IMR PWFRK P+ F I + + +D+ T
Sbjct: 269 ESKRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPTTTA-- 326
Query: 298 DRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEG 357
SPKFFNAFEFISSMSSGFDLS+LFE+K+K SMFTSR+SA IM K+EG
Sbjct: 327 -TTATTTTTPVSPKFFNAFEFISSMSSGFDLSSLFESKRKLRSMFTSRWSASEIMGKLEG 385
Query: 358 VAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAK 417
+ K MN KV + KDFK++L G +EGRKG ++V AEVFEVAPEVAVVE KS+GDTLEY +
Sbjct: 386 IGKEMNMKVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNR 445
Query: 418 FCEEDVRPALKDIVWTWQGDNIN 440
EE VRPAL++IVW+W GDN N
Sbjct: 446 LYEEHVRPALEEIVWSWHGDNHN 468
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SEZ7|CIPKG_ARATH CBL-interacting serine/threonine-protein kinase 16 OS=Arabidopsis thaliana GN=CIPK16 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 571 bits (1471), Expect = e-162, Method: Compositional matrix adjust.
Identities = 285/441 (64%), Positives = 345/441 (78%), Gaps = 12/441 (2%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKEFMMEQIKREISVMR 65
VLF KY +GRLLG G FAKVY+G ++ TG+ VAIKVI KD + K+ MMEQI+REI+VMR
Sbjct: 10 VLFDKYNIGRLLGTGNFAKVYHGTEISTGDDVAIKVIKKDHVFKRRGMMEQIEREIAVMR 69
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDF 124
L+RHPNVVELREVMATKKKIF MEYV GGELF + R G+L EDLARKYFQQLISAVDF
Sbjct: 70 LLRHPNVVELREVMATKKKIFFVMEYVNGGELFEMIDRDGKLPEDLARKYFQQLISAVDF 129
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL--PEQL-----RNDGLLHTQCGTPAY 177
CHSRGV HRD+KPENLLLD DLK++DFGLSAL PE L +D LLHT+CGTPAY
Sbjct: 130 CHSRGVFHRDIKPENLLLDGEGDLKVTDFGLSALMMPEGLGGRRGSSDDLLHTRCGTPAY 189
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWIST 237
VAPEVLR KGYDG+ AD+WSCG++LY LLAGFLPF DEN+M +Y K+FKAE +PPW S
Sbjct: 190 VAPEVLRNKGYDGAMADIWSCGIVLYALLAGFLPFIDENVMTLYTKIFKAECEFPPWFSL 249
Query: 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTEN 297
++K L+S+LLV DPE+RI++ I +PWFRK FT VAFSI D+ K +
Sbjct: 250 ESKELLSRLLVPDPEQRISMSEIKMIPWFRKNFTPSVAFSI---DETIPSPPEPPTKKKK 306
Query: 298 DRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEG 357
N +E+ +SP+ FNAF+FI+SMSSGFDLSNLFE K+K MFTS++ A+ + E++E
Sbjct: 307 KDLNEKEDDGASPRSFNAFQFITSMSSGFDLSNLFEIKRKPKRMFTSKFPAKSVKERLET 366
Query: 358 VAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAK 417
A+ M+ +V VKD K++L+ +EGRKG LSV AEVFEVAPEV+VVEF K+SGDTLEY
Sbjct: 367 AAREMDMRVKHVKDCKMKLQRRTEGRKGRLSVTAEVFEVAPEVSVVEFCKTSGDTLEYYL 426
Query: 418 FCEEDVRPALKDIVWTWQGDN 438
FCE+DVRPALKDIVW+WQGD+
Sbjct: 427 FCEDDVRPALKDIVWSWQGDD 447
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ERS4|CIPKG_ORYSJ CBL-interacting protein kinase 16 OS=Oryza sativa subsp. japonica GN=CIPK16 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 556 bits (1433), Expect = e-157, Method: Compositional matrix adjust.
Identities = 261/436 (59%), Positives = 333/436 (76%), Gaps = 10/436 (2%)
Query: 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK-EFMMEQIKREIS 62
ER ++ G+YE+GRLLG+GTFAKVYYG+ L +GESVAIKVI+K +L++ E M+EQ++REIS
Sbjct: 14 ERKLVLGRYELGRLLGQGTFAKVYYGRDLRSGESVAIKVIDKARLRRTEGMVEQLRREIS 73
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
+MR+VRHPNVV +REV+A++ ++FV MEY +GGELFAKVARGRL E+ AR+YFQQL++AV
Sbjct: 74 IMRMVRHPNVVGIREVLASRARVFVVMEYARGGELFAKVARGRLTEEHARRYFQQLVAAV 133
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
FCH RGV+HRDLKPENLLLDE LK++DFGL+ALPEQLR DGLLHTQCGTPAYVAPEV
Sbjct: 134 GFCHGRGVAHRDLKPENLLLDEEGRLKVTDFGLAALPEQLRQDGLLHTQCGTPAYVAPEV 193
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRK+GYDG++ADLWSCGV+LYVLL GFLPFQ EN MY+K+FKAE+ PPW+S DA+RL
Sbjct: 194 LRKRGYDGARADLWSCGVVLYVLLCGFLPFQHENYAKMYQKIFKAEYQVPPWVSGDARRL 253
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
I +LLV DP +RI+I IMR PWF+KGF PV S +DD +
Sbjct: 254 IVRLLVVDPAKRISIPEIMRTPWFKKGFVPPVPTSPVSPKKWEEDDVLL---------DG 304
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
+ SP+ NAF+ ISSMSSGFDLS +FE+++K ++FTSR A +++K+E V + +
Sbjct: 305 GDSGAMSPRTCNAFQLISSMSSGFDLSGMFESEQKAATVFTSRAPAATVIQKLEAVGRSL 364
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
+ + K +K+RL ++G G L+V E EVA +VAVVEF+ +GD LE+ KFC D
Sbjct: 365 GYSATRGKGWKLRLEATADGANGRLAVTVEALEVAADVAVVEFAHDAGDELEFNKFCAVD 424
Query: 423 VRPALKDIVWTWQGDN 438
VRP L DIVW WQGD
Sbjct: 425 VRPGLADIVWAWQGDR 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 515 bits (1327), Expect = e-145, Method: Compositional matrix adjust.
Identities = 248/442 (56%), Positives = 327/442 (73%), Gaps = 6/442 (1%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
ME++ +L +YE+GR+LG+GTFAKVY+ + L + +SVAIKVI+K+++ + M++QIKRE
Sbjct: 1 MEKKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
IS+MRLVRHPN+V+L EVMA+K KI+ AMEYV+GGELF++VARGRL+ED ARKYFQQLI
Sbjct: 61 ISIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIG 120
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
AVDFCHSRGV HRDLKPENLL+DEN +LK+SDFGLSA E + DGLLHT CGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAP 180
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
E++ K+GYDG+KAD+WSCGVIL+VLLAG+LPF D N+M MYRK+ K + +P W +TD +
Sbjct: 181 EIINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVR 240
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRH 300
RL+S+LL +P RIT++ ++ PWF+KG+ V S ++ D A D
Sbjct: 241 RLLSRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNNLKDVHTAFSADHKDNE 300
Query: 301 NNQEEKVSS--PKFFNAFEFISSMSSGFDLSNLFENKK--KTGSMFTSRYSARHIMEKIE 356
+E SS P NAF+ I S+S GFDLS LFEN K K S F ++ A I+ K+E
Sbjct: 301 GKAKEPASSLKPVSLNAFDII-SLSKGFDLSGLFENDKEQKADSRFMTQKPASAIVSKLE 359
Query: 357 GVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYA 416
+A+ +FKV K +D ++L+G EGRKG L++ AE+FEV P VVE KS+GDTLEY
Sbjct: 360 QIAETESFKVKK-QDGLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDTLEYE 418
Query: 417 KFCEEDVRPALKDIVWTWQGDN 438
KFC + +RP+L+DI W Q ++
Sbjct: 419 KFCNKGLRPSLRDICWDGQSEH 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1291), Expect = e-141, Method: Compositional matrix adjust.
Identities = 247/435 (56%), Positives = 316/435 (72%), Gaps = 6/435 (1%)
Query: 1 MEEER-HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKR 59
M E+R ++L KYEMG+LLG+GTFAKVY+ + T ESVAIK+I+K+++ K +M+QIKR
Sbjct: 1 MAEQRGNMLMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKR 60
Query: 60 EISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLI 119
EISVM+LVRHPN+V+L EVMATK KI+ +E+VKGGELF KV RGRL+ED ARKYFQQLI
Sbjct: 61 EISVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLI 120
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179
AVDFCHSRGV HRDLKPENLLLDEN +LK+SDFGLSAL + R DGLLHT CGTPAYVA
Sbjct: 121 CAVDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVA 180
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDA 239
PEV+ ++GYDG+KAD+WSCGVIL+VLLAG+LPF D+N+M+MY+K+ KAEF P W +TD
Sbjct: 181 PEVINRRGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDV 240
Query: 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDR 299
+RL+ ++L +P RI++ IM PWFRKG + Q D D + T+ D
Sbjct: 241 RRLLLRILDPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMS----TDFDS 296
Query: 300 HNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVA 359
N+ P NAF+ I S+S+G DLS +FE K S FTS +A I+ KIE +A
Sbjct: 297 FNSAPTLEKKPSNLNAFDII-SLSTGLDLSGMFEESDKKESKFTSTSTASTIISKIEDIA 355
Query: 360 KGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFC 419
KG+ K+ K +++ G GRKG + + AE+FEV P +VE K++GDTLEY K
Sbjct: 356 KGLRLKLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELKKTNGDTLEYRKVL 415
Query: 420 EEDVRPALKDIVWTW 434
+++RPALKDIVW W
Sbjct: 416 NQEMRPALKDIVWAW 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 497 bits (1280), Expect = e-140, Method: Compositional matrix adjust.
Identities = 248/440 (56%), Positives = 318/440 (72%), Gaps = 19/440 (4%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
M++ VL KYE+GRLLG+GTFAKVY+ + + TGESVAIKVI+K ++ K +++QIKRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
ISVMRLVRHP+VV L EVMA+K KI+ AMEYVKGGELF KV++G+L+E++ARKYFQQLI
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
A+D+CHSRGV HRDLKPENLLLDEN DLKISDFGLSAL E + DGLLHT CGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ KKGYDG+KAD+WSCGV+LYVLLAGFLPF ++N++ MYRK+ K EF P W + K
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTR---PVAFSITQHDDDGDDDQAATEKTEN 297
+L+S++L +P RI I+ IM WF+KGF + P + Q D D AA
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFS---- 296
Query: 298 DRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEG 357
P +NAF+ ISS+S GFDLS LFE ++++ S FT++ A+ I+ K E
Sbjct: 297 ----------VKPMSYNAFDLISSLSQGFDLSGLFEKEERSESKFTTKKDAKEIVSKFEE 346
Query: 358 VAKGMN-FKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYA 416
+A F + K D +++ EGRKG L++ E+FEV +VEF KS GDT+EY
Sbjct: 347 IATSSERFNLTK-SDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYK 405
Query: 417 KFCEEDVRPALKDIVWTWQG 436
+FC+ ++RP+LKDIVW WQG
Sbjct: 406 QFCDRELRPSLKDIVWKWQG 425
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1264), Expect = e-138, Method: Compositional matrix adjust.
Identities = 249/443 (56%), Positives = 319/443 (72%), Gaps = 7/443 (1%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
+E+ ++L +YE+G+LLG+GTFAKVY+G+ ++T +SVAIKVI+KD++ K +M+QIKRE
Sbjct: 4 LEKNGNILLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKRE 63
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
ISVM+LVRHPN+V+L EVMATK KI+ +EYVKGGELF KVA+GRL+ED ARKYFQQL+S
Sbjct: 64 ISVMKLVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVS 123
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
AVDFCHSRGV HRDLKPENLL+DEN +LKI+DFGLSAL E R DGLLHT CGTPAYVAP
Sbjct: 124 AVDFCHSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAP 183
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ +KGYDG K D WSCGVIL+VL+AG+LPFQD N+M MYRK+ KAEF P W S+D +
Sbjct: 184 EVISRKGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVR 243
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGD---DDQAATEKTEN 297
+L+S++L +P R+ I IM WF+KG + + ++ D +
Sbjct: 244 KLVSRILDPNPRSRMPITKIMETYWFKKGLDSKLILKNVETNEPVTALADVNVVFSSMGS 303
Query: 298 DRHNNQEEKVSSPKF--FNAFEFISSMSSGFDLSNLF-ENKKKTGSMFTSRYSARHIMEK 354
EEK + K NAF+ I S+S GFDLS LF E KK + FTS SA I+ K
Sbjct: 304 SSSKKTEEKQDAGKLTNLNAFDII-SLSEGFDLSGLFEETDKKKEARFTSSQSASAIISK 362
Query: 355 IEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLE 414
+E VA V K + +++ G SEGRKG L++ AE+FEV P +VE K++GDTLE
Sbjct: 363 LEDVASCSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEIKKNNGDTLE 422
Query: 415 YAKFCEEDVRPALKDIVWTWQGD 437
Y +ED++PALKDIVW WQG+
Sbjct: 423 YQHLWKEDMKPALKDIVWAWQGE 445
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C562|CIPKA_ARATH CBL-interacting serine/threonine-protein kinase 10 OS=Arabidopsis thaliana GN=CIPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1259), Expect = e-137, Method: Compositional matrix adjust.
Identities = 245/452 (54%), Positives = 315/452 (69%), Gaps = 17/452 (3%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
ME + VL KY++GRLLG+GTFAKVYYG+ ++T +SVAIK+I+K+++ K ++EQIKRE
Sbjct: 1 MENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKRE 60
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
ISVMR+ RHPNVVEL EVMATK +I+ MEY KGGELF KVA+G+LR+D+A KYF QLI+
Sbjct: 61 ISVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLIN 120
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
AVDFCHSR V HRD+KPENLLLD+NE+LK+SDFGLSAL + R DGLLHT CGTPAYVAP
Sbjct: 121 AVDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ +KGYDG+KAD+WSCGV+L+VLLAG+LPF D N+M MYRK+ KA+F P W + + +
Sbjct: 181 EVINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVR 240
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGF---------------TRPVAFSITQHDDDG 285
RL+ K+L +PE RITI I WFRKG + + T + G
Sbjct: 241 RLLCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 286 DDDQAATEKTENDRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSR 345
+ A DR +E P NAF+ I ++S+GFDL+ LF + K S FTS+
Sbjct: 301 PSENGAGPSENGDRV-TEENHTDEPTNLNAFDLI-ALSAGFDLAGLFGDDNKRESRFTSQ 358
Query: 346 YSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEF 405
A I+ K+E VA+ + + K + +L EGRKG LS+ AE+F+V P +VE
Sbjct: 359 KPASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEV 418
Query: 406 SKSSGDTLEYAKFCEEDVRPALKDIVWTWQGD 437
KS+GDTLEY K ED+RPAL DIVW WQG+
Sbjct: 419 KKSNGDTLEYQKLVAEDLRPALSDIVWVWQGE 450
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10LQ2|CIPKA_ORYSJ CBL-interacting protein kinase 10 OS=Oryza sativa subsp. japonica GN=CIPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-136, Method: Compositional matrix adjust.
Identities = 244/442 (55%), Positives = 330/442 (74%), Gaps = 8/442 (1%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
+E++ ++L +YE+G+LLG+G+FAKVY+G+ + +SVAIKVI+K+++ K +M+QI+RE
Sbjct: 2 VEQKGNILMKRYEIGKLLGQGSFAKVYHGRNIKNSQSVAIKVIDKEKILKCELMDQIRRE 61
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
ISVM LVRHP +V+L EVMATK KI+ +EYVKGGELF KV RGRL+E++ARKYFQQLIS
Sbjct: 62 ISVMNLVRHPCIVQLYEVMATKTKIYFILEYVKGGELFNKVRRGRLKEEVARKYFQQLIS 121
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
A+DFCHSRGV HRDLKPENLLLDEN +LKISDFGLSAL E R DGLLHT CGTPAYVAP
Sbjct: 122 AIDFCHSRGVYHRDLKPENLLLDENRNLKISDFGLSALAECKRQDGLLHTTCGTPAYVAP 181
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ +KGYDG+KAD+W+CGVILYVLLAG+LPFQD+N++NMY+K+ KAEF +P W S+D +
Sbjct: 182 EVINRKGYDGAKADVWACGVILYVLLAGYLPFQDKNVINMYKKICKAEFKWPSWFSSDIR 241
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDD----DQAATEKTE 296
+L+ ++L +P RI++ IM PWFR G + + T D D D +T
Sbjct: 242 KLLRRILDPNPATRISVSEIMEDPWFRVGLNSDL-LNKTIPTDKVDKVVHVDMDSTFGNL 300
Query: 297 NDRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKK-KTGSMFTSRYSARHIMEKI 355
++ N +++ + NAF+ I S+SSGFDLS +FE++ K S FTS +A I +K+
Sbjct: 301 SNNINEGKQEAENLTSLNAFDII-SLSSGFDLSAMFEDENSKEESKFTSTNTATTITKKL 359
Query: 356 EGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEY 415
E VAK + K K +++ G GRKG +S+ AE+F++ P+ +VEF+K +GDTLEY
Sbjct: 360 EDVAKNLRLKFLKKNGGLLKMEGSKPGRKGVMSINAEIFQITPDFHLVEFTKINGDTLEY 419
Query: 416 AKFCEEDVRPALKDIVWTWQGD 437
K ++++RPALKDIVW WQG+
Sbjct: 420 QK-VKQEMRPALKDIVWAWQGE 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 459 | ||||||
| 255548756 | 441 | CBL-interacting serine/threonine-protein | 0.958 | 0.997 | 0.810 | 0.0 | |
| 345104079 | 448 | calcineurin B-like protein-interacting p | 0.958 | 0.982 | 0.783 | 0.0 | |
| 345104083 | 448 | calcineurin B-like protein-interacting p | 0.958 | 0.982 | 0.787 | 0.0 | |
| 345104047 | 448 | calcineurin B-like protein-interacting p | 0.958 | 0.982 | 0.785 | 0.0 | |
| 345104075 | 448 | calcineurin B-like protein-interacting p | 0.958 | 0.982 | 0.783 | 0.0 | |
| 345104053 | 448 | calcineurin B-like protein-interacting p | 0.958 | 0.982 | 0.785 | 0.0 | |
| 345104045 | 448 | calcineurin B-like protein-interacting p | 0.958 | 0.982 | 0.785 | 0.0 | |
| 345104063 | 446 | calcineurin B-like protein-interacting p | 0.958 | 0.986 | 0.785 | 0.0 | |
| 345104049 | 448 | calcineurin B-like protein-interacting p | 0.958 | 0.982 | 0.783 | 0.0 | |
| 145105398 | 446 | CBL-interacting protein kinase [Gossypiu | 0.958 | 0.986 | 0.785 | 0.0 |
| >gi|255548756|ref|XP_002515434.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223545378|gb|EEF46883.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/448 (81%), Positives = 399/448 (89%), Gaps = 8/448 (1%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLF KYE+GRLLGKGTFAKVYYGK + TGESVAIKVI+KDQ+KKE MMEQIKREIS
Sbjct: 2 EERHVLFEKYEIGRLLGKGTFAKVYYGKNVETGESVAIKVISKDQVKKEGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
+MRLVRHPNVVEL+EV+ATK KIF MEYV+GGELFAKVA+G+L+ED+ARKYFQQLISAV
Sbjct: 62 IMRLVRHPNVVELKEVLATKTKIFFIMEYVRGGELFAKVAKGKLKEDVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDENEDLK+SDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDENEDLKVSDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGSKAD+WSCGVILYVLLAGFLPFQDENIM MYRKVFKAEF P W STDAKRL
Sbjct: 182 LRKKGYDGSKADIWSCGVILYVLLAGFLPFQDENIMKMYRKVFKAEFECPAWFSTDAKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
IS+LLV+DP+RRITI +IMRVPWF+KG TRPV FS+ D + T E D +
Sbjct: 242 ISRLLVADPQRRITIPAIMRVPWFQKGLTRPVTFSVQ------DSNLGKTAAAEEDESLS 295
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
KVSSPKFFNAFEFISSMSSGFDLS+LFENK+KTGS+FTS++SA I+ KIEGVAKG+
Sbjct: 296 VVTKVSSPKFFNAFEFISSMSSGFDLSSLFENKRKTGSVFTSKFSAGAIINKIEGVAKGL 355
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NFK+AKVKDFK++L+G EGRKG LSV AEVFEVAPE+A+VEFSKSSGDTLEYAKFCEED
Sbjct: 356 NFKIAKVKDFKVKLQGPLEGRKGQLSVTAEVFEVAPELALVEFSKSSGDTLEYAKFCEED 415
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQ 450
VRPALKDIVWTWQGD +N GEDCE Q
Sbjct: 416 VRPALKDIVWTWQGDTVNG--GEDCEKQ 441
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104079|gb|AEN70861.1| calcineurin B-like protein-interacting protein kinase [Gossypium davidsonii] gi|345104081|gb|AEN70862.1| calcineurin B-like protein-interacting protein kinase [Gossypium klotzschianum] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/452 (78%), Positives = 400/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLFGKYEMGRLLGKGTFAKVYYGK+L TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF ME+V+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEHVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AF+I + D DD+ A ++ T
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFTIQEQID--DDESAPSKST------- 292
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K+SSPKFFNAFEFISSMSSGFDLS +FE+K+K+G+MFTSR SA IM K+E VAKG+
Sbjct: 293 ---KLSSPKFFNAFEFISSMSSGFDLSGMFEDKRKSGTMFTSRCSASAIMSKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V AEVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD+ N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSFNEAEEREKQVQQDTA 441
|
Source: Gossypium davidsonii Species: Gossypium davidsonii Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104083|gb|AEN70863.1| calcineurin B-like protein-interacting protein kinase [Gossypium aridum] gi|345104087|gb|AEN70865.1| calcineurin B-like protein-interacting protein kinase [Gossypium lobatum] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1897), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/452 (78%), Positives = 398/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLFGKYEMGRLLGKGTFAKVYYGK+L TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF MEYV+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEYVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AFSI + D DD+ A ++ T
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPID--DDESAPSKST------- 292
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K SSPKFFNAFEFISSMSSGFDLS +FE K+K+G+MFTSR SA IM K+E VAKG+
Sbjct: 293 ---KPSSPKFFNAFEFISSMSSGFDLSGMFEKKRKSGTMFTSRCSASAIMSKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V AEVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD+ N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSFNEAEEREKQVQEDTA 441
|
Source: Gossypium aridum Species: Gossypium aridum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104047|gb|AEN70845.1| calcineurin B-like protein-interacting protein kinase [Gossypium schwendimanii] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/452 (78%), Positives = 398/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLFGKYEMGRLLGKGTFAKVYYGK++ TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERHVLFGKYEMGRLLGKGTFAKVYYGKEIATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF MEYV+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEYVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AFSI + D DD+ A ++ T
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPID--DDESAPSKST------- 292
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K SSPKFFNAFEFISSMSSGFDLS +FE K+K+G+MFTSR SA IM K+E VAKG+
Sbjct: 293 ---KPSSPKFFNAFEFISSMSSGFDLSGMFEKKRKSGTMFTSRCSASAIMSKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V AEVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD+ N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSFNEAEEREKQVQQDTA 441
|
Source: Gossypium schwendimanii Species: Gossypium schwendimanii Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104075|gb|AEN70859.1| calcineurin B-like protein-interacting protein kinase [Gossypium armourianum] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/452 (78%), Positives = 400/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLFGKYEMGRLLGKGTFAKVYYGK+L TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF ME+V+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEHVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AFSI + D DD+ A ++ T
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPID--DDESAPSKST------- 292
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K+SSPKFFNAFEFISSMSSGFDLS +FE+K+K+G+MFTSR SA IM K+E VAKG+
Sbjct: 293 ---KLSSPKFFNAFEFISSMSSGFDLSGMFEDKRKSGTMFTSRCSASAIMSKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V EVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLLVTTEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD++N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSLNEAEEREKQVQQDTA 441
|
Source: Gossypium armourianum Species: Gossypium armourianum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104053|gb|AEN70848.1| calcineurin B-like protein-interacting protein kinase [Gossypium mustelinum] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/452 (78%), Positives = 399/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLFGKYEMGRLLGKGTFAKVYYGK+L TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF ME+V+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEHVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AFSI + D DD+ A ++ T
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPID--DDESAPSKST------- 292
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K SSPKFFNAFEFISSMSSGFDLS +FE+K+K+G+MFTSR SA IM K+E VAKG+
Sbjct: 293 ---KPSSPKFFNAFEFISSMSSGFDLSGMFEDKRKSGTMFTSRCSASAIMSKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V AEVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD+ N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSFNEAEEREKQVQQDTA 441
|
Source: Gossypium mustelinum Species: Gossypium mustelinum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104045|gb|AEN70844.1| calcineurin B-like protein-interacting protein kinase [Gossypium laxum] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1892), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/452 (78%), Positives = 398/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLFGKYEMGRLLGKGTFAKVYYGK+L TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF MEYV+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEYVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AFSI + D DD+ A ++ T
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPID--DDESAPSKST------- 292
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K SSPKFFNAFEFISSMSSGFDLS +FE K+K+G+MFTSR SA I+ K+E VAKG+
Sbjct: 293 ---KPSSPKFFNAFEFISSMSSGFDLSGMFEKKRKSGTMFTSRCSASAIISKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V AEVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD+ N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSFNEAEEREKQVQEDTA 441
|
Source: Gossypium laxum Species: Gossypium laxum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104063|gb|AEN70853.1| calcineurin B-like protein-interacting protein kinase [Gossypium barbadense var. brasiliense] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/452 (78%), Positives = 399/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLFGKYEMGRLLGKGTFAKVYYGK+L TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF ME+V+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEHVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDE EDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDEKEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AFSI + D DD+ A ++ T
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPID--DDESAPSKST------- 292
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K+SSPKFFNAFEFISSMSSGFDLS LFE+K+K+G+MFTSR SA IM K+E VAKG+
Sbjct: 293 ---KLSSPKFFNAFEFISSMSSGFDLSGLFEDKRKSGTMFTSRCSASAIMSKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V AEVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLFVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD+ N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSFNEAEEHEKQVQQDTA 441
|
Source: Gossypium barbadense var. brasiliense Species: Gossypium barbadense Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345104049|gb|AEN70846.1| calcineurin B-like protein-interacting protein kinase [Gossypium turneri] gi|345104077|gb|AEN70860.1| calcineurin B-like protein-interacting protein kinase [Gossypium harknessii] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/452 (78%), Positives = 401/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EER+VLFGKYEMGRLLGKGTFAKVYYGK+L TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERNVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF ME+V+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEHVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AFSI + D DD+ A ++ T
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSIQEPID--DDESAPSKST------- 292
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K+SSPKFFNAFEFISSMSSGFDLS +FE+K+K+G+MFTSR SA IM K+E VAKG+
Sbjct: 293 ---KLSSPKFFNAFEFISSMSSGFDLSGMFEDKRKSGTMFTSRCSASAIMSKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V AEVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLLVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD++N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSLNEAEEREKQVQQDTA 441
|
Source: Gossypium turneri Species: Gossypium turneri Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145105398|gb|ABP35583.1| CBL-interacting protein kinase [Gossypium hirsutum] gi|324984047|gb|ADY68806.1| CBL-interacting protein kinase [Gossypium hirsutum] gi|345104067|gb|AEN70855.1| calcineurin B-like protein-interacting protein kinase [Gossypium barbadense var. peruvianum] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/452 (78%), Positives = 399/452 (88%), Gaps = 12/452 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
EERHVLFGKYEMGRLLGKGTFAKVYYGK+L TGESVA+KVI+KDQ+KK+ MMEQIKREIS
Sbjct: 2 EERHVLFGKYEMGRLLGKGTFAKVYYGKELATGESVAVKVISKDQVKKKGMMEQIKREIS 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
VMRLVRHPN+VEL+EVMATKKKIF ME+V+GGELFAKV +G+L+E +ARKYFQQLISAV
Sbjct: 62 VMRLVRHPNIVELKEVMATKKKIFFVMEHVRGGELFAKVYKGKLKEHVARKYFQQLISAV 121
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
DFCHSRGVSHRDLKPENLLLDE EDLKISDFGLSALPEQL NDGLLHTQCGTPAYVAPEV
Sbjct: 122 DFCHSRGVSHRDLKPENLLLDEKEDLKISDFGLSALPEQLLNDGLLHTQCGTPAYVAPEV 181
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
LRKKGYDGS+AD+WSCGV+LYVLLAGFLPFQDEN+M MYRKVFKAEF +P W ST++KRL
Sbjct: 182 LRKKGYDGSRADIWSCGVVLYVLLAGFLPFQDENMMKMYRKVFKAEFEFPTWFSTESKRL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
ISKLLV+DPE+RITI +IMR PWFRK FTRP+AFSI + DDD++A K+
Sbjct: 242 ISKLLVADPEKRITIPAIMRDPWFRKEFTRPLAFSI---QEPIDDDESAPSKS------- 291
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVAKGM 362
K+SSPKFFNAFEFISSMSSGFDLS LFE+K+K+G+MFTSR SA IM K+E VAKG+
Sbjct: 292 --AKLSSPKFFNAFEFISSMSSGFDLSGLFEDKRKSGTMFTSRCSASAIMSKVEAVAKGL 349
Query: 363 NFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEED 422
NF+V K KDFK+RL+G SEGRKG L V AEVFEVAPEVAVVEFSKS+GDTLEYAKFCEED
Sbjct: 350 NFRVGKAKDFKMRLQGSSEGRKGRLFVTAEVFEVAPEVAVVEFSKSAGDTLEYAKFCEED 409
Query: 423 VRPALKDIVWTWQGDNINKVEGEDCEMQLSNA 454
VRPALKDIVWTWQGD+ N+ E + ++Q A
Sbjct: 410 VRPALKDIVWTWQGDSFNEAEEHEKQVQQDTA 441
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 459 | ||||||
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.967 | 0.997 | 0.658 | 3.8e-156 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.952 | 0.895 | 0.650 | 2.3e-151 | |
| TAIR|locus:2040219 | 469 | CIPK16 "CBL-interacting protei | 0.947 | 0.927 | 0.584 | 2.1e-132 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.947 | 0.990 | 0.509 | 1.7e-114 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.895 | 0.931 | 0.526 | 3.6e-112 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.978 | 0.937 | 0.484 | 2.1e-109 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.941 | 0.896 | 0.480 | 7.5e-105 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.945 | 0.951 | 0.489 | 5.3e-104 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.910 | 0.992 | 0.493 | 4.7e-103 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.915 | 0.858 | 0.473 | 7.7e-103 |
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1522 (540.8 bits), Expect = 3.8e-156, P = 3.8e-156
Identities = 295/448 (65%), Positives = 345/448 (77%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQ-LKKEFMMEQIKR 59
MEEER VLFGKYEMGRLLGKGTFAKVYYGK+++ GE VAIKVINKDQ +K+ MMEQIKR
Sbjct: 1 MEEERRVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKR 60
Query: 60 EISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLI 119
EIS+M+LVRHPN+VEL+EVMATK KIF ME+VKGGELF K+++G+L ED AR+YFQQLI
Sbjct: 61 EISIMKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISKGKLHEDAARRYFQQLI 120
Query: 120 SAVDFCHSRGVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179
SAVD+CHSRGVSHR ISDFGLSALPEQ+ DGLLHTQCGTPAYVA
Sbjct: 121 SAVDYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVA 180
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDA 239
PEVL+KKGYDG+KAD+WSCGV+LYVLLAG LPFQDEN+MNMYRK+F+A+F +PPW S +A
Sbjct: 181 PEVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEA 240
Query: 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHXXXXXXXQAATEKTENDR 299
+RLISKLLV DP+RRI+I +IMR PW RK FT P+AF I + E+ + D
Sbjct: 241 RRLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEEDGDC 300
Query: 300 HNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVA 359
N Q E +S PKFFNAFEFISSMSSGFDLS+LFE+K+K S+FTSR SA +MEKIE V
Sbjct: 301 EN-QTEPIS-PKFFNAFEFISSMSSGFDLSSLFESKRKVQSVFTSRSSATEVMEKIETVT 358
Query: 360 KGMNFKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKSSGDTLEYAKFC 419
K MN KV + KDFK+++ G +EGRKG LS F KS+GDTLEY +
Sbjct: 359 KEMNMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYDRLY 418
Query: 420 EEDVRPALKDIVWTWQGDNINKVEGEDC 447
EE+VRPAL DIVW+W GDN N EDC
Sbjct: 419 EEEVRPALNDIVWSWHGDN-NNTSSEDC 445
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1477 (525.0 bits), Expect = 2.3e-151, P = 2.3e-151
Identities = 288/443 (65%), Positives = 335/443 (75%)
Query: 1 MEEERH---VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQI 57
MEEE+ VLF KYEMGRLLGKGTF KVYYGK++ TGESVAIK+INKDQ+K+E MMEQI
Sbjct: 29 MEEEQQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQI 88
Query: 58 KREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQ 117
KREIS+MRLVRHPN+VEL+EVMATK KIF MEYVKGGELF+K+ +G+L+ED ARKYFQQ
Sbjct: 89 KREISIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQ 148
Query: 118 LISAVDFCHSRGVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAY 177
LISAVDFCHSRGVSHR +SDFGLSALPEQ+ DGLLHTQCGTPAY
Sbjct: 149 LISAVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAY 208
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWIST 237
VAPEVLRKKGYDG+K D+WSCG+ILYVLLAGFLPFQDEN+M MYRK+FK+EF YPPW S
Sbjct: 209 VAPEVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSP 268
Query: 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHXXXXXXXQAATEKTEN 297
++KRLISKLLV DP +RI+I +IMR PWFRK P+ F I + + T T
Sbjct: 269 ESKRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPT--TTA 326
Query: 298 DRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEG 357
VS PKFFNAFEFISSMSSGFDLS+LFE+K+K SMFTSR+SA IM K+EG
Sbjct: 327 TTATTTTTPVS-PKFFNAFEFISSMSSGFDLSSLFESKRKLRSMFTSRWSASEIMGKLEG 385
Query: 358 VAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKSSGDTLEYAK 417
+ K MN KV + KDFK++L G +EGRKG ++ KS+GDTLEY +
Sbjct: 386 IGKEMNMKVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNR 445
Query: 418 FCEEDVRPALKDIVWTWQGDNIN 440
EE VRPAL++IVW+W GDN N
Sbjct: 446 LYEEHVRPALEEIVWSWHGDNHN 468
|
|
| TAIR|locus:2040219 CIPK16 "CBL-interacting protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1298 (462.0 bits), Expect = 2.1e-132, P = 2.1e-132
Identities = 263/450 (58%), Positives = 323/450 (71%)
Query: 1 MEEERH---VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKEFMMEQ 56
MEE VLF KY +GRLLG G FAKVY+G ++ TG+ VAIKVI KD + K+ MMEQ
Sbjct: 1 MEESNRSSTVLFDKYNIGRLLGTGNFAKVYHGTEISTGDDVAIKVIKKDHVFKRRGMMEQ 60
Query: 57 IKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYF 115
I+REI+VMRL+RHPNVVELREVMATKKKIF MEYV GGELF + R G+L EDLARKYF
Sbjct: 61 IEREIAVMRLLRHPNVVELREVMATKKKIFFVMEYVNGGELFEMIDRDGKLPEDLARKYF 120
Query: 116 QQLISAVDFCHSRGVSHRXXXXXXXXXXXXXXXXISDFGLSAL--PEQL-----RNDGLL 168
QQLISAVDFCHSRGV HR ++DFGLSAL PE L +D LL
Sbjct: 121 QQLISAVDFCHSRGVFHRDIKPENLLLDGEGDLKVTDFGLSALMMPEGLGGRRGSSDDLL 180
Query: 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE 228
HT+CGTPAYVAPEVLR KGYDG+ AD+WSCG++LY LLAGFLPF DEN+M +Y K+FKAE
Sbjct: 181 HTRCGTPAYVAPEVLRNKGYDGAMADIWSCGIVLYALLAGFLPFIDENVMTLYTKIFKAE 240
Query: 229 FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHXXXXXXX 288
+PPW S ++K L+S+LLV DPE+RI++ I +PWFRK FT VAFSI +
Sbjct: 241 CEFPPWFSLESKELLSRLLVPDPEQRISMSEIKMIPWFRKNFTPSVAFSIDE--TIPSPP 298
Query: 289 QAATEKTENDRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSA 348
+ T+K + D N +E+ +SP+ FNAF+FI+SMSSGFDLSNLFE K+K MFTS++ A
Sbjct: 299 EPPTKKKKKDL-NEKEDDGASPRSFNAFQFITSMSSGFDLSNLFEIKRKPKRMFTSKFPA 357
Query: 349 RHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKS 408
+ + E++E A+ M+ +V VKD K++L+ +EGRKG LS F K+
Sbjct: 358 KSVKERLETAAREMDMRVKHVKDCKMKLQRRTEGRKGRLSVTAEVFEVAPEVSVVEFCKT 417
Query: 409 SGDTLEYAKFCEEDVRPALKDIVWTWQGDN 438
SGDTLEY FCE+DVRPALKDIVW+WQGD+
Sbjct: 418 SGDTLEYYLFCEDDVRPALKDIVWSWQGDD 447
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.7e-114, P = 1.7e-114
Identities = 230/451 (50%), Positives = 300/451 (66%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
M++ VL KYE+GRLLG+GTFAKVY+ + + TGESVAIKVI+K ++ K +++QIKRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
ISVMRLVRHP+VV L EVMA+K KI+ AMEYVKGGELF KV++G+L+E++ARKYFQQLI
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AVDFCHSRGVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
A+D+CHSRGV HR ISDFGLSAL E + DGLLHT CGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ KKGYDG+KAD+WSCGV+LYVLLAGFLPF ++N++ MYRK+ K EF P W + K
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTR-PVAFSITQHXXXXXXXQAATEKTENDR 299
+L+S++L +P RI I+ IM WF+KGF + S H + +D
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQI---------DSLISDV 291
Query: 300 HNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEKIEGVA 359
H K P +NAF+ ISS+S GFDLS LFE ++++ S FT++ A+ I+ K E +A
Sbjct: 292 HAAFSVK---PMSYNAFDLISSLSQGFDLSGLFEKEERSESKFTTKKDAKEIVSKFEEIA 348
Query: 360 KGMN-FKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKSSGDTLEYAKF 418
F + K D +++ EGRKG L+ F KS GDT+EY +F
Sbjct: 349 TSSERFNLTK-SDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQF 407
Query: 419 CEEDVRPALKDIVWTWQGDNINKVEGEDCEM 449
C+ ++RP+LKDIVW WQG+N N E E+
Sbjct: 408 CDRELRPSLKDIVWKWQGNN-NNSNNEKIEV 437
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 229/435 (52%), Positives = 292/435 (67%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
+L G+YE+GRLLG GTFAKVY+ + + TG+SVA+KV+ K+++ K M++QIKREISVMR+
Sbjct: 19 LLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRM 78
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
V+HPN+VEL EVMA+K KI+ AME V+GGELFAKVA+GRLRED+AR YFQQLISAVDFCH
Sbjct: 79 VKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCH 138
Query: 127 SRGVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
SRGV HR ++DFGLSA E L+ DGLLHT CGTPAYVAPEV+ KK
Sbjct: 139 SRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKK 198
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKL 246
GYDG+KADLWSCGVIL+VLLAG+LPFQD+N++NMYRK+++ +F P W+S+DA+RL++KL
Sbjct: 199 GYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKL 258
Query: 247 LVSDPERRITIQSIMRVPWFRKGFTR----PVAFSITQHXXXXXXXQAATEKTENDRHNN 302
L +P RITI+ +M PWF+K TR PVA +IT E + H +
Sbjct: 259 LDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATIT----------TTEEDVDFLVHKS 308
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSM---FTSRYSARHIMEKIEGVA 359
+EE + NAF I+ +S GFDLS LFE KKK F + A ++ +E A
Sbjct: 309 KEETET----LNAFHIIA-LSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAA 363
Query: 360 K-GMNFKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKSSGDTLEYAKF 418
+ G F V K + ++R+ G GRKG L+ K GDTLEY F
Sbjct: 364 RVGNKFDVRK-SESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNF 422
Query: 419 CEEDVRPALKDIVWT 433
C +RPALKDI WT
Sbjct: 423 CSTALRPALKDIFWT 437
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 2.1e-109, P = 2.1e-109
Identities = 225/464 (48%), Positives = 291/464 (62%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
ME + VL KY++GRLLG+GTFAKVYYG+ ++T +SVAIK+I+K+++ K ++EQIKRE
Sbjct: 1 MENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKRE 60
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
ISVMR+ RHPNVVEL EVMATK +I+ MEY KGGELF KVA+G+LR+D+A KYF QLI+
Sbjct: 61 ISVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLIN 120
Query: 121 AVDFCHSRGVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
AVDFCHSR V HR +SDFGLSAL + R DGLLHT CGTPAYVAP
Sbjct: 121 AVDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ +KGYDG+KAD+WSCGV+L+VLLAG+LPF D N+M MYRK+ KA+F P W + + +
Sbjct: 181 EVINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVR 240
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGF---TRPVAFSITQHXXXXXXXQAATEK--- 294
RL+ K+L +PE RITI I WFRKG + + + + E
Sbjct: 241 RLLCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 295 --------TENDRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRY 346
+EN +E P NAF+ I+ +S+GFDL+ LF + K S FTS+
Sbjct: 301 PSENGAGPSENGDRVTEENHTDEPTNLNAFDLIA-LSAGFDLAGLFGDDNKRESRFTSQK 359
Query: 347 SARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFS 406
A I+ K+E VA+ + + K + +L EGRKG LS
Sbjct: 360 PASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVK 419
Query: 407 KSSGDTLEYAKFCEEDVRPALKDIVWTWQGDNINKVEGEDCEMQ 450
KS+GDTLEY K ED+RPAL DIVW WQG+ ++ E Q
Sbjct: 420 KSNGDTLEYQKLVAEDLRPALSDIVWVWQGEKDELTSQQETEYQ 463
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
Identities = 212/441 (48%), Positives = 286/441 (64%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
GKYE+GR LG+GTFAKV + + + G++VAIKVI+K+++ K M+ QIKREIS M+L++H
Sbjct: 29 GKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIKH 88
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVA-RGRLREDLARKYFQQLISAVDFCHSR 128
PNV+ + EVMA+K KI+ +E+V GGELF K++ GRL+ED ARKYFQQLI+AVD+CHSR
Sbjct: 89 PNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHSR 148
Query: 129 GVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
GV HR +SDFGLSALP+Q+R DGLLHT CGTP YVAPEV+ KGY
Sbjct: 149 GVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGY 208
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248
DG+KADLWSCGVIL+VL+AG+LPF+D N+ ++Y+K+FKAEF PPW S AK+LI ++L
Sbjct: 209 DGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILD 268
Query: 249 SDPERRITIQSIMRVPWFRKGFTRPVAFSITQHXXXXXXXQAATEKTENDRHNNQEEKVS 308
+P RIT ++ WF+KG+ P + + +++N +EE +
Sbjct: 269 PNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGLK 328
Query: 309 SPKFFNAFEFISSMSSGFDLSNLFENKK---KTGSMFTSRYSARHIMEKIEGVAKGMNFK 365
+P NAFE IS+ S G +L +LFE + K + FTS+ SA I+ KIE A M F
Sbjct: 329 TPVTMNAFELIST-SQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFD 387
Query: 366 VAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKSSGDTLEYAKFCEEDVRP 425
V K ++K++L G+ GRKG L+ KS GDTLE+ KF + ++
Sbjct: 388 V-KTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYK-NLTT 445
Query: 426 ALKDIVWTWQGDNINKVEGED 446
LKDIVW + K EG D
Sbjct: 446 GLKDIVWKTIDEE--KEEGTD 464
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1030 (367.6 bits), Expect = 5.3e-104, P = 5.3e-104
Identities = 216/441 (48%), Positives = 279/441 (63%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
ME + VL +YE+GRLLG+GTFAKVY+G+ T ESVAIK+I+KD++ + + +QIKRE
Sbjct: 1 MENKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKRE 60
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
ISVMR+ +HPNVVEL EVMATK +I+ +EY KGGELF KVA+G+L+ED+A KYF QLIS
Sbjct: 61 ISVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLIS 120
Query: 121 AVDFCHSRGVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
AVDFCHSRGV HR +SDFGLSAL + R DGLLHT CGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ +KGY+G+KAD+WSCGV+L+VLLAG+LPF D N+M MYRK+ KA+F P W + + K
Sbjct: 181 EVINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVK 240
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGF---TRPVAFSITQHXXXXXXXQAATEKTEN 297
RL+ K+L + E RITI I WFRKG + + Q A +N
Sbjct: 241 RLLCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQN 300
Query: 298 DRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENK-KKTGSMFTSRYSARHIMEKIE 356
+ N E + NAF+ I+ +S+GF L+ LF + K S F S+ A I+ K+
Sbjct: 301 ENGENHEPPRLAT--LNAFDIIA-LSTGFGLAGLFGDVYDKRESRFASQKPASEIISKLV 357
Query: 357 GVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKSSGDTLEYA 416
VAK + K+ K +L EG+ G L+ K +GDT+EY
Sbjct: 358 EVAKCLKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQ 417
Query: 417 KFCEEDVRPALKDIVWTWQGD 437
K EED+RPAL DIVW WQG+
Sbjct: 418 KLVEEDLRPALADIVWVWQGE 438
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1021 (364.5 bits), Expect = 4.7e-103, P = 4.7e-103
Identities = 215/436 (49%), Positives = 278/436 (63%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
ME++ VL +YE+G+ LG+GTFAKVY+ + L TG+SVAIKVI+K+++ K M EQIKRE
Sbjct: 1 MEKKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
IS MRL+RHPN+VEL EVMATK KI+ ME+VKGGELF KV+ G+LRED+ARKYFQQL+
Sbjct: 61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKVSTGKLREDVARKYFQQLVR 120
Query: 121 AVDFCHSRGVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
AVDFCHSRGV HR ISDFGLSAL + R DGLLHT CGTPAYVAP
Sbjct: 121 AVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAP 180
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ + GYDG KAD+WSCGVIL+VLLAG+LPF+D N+M +Y+K+ KAE +P W++ AK
Sbjct: 181 EVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAK 240
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHXXXXXXXQA-ATEKTENDR 299
RL+ ++L +P R++ + IM+ WFRKG V S+ + + A+ + E R
Sbjct: 241 RLLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVDAEAEGNASAEKEKKR 300
Query: 300 HNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSM-FTSRYSARHIMEKIEGV 358
N NAFE IS +S+GFDLS LFE ++ M FTS A I EK+ +
Sbjct: 301 CIN----------LNAFEIIS-LSTGFDLSGLFEKGEEKEEMRFTSNREASEITEKLVEI 349
Query: 359 AKGMNFKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKSSGDTLEYAKF 418
K + KV K K+ + R++ +E KS GDT EY +
Sbjct: 350 GKDLKMKVRK-KEHEWRVKMSAEATV----VEAEVFEIAPSYHMVVLKKSGGDTAEYKRV 404
Query: 419 CEEDVRPALKDIVWTW 434
+E +RPAL D V W
Sbjct: 405 MKESIRPALIDFVLAW 420
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 7.7e-103, P = 7.7e-103
Identities = 208/439 (47%), Positives = 280/439 (63%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
++ G+YEMG+LLG GTFAKVY + + T ESVAIKVI+K+++ K ++ IKREIS++R
Sbjct: 21 LILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRR 80
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
VRHPN+V+L EVMATK KI+ MEYV+GGELF KVA+GRL+E++ARKYFQQLISAV FCH
Sbjct: 81 VRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFCH 140
Query: 127 SRGVSHRXXXXXXXXXXXXXXXXISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+RGV HR +SDFGLSA+ +Q+R DGL HT CGTPAYVAPEVL +K
Sbjct: 141 ARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARK 200
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKL 246
GYD +K D+WSCGVIL+VL+AG+LPF D N+M MY+K+++ EF P W ST+ RL+SKL
Sbjct: 201 GYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKL 260
Query: 247 LVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHXX--XXXXXQAATEKTENDRHNNQE 304
L ++PE+R T IM WF+KGF + + F + + ++ E+DR +
Sbjct: 261 LETNPEKRFTFPEIMENSWFKKGF-KHIKFYVEDDKLCNVVDDDELESDSVESDRDSAAS 319
Query: 305 EK-------------VSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHI 351
E + P NAF+ IS S GFDLS LF++ + GS F S I
Sbjct: 320 ESEIEYLEPRRRVGGLPRPASLNAFDIIS-FSQGFDLSGLFDDDGE-GSRFVSGAPVSKI 377
Query: 352 MEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSXXXXXXXXXXXXXXXXFSKSSGD 411
+ K+E +AK ++F V K KD ++ L G +G KGPL+ K GD
Sbjct: 378 ISKLEEIAKVVSFTVRK-KDCRVSLEGSRQGVKGPLTIAAEIFELTPSLVVVEVKKKGGD 436
Query: 412 TLEYAKFCEEDVRPALKDI 430
EY FC +++P L+++
Sbjct: 437 KTEYEDFCNNELKPKLQNL 455
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LEU7 | CIPK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7165 | 0.9673 | 0.9977 | yes | no |
| Q8W1D5 | CIPKP_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7133 | 0.9520 | 0.8954 | no | no |
| Q6ERS4 | CIPKG_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5986 | 0.9281 | 0.9342 | yes | no |
| Q9LWM4 | CIPK5_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5610 | 0.9498 | 0.9457 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK6 | SubName- Full=CBL-interacting protein kinase 6; (451 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 459 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-104 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-94 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-77 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-70 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-69 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-67 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-66 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-65 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-62 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-57 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-56 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-54 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-53 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-53 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-51 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-51 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-49 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-49 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-49 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-49 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-48 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-48 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-47 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-47 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-47 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-46 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 3e-46 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-46 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-45 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-45 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-45 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-45 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-45 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-45 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-45 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-44 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-44 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-44 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-43 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-43 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-42 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-42 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-41 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-41 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-40 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-40 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-40 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-40 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-40 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-39 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-39 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-39 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-38 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-38 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-37 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-37 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-36 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-36 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-36 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-36 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-36 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-36 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-36 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-35 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-35 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-35 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-35 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-35 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-34 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-34 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-34 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-34 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-33 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-33 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-33 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-32 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-32 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-32 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-31 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-31 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-31 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-31 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-30 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-30 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-30 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-30 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-29 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-29 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-28 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-28 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-27 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-27 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-27 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-27 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-26 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-26 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-26 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-25 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-25 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-24 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-24 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-24 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-24 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-23 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-23 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-23 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-22 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-21 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-20 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-20 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-19 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 3e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-05 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 5e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 8e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 5e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.004 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 309 bits (794), Expect = e-104
Identities = 122/260 (46%), Positives = 176/260 (67%), Gaps = 11/260 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE+ LG+G+F KVY + TG+ VAIKVI K ++KK+ E+I REI +++ ++HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRGV 130
+V L +V + K+++ MEY +GG+LF RGRL ED AR Y +Q++SA+++ HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
HRDLKPEN+LLDE+ +K++DFGL+ QL L T GTP Y+APEVL KGY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 191 SKADLWSCGVILYVLLAGFLPFQ-DENIMNMYRKVFKAEFVYPPW---ISTDAKRLISKL 246
D+WS GVILY LL G PF D+ ++ +++K+ K + +PP IS +AK LI KL
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 247 LVSDPERRITIQSIMRVPWF 266
LV DPE+R+T + ++ P+F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 284 bits (729), Expect = 5e-94
Identities = 113/263 (42%), Positives = 157/263 (59%), Gaps = 11/263 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE+ R LG G+F VY K TG+ VA+K++ K K + REI ++R + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
+V L + K +++ MEY +GG+LF ++R G L ED A+K Q++ +++ HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
HRDLKPEN+LLDEN +KI+DFGL+ L++ L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-----EFVYPPWIST--DAKRLI 243
K D+WS GVILY LL G PF ENI++ + + + EF P W S +AK LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 244 SKLLVSDPERRITIQSIMRVPWF 266
K L DP +R T + I++ PWF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 4e-77
Identities = 98/253 (38%), Positives = 155/253 (61%), Gaps = 7/253 (2%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LGKG+F KV ++ TG+ A+KV+ K ++ K +E E +++ + HP +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 78 VMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLK 136
T++K+++ +EY GGELF+ +++ GR E+ AR Y +++ A+++ HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 137 PENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLW 196
PEN+LLD + +K++DFGL+ E +T CGTP Y+APEVL KGY + D W
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDWW 177
Query: 197 SCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRIT 256
S GV+LY +L G PF E+ +Y K+ K +P ++S +A+ LIS LL DP +R+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 257 ---IQSIMRVPWF 266
+ I P+F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 3e-70
Identities = 92/250 (36%), Positives = 136/250 (54%), Gaps = 38/250 (15%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG+G F VY + TG+ VAIK+I K+ ++E++ REI +++ + HPN+V+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58
Query: 78 VMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDL 135
V + +++ MEY +GG L + G+L ED + Q++ +++ HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 136 KPENLLLDENED-LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
KPEN+LLD + +K++DFGLS L + LL T GTPAY+APEVL KGY K+D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
+WS GVILY L + K LI K+L DPE+R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 255 ITIQSIMRVP 264
+ + I+
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 1e-69
Identities = 95/262 (36%), Positives = 155/262 (59%), Gaps = 12/262 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E + LG G+F +V + +G+ A+K+++K ++ K +E + E +++ +RHP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
+V L +++ MEYV GGELF+ + + GR E +AR Y Q++ A+++ HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+RDLKPENLLLD + +KI+DFG + R G +T CGTP Y+APE++ KGY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250
+ D W+ G+++Y +LAG+ PF D+N + +Y K+ + + +P + S DAK LI LL D
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 251 PERRI-----TIQSIMRVPWFR 267
+R+ + I PWF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-67
Identities = 95/261 (36%), Positives = 150/261 (57%), Gaps = 13/261 (4%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+ KG + +V+ K+ TG+ AIKVI K + ++ ++Q+ E ++ + P VV+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 78 VMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLK 136
KK +++ MEY+ GG+L + + G L ED+AR Y +++ A+++ HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 137 PENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ------CGTPAYVAPEVLRKKGYDG 190
P+N+L+D N LK++DFGLS + R L + GTP Y+APEV+ +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP--PWISTDAKRLISKLLV 248
D WS G ILY L G PF E +++ + + +P +S +A LISKLLV
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 249 SDPERRI---TIQSIMRVPWF 266
DPE+R+ +I+ I P+F
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-66
Identities = 90/264 (34%), Positives = 150/264 (56%), Gaps = 18/264 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KYE+ + +GKG+F KVY ++ G+ +K I+ + ++ E E+ +++ + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLNHP 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGR-----LREDLARKYFQQLISAVDFC 125
N+++ E K K+ + MEY GG+L K+ + + E+ +F QL A+ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG-LLHTQCGTPAYVAPEVLR 184
HSR + HRD+KP+N+ L N +K+ DFG+S + L + L T GTP Y++PE+ +
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGIS---KVLSSTVDLAKTVVGTPYYLSPELCQ 176
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI----STDAK 240
K Y+ K+D+WS G +LY L PF+ EN++ + K+ K + YPP I S++ +
Sbjct: 177 NKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPP-IPSQYSSELR 232
Query: 241 RLISKLLVSDPERRITIQSIMRVP 264
L+S LL DPE R +I I++ P
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 210 bits (538), Expect = 3e-65
Identities = 95/279 (34%), Positives = 156/279 (55%), Gaps = 25/279 (8%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHP 70
++ G+++G+G+F+ V K+ T + AIK+++K QL KE ++ +K E V+ RL HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG 129
+++L ++ ++ +EY GEL + + G L E R Y +++ A+++ HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLS------ALPEQLRNDGLLHTQ------------ 171
+ HRDLKPEN+LLD++ +KI+DFG + + PE + D
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY 231
GT YV+PE+L +K G +DLW+ G I+Y +L G PF+ N ++K+ K E+ +
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 232 PPWISTDAKRLISKLLVSDPERRITI----QSIMRVPWF 266
PP DAK LI KLLV DP+ R+ + + P+F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 3e-62
Identities = 81/264 (30%), Positives = 141/264 (53%), Gaps = 12/264 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
++ G LLG+G+F VY TGE +A+K + +E +E ++REI ++ ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59
Query: 71 NVVELR--EVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS 127
N+V E K + + +EYV GG L + + + G+L E + RKY +Q++ + + HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
G+ HRD+K N+L+D + +K++DFG + + + GTP ++APEV+R +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-----VYPPWISTDAKRL 242
Y G AD+WS G + + G P+ + N ++K P +S +AK
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPW--SELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 243 ISKLLVSDPERRITIQSIMRVPWF 266
+ K L DP++R T +++ P+
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-57
Identities = 98/259 (37%), Positives = 138/259 (53%), Gaps = 14/259 (5%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G F +V K + A+K + K + + E I E ++ HP +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 78 VMATKKKIFVAMEYVKGGELF-AKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLK 136
KK I++ MEY GGEL+ RG E AR Y ++ A ++ H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 137 PENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLW 196
PENLLLD N +K+ DFG + ++L++ T CGTP YVAPE++ KGYD S D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 197 SCGVILYVLLAGFLPFQ--DENIMNMYRKVFKAEFV--YPPWISTDAKRLISKLLVSDPE 252
S G++LY LL G PF DE+ M +Y + K +P +I AK LI +LL +PE
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 253 RRI--TIQSIMRV---PWF 266
R+ I + WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 191 bits (485), Expect = 2e-56
Identities = 99/336 (29%), Positives = 151/336 (44%), Gaps = 28/336 (8%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y + R LG+G+F +VY + VA+KV+ K K +E+ REI ++ + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 71 -NVVELREVMATKKKIFVAMEYVKGGELFA----KVARGRLREDLARKYFQQLISAVDFC 125
N+V+L + + +++ MEYV GG L +G L E A Q++SA+++
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 126 HSRGVSHRDLKPENLLLDENED-LKISDFGLSAL----PEQLRNDGLLHTQCGTPAYVAP 180
HS+G+ HRD+KPEN+LLD + +K+ DFGL+ L L T GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 181 EVLR--KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA----------- 227
EVL Y S +D+WS G+ LY LL G PF+ E + + K
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 228 --EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDG 285
P IS A L+ KLL DP+ R++ S + + S DD
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 286 DDDQAATEKTENDRHNNQEEKVSSPKFFNAFEFISS 321
+ + + ++ S + S
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFS 333
|
Length = 384 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 2e-54
Identities = 90/263 (34%), Positives = 149/263 (56%), Gaps = 14/263 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+EMG LG G+F +V K TGE AIK + K ++ K ++ + +E S++ + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
+V + + +++ +E+V GGELF + + GR D+A+ Y +L+ A ++ HS+ +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
+RDLKPENLLLD +K++DFG + +P++ T CGTP Y+APEV++ KG+
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT------FTLCGTPEYLAPEVIQSKGH- 192
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249
G D W+ GV+LY +AG+ PF D+ +Y K+ +P W A+ L+ LL +
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT 252
Query: 250 DPERRI-----TIQSIMRVPWFR 267
D +R+ + + P+F
Sbjct: 253 DHTKRLGTLKGGVADVKNHPYFH 275
|
Length = 329 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 7e-53
Identities = 88/291 (30%), Positives = 147/291 (50%), Gaps = 45/291 (15%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE LG+GT+ VY + TGE VA+K I D ++ + REIS+++ ++HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-REISLLKELKHPN 59
Query: 72 VVELREVMATKKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
+V+L +V+ T++K+++ EY K + G L +L + QL+ + +CHS
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKK---YLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQ-CGTPAYVAPEVL-R 184
+ HRDLKP+N+L++ + LK++DFGL+ A LR +T T Y APE+L
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT----YTHEVVTLWYRAPEILLG 172
Query: 185 KKGYDGSKADLWSCGVILYVLLAG-------------FLPFQ------DENIMNMYR-KV 224
K Y + D+WS G I ++ G F FQ +E+ + +
Sbjct: 173 SKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 225 FKAEF-VYP--------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
+K F +P P + + L+SK+L +P +RI+ + ++ P+F
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 9e-53
Identities = 84/263 (31%), Positives = 146/263 (55%), Gaps = 12/263 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
E + +G GTF +V+ + ++ A+KV+ ++ + + + E V++ V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRGV 130
++ L ++ +++ MEYV GGELF+ + GR Y +++ A+++ HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+RDLKPEN+LLD+ +K++DFG + ++LR+ T CGTP Y+APEV++ KG+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDR--TWTLCGTPEYLAPEVIQSKGH-N 176
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250
D W+ G+++Y +L G+ PF D+N +Y K+ + +P + AK LI KLLV D
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 251 PERRI-----TIQSIMRVPWFRK 268
RR+ + WF+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-51
Identities = 94/259 (36%), Positives = 147/259 (56%), Gaps = 10/259 (3%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
++LGKG+F KV + T E A+KV+ KD + ++ +E E V+ L +HP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L TK ++F MEYV GG+L + R GR E AR Y +++ + F H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD +KI+DFG+ E + T CGTP Y+APE+L + Y +
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPYGPA-V 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W+ GV+LY +LAG PF+ ++ +++ + + E YP W+S +AK ++ L +PE+
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 254 RITI-----QSIMRVPWFR 267
R+ Q I P+FR
Sbjct: 238 RLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-51
Identities = 93/258 (36%), Positives = 148/258 (57%), Gaps = 9/258 (3%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+LLGKGTF KV ++ TG+ A+K++ K+ + + + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVARGRL-REDLARKYFQQLISAVDFCHSRGVSHRD 134
+ T ++ MEY GGELF ++R R+ ED AR Y +++SA+ + HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
LK ENL+LD++ +KI+DFGL E + + + T CGTP Y+APEVL Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
W GV++Y ++ G LPF +++ ++ + E +P +S +AK L++ LL DP++R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 255 I-----TIQSIMRVPWFR 267
+ + IM +F
Sbjct: 238 LGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 5e-51
Identities = 87/263 (33%), Positives = 140/263 (53%), Gaps = 18/263 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+E+ +GKG F +VY + TG+ VAIKVI L+ + E+I EI +++ +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 71 NVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSR 128
N+V+ K ++++ ME+ GG L K L E ++L+ +++ HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
G+ HRD+K N+LL + ++K+ DFGLSA QL + +T GTP ++APEV+ K Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP------WISTDAKRL 242
D KAD+WS G+ L G P+ + M + +FK PP S + K
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPM---KALFKIATNGPPGLRNPEKWSDEFKDF 230
Query: 243 ISKLLVSDPERRITIQSIMRVPW 265
+ K L +PE+R T + +++ P+
Sbjct: 231 LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 91/260 (35%), Positives = 146/260 (56%), Gaps = 11/260 (4%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVE 74
R+LGKG+F KV + +G A+KV+ KD + ++ +E E ++ L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L T ++F ME+V GG+L + + R E AR Y ++ SA+ F H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD K++DFG+ E + N T CGTP Y+APE+L++ Y G
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W+ GV+LY +L G PF+ EN +++ + E VYP W+S DA ++ + +P
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 254 RITI------QSIMRVPWFR 267
R+ ++I+R P+F+
Sbjct: 238 RLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-49
Identities = 103/295 (34%), Positives = 162/295 (54%), Gaps = 18/295 (6%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+LLGKGTF KV ++ +G+ A+K++ K+ + + + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVARGRL-REDLARKYFQQLISAVDFCHSRGVSHRD 134
+ TK ++ MEYV GGELF ++R R+ ED R Y +++SA+D+ HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
LK ENL+LD++ +KI+DFGL E + + + T CGTP Y+APEVL Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
W GV++Y ++ G LPF +++ ++ + + +P +S DAK L+S LL+ DP +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 255 I-----TIQSIMR------VPW---FRKGFTRPVAFSITQHDDDGDDDQAATEKT 295
+ + IMR V W + K P +T D D+ T +T
Sbjct: 238 LGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQT 292
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 107/357 (29%), Positives = 168/357 (47%), Gaps = 62/357 (17%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQI---KREISVMRLVR 68
+E+ +++G+G F +V+ + TG+ A+KV+ K + K QI + E ++
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK---RNQIAHVRAERDILADAD 59
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS 127
P +V+L ++ +++ MEY+ GG+L + R E+ AR Y +L+ A+D H
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSA------LPEQLRNDGLL------------- 168
G HRD+KP+N+L+D + +K++DFGL E ND
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 169 --------HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM 220
++ GTP Y+APEVLR Y D WS GVILY +L GF PF + +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 221 YRKV--FKAEFVYPP--WISTDAKRLISKLLVSDPERRIT-IQSIMRVPWFRKGF----- 270
Y K+ +K +PP +S +A LI +LL DPE R+ + I P+F KG
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFF-KGIDWENL 296
Query: 271 --TRPVAFSI-------TQHDDDGDDDQAATEKTENDRHNNQEEKVSSPKFFNAFEF 318
T+P F T + DD +DD K +D + +K++ K F
Sbjct: 297 RETKP-PFVPELSSPLDTSNFDDFEDD-----KDLSDYLSQNSKKLNKGKQLAFVGF 347
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 4e-49
Identities = 89/241 (36%), Positives = 144/241 (59%), Gaps = 4/241 (1%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+LLGKGTF KV ++ TG A+K++ K+ + + + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVARGRL-REDLARKYFQQLISAVDFCHSRGVSHRD 134
+ T ++ MEY GGELF ++R R+ E+ AR Y +++SA+++ HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
+K ENL+LD++ +KI+DFGL E + + + T CGTP Y+APEVL Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
W GV++Y ++ G LPF +++ ++ + E +P +S +AK L++ LL DP++R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 255 I 255
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 2e-48
Identities = 95/256 (37%), Positives = 141/256 (55%), Gaps = 9/256 (3%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+GKG+F KV ++ T A+K I K + + E +V+ V P +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 78 VMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLK 136
+ +K+++ + ++ GGELF + R GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 137 PENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA-DL 195
PEN+LLD + + DFGL L +++D +T CGTP Y+APE+L GY +KA D
Sbjct: 121 PENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGY--TKAVDW 176
Query: 196 WSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRI 255
W+ GV+LY +L G PF DEN+ MYRK+ + +P DAK L+ LL DP RR+
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236
Query: 256 TI---QSIMRVPWFRK 268
Q I P+F +
Sbjct: 237 GYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-48
Identities = 84/265 (31%), Positives = 137/265 (51%), Gaps = 12/265 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+++ G +G GTF KVY L TGE +A+K I + +++I E+ V+ L++HP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK-TIKEIADEMKVLELLKHP 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRG 129
N+V+ V ++K+++ MEY GG L + GR L E + R Y QL+ + + HS G
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRD+KP N+ LD N +K+ DFG + + + GTPAY+APEV+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAPEVITGG 178
Query: 187 GYDG--SKADLWSCGVILYVLLAGFLPF--QDENIMNMYRKVFKAEFVYPP--WISTDAK 240
G AD+WS G ++ + G P+ D M+ + P +S + K
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238
Query: 241 RLISKLLVSDPERRITIQSIMRVPW 265
+ + L SDP++R T +++ P+
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 8e-48
Identities = 81/268 (30%), Positives = 143/268 (53%), Gaps = 19/268 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLVRH 69
YE+ +GKG+F V ++ G+ + K I+ + KE +Q+ E++++R ++H
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELKH 58
Query: 70 PNVVEL--REVMATKKKIFVAMEYVKGGELF-----AKVARGRLREDLARKYFQQLISAV 122
PN+V R + + + +++ MEY +GG+L K R + E+ + QL+ A+
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 123 DFCHSRGVS-----HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY 177
CH+R HRDLKP N+ LD N ++K+ DFGL+ + + T GTP Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYY 176
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWIS 236
++PE L YD K+D+WS G ++Y L A PF N + + K+ + +F P S
Sbjct: 177 MSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS 235
Query: 237 TDAKRLISKLLVSDPERRITIQSIMRVP 264
++ +I +L DP++R + + ++++P
Sbjct: 236 SELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-47
Identities = 81/259 (31%), Positives = 141/259 (54%), Gaps = 8/259 (3%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y++G L+G+G F VY G L TG+ VAIK I+ +++K+E + I +EI +++ ++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG 129
N+V+ + T +++ +EY + G L + + G E L Y Q++ + + H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLR-NDGLLHTQCGTPAYVAPEVLRKKGY 188
V HRD+K N+L ++ +K++DFG++ +L + GTP ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVAT---KLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMN-MYRKVFKAEFVYPPWISTDAKRLISKLL 247
+ +D+WS G + LL G P+ D N M ++R V P IS + K + +
Sbjct: 177 S-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235
Query: 248 VSDPERRITIQSIMRVPWF 266
DP R T + +++ PW
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 5e-47
Identities = 90/242 (37%), Positives = 133/242 (54%), Gaps = 5/242 (2%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVE 74
+++GKG+F KV K G+ A+KV+ K + K+ + I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L T K++ ++YV GGELF + R R E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLKPEN+LLD + ++DFGL E + + T CGTP Y+APEVLRK+ YD +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-V 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W G +LY +L G PF + MY + P IS A+ L+ LL D +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 254 RI 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 8e-47
Identities = 99/324 (30%), Positives = 167/324 (51%), Gaps = 22/324 (6%)
Query: 16 RLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQL-KKEFMMEQIKREISVMRLVRHPN 71
++LGKG + KV+ +++ TG+ A+KV+ K + + + K E +++ V+HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
+V+L T K+++ +EY+ GGELF + R G ED A Y ++ A++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+RDLKPEN+LLD +K++DFGL E + + HT CGT Y+APE+L + G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250
D WS G ++Y +L G PF EN K+ K + PP+++ +A+ L+ KLL +
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 251 PERRI-----TIQSIMRVPWFR---------KGFTRPVAFSITQHDDDGDDDQAATEKTE 296
P R+ + P+FR + P + +D D T +T
Sbjct: 239 PSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTP 298
Query: 297 NDRHNNQEEKVSSPKFFNAFEFIS 320
D ++ S+ + F F +++
Sbjct: 299 VDSPDDSTLSESANQIFLGFTYVA 322
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 93/242 (38%), Positives = 145/242 (59%), Gaps = 5/242 (2%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+LLGKGTF KV K+ TG A+K++ K+ + + + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVARGRL-REDLARKYFQQLISAVDFCHS-RGVSHR 133
+ T ++ MEY GGELF ++R R+ ED AR Y +++SA+D+ HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK ENL+LD++ +KI+DFGL E +++ + T CGTP Y+APEVL Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W GV++Y ++ G LPF +++ ++ + E +P +S +AK L+S LL DP++
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 254 RI 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-46
Identities = 61/117 (52%), Positives = 79/117 (67%), Gaps = 3/117 (2%)
Query: 314 NAFEFISSMSSGFDLSNLFE--NKKKTGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVKD 371
NAF+ IS +SSG DLS LFE ++ K + FTSR A I+EK+E AK + F+V K K+
Sbjct: 1 NAFDLIS-LSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59
Query: 372 FKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEEDVRPALK 428
++L G GRKG L+V EVFEV P + VVE KS+GDTLEY KF ++ +RP LK
Sbjct: 60 GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 9e-46
Identities = 86/257 (33%), Positives = 136/257 (52%), Gaps = 16/257 (6%)
Query: 20 KGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH-PNVVELREV 78
KG F VY K+ TG+ AIKV+ K + + + +K E ++M + P V +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 79 MATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKP 137
+K +++ MEY+ GG+ + + G L ED A++Y +++ V+ H RG+ HRD+KP
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP 125
Query: 138 ENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWS 197
ENLL+D+ LK++DFGLS RN GTP Y+APE + G D +D WS
Sbjct: 126 ENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVG-DDKMSDWWS 178
Query: 198 CGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTDAKRLISKLLVSDPER 253
G +++ L G+ PF E ++ + +P + S +A LI++LL DP +
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238
Query: 254 RI---TIQSIMRVPWFR 267
R+ Q I P+F+
Sbjct: 239 RLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-45
Identities = 86/262 (32%), Positives = 145/262 (55%), Gaps = 12/262 (4%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVE 74
++LGKG+F KV + T E AIKV+ KD + ++ ++ E ++ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L TK ++F MEYV GG+L ++ R R E +R Y ++ A+ F H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD K++DFG+ E + N T CGTP Y+APE+L++ Y S
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEYGPS-V 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W+ GV++Y ++AG PF+ +N +++ + + +YP W+S +A ++ + +P +
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 254 RI-------TIQSIMRVPWFRK 268
R+ +I + P+F++
Sbjct: 238 RLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 90/265 (33%), Positives = 140/265 (52%), Gaps = 25/265 (9%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+G + +V+ K+ TGE VA+K + K L K + + E ++ + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 78 VMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLK 136
+ +++AMEYV GG+ + G L ED AR Y ++ AVD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 137 PENLLLDENEDLKISDFGLSALPEQLRNDGLL---HTQCGTPAYVAPEVLRKKGYDGSKA 193
PEN L+D + +K++DFGLS G++ ++ G+P Y+APEVLR KGYD +
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYDFT-V 179
Query: 194 DLWSCGVILYVLLAGFLPFQ----DENIMNMYRKVFKAEFVYPPW------ISTDAKRLI 243
D WS G +LY L GF PF +E N+ +K P + +S +A LI
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY--WKETLQRPVYDDPRFNLSDEAWDLI 237
Query: 244 SKLLVSDPERRITIQSIMRVPWFRK 268
+KL+ R +++ I P+F++
Sbjct: 238 TKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 2e-45
Identities = 88/242 (36%), Positives = 132/242 (54%), Gaps = 5/242 (2%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVE 74
+++GKG+F KV K+ G A+KV+ K + K+ I E +V+ + ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L T +K++ ++YV GGELF + R R E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLKPEN+LLD + ++DFGL E + + T CGTP Y+APEVLRK+ YD +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-V 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W G +LY +L G PF ++ MY + P + A L+ LL D R
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 254 RI 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 85/288 (29%), Positives = 146/288 (50%), Gaps = 37/288 (12%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+LLGKG +V+ + TG+ A+KV++K ++ K ++++ E ++ + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 76 REVMATKKKIFVAMEYVKGGELFA---KVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
T+ + + M+Y GGELF + L E++AR Y +++ A+++ H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 133 RDLKPENLLLDENEDLKISDFGLS-------ALPEQ----LRNDGLLHTQ---------- 171
RDLKPEN+LL E+ + +SDF LS + +++
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 172 ------CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF 225
GT Y+APEV+ G+ + D W+ G++LY +L G PF+ N + +
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 226 KAEFVYP--PWISTDAKRLISKLLVSDPERRITIQS----IMRVPWFR 267
K E +P P +S+ A+ LI KLLV DP +R+ + I + P+FR
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-45
Identities = 78/261 (29%), Positives = 148/261 (56%), Gaps = 10/261 (3%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E+ R++GKG F KV ++ T + A+K +NK + ++ + + E +++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
+V L ++ +++ ++ + GG+L + + + E+ + + +++ A+++ HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
HRD+KP+N+LLDE + I+DF ++ ++ D L + GTP Y+APEVL ++GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 191 SKADLWSCGVILYVLLAGFLPFQ--DENIMNMYRKVFK-AEFVYPPWISTDAKRLISKLL 247
D WS GV Y L G P++ I + R + A+ +YP ST+A I+KLL
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 248 VSDPERRI--TIQSIMRVPWF 266
DP++R+ ++ + P+F
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 6e-45
Identities = 87/258 (33%), Positives = 139/258 (53%), Gaps = 18/258 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQ-LKKEFMMEQIKREISVMRLV 67
+E+ R+LG G + KV+ +++ G+ A+KV+ K ++K E + E V+ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 68 RH-PNVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFC 125
R P +V L T K+ + ++YV GGELF + R E R Y +++ A+D
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSAL---PEQLRNDGLLHTQCGTPAYVAPEV 182
H G+ +RD+K EN+LLD + ++DFGLS E+ R ++ CGT Y+APEV
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA----YSFCGTIEYMAPEV 177
Query: 183 LRKKGYDGSKA-DLWSCGVILYVLLAGFLPFQDENIMN----MYRKVFKAEFVYPPWIST 237
+R KA D WS GV+ + LL G PF + N + R++ K++ +P +S
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237
Query: 238 DAKRLISKLLVSDPERRI 255
+A+ I KLL DP++R+
Sbjct: 238 EARDFIQKLLEKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 7e-45
Identities = 74/259 (28%), Positives = 135/259 (52%), Gaps = 12/259 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+++ + LGKG++ VY K+L + A+K ++ + ++ + + EI ++ V HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGR-----LREDLARKYFQQLISAVDFCH 126
++ +E K+ + MEY G+L +++ + + E + F QL+ + H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ + HRDLK N+LL N+ +KI D G+S + ++ + TQ GTP Y+APEV + +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISK 245
Y K+D+WS G +LY + PF+ ++ ++ KV + ++ PP S D + I
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 246 LLVSDPERRITIQSIMRVP 264
+L P+ R I+ P
Sbjct: 236 MLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 4e-44
Identities = 95/255 (37%), Positives = 146/255 (57%), Gaps = 6/255 (2%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
++LGKG+F KV + T E AIK + KD + ++ +E E V+ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L TK+ +F MEY+ GG+L + + GR E AR Y ++I + F H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD++ +KI+DFG+ E + +G T CGTP Y+APE+L+ + Y+ S
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYNES-V 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D WS GV+LY +L G PF E+ ++ + +P WIS +AK +SKL DP +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 254 RITIQSIMRV-PWFR 267
R+ + +R P+FR
Sbjct: 238 RLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 91/257 (35%), Positives = 145/257 (56%), Gaps = 8/257 (3%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
++LGKG+F KV+ + T + AIK + KD + + +E E V+ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYF--QQLISAVDFCHSRGVSH 132
L TK+ +F MEY+ GG+L + + DL R F ++I + F HS+G+ +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 133 RDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSK 192
RDLK +N+LLD + +KI+DFG+ E + D T CGTP Y+APE+L + Y +
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTS 176
Query: 193 ADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPE 252
D WS GV+LY +L G PF + +++ + YP W++ +AK ++ KL V +PE
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPE 236
Query: 253 RRITIQSIMRV-PWFRK 268
RR+ ++ +R P+FR+
Sbjct: 237 RRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 6e-44
Identities = 85/293 (29%), Positives = 131/293 (44%), Gaps = 48/293 (16%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIK----REISVMRLV 67
Y+ +G+GT+ VY + +TGE VAIK ++K F E I REI +++ +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK-----KIKLRFESEGIPKTALREIKLLKEL 55
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGR---LREDLARKYFQQLISAVDF 124
HPN+++L +V K +++ E++ K+ + R L E L + Y QL+ + F
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT-QCGTPAYVAPEVL 183
CHS G+ HRDLKPENLL++ LK++DFGL+ + +T T Y APE+L
Sbjct: 114 CHSHGILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYTHYVVTRWYRAPELL 170
Query: 184 RKKGYDGSKADLWSCGVILYVLLAG--FLP---------------------FQDENIMNM 220
+ D+WS G I LL+ P +
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 221 YRKVFKAEFVYP-------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
F P S A L+S++L DP +RIT + + P+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 97/305 (31%), Positives = 175/305 (57%), Gaps = 30/305 (9%)
Query: 16 RLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLK-KEFMMEQIKREISVMRLVRHPN 71
++LG+G+F KV+ +++ G+ A+KV+ K LK ++ + +++R+I V HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPF 59
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRL-REDLARKYFQQLISAVDFCHSRGV 130
+V+L T+ K+++ +++++GG+LF ++++ + E+ + Y +L A+D HS G+
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+RDLKPEN+LLDE +K++DFGLS E + ++ ++ CGT Y+APEV+ ++G+
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 191 SKADLWSCGVILYVLLAGFLPFQDEN---IMNMYRKVFKAEFVYPPWISTDAKRLISKLL 247
S AD WS GV+++ +L G LPFQ ++ M M + KA+ P ++S +A+ L+ L
Sbjct: 178 S-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---ILKAKLGMPQFLSPEAQSLLRALF 233
Query: 248 VSDPERRI-----TIQSIMRVPWF---------RKGFTRPVAFSITQHDDDGDDDQAATE 293
+P R+ ++ I R P+F R+ P ++ + DD D T
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTS 293
Query: 294 KTEND 298
+T D
Sbjct: 294 RTPKD 298
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 7e-43
Identities = 87/242 (35%), Positives = 133/242 (54%), Gaps = 5/242 (2%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVE 74
+++GKG+F KV + + A+KV+ K + K+ + I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L T K++ ++Y+ GGELF + R R E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLKPEN+LLD + ++DFGL E + ++G T CGTP Y+APEVL K+ YD +
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT-V 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W G +LY +L G PF N MY + P I+ A+ L+ LL D +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 254 RI 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 1e-42
Identities = 98/295 (33%), Positives = 153/295 (51%), Gaps = 18/295 (6%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVE 74
+++GKG+F KV K+ + G+ A+KV+ K + + I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L T +K++ +++V GGELF + R R E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLKPEN+LLD + ++DFGL E + T CGTP Y+APEV+RK+ YD +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-V 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W G +LY +L G PF ++ MY + V P S A ++ +LL D +R
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 254 RITIQ----SIMRVPWF---------RKGFTRPVAFSITQHDDDGDDDQAATEKT 295
R+ + I P+F +K P ++ DD + D TE+T
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEET 292
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 88/293 (30%), Positives = 137/293 (46%), Gaps = 44/293 (15%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE +G+GT+ +VY + TGE VA+K I + K+ F + I REI +++ +RHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI-REIKLLQKLRHPN 59
Query: 72 VVELREVMATKKK--IFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVDFC 125
+V L+E++ +K K I++ EY+ G + E + Y +QL+ + +
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG---LLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR- 184
HS G+ HRD+K N+L++ + LK++DFGL A P RN + T Y PE+L
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA----------EFVYPPW 234
Y G + D+WS G IL L G FQ + K+F+ PW
Sbjct: 176 ATRY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234
Query: 235 ---------------------ISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
I A L+ KLL DP++RI+ ++ +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 77/260 (29%), Positives = 140/260 (53%), Gaps = 10/260 (3%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIK---VINKDQLKKEFMMEQIKREISVMRLV 67
++ G LLG G+F VY G L G+ A+K + + Q +E ++Q+++EI+++ +
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQE-AVKQLEQEIALLSKL 59
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCH 126
+HPN+V+ + +++ +E V GG L + + G E + R Y +Q++ +++ H
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
R HRD+K N+L+D N +K++DFG++ +Q+ + G+P ++APEV+ ++
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPF-QDENIMNMYRKV-FKAEFVYPPWISTDAKRLIS 244
G G AD+WS G + + G P+ Q E + +++ K P +S +AK I
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236
Query: 245 KLLVSDPERRITIQSIMRVP 264
K L DP R T ++ P
Sbjct: 237 KCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 87/297 (29%), Positives = 135/297 (45%), Gaps = 51/297 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIK----REISVMRL 66
+YE G+ LG+GT+A VY + TG VAIK I + K+ + I REI +++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA--KDGINFTALREIKLLQE 58
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLA--RKYFQQLISAVDF 124
++HPN++ L +V K I + E++ +L + + A + Y + +++
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAPE 181
HS + HRDLKP NLL+ + LK++DFGL+ P + + Q T Y APE
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-----NRKMTHQVVTRWYRAPE 172
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAG--FLP-----------FQ------DENIMNMYR 222
+L + G D+WS G I LL FLP F+ +EN +
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 223 ------------KVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
K F P S DA L+ +LL +P +RIT + + P+F
Sbjct: 233 LPDYVEFKPFPPTPLKQIF---PAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 9e-42
Identities = 84/259 (32%), Positives = 137/259 (52%), Gaps = 10/259 (3%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KYE R++G+G F V+ ++ + V IK I +Q+ K+ + E V++L+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHP 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGG---ELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
N++E E K + + MEY GG E K L ED +F Q++ A+ H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 128 RGVSHRDLKPENLLLDENED-LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ + HRDLK +N+LLD+++ +KI DFG+S + L + +T GTP Y++PE+ K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGIS---KILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLISK 245
Y+ K+D+W+ G +LY L + F+ N+ + K+ F S D ++LI
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 246 LLVSDPERRITIQSIMRVP 264
+L DP +R + IM P
Sbjct: 236 MLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 75/265 (28%), Positives = 139/265 (52%), Gaps = 16/265 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y+ +G+G +VY TG+ VAIK + + E I EI +M+ +HP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN----KELIINEILIMKDCKHP 75
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSR 128
N+V+ + +++V MEY+ GG L + R+ E ++++ +++ HS+
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSAL--PEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
V HRD+K +N+LL ++ +K++DFG +A E+ + ++ GTP ++APEV+++K
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRK 191
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVFKA--EFVYPPWISTDAKRLI 243
Y K D+WS G++ + G P+ E + ++ K P S + K +
Sbjct: 192 DYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250
Query: 244 SKLLVSDPERRITIQSIMRVPWFRK 268
+K LV DPE+R + + +++ P+ +K
Sbjct: 251 NKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 93/296 (31%), Positives = 137/296 (46%), Gaps = 51/296 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK--EFMMEQIKREISVMRLVR 68
+Y++ +G+G V+ K TGE+VA+K + L++ + Q REI ++ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA---LRRLEGGIPNQALREIKALQACQ 57
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGR---LREDLARKYFQQLISAVDFC 125
HP VV+L +V + MEY+ ++V R L E + Y + L+ V +
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMPSD--LSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSAL--PEQLRNDGLLHTQCGTPAYVAPEVL 183
H+ G+ HRDLKP NLL+ + LKI+DFGL+ L E+ R L Q T Y APE+L
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR---LYSHQVATRWYRAPELL 172
Query: 184 ---RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-----EFVYP--- 232
RK YD DLW+ G I LL G F EN + VF+ E +P
Sbjct: 173 YGARK--YDPG-VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 233 ----------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P S +A L+ LLV DP +R++ +R P+F
Sbjct: 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 5e-41
Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 24/272 (8%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE+ ++G G A VY L E VAIK I+ ++ + ++++++E+ M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPN 60
Query: 72 VVELREVMATKKKIFVAMEYVKGGELF----AKVARGRLREDLARKYFQQLISAVDFCHS 127
VV+ ++++ M Y+ GG L + RG L E + ++++ +++ HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ--LRNDGLLHTQCGTPAYVAPEVL-R 184
G HRD+K N+LL E+ +KI+DFG+SA R + T GTP ++APEV+ +
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF-KAEFVYPPWISTDA---- 239
GYD KAD+WS G+ L G P+ M KV PP + T A
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPM----KVLMLTLQNDPPSLETGADYKK 235
Query: 240 -----KRLISKLLVSDPERRITIQSIMRVPWF 266
+++IS L DP +R T + +++ +F
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 88/256 (34%), Positives = 146/256 (57%), Gaps = 15/256 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQL-KKEFMMEQIKREISVMRLV 67
+E+ ++LG G + KV+ +++ TG+ A+KV+ K L +K +E + E +V+ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 68 RH-PNVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFC 125
R P +V L T+ K+ + ++YV GGE+F + R ED R Y ++I A++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSA--LPEQLRNDGLLHTQCGTPAYVAPEVL 183
H G+ +RD+K EN+LLD + ++DFGLS L E+ ++ CGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN----MYRKVFKAEFVYPPWISTDA 239
R KG G D WS G++++ LL G PF E N + R++ K + +P +I +A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 240 KRLISKLLVSDPERRI 255
+ L+ KLL DP++R+
Sbjct: 239 QDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 100/334 (29%), Positives = 165/334 (49%), Gaps = 40/334 (11%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE----FMMEQIKREISVMRLV 67
+++ +++G+G F +V + + + A+K+++K ++ K F E+ R+I M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE--RDI--MAHA 100
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
+V+L K +++ MEY+ GG+L ++ + E AR Y +++ A+D HS
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHS 160
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH--TQCGTPAYVAPEVLRK 185
G HRD+KP+N+LLD++ LK++DFG ++ +G++ T GTP Y++PEVL+
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 186 KGYD---GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF--KAEFVYP--PWISTD 238
+G D G + D WS GV LY +L G PF ++++ Y K+ K +P IS
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277
Query: 239 AKRLISKLLVSDPER--RITIQSIMRVPWFR---------KGFTRPVAFSITQHDDDGDD 287
AK LI L R R + I P+F+ + PV + D
Sbjct: 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPEL-----SSDI 332
Query: 288 DQAATEKTENDRHNNQEEKVSSPKFF--NAFEFI 319
D + + E+D N EE PK F N FI
Sbjct: 333 DTSNFDDIEDDDKN--EETFPLPKAFAGNQLPFI 364
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 86/261 (32%), Positives = 138/261 (52%), Gaps = 18/261 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E +L+ G + VY + T + A+K INK L ++Q+ E ++ +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
VV + TK+ + + MEYV+GG+ + G L D+AR YF + + A+++ H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL------------LHTQ-CGTPAY 177
HRDLKP+NLL+ +K++DFGLS + L L Q CGTP Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW--- 234
+APEV+ ++GY G D W+ G+ILY L G +PF + ++ +V + +P
Sbjct: 183 IAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 235 ISTDAKRLISKLLVSDPERRI 255
+ DA+ LIS+LL +P R+
Sbjct: 242 LPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 82/270 (30%), Positives = 143/270 (52%), Gaps = 17/270 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+++ L+G+G F +V ++ TG+ A+KV+ K L + + + E ++ + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRG 129
+ +L+ K +++ MEY GG+L + + R + ED+A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ--CGTPAYVAPEVLR--- 184
HRD+KPEN+L+D +K++DFG +A +L + +++++ GTP Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 185 --KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV--FKAEFVYP--PWISTD 238
KG G + D WS GVI Y ++ G PF + Y + F+ +P P +S+D
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRK 268
LI LL + R+ + + P+F K
Sbjct: 240 FLDLIQSLLCG-QKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 8e-40
Identities = 83/263 (31%), Positives = 127/263 (48%), Gaps = 21/263 (7%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQI--------KREISVMRLVRH 69
LG+G F KV + TGE AIK LKK ++ + KR RH
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKA-----LKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
P +V L T+ + MEY GG+L + E A Y ++ + + H
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
+ +RDLK +NLLLD +KI+DFGL E + T CGTP ++APEVL + Y
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249
+ D W GV++Y +L G PF ++ ++ + E YP ++S +A ++ +LL
Sbjct: 180 RA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238
Query: 250 DPERRI-----TIQSIMRVPWFR 267
+PERR+ + + + P+FR
Sbjct: 239 NPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 80/264 (30%), Positives = 135/264 (51%), Gaps = 15/264 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+ + +GKG+F +VY T + VAIKVI+ ++ + E +E I++EI + R P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
+ + K+++ MEY GG + G+L E ++++ +++ H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVAPEVLRKKGYD 189
HRD+K N+LL E D+K++DFG+S QL + +T GTP ++APEV+++ GYD
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-----WISTDAKRLIS 244
KAD+WS G+ L G P D + M + + K PP S K +S
Sbjct: 177 -EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKDFVS 232
Query: 245 KLLVSDPERRITIQSIMRVPWFRK 268
L DP+ R + + +++ + +K
Sbjct: 233 LCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-39
Identities = 86/255 (33%), Positives = 140/255 (54%), Gaps = 6/255 (2%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
++LGKG+F KV + GE A+K + KD + + +E E V+ L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVA-RGRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L TK+ +F ME++ GG+L + +GR A Y +++ + F HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N++LD + +KI+DFG+ E + D T CGTP Y+APE+L+ Y S
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-V 177
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D WS GV+LY +L G PF ++ ++ + YP WI+ ++K ++ KL DP R
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 254 RITIQSIMRV-PWFR 267
R+ + +R P+F+
Sbjct: 238 RLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 85/244 (34%), Positives = 137/244 (56%), Gaps = 9/244 (3%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQL--KKEFMMEQIKREISVMRLVRH-PNVVE 74
+GKGTF +VY ++ T A+KV++K ++ KKE +R I V L+ P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L+ T +++ +Y+ GGELF + + GR ED A+ Y +L+ A++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV-LRKKGYDGSK 192
DLKPEN+LLD + + DFGLS L ++ +T CGT Y+APEV L +KGY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 193 ADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-WISTDAKRLISKLLVSDP 251
D WS GV+++ + G+ PF E+ MYR + + +P +S + ++ + LL +P
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 252 ERRI 255
+ R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 6e-39
Identities = 89/301 (29%), Positives = 144/301 (47%), Gaps = 48/301 (15%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINK-DQLKKEFMMEQIKREISVMRLVRHP 70
+E +++G+G F +V ++ TG A+K + K + L+KE + ++ E ++ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKE-QVAHVRAERDILAEADNP 61
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG 129
VV+L + +++ MEY+ GG++ + + E+ R Y + I A+D H G
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSA-------------LPEQLRNDGLLHTQ----- 171
HRD+KP+NLLLD +K+SDFGL L L ++ L
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 172 ------------------CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ 213
GTP Y+APEV + GY + D WS GVI+Y +L G+ PF
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFC 240
Query: 214 DENIMNMYRKV--FKAEFVYPP--WISTDAKRLISKLLVSDPERRI---TIQSIMRVPWF 266
+N YRK+ +K +P +S +AK LI +L + ERR+ + I P+F
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFF 299
Query: 267 R 267
+
Sbjct: 300 K 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 74/261 (28%), Positives = 139/261 (53%), Gaps = 7/261 (2%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME--QIKREISVMRLVRH 69
+ G+LLG+G F +VY + TG +A+K + D E E ++ EI +++ ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSR 128
+V+ + + + + MEY+ GG + ++ A G L E + RKY +Q++ V++ HS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG-LLHTQCGTPAYVAPEVLRKKG 187
+ HRD+K N+L D ++K+ DFG S + + + G + + GTP +++PEV+ +G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--AEFVYPPWISTDAKRLISK 245
Y G KAD+WS G + +L P+ + M K+ P +S DA+ + +
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 246 LLVSDPERRITIQSIMRVPWF 266
V + ++R + + ++R +
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 7e-38
Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 44/285 (15%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG+GT+A VY G+ TGE VA+K I+ D +E REIS+M+ ++H N+V L +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 78 VMATKKKIFVAMEYVKGG---ELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
V+ T+ K+ + EY+ + RG L + + + QL+ + FCH V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGL----LHTQCGTPAYVAPEVLRKKGYDG 190
LKP+NLL+++ +LK++DFGL+ R G+ + T Y AP+VL
Sbjct: 126 LKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK-----AEFVYP------------- 232
+ D+WS G I+ ++ G F N + K+F+ E +P
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239
Query: 233 -----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P L+ +LL +PE RI+ ++ PWF
Sbjct: 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-38
Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 32/273 (11%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
E ++LG+G+ VY + TG+ A+K I+ D E +Q+ RE+ +R P V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCESPYV 61
Query: 73 VELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKY-----------FQQLISA 121
V+ + +I + +EY+ GG L DL +K +Q++
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSL----------ADLLKKVGKIPEPVLAYIARQILKG 111
Query: 122 VDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
+D+ H+ R + HRD+KP NLL++ ++KI+DFG+S + E +T GT Y++P
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFVGTVTYMSP 169
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN----MYRKVFKAEFVYPP-WI 235
E ++ + AD+WS G+ L G PF + M P
Sbjct: 170 ERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228
Query: 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
S + + IS L DP++R + +++ P+ +K
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 84/263 (31%), Positives = 140/263 (53%), Gaps = 13/263 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLVRH 69
+YE+ + +G+G+F K+Y K E IK I+ ++ KE E K+E+ ++ ++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE--KEASKKEVILLAKMKH 58
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGR---LREDLARKYFQQLISAVDFCH 126
PN+V ++F+ MEY GG+L ++ R R ED +F Q+ + H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 127 SRGVSHRDLKPENLLLDENEDL-KISDFGLSALPEQLRNDGLLHTQC-GTPAYVAPEVLR 184
R + HRD+K +N+ L +N + K+ DFG++ QL + L C GTP Y++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLI 243
+ Y+ +K D+WS G +LY L PF+ N+ + K+ + F P S D + LI
Sbjct: 176 NRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234
Query: 244 SKLLVSDPERRITIQSIMRVPWF 266
S+L P R +I SI++ P+
Sbjct: 235 SQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 87/291 (29%), Positives = 133/291 (45%), Gaps = 37/291 (12%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
KYE+ ++G+G + V + TGE VAIK K+ E + + RE+ V+R +RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRH 59
Query: 70 PNVVELREVMATKKKIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
N+V L+E K ++++ EYV+ EL G L D R Y QL+ A+ +CHS
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHS 118
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
+ HRD+KPEN+L+ E+ LK+ DFG A + R L T Y APE+L
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDEN-------IMNMYRKVFKA------------- 227
G D+W+ G I+ LL G F ++ I + +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 228 ------------EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
E YP +S+ A + L DP+ R+T +++ P+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 4e-37
Identities = 87/292 (29%), Positives = 135/292 (46%), Gaps = 46/292 (15%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF--MMEQIK-REI-SVMRLV 67
Y++ + LG GTF VY + TGE VAIK ++KK+F E + RE+ S+ +L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK-----KMKKKFYSWEECMNLREVKSLRKLN 55
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLISAVDFC 125
HPN+V+L+EV +++ EY++G +L E + R Q++ +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK 185
H G HRDLKPENLL+ E +KI+DFGL+ ++R+ T Y APE+L +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLA---REIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLP-FQDENIMNMYRKVF------------------- 225
S D+W+ G I+ L P F + ++ K+
Sbjct: 173 STSYSSPVDIWALGCIM-AELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231
Query: 226 KAEFVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
K F +P P S +A LI +L DP++R T ++ P+F
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 80/241 (33%), Positives = 132/241 (54%), Gaps = 5/241 (2%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN-VVEL 75
+LGKG+F KV ++ T E AIK++ KD + ++ +E E V+ L P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
T +++ MEYV GG+L + + G+ +E A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
LK +N++LD +KI+DFG+ E + T CGTP Y+APE++ + Y S D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS-VD 183
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
W+ GV+LY +LAG PF E+ +++ + + YP +S +A + LL P +R
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
Query: 255 I 255
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 74/265 (27%), Positives = 131/265 (49%), Gaps = 13/265 (4%)
Query: 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK---EFMMEQIKREISVMRLVRHPN 71
G+ LG G F+ Y + + TG +A+K + + E ++E +++EI +M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
++ + + +E++ GG + +++ G +E + Y +QL+ + + H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 131 SHRDLKPENLLLDEN-EDLKISDFGLSA-LPEQLRNDGLLHTQ-CGTPAYVAPEVLRKKG 187
HRD+K NLL+D + L+I+DFG +A L + G Q GT A++APEVLR +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK-AEFVYPPWI----STDAKRL 242
Y G D+WS G ++ + P+ E N +FK A P I S + +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 243 ISKLLVSDPERRITIQSIMRVPWFR 267
+ L PE R + +++ P FR
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 86/274 (31%), Positives = 143/274 (52%), Gaps = 23/274 (8%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVIN-KDQLKKEFMMEQIKREISVMRLVRH 69
KY +G+G VY + TG+ VAIK +N + Q KKE I EI VMR +H
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL----IINEILVMRENKH 75
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
PN+V + +++V MEY+ GG L V + E ++ + A++F HS
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSA--LPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
V HRD+K +N+LL + +K++DFG A PEQ + T GTP ++APEV+ +K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKA 191
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF------KAEFVYPPWISTDAKR 241
Y G K D+WS G++ ++ G P+ +EN + R ++ E P +S +
Sbjct: 192 Y-GPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGTPELQNPEKLSAIFRD 247
Query: 242 LISKLLVSDPERRITIQSIMRVPWFRKGFTRPVA 275
+++ L D E+R + + +++ P+ + +P++
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK--IAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 100/327 (30%), Positives = 166/327 (50%), Gaps = 26/327 (7%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE+ +++G+G F +V + T + A+K+++K ++ K E +M P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVS 131
VV+L + +++ MEY+ GG+L ++ + E AR Y +++ A+D HS G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH--TQCGTPAYVAPEVLRKK--- 186
HRD+KP+N+LLD++ LK++DFG ++ +G++ T GTP Y++PEVL+ +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF--KAEFVYP--PWISTDAKRL 242
GY G + D WS GV LY +L G PF ++++ Y K+ K +P IS +AK L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281
Query: 243 ISKLLVSDPERRI---TIQSIMRVPWFRKG-----FTRPVAFSITQHDDDGDDDQAATEK 294
I L +D E R+ ++ I R +F+ R + D D D + +
Sbjct: 282 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP-DLSSDIDTSNFDD 339
Query: 295 TENDRHNNQEEKVSSPKFF--NAFEFI 319
E D+ +EE PK F N F+
Sbjct: 340 IEEDK--GEEETFPIPKAFVGNQLPFV 364
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 76/269 (28%), Positives = 144/269 (53%), Gaps = 20/269 (7%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
L+ + E+ +G+G + VY GK + TG VA+K+IN D + + I+RE++++ +
Sbjct: 2 LYQRLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQL 56
Query: 68 RH---PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
R PN+ + ++++ MEY +GG + + G + E ++++ A+ +
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
H GV HRD+K N+L+ ++K+ DFG++AL Q N T GTP ++APEV+
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEVIT 174
Query: 185 K-KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI-----STD 238
+ K YD +KAD+WS G+ +Y + G P+ D + + K++ PP + S
Sbjct: 175 EGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKL 230
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFR 267
+ ++ L +P+ R++ + +++ W +
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 93/268 (34%), Positives = 135/268 (50%), Gaps = 40/268 (14%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
YE+ + +G GT+ VY + + TGE VAIKVI K + +F E I++EIS+++ RHP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDF--EIIQQEISMLKECRHP 60
Query: 71 NVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSR 128
N+V + K+++ MEY GG L +V RG L E ++ + + + H
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQL------RNDGLLHTQCGTPAYVAPEV 182
G HRD+K N+LL E+ D+K++DFG+SA QL R + GTP ++APEV
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA---QLTATIAKRK-----SFIGTPYWMAPEV 172
Query: 183 L---RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN----MYRKVFKAEFVYPP-- 233
RK GYDG K D+W+ G+ L P D + M + + F PP
Sbjct: 173 AAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-----PPKL 226
Query: 234 -----WISTDAKRLISKLLVSDPERRIT 256
W S I K L DP++R T
Sbjct: 227 KDKEKW-SPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 80/241 (33%), Positives = 136/241 (56%), Gaps = 5/241 (2%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVEL 75
+LGKG+F KV ++ T E AIK++ KD + ++ +E E V+ L + P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
T +++ MEYV GG+L ++ + GR +E A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
LK +N++LD +KI+DFG+ E + + T CGTP Y+APE++ + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
W+ GV+LY +LAG PF+ E+ +++ + + YP +S +A + L+ P +R
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243
Query: 255 I 255
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 75/267 (28%), Positives = 141/267 (52%), Gaps = 17/267 (6%)
Query: 15 GRLLGKGTFAKVYYGKQLMTGESVAIK-------VINKDQLKKEFMMEQIKREISVMRLV 67
G L+GKGT+ +VY + TGE +A+K + + +++ M++ ++ EI ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCH 126
H N+V+ T++ + + +EYV GG + + + GR E L R + +Q++ + + H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV--LR 184
S+G+ HRDLK +NLL+D + KISDFG+S + + ++ + G+ ++APEV
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP------PWISTD 238
+GY K D+WS G ++ + AG P+ DE + K+ P +S
Sbjct: 186 SQGYSA-KVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPW 265
A ++ +P+ R T + +++ P+
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 76/261 (29%), Positives = 141/261 (54%), Gaps = 14/261 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY + +G+G+F K K G+ IK IN ++ + E+ ++E++V+ ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHP 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGR---LREDLARKYFQQLISAVDFCHS 127
N+V+ +E +++ M+Y +GG+L+ K+ R ED +F Q+ A+ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC-GTPAYVAPEVLRKK 186
R + HRD+K +N+ L ++ +K+ DFG++ + L + L C GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARV---LNSTVELARTCIGTPYYLSPEICENR 176
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP---WISTDAKRLI 243
Y+ +K+D+W+ G +LY + F+ N+ N+ K+ + YPP S D + L+
Sbjct: 177 PYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YPPVSSHYSYDLRNLV 233
Query: 244 SKLLVSDPERRITIQSIMRVP 264
S+L +P R ++ SI+
Sbjct: 234 SQLFKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 79/258 (30%), Positives = 134/258 (51%), Gaps = 13/258 (5%)
Query: 16 RLLGKGTFAKVYYGK-QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVE 74
R LG G+F +V + VAIK K ++ K+ ++ + E ++ + HP V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARG-RLREDLARKYFQQLISAVDFCHSRGVSHR 133
L + +++ +E+V GGE F + R R D+ Y Q++ ++ S + +R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLKPENLLLD++ +K++DFG + + + +T CGTP Y+APE+L G+ G A
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGH-GKAA 209
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W+ G+ +Y +L G PF + +Y+K+ + +P ++ + K L+ KLL D +
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTK 269
Query: 254 RI-----TIQSIMRVPWF 266
R Q++ PWF
Sbjct: 270 RYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 80/251 (31%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
R++G+G++AKV + T A+KVI K+ + + ++ ++ E V HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L T+ ++F +E+V GG+L + R R L E+ AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD +K++D+G+ E +R T CGTP Y+APE+LR + Y S
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 177
Query: 194 DLWSCGVILYVLLAGFLPF-----QDENIMN----MYRKVFKAEFVYPPWISTDAKRLIS 244
D W+ GV+++ ++AG PF D N +++ + + + P +S A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 245 KLLVSDPERRI 255
L DP+ R+
Sbjct: 238 GFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 74/256 (28%), Positives = 137/256 (53%), Gaps = 13/256 (5%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+G+ V TG VA+K ++ L+K+ E + E+ +MR +HPN+VE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 78 VMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKP 137
+++V ME+++GG L V R+ E+ ++ A+ F H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 138 ENLLLDENEDLKISDFGLSA-LPEQL-RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADL 195
+++LL + +K+SDFG A + +++ R L+ GTP ++APEV+ + Y G++ D+
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPY-GTEVDI 198
Query: 196 WSCGVILYVLLAGFLPFQDE---NIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPE 252
WS G+++ ++ G P+ +E M R + +S + + ++LV DP
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPA 258
Query: 253 RRITIQSIMRVPWFRK 268
+R T ++ P+ K
Sbjct: 259 QRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-35
Identities = 85/266 (31%), Positives = 133/266 (50%), Gaps = 22/266 (8%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE--FMMEQIKREISVMRLVRHPNVVEL 75
LGKG F +V + TG+ A K ++K +LKK M +++I + V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 76 REVMATKKKIFVAMEYVKGGEL---FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
TK + + M + GG+L V E A Y Q+I ++ H R + +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 133 RDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS 191
RDLKPEN+LLD++ +++ISD GL+ L + + + GTP Y+APEVL+ + YD S
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKK----IKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 192 KADLWSCGVILYVLLAGFLPFQD--ENIMN--MYRKVFKAEFVYPPWISTDAKRLISKLL 247
D ++ G LY ++AG PF+ E + + R+ + YP S +AK L LL
Sbjct: 175 -VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233
Query: 248 VSDPERRI-----TIQSIMRVPWFRK 268
DPE+R+ + + P F+
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 46/286 (16%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+GT+ VY + +TGE VA+K I + + E + REIS+++ + HPN+V L +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 78 VMATKKKIFVAMEYV-----KGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
V+ ++ K+++ E++ K + L + Y QL+ + +CHS V H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP---PLIKSYLYQLLQGIAYCHSHRVLH 122
Query: 133 RDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS 191
RDLKP+NLL+D LK++DFGL+ A +R H + T Y APE+L +
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTH-EVVTLWYRAPEILLGSRQYST 179
Query: 192 KADLWSCGVIL------YVLLAG-------FLPFQ-----DENIMNMYRKV--FKAEFVY 231
D+WS G I L G F F+ DE++ + +K F
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF-- 237
Query: 232 PPW-----------ISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P W + D L+SK+LV DP +RI+ ++ ++ P+F
Sbjct: 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 94/279 (33%), Positives = 152/279 (54%), Gaps = 36/279 (12%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKR-EISVMR----- 65
+E+ +++G+G F +V K TG+ A+K++NK E +KR E + R
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK--------WEMLKRAETACFREERDV 54
Query: 66 LVRHPN--VVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISA 121
LV + L + +++ M+Y GG+L +++ RL ED+AR Y +++ A
Sbjct: 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLA 114
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ--CGTPAYVA 179
+D H G HRD+KP+N+LLD+N ++++DFG S L +L DG + + GTP Y++
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYIS 171
Query: 180 PEVLRK----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV--FKAEFVYPP 233
PE+L+ KG G + D WS GV +Y +L G PF E+++ Y K+ K F +PP
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP 231
Query: 234 W---ISTDAKRLISKLLVSDPERRI---TIQSIMRVPWF 266
+S +AK LI +L+ S PE R+ +Q P+F
Sbjct: 232 DVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 91/303 (30%), Positives = 140/303 (46%), Gaps = 74/303 (24%)
Query: 16 RLLGK---GTFAKVYYGKQLMTGESVAIKVINKDQLKKEFM-MEQIK--REISVMRLVR- 68
++LGK GTF++V + TG+ AIK +KK F +EQ+ REI +R +
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIK-----CMKKHFKSLEQVNNLREIQALRRLSP 56
Query: 69 HPNVVELREVMATKKK-----IFVAM-----EYVKGGELFAKVARGRLREDLARKYFQQL 118
HPN++ L EV+ +K +F M E +KG + L E + Y QL
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG-------RKRPLPEKRVKSYMYQL 109
Query: 119 ISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFG-----LSALPEQLRNDGLLHTQ-C 172
+ ++D H G+ HRD+KPEN+L+ ++ LK++DFG S P +T+
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP---------YTEYI 159
Query: 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN---------------- 216
T Y APE L GY G K D+W+ G + + +L+ F F N
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 217 --IMNMYRKVFKAEFVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRV 263
++ +RK + +P P S + L+ KLL DP+ RIT + +R
Sbjct: 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
Query: 264 PWF 266
P+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-35
Identities = 87/274 (31%), Positives = 155/274 (56%), Gaps = 19/274 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQL-KKEFMMEQIKREISVMRLV 67
+E+ ++LG G + KV+ +++ +G+ A+KV+ K + +K E + E V+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 68 RH-PNVVELREVMATKKKIFVAMEYVKGGELFAKVA-RGRLREDLARKYFQQLISAVDFC 125
R P +V L T K+ + ++Y+ GGELF ++ R R +E + Y +++ A++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR- 184
H G+ +RD+K EN+LLD N + ++DFGLS + + ++ CGT Y+AP+++R
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRG 180
Query: 185 -KKGYDGSKADLWSCGVILYVLLAGFLPFQ---DENIM-NMYRKVFKAEFVYPPWISTDA 239
G+D + D WS GV++Y LL G PF ++N + R++ K+E YP +S A
Sbjct: 181 GDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 240 KRLISKLLVSDPERRI-----TIQSIMRVPWFRK 268
K +I +LL+ DP++R+ I + P+F+K
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 79/241 (32%), Positives = 133/241 (55%), Gaps = 5/241 (2%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVEL 75
+LGKG+F KV ++ T E AIK++ KD + ++ +E E V+ L + P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
T +++ MEYV GG+L + + G+ +E A Y ++ + F H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
LK +N++LD +KI+DFG+ E + + T CGTP Y+APE++ + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
W+ GV+LY +LAG PF E+ +++ + + YP +S +A + L+ P +R
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
Query: 255 I 255
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 77/267 (28%), Positives = 139/267 (52%), Gaps = 13/267 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVIN------KDQLKKEFMMEQIKREISVM 64
K+ G L+G G+F VY G +GE +A+K + + +K M++ + REI+++
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVD 123
+ ++H N+V+ + + +EYV GG + A + G E L R + +Q++ ++
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ----CGTPAYVA 179
+ H+RG+ HRD+K N+L+D +KISDFG+S E + G+ ++A
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN-MYRKVFKAEFVYPPWISTD 238
PEV+++ Y KAD+WS G ++ +L G PF D + +++ A P IS++
Sbjct: 181 PEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPW 265
A + K D +R T +++ P+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 81/297 (27%), Positives = 134/297 (45%), Gaps = 52/297 (17%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR--- 68
YE +G+G + VY + L TG VA+K + + L +E + REI++++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 69 HPNVVELREVMATKK-----KIFVAMEYVKG--GELFAKVARGRLREDLARKYFQQLISA 121
HPN+V L +V + K+ + E+V +K + L + + +QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181
VDF HS + HRDLKP+N+L+ + +KI+DFGL+ + + L + T Y APE
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTLWYRAPE 176
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFL--P-FQDENIMNMYRKVF------------- 225
VL + Y + D+WS G I L F P F+ + + K+F
Sbjct: 177 VLLQSSY-ATPVDMWSVGCIFAEL---FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232
Query: 226 ----------------KAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
FV P I + L+ K+L +P +RI+ ++ P+F
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFV--PEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 13 EMGRLLGKGTFAKVYYGKQLM----TGESVAIKVINKD---QLKKEFMMEQIKREISVMR 65
+G+ LG+G F +VY GK VA+K + +D Q +EF+ RE +MR
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-----REARIMR 56
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVD 123
+ HPNVV+L V ++ +++ MEY++GG+L + + R +L + Q+ ++
Sbjct: 57 KLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT-P-AYVAPE 181
+ S+ HRDL N L+ EN +KISDFGLS L +D + G P ++APE
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVYPPWISTDA- 239
L++ + SK+D+WS GV+L+ + G P+ + + + + P
Sbjct: 174 SLKEGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL 232
Query: 240 KRLISKLLVSDPERRITIQSIMR 262
L+ + DPE R T ++
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-34
Identities = 80/252 (31%), Positives = 140/252 (55%), Gaps = 12/252 (4%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVE 74
R++G+G++AKV + + A+KV+ K+ + + ++ ++ E V + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L T ++F+ +EYV GG+L + R R L E+ AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD + +K++D+G+ E L T CGTP Y+APE+LR + Y G
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 194 DLWSCGVILYVLLAGFLPFQ---DENIMN----MYRKVFKAEFVYPPWISTDAKRLISKL 246
D W+ GV+++ ++AG PF D MN +++ + + P ++S A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 247 LVSDPERRITIQ 258
L DP+ R+ Q
Sbjct: 238 LNKDPKERLGCQ 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 4e-34
Identities = 80/251 (31%), Positives = 140/251 (55%), Gaps = 14/251 (5%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVE 74
R++G+G++AKV + T A+KV+ K+ + + ++ ++ E V + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHR 133
L T+ ++F +EYV GG+L + R R L E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD +K++D+G+ E LR T CGTP Y+APE+LR + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 194 DLWSCGVILYVLLAGFLPFQ--------DENIMN-MYRKVFKAEFVYPPWISTDAKRLIS 244
D W+ GV+++ ++AG PF D+N + +++ + + + P +S A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 245 KLLVSDPERRI 255
L DP+ R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 84/268 (31%), Positives = 147/268 (54%), Gaps = 16/268 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
Y++ +++G+G F +V + + + A+K+++K ++ K E +M P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVS 131
VV+L K +++ MEY+ GG+L ++ + E A+ Y +++ A+D HS G+
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164
Query: 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH--TQCGTPAYVAPEVLRKK--- 186
HRD+KP+N+LLD++ LK++DFG ++ G++ T GTP Y++PEVL+ +
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCM---KMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF--KAEFVYPP--WISTDAKRL 242
GY G + D WS GV L+ +L G PF ++++ Y K+ K +P IS AK L
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281
Query: 243 ISKLLVSDPERRI---TIQSIMRVPWFR 267
I L +D E R+ ++ I + P+F+
Sbjct: 282 ICAFL-TDREVRLGRNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 77/260 (29%), Positives = 131/260 (50%), Gaps = 23/260 (8%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELR 76
LG+G++ VY TG+ VAIKV+ ++ +++I +EIS+++ P +V+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYY 64
Query: 77 EVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
+++ MEY G + K+ L E+ Q + +++ HS HRD
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
+K N+LL+E K++DFG+S QL + +T GTP ++APEV+++ GY+ +KA
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSG---QLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-NKA 180
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-------WISTDAKRLISKL 246
D+WS G+ + G P+ D + M R +F PP W S + + K
Sbjct: 181 DIWSLGITAIEMAEGKPPYSDIHPM---RAIFMIPNKPPPTLSDPEKW-SPEFNDFVKKC 236
Query: 247 LVSDPERRITIQSIMRVPWF 266
LV DPE R + +++ P+
Sbjct: 237 LVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 81/281 (28%), Positives = 141/281 (50%), Gaps = 36/281 (12%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+GT+ VY + +TGE VA+K I D + E + REIS+++ + HPN+V+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 78 VMATKKKIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDL 135
V+ T+ K+++ E++ + + L + Y QL+ + FCHS V HRDL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 136 KPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
KP+NLL++ +K++DFGL+ A +R H + T Y APE+L Y + D
Sbjct: 127 KPQNLLINTEGAIKLADFGLARAFGVPVRT--YTH-EVVTLWYRAPEILLGCKYYSTAVD 183
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-----EFVYP----------------- 232
+WS G I ++ F ++ ++ ++F+ E V+P
Sbjct: 184 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR 243
Query: 233 -------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P + D + L+S++L DP +RI+ ++ + P+F
Sbjct: 244 QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 8e-34
Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E+ +GKG+F V+ + A+K I+ ++ + E+ E V+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSSY 60
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL--FAKVARGR-LREDLARKYFQQLISAVDFCHSR 128
++ E K K+ + MEY + G+L K+ RGR L ED ++F Q++ + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
+ HRD+K NL LD +++KI D G++ L N +T GTP Y++PE+ K Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW---ISTDAKRLISK 245
+ K+D+W+ GV+LY G PF N + K+ + V+PP S +LI +
Sbjct: 179 N-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQMYSQQLAQLIDQ 235
Query: 246 LLVSDPERRITIQSIMRVP 264
L D +R ++R P
Sbjct: 236 CLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 89/264 (33%), Positives = 135/264 (51%), Gaps = 26/264 (9%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G F KVY + TG A K+I Q++ E +E EI ++ +HPN+V L E
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 78 VMATKKKIFVAMEYVKGGELFA---KVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
+ K+++ +E+ GG L + ++ RG L E R +Q++ A++F HS V HRD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVL-----RKKGYD 189
LK N+LL + D+K++DFG+SA T GTP ++APEV+ + YD
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-------WISTDAKRL 242
KAD+WS G+ L L P + N M + K+ K+E PP W S+
Sbjct: 187 -YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQPSKW-SSSFNDF 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWF 266
+ LV DP+ R T +++ P+
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 82/272 (30%), Positives = 140/272 (51%), Gaps = 30/272 (11%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF-MMEQIKR-----EISV 63
G +++ + +GKG F+ VY L+ G VA+K + + F MM+ R EI +
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV------QIFEMMDAKARQDCLKEIDL 55
Query: 64 MRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL------FAKVARGRLREDLARKYFQQ 117
++ + HPNV++ ++ + +E G+L F K R + E KYF Q
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQ 114
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY 177
L SA++ HS+ + HRD+KP N+ + +K+ D GL H+ GTP Y
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYY 172
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE--NIMNMYRKVFKAEFVYPP-- 233
++PE + + GY+ K+D+WS G +LY + A PF + N+ ++ +K+ K + YPP
Sbjct: 173 MSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLP 229
Query: 234 --WISTDAKRLISKLLVSDPERRITIQSIMRV 263
S + + L+S+ + DPE+R I +++V
Sbjct: 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 75/258 (29%), Positives = 128/258 (49%), Gaps = 10/258 (3%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
Y R+LGKG F + ++ V K +N +L E EI ++ L++HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPN 60
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGR---LREDLARKYFQQLISAVDFCHSR 128
++ + + MEY GG L+ K+ R + E++ Y Q++SAV + H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC-GTPAYVAPEVLRKKG 187
G+ HRD+K N+ L + +K+ DFG+S + L ++ + GTP Y++PE+ +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISKL 246
Y+ K+D+W+ G +LY LL F N +N+ K+ + + S++ L+ L
Sbjct: 178 YN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236
Query: 247 LVSDPERRITIQSIMRVP 264
L DPE+R T ++ P
Sbjct: 237 LQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 35/270 (12%)
Query: 13 EMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKD---QLKKEFMMEQIKREISVMR 65
+G+ LG+G F +VY G VA+K + +D Q +EF+ RE +MR
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-----REARIMR 56
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYF--QQLIS-AV 122
+ HPN+V+L V ++ + + MEY+ GG+L LR K L+S A+
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL-----LDYLR-KNRPKELSLSDLLSFAL 110
Query: 123 DFC------HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT-P 175
S+ HRDL N L+ EN +KISDFGLS L +D + G P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYKVKGGKLP 167
Query: 176 -AYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVYPP 233
++APE L++ + SK+D+WS GV+L+ + G P+ + + + K + P
Sbjct: 168 IRWMAPESLKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP 226
Query: 234 WISTDA-KRLISKLLVSDPERRITIQSIMR 262
+L+ + DPE R T ++
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 83/262 (31%), Positives = 136/262 (51%), Gaps = 13/262 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY +G+G VY + TG+ VAIK +N Q K+ E I EI VMR ++P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNP 76
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
N+V + +++V MEY+ GG L V + E ++ + A+DF HS V
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSA--LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
HRD+K +N+LL + +K++DFG A PEQ + T GTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAY 192
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF---KAEFVYPPWISTDAKRLISK 245
G K D+WS G++ ++ G P+ +EN + + E P +S + +++
Sbjct: 193 -GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251
Query: 246 LLVSDPERRITIQSIMRVPWFR 267
L D +RR + + +++ P+ +
Sbjct: 252 CLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 6e-33
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 23/264 (8%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKD---QLKKEFMMEQIKREISVMR 65
E+G+ LG+G F +VY G GE VA+K + + + ++EF+ E S+M+
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-----EEASIMK 56
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVD 123
+ HPN+V L V + +++ EY+ GG+L F + +L + Q+ ++
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP---AYVAP 180
+ S+ HRDL N L+ EN +KISDFGLS + D + G ++AP
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS---RDIYEDDYYRKRGGGKLPIKWMAP 173
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVYPPWISTDA 239
E L+ + SK+D+WS GV+L+ + G P+ + + + + P D
Sbjct: 174 ESLKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDE 232
Query: 240 -KRLISKLLVSDPERRITIQSIMR 262
L+ + DPE R T ++
Sbjct: 233 LYELMLQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 86/295 (29%), Positives = 137/295 (46%), Gaps = 60/295 (20%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+GT+ VY + +GE VA+K + D + + + REI+++ +RHPN+VEL+E
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELKE 73
Query: 78 VMATKK--KIFVAMEYVKGGELFAKVARGRLREDLARKY--------FQQLISAVDFCHS 127
V+ K IF+ MEY + +L L +++ + QL+ + + H
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DL------ASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE 126
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-----YVAPEV 182
+ HRDLK NLLL + LKI+DFGL+ R G L + TP Y APE+
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADFGLA------RTYG-LPAKPMTPKVVTLWYRAPEL 179
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAG--FLPFQ----------------DENIMNMYRKV 224
L + D+W+ G IL LLA LP + +E+I + +
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239
Query: 225 FKAE-FVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
F P PW+S RL++ LL+ DP++R T + + +F+
Sbjct: 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-33
Identities = 79/257 (30%), Positives = 136/257 (52%), Gaps = 13/257 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFM-MEQIKREISVMRLVRH 69
+Y + R++G+G+F + + + + + A+K I +L K +E ++E ++ ++H
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI---RLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVA--RGRL-REDLARKYFQQLISAVDFCH 126
PN+V +E +++ MEY GG+L K+ RG+L ED ++F Q+ V H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH-TQCGTPAYVAPEVLRK 185
+ V HRD+K +N+ L +N +K+ DFG + L L + G T GTP YV PE+
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL---LTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLIS 244
Y+ +K+D+WS G ILY L PFQ + N+ KV + + P S + + LI
Sbjct: 175 MPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233
Query: 245 KLLVSDPERRITIQSIM 261
++ +P R + +I+
Sbjct: 234 QMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 86/329 (26%), Positives = 137/329 (41%), Gaps = 63/329 (19%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+YE+ + +G G + V TG VAIK I+ + ++I REI ++R +RH
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHE 59
Query: 71 NVVELREVMATKKK-----IFVAMEYVKGGELFAKVARGRLREDLARKYFQ----QLISA 121
N++ L +++ +++ E +L KV + + L + Q Q++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVIKSP--QPLTDDHIQYFLYQILRG 115
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYV-- 178
+ + HS V HRDLKP N+L++ N DLKI DFGL+ + G L T+ YV
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-TE-----YVVT 169
Query: 179 ----APEV-LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF------KA 227
APE+ L Y + D+WS G I LL F + ++ +
Sbjct: 170 RWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 228 EFVYP-------------------PW------ISTDAKRLISKLLVSDPERRITIQSIMR 262
E + P S +A L+ K+LV DP++RIT +
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 263 VPWFRKGFTR---PVAFSITQHDDDGDDD 288
P+ + PVA D DD+
Sbjct: 289 HPYLAQLHDPEDEPVAKPPFDFDFFDDDE 317
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 66/295 (22%)
Query: 21 GTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM- 79
GT+ VY + TGE VA+K + ++ K+ F + + REI+++ ++HPN+V ++EV+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVKEVVV 74
Query: 80 -ATKKKIFVAMEYVKGGELFAKVARGRLREDLA---RKYF-QQLISAVDFCHSRGVSHRD 134
+ KI++ MEYV E K +++ K QL+S V H + HRD
Sbjct: 75 GSNLDKIYMVMEYV---EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD 131
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-----------YVAPEVL 183
LK NLLL+ LKI DFGL+ + G+P Y APE+L
Sbjct: 132 LKTSNLLLNNRGILKICDFGLA-------------REYGSPLKPYTQLVVTLWYRAPELL 178
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---------------- 227
+ D+WS G I LL F ++ ++ K+FK
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238
Query: 228 -----EFVYPPW-----------ISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
F P+ +S + L+++LL DP +RI+ + ++ P+F
Sbjct: 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 84/270 (31%), Positives = 145/270 (53%), Gaps = 18/270 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E+ +++G+G F +V K + A+K++NK ++ K + E V+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRG 129
+ L + +++ M+Y GG+L +++ RL ED+AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ--CGTPAYVAPEVLRK-- 185
HRD+KP+N+L+D N ++++DFG S L +L DG + + GTP Y++PE+L+
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 --KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF--KAEFVYPPW---ISTD 238
KG G + D WS GV +Y +L G PF E+++ Y K+ K F +P +S D
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 239 AKRLISKLLVSDPER--RITIQSIMRVPWF 266
AK LI +L+ S R + I+ + P+F
Sbjct: 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 81/281 (28%), Positives = 143/281 (50%), Gaps = 37/281 (13%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVR 68
G +E+ ++G+GT+ KVY + TG+ VAIK+++ + ++E +IK E +++R
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE----EIKEEYNILRKYSN 61
Query: 69 HPNVVE------LREVMATKKKIFVAMEYVKGG---ELFAKVAR--GRLREDLARKYFQQ 117
HPN+ + ++++ ME GG +L + + RL+E+ ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL-RNDGLLHTQCGTPA 176
+ + + H V HRD+K +N+LL +N ++K+ DFG+SA QL G +T GTP
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTPY 178
Query: 177 YVAPEVL-----RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY 231
++APEV+ YD +++D+WS G+ L G P D + M R +FK
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPM---RALFKIPRNP 234
Query: 232 PP-------WISTDAKRLISKLLVSDPERRITIQSIMRVPW 265
PP W S IS+ L+ + E+R ++ ++ P+
Sbjct: 235 PPTLKSPENW-SKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 82/257 (31%), Positives = 139/257 (54%), Gaps = 17/257 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E+ +++G+G F +V K T A+K++NK ++ K + E +V+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRG 129
+ L + +++ M+Y GG+L +++ RL ED+AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ--CGTPAYVAPEVLRK-- 185
HRD+KP+N+LLD N ++++DFG S L ++ DG + + GTP Y++PE+L+
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 --KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPPWI---STD 238
G G + D WS GV +Y +L G PF E+++ Y K+ E F +P I S +
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 239 AKRLISKLLVSDPERRI 255
AK LI +L+ S ERR+
Sbjct: 240 AKDLIQRLICSR-ERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 81/262 (30%), Positives = 138/262 (52%), Gaps = 13/262 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY +G+G V+ + TG+ VAIK IN L+K+ E I EI VM+ +++P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNP 76
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
N+V + ++FV MEY+ GG L V + E ++ + A++F H+ V
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSA--LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
HRD+K +N+LL + +K++DFG A PEQ + T GTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAY 192
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF---KAEFVYPPWISTDAKRLISK 245
G K D+WS G++ ++ G P+ +EN + + E P +S + +++
Sbjct: 193 -GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251
Query: 246 LLVSDPERRITIQSIMRVPWFR 267
L D E+R + + +++ P+ +
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 82/292 (28%), Positives = 141/292 (48%), Gaps = 44/292 (15%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KYE +G+GT+ V+ K T E VA+K + D E + REI +++ ++H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGG-ELFAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
N+V L +V+ + KK+ + EY + + G + ++ + + QL+ + FCHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL----LHTQCGTPAYVAPEVL-R 184
V HRDLKP+NLL+++N +LK++DFGL+ R G+ + T Y P+VL
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLA------RAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLP-FQDENIMNMYRKVFK-----AEFVYP------ 232
K Y S D+WS G I L P F ++ + +++F+ E +P
Sbjct: 174 AKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232
Query: 233 ------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P +++ + L+ LLV +P +RI+ + ++ P+F
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 92/273 (33%), Positives = 137/273 (50%), Gaps = 26/273 (9%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKR----EISVMRL 66
KY + R+LG G V K++ GE A+KV++ E M E K E+ +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDM-----EGMSEADKNRAQAEVCCLLN 87
Query: 67 VRHPNVVELREVMATKKK--------IFVAMEYVKGGELF------AKVARGRLREDLAR 112
++V+ E A K I + ++Y G+L AK R RE A
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT-FREHEAG 146
Query: 113 KYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172
F Q++ AV HS+ + HRD+K N+LL N +K+ DFG S + +D + T C
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VY 231
GTP YVAPE+ R+K Y KAD++S GV+LY LL PF EN+ + K +
Sbjct: 207 GTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265
Query: 232 PPWISTDAKRLISKLLVSDPERRITIQSIMRVP 264
PP IS + + +++ LL SDP+RR + ++ +P
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 23/269 (8%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
E LG G V TG+ +A+K I + + +QI RE+ ++ P +
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ--KQILRELDILHKCNSPYI 61
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHS-RG 129
V I + MEY+ GG L K +GR+ E + K ++ + + H
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
+ HRD+KP N+L++ +K+ DFG+S QL N L T GT +Y+APE ++ Y
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNS-LAKTFVGTSSYMAPERIQGNDY- 176
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDEN-----IMNMYRKVFKAEFVYPPWI-----STDA 239
K+D+WS G+ L L G P+ EN I + + + PP + S D
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDF 233
Query: 240 KRLISKLLVSDPERRITIQSIMRVPWFRK 268
+ ++ L+ DP R + + ++ P+ +K
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-31
Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI--NKDQLKKEFMMEQIKREISVMR 65
+ E +G G VY TG A+KVI N + + + QI REI ++R
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE----DTVRRQICREIEILR 127
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDF 124
V HPNVV+ ++ +I V +E++ GG L +A + D+AR Q++S + +
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAY 183
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV-- 182
H R + HRD+KP NLL++ +++KI+DFG+S + Q + ++ GT AY++PE
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERIN 241
Query: 183 --LRKKGYDGSKADLWSCGVILYVLLAGFLPF----QDENIMNMYRKVFKAEFVYPPWIS 236
L YDG D+WS GV + G PF Q + M P S
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301
Query: 237 TDAKRLISKLLVSDPERRITIQSIMRVPW 265
+ + IS L +P +R + +++ P+
Sbjct: 302 REFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 79/265 (29%), Positives = 140/265 (52%), Gaps = 25/265 (9%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGES-VAIKVIN-------KDQLKKEFMMEQIKREISV 63
Y + LG G F VY ++ G++ +A+K IN KD+ +++ + I E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 64 MR-LVRHPNVVELREVMATKKKIFVAMEYVKG---GELFA--KVARGRLREDLARKYFQQ 117
++ +RHPN+V + ++++ M+ ++G GE F K + R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 118 LISAVDFCH-SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
++ A+ + H + + HRDL P N++L E++ + I+DFGL+ +Q + + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA---KQKQPESKLTSVVGTIL 178
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW-- 234
Y PE+++ + Y G KAD+W+ G ILY + PF N++++ K+ +A VY P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPLPE 235
Query: 235 --ISTDAKRLISKLLVSDPERRITI 257
S D +I+ L D E R I
Sbjct: 236 GMYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 84/288 (29%), Positives = 143/288 (49%), Gaps = 49/288 (17%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+GT+ VY G+ TG+ VA+K I + ++E + REIS+++ ++HPN+V L++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 78 VMATKKKIFVAMEYVK---GGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
V+ + ++++ E++ L + + +L + Y Q++ + FCHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGL---LHT-QCGTPAYVAPEVLRKKGYDG 190
LKP+NLL+D +K++DFGL+ R G+ ++T + T Y APEVL
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYS 180
Query: 191 SKADLWSCGVILYVLLAGFLP-FQ-DENIMNMYR-------------------KVFKAEF 229
+ D+WS G I + +A P F D I ++R +K F
Sbjct: 181 TPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239
Query: 230 VYPPW-----------ISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P W + D L+ K+L+ DP +RI+ + + P+F
Sbjct: 240 --PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 79/257 (30%), Positives = 134/257 (52%), Gaps = 13/257 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY +G+G VY + TG+ VAI+ +N Q K+ E I EI VMR ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
N+V + +++V MEY+ GG L V + E ++ + A++F HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSA--LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
HRD+K +N+LL + +K++DFG A PEQ + ++ GTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAY 193
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF---KAEFVYPPWISTDAKRLISK 245
G K D+WS G++ ++ G P+ +EN + + E P +S + +++
Sbjct: 194 -GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 246 LLVSDPERRITIQSIMR 262
L D E+R + + +++
Sbjct: 253 CLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 92/297 (30%), Positives = 146/297 (49%), Gaps = 45/297 (15%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINK-DQLKKEFMMEQIKREISVMRLVRHP 70
+E +++G+G F +V ++ TG A+K++ K D L+KE + I+ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEADGA 61
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRG 129
VV++ K+ +++ ME++ GG++ + + L E+ + Y + + A+D H G
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 130 VSHRDLKPENLLLDENEDLKISDFGL-SALPEQLRND----------------------- 165
HRD+KP+NLLLD +K+SDFGL + L + R +
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 166 ---------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN 216
L ++ GTP Y+APEV + GY+ D WS GVI+Y +L G+ PF E
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 217 IMNMYRKV--FKAEFVYPPW--ISTDAKRLISKLLVSDPERRI---TIQSIMRVPWF 266
YRKV +K V+PP IS AK LI + D E RI ++ I P+F
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 81/301 (26%), Positives = 128/301 (42%), Gaps = 51/301 (16%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+ +G G F +V +++ T A+K + K + +K E ++ + VV+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
K ++ M+Y+ GG++ + + R G EDLAR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 135 LKPENLLLDENEDLKISDFGLSA-----------------------LPEQLRNDG----- 166
+KP+N+L+D + +K++DFGL E+
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 167 -------------LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ 213
L H+ GTP Y+APEVL + GY D WS GVILY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFL 245
Query: 214 DENIMNMYRKV--FKAEFVYPPWI--STDAKRLISKLLVSDPERRITIQSIMRV---PWF 266
+ KV ++ P S +A LI + L E R+ + P+F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
Query: 267 R 267
+
Sbjct: 305 K 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 83/303 (27%), Positives = 136/303 (44%), Gaps = 57/303 (18%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
K+++ +G+GT+ +VY + TGE VA+K + D K+ F + I REI ++R + H
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLNHR 66
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-------GRLR-------EDLARKYFQ 116
N+V L+E++ K+ A+++ K F V G L ED + + +
Sbjct: 67 NIVNLKEIVTDKQD---ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT-QCGTP 175
QL+ +++CH + HRD+K N+LL+ +K++DFGL+ L + +T + T
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPYTNKVITL 181
Query: 176 AYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM----------------- 218
Y PE+L + G D+WSCG IL L FQ +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241
Query: 219 ----------------NMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
YR+ + EF + P T A L+ +L DP +R T + +
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIP---TPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 263 VPW 265
PW
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 28/265 (10%)
Query: 16 RLLGKGTFAKVYYGKQLMTGES---VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
+ LG+G F +VY GK VA+K + +D ++E + +E VM+ + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 73 VELREVMATKKKIFVAMEYVKGGEL----------FAKVARGRLREDLARKYFQQLISAV 122
V L V ++ +++ +EY++GG+L F + L + Q+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV---A 179
++ S+ HRDL N L+ E+ +KISDFGLS + +D + G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS---RDVYDDDYYRKKTGGKLPIRWMA 175
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPF---QDENIMNMYRKVFKAEFVYPPWI 235
PE L+ + SK+D+WS GV+L+ + G P+ +E ++ RK ++ P +
Sbjct: 176 PESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK--PEYC 232
Query: 236 STDAKRLISKLLVSDPERRITIQSI 260
+ L+ DPE R T +
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 86/274 (31%), Positives = 141/274 (51%), Gaps = 18/274 (6%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
LF K E +GKG+F +VY G T E VAIK+I+ ++ + E +E I++EI+V+
Sbjct: 5 LFTKLER---IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQC 59
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
P + K+++ MEY+ GG + G L E ++++ +D+ HS
Sbjct: 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVAPEVLRKK 186
HRD+K N+LL E D+K++DFG++ QL + + +T GTP ++APEV+++
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI----STDAKRL 242
YD KAD+WS G+ L G P D + M R +F PP + S K
Sbjct: 177 AYD-FKADIWSLGITAIELAKGEPPNSDLHPM---RVLFLIPKNSPPTLEGQYSKPFKEF 232
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAF 276
+ L DP R T + +++ + + +T+ +F
Sbjct: 233 VEACLNKDPRFRPTAKELLKHKFITR-YTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 84/305 (27%), Positives = 144/305 (47%), Gaps = 55/305 (18%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+++GKG F +V ++ TG+ A+K + K ++ K+ + +K E V+ P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVARGRL-REDLARKYFQQLISAVDFCHSRGVSHRD 134
+ +++ ME++ GG+L + + ED+ R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 135 LKPENLLLDENEDLKISDFGLS---------ALPEQLRNDG------------------- 166
+KP+N+L+D +K+SDFGLS A ++L
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 167 -----------------LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGF 209
+ ++ GTP Y+APE+ ++GY G + D WS G I++ L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 210 LPFQDENIMNMYRKV--FKAEFVYPPWI--STDAKRLISKLLVSDPERRI---TIQSIMR 262
PF EN YRK+ ++ +P I S +A+ LI +L+ ++ E R+ I
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENRLGRGGAHEIKS 304
Query: 263 VPWFR 267
P+FR
Sbjct: 305 HPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 83/296 (28%), Positives = 145/296 (48%), Gaps = 49/296 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+YE +G+GT+ VY + +T E++A+K I +Q + E + REIS+++ ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHG 61
Query: 71 NVVELREVMATKKKIFVAMEYVK--------GGELFAKVARGRLREDLARKYFQQLISAV 122
N+V L++V+ ++K++++ EY+ FAK R L + Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR------LIKTYLYQILRGI 115
Query: 123 DFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAP 180
+CHS V HRDLKP+NLL+D LK++DFGL+ A +R H + T Y AP
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTH-EVVTLWYRAP 172
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------- 227
E+L + + D+WS G I ++ F ++ ++ K+F+
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 228 -----EFVYPPWISTDAKR-----------LISKLLVSDPERRITIQSIMRVPWFR 267
+ +P W D L+SK+L DP +RIT ++ + +F+
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 80/266 (30%), Positives = 130/266 (48%), Gaps = 16/266 (6%)
Query: 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
+ + + +G+G F++VY L+ G VA+K + L +EI +++ +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGEL------FAKVARGRLREDLARKYFQQLISAV 122
HPNV++ ++ + +E G+L F K R + E KYF QL SA+
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPEKTVWKYFVQLCSAL 119
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
+ HSR V HRD+KP N+ + +K+ D GL H+ GTP Y++PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPER 177
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPW----IST 237
+ + GY+ K+D+WS G +LY + A PF + MN+Y K E YPP S
Sbjct: 178 IHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEQCDYPPLPSDHYSE 235
Query: 238 DAKRLISKLLVSDPERRITIQSIMRV 263
+ ++L++ + DPE+R I + V
Sbjct: 236 ELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-29
Identities = 73/263 (27%), Positives = 136/263 (51%), Gaps = 16/263 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+++ + +G+G F++VY L+ + VA+K + ++ + +EI +++ + HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL-----FAKVARGRLREDLARKYFQQLISAVDFCH 126
V++ + ++ + +E G+L + K + + E KYF QL SAV+ H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
SR V HRD+KP N+ + +K+ D GL H+ GTP Y++PE + +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN 181
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDE--NIMNMYRKVFKAEFVYPPW----ISTDAK 240
GY+ K+D+WS G +LY + A PF + N+ ++ +K+ + + YPP S +
Sbjct: 182 GYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSEKLR 238
Query: 241 RLISKLLVSDPERRITIQSIMRV 263
L+S + DP++R I + ++
Sbjct: 239 ELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 75/258 (29%), Positives = 143/258 (55%), Gaps = 21/258 (8%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+G+ V ++ +G VA+K+++ L+K+ E + E+ +MR +H NVVE+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 78 VMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKP 137
++++V ME+++GG L V++ RL E+ + ++ A+ + HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 138 ENLLLDENEDLKISDFGLSALPEQLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLW 196
+++LL + +K+SDFG A Q+ D + GTP ++APEV+ + Y G++ D+W
Sbjct: 146 DSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 197 SCGVILYVLLAGFLP-FQDENIMNMYRKVFKAEFVYPPWISTDAKRL-------ISKLLV 248
S G+++ ++ G P F D + M R + PP +A ++ + ++L
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKR--LRDS---PPPKLKNAHKISPVLRDFLERMLT 256
Query: 249 SDPERRITIQSIMRVPWF 266
+P+ R T Q ++ P+
Sbjct: 257 REPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 76/257 (29%), Positives = 133/257 (51%), Gaps = 13/257 (5%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+G+ V +G+ VA+K K L+K+ E + E+ +MR +H NVVE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 78 VMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKP 137
+++V ME+++GG L V R+ E+ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 138 ENLLLDENEDLKISDFGLSAL--PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADL 195
+++LL + +K+SDFG A E R L+ GTP ++APE++ + Y G + D+
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPELISRLPY-GPEVDI 199
Query: 196 WSCGVILYVLLAGFLPFQDE---NIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPE 252
WS G+++ ++ G P+ +E M M R + +S K + +LLV DP
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259
Query: 253 RRITIQSIMRVPWFRKG 269
+R T +++ P+ K
Sbjct: 260 QRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 80/263 (30%), Positives = 142/263 (53%), Gaps = 14/263 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME--QIKREISVMRLVRH 69
+ +G+LLG+G F +VY TG +A+K + D +E E ++ EI +++ +RH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 70 PNVVE----LREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDF 124
+V+ LR+ +KK+ + +EY+ GG + ++ A G L E++ R+Y +Q++ V +
Sbjct: 64 DRIVQYYGCLRD--PEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVAPEVL 183
HS + HRD+K N+L D ++K+ DFG S + + G + + GTP +++PEV+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP--PWISTDAKR 241
+GY G KAD+WS + +L P+ + M K+ + P P +DA R
Sbjct: 182 SGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTKPMLPDGVSDACR 239
Query: 242 LISKLLVSDPERRITIQSIMRVP 264
K + + +RR T + ++R P
Sbjct: 240 DFLKQIFVEEKRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 5e-28
Identities = 83/260 (31%), Positives = 136/260 (52%), Gaps = 17/260 (6%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
LF K E +GKG+F +V+ G T + VAIK+I+ ++ + E +E I++EI+V+
Sbjct: 5 LFTKLER---IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQC 59
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
P V + K+++ MEY+ GG + G E ++++ +D+ HS
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVAPEVLRKK 186
HRD+K N+LL E D+K++DFG++ QL + + +T GTP ++APEV+++
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTD----AKRL 242
YD SKAD+WS G+ L G P D M+ R +F PP ++ + K
Sbjct: 177 AYD-SKADIWSLGITAIELAKGEPPNSD---MHPMRVLFLIPKNNPPTLTGEFSKPFKEF 232
Query: 243 ISKLLVSDPERRITIQSIMR 262
I L DP R T + +++
Sbjct: 233 IDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 101/317 (31%), Positives = 150/317 (47%), Gaps = 61/317 (19%)
Query: 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI-----NKDQLKKEFMMEQIK 58
++H+L KYE+ + LGKG + V+ T E VA+K I N ++ F
Sbjct: 2 DKHIL-RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF------ 54
Query: 59 REISVMR-LVRHPNVVELREVM--ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKY- 114
REI ++ L HPN+V+L V+ K I++ EY++ +L A V R + ED+ ++Y
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHA-VIRANILEDVHKRYI 112
Query: 115 FQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGL----SALPEQLRNDGLLHT 170
QL+ A+ + HS V HRDLKP N+LL+ + +K++DFGL S L E N L T
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL--T 170
Query: 171 Q-CGTPAYVAPEVLRK-KGYDGSKA-DLWSCGVILYVLLAGFLPFQDENIMNMYRKV--- 224
T Y APE+L Y +K D+WS G IL +L G F + +N K+
Sbjct: 171 DYVATRWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228
Query: 225 -----------FKAEFVYP-----------------PWISTDAKRLISKLLVSDPERRIT 256
K+ F P S DA L+ KLLV +P +R+T
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT 288
Query: 257 IQSIMRVPWFRKGFTRP 273
+ + P+ + F P
Sbjct: 289 AEEALEHPYVAQ-FHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 8e-28
Identities = 76/252 (30%), Positives = 131/252 (51%), Gaps = 13/252 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME--QIKREISVMRLVRH 69
+ +G+LLG+G F +VY TG +A+K + D E E ++ EI +++ + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 70 PNVVE----LREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDF 124
+V+ LR+ M IF ME++ GG + ++ + G L E++ RKY +Q++ V +
Sbjct: 64 ERIVQYYGCLRDPMERTLSIF--MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVAPEVL 183
HS + HRD+K N+L D ++K+ DFG S + + G + + GTP +++PEV+
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--AEFVYPPWISTDAKR 241
+GY G KAD+WS G + +L P+ + M K+ V PP +S +
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240
Query: 242 LISKLLVSDPER 253
+ ++ V R
Sbjct: 241 FLKRIFVEAKLR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 83/249 (33%), Positives = 128/249 (51%), Gaps = 16/249 (6%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LGKG F +V + TG+ A K +NK +LKK E E ++ V +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 78 VMATKKKIFVAMEYVKGGELFAKV-----ARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
TK + + M + GG+L + E A Y Q+IS ++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 133 RDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ--CGTPAYVAPEVLRKKGYDG 190
RDLKPEN+LLD + +++ISD GL+ +L+ DG T+ GTP ++APE+L+ + YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV---ELK-DGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 191 SKADLWSCGVILYVLLAGFLPF--QDENIMN--MYRKVFKAEFVYPPWISTDAKRLISKL 246
S D ++ GV LY ++A PF + E + N + +++ YP S +K L
Sbjct: 177 S-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 247 LVSDPERRI 255
L DPE+R+
Sbjct: 236 LAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 84/267 (31%), Positives = 131/267 (49%), Gaps = 28/267 (10%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G F KVY K TG A KVI + K E +E EI ++ HP +V+L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 78 VMATKKKIFVAMEYVKGGELFA---KVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
K+++ +E+ GG + A ++ RG L E + +Q++ A+ + HS + HRD
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 135 LKPENLLLDENEDLKISDFGLSA--LPEQLRNDGLLHTQCGTPAYVAPEV-----LRKKG 187
LK N+LL + D+K++DFG+SA + R D + GTP ++APEV ++
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKDTP 191
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK------R 241
YD KAD+WS G+ L + P + N M + K+ K+E PP +S +K
Sbjct: 192 YD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLSQPSKWSMEFRD 247
Query: 242 LISKLLVSDPERRITIQSIMRVPWFRK 268
+ L PE R + ++ P+
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 12/210 (5%)
Query: 12 YEMGRLLGKGTFAKVYYG----KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
+ G +LGKG + VY G QL+ + V + N +KE+ E+++ E+ +++ +
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY--EKLQEEVDLLKSL 59
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCH 126
+H N+V+ I + ME+V GG + + + R G L E + KY +Q++ V + H
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFG----LSALPEQLRNDGLLHTQCGTPAYVAPEV 182
+ V HRD+K N++L N +K+ DFG L+ + + +L + GTP ++APEV
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPF 212
+ + GY G K+D+WS G ++ + G P
Sbjct: 180 INESGY-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 85/271 (31%), Positives = 133/271 (49%), Gaps = 41/271 (15%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINK-DQLKKEFMMEQIKREISVMRLVRHP 70
+E +++G+G F +V ++ TG A+K++ K D L+KE + I+ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEADSL 61
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRG 129
VV++ K +++ ME++ GG++ + + L E+ + Y + + A+D H G
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLS-----------------ALPEQL---------- 162
HRD+KP+NLLLD +K+SDFGL +LP
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 163 -----RN-DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN 216
RN L + GTP Y+APEV + GY+ D WS GVI+Y +L G+ PF E
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 217 IMNMYRKV--FKAEFVYPPW--ISTDAKRLI 243
Y+KV +K ++PP IS AK LI
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 73/258 (28%), Positives = 138/258 (53%), Gaps = 19/258 (7%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G+G+ V + TG+ VA+K K L+K+ E + E+ +MR H NVV++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 78 VMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKP 137
+++V ME+++GG L V R+ E+ ++ A+ + H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 138 ENLLLDENEDLKISDFGLSAL--PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADL 195
+++LL + +K+SDFG A E + L+ GTP ++APEV+ + Y G++ D+
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPY-GTEVDI 201
Query: 196 WSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW------ISTDAKRLISKLLVS 249
WS G+++ ++ G P+ +E + R++ PP +S+ + + +LV
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN---LPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 250 DPERRITIQSIMRVPWFR 267
+P +R T Q +++ P+ +
Sbjct: 259 EPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIK 58
E+RH+ F + LG+G F KV + TGE VA+K +N +E +
Sbjct: 2 EKRHLKFI-----KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EEQHRSDFE 54
Query: 59 REISVMRLVRHPNVVELREVM--ATKKKIFVAMEYVKGGELFAKVARGRLREDLAR--KY 114
REI ++R + H N+V+ + V + + + MEY+ G L + R R + +L R +
Sbjct: 55 REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF 114
Query: 115 FQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ------LRNDGLL 168
Q+ +D+ S+ HRDL N+L++ + +KISDFGL+ + + ++ G
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLL 206
+ APE LR + S +D+WS GV LY L
Sbjct: 175 PIF-----WYAPECLRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 78/261 (29%), Positives = 136/261 (52%), Gaps = 19/261 (7%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
LF K E +GKG+F +V+ G T + VAIK+I+ ++ + E +E I++EI+V+
Sbjct: 5 LFTKLEK---IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQC 59
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
P V + K+++ MEY+ GG + G L E ++++ +D+ HS
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSA--LPEQLRNDGLLHTQCGTPAYVAPEVLRK 185
HRD+K N+LL E+ ++K++DFG++ Q++ + + GTP ++APEV+++
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQ 175
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI----STDAKR 241
YD SKAD+WS G+ L G P + + M + + K PP + S K
Sbjct: 176 SAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKE 231
Query: 242 LISKLLVSDPERRITIQSIMR 262
+ L +P R T + +++
Sbjct: 232 FVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 95/344 (27%), Positives = 144/344 (41%), Gaps = 63/344 (18%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+ LG G F +V +++ T A+K + K + + +K E ++ + VV L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
K ++ M+Y+ GG++ + + R G EDLAR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 135 LKPENLLLDENEDLKISDFGLSA------------LPEQLRNDG---------------- 166
+KP+N+L+D + +K++DFGL + +R D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 167 -----------------LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGF 209
L H+ GTP Y+APEVL + GY D WS GVILY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 210 LPFQDENIMNMYRKVFK--AEFVYPPW--ISTDAKRLISKLLVSDPERRI---TIQSIMR 262
PF + + KV PP +S +A LI K L PE R+ I
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKA 304
Query: 263 VPWFR--------KGFTRPVAFSITQHDDDGDDDQAATEKTEND 298
P+F+ + + P IT D + D +K +D
Sbjct: 305 HPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSD 348
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 41/279 (14%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y + +G G F V + +TG++VAIK I K + ++ RE+ +++ +RH
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYRELKLLKHLRHE 69
Query: 71 NVVELREV-MATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
N++ L ++ ++ + I+ E + G +L + L + + + Q++ + + HS G
Sbjct: 70 NIISLSDIFISPLEDIYFVTE-LLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG 128
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
V HRDLKP N+L++EN DLKI DFGL A + + G + T+ Y APE++
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTR----YYRAPEIMLTWQKY 183
Query: 190 GSKADLWSCGVILYVLLAG--FLPFQD-------------------------ENIMNMYR 222
+ D+WS G I +L G P +D EN + +
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 223 KVFKAEFVYP-----PWISTDAKRLISKLLVSDPERRIT 256
+ K E V P A L+ K+LV DP++RI+
Sbjct: 244 SLPKREPV-PFSEKFKNADPSAIDLLEKMLVFDPQKRIS 281
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 14/264 (5%)
Query: 11 KYEMGRLLGKGTFAKVYY--GKQLMTGESVAI-KVINKDQLKKEFMMEQIKREISVMRLV 67
+Y + + LGKG+F VY K+ + E + + K I +L + Q +E ++ +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV-QANQEAQLLSKL 59
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKV-----ARGRLREDLARKYFQQLISAV 122
HP +V+ + + EY +G +L K+ L E+ ++F QL+ V
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
+ H R + HRDLK +N+ L N LKI DFG+S L + + L T GTP Y++PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEA 176
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKR 241
L+ +GYD SK+D+WS G ILY + F+ +N +++ ++ + P S
Sbjct: 177 LKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235
Query: 242 LISKLLVSDPERRITIQSIMRVPW 265
++ +L DP R + I+R P+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 77/265 (29%), Positives = 138/265 (52%), Gaps = 16/265 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME--QIKREISVMRLVRH 69
+ G+LLG+G F +VY + TG +A K + D E E ++ EI +++ ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 70 PNVVE----LREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDF 124
+V+ LR+ +K + + MEY+ GG + ++ A G L E + RKY +Q++ + +
Sbjct: 64 ERIVQYYGCLRD--RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVAPEVL 183
HS + HRD+K N+L D ++K+ DFG S + + G + + GTP +++PEV+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW---ISTDAK 240
+GY G KAD+WS G + +L P+ + M K+ + P IS A+
Sbjct: 182 SGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTNPQLPSHISEHAR 239
Query: 241 RLISKLLVSDPERRITIQSIMRVPW 265
+ + V + R + + ++R P+
Sbjct: 240 DFLGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 68/195 (34%), Positives = 105/195 (53%), Gaps = 8/195 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
K+E+ ++G+G + V + T E VAIK KD + E + E RE+ ++R ++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 71 NVVELREVMATKKKIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLISAVDFCHSR 128
N+VEL+E + K+++ EYV+ EL ++ G + R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP-PEKVRSYIYQLIKAIHWCHKN 119
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
+ HRD+KPENLL+ N+ LK+ DFG + L E ++ T Y +PE+L
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG--SNANYTEYVATRWYRSPELLLGAP 177
Query: 188 YDGSKADLWSCGVIL 202
Y G D+WS G IL
Sbjct: 178 Y-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 75/223 (33%), Positives = 115/223 (51%), Gaps = 23/223 (10%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI----NKDQLKKEFMMEQIKREISVMRL 66
KYE L+G+G++ V K TG+ VAIK + +KK M REI +++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQ 56
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDF 124
+RH N+V L EV KK++++ E+V L K G L E RKY Q++ ++F
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEF 115
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAPE 181
CHS + HRD+KPEN+L+ ++ +K+ DFG + A P ++ D T Y APE
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD-----YVATRWYRAPE 170
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAG--FLPFQDENIMNMYR 222
+L G D+W+ G ++ +L G P D +I +Y
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 77/283 (27%), Positives = 139/283 (49%), Gaps = 41/283 (14%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG+GT+A VY G+ +T VA+K I + +E RE+S+++ ++H N+V L +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 78 VMATKKKIFVAMEYV-KGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLK 136
++ T+K + + EY+ K + + + + + QL+ +++CH R V HRDLK
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 137 PENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
P+NLL++E +LK++DFGL+ ++P + ++ ++ T Y P++L ++
Sbjct: 132 PQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDYSTQI 186
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK----------------AEFV---YP-- 232
D+W G I Y + G F + +F+ EF YP
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKY 246
Query: 233 ---------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P + +D L+SKLL + +RI+ + M+ P+F
Sbjct: 247 RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 85/288 (29%), Positives = 126/288 (43%), Gaps = 51/288 (17%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+ LG G F +V ++ T A+K + K + + +K E ++ + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
K ++ M+Y+ GG++ + + R E LAR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 135 LKPENLLLDENEDLKISDFGL----------------------SALPEQLRND------- 165
+KP+N+L+D + +K++DFGL S P L +D
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 166 ----------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGF 209
L H+ GTP Y+APEVL +KGY D WS GVIL+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 210 LPFQDENIMNMYRKVFKAE--FVYPPWI--STDAKRLISKLLVSDPER 253
PF KV E PP + S +A LI+KL S ER
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 49/299 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH- 69
YE +G+GT+ KVY + TG+ VA+K + ++ +E + REIS+++++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSES 60
Query: 70 PNVVELREVMATKKK-----IFVAMEYV-----KGGELFAKVARGRLREDLARKYFQQLI 119
+V L +V ++K +++ EY+ K + + L + + QL+
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 120 SAVDFCHSRGVSHRDLKPENLLLD-ENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTP 175
V CH GV HRDLKP+NLL+D + LKI+D GL ++P + ++ T
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-----TL 175
Query: 176 AYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------- 227
Y APEVL + + D+WS G I + F ++ + +FK
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 228 ---------EFVYPPWISTDAKR-----------LISKLLVSDPERRITIQSIMRVPWF 266
+P W D R L+ K+L DP +RI+ ++ + P+F
Sbjct: 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 18/265 (6%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
R+LGKG F +V + TG+ A K + K ++KK E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 76 REVMATKKKIFVAMEYVKGGEL---FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
TK + + + + GG+L + E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 133 RDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS 191
RDLKPEN+LLD+ ++ISD GL+ +PE + + GT Y+APEVL + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPE----GESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 192 KADLWSCGVILYVLLAGFLPF--QDENIM--NMYRKVFKAEFVYPPWISTDAKRLISKLL 247
D W G ++Y ++ G PF + E + + R+V + E VY S +AK + LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 248 VSDPERRITIQ-----SIMRVPWFR 267
DP++R+ Q + R P+FR
Sbjct: 241 TKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 81/270 (30%), Positives = 135/270 (50%), Gaps = 22/270 (8%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G F KVY + TG A KVI+ K E +E EI ++ HPN+V+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDT---KSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 78 VMATKKKIFVAMEYVKGGELFA---KVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
+ +++ +E+ GG + A ++ R L E R +Q + A+++ H + HRD
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQL--RNDGLLHTQCGTPAYVAPEVL-----RKKG 187
LK N+L + D+K++DFG+SA + R D + GTP ++APEV+ + +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRP 184
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKRLIS 244
YD KAD+WS G+ L + P + N M + K+ K+E P S++ K +
Sbjct: 185 YD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243
Query: 245 KLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
K L + + R T +++ P+ +P+
Sbjct: 244 KCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 16/265 (6%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
R+LGKG F +V + TG+ A K + K ++KK E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 76 REVMATKKKIFVAMEYVKGGEL---FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
TK + + + + GG+L + E+ A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 133 RDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSK 192
RDLKPEN+LLD+ ++ISD GL+ ++ + + GT Y+APEV++ + Y S
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERYTFS- 181
Query: 193 ADLWSCGVILYVLLAGFLPFQ--DENIM--NMYRKVFKAEFVYPPWISTDAKRLISKLLV 248
D W G ++Y ++ G PF+ E + + R+V + + Y S A+ + +LL
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 249 SDPERRITIQS-----IMRVPWFRK 268
DP R+ + + P+FR
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 81/308 (26%), Positives = 137/308 (44%), Gaps = 59/308 (19%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIK-VINKDQLKKEFMMEQIKREISVMRLVRHP 70
YE+ LG+GTF +VY +Q+ TG VA+K ++ ++ K+ REI +++ ++HP
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHP 67
Query: 71 NVVELREVMA---------TKKKIFVAMEYVK---GGELFAKVARGRLREDLARKYFQQL 118
NVV L + MA + +++ Y+ G L + +L E + Y QL
Sbjct: 68 NVVPLID-MAVERPDKSKRKRGSVYMVTPYMDHDLSGLL--ENPSVKLTESQIKCYMLQL 124
Query: 119 ISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL----PEQLRNDGLLHTQCGT 174
+ +++ H + HRD+K N+L+D LKI+DFGL+ P + G T+ T
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 175 PA-----YVAPE-VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA- 227
Y PE +L ++ Y + D+W G + + Q ++ ++ +FK
Sbjct: 185 NLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 228 ----EFVYPPW----------ISTDAKR---------------LISKLLVSDPERRITIQ 258
E +P W T+ R L+SKLL DP +R+T
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303
Query: 259 SIMRVPWF 266
+ P+F
Sbjct: 304 DALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 52/290 (17%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
Y+ +G+G + V TG VAIK I+ + + ++ REI ++R +H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHEN 64
Query: 72 VVELREVM-----ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
++ + +++ + +++ E ++ +L+ + L D + + Q++ + + H
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGL--SALPEQLRNDGLLHTQCGTPAYVAPEV-L 183
S V HRDLKP NLLL+ N DLKI DFGL A PE + G L T Y APE+ L
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVATRWYRAPEIML 182
Query: 184 RKKGYDGSKA-DLWSCGVILYVLLA------------------GFL--PFQDE--NIMNM 220
KGY +KA D+WS G IL +L+ G L P Q++ I+++
Sbjct: 183 NSKGY--TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 221 -----------YRKV-FKAEFVYPPWISTDAKRLISKLLVSDPERRITIQ 258
KV + F P A L+ K+L +P +RIT++
Sbjct: 241 RARNYIKSLPFKPKVPWNKLF---PNADPKALDLLDKMLTFNPHKRITVE 287
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 7e-25
Identities = 76/247 (30%), Positives = 126/247 (51%), Gaps = 13/247 (5%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH---PNVV 73
++G+G F +VY ++ TG+ A+K ++K ++K + E ++ LV P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 74 ELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSH 132
+ T K+ ++ + GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 133 RDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK-GYDGS 191
RDLKP N+LLDE+ ++ISD GL+ + + H GT Y+APEVL+K YD S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-S 175
Query: 192 KADLWSCGVILYVLLAGFLPFQDENIMNMY---RKVFKAEFVYPPWISTDAKRLISKLLV 248
AD +S G +L+ LL G PF+ + + R P S + + L+ LL
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 249 SDPERRI 255
D RR+
Sbjct: 236 RDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-25
Identities = 69/217 (31%), Positives = 112/217 (51%), Gaps = 9/217 (4%)
Query: 58 KREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARK---- 113
+ E+ + H +V+ + + K+ + MEY GG+L K + RL+E L +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEV 171
Query: 114 --YFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ 171
F Q++ A+D HSR + HRDLK N+ L +K+ DFG S + + +
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-V 230
CGTP Y+APE+ +K Y KAD+WS GVILY LL PF+ + + ++V ++
Sbjct: 232 CGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 231 YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
+P +S+ K L+ LL +P R T Q ++ + +
Sbjct: 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 84/298 (28%), Positives = 141/298 (47%), Gaps = 47/298 (15%)
Query: 9 FGK---YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
FGK Y+ LG+G++A VY G+ +TG+ VA+K I + +E RE S+++
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLK 58
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYV-KGGELFAKVARGRLREDLARKYFQQLISAVDF 124
++H N+V L +++ TKK + + EY+ + + G L R + QL+ + +
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAPE 181
CH R V HRDLKP+NLL+ E +LK++DFGL+ ++P + ++ ++ T Y P+
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-----TLWYRPPD 173
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ-DENIMNMYRKVFK-------------- 226
VL + D+W G I Y + G F ++ + K+F+
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233
Query: 227 --AEFV------YPP----------WISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
EF YPP + L K L +P++RI+ M+ P+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 81/276 (29%), Positives = 125/276 (45%), Gaps = 28/276 (10%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
K LG+G V + TG A+K I D + +QI RE+ + + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKS 58
Query: 70 PNVVELREVMATKKK--IFVAMEYVKGGEL---FAKVAR--GRLREDLARKYFQQLISAV 122
P +V+ + I +AMEY +GG L + KV + GR+ E + K + ++ +
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
+ HSR + HRD+KP N+LL +K+ DFG+S +L N L T GT Y+APE
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNS-LAGTFTGTSFYMAPER 174
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI--------MNMYRKVFKAEFVYPP- 233
++ K Y +D+WS G+ L + PF E ++ + E P
Sbjct: 175 IQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233
Query: 234 ----WISTDAKRLISKLLVSDPERRITIQSIMRVPW 265
W S + K I + L DP RR T ++ PW
Sbjct: 234 NGIKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 77/302 (25%), Positives = 129/302 (42%), Gaps = 58/302 (19%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME----QIKREISVMRL 66
+Y+ +G G + +V TG VAIK +L + F + RE+ +++
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-----KLSRPFQSAIHAKRTYRELRLLKH 70
Query: 67 VRHPNVVELREV------MATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
+ H NV+ L +V + + +++ + G +L V +L +D + Q++
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
+ + HS G+ HRDLKP N+ ++E+ +LKI DFGL+ D + T Y AP
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAP 184
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------IMN-------------- 219
E++ + D+WS G I+ LL G F + IMN
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 220 -------------MYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
M +K FK F + A L+ K+LV DP++RIT + P+
Sbjct: 245 SESARNYIQSLPQMPKKDFKEVF---SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
Query: 267 RK 268
+
Sbjct: 302 AE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 80/296 (27%), Positives = 141/296 (47%), Gaps = 46/296 (15%)
Query: 9 FGKYE----MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM 64
FGK E + +L G+GT+A V+ G+ +T VA+K I + +E RE+S++
Sbjct: 1 FGKLETYVKLDKL-GEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLL 57
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQ-QLISAVD 123
+ ++H N+V L +++ T++ + + EY+ G L K F QL+ +
Sbjct: 58 KNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLS 117
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAP 180
+CH R + HRDLKP+NLL++E +LK++DFGL+ ++P + ++ ++ T Y P
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPP 172
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK-----AEFVYP--- 232
+VL + D+W G ILY + G F + +F+ E +P
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232
Query: 233 ----------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P + TD L+S LL+ + + RI+ ++ +R +F
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 76/301 (25%), Positives = 133/301 (44%), Gaps = 50/301 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIK----REISVMRL 66
+Y+ +G G + V +G+ VAIK I F + + RE+ ++R
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-----PHAFDVPTLAKRTLRELKILRH 60
Query: 67 VRHPNVVELREVMATK----KKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISA 121
+H N++ +R+++ K ++V M+ + +L + + L E+ R + QL+
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGL--SALPEQLRNDGLLHTQCGTPAYVA 179
+ + HS V HRDLKP NLL++E+ +L+I DFG+ + + T Y A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 180 PEVLRKKGYDGSKADLWSCGVIL--------------YV----LLAGFLPFQDENIMN-- 219
PE+L + D+WS G I YV L+ L E ++N
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239
Query: 220 ---MYRKVFKA---------EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
RK + ++P S +A L+S++L DPE RIT++ ++ P+
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPK-ASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
Query: 268 K 268
+
Sbjct: 299 Q 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 77/251 (30%), Positives = 121/251 (48%), Gaps = 13/251 (5%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
R+LGKG F +V + TG+ A K + K ++KK E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 76 REVMATKKKIFVAMEYVKGGEL---FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
TK + + + + GG+L + E A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 133 RDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS 191
RDLKPEN+LLD++ ++ISD GL+ +PE + + GT Y+APEV++ + Y S
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPE----GQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 192 KADLWSCGVILYVLLAGFLPFQDENIM----NMYRKVFKAEFVYPPWISTDAKRLISKLL 247
D W+ G +LY ++AG PFQ + R V + + Y S DA+ L LL
Sbjct: 182 -PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240
Query: 248 VSDPERRITIQ 258
DP+ R+ Q
Sbjct: 241 CKDPKERLGCQ 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 76/264 (28%), Positives = 133/264 (50%), Gaps = 17/264 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E+ + +G GT+ VY + + TGE AIKVI K + ++F + +++EI +M+ +H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAV--VQQEIIMMKDCKHSN 67
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRGV 130
+V + K+++ ME+ GG L G L E ++ + + + HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVL---RKKG 187
HRD+K N+LL +N +K++DFG+SA + + GTP ++APEV RK G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK------R 241
Y+ D+W+ G+ L P D + M + K+ F PP + K
Sbjct: 186 YN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF-QPPKLKDKMKWSNSFHH 243
Query: 242 LISKLLVSDPERRITIQSIMRVPW 265
+ L +P++R T + +++ P+
Sbjct: 244 FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 84/301 (27%), Positives = 130/301 (43%), Gaps = 57/301 (18%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI-----NKDQLKKEFMMEQIKREISVMR 65
KY + +G+G + V K T E VAIK I N+ K+ REI ++R
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL------REIKLLR 59
Query: 66 LVRHPNVVELREVM-ATKKKIF--VAMEYVKGGEL----FAKVARGR--LREDLARKYFQ 116
+ H NV+ ++++M ++ F V + Y EL ++ R L +D + +
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFNDVYIVY----ELMDTDLHQIIRSSQTLSDDHCQYFLY 115
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
QL+ + + HS V HRDLKP NLLL+ N DLKI DFGL+ + + T
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRW 173
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------IMNMY-------- 221
Y APE+L + D+WS G I LL F ++ I +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233
Query: 222 --------RKVFKAEFVYP--------PWISTDAKRLISKLLVSDPERRITIQSIMRVPW 265
R+ ++ P P + A L+ K+LV DP +RIT++ + P+
Sbjct: 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293
Query: 266 F 266
Sbjct: 294 L 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 74/246 (30%), Positives = 124/246 (50%), Gaps = 11/246 (4%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH---PNVV 73
++G+G F +VY ++ TG+ A+K ++K ++K + E ++ LV P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 74 ELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSH 132
+ T K+ ++ + GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 133 RDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSK 192
RDLKP N+LLDE+ ++ISD GL+ + + H GT Y+APEVL+K S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 193 ADLWSCGVILYVLLAGFLPFQDENIMNMY---RKVFKAEFVYPPWISTDAKRLISKLLVS 249
AD +S G +L+ LL G PF+ + + R P S + K L+ LL
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236
Query: 250 DPERRI 255
D +R+
Sbjct: 237 DVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 78/277 (28%), Positives = 141/277 (50%), Gaps = 32/277 (11%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVR 68
G +E+ ++G GT+ +VY G+ + TG+ AIKV++ + ++E +IK EI++++
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE----EIKLEINMLKKYSH 71
Query: 69 HPNVVELREVMATKK------KIFVAMEYVKGG---ELFAKVARGRLREDLARKYFQQLI 119
H N+ K ++++ ME+ G +L L+ED ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL-RNDGLLHTQCGTPAYV 178
+ H+ V HRD+K +N+LL EN ++K+ DFG+SA QL R G +T GTP ++
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWM 188
Query: 179 APEVLR-----KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP 233
APEV+ YD ++D+WS G+ + G P D M+ R +F PP
Sbjct: 189 APEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCD---MHPMRALFLIPRNPPP 244
Query: 234 WISTD--AKRLISKL---LVSDPERRITIQSIMRVPW 265
+ + +K+ I + LV + R + + +++ P+
Sbjct: 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 71/205 (34%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIK--VINKD--QLKKEFMMEQIKREISVMRL 66
KYE +G+G++ V+ + TG+ VAIK V ++D +KK + REI +++
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----REIRMLKQ 56
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDF 124
++HPN+V L EV K+K+ + EY L K RG + E L +K Q + AV+F
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNF 115
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC-GTPAYVAPEVL 183
CH HRD+KPEN+L+ + +K+ DFG + + L G +T T Y APE+L
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARI---LTGPGDDYTDYVATRWYRAPELL 172
Query: 184 RKKGYDGSKADLWSCGVILYVLLAG 208
G D+W+ G + LL G
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 13/234 (5%)
Query: 33 MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL-REVMATKKKIFVAMEY 91
MTG VAIK++ D ++E + +RE ++ + HPN+V L A +F EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 92 VKGGELFAKVA-RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL---DENED 147
V G L +A G L + Q++ A+ H++G+ HRDLKP+N+++
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 148 LKISDFGLSALPEQLRNDGLL-----HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVIL 202
K+ DFG+ L +R+ + GTP Y APE LR + +DL++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179
Query: 203 YVLLAGFLPFQDENIMN-MYRKVFKAEFVYPPWI-STDAKRLISKLLVSDPERR 254
L G Q ++ +Y+++ + PPWI +++ K L DP +R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 68/262 (25%), Positives = 142/262 (54%), Gaps = 15/262 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVIN-KDQLKKEFMMEQIKREISVMRLVRHP 70
Y R++GKG++ +V + G+ IK +N ++ ++E + ++E ++ ++HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE--RKAAEQEAQLLSQLKHP 59
Query: 71 NVVELREVMATKK-KIFVAMEYVKGGELFAKVARGR---LREDLARKYFQQLISAVDFCH 126
N+V RE + +++ M + +GG+L+ K+ + L E+ ++F Q+ A+ + H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ + HRDLK +N+ L +K+ D G++ + E + D + T GTP Y++PE+ K
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCD-MASTLIGTPYYMSPELFSNK 177
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL---I 243
Y+ K+D+W+ G +Y + F +++ ++ ++ + + PP + L I
Sbjct: 178 PYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--PPMPKDYSPELGELI 234
Query: 244 SKLLVSDPERRITIQSIMRVPW 265
+ +L PE+R +++SI+R P+
Sbjct: 235 ATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 80/263 (30%), Positives = 130/263 (49%), Gaps = 24/263 (9%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVI-NKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+LGKGT+ VY + L T +AIK I +D + + E EI++ ++H N+V+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE----EIALHSYLKHRNIVQY 70
Query: 76 REVMATKKKIFVAMEYVKGGELFA----KVARGRLREDLARKYFQQLISAVDFCHSRGVS 131
+ + ME V GG L A K + E Y +Q++ + + H +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 132 HRDLKPENLLLDENED-LKISDFGLSALPEQLRNDGL---LHTQCGTPAYVAPEVLRK-- 185
HRD+K +N+L++ +KISDFG S R G+ T GT Y+APEV+ K
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQD--ENIMNMYR-KVFKAEFVYPPWISTDAKRL 242
+GY G+ AD+WS G + + G PF + E M++ +FK P +S +AK
Sbjct: 186 RGY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 243 ISKLLVSDPERRITIQSIMRVPW 265
I + DP++R + +++ P+
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 89/305 (29%), Positives = 140/305 (45%), Gaps = 59/305 (19%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y++ ++GKG++ V TGE VAIK IN D + +I REI ++RL+RHP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHP 59
Query: 71 NVVELREVM-----ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQ----QLISA 121
++VE++ +M K I+V E + +L + + +DL ++ Q QL+ A
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVI---KANDDLTPEHHQFFLYQLLRA 115
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ-CGTPAYVAP 180
+ + H+ V HRDLKP+N+L + + LKI DFGL+ + + T T Y AP
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 181 EVLRKKGYDGSK----ADLWSCGVILYVLLAGFLPFQDENI------------------- 217
E+ G SK D+WS G I +L G F +N+
Sbjct: 176 ELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 218 ------------MNMYRKV---FKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
+M +K F +F P A RL+ +LL DP+ R T + +
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKF---PNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 263 VPWFR 267
P+F+
Sbjct: 290 DPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 66/200 (33%), Positives = 97/200 (48%), Gaps = 26/200 (13%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNV 72
+GKG F VY G L VA+K LK++F+ E +++ HPN+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEA-----EILKQYDHPNI 54
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISA---VDFCHS 127
V+L V K+ I++ ME V GG L F + + RL +K Q + A +++ S
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLLQMSLDAAAGMEYLES 111
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP----AYVAPEVL 183
+ HRDL N L+ EN LKISDFG+S E G+ G + APE L
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEE----GGIYTVSDGLKQIPIKWTAPEAL 167
Query: 184 RKKGYDGSKADLWSCGVILY 203
Y S++D+WS G++L+
Sbjct: 168 NYGRYT-SESDVWSYGILLW 186
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-23
Identities = 67/225 (29%), Positives = 118/225 (52%), Gaps = 15/225 (6%)
Query: 9 FGK---YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
FGK YE LG+G++A VY GK + G+ VA+KVI + +E RE S+++
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLK 58
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDF 124
++H N+V L +++ TK+ + + EYV + G L + + + QL+ + +
Sbjct: 59 GLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAPE 181
H R + HRDLKP+NLL+ + +LK++DFGL+ ++P ++ ++ T Y P+
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPD 173
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVF 225
VL + D+W G I ++ G F ++I + ++F
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
KYE +G+GTF +V+ + T + VA+K + + K+ F + + REI +++L++
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL-REIKILQLLK 69
Query: 69 HPNVVELREVMATKKK--------IFVAMEYVK---GGELFAKVARGRLREDLARKYFQQ 117
H NVV L E+ TK ++ E+ + G L K + L E +K +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE--IKKVMKM 127
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG--LLHTQCGTP 175
L++ + + H + HRD+K N+L+ ++ LK++DFGL+ +N + T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 176 AYVAPEVLRKKGYDGSKADLWSCGVIL 202
Y PE+L + G D+W G I+
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 21/197 (10%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
++G +GKG F V G G+ VA+K + KD + E SVM +RHPN+
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCL-KDDST---AAQAFLAEASVMTTLRHPNL 62
Query: 73 VELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC------H 126
V+L V+ +++ EY+ G L R R R + QQL A+D C
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLV-DYLRSRGRAVITLA--QQLGFALDVCEGMEYLE 119
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRDL N+L+ E+ K+SDFGL+ Q ++ G L + + APE LR+K
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK-----WTAPEALREK 174
Query: 187 GYDGSKADLWSCGVILY 203
+ +K+D+WS G++L+
Sbjct: 175 KFS-TKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 6e-23
Identities = 82/282 (29%), Positives = 138/282 (48%), Gaps = 42/282 (14%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVR 68
G +E+ L+G GT+ +VY G+ + TG+ AIKV++ ++E +IK+EI++++
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE----EIKQEINMLKKYSH 61
Query: 69 HPNVVELREVMATKK------KIFVAMEYVKGG---ELFAKVARGRLREDLARKYFQQLI 119
H N+ K ++++ ME+ G +L L+E+ ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL-RNDGLLHTQCGTPAYV 178
+ H V HRD+K +N+LL EN ++K+ DFG+SA QL R G +T GTP ++
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWM 178
Query: 179 APEVLR-----KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP- 232
APEV+ YD K+DLWS G+ + G P D + M +A F+ P
Sbjct: 179 APEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPR 230
Query: 233 ---------PWISTDAKRLISKLLVSDPERRITIQSIMRVPW 265
W S + I LV + +R T + +M+ P+
Sbjct: 231 NPAPRLKSKKW-SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-23
Identities = 75/296 (25%), Positives = 142/296 (47%), Gaps = 44/296 (14%)
Query: 9 FGKYEMG---RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
FGK E LG+GT+A V+ G+ +T VA+K I + +E RE+S+++
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLK 59
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYV-KGGELFAKVARGRLREDLARKYFQQLISAVDF 124
++H N+V L +++ T K + + EY+ K + + + + + Q++ + +
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAPE 181
CH R V HRDLKP+NLL++E +LK++DFGL+ ++P + ++ ++ T Y P+
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPD 174
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK-----AEFVYP---- 232
VL ++ D+W G I + + +G F + + +F+ E +P
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234
Query: 233 ---------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
P + T+ L++K L + ++RI+ + M+ +FR
Sbjct: 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-23
Identities = 74/260 (28%), Positives = 130/260 (50%), Gaps = 17/260 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE+ + +G GT+ VY + L TGE A+K+I + +F + I++EI +++ +H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSL--IQQEIFMVKECKHCN 67
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRGV 130
+V +++K+++ MEY GG L G L E ++ + + + HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV--LRKKGY 188
HRD+K N+LL +N D+K++DFG++A + + GTP ++APEV + K G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-------WISTDAKR 241
D+W+ G+ L P D + M + K+ F PP W S+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-QPPKLKDKTKW-SSTFHN 243
Query: 242 LISKLLVSDPERRITIQSIM 261
+ L +P++R T + ++
Sbjct: 244 FVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 1e-22
Identities = 68/246 (27%), Positives = 124/246 (50%), Gaps = 12/246 (4%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LGKG F +V + TG+ A K ++K +LKK+ + E ++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 78 VMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLAR--KYFQQLISAVDFCHSRGVSHRD 134
+K + + M + GG+L + G ++ R Y Q+ + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
+KPEN+LLD+ + ++SD GL+ +L++ + + GT Y+APE+L+++ Y D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VD 176
Query: 195 LWSCGVILYVLLAGFLPFQD--ENIM--NMYRKVFKAEFVYPPW-ISTDAKRLISKLLVS 249
++ G +Y ++AG PF+D E + + R+ + E + + ++K + L
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236
Query: 250 DPERRI 255
PE R+
Sbjct: 237 KPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 25/269 (9%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
R +G G+F VY+ + + T E VAIK ++ + + I +E+ ++ +RHPN +E
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 76 REVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
+ + ++ MEY G +V + L+E + + + HS HRD
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140
Query: 135 LKPENLLLDENEDLKISDFGLSAL--PEQLRNDGLLHTQCGTPAYVAPEV---LRKKGYD 189
+K N+LL E +K++DFG ++L P + GTP ++APEV + + YD
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPAN--------SFVGTPYWMAPEVILAMDEGQYD 192
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDA-----KRLIS 244
G K D+WS G+ L P + N M+ + + + P +S++ + +
Sbjct: 193 G-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNFVD 248
Query: 245 KLLVSDPERRITIQSIMRVPWFRKGFTRP 273
L P+ R + + +++ + + RP
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLR--ERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-22
Identities = 45/138 (32%), Positives = 82/138 (59%), Gaps = 1/138 (0%)
Query: 20 KGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM 79
+G F KVY G++ + A+KV+ K + + M+ Q++ E + L + P +V L +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 80 ATKKKIFVAMEYVKGGELFAKVA-RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPE 138
+ +++ MEY+ GG++ + + G E++A KY ++ A+D+ H G+ HRDLKP+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133
Query: 139 NLLLDENEDLKISDFGLS 156
N+L+ +K++DFGLS
Sbjct: 134 NMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 55/305 (18%)
Query: 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIK-----------REISV 63
G LG+GT+ KV +TG+ VAIK + ++ + ++ RE+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 64 MRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKV--ARGRLREDLARKYFQQLISA 121
M ++H N++ L +V I + M+ + KV + RL E + Q+++
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILNG 131
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCG----- 173
++ H HRDL P N+ ++ KI+DFGL+ P T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 174 ----TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--- 226
T Y APE+L D+WS G I LL G F EN ++ ++F+
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 227 ----------------AEFV---------YPPWISTDAKRLISKLLVSDPERRITIQSIM 261
EF P S DA L+ LL +P RI+ + +
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 262 RVPWF 266
+ +F
Sbjct: 312 KHEYF 316
|
Length = 335 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 8e-22
Identities = 74/248 (29%), Positives = 118/248 (47%), Gaps = 13/248 (5%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
R+LGKG F +V + TG+ A K + K ++KK E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 76 REVMATKKKIFVAMEYVKGGEL---FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
TK + + + + GG+L + E A Y +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 133 RDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS 191
RDLKPEN+LLD+ ++ISD GL+ +PE G + GT Y+APEV+ + Y S
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG----RVGTVGYMAPEVINNEKYTFS 181
Query: 192 KADLWSCGVILYVLLAGFLPFQ--DENIM--NMYRKVFKAEFVYPPWISTDAKRLISKLL 247
D W G ++Y ++ G PF+ E + + R+V + + Y S DAK + LL
Sbjct: 182 -PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 248 VSDPERRI 255
+P+ R+
Sbjct: 241 TKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-21
Identities = 74/239 (30%), Positives = 119/239 (49%), Gaps = 38/239 (15%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+YE+ + +G G F +V+ K T E K I+ LK E Q+ E++VMR ++H
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHK 72
Query: 71 NVVEL--REVMATKKKIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVD 123
N+V R + +K+++ ME+ G+L + + G++ E +QL+ A+
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 124 FCHS-------RGVSHRDLKPENLLLD-----------ENEDL------KISDFGLSALP 159
+CH+ V HRDLKP+N+ L + +L KI DFGLS
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS--- 189
Query: 160 EQLRNDGLLHTQCGTPAYVAPEVL--RKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN 216
+ + + + H+ GTP Y +PE+L K YD K+D+W+ G I+Y L +G PF N
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 20/265 (7%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LGKG + VY TG ++A+K I + + +F QI E+ ++ P +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFYG 66
Query: 78 VMATKKKIFVAMEYVKGGEL----FAKVARGRLREDLARKYFQQLISAVDFCHSR-GVSH 132
+ +++ MEY+ G L VA + ED+ R+ ++ + F + H
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 133 RDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS- 191
RD+KP N+L++ N +K+ DFG+S L T G +Y+APE ++ G + +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 192 ----KADLWSCGVILYVLLAGFLPFQDENIMNMYRK----VFKAEFVYPPWISTDAKRLI 243
++D+WS G+ + + G P+ E N++ + V P S DA+ +
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242
Query: 244 SKLLVSDPERRITIQSIMRVPWFRK 268
+K L P RR T ++ PW K
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 69/257 (26%), Positives = 123/257 (47%), Gaps = 21/257 (8%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNVVE 74
+G+G F +V+ G+ VA+K + LK +F+ E +++ HPN+V
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEA-----RILKQYSHPNIVR 57
Query: 75 LREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
L V K+ I++ ME V+GG+ F + RL+ + + + +++ S+ H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 133 RDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP----AYVAPEVLRKKGY 188
RDL N L+ E LKISDFG+S E DG+ + G + APE L Y
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE----DGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 189 DGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVYPPWISTDA-KRLISKL 246
S++D+WS G++L+ + G +P+ + + + + + P + DA RL+ +
Sbjct: 174 S-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERC 232
Query: 247 LVSDPERRITIQSIMRV 263
DP +R + ++ +
Sbjct: 233 WEYDPGQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 6e-21
Identities = 68/257 (26%), Positives = 123/257 (47%), Gaps = 23/257 (8%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+ LG G F V+ GK VAIK IN+ + +E +E+ K VM + HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64
Query: 76 REVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHR 133
V +K +++ E+++ G L + + +G+L +D+ Q + +++ HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP---AYVAPEVLRKKGYDG 190
DL N L+ +K+SDFG++ + D + G + PEV Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT----RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 191 SKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249
SK+D+WS GV+++ V G +PF+ ++ + + + +Y P + A + +++ S
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL---ASMTVYEVMYS 236
Query: 250 ----DPERRITIQSIMR 262
PE R T ++R
Sbjct: 237 CWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-21
Identities = 87/337 (25%), Positives = 151/337 (44%), Gaps = 47/337 (13%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y + +G G + V TGE VAIK +++ + E ++ RE+++++ ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHE 74
Query: 71 NVVELREVMATK------KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
NV+ L +V + + ++ M Y++ K+ L ED + Q++ + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
HS G+ HRDLKP NL ++E+ +LKI DFGL+ D + T Y APEV+
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVIL 187
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------EFV-------- 230
+ D+WS G I+ +L G F+ ++ ++ ++ K EFV
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247
Query: 231 ---------YP--------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
YP P S A L+ K+L D ++R+T + P+F F
Sbjct: 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS-FRDA 306
Query: 274 VAFSITQHDDDGDDDQAATEKTENDRHNNQEEKVSSP 310
+ Q DD +++ + E +H +E K SP
Sbjct: 307 DEETEQQPYDDSLENEKLSVD-EWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 9e-21
Identities = 75/303 (24%), Positives = 137/303 (45%), Gaps = 55/303 (18%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ + +G G V + G +VA+K +++ + + ++ RE+ +++ V H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHK 80
Query: 71 NVVELREVMATKKK------IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
N++ L V +K +++ ME + +V L + Q++ +
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH 138
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
HS G+ HRDLKP N+++ + LKI DFGL+ + ++ T Y APEV+
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AEF--------- 229
GY D+WS G I+ L+ G + FQ + ++ + KV + AEF
Sbjct: 196 GMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254
Query: 230 ----------------VYPPWI-----------STDAKRLISKLLVSDPERRITIQSIMR 262
++P WI ++ A+ L+SK+LV DP++RI++ +R
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314
Query: 263 VPW 265
P+
Sbjct: 315 HPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG+G++A VY G + G+ VA+KVI+ +E + RE S+++ ++H N+V L +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 78 VMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDL 135
++ TK+ + EY+ +L + + G L R + QL+ + + H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 136 KPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSK 192
KP+NLL+ +LK++DFGL+ ++P Q + ++ T Y P+VL S
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYS-----SEVVTLWYRPPDVLLGATDYSSA 184
Query: 193 ADLWSCGVILYVLLAG 208
D+W G I +L G
Sbjct: 185 LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 56/288 (19%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+Y++ RL+GKG +VY + VA+K I +D + + ++ RE + + H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGR--LREDLARK--------YFQQ 117
P +V + + + ++ M Y++G L K + L ++LA K F +
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND---------GLL 168
+ + +++ HS+GV HRDLKP+N+LL ++ I D+G + + D +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 169 HTQ-------CGTPAYVAPEVLRKKGYDGS-KADLWSCGVILYVLLAGFLPFQDENIMNM 220
++ GTP Y+APE R G S D+++ GVILY +L P++ + +
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 221 --------------YRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
YR++ PP++S ++ K L DP R
Sbjct: 240 SYRDVILSPIEVAPYREI-------PPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 44/286 (15%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G G + V TG VAIK + + + E ++ RE+ +++ ++H NV+ L +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 78 VMATKKKI------FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVS 131
V + ++ M ++ G +L + +L ED + Q++ + + H+ G+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140
Query: 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS 191
HRDLKP NL ++E+ +LKI DFGL+ + D + T Y APEV+ +
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQ 195
Query: 192 KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AEFVYP------------- 232
D+WS G I+ +L G F+ + ++ ++ K EFV
Sbjct: 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255
Query: 233 ------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P + A ++ K+LV D E RIT + P+F
Sbjct: 256 PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVR 68
+E+ +GKGT+ KVY G A+K++ D + + E+I+ E ++++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISD--VDEEIEAEYNILQSLPN 77
Query: 69 HPNVVELREVMATKKK-----IFVAMEYVKGGELFAKVARG------RLREDLARKYFQQ 117
HPNVV+ + K +++ +E GG + ++ +G RL E +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYG 136
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPA 176
+ + H+ + HRD+K N+LL +K+ DFG+SA QL + L +T GTP
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTSVGTPF 193
Query: 177 YVAPEVLR-KKGYDGS---KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP 232
++APEV+ ++ YD S + D+WS G+ L G P D M+ + +FK P
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD---MHPVKTLFKIPRNPP 250
Query: 233 PWISTDAK------RLISKLLVSDPERRITIQSIMRVPWFR 267
P + K IS+ L+ D E R ++ ++ P+ +
Sbjct: 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 30/268 (11%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G V K + TG +A KV++ K + +QI RE+ +M R P +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 78 VMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSR-GVSHRD 134
+ I + ME++ G L K G + ++ K ++ + + ++ + HRD
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
+KP N+L++ +K+ DFG+S +L N + T GT Y++PE ++ Y K+D
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSG---ELINS-IADTFVGTSTYMSPERIQGGKYT-VKSD 184
Query: 195 LWSCGVILYVLLAGFLPFQDEN-----------IMNMYRKVFKAEFVYPPWI-----STD 238
+WS G+ + L G PF N I+++ +++ + PP + D
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---PPRLPSSDFPED 241
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWF 266
+ + L+ DP R T Q + +P F
Sbjct: 242 LRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 34/274 (12%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVRHP 70
+E+ +GKGT+ KV+ G A+K++ D + + E+I+ E ++++ L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHD--IDEEIEAEYNILKALSDHP 75
Query: 71 NVVEL-----REVMATKKKIFVAMEYVKGGEL--FAK--VARG-RLREDLARKYFQQLIS 120
NVV+ ++ + ++++ +E GG + K + RG R+ E + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVA 179
+ H HRD+K N+LL +K+ DFG+SA QL + L +T GTP ++A
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTSVGTPFWMA 192
Query: 180 PEVLR-----KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW 234
PEV+ YD ++ D+WS G+ L G P D + M R +FK PP
Sbjct: 193 PEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPM---RALFKIPRNPPPT 248
Query: 235 I------STDAKRLISKLLVSDPERRITIQSIMR 262
+ S + I K L D E+R T+ +++
Sbjct: 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 82/300 (27%), Positives = 137/300 (45%), Gaps = 53/300 (17%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMT--GESVAIKVINKDQLKKEFMMEQIKREISVMRLVR- 68
YE+ + LG+G + V + T E+VAIK I + K+ + ++ RE+ ++R R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRG 60
Query: 69 HPNVVELREV----MATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYF-QQLISAVD 123
H N+ L ++ ++++ E ++ +L + G+ D + F Q++ +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA--LPEQLRNDGLLHTQCGTPAYVAPE 181
+ HS V HRDLKP NLL++ + +LKI DFGL+ N G + T Y APE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 182 V-LRKKGYDGSKA-DLWSCGVILYVLLAGFLPFQ------------------DENIM--- 218
+ L + Y +KA D+WS G IL LL F+ DE +
Sbjct: 180 IMLSFQSY--TKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 219 -------------NMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPW 265
N+ +K F++ F + A L+ KLL DP +RI+++ + P+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNA---NPLALDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 4e-20
Identities = 66/242 (27%), Positives = 119/242 (49%), Gaps = 23/242 (9%)
Query: 40 IKVINKDQLKKEFMMEQIKR------EISVMRLVR-HPNVVELREVMATKKKIFVAMEYV 92
+ V+ +K F+ + IK E V +L++ +PN ++L + T K + M+Y+
Sbjct: 32 VSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91
Query: 93 KGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED-LKI 150
K G+LF + G+L E +K +QL+ A++ H + H D+K EN+L D +D + +
Sbjct: 92 KDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYL 151
Query: 151 SDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFL 210
D+GL + G GT Y +PE ++ YD S D W+ GV+ Y LL G
Sbjct: 152 CDYGLC------KIIGTPSCYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKH 204
Query: 211 PF---QDE--NIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR-ITIQSIMRVP 264
PF +DE ++ ++ ++ K + + +S +A + +L + R I++ P
Sbjct: 205 PFKEDEDEELDLESLLKRQQK-KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263
Query: 265 WF 266
+
Sbjct: 264 FL 265
|
Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 21/196 (10%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNVV 73
LLGKG F +V+ G L VA+K +D +LK +F+ E +++ HPN+V
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFL-----SEARILKQYDHPNIV 55
Query: 74 ELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGVS 131
+L V ++ I++ ME V GG+ F + + L+ K+ + + + S+
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP----AYVAPEVLRKKG 187
HRDL N L+ EN LKISDFG+S + D +++ G + APE L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 188 YDGSKADLWSCGVILY 203
Y S++D+WS G++L+
Sbjct: 171 YS-SESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVE 74
+ LG G F V+ GK VAIK+I + + ++ +E+ K VM + HPN+V+
Sbjct: 9 LKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAK----VMMKLSHPNLVQ 63
Query: 75 LREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSH 132
L V ++ IF+ EY+ G L + + +G+L + + A+++ S G H
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123
Query: 133 RDLKPENLLLDENEDLKISDFGLS--ALPEQLRNDGLLHTQCGTP---AYVAPEVLRKKG 187
RDL N L+ E+ +K+SDFGL+ L +Q + GT + PEV
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ------GTKFPVKWAPPEVFDYSR 177
Query: 188 YDGSKADLWSCGVILY-VLLAGFLPF 212
+ SK+D+WS GV+++ V G +P+
Sbjct: 178 FS-SKSDVWSFGVLMWEVFSEGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 77/338 (22%), Positives = 141/338 (41%), Gaps = 55/338 (16%)
Query: 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
L +Y R LG G+ V+ + VA+K I + ++ REI ++R
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS---VKHALREIKIIR 57
Query: 66 LVRHPNVVELREVMATK--------------KKIFVAMEYVKGGELFAKVARGRLREDLA 111
+ H N+V++ EV+ +++ EY++ +L + +G L E+ A
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHA 116
Query: 112 RKYFQQLISAVDFCHSRGVSHRDLKPENLLLD-ENEDLKISDFGLSALPEQ-LRNDGLLH 169
R + QL+ + + HS V HRDLKP N+ ++ E+ LKI DFGL+ + + + G L
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF 229
T Y +P +L D+W+ G I +L G F + + + + ++
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 230 V----------------------YP--------PWISTDAKRLISKLLVSDPERRITIQS 259
V P P ++ +A + ++L +P R+T +
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296
Query: 260 IMRVPWFRKGFTRPVAFSITQH----DDDGDDDQAATE 293
+ P+ ++ P ++ H +D+ DD TE
Sbjct: 297 ALMHPYM-SCYSCPFDEPVSLHPFHIEDELDDILLMTE 333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 1e-19
Identities = 30/59 (50%), Positives = 38/59 (64%), Gaps = 4/59 (6%)
Query: 313 FNAFEFISSMSSGFDLSNLFENKK---KTGSMFTSRYSARHIMEKIEGVAKGMNFKVAK 368
NAF+ IS +SSG DLS LFE +K K + FTSR A I+ K+E +AK + FKV K
Sbjct: 1 LNAFDLIS-LSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 46/295 (15%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-- 68
+YE +G G + VY + +G VA+K + + Q ++ + RE+++++ +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 69 -HPNVVELREVMATKK-----KIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLIS 120
HPN+V L +V AT + K+ + E+V KV L + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE-QLRNDGLLHTQCGTPAYVA 179
+DF H+ + HRDLKPEN+L+ +K++DFGL+ + Q+ ++ T Y A
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YRA 175
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVL---------------------LAGFLPFQDE--N 216
PEVL + Y + D+WS G I + L G LP +D+
Sbjct: 176 PEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDWPR 233
Query: 217 IMNMYRKVFKAEFVYP-----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
+ + R F P P I +L+ ++L +P +RI+ ++ P+F
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 11 KYEMGRLLGKGTFAKVY--YGKQLMTGES---VAIKVINKDQL---KKEFMMEQIKREIS 62
K + R LG+G+F VY K ++ GE VAIK +N++ + EF+ E S
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA-----S 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKY-------- 114
VM+ +VV L V++T + V ME + G+L + + R +
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 115 FQ---QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL---PEQLRNDG-- 166
Q ++ + + ++ HRDL N ++ E+ +KI DFG++ + R G
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQ 213
LL + ++APE L K G +K+D+WS GV+L+ + P+Q
Sbjct: 182 LLPVR-----WMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 80/308 (25%), Positives = 133/308 (43%), Gaps = 61/308 (19%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVI-----NKDQLKKEFMMEQIKREISVMRLV 67
E R +G G F V+ G+ VA+K + N K+ F RE+ ++
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF------RELKMLCFF 56
Query: 68 RHPNVVELREVMATK-----KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
+H NV+ +++ ++I+V E ++ V+ L D + + Q++ +
Sbjct: 57 KHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ-CGTPAYVAPE 181
+ HS G+ HRD+KP NLL++ N LKI DFGL+ + E ++ TQ T Y APE
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP--DESKHMTQEVVTQYYRAPE 174
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------IMN--------------- 219
+L + S D+WS G I LL + FQ ++ I +
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234
Query: 220 -----MYRKVFKAEFVYPP------WISTDAKR----LISKLLVSDPERRITIQSIMRVP 264
+ R K PP +S+ A L+ ++LV DP++RI+ + P
Sbjct: 235 GARAHILRGPHK-----PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289
Query: 265 WFRKGFTR 272
+ +G R
Sbjct: 290 YLDEGRLR 297
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-19
Identities = 57/244 (23%), Positives = 113/244 (46%), Gaps = 35/244 (14%)
Query: 21 GTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA 80
G KV T ++ +K L+K + + I + V PN+V L + +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILK-----GLRKSSEYSRERLTI-IPHCV--PNMVCLHKYIV 55
Query: 81 TKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPEN 139
++ +F+ +++ +GG+L++ +++ + E+ +++ +++ A+D H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 140 LLLDENEDLKISDFG-LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSC 198
+LLD+ ++++ F S + + + + + C APEV + D WS
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV-GGISEETEACDWWSL 168
Query: 199 GVILYVLLAGFL-----P--FQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDP 251
G IL+ LL G P +N+ P W+S +A+ L+ +LL +P
Sbjct: 169 GAILFELLTGKTLVECHPSGINTHTTLNI-----------PEWVSEEARSLLQQLLQFNP 217
Query: 252 ERRI 255
R+
Sbjct: 218 TERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-19
Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 18/200 (9%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+GKG F V G G VA+K I D + F+ E SVM +RH N+V+L
Sbjct: 14 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEA-----SVMTQLRHSNLVQLLG 66
Query: 78 VMATKK-KIFVAMEYVKGGELFAKV-ARGR--LREDLARKYFQQLISAVDFCHSRGVSHR 133
V+ +K +++ EY+ G L + +RGR L D K+ + A+++ + HR
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DL N+L+ E+ K+SDFGL+ ++ G L + + APE LR+K + +K+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAPEALREKKFS-TKS 180
Query: 194 DLWSCGVILYVLLA-GFLPF 212
D+WS G++L+ + + G +P+
Sbjct: 181 DVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 30/264 (11%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
K +G ++G+G F V G+ TG+ VA+K I D + F+ E +VM + H
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFL-----EETAVMTKLHHK 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLAR--KYFQQLISAVDFCH 126
N+V L V+ +++ ME + G L F + RGR + + ++ + +++
Sbjct: 60 NLVRLLGVI-LHNGLYIVMELMSKGNLVNFLR-TRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
S+ + HRDL N+L+ E+ K+SDFGL+ + ++ L + + APE L+ K
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHK 172
Query: 187 GYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKAEFVYPP-WISTDAKRLIS 244
+ SK+D+WS GV+L+ V G P+ ++ + V K + PP D L++
Sbjct: 173 KFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT 231
Query: 245 KLLVSDPERRITIQSIMRVPWFRK 268
++P++R P F K
Sbjct: 232 SCWETEPKKR---------PSFHK 246
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 85/324 (26%), Positives = 135/324 (41%), Gaps = 76/324 (23%)
Query: 11 KYEMGRLLGKGTFAKVY--YGKQLMTGESVAIKVINKDQLKKE-FMMEQIKREISVMRLV 67
KYE+ +G+GT+ +VY K G+ AIK D+ + REI+++R +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC-REIALLREL 59
Query: 68 RHPNVVELREVMATK--KKIFVAMEYVKGGELFAKV------ARGRLREDLARKYFQQLI 119
+H NVV L EV K +++ +Y + +L+ + R + + + Q++
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 120 SAVDFCHSRGVSHRDLKPENLLL--DENED--LKISDFGL-----SALPEQLRNDGLLHT 170
+ V + HS V HRDLKP N+L+ + E +KI D GL + L D ++ T
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 171 QCGTPAYVAPEVLR-KKGYDGSKA-DLWSCGVILYVLLAG---F----------LPFQDE 215
Y APE+L + Y +KA D+W+ G I LL F PFQ +
Sbjct: 179 IW----YRAPELLLGARHY--TKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 216 ------------------NIMNM--YRKVFKAEF-----------VYPPWISTDAKR--L 242
+I M Y + K D++ L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 243 ISKLLVSDPERRITIQSIMRVPWF 266
+ KLL DP +RIT + + P+F
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 72/266 (27%), Positives = 124/266 (46%), Gaps = 25/266 (9%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH--PNVVE 74
+G GT +VY + TG +A+K + + K+E ++I ++ V+ L H P +V+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVV-LKSHDCPYIVK 78
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSR-GV 130
T +F+ ME + K+ + G + ED+ K ++ A+ + + GV
Sbjct: 79 CYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT-QCGTPAYVAPEVL----RK 185
HRD+KP N+LLD + ++K+ DFG+S D T G AY+APE +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVFKAEFVYPPW---ISTDAKR 241
YD +AD+WS G+ L L G P+++ + K+ + E P S D
Sbjct: 193 PKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCS 251
Query: 242 LISKLLVSDPERRITIQSIMRVPWFR 267
+ L D +R + +++ P+ R
Sbjct: 252 FVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTG-ESVAIKVINKDQLKKEFMMEQIKREISVMRLVR- 68
+YE +G+G + KV+ + L G VA+K + + Q +E M RE++V+R +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 69 --HPNVVELREVMATKK-----KIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLI 119
HPNVV L +V + K+ + E+V KV + + + QL+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179
+DF HS V HRDLKP+N+L+ + +K++DFGL+ + L + T Y A
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 177
Query: 180 PEVLRKKGYDGSKADLWSCGVIL 202
PEVL + Y + DLWS G I
Sbjct: 178 PEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKV----YYGKQLMTGESVAIKVINKDQLKKEFMMEQIK 58
EERH+ F + LGKG F V Y Q TGE VA+K K Q + +
Sbjct: 2 EERHLKFIQ-----QLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFE 53
Query: 59 REISVMRLVRHPNVVELREVM--ATKKKIFVAMEYVKGGELFAKVARGRLREDLAR--KY 114
REI +++ ++H N+V+ + V A ++ + + MEY+ G L + + R R D + Y
Sbjct: 54 REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY 113
Query: 115 FQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT 174
Q+ +++ S+ HRDL N+L++ +KI DFGL+ + Q + + +
Sbjct: 114 ASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 175 PAY-VAPEVLRKKGYDGSKADLWSCGVILYVL 205
P + APE L + + +D+WS GV+LY L
Sbjct: 174 PIFWYAPESLTESKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 45/268 (16%)
Query: 18 LGKGTFAKVYYGKQLMTGE-SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELR 76
LG G F V YGK G+ VAIK+I + + ++ +E+ K VM + H +V+L
Sbjct: 12 LGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMKLSHEKLVQLY 65
Query: 77 EVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS-------AVDFCHSRG 129
V ++ I++ EY+ G L LRE R QL+ + + S+
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLL-----NYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV---APEVLRKK 186
HRDL N L+D+ +K+SDFGLS + D + G+ V PEVL
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLS----RYVLDDEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 187 GYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245
+ SK+D+W+ GV+++ V G +P++ N KV + +Y P ++++
Sbjct: 177 KFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE------- 228
Query: 246 LLVSDPERRITIQSIMRVPWFRKGFTRP 273
+ +IM W K RP
Sbjct: 229 ----------KVYAIMYSCWHEKAEERP 246
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 69/264 (26%), Positives = 124/264 (46%), Gaps = 16/264 (6%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKDQLKKEFMMEQIKREISVMR 65
+ E ++LG G F VY G + GE VAIKV+ ++ K ++I E VM
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN--KEILDEAYVMA 64
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVD 123
V HP+VV L + + + + + + G L V + + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG-TP-AYVAPE 181
+ + + HRDL N+L+ + +KI+DFGL+ L + ++ H + G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALE 181
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVYPPWIST-DA 239
+ + Y K+D+WS GV ++ L+ G P++ + + + K E + P I T D
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240
Query: 240 KRLISKLLVSDPERRITIQSIMRV 263
++ K + D E R T + ++
Sbjct: 241 YMVLVKCWMIDAESRPTFKELINE 264
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-18
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 11/217 (5%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
R +G G+F VY+ + + T E VAIK ++ + + I +E+ ++ ++HPN +E
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 76 REVMATKKKIFVAMEYVKG-GELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
+ + ++ MEY G +V + L+E + + + HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV---LRKKGYDGS 191
+K N+LL E +K++DFG +++ ++ GTP ++APEV + + YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDG- 203
Query: 192 KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE 228
K D+WS G+ L P + N M+ + + E
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 240
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 80/276 (28%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 16 RLLGKGTFAKV----YYGKQLMTGESVAIKVINKDQLKKEFMMEQI---KREISVMRLVR 68
R LG+G F KV Y + TGE VA+K LK E I K+EI ++R +
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEILRNLY 64
Query: 69 HPNVVELREVMATK--KKIFVAMEYVKGGELFAKVARGRLREDLAR--KYFQQLISAVDF 124
H N+V+ + + I + ME++ G L + R + + +L + KY Q+ +D+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY-VAPEVL 183
SR HRDL N+L++ +KI DFGL+ E + + +P + APE L
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 184 -RKKGYDGSKADLWSCGVILYVLL----------AGFL----PFQDENIMNMYRKVFKAE 228
+ K Y S D+WS GV LY LL FL P + + +V +
Sbjct: 185 IQSKFYIAS--DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242
Query: 229 --FVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
PP + +L+ K P +R T Q+++
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 64/259 (24%), Positives = 120/259 (46%), Gaps = 20/259 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ +G G + V TG VA+K +++ + ++ RE+ +++ ++H
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHE 76
Query: 71 NVVELREVMATKKKI-----FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC 125
NV+ L +V + + + ++ G +L V +L +D + Q++ + +
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 136
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK 185
HS + HRDLKP NL ++E+ +LKI DFGL+ D + T Y APE++
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLN 191
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245
+ D+WS G I+ LL G F + ++ + + + + T L+ K
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-------VGTPGAELLKK 244
Query: 246 LLVSDPERRITIQSIMRVP 264
+S R IQS+ ++P
Sbjct: 245 --ISSESARNYIQSLTQMP 261
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 67/255 (26%), Positives = 117/255 (45%), Gaps = 17/255 (6%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLVRHPNV 72
M LG G + +VY G +VA+K + +D ++ +EF+ +E +VM+ ++HPN+
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-----KEAAVMKEIKHPNL 64
Query: 73 VELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQ---QLISAVDFCHSRG 129
V+L V + ++ E++ G L + +E A Q+ SA+++ +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL-HTQCGTP-AYVAPEVLRKKG 187
HRDL N L+ EN +K++DFGLS L + D H P + APE L
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 188 YDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISK 245
+ K+D+W+ GV+L+ + G P+ ++ +Y + K P L+
Sbjct: 182 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240
Query: 246 LLVSDPERRITIQSI 260
+P R + I
Sbjct: 241 CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 11/217 (5%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
R +G G+F VY+ + + E VAIK ++ + + I +E+ ++ +RHPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 76 REVMATKKKIFVAMEYVKG-GELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
R + ++ MEY G +V + L+E + + + HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV---LRKKGYDGS 191
+K N+LL E +K+ DFG +++ + GTP ++APEV + + YDG
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG- 193
Query: 192 KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE 228
K D+WS G+ L P + N M+ + + E
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 55/218 (25%), Positives = 108/218 (49%), Gaps = 13/218 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+ + R LG G F +V+ G VAIK++ D L K + ++E+ ++ +RH +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHKH 63
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQ-QLISAVDFCHSR 128
++ L V + + +++ E ++ G L F + G++ + Q+ + + +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVLRKKG 187
HRDL N+L+ E+ K++DFGL+ L ++ D L + P + APE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 188 YDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
+ +K+D+WS G++LY + G +P+ N +Y ++
Sbjct: 181 FS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 24/215 (11%)
Query: 13 EMGRLLGKGTFAKV----YYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
+ R+LG+G F KV Y TGE VA+K + ++ ++ K+EI++++ +
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ--NTSGWKKEINILKTLY 64
Query: 69 HPNVVELREVMATK--KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
H N+V+ + + + K + + MEYV G L + + +L + QQ+ + + H
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPE-----QLRNDGLLHTQCGTPAY-VA 179
S+ HRDL N+LLD + +KI DFGL+ A+PE ++R DG +P + A
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYA 178
Query: 180 PEVLRK-KGYDGSKADLWSCGVILYVLLAGFLPFQ 213
E L++ K S D+WS GV LY LL Q
Sbjct: 179 VECLKENKFSYAS--DVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 56/299 (18%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
Y++G ++G G+F VY + T E VAIK + +D K RE+ +M+ + H N
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK-------NRELLIMKNLNHIN 120
Query: 72 VVELREVMATK------KKIF--VAMEYVKGGELFAKVARGRLRED------LARKYFQQ 117
++ L++ T+ K IF V ME++ + K + R + L + Y Q
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
L A+ + HS+ + HRDLKP+NLL+D N LK+ DFG + L + C +
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLAGQRSVSYIC-SRF 235
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--------- 227
Y APE++ + DLWS G I+ ++ G+ F ++ ++ ++ +
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 228 --------------------EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
+ V+P DA IS+ L +P +R+ + P+F
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 65/277 (23%), Positives = 122/277 (44%), Gaps = 19/277 (6%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G G+F VY+ T E VA+K ++ + + I +E+ ++ ++HPN +E +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 78 VMATKKKIFVAMEYVKG-GELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLK 136
+ ++ MEY G +V + L+E + + + HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 137 PENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV---LRKKGYDGSKA 193
N+LL E +K++DFG ++ ++ GTP ++APEV + + YDG K
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDG-KV 201
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDA-----KRLISKLLV 248
D+WS G+ L P + N M+ + + + P + ++ + + L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLQSNEWTDSFRGFVDYCLQ 258
Query: 249 SDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDG 285
P+ R ++R + R+ V + Q D
Sbjct: 259 KIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDA 295
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 77/314 (24%), Positives = 138/314 (43%), Gaps = 70/314 (22%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMM----EQIKREISVMRL 66
+Y+ + +G G V +TG++VAIK +L + F ++ RE+ +M+L
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK-----KLSRPFQNVTHAKRAYRELVLMKL 71
Query: 67 VRHPNVVELREVMATKKK------IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
V H N++ L V +K +++ ME + +V + L + Q++
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQMLC 129
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT-QCGTPAYVA 179
+ HS G+ HRDLKP N+++ + LKI DFGL+ + + T T Y A
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRA 185
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AEFV--- 230
PEV+ GY D+WS G I+ ++ G + F + ++ + K+ + EF+
Sbjct: 186 PEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 231 ----------------------YPPWI------------STDAKRLISKLLVSDPERRIT 256
+P + ++ A+ L+SK+LV DPE+RI+
Sbjct: 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 257 IQSIMRVP----WF 266
+ ++ P W+
Sbjct: 305 VDDALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 78/334 (23%), Positives = 143/334 (42%), Gaps = 56/334 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ +G G + V + VA+K +++ + + RE+ +++ ++H
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHE 74
Query: 71 NVVELREVM--ATKKKIFVAMEYVK---GGELFAKVARGRLREDLARKYFQQLISAVDFC 125
NV+ L +V AT + F + V G +L V +L ++ + QL+ + +
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK 185
HS G+ HRDLKP N+ ++E+ +L+I DFGL+ + D + T Y APE++
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLN 189
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AEFV--------- 230
+ D+WS G I+ LL G F + ++ +++ + E +
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249
Query: 231 -----YPPWISTDAKR-----------LISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
P D K+ L+ K+LV D ++RI+ + P+F
Sbjct: 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF-------- 301
Query: 275 AFSITQHDDDGDDDQAA--TEKTENDRHNNQEEK 306
+Q+ D D+ +A E EN +E K
Sbjct: 302 ----SQYHDPEDEPEAEPYDESPENKERTIEEWK 331
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNVVE 74
LG G VY L+T +A+KVI D +L+K QI E+ ++ P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK-----QIMSELEILYKCDSPYIIG 63
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
+ +I + E++ GG L ++ E + + ++ + + S + HRD
Sbjct: 64 FYGAFFVENRISICTEFMDGGSL---DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
+KP N+L++ +K+ DFG+S QL N + T GT AY+APE + + Y G +D
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVST---QLVNS-IAKTYVGTNAYMAPERISGEQY-GIHSD 175
Query: 195 LWSCGVILYVLLAGFLPF 212
+WS G+ L G P+
Sbjct: 176 VWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 16 RLLGKGTFAKVYYGKQLMTGE---SVAIKVIN---KDQLKKEFMMEQIKREISVMRLVRH 69
+++G G F +V G+ + G+ VAIK + D+ + +F+ E S+M H
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-----TEASIMGQFDH 64
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHS 127
PN++ L V+ + + + EY++ G L F + G+ + + S + +
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG-TPA-YVAPEVLRK 185
HRDL N+L++ N K+SDFGLS E + T+ G P + APE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEAIAY 182
Query: 186 KGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ + S +D+WS G++++ V+ G P+ D
Sbjct: 183 RKFT-SASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVV 73
+ R LG G F +V+ G T + VA+K + + E ++ E +M+ +RH +V
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQ----EAQIMKKLRHDKLV 64
Query: 74 ELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARK-YFQQLI-------SAVDFC 125
+L V + ++ I++ EY+ G L L+ +K QL+ + +
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD-----FLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVLR 184
SR HRDL N+L+ EN KI+DFGL+ L E ++ P + APE
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIKWTAPEAAN 177
Query: 185 KKGYDGSKADLWSCGVILY 203
G K+D+WS G++L
Sbjct: 178 -YGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 4e-16
Identities = 70/306 (22%), Positives = 130/306 (42%), Gaps = 61/306 (19%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ + +G G V + +VAIK +++ + + ++ RE+ +M+ V H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 76
Query: 71 NVVELREVMATKKK------IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
N++ L V +K +++ ME + +V + L + Q++ +
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG---LLHTQCGTPAYVAPE 181
HS G+ HRDLKP N+++ + LKI DFGL+ R G ++ T Y APE
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 188
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--------------- 226
V+ GY D+WS G I+ ++ + F + ++ + KV +
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 227 ------------AEFVYPPWI---------------STDAKRLISKLLVSDPERRITIQS 259
A +P ++ A+ L+SK+LV DP +RI++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 260 IMRVPW 265
++ P+
Sbjct: 308 ALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 70/306 (22%), Positives = 132/306 (43%), Gaps = 61/306 (19%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ + +G G V + +VAIK +++ + + ++ RE+ +M+ V H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 83
Query: 71 NVVELREVMATKKK------IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
N++ L V +K +++ ME + +V + L + Q++ +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG---LLHTQCGTPAYVAPE 181
HS G+ HRDLKP N+++ + LKI DFGL+ R G ++ T Y APE
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPE 195
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV----------------- 224
V+ GY D+WS G I+ ++ G + F + ++ + KV
Sbjct: 196 VILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 225 --------------FKAEFVYPPWI-----------STDAKRLISKLLVSDPERRITIQS 259
+ E ++P + ++ A+ L+SK+LV D +RI++
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314
Query: 260 IMRVPW 265
++ P+
Sbjct: 315 ALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 65/280 (23%), Positives = 122/280 (43%), Gaps = 42/280 (15%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
Y + + L G+ +V+ + + V +K+ K E M+ ++ V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAML---------LQNVNHPS 118
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRG 129
V+ +++ + + + + + +L+ + + L D A +Q++ + + H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND-GLLHTQCGTPAYVAPEVLRKKGY 188
+ HRD+K EN+ +++ + + I D G + P GL GT APEVL + Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK-VFKAEFVYP--PWISTDAK--RLI 243
+ SKAD+WS G++L+ +LA Y +F+ P S + ++I
Sbjct: 234 N-SKADIWSAGIVLFEMLA-------------YPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 244 SKLLV------SDPERRITIQSIMRVPWFRKGFTRPVAFS 277
S L V DP R+ I R+ +TR F
Sbjct: 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQ 319
|
Length = 357 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 70/274 (25%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVIN---KDQLKKEFMMEQIKREISVMRLVRHPNVVE 74
LG+G + V + + TG +A+K I Q +K +M+ +IS MR V P V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL---DIS-MRSVDCPYTVT 64
Query: 75 LREVMATKKKIFVAMEYVKGG--ELFAKVARGRLR--EDLARKYFQQLISAVDFCHSR-G 129
+ + +++ ME + + + KV L ED+ K ++ A+++ HS+
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPE----VLRK 185
V HRD+KP N+L++ N +K+ DFG+S L + G Y+APE L +
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPELNQ 181
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI-----STDAK 240
KGYD K+D+WS G+ + L G P+ ++ ++++ + P + S + +
Sbjct: 182 KGYD-VKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
++K L + + R +++ P+F ++
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 17 LLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVV 73
LG G+F V G+ +G VA+K + D+L +M+ +E ++M + H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLI 59
Query: 74 ELREVMATKKKIFVAMEYVKGGELF---AKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
L V+ T + V E G L K A G Y Q+ + + + S+
Sbjct: 60 RLYGVVLTHPLMMVT-ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 131 SHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTP-AYVAPEVLRKKGY 188
HRDL N+LL ++ +KI DFGL ALP+ + ++ P A+ APE LR + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQN-EDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 189 DGSKADLWSCGVILYVLLA-GFLPF 212
+D+W GV L+ + G P+
Sbjct: 178 S-HASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 35/235 (14%)
Query: 18 LGKGTFAKVYYGKQLMTGE-----SVAIKVINKD---QLKKEFMMEQIKREISVMRLVRH 69
LG+G F KVY G+ E SVAIK + ++ ++++EF ++E +M ++H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEF-----RQEAELMSDLQH 67
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELF---------AKVARGRLREDLARKYFQ---- 116
PN+V L V ++ + EY+ G+L + V E +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 117 ----QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172
Q+ + +++ S HRDL N L+ E +KISDFGLS +
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLP---FQDENIMNMYRK 223
++ PE + G +++D+WS GV+L+ + + G P F ++ ++ M R
Sbjct: 188 LPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 13 EMGRLLGKGTFAKVYYGK-QLMTGE--SVAIKV--INKDQLKKEFMMEQIKREISVMRLV 67
+GR +G+G F VY G E +VA+K +E ++ E +MR
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ----EAYIMRQF 64
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLAR--KYFQQLISAVDFC 125
HP++V+L V+ T+ +++ ME GEL + + + DLA Y QL +A+ +
Sbjct: 65 DHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT-P-AYVAPEVL 183
S+ HRD+ N+L+ + +K+ DFGLS L ++ G P ++APE +
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESI 180
Query: 184 RKKGYDGSKADLWSCGVILY-VLLAGFLPFQ 213
+ + S +D+W GV ++ +L+ G PFQ
Sbjct: 181 NFRRFT-SASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 16 RLLGKGTFAKVYYGKQLMTGE---SVAIKVIN---KDQLKKEFMMEQIKREISVMRLVRH 69
+++G G F +V G+ + G+ VAIK + ++ +++F+ E S+M H
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-----SEASIMGQFDH 64
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHS 127
PN++ L V+ K + + EY++ G L F + G+ + + S + +
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-YVAPEVLRKK 186
G HRDL N+L++ N K+SDFGLS + E P + APE + +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 187 GYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ S +D+WS G++++ V+ G P+ +
Sbjct: 185 KFT-SASDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
+G G F V+ G L + VAIK I + + +E E VM + HP +V+L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEE----DFIEEAQVMMKLSHPKLVQLYG 66
Query: 78 VMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDL 135
V + I + E+++ G L + + RG+ ++ + + + S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 136 KPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP---AYVAPEVLRKKGYDGSK 192
N L+ EN+ +K+SDFG++ + D + GT + +PEV Y SK
Sbjct: 127 AARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SK 181
Query: 193 ADLWSCGVILY-VLLAGFLPFQD 214
+D+WS GV+++ V G P+++
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 56/223 (25%), Positives = 102/223 (45%), Gaps = 18/223 (8%)
Query: 13 EMGRLLGKGTF--AKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
E+ L+GK V+ K T VA+K IN D KE ++ +++EI R ++HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE-DLKLLQQEIITSRQLQHP 59
Query: 71 NVVELREVMATKKKIFVAMEYVKGG---ELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
N++ +++V + G +L L E + +++A+D+ HS
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY-------VAP 180
+G HR +K ++LL + + +S GL +++ P ++P
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 181 EVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY 221
EVL++ +GY+ K+D++S G+ L G +PF+D M
Sbjct: 178 EVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 22/195 (11%)
Query: 56 QIKREISVMRLVRHPNVVELREV--------MATKKKIFVAMEYVKGGELFAKVARGRLR 107
Q++ EI + + H N++++ E+ M T+K F ++ K R L+
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK-DRPLLK 267
Query: 108 EDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167
+ R +QL+ AV++ H + + HRD+K EN+ L+ + + + DFG +A+P + +
Sbjct: 268 Q--TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREAF 324
Query: 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQD--ENIMNMYRKV 224
+ GT A +PE+L GY D+WSCG+IL +L+ F P D K+
Sbjct: 325 DYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
Query: 225 FKA------EFVYPP 233
+ EF PP
Sbjct: 384 IDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 66/281 (23%), Positives = 124/281 (44%), Gaps = 36/281 (12%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREI-SVMRLVRHPNVVEL 75
+G+G F V +G +A+K I +KE +++ ++ VMR P +V+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRSSDCPYIVKF 68
Query: 76 REVMATKKKIFVAMEYVKGG-ELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVS--- 131
+ + ++ ME + + F K L+ + ++++ + + ++
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP----EEILGKIAVATVKALNYLK 124
Query: 132 ------HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVL-- 183
HRD+KP N+LLD N ++K+ DFG+S QL + G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDP 181
Query: 184 -RKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVFKAEFVYPPWISTDA-- 239
+ GYD ++D+WS G+ LY + G P+ N + + +V K + PP +S
Sbjct: 182 SARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD---PPILSNSEER 237
Query: 240 ------KRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
I+ L+ D +R + ++ P+ + R V
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNV 278
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 64/248 (25%), Positives = 107/248 (43%), Gaps = 40/248 (16%)
Query: 59 REISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQ 117
REI +++ + H ++ L K + + M K +LF V R G L + A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY 177
L+ A+ + H RG+ HRD+K EN+ LDE E+ + DFG + + + + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPF------------------------- 212
+PE+L Y +K D+WS G++L+ + +
Sbjct: 254 NSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312
Query: 213 --QDENI-----MNMYRKVFKAEFVYPPWI-----STDAKRLISKLLVSDPERRITIQSI 260
Q+ + Y V + + PP I D + LI+K+L D E R + Q I
Sbjct: 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI 372
Query: 261 MRVPWFRK 268
+ +P F K
Sbjct: 373 LSLPLFTK 380
|
Length = 392 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 66/270 (24%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
+ +GR+LGKG F V + + + VA+K++ D + +E+ RE + M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFD 59
Query: 69 HPNVVELREV---MATKKKIFVAM---EYVKGGELFAKVARGRLREDLARKYFQQLI--- 119
HPNV++L V K ++ + M ++K G+L + R+ E+ Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 120 ----SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP 175
S +++ S+ HRDL N +L+EN + ++DFGLS +++ + C +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCASK 176
Query: 176 ---AYVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKAE-FV 230
++A E L Y + +D+W+ GV ++ ++ G P+ +Y + K
Sbjct: 177 LPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235
Query: 231 YPPWISTDAKRLISKLLVSDPERRITIQSI 260
PP D L+ + +P+ R + Q +
Sbjct: 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 54/218 (24%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 17 LLGKGTFAKVYYGKQLMTGES---VAIKVIN---KDQLKKEFMMEQIKREISVMRLVRHP 70
++G G F +V G+ + G+ VAIK + ++ +++F+ E S+M HP
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL-----SEASIMGQFDHP 65
Query: 71 NVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSR 128
N++ L V+ + + + E+++ G L F + G+ + + + + +
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA---YVAPEVLRK 185
HRDL N+L++ N K+SDFGLS E +D + G + APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 186 KGYDGSKADLWSCGVILY-VLLAGFLPFQD---ENIMN 219
+ + S +D+WS G++++ V+ G P+ D ++++N
Sbjct: 186 RKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLVRHPN 71
++ R LG G F +V+ G T VA+K + + K+F+ E +M+ +RHP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFL-----AEAQIMKKLRHPK 62
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLRE-------DLARKYFQQLISAVDF 124
+++L V ++ I++ E +K G L + G R D+A Q+ S + +
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQVASGMAY 118
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVL 183
++ HRDL N+L+ EN K++DFGL+ + ++ + P + APE
Sbjct: 119 LEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE--DIYEAREGAKFPIKWTAPEAA 176
Query: 184 RKKGYDGSKADLWSCGVILYVLLA-GFLPF 212
+ K+D+WS G++L ++ G +P+
Sbjct: 177 LYNRFS-IKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G V+ +G +A K+I+ + K + QI RE+ V+ P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 78 VMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSR-GVSHRDL 135
+ +I + ME++ GG L + + GR+ E + K +I + + + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 136 KPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADL 195
KP N+L++ ++K+ DFG+S QL D + ++ GT +Y++PE L+ Y ++D+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG---QLI-DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 196 WSCGVILYVLLAGFLP 211
WS G+ L + G P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 43/286 (15%)
Query: 11 KYEMGRLLGKGTFAKVYYG-----KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
+G+ LG+G F KV K +VA+K++ ++ E + E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR--DLLSEFNLLK 58
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGELFA------KVARGRLREDLARK------ 113
V HP+V++L + + + +EY K G L + KV L D R
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 114 -------------YFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160
+ Q+ + + + HRDL N+L+ E +KISDFGLS +
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--D 176
Query: 161 QLRNDGLL-HTQCGTPA-YVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPF---QD 214
D + ++ P ++A E L Y +++D+WS GV+L+ ++ G P+
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 215 ENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSI 260
E + N+ + ++ E P S + L+ +P++R T I
Sbjct: 236 ERLFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G V + +G +A K+I+ + K + QI RE+ V+ P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 78 VMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSR-GVSHRD 134
+ +I + ME++ GG L K A+ R+ E++ K ++ + + + + HRD
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRD 129
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
+KP N+L++ ++K+ DFG+S QL D + ++ GT +Y++PE L+ Y ++D
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSG---QLI-DSMANSFVGTRSYMSPERLQGTHYS-VQSD 184
Query: 195 LWSCGVILYVLLAGFLP 211
+WS G+ L L G P
Sbjct: 185 IWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 23/262 (8%)
Query: 16 RLLGKGTFAKVYYGKQLMTGES---VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
R++GKG F VY+G + + A+K +N+ +E +EQ +E +M+ HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNV 58
Query: 73 VELREVMATKKKI-FVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS-------AVDF 124
+ L + + V + Y+K G+L R +R + + LI +++
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDL-----RNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPA-YVAPEV 182
S+ HRDL N +LDE+ +K++DFGL+ + ++ HT P ++A E
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 183 LRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVYPPWISTDA-K 240
L+ + + +K+D+WS GV+L+ L+ G P+ D + ++ + + + P D
Sbjct: 174 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY 232
Query: 241 RLISKLLVSDPERRITIQSIMR 262
++ PE R T ++
Sbjct: 233 EVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 50/279 (17%)
Query: 16 RLLGKGTFAKVYYGKQLM-----TGES-VAIKVINK---DQLKKEFMMEQIKREISVMRL 66
LG G F +VY G +G VA+K + K DQ KKEF+ +E +M
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFL-----KEAHLMSN 55
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
HPN+V+L V + ++ ME ++GG+L + LR+ ++ L++ +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS-----YLRDARVERFGPPLLTLKELLD 110
Query: 127 -----SRGVS--------HRDLKPENLLLDENED-----LKISDFGL-----SALPEQLR 163
++G HRDL N L+ E +KI DFGL + +
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYR 222
+GLL + ++APE L G +++D+WS GV+++ +L G P+ N + +
Sbjct: 171 GEGLLPVR-----WMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224
Query: 223 KVFKAEFVYPPWISTDAKR-LISKLLVSDPERRITIQSI 260
V + P D L++ DP R T I
Sbjct: 225 HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRI 263
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G V +G +A K+I+ + K + QI RE+ V+ P +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 78 VMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDL 135
+ +I + ME++ GG L + + GR+ E++ K ++ + + + HRD+
Sbjct: 67 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDV 126
Query: 136 KPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADL 195
KP N+L++ ++K+ DFG+S QL D + ++ GT +Y++PE L+ Y ++D+
Sbjct: 127 KPSNILVNSRGEIKLCDFGVSG---QL-IDSMANSFVGTRSYMSPERLQGTHY-TVQSDI 181
Query: 196 WSCGVILYVLLAGFLP 211
WS G+ L + G P
Sbjct: 182 WSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 81/328 (24%), Positives = 142/328 (43%), Gaps = 85/328 (25%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIK---------REI 61
+YE G +G+GT+ VY K + KD+ KE+ ++QI+ REI
Sbjct: 3 EYE-GCKVGRGTYGHVYKAK----------RKDGKDE--KEYALKQIEGTGISMSACREI 49
Query: 62 SVMRLVRHPNVVELREVMAT--KKKIFVAMEYVKGGEL----FAKVARG-----RLREDL 110
+++R ++HPNV+ L++V + +K+++ +Y + F + ++ +L +
Sbjct: 50 ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109
Query: 111 ARKYFQQLISAVDFCHSRGVSHRDLKPENLLL----DENEDLKISDFGLSAL-PEQLRND 165
+ Q++ + + H+ V HRDLKP N+L+ E +KI+D G + L L+
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA------------------ 207
L T Y APE+L + D+W+ G I LL
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 229
Query: 208 ------------GFLPFQD-ENIMNM---------YRKVFKA-----EFVYPPWISTDAK 240
GF +D E+I M +R+ A +++ + D+K
Sbjct: 230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSK 289
Query: 241 --RLISKLLVSDPERRITIQSIMRVPWF 266
L+ KLL DP +RIT + ++ P+F
Sbjct: 290 VFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 41/238 (17%)
Query: 18 LGKGTFAKVYYGKQLMTG----ESVAIKV---INKDQLKKEFMMEQIKREISVMRLVRHP 70
LG+ F K+Y G + G + VAIK IN Q EF ++E S+M + HP
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEF-----QQEASLMAELHHP 67
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELF--------------AKVARGRLREDLARKYFQ 116
N+V L V+ ++ + + EY+ G+L + G ++ L F
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 117 ----QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172
Q+ + +++ S H+DL N+L+ E +KISD GLS ++ + Q
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS---REIYSADYYRVQP 184
Query: 173 GT--PA-YVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLP---FQDENIMNMYRK 223
+ P ++ PE + + S +D+WS GV+L+ + + G P F ++ ++ M RK
Sbjct: 185 KSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 79/329 (24%), Positives = 139/329 (42%), Gaps = 87/329 (26%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKD-QLKKEFMMEQIK---------RE 60
+YE G +G+GT+ VY K+ KD + +++ ++QI+ RE
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKR-------------KDGKDDRDYALKQIEGTGISMSACRE 48
Query: 61 ISVMRLVRHPNVVELREVMAT--KKKIFVAMEYVKGGEL----FAKVARG-----RLRED 109
I+++R ++HPNV+ L++V + +K+++ +Y + F + ++ +L
Sbjct: 49 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 108
Query: 110 LARKYFQQLISAVDFCHSRGVSHRDLKPENLLL----DENEDLKISDFGLSAL-PEQLRN 164
+ + Q++ + + H+ V HRDLKP N+L+ E +KI+D G + L L+
Sbjct: 109 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA----------------- 207
L T Y APE+L + D+W+ G I LL
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 228
Query: 208 -------------GFLPFQD-ENIMNM--------------YRKVFKAEFVYPPWISTDA 239
GF +D E+I M Y +++ + D+
Sbjct: 229 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 288
Query: 240 K--RLISKLLVSDPERRITIQSIMRVPWF 266
K L+ KLL DP +RIT + M+ P+F
Sbjct: 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 69/249 (27%), Positives = 116/249 (46%), Gaps = 19/249 (7%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG+G F +V+ G T VAIK + + E ++ E VM+ +RH +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLYA 68
Query: 78 VMATKKKIFVAMEYVKGGEL--FAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHRD 134
V+ +++ I++ EY+ G L F K G+ LR Q+ S + + HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVLRKKGYDGSKA 193
L+ N+L+ EN K++DFGL+ L E N+ P + APE G K+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIKS 184
Query: 194 DLWSCGVILYVLLA-GFLPFQ---DENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249
D+WS G++L L G +P+ + +++ + ++ PP L+ +
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--PPECPESLHDLMCQCWRK 242
Query: 250 DPERRITIQ 258
+PE R T +
Sbjct: 243 EPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 18/237 (7%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
E+GR G VY + TG V +++ + + +E ++ ++ E+ + RHPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNI 61
Query: 73 VELREVMATKKKIFVA---MEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
+ V T ++V M Y L + E L + +++ H G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY-------VAPEV 182
HR++K ++L+ + + +S GLS L +RN P + ++PE+
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 183 LRKK--GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWIST 237
LR+ GY+ K+D++S G+ L G +PFQD M + K P I+T
Sbjct: 180 LRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 11 KYEMGRLLGKGTFAKV----YYGKQLMTGES-VAIKVINKDQLKKEFMMEQIKREISVMR 65
+ +G+ LG+G F +V G S VA+K++ D +K+ + E+ +M+
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS--DLVSEMEMMK 70
Query: 66 LV-RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKY---------- 114
++ +H N++ L V + ++V +EY G L + R + A
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 115 FQQLIS-------AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL----- 162
+ L+S ++F S+ HRDL N+L+ E+ +KI+DFGL+ +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203
+G L + ++APE L + Y ++D+WS GV+L+
Sbjct: 191 TTNGRLPVK-----WMAPEALFDRVYT-HQSDVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
++ + LG G F +V+ G VA+K + + + +E E ++M+ ++H +
Sbjct: 9 KLVKKLGAGQFGEVWMG-YYNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTLQHDKL 63
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAKVARG-RLREDLARKYFQQLISAVDFCHSRG 129
V L V+ ++ I++ EY+ G L F K G ++ + Q+ + + +
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVLRKKGY 188
HRDL+ N+L+ E+ KI+DFGL+ + E N+ P + APE + +
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 189 DGSKADLWSCGVILY-VLLAGFLPF 212
K+D+WS G++LY ++ G +P+
Sbjct: 182 T-IKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 10/206 (4%)
Query: 16 RLLGKGTFAKVYYGKQLMTGES---VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
+++G G F +V+ G M G VAIK + +K+ + E S+M H N+
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ--RQDFLSEASIMGQFSHHNI 68
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
+ L V+ K + EY++ G L + + G + + + + +
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-YVAPEVLRKKGYD 189
HRDL N+L++ N + K+SDFGLS + E + P + APE + + +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF- 187
Query: 190 GSKADLWSCGVILY-VLLAGFLPFQD 214
S +D+WS G++++ V+ G P+ D
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 18 LGKGTFAKVYYGKQLMTGES---VAIKVINKDQL---KKEFMMEQIKREISVMRLVRHPN 71
LG G F V G LM VA+K + ++ + KKEF+ RE SVM + HP
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-----REASVMAQLDHPC 57
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
+V L V + + V ME G L + K R DL + Q+ + + S+
Sbjct: 58 IVRLIGVCKGEPLMLV-MELAPLGPLLKYLKKRREIPVSDLK-ELAHQVAMGMAYLESKH 115
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLR--NDGLLHTQCGT-P-AYVAPEVLRK 185
HRDL N+LL KISDFG+S L +D T G P + APE +
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMS---RALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 186 KGYDGSKADLWSCGVILYVLLA-GFLPFQD 214
+ SK+D+WS GV L+ + G P+ +
Sbjct: 173 GKFS-SKSDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 68/280 (24%), Positives = 112/280 (40%), Gaps = 47/280 (16%)
Query: 13 EMGRLLGKGTFAKVYYGKQL-MTGESVAIKV-------INKDQLKKEFMMEQIKREISVM 64
+ R LG G F +VY G G++V ++V +Q + +F+ME + +M
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-----IM 63
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAV 122
H N+V L V + F+ +E + GG+L F + R R + L A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 123 DF---CH---SRGVSHRDLKPENLLLD---ENEDLKISDFGLSALPEQLRNDGLLHTQCG 173
D C HRD+ N LL KI+DFG++ + R + + G
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRAS---YYRKG 178
Query: 174 TPA-----YVAPEVLRKKGYDG---SKADLWSCGVILY-VLLAGFLPF---QDENIMNMY 221
A ++ PE DG SK D+WS GV+L+ + G++P+ ++ +M
Sbjct: 179 GRAMLPIKWMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
Query: 222 RKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIM 261
P R+++ PE R +I+
Sbjct: 235 --TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 18/194 (9%)
Query: 34 TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA---ME 90
TGE V ++ IN + E M+ ++ E+ V +L HPN+V R +++V M
Sbjct: 24 TGEYVTVRRINLEACTNE-MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 91 YVKGGELFAKVARGRLREDLARKY-FQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLK 149
Y +L + E LA Y Q ++ A+D+ H G HR +K ++L+ + D K
Sbjct: 83 YGSAKDLICTHFMDGMSE-LAIAYILQGVLKALDYIHHMGYVHRSVKASHILI--SVDGK 139
Query: 150 ISDFGLSALPEQLRNDGLLHTQCGTPAY-------VAPEVLRK--KGYDGSKADLWSCGV 200
+ GL + + + L P Y ++PEVL++ +GYD +K+D++S G+
Sbjct: 140 VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGI 198
Query: 201 ILYVLLAGFLPFQD 214
L G +PF+D
Sbjct: 199 TACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 69/267 (25%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES-----VAIKVINK--DQLKKEFMMEQIKREISVM- 64
G+ LG G F KV +S VA+K++ ++E +M ++K +M
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK----IMS 93
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGR-----LREDLARKYFQQLI 119
L H N+V L I V EY G+L + R R L + L+ Y Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY--QVA 151
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--PA- 176
+ F S+ HRDL N+LL + +KI DFGL+ + ND + P
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA---RDIMNDSNYVVKGNARLPVK 208
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEF--VYPP 233
++APE + Y ++D+WS G++L+ + + G P+ + + + K+ K + P
Sbjct: 209 WMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
Query: 234 WISTDAKRLISKLLVSDPERRITIQSI 260
+ ++ +DP +R T + I
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 18/219 (8%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
++ + LG G F +V+ G VAIK + + + E + E ++M+ ++HP +
Sbjct: 9 KLVKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRL 63
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAKVARG-RLREDLARKYFQQLISAVDFCHSRG 129
V L V+ T++ I++ EY++ G L F K G +L + Q+ + F +
Sbjct: 64 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVLRKKGY 188
HRDL+ N+L+ E KI+DFGL+ L E N+ P + APE + G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGT 179
Query: 189 DGSKADLWSCGVILY-VLLAGFLPF----QDENIMNMYR 222
K+D+WS G++L ++ G +P+ E I N+ R
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 116 QQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP 175
+QL+SA+D+ H G+ HRD+K EN+L++ ED+ + DFG + + + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 176 AYVAPEVLRKKGYDGSKADLWSCGVILY 203
APEVL Y S D+WS G++++
Sbjct: 327 DTNAPEVLAGDPYTPS-VDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 69/293 (23%), Positives = 132/293 (45%), Gaps = 51/293 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGE-------SVAIKVINKDQLKKEFMMEQIKREISV 63
K +G+ LG+G F +V + L + +VA+K++ D +K+ + + E+ +
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 73
Query: 64 MRLV-RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKY-------- 114
M+++ +H N++ L ++V +EY G L + R R + Y
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL-REYLRARRPPGMEYSYDIARVPDE 132
Query: 115 ---FQQLIS-------AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164
F+ L+S +++ S+ HRDL N+L+ EN +KI+DFGL+ + N
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA---RDVNN 189
Query: 165 -DGLLHTQCG--TPAYVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNM 220
D T G ++APE L + Y ++D+WS GV+++ + G P+ + +
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
Query: 221 YRKVFKAEFVYPP--------------WISTDAKRLISKLLVSDPERRITIQS 259
++ + + + P W + + R K LV D +R +T+ +
Sbjct: 249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG G F +V+ G + VA+K + + E +E E +M+ +RH +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQLYA 68
Query: 78 VMATKKKIFVAMEYVKGGEL--FAKVARGRLRE-----DLARKYFQQLISAVDFCHSRGV 130
V+ +++ I++ EY+ G L F K GR + D+A Q+ + + +
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYIERMNY 123
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVLRKKGYD 189
HRDL+ N+L+ + KI+DFGL+ L E N+ P + APE G
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRF 180
Query: 190 GSKADLWSCGVILYVLLA-GFLPFQDEN 216
K+D+WS G++L L+ G +P+ N
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGES---VAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+G+ LG+G F V G QL +S VA+K + K + ME E M+ HP
Sbjct: 3 LGKTLGEGEFGSVMEG-QLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 71 NVVELREV--MATKKKIF----VAMEYVKGGELFAKVARGRLRE-------DLARKYFQQ 117
NV+ L V + + + V + ++K G+L + + RL + + K+
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ---CGT 174
+ S +++ S+ HRDL N +L+EN ++ ++DFGLS +++ N G + Q
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS---KKIYN-GDYYRQGRIAKM 176
Query: 175 PA-YVAPEVLRKKGYDGSKADLWSCGVILY 203
P ++A E L + Y +K+D+WS GV ++
Sbjct: 177 PVKWIAIESLADRVYT-TKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 76/330 (23%), Positives = 145/330 (43%), Gaps = 70/330 (21%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGE-------SVAIKVINKDQLKKEFMMEQIKREISV 63
+ +G+ LG+G F +V + + + +VA+K++ D K+ + + E+ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSDLVSEMEM 70
Query: 64 MRLV-RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDL-ARK-------- 113
M+++ +H N++ L ++V +EY ++G LRE L AR+
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYA---------SKGNLREYLRARRPPGMDYSF 121
Query: 114 ----------YFQQLIS-------AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156
F+ L+S +++ S+ HRDL N+L+ E+ +KI+DFGL+
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 157 ALPEQLRNDGLLHTQCGT-PA-YVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQ 213
+ D T G P ++APE L + Y ++D+WS GV+L+ + G P+
Sbjct: 182 RDVHNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 214 DENIMNMYRKVFKAEFVYPP--------------WISTDAKRLISKLLVSDPERRITIQS 259
+ +++ + + + P W + ++R K LV D +R +T+ S
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298
Query: 260 I-----MRVPWFRKGFTRPVAFSITQHDDD 284
+ VP+ + P + S DD
Sbjct: 299 TDEYLDLSVPFEQYSPGCPDSPSSCSSGDD 328
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77
LG+G F +V+ G T + VAIK + + E ++ E +M+ +RH +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLYA 68
Query: 78 VMATKKKIFVAMEYVKGGEL--FAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHRD 134
V+ +++ I++ E++ G L F K G+ L+ Q+ + + HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVLRKKGYDGSKA 193
L+ N+L+ +N KI+DFGL+ L E N+ P + APE G K+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIKS 184
Query: 194 DLWSCGVILYVLLA-GFLPF 212
D+WS G++L L+ G +P+
Sbjct: 185 DVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 14 MGRLLGKGTFAKVYYG---KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+G++LG+G F V G + + VA+K + D +E+ E + M+ HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFDHP 61
Query: 71 NVVELREV---MATKKKI---FVAMEYVKGGELFAKVARGRLREDLARKYFQQLI----- 119
NV++L V ++ +KI V + ++K G+L + + RL + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 120 --SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-- 175
+++ +R HRDL N +L E+ + ++DFGLS +++ +
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKMP 178
Query: 176 -AYVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPF 212
++A E L + Y SK+D+W+ GV ++ + G P+
Sbjct: 179 VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 61/226 (26%), Positives = 108/226 (47%), Gaps = 50/226 (22%)
Query: 14 MGRLLGKGTFAKVY----YGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRL 66
+G+ LG+G F +V YG + +VA+K++ + K+ + + E+ +M+L
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD--LADLISEMELMKL 73
Query: 67 V-RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDL-ARK----------- 113
+ +H N++ L V + ++V +EY A+G LRE L AR+
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYA---------AKGNLREFLRARRPPGPDYTFDIT 124
Query: 114 -------YFQQLISAV-------DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159
F+ L+S ++ SR HRDL N+L+ E+ +KI+DFGL+
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 160 EQLRNDGLLHTQCG-TPA-YVAPEVLRKKGYDGSKADLWSCGVILY 203
+ D T G P ++APE L + Y ++D+WS G++++
Sbjct: 185 HDI--DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 67/277 (24%), Positives = 121/277 (43%), Gaps = 16/277 (5%)
Query: 16 RLLGKGTFAKVYYGKQLMTGES----VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
++LG G F VY G + GE VAIK + + K ++I E VM V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPH 70
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
V L + T + G L + + + + + Q+ +++ R +
Sbjct: 71 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG-TP-AYVAPEVLRKKGY 188
HRDL N+L+ + +KI+DFGL+ L ++ H + G P ++A E + + Y
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 189 DGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKL 246
++D+WS GV ++ L+ G P+ + + K E PP + D ++ K
Sbjct: 189 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 247
Query: 247 LVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDD 283
+ D + R + + + F K P + + Q D+
Sbjct: 248 WMIDADSRPKFREL--IIEFSKMARDPQRYLVIQGDE 282
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 13 EMGRLLGKGTFAKVY---YGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
++ + LG G F +V+ Y K VA+K + + E + E +VM+ ++H
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGSMSVEAFLA----EANVMKTLQH 60
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLAR--KYFQQLISAVDFC 125
+V+L V+ TK+ I++ E++ G L F K G ++ L + + Q+ + F
Sbjct: 61 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI 118
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPEVLR 184
R HRDL+ N+L+ + KI+DFGL+ + E N+ P + APE +
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAIN 176
Query: 185 KKGYDGSKADLWSCGVILYVLLA-GFLPF 212
+ K+D+WS G++L ++ G +P+
Sbjct: 177 FGSFT-IKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 65/261 (24%), Positives = 117/261 (44%), Gaps = 64/261 (24%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQ--LMTGES---VAIKVINKD---QLKKEFMMEQIKREI 61
E R +G+G F +V+ + L+ E VA+K++ ++ ++ +F +RE
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF-----QREA 59
Query: 62 SVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLA------RK 113
++M HPN+V+L V A K + + EY+ G+L F + R + L+ RK
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 114 YFQ---QLISAVDFCHSRGVS------------HRDLKPENLLLDENEDLKISDFGLSA- 157
L C ++ V+ HRDL N L+ EN +KI+DFGLS
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 158 --LPEQLR---NDGLLHTQCGTPA-YVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFL 210
+ + ND + P ++ PE + Y +++D+W+ GV+L+ + + G
Sbjct: 180 IYSADYYKASENDAI-------PIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQ 231
Query: 211 PF------------QDENIMN 219
P+ +D N+++
Sbjct: 232 PYYGMAHEEVIYYVRDGNVLS 252
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 39/235 (16%)
Query: 17 LLGKGTFAKVYYGKQLMTGE--SVAIKVINKDQLKKEFMMEQIKR----EISVM-RLVRH 69
++G+G F +V G + AIK++ KEF E R E+ V+ +L H
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKML------KEFASENDHRDFAGELEVLCKLGHH 62
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLRED---LARKY-------FQQLI 119
PN++ L + +++A+EY G L + + R+ E A+++ QQL+
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 120 S-AVD------FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL--RNDGLLHT 170
A D + + HRDL N+L+ EN KI+DFGLS E + G L
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV 182
Query: 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKV 224
+ ++A E L Y +K+D+WS GV+L+ +++ G P+ +Y K+
Sbjct: 183 R-----WMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 40/152 (26%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 60 EISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGR---LREDLARKYFQ 116
E ++R + HP++++L+ K + + K +L+ +A R + + LA + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIE--R 189
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
++ A+ + H + HRD+K EN+ ++ D+ + DFG + P + N + GT A
Sbjct: 190 SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKYYGWAGTIA 248
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAG 208
APE+L + Y G D+WS G++L+ +
Sbjct: 249 TNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 67/291 (23%), Positives = 130/291 (44%), Gaps = 53/291 (18%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGES-------VAIKVINKDQLKKEFMMEQIKREISVMRL 66
+G+ LG+G F +V + + + VA+K++ D +K+ + + E+ +M++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 79
Query: 67 V-RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKY----------- 114
+ +H N++ L ++V +EY G L + R R +Y
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYCYNPTQVPEEQ 136
Query: 115 --FQQLIS-------AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165
F+ L+S +++ S+ HRDL N+L+ E+ +KI+DFGL+ + D
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 194
Query: 166 GLLHTQCGT-PA-YVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYR 222
T G P ++APE L + Y ++D+WS GV+L+ + G P+ + +++
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253
Query: 223 KVFKAEFVYPP--------------WISTDAKRLISKLLVSDPERRITIQS 259
+ + + P W + ++R K LV D +R + + S
Sbjct: 254 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 51/241 (21%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK--------KEFMMEQIKREIS-----V 63
++G+G F +V I KD L+ KE+ + R+ + +
Sbjct: 2 VIGEGNFGQVLKA------------RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 49
Query: 64 MRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLRED---LARKY------ 114
+L HPN++ L + +++A+EY G L + + R+ E A
Sbjct: 50 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 109
Query: 115 -FQQLI-------SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL--RN 164
QQL+ +D+ + HRDL N+L+ EN KI+DFGLS E +
Sbjct: 110 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 169
Query: 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRK 223
G L + ++A E L Y + +D+WS GV+L+ +++ G P+ +Y K
Sbjct: 170 MGRLPVR-----WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 224 V 224
+
Sbjct: 224 L 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 30/165 (18%)
Query: 16 RLLGKGTFAKVYYGK--QLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVMRLV 67
R LG+G F KV+ G+ L VA+K + + + +K+F RE ++
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE-----REAELLTNF 65
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR----------------GRLREDLA 111
+H N+V+ V + EY++ G+L K R G L
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 112 RKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156
+ Q+ S + + S+ HRDL N L+ + +KI DFG+S
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 7/190 (3%)
Query: 18 LGKGTFAKVYYG--KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
LG G F V G K + ++VA+K++ K+ + +++ RE +VM+ + +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHRD 134
+ + + V ME + G L + + + + E + Q+ + + HRD
Sbjct: 62 IGICEAESWMLV-MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-YVAPEVLRKKGYDGSKA 193
L N+LL KISDFGLS N T P + APE + + SK+
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKS 179
Query: 194 DLWSCGVILY 203
D+WS GV+++
Sbjct: 180 DVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP 232
GTP Y+APE+L K + G D W+ GV L+ L G PF DE +++ + +
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI--- 597
Query: 233 PW------ISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
PW +S +A+ I LL DP +R ++ + + P F
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 17 LLGKGTFAKVYYGKQLMTGES-----VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
LG+G F +V+ K E V +K + K K E + + +RE+ + R + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK--TKDENLQSEFRRELDMFRKLSHKN 69
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
VV L + + ++ +EY G+L F + + + + + A+ + G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 130 VS--------HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-YVAP 180
+ HRDL N L+ ++K+S LS + ++ P ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWLAP 187
Query: 181 EVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
E +++ + +K+D+WS GV+++ V G LPF
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 18/278 (6%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESV----AIKVINKDQLKK---EFMMEQIKREISVMRLVR 68
++LG G F VY G + GE+V AIK++N+ K EFM E + +M +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-----IMASMD 67
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDFCHS 127
HP++V L V + V G L + + + L + Q+ + +
Sbjct: 68 HPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
R + HRDL N+L+ +KI+DFGL+ L E + ++A E + +
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 188 YDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISK 245
+ ++D+WS GV ++ L+ G P+ + + K E PP + D ++ K
Sbjct: 188 FT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVK 246
Query: 246 LLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDD 283
+ D + R + + F + P + + Q DD
Sbjct: 247 CWMIDADSRPKFKEL--AAEFSRMARDPQRYLVIQGDD 282
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 41/253 (16%)
Query: 18 LGKGTFAKVYYGKQLMTG-----ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
LG+ F KVY G T ++VAIK + KD+ + + E+ K E + ++HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGP-LREEFKHEAMMRSRLQHPNI 70
Query: 73 VELREVMATKKKIFVAMEYVKGGELFA-----------------KVARGRLREDLARKYF 115
V L V+ ++ + + Y +L K + L
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 116 QQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGL-----SALPEQLRNDGLLHT 170
Q+ + ++F S V H+DL N+L+ + ++KISD GL +A +L + LL
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPF-----QDENIMNMYRKV 224
+ +++PE + G +D+WS GV+L+ + + G P+ QD M R+V
Sbjct: 191 R-----WMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244
Query: 225 FKAEFVYPPWIST 237
P W+ T
Sbjct: 245 LPCPDDCPAWVYT 257
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 22/222 (9%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKR---EISVMRLVRHPNVV 73
LL +GTF +++YG + +V K +K Q+ E ++ + H N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVK-TVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 74 E-LREVMATKKKIFVAMEYVKGGELFAKVARGRLRE-DLARKYFQ--------QLISAVD 123
L + + FV Y+ G L + + RL E + + Q+ +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL-RND-GLLHTQCGTP-AYVAP 180
+ H RGV H+D+ N ++DE +KI+D +AL L D L P ++A
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMY 221
E L K Y S +D+WS GV+L+ L+ G P+ + + M
Sbjct: 189 ESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 18 LGKGTFAKVYYGK--QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+G G F KV G+ + M+ V +K + E + +E+ R + HPNV++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQC 60
Query: 76 REVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQL----ISAVDFCHSRG 129
+ +E+ G+L + + RG + + + Q++ S + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC-GTP-AYVAPEVLRKKG 187
H DL N L + +KI D+GL+ EQ D + C P ++APE++ +G
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 188 YD------GSKADLWSCGVILYVLL-AGFLPFQD 214
D K+++WS GV ++ L A P+ D
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 11 KYEMGRLLGKGTFAKVYYG--KQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMR 65
K M R LG+G+F VY G K ++ E VAIK +N+ +E + + E SVM+
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLA--------RKYFQ- 116
+VV L V++ + V ME + G+L + + R + +K Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 117 --QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR-----NDGLLH 169
++ + + ++ HRDL N ++ E+ +KI DFG++ + GLL
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203
+ +++PE L K G + +D+WS GV+L+
Sbjct: 185 VR-----WMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 26/198 (13%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINK-DQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
++ +G Y GK + G +K IN + + I+ M ++HPN+V+L
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE--------IADMGKLQHPNIVKL 748
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH---SRGVSH 132
+ ++K ++ EY++G L ++V R L + RK + A+ F H S V
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNL-SEVLRN-LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 133 RDLKPENLLLDENED--LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+L PE +++D ++ L++S LP L D + AYVAPE K
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLS------LPGLLCTD---TKCFISSAYVAPETRETKDIT- 856
Query: 191 SKADLWSCGVILYVLLAG 208
K+D++ G+IL LL G
Sbjct: 857 EKSDIYGFGLILIELLTG 874
|
Length = 968 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINKDQLKKEFMMEQIKREISVMR 65
K + R LG+G+F VY G + ++ GE+ VA+K +N+ +E + + E SVM+
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVAR-------GRLREDLARKYFQ 116
+VV L V++ + V ME + G+L + + R GR L ++ Q
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL-QEMIQ 123
Query: 117 ---QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND-------G 166
++ + + +++ HRDL N ++ + +KI DFG++ + D G
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKG 181
Query: 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203
LL + ++APE L K G + +D+WS GV+L+
Sbjct: 182 LLPVR-----WMAPESL-KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 14 MGRLLGKGTFAKVYYGK--QLMTGES---VAIKVIN--KDQLKKEFMMEQIKREISVMRL 66
+ R LG+G F KV+ + L + VA+K + D +K+F RE ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDF-----HREAELLTN 63
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAK--------VARGRLREDLARKYF- 115
++H ++V+ V + + EY+K G+L F + +A G +L +
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 116 ---QQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA---LPEQLRNDGLLH 169
QQ+ + + + S+ HRDL N L+ EN +KI DFG+S + R G H
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--H 181
Query: 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203
T ++ PE + + + +++D+WS GV+L+
Sbjct: 182 TMLPI-RWMPPESIMYRKFT-TESDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 39/269 (14%)
Query: 18 LGKGTFAKVYYG------KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
LG+GTF +Y G + G + V+ K S+M + H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
+V+L V + I V EYVK G L F + + +QL SA+ + +
Sbjct: 63 LVKLYGVCVRDENIMV-EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 130 VSHRDLKPENLLL---DENE----DLKISDFG--LSALPEQLRNDGLLHTQCGTPAYVAP 180
+ H ++ +N+L+ NE +K+SD G ++ L + R + + ++AP
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------PWIAP 173
Query: 181 EVLRKKGYDGSK-----ADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKAEFVYP-P 233
E +R +G AD WS G L + G P + R ++ + P P
Sbjct: 174 ECIR----NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQDQHRLPMP 228
Query: 234 WISTDAKRLISKLLVSDPERRITIQSIMR 262
+ A LI++ DP +R + ++I+R
Sbjct: 229 DCAELAN-LINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 74/293 (25%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKR------------EISVM 64
++G+G F +V + I KD L+ + ++++K E+ V+
Sbjct: 14 VIGEGNFGQVLKAR------------IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 61
Query: 65 -RLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLRED-----LARKYF--- 115
+L HPN++ L + +++A+EY G L + + R+ E +A
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 116 --QQLIS-------AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL--RN 164
QQL+ +D+ + HRDL N+L+ EN KI+DFGLS E +
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 181
Query: 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRK 223
G L + ++A E L Y + +D+WS GV+L+ +++ G P+ +Y K
Sbjct: 182 MGRLPVR-----WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 224 V---FKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
+ ++ E K L D E + +MR W K + RP
Sbjct: 236 LPQGYRLE----------------KPLNCDDE----VYDLMRQCWREKPYERP 268
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 20/134 (14%)
Query: 38 VAIKVINKDQLKK---EFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94
VA+K++ +D K +F+ +EI +M ++ PN++ L V T + + EY++
Sbjct: 49 VAVKMLREDANKNARNDFL-----KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 95 GELFAKVARGRLREDLA------------RKYFQQLISAVDFCHSRGVSHRDLKPENLLL 142
G+L ++R +E Q+ S + + S HRDL N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 143 DENEDLKISDFGLS 156
+N +KI+DFG+S
Sbjct: 164 GKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 14/248 (5%)
Query: 16 RLLGKGTFAKVYYGKQLMTGES----VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
++LG G F VY G + GE+ VAIKV+ ++ K ++I E VM V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA--NKEILDEAYVMAGVGSPY 70
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
V L + T V G L + + + R+ + Q+ + + +
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG-TP-AYVAPEVLRKKGY 188
HRDL N+L+ +KI+DFGL+ L + ++ H G P ++A E + + +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILHRRF 188
Query: 189 DGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKL 246
++D+WS GV ++ L+ G P+ + + K E PP + D ++ K
Sbjct: 189 T-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKC 247
Query: 247 LVSDPERR 254
+ D E R
Sbjct: 248 WMIDSECR 255
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 16 RLLGKGTFAKVYYGKQLMTGES---VAIKVIN---KDQLKKEFMMEQIKREISVMRLVRH 69
R+LG G F ++ G + + VAI + D+ ++ F+ E + H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAE-----ALTLGQFDH 65
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHS 127
N+V L V+ + + EY+ G L F + G+L L S + +
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG-TPA-YVAPEVLRK 185
G H+ L +L++ + KIS F L E +++ + T G +P + APE + +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVLWAAPEAI-Q 181
Query: 186 KGYDGSKADLWSCGVILYVLLA-GFLPFQD 214
+ S +D+WS G++++ +++ G P+ D
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 18 LGKGTFAKVYYGKQLMTGE-------SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
LG+GTF K++ G + G+ V +KV++K E S+M + H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHK 59
Query: 71 NVVELREV-MATKKKIFVAMEYVKGGELFAKVARGRLREDLARKY--FQQLISAVDFCHS 127
++V V + + I V EYVK G L + + + +++ K +QL A+ F
Sbjct: 60 HLVLNYGVCVCGDESIMV-QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 128 RGVSHRDLKPENLLLDENED--------LKISDFGLS--ALPEQLRNDGLLHTQCGTPAY 177
+G++H ++ +N+LL ED +K+SD G+S LP+++ + + +
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI--------PW 170
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV------- 230
V PE + AD WS G L+ + +G + ++ K +F
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSALDSQKKLQFYEDRHQLP 225
Query: 231 YPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
P W T+ LI++ + +P+ R + ++I+R
Sbjct: 226 APKW--TELANLINQCMDYEPDFRPSFRAIIR 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 35/169 (20%)
Query: 18 LGKGTFAKVYY----GKQLMTGES----------VAIKVINKDQLK---KEFMMEQIKRE 60
LG+G F +V+ G GE VA+K++ D K +F+ +E
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-----KE 67
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARK------- 113
I +M +++PN++ L V + + + EY++ G+L +++ +
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 114 ------YFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156
Q+ S + + S HRDL N L+ + +KI+DFG+S
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 57/261 (21%)
Query: 38 VAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94
VA+KV+ D +++F+ +E+ ++ + PN+ L V + + MEY++
Sbjct: 49 VAVKVLRPDASDNAREDFL-----KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 95 GELFAKVARGRLREDLARKYFQ-------------QLISAVDFCHSRGVSHRDLKPENLL 141
G+L + + + E Q+ S + + S HRDL N L
Sbjct: 104 GDL-NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162
Query: 142 LDENEDLKISDFGLSALPEQLRNDGLLHT------QCGTPA---YVAPE-VLRKKGYDGS 191
+ +N +KI+DFG+S RN L++ Q P ++A E VL K +
Sbjct: 163 VGKNYTIKIADFGMS------RN---LYSSDYYRVQGRAPLPIRWMAWESVLLGKF--TT 211
Query: 192 KADLWSCGVILY--VLLAGFLPFQD-------ENIMNMYRKVFKAEFVY---PPWISTDA 239
K+D+W+ GV L+ + L P++ EN + +R +Y PP D
Sbjct: 212 KSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD--DGRQIYLPRPPNCPKDI 269
Query: 240 KRLISKLLVSDPERRITIQSI 260
L+ + D E R T + I
Sbjct: 270 YELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 108 EDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS----ALPEQLR 163
EDL FQ + ++F SR HRDL N+LL EN +KI DFGL+ P+ +R
Sbjct: 174 EDLICYSFQ-VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232
Query: 164 NDGLLHTQCGTP-AYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMY 221
P ++APE + K Y +++D+WS GV+L+ + + G P+ I +
Sbjct: 233 KG-----SARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286
Query: 222 RKVFK--AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263
+ K P + + R++ DP+ R T +++ +
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEI 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 15/194 (7%)
Query: 18 LGKGTFAKVYYGKQLMTGES--VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
LG G F V G M + VAIKV+ + K + +++ RE +M + +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKS--VRDEMMREAEIMHQLDNPYIVRM 60
Query: 76 REVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHR 133
V + + V ME GG L F + + + Q+ + + + HR
Sbjct: 61 IGVCEAEALMLV-MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 134 DLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTP---AYVAPEVLRKKGYD 189
DL N+LL KISDFGLS AL +D + + APE + + +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 190 GSKADLWSCGVILY 203
S++D+WS G+ ++
Sbjct: 177 -SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 61/257 (23%), Positives = 112/257 (43%), Gaps = 18/257 (7%)
Query: 15 GRLLGKGTFAKVYYGKQLMTGES----VAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+LLG G F V+ G + G+S VAIK I ++ F ++I + M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF--QEITDHMLAMGSLDHA 69
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSR 128
+V L + V + G L V R L + Q+ + +
Sbjct: 70 YIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSAL--PEQLRNDGLLHTQCGTP-AYVAPEVLRK 185
+ HR+L N+LL + ++I+DFG++ L P+ + +++ TP ++A E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK---YFYSEHKTPIKWMALESILF 185
Query: 186 KGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVYPPWIST-DAKRLI 243
Y ++D+WS GV ++ +++ G P+ + + K E + P I T D ++
Sbjct: 186 GRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM 244
Query: 244 SKLLVSDPERRITIQSI 260
K + D R T + +
Sbjct: 245 VKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 38/101 (37%), Positives = 56/101 (55%), Gaps = 12/101 (11%)
Query: 108 EDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS----ALPEQLR 163
EDL FQ + ++F SR HRDL N+LL EN +KI DFGL+ P+ +R
Sbjct: 173 EDLISYSFQ-VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 164 N-DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203
D L + ++APE + K Y +++D+WS GV+L+
Sbjct: 232 KGDARLPLK-----WMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 64/273 (23%), Positives = 114/273 (41%), Gaps = 44/273 (16%)
Query: 18 LGKGTFAKVYYGK--------QLMTGESVAIKVINKDQLKKEFMMEQIKREISV------ 63
LG+GT ++Y G IKVI K +++ R+IS+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK-------VLDPSHRDISLAFFETA 55
Query: 64 --MRLVRHPNVVELREVMATKKKIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLI 119
MR V H ++V L V + + E+V+ G +LF L K +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA 115
Query: 120 SAVDFCHSRGVSHRDLKPENLLL-DENED------LKISDFG--LSALPEQLRNDGLLHT 170
SA+ + + + H ++ +N+LL E D +K+SD G ++ L Q + +
Sbjct: 116 SALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--- 172
Query: 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKAEF 229
++APE + AD WS G L+ + G +P +D+ + R ++ +
Sbjct: 173 -----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC 226
Query: 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
+ + L++ + DP +R ++IMR
Sbjct: 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-07
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 3/83 (3%)
Query: 342 FTSRYSARHIMEKIEGVAKGMNFK-VAKVKDFKIRLRG--DSEGRKGPLSVIAEVFEVAP 398
SR I E I V +G V ++ +F I + D EV+EV P
Sbjct: 8 IHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVYEVGP 67
Query: 399 EVAVVEFSKSSGDTLEYAKFCEE 421
+ +V+F K +G T + K +
Sbjct: 68 GLFMVDFKKKTGSTKTFTKLATK 90
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGES-----VAIKVINKDQL--KKEFMMEQIKREISVMRL 66
+ R LG+G F KV+ + + VA+K + L +K+F +RE ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF-----QREAELLTN 63
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKV---------------ARGRLRED 109
++H ++V+ V + + EY+K G+L F + A+G L
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 110 LARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA---LPEQLRNDG 166
Q+ S + + S+ HRDL N L+ N +KI DFG+S + R G
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203
HT ++ PE + + + +++D+WS GVIL+
Sbjct: 184 --HTMLPI-RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 114 YFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS----ALPEQLRN-DGLL 168
Y Q+ ++F SR HRDL N+LL EN +KI DFGL+ P+ +R D L
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203
+ ++APE + + Y ++D+WS GV+L+
Sbjct: 244 PLK-----WMAPETIFDRVYT-IQSDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 20/97 (20%)
Query: 97 LFAKV---ARGRLRED-LARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKIS 151
L KV +G RE+ + + +Q++ A+D HS G+ HRD+KP+N++ E KI
Sbjct: 239 LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKII 298
Query: 152 DFGLSALPEQLR-------NDGLLHTQCGTPAYVAPE 181
D G +A LR + LL P Y APE
Sbjct: 299 DLGAAA---DLRVGINYIPKEFLL-----DPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 33/151 (21%), Positives = 65/151 (43%), Gaps = 24/151 (15%)
Query: 16 RLLGKGTFAKVYYGKQLMT-GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH----- 69
+LL G +VY L T E +K+ + + +RE+++++L+
Sbjct: 4 KLLKGGLTNRVY---LLGTKDEDYVLKINPSREKGADR-----EREVAILQLLARKGLPV 55
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQL--ISAVDFCHS 127
P V+ E ++ ME+++G L +ED+A + + L + +
Sbjct: 56 PKVLASGES---DGWSYLLMEWIEGETL--DEVSEEEKEDIAEQLAELLAKLHQLP---L 107
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSAL 158
+ H DL P N+L+D+ + L I D+ +
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 62 SVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYF--QQLI 119
S+M V H ++ + V + + E+V+ G L + + + R +A K QQL
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 120 SAVDFCHSRGVSHRDLKPENLLL-----DENED--LKISDFGLS--ALPEQLRNDGLLHT 170
SA+ + + + H ++ +N+LL E +K+SD G+S AL + R + +
Sbjct: 128 SALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--- 184
Query: 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCG-VILYVLLAGFLPFQDENIMNMYRKVFKAEF 229
++APE + + AD WS G +L + G +P ++ R ++ +
Sbjct: 185 -----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKH 238
Query: 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
P + LIS+ L +P +R + ++I+R
Sbjct: 239 RLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 18 LGKGTFAKVYYGK--QLMTGES---VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
LG+G F KV+ + L+ + VA+K + + E + +RE ++ +++H ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHI 69
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAK--------------VARGRLREDLARKYFQ 116
V V + + + EY++ G+L F + VA G+L
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA---LPEQLRNDG--LLHTQ 171
Q+ S + + S HRDL N L+ + +KI DFG+S + R G +L +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203
++ PE + + + +++D+WS GV+L+
Sbjct: 190 -----WMPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIK--REISVMRLVRHPNVVEL 75
+G G F KV G ++ +G + A +V+ K+ + EQ+K E R ++H N+++
Sbjct: 3 IGNGWFGKVILG-EVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLA------RKYFQQLISAVDFCHSRG 129
+ ME+ G+L + R E + ++ ++ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT-QCGTP-AYVAPEVLRKKG 187
H DL N LL + +KI D+GLS + + D + Q P ++APE++ +
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 188 -----YDGSK-ADLWSCGVILYVLL 206
D +K +++WS GV ++ L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 5e-05
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 5/67 (7%)
Query: 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146
V MEY+ G EL R R+ ED + +++ + + G+ H DL N+L+D++E
Sbjct: 108 VVMEYIDGVEL----YRVRVLED-PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162
Query: 147 DLKISDF 153
+ I D+
Sbjct: 163 KIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI-NKDQLKKEFMMEQIKREI 61
E+ V ++++ LLG+GTF KV E A+K++ N + ++ K EI
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRD-----AKIEI 176
Query: 62 SVMRLVRHPNVVELREVMATKK-------KIFVAMEYVKGGELFAKVARGRL-REDLARK 113
M VR + + +M ++ + + M L + G LA+
Sbjct: 177 QFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI 236
Query: 114 YFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPE---QLRNDGL-- 167
FQ + A+D+ H+ + H DLKPEN+L+ E D + ALP ++R L
Sbjct: 237 IFQTGV-ALDYFHTELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGG 294
Query: 168 ----LHTQCG---TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFL 210
H++ T Y +PEV+ G+ S D+WS G I+Y L G L
Sbjct: 295 CCDERHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 6e-05
Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 23/153 (15%)
Query: 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP---- 70
+L+ +G A++Y G L IK + K ++ K + ++ I R R
Sbjct: 1 MKLIKRGAEAEIYLGDFL------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMS 54
Query: 71 -------NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVD 123
NV + V I MEY++G L + + +++ V
Sbjct: 55 RARKAGVNVPAVYFVDPENFII--VMEYIEGEPLKDLINSN---GMEELELSREIGRLVG 109
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156
HS G+ H DL N++L + + DFGL+
Sbjct: 110 KLHSAGIIHGDLTTSNMILSGG-KIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 24/80 (30%), Positives = 37/80 (46%), Gaps = 6/80 (7%)
Query: 142 LDENEDLKISDFGLSALPEQLRNDGLLHTQC-----GTPAYVAPEVLRKKGYDGSKADLW 196
L E S L L+ DG + + P ++APEV++ + Y KAD++
Sbjct: 30 LRELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRPDPYFMAPEVIQGQSYT-EKADIY 88
Query: 197 SCGVILYVLLAGFLPFQDEN 216
S G+ LY L LP+ +E
Sbjct: 89 SLGITLYEALDYELPYNEER 108
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 37/144 (25%), Positives = 73/144 (50%), Gaps = 10/144 (6%)
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT-- 174
Q+ ++F S+ HRDL N+LL + + +KI DFGL+ + +D ++ T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA---RDIMHDSNYVSKGSTFL 301
Query: 175 PA-YVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEF--V 230
P ++APE + Y + +D+WS G++L+ + + G P+ + + + K+ +
Sbjct: 302 PVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 231 YPPWISTDAKRLISKLLVSDPERR 254
P + + ++ K S+PE+R
Sbjct: 361 KPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 35/142 (24%), Positives = 64/142 (45%), Gaps = 28/142 (19%)
Query: 38 VAIKVINKDQLKK---EFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94
VA+K++ D K +F+ +E+ ++ ++ PN++ L V + + + EY++
Sbjct: 49 VAVKILRPDANKNARNDFL-----KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 95 GELFAKVARGRLRED--------------LARKY------FQQLISAVDFCHSRGVSHRD 134
G+L ++ L + A Y Q+ S + + S HRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 135 LKPENLLLDENEDLKISDFGLS 156
L N L+ EN +KI+DFG+S
Sbjct: 164 LATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 42/161 (26%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 108 EDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG- 166
EDL + Q+ + F S+ HRDL N+LL KI DFGL+ +RND
Sbjct: 214 EDLL-SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDSN 269
Query: 167 -LLHTQCGTPA-YVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRK 223
++ P ++APE + Y ++D+WS G++L+ + + G P+ + + + K
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 224 VFKAEF--VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
+ K + + P ++ ++ +DP +R T + I++
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 41/198 (20%), Positives = 71/198 (35%), Gaps = 72/198 (36%)
Query: 24 AKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-----RHP-------- 70
A+V+ L +GE VA+KV + E+I+ ++ ++R + R P
Sbjct: 139 AQVHRAV-LKSGEEVAVKVQRPG------IRERIEADLKLLRRLARLIKRLPPGGRRLDL 191
Query: 71 ----------------------NVVELREVMA--------------TKKKIFVAMEYVKG 94
N RE T +++ ME++ G
Sbjct: 192 VEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLT-MEWIDG 250
Query: 95 ---GELFAKVARGR----LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED 147
++ A + G L E L R + +QL+ D G H D P N+L+ +
Sbjct: 251 IKISDIAALKSAGIDRKELAELLVRAFLRQLL--RD-----GFFHADPHPGNILVRSDGR 303
Query: 148 LKISDFGLSA-LPEQLRN 164
+ + DFG+ L + R
Sbjct: 304 IVLLDFGIVGRLDPKFRR 321
|
Length = 517 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 17/46 (36%), Positives = 30/46 (65%)
Query: 109 DLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFG 154
++ + +Q+++ + H G+ HRD+KPENLL+ + +KI DFG
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 37/177 (20%), Positives = 79/177 (44%), Gaps = 38/177 (21%)
Query: 8 LFGK-YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
+ GK +++ +L+G G F VY + + IN + K +E ++ E VM
Sbjct: 9 ITGKEWKIDKLIGCGGFGCVY------ETQCASDHCINNQAVAK---IENLENETIVMET 59
Query: 67 VRHPNVVELREVMATK--KKI----------------------FVAME--YVKGGELFAK 100
+ + N+ ++ ++ K I F+ +E E+F +
Sbjct: 60 LVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR 119
Query: 101 VARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157
+ + L + + +++ +++ H G+SH D+KPEN+++D N I D+G+++
Sbjct: 120 IKC--KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 30/102 (29%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT-- 174
Q+ + ++F S+ HRDL N+L+ E + +KI DFGL+ + D ++ T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA---RDIMRDSNYISKGSTFL 303
Query: 175 P-AYVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
P ++APE + Y + +D+WS G++L+ + G P+ +
Sbjct: 304 PLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 50/250 (20%), Positives = 101/250 (40%), Gaps = 42/250 (16%)
Query: 35 GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELR----EVMATKKKIFVAME 90
+ V I+ K + +++ + EI +R + N++++ +++ ++ + +E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 91 YVKGGELFAKVARGRLREDLARK----YFQQLISAVDFC-------HSRGVSHRDLKPEN 139
Y RG LRE L ++ + +L A+D C +++L +
Sbjct: 103 YCT---------RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS 153
Query: 140 LLLDENEDLKISDFGL----SALPEQLRNDGLLHTQCGTPAYVAPEVLRK--KGYDGSKA 193
L+ EN LKI GL S+ P + N Y + ++L Y K
Sbjct: 154 FLVTENYKLKIICHGLEKILSSPPFKNVNF---------MVYFSYKMLNDIFSEYT-IKD 203
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--AEFVYPPWISTDAKRLISKLLVSDP 251
D++S GV+L+ + G +PF++ +Y + P + K ++ D
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263
Query: 252 ERRITIQSIM 261
+R I+ I+
Sbjct: 264 IKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.004
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146
V MEY++G EL R RL + + +++ V + RG+ H DL N+L+ E+
Sbjct: 184 VVMEYIEGVEL----YRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239
Query: 147 DLKISDF 153
D+ + D+
Sbjct: 240 DIVVIDW 246
|
Length = 304 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.004
Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 18/147 (12%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKV-INK----DQLKKEFMMEQIKREISVMRLVRHP- 70
L+ KG A +Y G L G IK + K +L + E+ + E ++ R
Sbjct: 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG 58
Query: 71 -NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
N + +V K I MEY++G L + G + +++ V H G
Sbjct: 59 VNTPVVYDVDPDNKTI--VMEYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKAG 110
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLS 156
+ H DL N+++ ++ L + DFGL
Sbjct: 111 IVHGDLTTSNIIVR-DDKLYLIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 459 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.22 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.18 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.14 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.02 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.96 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.74 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.59 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.54 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.38 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.16 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.91 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.83 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.56 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.54 | |
| PLN02236 | 344 | choline kinase | 96.37 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.37 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.16 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.13 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.33 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.16 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.94 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.65 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.35 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.34 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-65 Score=512.85 Aligned_cols=339 Identities=51% Similarity=0.856 Sum_probs=277.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH--HHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE--FMMEQIKREISVMRLVR-HPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 83 (459)
...++|.+++.||+|+||+|++|.+..+|..||+|+++++..... ...+.+.+|+.++++++ ||||+++++++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 678899999999999999999999999999999998887643311 35677889999999998 999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFGla~~~~~ 161 (459)
++|+|||||.||+|++++.. +++.|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 99999999999999999987 899999999999999999999999999999999999999999 999999999999764
Q ss_pred ccCCCccccccCCCcccChhhHhhcC-CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCC-CHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKG-YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI-STDA 239 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~ 239 (459)
..+..+.+.||||.|+|||++.+.+ |++.++|||||||+||.|++|+.||++.+...++.++.++.+.+|.++ |+++
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 4567889999999999999999988 999999999999999999999999999999999999999999999999 9999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCccccc-CCCCC--cccccccCC---CCCCchhHhhhhhccccccccccccCCCcCC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRK-GFTRP--VAFSITQHD---DDGDDDQAATEKTENDRHNNQEEKVSSPKFF 313 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~-~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (459)
++||++||.+||.+|+|+.+|++||||+. ....+ ......... ....+......................+...
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPWFQKENPLPSDELPSEVAPSAPSAPSAKDSVSPVETEDEKPLSPTSTPESLPLSL 331 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChhhccCCCCCcccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999997 43222 111100000 0000000000000000000000010035577
Q ss_pred ChhhHhhhcCCCC--CCCccccccC-cccceeecCCC
Q 012637 314 NAFEFISSMSSGF--DLSNLFENKK-KTGSMFTSRYS 347 (459)
Q Consensus 314 ~~~~~~~~~s~~~--~~s~~~~~~~-~~~trf~s~~~ 347 (459)
++++.+++++++. ++++++.... ++..+|.+..+
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (370)
T KOG0583|consen 332 NAYDLGSSLSTGINEALSGLFENEKEKEEPRFASLTS 368 (370)
T ss_pred Chhhhcccccccccccccccccccccchhhhhhhccc
Confidence 8888888788888 8888887654 45566666543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-65 Score=497.26 Aligned_cols=260 Identities=40% Similarity=0.740 Sum_probs=234.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHH----HHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF----MMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
.+.+.|.+.++||+|+||.|.+|..+.||+.||||++++....... -...+.+|+.||++|+|||||+++++++..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 4778899999999999999999999999999999999887654321 234478999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC---CCeEEeecCCCcc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN---EDLKISDFGLSAL 158 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~---~~lKl~DFGla~~ 158 (459)
...||||||++||+|++++.. +.+.|+..+.||+||+.|+.|||++||+||||||||||+..+ ..+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999999999999976 789999999999999999999999999999999999999876 7899999999997
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCC--CCCcchhhhHHHHHHHHhhCCCCCCCchHHH-HHHHHHhccCCCC--C
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGY--DGSKADLWSCGVILYVLLAGFLPFQDENIMN-MYRKVFKAEFVYP--P 233 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~~~p--~ 233 (459)
.+ ....+.|.||||.|+|||++.+.++ ++.++|||||||+||.+|+|++||.+..... +.++|.++.+.+- .
T Consensus 329 ~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 329 SG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred cc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 54 5678899999999999999987654 4468999999999999999999999876555 8889999988764 3
Q ss_pred C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 234 W--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 234 ~--~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
| +|.++++||++||..||++|||++|+|+||||+..
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 4 79999999999999999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-63 Score=503.61 Aligned_cols=260 Identities=39% Similarity=0.711 Sum_probs=247.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|..++.||+|||+.||.+++..+|+.||+|++.+..+.+....+.+.+||.|++.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 36999999999999999999999999999999999998888888999999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
|+|+.++|..++++ +.++|.+|+.|++||+.||.|||++||+|||||..|+||+++-+|||+|||||+.... .+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 99999999999876 7899999999999999999999999999999999999999999999999999998764 34556
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
.|.||||.|+|||++...++ +..+||||+||+||.||+|++||+..+..+.|.+|...++.+|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 78999999999999998776 59999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccCCCC
Q 012637 249 SDPERRITIQSIMRVPWFRKGFTR 272 (459)
Q Consensus 249 ~dP~~R~t~~eil~hpw~~~~~~~ 272 (459)
+||.+|||+++||.|+||+.++.+
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcC
Confidence 999999999999999999776543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-64 Score=508.33 Aligned_cols=261 Identities=42% Similarity=0.764 Sum_probs=246.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
..+|-|+++++||.|+-|.|.+|++..||+.+|||++.+..-........|.+||.||+.+.||||+++|+++++..++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 35788999999999999999999999999999999998874434444567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+|+||++||+||+++.+ |+++|.++++||+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+ ..++
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL---e~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL---EVPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec---ccCC
Confidence 99999999999999865 9999999999999999999999999999999999999999999999999999986 3367
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
..+.|.||+|.|.|||++.+.+|+|.++||||||||||.||+|++||++.+...++.++.++.+..|..+|+++++||++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
||..||.+|+|.+||++|||+....
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999998643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-61 Score=459.97 Aligned_cols=259 Identities=38% Similarity=0.732 Sum_probs=241.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.-.+.|++.+.||+|+||+|++++.+.|++.||+|+++|..+......+.+..|..||..++||+||+++..|++..++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44678999999999999999999999999999999999998888778899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+|+||+.||+|+..+.+ +.++|+.++.|+.+|+.||.|||++||+||||||||||||.+|+++|+|||||+.... .+
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 99999999999999985 8999999999999999999999999999999999999999999999999999985432 33
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC-CCCCCHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY-PPWISTDAKRLIS 244 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~Li~ 244 (459)
....+.|||+.|||||++.+.+|+ ..+|+|||||++|+|++|.+||.+.+...++++|.++.... |..+|.++++||+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 455678999999999999999986 89999999999999999999999999999999999999544 4459999999999
Q ss_pred HhcCCCCCCCC----CHHHHhcCccccc
Q 012637 245 KLLVSDPERRI----TIQSIMRVPWFRK 268 (459)
Q Consensus 245 ~~L~~dP~~R~----t~~eil~hpw~~~ 268 (459)
++|..||++|. .+.+|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999996 6899999999974
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-60 Score=442.93 Aligned_cols=256 Identities=38% Similarity=0.727 Sum_probs=243.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.-.++|++.++||.|+||.|.+++++.+|..||+|++++..+.+-...+++.+|.++|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 55678999999999999999999999999999999999998888778899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|||||++||+||.++++ ++++|..+++|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+.. .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----S 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----c
Confidence 99999999999999987 89999999999999999999999999999999999999999999999999999853 2
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
+..-|.||||.|+|||++..++|. .++|+|||||++|||++|++||.+.++..+|.+|..++..+|+.+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 346789999999999999999986 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----CHHHHhcCccccc
Q 012637 246 LLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 246 ~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
+|+.|-.+|. ..++|.+||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999994 5789999999984
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-59 Score=448.45 Aligned_cols=264 Identities=42% Similarity=0.758 Sum_probs=250.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.+..||++.++||+|.||+|.+|+....|+.||||.|.++.+.++..+-.|.+||.||+.|+||||+.+|++|+..+++.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 56789999999999999999999999999999999999999999989999999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|||||+.+|+|++++.+ +.|+|.+++++|+||++|+.|||.++++|||||.+|||||.|+++||+||||+.++. ..
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cc
Confidence 99999999999999976 899999999999999999999999999999999999999999999999999998754 56
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
.++.|.||+|.|.+||++.+.+|.|+.+|-|||||+||.|+.|..||++.+...+.++|.++.+.-|. .+.++.-||++
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRw 285 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRW 285 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999999999887776 46678999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCCCCCc
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKGFTRPV 274 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~~~~~~ 274 (459)
||..||++|.|+++|-.|=|++-++..++
T Consensus 286 mLmVNP~RRATieDiAsHWWvNwgy~~~V 314 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVNWGYNMPV 314 (668)
T ss_pred HHhcCcccchhHHHHhhhheeeccccccc
Confidence 99999999999999999999987776554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-58 Score=458.62 Aligned_cols=260 Identities=34% Similarity=0.645 Sum_probs=242.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIF 86 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (459)
-..+|..++.||.|+|++|++|+++.+++.||||+++|..+.++...+.+.+|-.+|.+| .||.|++|+-.|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 457899999999999999999999999999999999999888888888999999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+|+||+++|+|.++|.+ |.|+|.-++.|+.||+.||+|||++|||||||||||||||.++++||+|||.|+.+......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999987 99999999999999999999999999999999999999999999999999999876542211
Q ss_pred -----------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCC
Q 012637 166 -----------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW 234 (459)
Q Consensus 166 -----------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 234 (459)
....+.+||-.|++||+|.... .+..+|||+||||||.|++|.+||.+.+.--++++|...++.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 1113468999999999998765 4689999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+++.+++||.++|..||.+|+|+.+|.+||||..
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-57 Score=439.23 Aligned_cols=260 Identities=38% Similarity=0.687 Sum_probs=237.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
....++|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .....+.+..||.+|+.++|||||+++++..+.+.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 3457899999999999999999999999999999999998876 344677889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC------CCeEEeecCCCcc
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN------EDLKISDFGLSAL 158 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~------~~lKl~DFGla~~ 158 (459)
|+|||||.||+|.+++.. ++++|..++.++.||+.||++||+++|+||||||+||||+.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999999987 799999999999999999999999999999999999999875 3589999999997
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC---CCCC
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY---PPWI 235 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~ 235 (459)
.. ......+.||+|.|||||++....|+ .|+|+||+|+|||+|++|+.||+..+..+++..+.++.... |.++
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 65 55677899999999999999988887 89999999999999999999999999999998887775443 3467
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+....+|+...|..+|..|.+..+-+.||++....
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 88889999999999999999999999999997643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=430.52 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=230.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE-EE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK-IF 86 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 86 (459)
..+..+.++.||+|+.|+||+|+|+.|++.+|+|++... .+....+++.+|+.+++.++|||||.+|+.|.++.. ++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 344677889999999999999999999999999999432 345577899999999999999999999999999995 99
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||+||+|.+.+.. ++++|.....++.++++||.|||. ++|+||||||+|||++..|.+||||||.+.....
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 99999999999999876 899999999999999999999995 9999999999999999999999999999986543
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc-----hHHHHHHHHHhcc-CCCCCC-CCH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE-----NIMNMYRKVFKAE-FVYPPW-IST 237 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~ 237 (459)
....+..||..|||||.+.+..|. .++||||||+.++|+.+|++||... +..+++..|..+. +..|.. +|+
T Consensus 232 -S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 -SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred -hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 366788999999999999998885 8899999999999999999999875 6778888888754 456665 999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
++++||..||++||.+|||+.|+++|||+++.
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 99999999999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-56 Score=445.91 Aligned_cols=260 Identities=37% Similarity=0.667 Sum_probs=234.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+-.+.|++.+.||+||||.||+|+-+.||+.||+|++.|+.......++.++.|-.+|....+|+||+++..|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 45678999999999999999999999999999999999988877778899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc---
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL--- 162 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~--- 162 (459)
|||||++||++..++.. +.|+|+.+++|+.+++.|++-||+.|++||||||+|+|||..|++||+|||||+-....
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999998876 89999999999999999999999999999999999999999999999999998532110
Q ss_pred -----------------cCC-------------------------CccccccCCCcccChhhHhhcCCCCCcchhhhHHH
Q 012637 163 -----------------RND-------------------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGV 200 (459)
Q Consensus 163 -----------------~~~-------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGv 200 (459)
..+ ......+|||.|||||++.+.+|. ..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHH
Confidence 000 011234699999999999999975 9999999999
Q ss_pred HHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCCC--CCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 012637 201 ILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPP--WISTDAKRLISKLLVSDPERRI---TIQSIMRVPWFRK 268 (459)
Q Consensus 201 il~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~R~---t~~eil~hpw~~~ 268 (459)
|+||||.|++||.+.++.+.+++|.... +.+|. .+++++.+||.+||. ||++|. +++||.+||||+.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999999999999998665 55564 478999999999999 999998 4999999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-58 Score=417.92 Aligned_cols=260 Identities=36% Similarity=0.697 Sum_probs=236.2
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
.+.+.+.|++.+.||+|+|+.|+++.+..||+.+|+|+++...+... ..+.+.+|++|.+.|+||||+++++.+.+...
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 55778899999999999999999999999999999999987766554 56789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CCCeEEeecCCCcccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NEDLKISDFGLSALPE 160 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~~lKl~DFGla~~~~ 160 (459)
.|+|+|++.|++|+.-|.. --++|..+-.+++||+.+|.|||.+||+|||+||+|+|+.. ..-+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999999766644 56899999999999999999999999999999999999964 3469999999998544
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC----CCC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP----WIS 236 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 236 (459)
.........|||.|||||++...+|. .++|||+||||||.||.|++||.+.+...+|++|+.+.+.+|+ .++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 34456677899999999999998885 8899999999999999999999999999999999999887764 389
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+++++|+++||..||.+|+|+.|+|+|||+...
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-56 Score=437.47 Aligned_cols=268 Identities=36% Similarity=0.663 Sum_probs=237.0
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHH-----------HHHHHHHHHHHHHhcCCCCcce
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF-----------MMEQIKREISVMRLVRHPNVVE 74 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~i~~Ei~il~~l~hpnIv~ 74 (459)
...+++|++.+.||+|.||.|.+|++..+++.||||++.+....... ..+++++||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34678999999999999999999999999999999999875433221 2468999999999999999999
Q ss_pred eEEEEEeC--CEEEEEEeccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEe
Q 012637 75 LREVMATK--KKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKIS 151 (459)
Q Consensus 75 l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~ 151 (459)
++++..+. +++|||+|||..|++...-.... +++.+|+.|++.++.||+|||.+||+||||||.|+||+++|++||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99999764 68999999999998865544455 9999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccc---cCCCccccccCCCcccChhhHhh---cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHH
Q 012637 152 DFGLSALPEQL---RNDGLLHTQCGTPAYVAPEVLRK---KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF 225 (459)
Q Consensus 152 DFGla~~~~~~---~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~ 225 (459)
|||.+..+... +.+..+....|||.|+|||.+.. ..+.+.+.||||+||+||.|+.|.+||.+....+++.+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99998765221 22334556889999999999987 5678999999999999999999999999999999999999
Q ss_pred hccCCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 012637 226 KAEFVYPPW--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273 (459)
Q Consensus 226 ~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~~~ 273 (459)
.....+|.. +..++++||.+||.+||++|+++.+|..|||.......+
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 998888865 799999999999999999999999999999998765443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-55 Score=450.88 Aligned_cols=260 Identities=34% Similarity=0.625 Sum_probs=244.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
.+-.++|++.++||+|+||+|++|..+.+++.||||++.|+.+......+..+.|-+|+... +||.+++++..|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 45678899999999999999999999999999999999999888777889999999999998 59999999999999999
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 85 IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+|+||||+.||++...+..+.++|..|+.|+..++.||.|||++||+|||||.+|||||.+|++||+|||+++. ....
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCCC
Confidence 99999999999976666669999999999999999999999999999999999999999999999999999983 3335
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
+....|.||||.|||||++.+..|. ..+|+|||||+||+||.|..||.+++.++++..|...++.+|.|+|.++.++++
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred CCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 5577899999999999999999885 999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 245 KLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 245 ~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
++|..||++|.. +++|++||||+.
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCcccc
Confidence 999999999995 589999999985
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-55 Score=433.25 Aligned_cols=261 Identities=39% Similarity=0.730 Sum_probs=244.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+.|=|.+.++||+|-|+.|.+|++..||+.||||++++.++... ...++.+|+++|+.++|||||++|++..+..++|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 45679999999999999999999999999999999999877554 35678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEeecCCCcccccccC
Q 012637 88 AMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~~~~~~~~ 164 (459)
|+|+-.||+|+++|.+ ..++|+.++.||.||+.|+.|||+..++||||||||+.+-+ -|-+||+|||++..+. +
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~---P 171 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ---P 171 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC---C
Confidence 9999999999999976 68999999999999999999999999999999999987764 5999999999998654 5
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
+..+.+.||+..|-|||++.+..|+.+++||||||||||-|++|.+||+..+..+.+..|+.+.+..|..+|.++++||.
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ 251 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence 66788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012637 245 KLLVSDPERRITIQSIMRVPWFRKGFTR 272 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~~~~~~~ 272 (459)
.||..||++|.|.++|..|+|++.....
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCCCC
Confidence 9999999999999999999999976544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-55 Score=436.21 Aligned_cols=257 Identities=34% Similarity=0.650 Sum_probs=239.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|.+.+.||+|+||.||+|+.+.|.+.||||.++|..-. +.....+.+|++|++.++|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 36899999999999999999999999999999999876543 34678899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
.|||.| +|+.++.. +.++|+.++.++.||++||.|||+++|.|||+||.|||++.+|.+|+||||+|+.+.. +...
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 99999987 8999999999999999999999999999999999999999999999999999987654 3345
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLL 247 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 247 (459)
.....|||.|||||++.+.+|+ ..+|+||||||||||++|++||-..+..++.+.|.+....+|...|.++.+||..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 5667899999999999999887 889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccCC
Q 012637 248 VSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 248 ~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+||.+|+|+.+++.|||++...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999998654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=405.01 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=219.7
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|+....+|+|+||.||+++++.||+.||||.+-.+ -.++...+-..|||++|++++|||+|.++++|....++++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 6799999999999999999999999999999998533 233444556689999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
|||+..-|.++-.. ++++++.++.|++|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... ++...
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~Y 158 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNY 158 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchh
Confidence 99987544444332 7899999999999999999999999999999999999999999999999999997654 44556
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--------------c-----C
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--------------E-----F 229 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------~-----~ 229 (459)
+..+.|++|+|||.+.+...+|.++||||+||++.||++|.+.|++.+..+.+..|.+. . .
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 67789999999999999777789999999999999999999999998876655444321 0 1
Q ss_pred CCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 230 VYP------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 230 ~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
.+| +.++..+.+|+++||..||.+|++.+++|.||||.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 112 23677889999999999999999999999999994
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=394.85 Aligned_cols=259 Identities=37% Similarity=0.683 Sum_probs=244.7
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
++.-.++|++++.||+|-||.||+|+.+.++-.||+|++-++.+.......++.+|+.|.+.|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 45678899999999999999999999999999999999999888777778899999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+|+++||++.|+++..+.. .+++|..+..|.+|++.||.|||..+|+||||||+|+|++..|.+||+|||-+-..
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-- 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-- 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec--
Confidence 9999999999999999983 56999999999999999999999999999999999999999999999999998632
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKR 241 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (459)
+.+.-.+.|||..|.|||+..+.+++ ..+|+|++||+.|+++.|.+||...+..+.|+.|.+.++.+|..++.++++
T Consensus 175 --p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 175 --PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD 251 (281)
T ss_pred --CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence 34556789999999999999999887 889999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
||.+||..+|.+|.+..|++.|||+..
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-55 Score=405.59 Aligned_cols=246 Identities=32% Similarity=0.587 Sum_probs=220.4
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEE-EE-EeCCEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE-VM-ATKKKI 85 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-~~-~~~~~~ 85 (459)
....|++.++||+|+||+||++.+..+|+.||.|.+.-... +....+.+..||.+|+.|+|||||++++ .+ ++...+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 34569999999999999999999999999999999974333 3445677889999999999999999998 33 445559
Q ss_pred EEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CC--cEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 86 FVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHS--RG--VSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~--~g--i~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
+||||||.+|+|...|.. ..++|..++.||.||+.||.+||+ .. |+||||||.||+|+.+|.+||+||||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999988863 569999999999999999999999 44 999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-CC-CC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YP-PW 234 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-~~ 234 (459)
+.+.. .....++.+|||.||+||++...+|+ .++||||+||++|||++-..||.+.+..++.++|..++++ +| ..
T Consensus 176 r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 176 RFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred hHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence 98764 34456778999999999999999997 9999999999999999999999999999999999999876 56 45
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCH
Q 012637 235 ISTDAKRLISKLLVSDPERRITI 257 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~ 257 (459)
.|.++..||..|+.+||..||+.
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCc
Confidence 89999999999999999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-53 Score=424.48 Aligned_cols=259 Identities=41% Similarity=0.753 Sum_probs=237.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 85 (459)
.+..+|++++.||+|.||.||+|+++.||+.+|+|++.+.........+.+.+|+.+|+++. |||||.+++++++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 45568999999999999999999999999999999999888766556678999999999998 99999999999999999
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC----CCeEEeecCCCccccc
Q 012637 86 FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN----EDLKISDFGLSALPEQ 161 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~----~~lKl~DFGla~~~~~ 161 (459)
|+|||+|.||+|++.+....++|..+..+++|++.++.|||+.||+||||||||+|+... +.+|++|||+|.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999976559999999999999999999999999999999999999744 4799999999986543
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC--CC--CCH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP--PW--IST 237 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~ 237 (459)
.....+.||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+....+.++..+++.++ +| +|.
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 5577899999999999999988875 899999999999999999999999999999999998877554 34 799
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+++||++||..||.+|+|+.++|+|||++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-53 Score=414.67 Aligned_cols=259 Identities=31% Similarity=0.572 Sum_probs=220.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC--EEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK--KIFV 87 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~l 87 (459)
-+|..++.||+|+||.||++.+..+|..+|||.+...... ..+.+.+|+.+|+.++|||||++++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4588999999999999999999999999999999765221 1677899999999999999999999754444 7999
Q ss_pred EEeccCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEeecCCCcccccc-c
Q 012637 88 AMEYVKGGELFAKVAR-G-RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLSALPEQL-R 163 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~~~~~~-~ 163 (459)
+|||++||+|.+++.+ + +++|+.++.|.+|++.||.|||++||+||||||+|||++. +|.+||+|||++...... .
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999999987 4 7999999999999999999999999999999999999999 799999999999865531 1
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC-chHHHHHHHHHhc--cCCCCCCCCHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKA--EFVYPPWISTDAK 240 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~ 240 (459)
.........|||.|||||++......+.++||||+||++.+|+||..||.. .........+... .+.+|.++|++++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 122234568999999999998633334589999999999999999999987 3444433334333 3577889999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
+||.+||..||++|||++++|+|||......
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999999999986543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=417.57 Aligned_cols=256 Identities=34% Similarity=0.694 Sum_probs=233.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 45689999999999999999999999999999999998665444445677899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+||||++||+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~---- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC----
Confidence 99999999999998876 6899999999999999999999999999999999999999999999999999975422
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|.+++..+++||.+
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 171 -RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 22356899999999999887764 8999999999999999999999998888888888888888999999999999999
Q ss_pred hcCCCCCCCCC-----HHHHhcCccccc
Q 012637 246 LLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 246 ~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
||+.||.+|++ ++++++||||..
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999997 799999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=420.70 Aligned_cols=260 Identities=33% Similarity=0.545 Sum_probs=226.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCC-
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKK- 83 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~- 83 (459)
..+.+||.+.+.||.|+||.||+|+.+.+|+.||||.+.+.-..-+..+ =.||+..|++|+ |||||++.+++.+..
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~--nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM--NLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH--HHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 4677899999999999999999999999999999999976544432222 258999999998 999999999998887
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.+|+||||++. .|+.+++. ..++|..++.|++||+.||+|+|.+|+.|||+||||||+..+..+||+|||||+-...
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999976 78998875 5699999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh---------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--------------- 226 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 226 (459)
....+..+.|++|+|||++...++++.++||||+|||++|+++-++.|+|.+..+.+.+|..
T Consensus 163 ---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 ---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred ---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 34456678899999999999999999999999999999999999999999887766655532
Q ss_pred ----ccCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 227 ----AEFVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 227 ----~~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
-.+.+| +..++++.+||.+||..||.+|||+.++|+||||+.+..
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 123333 237889999999999999999999999999999997643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=415.70 Aligned_cols=258 Identities=33% Similarity=0.531 Sum_probs=225.8
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--CEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--KKI 85 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (459)
..+.|+..++||+|+||.||+|++..||+.||+|.+..+..... ...-..|||.||++|.||||+++.+...+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 35678899999999999999999999999999999987765443 444567999999999999999999998776 789
Q ss_pred EEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|||+|||+. +|.-++... +|++.+++.|++||+.||+|||++||+|||||..|||||.+|++||+|||||+++....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999987 777777663 79999999999999999999999999999999999999999999999999999776432
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc----------cCCCC-
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA----------EFVYP- 232 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------~~~~p- 232 (459)
...++..+-|.+|+|||.|.+...++.++|+||+||||.||++|++.|++.+..+.+.+|.+. ...+|
T Consensus 273 -~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 -SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred -CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 334667778999999999999888889999999999999999999999999988888777642 01111
Q ss_pred ------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 233 ------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 233 ------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..++..+.+|+..||..||.+|.|+.++|+|+||..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 126889999999999999999999999999999943
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=385.31 Aligned_cols=255 Identities=33% Similarity=0.552 Sum_probs=224.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|...+.||+|.||.||+|++..||+.||||.+......+. ..-...|||+.|+.++||||+.++++|.+.+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 579999999999999999999999999999999987655433 3345679999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||++. +|...|+. ..++..+++.|+.|++.||+|||+++|+||||||.|+|++.+|.+||+|||+|+.+... +..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p--~~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP--NRI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC--Ccc
Confidence 99987 88888876 46899999999999999999999999999999999999999999999999999987653 333
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--------------------
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------------------- 227 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------- 227 (459)
....+-|++|+|||.+.+...++..+||||.|||+.||+-|.+-|.+.+..+.+..|.+.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 344478999999999999888889999999999999999999999999888777766542
Q ss_pred --cCCCC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 228 --EFVYP------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 228 --~~~~p------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.++.| +..+.++.+|+.+||..||.+|+|+.|+++||||+.
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 01111 225788999999999999999999999999999986
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=393.95 Aligned_cols=258 Identities=38% Similarity=0.699 Sum_probs=231.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc-----ccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-----KKEFMMEQIKREISVMRLV-RHPNVVELREVMAT 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (459)
+..+|...+.||+|..++|.++.++.+|+.+|+|+++.... ....+.+.-.+|+.||+++ .||+|++++++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 56789999999999999999999999999999999964321 1233567778999999999 69999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+..+++|+|.|+.|+|||++.+ -.++|..++.+++||+.|++|||.++|+||||||+|||+|++-++||+|||+|+...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999977 689999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCC-----CCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC--CC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGY-----DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY--PP 233 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~ 233 (459)
.+..+...||||+|.|||++...-| ++..+|+||||||+|.||.|.+||-.....-+++.|..+.+.+ |.
T Consensus 175 ---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 175 ---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 4556778899999999999975322 2478999999999999999999999988888999999887654 66
Q ss_pred C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 234 W--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 234 ~--~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
| +|..+++||++||+.||.+|+|++|+|+||||..
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 6 7889999999999999999999999999999953
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-52 Score=407.13 Aligned_cols=253 Identities=32% Similarity=0.628 Sum_probs=230.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654444344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||+++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999866 6799999999999999999999999999999999999999999999999999875432 12
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
.+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++.+++||.+||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 346799999999999887764 8999999999999999999999999988888988888888898999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 012637 249 SDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 249 ~dP~~R~t-----~~eil~hpw~~~ 268 (459)
.||.+|++ ++++++||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=410.52 Aligned_cols=250 Identities=36% Similarity=0.638 Sum_probs=225.7
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (459)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567789999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCC
Q 012637 96 ELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT 174 (459)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt 174 (459)
+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99998876 6799999999999999999999999999999999999999999999999999874221 22233456899
Q ss_pred CcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012637 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254 (459)
Q Consensus 175 ~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 254 (459)
+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+||.+||..||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999887764 8999999999999999999999998888888888888888899999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 012637 255 I-----TIQSIMRVPWFRK 268 (459)
Q Consensus 255 ~-----t~~eil~hpw~~~ 268 (459)
| ++.++++||||..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=422.78 Aligned_cols=263 Identities=41% Similarity=0.777 Sum_probs=248.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..-++.|.+.++||+|.|++|.+|++..|+..||||++++........ ..+.+|+++|+.++|||||+++.+.++...+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 456789999999999999999999999999999999999887766543 4489999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||+.+|++++++.+ +++.+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 999999999999999987 899999999999999999999999999999999999999999999999999999765 4
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
.....+.||+|.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+..++......+.+.+|..++.++.+||+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 56788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012637 245 KLLVSDPERRITIQSIMRVPWFRKGFTR 272 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~~~~~~~ 272 (459)
++|.++|.+|++.++|+.|+|.......
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999999876543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=395.45 Aligned_cols=261 Identities=30% Similarity=0.502 Sum_probs=224.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-----C
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-----K 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-----~ 82 (459)
+..+|...+.||+|+||.|+.|.++.+|+.||||.+.. .+.+.-..++..||+.+|+.++|+||+.+.+++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 44567778999999999999999999999999999852 34455567889999999999999999999999855 4
Q ss_pred CEEEEEEeccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+.+|+|+|+++ .+|...++.+. ++++.++.+++||+.||.|+|+.||+||||||.|+|++.++.+||+|||||+....
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 67999999994 48989998876 99999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh---------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--------------- 226 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 226 (459)
......++..+-|.+|+|||++.....++..+||||+||||.||++|++.|.+.+....+..|..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 33455566778899999999998766667999999999999999999999999876655544321
Q ss_pred --------ccCCCC--------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 227 --------AEFVYP--------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 227 --------~~~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.....| +..++.+.+|+.+||..||.+|+|++|+|+|||+..-.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 111111 35799999999999999999999999999999998643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=410.65 Aligned_cols=257 Identities=31% Similarity=0.612 Sum_probs=232.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCC-cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTG-ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
..-.++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 355678999999999999999999876655 6899999976655444456778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 9999999999999999976 6899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+...+|..+++.+.+||
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 2245689999999999987766 489999999999999999999999998888888888888888999999999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 244 SKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
++||+.||.+|+ |++++++||||..
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999996 8999999999975
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-52 Score=402.31 Aligned_cols=262 Identities=32% Similarity=0.534 Sum_probs=235.0
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+-...|++.+.||+|.-|+||+|+.+.++..+|+|+++++.+....-..++..|-.||+.++||.++.+|..+++....
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 34456789999999999999999999999999999999999888777788999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc-
Q 012637 86 FVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ- 161 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~- 161 (459)
|+|||||+||+|.....+ +.++|..+++|+.+++.||+|||-.|||+||||||||||.++|++.|+||.|+.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999999988865 5799999999999999999999999999999999999999999999999998742110
Q ss_pred --------------------------------ccC---------------------CCccccccCCCcccChhhHhhcCC
Q 012637 162 --------------------------------LRN---------------------DGLLHTQCGTPAYVAPEVLRKKGY 188 (459)
Q Consensus 162 --------------------------------~~~---------------------~~~~~~~~Gt~~y~APE~l~~~~~ 188 (459)
... +......+||-.|+|||++.+.+.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 001122358999999999999886
Q ss_pred CCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC--CCCHHHHHHHHHhcCCCCCCCCC----HHHHhc
Q 012637 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP--WISTDAKRLISKLLVSDPERRIT----IQSIMR 262 (459)
Q Consensus 189 ~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~R~t----~~eil~ 262 (459)
+.++|+|+|||+|||||.|..||.+.+..+.+.+|......+|. .++..++|||+++|.+||.+|.. ++||.+
T Consensus 313 -gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 -GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred -CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 59999999999999999999999999999999999998888875 47899999999999999999998 999999
Q ss_pred Cccccc
Q 012637 263 VPWFRK 268 (459)
Q Consensus 263 hpw~~~ 268 (459)
||||+.
T Consensus 392 HpFF~g 397 (459)
T KOG0610|consen 392 HPFFEG 397 (459)
T ss_pred CccccC
Confidence 999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-51 Score=403.07 Aligned_cols=249 Identities=37% Similarity=0.646 Sum_probs=224.5
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCch
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL 97 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (459)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765544444566788999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCc
Q 012637 98 FAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176 (459)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~ 176 (459)
.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999865 6899999999999999999999999999999999999999999999999999975322 1223345689999
Q ss_pred ccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCC-
Q 012637 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRI- 255 (459)
Q Consensus 177 y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~- 255 (459)
|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+......+|..+++++.+||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999887765 88999999999999999999999998888888888888888999999999999999999999997
Q ss_pred --CHHHHhcCcccccC
Q 012637 256 --TIQSIMRVPWFRKG 269 (459)
Q Consensus 256 --t~~eil~hpw~~~~ 269 (459)
++.++++||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=409.51 Aligned_cols=257 Identities=31% Similarity=0.566 Sum_probs=222.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC----
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN---- 164 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~---- 164 (459)
|||+||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999875 7899999999999999999999999999999999999999999999999999875321100
Q ss_pred -----------------------------CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc
Q 012637 165 -----------------------------DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE 215 (459)
Q Consensus 165 -----------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 215 (459)
.....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346899999999999887775 8999999999999999999999998
Q ss_pred hHHHHHHHHHhc--cCCCCC--CCCHHHHHHHHHhcCCCCC---CCCCHHHHhcCccccc
Q 012637 216 NIMNMYRKVFKA--EFVYPP--WISTDAKRLISKLLVSDPE---RRITIQSIMRVPWFRK 268 (459)
Q Consensus 216 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~---~R~t~~eil~hpw~~~ 268 (459)
+..+.+..+... ...+|+ .+++++++||.+|+. +|. .||+++||++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888877653 344554 368999999999875 444 4689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=414.10 Aligned_cols=255 Identities=30% Similarity=0.559 Sum_probs=228.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
..+|...+.||+|+-|.||.|+...+++.||||.++....... +-+.+|+.+|+..+|+|||++++.|.-.+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 3568889999999999999999999999999999987765443 5678999999999999999999999888999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 89 MEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
|||++||+|.|.+....++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++....... ..-
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKR 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--Ccc
Confidence 999999999999999899999999999999999999999999999999999999999999999999998655422 244
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHH-hc--cCCCCCCCCHHHHHHHHH
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF-KA--EFVYPPWISTDAKRLISK 245 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~--~~~~p~~~s~~~~~Li~~ 245 (459)
.+..|||.|||||++....| |.++||||||++++||+-|.+||-.+++...+..|. .+ ++..|..+|+.+++||.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 67889999999999999887 599999999999999999999998766654444443 33 455677899999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
||+.||.+|+|+.|+|+||||+..
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhhc
Confidence 999999999999999999999654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=401.98 Aligned_cols=254 Identities=31% Similarity=0.560 Sum_probs=227.0
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHH---HhcCCCCcceeEEEEEeCCEEEEE
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM---RLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999865443334456677777766 456799999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 89 MEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
|||++||+|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999864321 22233
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
.+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+.......|..+++++.+||.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999987766 48899999999999999999999999888888888888888888999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 012637 249 SDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 249 ~dP~~R~-----t~~eil~hpw~~~ 268 (459)
.||.+|| ++.++++||||+.
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=403.46 Aligned_cols=250 Identities=37% Similarity=0.676 Sum_probs=224.9
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (459)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445667889999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCC
Q 012637 96 ELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT 174 (459)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt 174 (459)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99988866 6799999999999999999999999999999999999999999999999999874221 12233456899
Q ss_pred CcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012637 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254 (459)
Q Consensus 175 ~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 254 (459)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||.+||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987766 48999999999999999999999988888888888888888899999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 012637 255 I-----TIQSIMRVPWFRK 268 (459)
Q Consensus 255 ~-----t~~eil~hpw~~~ 268 (459)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=392.57 Aligned_cols=263 Identities=30% Similarity=0.535 Sum_probs=230.1
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+.+-.+.|++...||.|.-++||+|+.+.+++.||||+++.++..+. .+.+.+|+..|+.++||||++++..|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 44566789999999999999999999999999999999998887664 7889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+|+||.|+.+|++++.+.. ..++|..+..++++++.||.|||++|-+|||||+.||||+.+|.|||+|||.+..+-.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999999975 5799999999999999999999999999999999999999999999999998764433
Q ss_pred ccCCC--ccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC-----
Q 012637 162 LRNDG--LLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----- 232 (459)
Q Consensus 162 ~~~~~--~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----- 232 (459)
.+... ...+..|||+|||||++.. .+|+ .|+||||+||+..||.+|..||....+..++-.-..+.++.+
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence 22211 1256689999999999543 4665 999999999999999999999999888776655555554422
Q ss_pred -----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 233 -----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 233 -----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
..++..++.+|..||+.||.+|||++++|+|+||++..
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 12677899999999999999999999999999998643
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=400.66 Aligned_cols=250 Identities=35% Similarity=0.668 Sum_probs=223.8
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999865443333456677888898876 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998865 6899999999999999999999999999999999999999999999999999874321 2223345689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+....+..+.......|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877664 889999999999999999999999999888899988888889999999999999999999999
Q ss_pred CCCH------HHHhcCccccc
Q 012637 254 RITI------QSIMRVPWFRK 268 (459)
Q Consensus 254 R~t~------~eil~hpw~~~ 268 (459)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=406.33 Aligned_cols=257 Identities=32% Similarity=0.614 Sum_probs=223.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998655444445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC---
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND--- 165 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~--- 165 (459)
|||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999866 67999999999999999999999999999999999999999999999999998643211000
Q ss_pred ---------------------------------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCC
Q 012637 166 ---------------------------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPF 212 (459)
Q Consensus 166 ---------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf 212 (459)
....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011235799999999999887775 8999999999999999999999
Q ss_pred CCchHHHHHHHHHhcc--CCCCC--CCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 012637 213 QDENIMNMYRKVFKAE--FVYPP--WISTDAKRLISKLLVSDPERRIT---IQSIMRVPWFRK 268 (459)
Q Consensus 213 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~R~t---~~eil~hpw~~~ 268 (459)
.+.+..+.+..+.... +..|. .+++++.+||.+||. +|.+|++ ++++++||||+.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988877777665432 33343 368999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=401.03 Aligned_cols=250 Identities=35% Similarity=0.643 Sum_probs=224.6
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (459)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567788999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCC
Q 012637 96 ELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT 174 (459)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt 174 (459)
+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99988866 6799999999999999999999999999999999999999999999999999874221 22233456799
Q ss_pred CcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012637 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254 (459)
Q Consensus 175 ~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 254 (459)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999877664 8999999999999999999999998888888888888888888999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 012637 255 I-----TIQSIMRVPWFRK 268 (459)
Q Consensus 255 ~-----t~~eil~hpw~~~ 268 (459)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=398.66 Aligned_cols=255 Identities=32% Similarity=0.583 Sum_probs=228.0
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CCcceeEEEEEeCCEEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH-PNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~ 89 (459)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.+.| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48999999999999999999999999999999987654444456678889999999976 56889999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999998865 6799999999999999999999999999999999999999999999999999864221 22233
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
...+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+..+.+..+......+|..+++++.+||.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999887764 8899999999999999999999999888888888888888899999999999999999
Q ss_pred CCCCCCCCH-----HHHhcCccccc
Q 012637 249 SDPERRITI-----QSIMRVPWFRK 268 (459)
Q Consensus 249 ~dP~~R~t~-----~eil~hpw~~~ 268 (459)
+||.+|+++ +++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=400.00 Aligned_cols=254 Identities=34% Similarity=0.559 Sum_probs=224.9
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999975 6799999999999999999999999999999999999999999999999999975432 33
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCCC------CCCHHHH
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPP------WISTDAK 240 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~ 240 (459)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456899999999999887665 89999999999999999999999988877766665422 22232 3589999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 241 RLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+||.+||..+|.+|||++++++||||...
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=398.65 Aligned_cols=250 Identities=33% Similarity=0.644 Sum_probs=224.5
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444456677899999876 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999988865 6899999999999999999999999999999999999999999999999999874322 2233445689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+.......|.+++.++.+||.+||++||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999877764 899999999999999999999999999999999998888889999999999999999999999
Q ss_pred CC-------CHHHHhcCccccc
Q 012637 254 RI-------TIQSIMRVPWFRK 268 (459)
Q Consensus 254 R~-------t~~eil~hpw~~~ 268 (459)
|+ +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=405.59 Aligned_cols=261 Identities=31% Similarity=0.540 Sum_probs=228.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45678999999999999999999999999999999997654444444556789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
+||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ..
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999997543211 11
Q ss_pred ccccccCCCcccChhhHhhcC---CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCCC--CCCHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKG---YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPP--WISTDA 239 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 239 (459)
...+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+..+.... ..+|. .+|.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 224568999999999997543 34589999999999999999999999998888888876543 44554 479999
Q ss_pred HHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012637 240 KRLISKLLVSDPER--RITIQSIMRVPWFRK 268 (459)
Q Consensus 240 ~~Li~~~L~~dP~~--R~t~~eil~hpw~~~ 268 (459)
.+||.+||+.+|.+ |+|++++++||||+.
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=405.85 Aligned_cols=257 Identities=32% Similarity=0.522 Sum_probs=220.6
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987665555566788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC-----
Q 012637 91 YVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN----- 164 (459)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~----- 164 (459)
||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999876 6799999999999999999999999999999999999999999999999999854311000
Q ss_pred ----------------------------------------CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHH
Q 012637 165 ----------------------------------------DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYV 204 (459)
Q Consensus 165 ----------------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ 204 (459)
.....+.+||+.|+|||++.+..+. .++||||+||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0011345799999999999887775 89999999999999
Q ss_pred HhhCCCCCCCchHHHHHHHHHh--ccCCCCC--CCCHHHHHHHHHhc--CCCCCCCCCHHHHhcCccccc
Q 012637 205 LLAGFLPFQDENIMNMYRKVFK--AEFVYPP--WISTDAKRLISKLL--VSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 205 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~Li~~~L--~~dP~~R~t~~eil~hpw~~~ 268 (459)
|++|..||...+.......+.. .....|. .+++++.+||.+|| .++|..|+|++++++||||..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 9999999998877666555543 2344444 47999999999966 455566999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=406.89 Aligned_cols=257 Identities=31% Similarity=0.586 Sum_probs=220.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444445677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC---
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND--- 165 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~--- 165 (459)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999876 67999999999999999999999999999999999999999999999999999632110000
Q ss_pred ------------------------------------------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHH
Q 012637 166 ------------------------------------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203 (459)
Q Consensus 166 ------------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ 203 (459)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 000135799999999999887764 8999999999999
Q ss_pred HHhhCCCCCCCchHHHHHHHHHh--ccCCCCC--CCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCccccc
Q 012637 204 VLLAGFLPFQDENIMNMYRKVFK--AEFVYPP--WISTDAKRLISKLLVSDPERR---ITIQSIMRVPWFRK 268 (459)
Q Consensus 204 ~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~Li~~~L~~dP~~R---~t~~eil~hpw~~~ 268 (459)
+|++|.+||.+.+..+.+..+.. ....+|. .++.++.+||.+||. +|.+| +|+.++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999999998887777776654 2344454 378999999999998 67765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=390.09 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=219.2
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999986654443334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|+++|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999877743 3689999999999999999999999999999999999999999999999999975421 222
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH----HHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM----NMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
....+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.. .....+......++..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999887765 8899999999999999999999875432 2333334445566777899999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 244 SKLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
++||+.||.+||| ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=399.82 Aligned_cols=250 Identities=37% Similarity=0.652 Sum_probs=224.2
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (459)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567788999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 96 ELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
+|..++.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998865 679999999999999999999997 7999999999999999999999999999864221 2223345679
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999877764 899999999999999999999999888888888888888888899999999999999999999
Q ss_pred CC-----CHHHHhcCccccc
Q 012637 254 RI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 254 R~-----t~~eil~hpw~~~ 268 (459)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=405.94 Aligned_cols=257 Identities=33% Similarity=0.565 Sum_probs=221.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998665444445678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc-----
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR----- 163 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~----- 163 (459)
|||+||+|.+.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999998876 679999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHH
Q 012637 164 ----------------------------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILY 203 (459)
Q Consensus 164 ----------------------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ 203 (459)
......+.+||+.|+|||++.+.+|. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011245799999999999888775 8999999999999
Q ss_pred HHhhCCCCCCCchHHHHHHHHHhc--cCCCC--CCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 012637 204 VLLAGFLPFQDENIMNMYRKVFKA--EFVYP--PWISTDAKRLISKLLVSDPERRIT---IQSIMRVPWFRK 268 (459)
Q Consensus 204 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t---~~eil~hpw~~~ 268 (459)
+|++|++||.+.+..+....+... ....| ..+++++.+||.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988877666665542 23334 347999999999987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=404.60 Aligned_cols=262 Identities=31% Similarity=0.556 Sum_probs=227.0
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567899999999999999999999999999999999765444443456678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 86 FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|+|||||+||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~-~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC-Cc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999754321 11
Q ss_pred CccccccCCCcccChhhHhhcC---CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCCC--CCCHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKG---YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPP--WISTD 238 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 238 (459)
....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||.+.+....+..+.... +.+|. .++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 1234678999999999997643 34589999999999999999999999988888777776533 44554 36999
Q ss_pred HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPER--RITIQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~--R~t~~eil~hpw~~~ 268 (459)
+++||.+||..+|.+ |+|++++++||||+.
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 999999999865544 899999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=389.55 Aligned_cols=253 Identities=28% Similarity=0.531 Sum_probs=213.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||.|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 468999999999999999999999999999999997543221 234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||++| +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CCc
Confidence 999986 88888754 3589999999999999999999999999999999999999999999999999875332 222
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------- 227 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 227 (459)
......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3345678999999999876544468999999999999999999999887766554433221
Q ss_pred cCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 228 EFVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 228 ~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
...+| +.+++++.+||.+||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00111 2368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=386.47 Aligned_cols=261 Identities=36% Similarity=0.654 Sum_probs=242.1
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
..+..+.|...++||+|.||+|.+++-+.+++.||||+++++-+........-..|-++|+.++||.+..+...|+...+
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 34567889999999999999999999999999999999999877766667777889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||||+.||+|+-.+.+ ..++|+.+++|-..|++||.|||+++|++||||.+|+|+|.+|++||+||||++. ...
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~ 320 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIK 320 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--ccc
Confidence 9999999999999998876 6799999999999999999999999999999999999999999999999999973 223
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
......+.||||.|.|||++....| +.++|+|.+||++|+|++|++||...+-..++..|...++.+|..++++++.|+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred ccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 4456678999999999999998877 599999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 244 SKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
..+|.+||++|. .+.||..|+||..
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 999999999998 4889999999974
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=395.65 Aligned_cols=251 Identities=33% Similarity=0.609 Sum_probs=221.3
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||.||+|.++.+|+.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999765432222345567788888765 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999988866 6899999999999999999999999999999999999999999999999999864221 2223456789
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+.......|.+++.++++||.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887764 889999999999999999999999888888888887778889999999999999999999999
Q ss_pred CCCH-HHHhcCcccccC
Q 012637 254 RITI-QSIMRVPWFRKG 269 (459)
Q Consensus 254 R~t~-~eil~hpw~~~~ 269 (459)
||++ +++++||||...
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9997 589999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=394.55 Aligned_cols=255 Identities=32% Similarity=0.584 Sum_probs=227.8
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999876544444455677788888877 5899999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||++||+|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999998865 7899999999999999999999999999999999999999999999999999874321 12233
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
...+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+......+|..++.++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456899999999999987775 8999999999999999999999999988888888888888899999999999999999
Q ss_pred CCCCCCCCH-----HHHhcCccccc
Q 012637 249 SDPERRITI-----QSIMRVPWFRK 268 (459)
Q Consensus 249 ~dP~~R~t~-----~eil~hpw~~~ 268 (459)
.||.+|++. .++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=400.81 Aligned_cols=257 Identities=33% Similarity=0.653 Sum_probs=226.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765444345667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc-----
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR----- 163 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~----- 163 (459)
||++|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999876 689999999999999999999999999999999999999999999999999997544321
Q ss_pred ----------------------CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHH
Q 012637 164 ----------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY 221 (459)
Q Consensus 164 ----------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~ 221 (459)
.........||+.|+|||++.+..+. .++|||||||+||+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00123456799999999999887664 8999999999999999999999998887777
Q ss_pred HHHHh--ccCCCCCC--CCHHHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 012637 222 RKVFK--AEFVYPPW--ISTDAKRLISKLLVSDPERRIT-IQSIMRVPWFRK 268 (459)
Q Consensus 222 ~~i~~--~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t-~~eil~hpw~~~ 268 (459)
..+.. .....|.. +++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77765 44445544 59999999999998 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=404.89 Aligned_cols=257 Identities=32% Similarity=0.544 Sum_probs=220.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654433444567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc-----
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR----- 163 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~----- 163 (459)
|||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999876 678999999999999999999999999999999999999999999999999985321100
Q ss_pred ------------------------------------CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh
Q 012637 164 ------------------------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA 207 (459)
Q Consensus 164 ------------------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~ 207 (459)
........+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011235799999999999887774 89999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHhc--cCCCCC--CCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 012637 208 GFLPFQDENIMNMYRKVFKA--EFVYPP--WISTDAKRLISKLLVSDPERRI---TIQSIMRVPWFRK 268 (459)
Q Consensus 208 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~~R~---t~~eil~hpw~~~ 268 (459)
|+.||.+.+..+....+... ....|. .+++++.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988877666555432 223333 47999999999987 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=386.61 Aligned_cols=254 Identities=29% Similarity=0.469 Sum_probs=213.0
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|+++.+++.||+|++....... ...+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 47999999999999999999999999999999997653322 24566789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||++++.+...... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-ccccc
Confidence 99999877655543 57999999999999999999999999999999999999999999999999999764321 11223
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------cC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------------------EF 229 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 229 (459)
...+||+.|+|||++.+..+. .++||||+||++|+|++|++||.+.+..+....+... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345799999999999887764 8999999999999999999999886654333222110 00
Q ss_pred CCC-------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 VYP-------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 ~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
..| ..+|.++.+||.+||++||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=395.90 Aligned_cols=250 Identities=31% Similarity=0.593 Sum_probs=219.1
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555567788999999998 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|..++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 999988865 7899999999999999999999999999999999999999999999999999863211 2233446789
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc---------hHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE---------NIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
|+.|+|||++.+..+. .++||||+||++|+|++|+.||... .....++.+.......|..++.++.+||.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887764 8999999999999999999999631 12234556667777888899999999999
Q ss_pred HhcCCCCCCCCC------HHHHhcCccccc
Q 012637 245 KLLVSDPERRIT------IQSIMRVPWFRK 268 (459)
Q Consensus 245 ~~L~~dP~~R~t------~~eil~hpw~~~ 268 (459)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=393.37 Aligned_cols=250 Identities=37% Similarity=0.675 Sum_probs=220.6
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||.||+|.+..+++.||+|++.++........+.+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999865543333445566777777655 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 999998865 6899999999999999999999999999999999999999999999999999974322 1233445689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+......+|.+++.++.+||.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877764 889999999999999999999999888888888887777888899999999999999999999
Q ss_pred CCCH-HHHhcCccccc
Q 012637 254 RITI-QSIMRVPWFRK 268 (459)
Q Consensus 254 R~t~-~eil~hpw~~~ 268 (459)
||++ .++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 9986 48999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=380.34 Aligned_cols=258 Identities=31% Similarity=0.445 Sum_probs=220.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CCEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KKKI 85 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (459)
.++.|+....|++|+||.||+|+|+.|++.||+|.++.+.-.....+ .-.|||.+|.+++|||||.+.++... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 35678999999999999999999999999999999976653333223 34589999999999999999998754 4679
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|||||||+. +|...+.. .++.+.+++.++.|++.|++|||.++|+||||||+|+|++..|.+||+|||||+.+...
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999999987 78888865 58999999999999999999999999999999999999999999999999999976542
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc----------------
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---------------- 227 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 227 (459)
-..++..+-|.+|+|||.+.+...++.++|+||+|||+.+|+++++.|.+.+..+...+|.+.
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 334555677999999999999887789999999999999999999999999887777666531
Q ss_pred ---cCCCC-----------CC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 ---EFVYP-----------PW--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 ---~~~~p-----------~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...++ ++ ++....+|++.+|..||.+|.|+++.|+|+||...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 01111 11 45888999999999999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=388.60 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=209.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||.||+|.++.+++.||+|++....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 478999999999999999999999999999999987543222 223567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+++ +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 999965 67776654 5799999999999999999999999999999999999999999999999999874322 122
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH-HHHHHHHHh--ccC--------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVFK--AEF-------------- 229 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~--~~~-------------- 229 (459)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+.. +..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 334567899999999987655556889999999999999999999987432 222222111 000
Q ss_pred -------CCC---------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 230 -------VYP---------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 230 -------~~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..| ...++++.+||.+||+.||++|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 001 0135678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=393.51 Aligned_cols=252 Identities=35% Similarity=0.656 Sum_probs=223.0
Q ss_pred eeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccc-cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 15 GRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.+.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47889999999765432 22334567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 91 YVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
|++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 9999999999876 6789999999999999999999999999999999999999999999999999864322 222334
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCC
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 249 (459)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+....|+.+++++.+||.+||++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 5689999999999987766 489999999999999999999999988888888888888888999999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccC
Q 012637 250 DPERRI-----TIQSIMRVPWFRKG 269 (459)
Q Consensus 250 dP~~R~-----t~~eil~hpw~~~~ 269 (459)
||.+|| +++++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=400.11 Aligned_cols=257 Identities=33% Similarity=0.606 Sum_probs=222.9
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999997654444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC----
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN---- 164 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~---- 164 (459)
|||+||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999865 6899999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc
Q 012637 165 -----------------------------DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE 215 (459)
Q Consensus 165 -----------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 215 (459)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245899999999999888775 8999999999999999999999998
Q ss_pred hHHHHHHHHHhc--cCCCCCC--CCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 012637 216 NIMNMYRKVFKA--EFVYPPW--ISTDAKRLISKLLVSDPERRI---TIQSIMRVPWFRK 268 (459)
Q Consensus 216 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~~R~---t~~eil~hpw~~~ 268 (459)
+....+..+... ...+|+. +++++++||.+|+. ||.+|+ +++++++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 888877777642 3344543 78999999999875 999998 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=393.59 Aligned_cols=250 Identities=36% Similarity=0.620 Sum_probs=220.2
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS-VMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654433333445555655 46789999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999998866 6799999999999999999999999999999999999999999999999999874321 2223345689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+.......++.+++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999887764 889999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 012637 254 RITI----QSIMRVPWFRK 268 (459)
Q Consensus 254 R~t~----~eil~hpw~~~ 268 (459)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=391.48 Aligned_cols=255 Identities=31% Similarity=0.578 Sum_probs=226.7
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.|+..+.||+|+||.||+|.++.+|+.||+|++.++........+.+..|+.+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765444444566778999998885 578889999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 99999999999876 7899999999999999999999999999999999999999999999999999874321 12223
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
...+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+......+|..++.++.+|+.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999877764 8999999999999999999999999888888888888888899999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 012637 249 SDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 249 ~dP~~R~t-----~~eil~hpw~~~ 268 (459)
+||.+|++ .+++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 579999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=392.00 Aligned_cols=250 Identities=37% Similarity=0.691 Sum_probs=224.3
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444556678899999888 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999998876 5899999999999999999999999999999999999999999999999999864221 2223345689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+......+|..++.++.+||.+||..||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 899999999999999999999999888888888888888888889999999999999999999
Q ss_pred CCCH-----HHHhcCccccc
Q 012637 254 RITI-----QSIMRVPWFRK 268 (459)
Q Consensus 254 R~t~-----~eil~hpw~~~ 268 (459)
|||+ .++++||||+.
T Consensus 238 R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 9999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=391.03 Aligned_cols=250 Identities=35% Similarity=0.654 Sum_probs=220.6
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||+||+|++..+++.||||++.+..............|..+++.+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999765433223345566788888764 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|...+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999876 6899999999999999999999999999999999999999999999999999864221 1223345679
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+......+|.+++.++.+||.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999877764 899999999999999999999999888888888877777788899999999999999999999
Q ss_pred CCCHH-HHhcCccccc
Q 012637 254 RITIQ-SIMRVPWFRK 268 (459)
Q Consensus 254 R~t~~-eil~hpw~~~ 268 (459)
||++. ++++||||+.
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 9999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=392.30 Aligned_cols=250 Identities=31% Similarity=0.597 Sum_probs=218.1
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555567788999998877 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999888865 6899999999999999999999999999999999999999999999999999874321 2223345689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC---------chHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD---------ENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.. .........+......+|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887764 899999999999999999999952 112234555666777888899999999999
Q ss_pred HhcCCCCCCCCC------HHHHhcCccccc
Q 012637 245 KLLVSDPERRIT------IQSIMRVPWFRK 268 (459)
Q Consensus 245 ~~L~~dP~~R~t------~~eil~hpw~~~ 268 (459)
+||+.||++||| ++++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=391.35 Aligned_cols=257 Identities=33% Similarity=0.607 Sum_probs=220.7
Q ss_pred CEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
+|++.+.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 47899999999765432 233456788999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence 999999999999998865 67999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc----hHHHHHHHHHhccCCCCCCCCHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE----NIMNMYRKVFKAEFVYPPWISTDAK 240 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (459)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122335689999999999987654568999999999999999999999643 3334455566666777788999999
Q ss_pred HHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 241 RLISKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
+||.+||+.||++|| +++++++||||+.
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 8889999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=394.02 Aligned_cols=257 Identities=31% Similarity=0.578 Sum_probs=222.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence 99999999999976 579999999999999999999999999999999999999999999999999997543211 112
Q ss_pred cccccCCCcccChhhHhh-----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCC--CCCCHH
Q 012637 168 LHTQCGTPAYVAPEVLRK-----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYP--PWISTD 238 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 238 (459)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+..+.... ..+| +.++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999873 2233588999999999999999999999888777777665432 2233 357999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+.+||.+||. +|.+|||++++++||||..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=396.96 Aligned_cols=262 Identities=32% Similarity=0.552 Sum_probs=226.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 44579999999999999999999999999999999997654444444566789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
+|||||+||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus 120 lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-Ccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999754321 111
Q ss_pred ccccccCCCcccChhhHhhcC---CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCCC--CCCHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKG---YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPP--WISTDA 239 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 239 (459)
...+.+||+.|+|||++.... +.+.++|||||||++|+|++|..||.+.+....+..+.... ..+|. .++..+
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 234568999999999997543 34589999999999999999999999998888888876543 33443 589999
Q ss_pred HHHHHHhcCCCCCC--CCCHHHHhcCcccccC
Q 012637 240 KRLISKLLVSDPER--RITIQSIMRVPWFRKG 269 (459)
Q Consensus 240 ~~Li~~~L~~dP~~--R~t~~eil~hpw~~~~ 269 (459)
++||.+||..+|.+ |+++++|++||||+..
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=393.10 Aligned_cols=249 Identities=31% Similarity=0.581 Sum_probs=217.8
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV---RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
||+|+||+||+|++..+|+.||+|++.+..............|..++..+ .||||+++++++.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765444333444556677777665 699999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999988865 6899999999999999999999999999999999999999999999999999874322 2233456789
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC-CCCHHHHHHHHHhcCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-WISTDAKRLISKLLVSDPE 252 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~Li~~~L~~dP~ 252 (459)
|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+..+...+|. .+++++.+||.+||.+||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999976554468999999999999999999999999888888888877777775 4799999999999999999
Q ss_pred CCC----CHHHHhcCccccc
Q 012637 253 RRI----TIQSIMRVPWFRK 268 (459)
Q Consensus 253 ~R~----t~~eil~hpw~~~ 268 (459)
+|| +++++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=390.57 Aligned_cols=250 Identities=35% Similarity=0.626 Sum_probs=219.6
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS-VMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654433334455556665 46778999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999988865 6899999999999999999999999999999999999999999999999999874221 2223345689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+.......++..+..+.++|.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999887775 899999999999999999999999988888888888877777889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 012637 254 RITI----QSIMRVPWFRK 268 (459)
Q Consensus 254 R~t~----~eil~hpw~~~ 268 (459)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=388.36 Aligned_cols=250 Identities=35% Similarity=0.599 Sum_probs=219.7
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS-VMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998655433333445556654 67889999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988865 6799999999999999999999999999999999999999999999999999874321 2223345689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+.......|+..+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999877765 789999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 012637 254 RITI----QSIMRVPWFRK 268 (459)
Q Consensus 254 R~t~----~eil~hpw~~~ 268 (459)
|+++ .++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=387.67 Aligned_cols=250 Identities=30% Similarity=0.584 Sum_probs=218.8
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555567788999999888 699999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999988865 6899999999999999999999999999999999999999999999999999874221 2223456789
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc-------hHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE-------NIMNMYRKVFKAEFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 246 (459)
|+.|+|||++.+..+. .++|||||||++|+|++|..||... .....++.+.......|..++..+.+||.+|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999887764 8999999999999999999999531 2234555666666778888999999999999
Q ss_pred cCCCCCCCCC------HHHHhcCccccc
Q 012637 247 LVSDPERRIT------IQSIMRVPWFRK 268 (459)
Q Consensus 247 L~~dP~~R~t------~~eil~hpw~~~ 268 (459)
|+.||.+|++ ++++++||||+.
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=387.89 Aligned_cols=250 Identities=34% Similarity=0.617 Sum_probs=218.3
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS-VMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998654433323334444544 56788999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999998876 6799999999999999999999999999999999999999999999999999874321 2233446689
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+.......++.+++.+.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887765 889999999999999999999999888888888887777778889999999999999999999
Q ss_pred CCCHH----HHhcCccccc
Q 012637 254 RITIQ----SIMRVPWFRK 268 (459)
Q Consensus 254 R~t~~----eil~hpw~~~ 268 (459)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=388.85 Aligned_cols=249 Identities=34% Similarity=0.654 Sum_probs=221.3
Q ss_pred eeecccCcEEEEEEEEc---CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q 012637 16 RLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYV 92 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (459)
+.||+|+||.||++++. .+|+.||+|++.+...... ....+.+|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999864 5789999999976543322 3345678999999999999999999999999999999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccc
Q 012637 93 KGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ 171 (459)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~ 171 (459)
+||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 99999999865 6799999999999999999999999999999999999999999999999999875432 12233456
Q ss_pred cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCC
Q 012637 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDP 251 (459)
Q Consensus 172 ~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 251 (459)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......|..+++++.+||.+||++||
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 89999999999987766 48999999999999999999999998888888888888888899999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q 012637 252 ERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 252 ~~R~t-----~~eil~hpw~~~ 268 (459)
.+||| ++++++||||..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCC
Confidence 99999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=394.74 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=229.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
-..|+..+.||+|+||.||+|.+..+++.||+|+++.+.... .++.+.+|+.+|..++++||.++|+.+.....+|++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 356888899999999999999999999999999999877655 478899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVARGRL-REDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l-~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||.||++.+.++.+.+ .|.++..++++++.||.|||+++.+|||||+.|||+..+|.+||+|||.+...... ...
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKR 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhc
Confidence 999999999999988665 99999999999999999999999999999999999999999999999999765432 223
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHHHHh
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISKL 246 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 246 (459)
..+..|||.|||||++.+.+|+ .++||||||++.++|++|.+||....++.....|.+..+ .+...+|+.+++|+..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 3788999999999999988887 899999999999999999999999888655555544332 22335899999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccCC
Q 012637 247 LVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
|+.||+.||||.++|+|+|++...
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999999999999999998743
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=386.21 Aligned_cols=255 Identities=31% Similarity=0.497 Sum_probs=207.7
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----CEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK-----KKI 85 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 85 (459)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998643222 22345678999999999999999999988543 358
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+|||||. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999996 588888865 6799999999999999999999999999999999999999999999999999975432111
Q ss_pred -CCccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh---------------
Q 012637 165 -DGLLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--------------- 226 (459)
Q Consensus 165 -~~~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 226 (459)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 112245679999999999875 334 5899999999999999999999987654332211110
Q ss_pred -----------ccCCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 227 -----------AEFVY-----PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 227 -----------~~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..... .+..++++.+||.+||+.||++|||++++++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000 1236788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=376.82 Aligned_cols=257 Identities=31% Similarity=0.514 Sum_probs=219.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC-cceeEEEEEeCC----
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN-VVELREVMATKK---- 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 83 (459)
...|...+.||+|+||+||+|+++.+|+.||+|.+..+.-. +.......+|+.+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45577788899999999999999999999999999866432 223455679999999999999 999999998887
Q ss_pred --EEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 84 --KIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
.+|+|+||++. +|..++.. ..++...++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999976 88888865 25888899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---------
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--------- 227 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------- 227 (459)
+.+.- +........+|.+|+|||++.+...++..+||||+|||+++|+++..-|.+.+..+....|.+-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 85542 2334566789999999999998866678999999999999999999999998887766666431
Q ss_pred ---------cCCCCCC------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 ---------EFVYPPW------------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 ---------~~~~p~~------------~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...+|.| .+++..+|+.+||+.+|.+|.|+..+|.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1122222 34588999999999999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=378.06 Aligned_cols=248 Identities=32% Similarity=0.491 Sum_probs=213.4
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCch
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL 97 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (459)
||+|+||+||+|.+..+|+.||+|.+.+.........+.+..|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766544443456678899999999999999999999999999999999999999
Q ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccccc
Q 012637 98 FAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172 (459)
Q Consensus 98 ~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~ 172 (459)
...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 877632 46999999999999999999999999999999999999999999999999998754321 12233457
Q ss_pred CCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH----HHHHHHHHhccCCCCCCCCHHHHHHHHHhcC
Q 012637 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI----MNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 173 Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ......+.......|..+++++.+|+.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999887765 899999999999999999999976532 2333444445556677789999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 012637 249 SDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 249 ~dP~~R~-----t~~eil~hpw~~~ 268 (459)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=384.10 Aligned_cols=258 Identities=32% Similarity=0.572 Sum_probs=219.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997654444445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||++||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999865 579999999999999999999999999999999999999999999999999986543211 111
Q ss_pred cccccCCCcccChhhHhh----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCC---CCCCHH
Q 012637 168 LHTQCGTPAYVAPEVLRK----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYP---PWISTD 238 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 238 (459)
....+||+.|+|||++.. ....+.++||||+||++|+|++|+.||.+.+..+.+..+.... +..| ..++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999974 2344678999999999999999999999888777777665432 2333 247999
Q ss_pred HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPER--RITIQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~--R~t~~eil~hpw~~~ 268 (459)
+++||.+||..++++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999764443 889999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=375.96 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=218.9
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976554443334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 9999999887753 4699999999999999999999999999999999999999999999999999875432 222
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH----HHHHHhccCCCCCCCCHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM----YRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.... ...+......+|..+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 345689999999999987666 4789999999999999999999987654332 22333444456667899999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 244 SKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
.+||..||.+|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=380.69 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=217.4
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..++|++.+.||+|+||.||+|++..+|..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999997542 23345678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
||||++||+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 9999999999999876 6799999999999999999999986 699999999999999999999999999875432
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHH--------------------
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF-------------------- 225 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-------------------- 225 (459)
......+||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+..++...+.
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 223455799999999999877664 89999999999999999999998765544322111
Q ss_pred --------------------------hcc-CCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 226 --------------------------KAE-FVY-PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 226 --------------------------~~~-~~~-p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
... ... ...+++++.+||.+||..||++|||+.+|++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 011 11368899999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=375.04 Aligned_cols=248 Identities=32% Similarity=0.511 Sum_probs=212.1
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--C---EE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--K---KI 85 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~---~~ 85 (459)
.|.-.+.+|+|+||.||.|....+++.||||.+-.+.-.. .+|+.+|+++.|||||++..+|... + +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 5888999999999999999999999999999986654322 2799999999999999999888543 2 45
Q ss_pred EEEEeccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecCCCccc
Q 012637 86 FVAMEYVKGGELFAKVA-----RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLSALP 159 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFGla~~~ 159 (459)
.+||||++. +|...++ ..+++.-.++-|.+||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 689999987 7888887 3689999999999999999999999999999999999999977 99999999999976
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc------------
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------ 227 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 227 (459)
... ....+...|+.|+|||.+.+...++.+.||||+||++.||+.|++-|.+.+..+.+..|.+.
T Consensus 177 ~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 542 22345567999999999999887889999999999999999999999998877666555431
Q ss_pred -----cCCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 -----EFVYP------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 -----~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+..+| ...++++.+|+.++|..+|.+|.++.|++.||||..-
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 11122 2368999999999999999999999999999999753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.63 Aligned_cols=256 Identities=28% Similarity=0.523 Sum_probs=236.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE-EEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK-IFV 87 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 87 (459)
.++|..++++|+|+||.+++++++..++.|++|.+...+..... .....+|+.++++++|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 47899999999999999999999999999999999887766543 3467899999999999999999999988888 999
Q ss_pred EEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 88 AMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
||+||+||++.+.|.+ .-++|+.+..||.|++.||.|||++.|+|||||+.||+++.++.+||+|||+|+.... .
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--E 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--c
Confidence 9999999999999976 3589999999999999999999999999999999999999999999999999998764 3
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLI 243 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li 243 (459)
.....+..|||.||+||++.+.+|. .++|||||||++|+|++-+.+|.+.+...+..+|.++. .+.|...+.+++.||
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 3467789999999999999999985 99999999999999999999999999999999998887 567788999999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCccccc
Q 012637 244 SKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+.||..+|..||++.++|.+|.++.
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999998864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=368.26 Aligned_cols=256 Identities=37% Similarity=0.676 Sum_probs=224.1
Q ss_pred ccccccCCEEEe-eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe
Q 012637 4 ERHVLFGKYEMG-RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT 81 (459)
Q Consensus 4 ~~~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (459)
+.+-+.+.|.+- ++||-|-.|+|-.+.++.||+.+|+|++... ...++|++++-+. .|||||.++++|+.
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 455677888887 5799999999999999999999999998532 3567899998877 69999999999854
Q ss_pred ----CCEEEEEEeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CCCeEEe
Q 012637 82 ----KKKIFVAMEYVKGGELFAKVAR-G--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NEDLKIS 151 (459)
Q Consensus 82 ----~~~~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~~lKl~ 151 (459)
..++.+|||.++||+||.+|.. | .++|.++..+++||..|+.|||+.+|+||||||||+|... |..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4678999999999999999976 3 4999999999999999999999999999999999999975 4579999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch----HHHHHHHHHhc
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN----IMNMYRKVFKA 227 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~ 227 (459)
|||+|+... ....+.+.|-||.|+|||++....|+ ..+|+||+||++|.||+|++||.... ...+..+|..+
T Consensus 207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred ccccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 999998644 34667899999999999999888876 88999999999999999999997643 23567788888
Q ss_pred cCCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 228 EFVYPP--W--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 228 ~~~~p~--~--~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
.+.+|. | +|.+++++|+.+|..+|.+|.|+++++.|||+.....
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 887774 4 7999999999999999999999999999999987543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=397.56 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=205.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK----- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (459)
..++|++++.||+|+||.||+|.+..+++.||||.+..+. ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3468999999999999999999999999999999886432 1234799999999999999999887432
Q ss_pred ---CEEEEEEeccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeec
Q 012637 83 ---KKIFVAMEYVKGGELFAKVA-----RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDF 153 (459)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DF 153 (459)
..+|+||||+++ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 357899999986 5655543 25799999999999999999999999999999999999999665 6999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc------
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------ 227 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------ 227 (459)
|+|+.... .......+||+.|+|||++.+....+.++|||||||+||+|++|.+||.+.+..+.+..+...
T Consensus 216 Gla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99985432 222335678999999999876554568999999999999999999999987665544433221
Q ss_pred -----------cC------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 228 -----------EF------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 228 -----------~~------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+ .+|...++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 01 123346789999999999999999999999999999975
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=375.97 Aligned_cols=257 Identities=27% Similarity=0.505 Sum_probs=214.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||.||+|++..+++.||+|.+....... ....+.+|+.++++++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 478999999999999999999999999999999987543222 223567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+++ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Ccc
Confidence 999986 77777654 4589999999999999999999999999999999999999999999999999875332 122
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------- 227 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 227 (459)
......||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2334578999999999976555568999999999999999999999887665444333211
Q ss_pred cCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 228 EFVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 228 ~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
....| +.+++++.+||.+||..||.+|||++|+++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 01111 23688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=400.83 Aligned_cols=260 Identities=33% Similarity=0.539 Sum_probs=226.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC---
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK--- 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (459)
...++|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34589999999999999999999999999999999998765433 34566889999999999999999998775432
Q ss_pred -----EEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeec
Q 012637 84 -----KIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDF 153 (459)
Q Consensus 84 -----~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DF 153 (459)
.+++||||+++|+|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999998853 36899999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCC
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYP 232 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p 232 (459)
|+++............+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+.. ..|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 999865433333344567899999999999887765 899999999999999999999999888887777766544 456
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+.+++++.+||.+||..||.+|||+.++++|||++.
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 778999999999999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=382.81 Aligned_cols=250 Identities=30% Similarity=0.525 Sum_probs=215.3
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcE-EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-E
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGES-VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK-K 84 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 84 (459)
+......+.+.||+|+||+||+|.. .|+. ||||++......... .+.+.+|+.+|++++|||||++++++.+.. .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3445566778899999999999985 4566 999999876655544 778999999999999999999999998887 7
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-cEeccCCCCCeEecCCC-CeEEeecCCCccc
Q 012637 85 IFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRG-VSHRDLKPENLLLDENE-DLKISDFGLSALP 159 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~g-i~HrDlkp~NILl~~~~-~lKl~DFGla~~~ 159 (459)
+++||||+++|+|..++.. +.++...+..++.||+.||+|||+++ |+||||||+|||++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999955 68999999999999999999999999 99999999999999998 9999999999864
Q ss_pred ccccCCCccccccCCCcccChhhHh--hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHH--hccCCCCCCC
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLR--KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF--KAEFVYPPWI 235 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~--~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~ 235 (459)
.... .......||+.|||||++. ...|+ .++||||+||+||+|+||..||.+....+....+. ...+..|...
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 4311 2233367999999999999 45665 99999999999999999999999988765555443 2344556679
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
++.+..|+.+||..||.+||++.+|+.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=384.28 Aligned_cols=258 Identities=27% Similarity=0.496 Sum_probs=211.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 567899999999999999999999999999999999965432 233456778999999999999999999998644
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..+|+||||++++ |...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDAN-LCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCcC-HHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 3589999999874 555553 468999999999999999999999999999999999999999999999999997432
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh--------------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK-------------- 226 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 226 (459)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..
T Consensus 175 ---~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 ---TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ---cCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 22233456789999999999887775 789999999999999999999987654332221110
Q ss_pred --------ccCC---------CC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 227 --------AEFV---------YP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 227 --------~~~~---------~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
.... +| ...++++++||.+||..||++|||+.|+++||||...+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 0000 01 113678999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=379.93 Aligned_cols=258 Identities=30% Similarity=0.551 Sum_probs=219.7
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654434434556788999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999975 57999999999999999999999999999999999999999999999999998643221 1112
Q ss_pred cccccCCCcccChhhHhh----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCCC---CCCHH
Q 012637 168 LHTQCGTPAYVAPEVLRK----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPP---WISTD 238 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 238 (459)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+..+.+..+.... +.+|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234689999999999863 2334589999999999999999999999988888887776543 23333 47999
Q ss_pred HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPER--RITIQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~--R~t~~eil~hpw~~~ 268 (459)
+++||.+||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765444 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=397.06 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=224.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCC-CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMT-GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.....|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++||||+++++++...+.+
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 3455699999999999999999998887 788999987543 233345678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 86 FVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
|+||||++||+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999887642 468999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDA 239 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~ 239 (459)
.........+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+.+..+..+.. ..|..+++++
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 3222223456689999999999987766 4899999999999999999999999888887777766554 3456689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+||.+||.+||++|||+++++.|||++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999974
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=371.09 Aligned_cols=251 Identities=30% Similarity=0.467 Sum_probs=206.9
Q ss_pred CCEEEeeeecccCcEEEEEEEEcC-CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCCcceeEEEEE-----
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLM-TGESVAIKVINKDQLKKEFMMEQIKREISVMRLV---RHPNVVELREVMA----- 80 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~----- 80 (459)
.+|++.+.||+|+||.||+|++.. +++.||+|.+........ ......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 468899999875433221 223455788877766 6999999999875
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
....+|+||||+++ +|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 34679999999974 78887754 458999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC--------
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-------- 229 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------- 229 (459)
.... .......+||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+..+.+..+.....
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 2233456799999999999877664 889999999999999999999998877666655542110
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 -------------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
...+.+++.+.+||.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=418.09 Aligned_cols=258 Identities=32% Similarity=0.576 Sum_probs=231.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|+++++||+|+||.|.+++++.|++.||+|++++-...+.....-+..|-.||.-.+.+-|++++..|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 46899999999999999999999999999999999875544444556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||++||+|..++.+ +++||+.|++|+..|+.||..||+.|.|||||||+|||||..|++||+|||.+-.+... ..-.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G~V~ 232 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-GTVR 232 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC-CcEE
Confidence 999999999999987 67999999999999999999999999999999999999999999999999998755421 1223
Q ss_pred cccccCCCcccChhhHhh----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCC--CCCCHHH
Q 012637 168 LHTQCGTPAYVAPEVLRK----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYP--PWISTDA 239 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~ 239 (459)
..+.+|||.|++||++.. .+.+|..+|+||+||++|+|+.|..||...+..+.|.+|..- .+.+| ..+|.++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 456789999999999973 356689999999999999999999999999999999999765 67888 4589999
Q ss_pred HHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 012637 240 KRLISKLLVSDPERRIT---IQSIMRVPWFRK 268 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t---~~eil~hpw~~~ 268 (459)
++||+++|. +|+.|.. +++|..||||..
T Consensus 313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 999999997 5888888 999999999975
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=379.52 Aligned_cols=258 Identities=30% Similarity=0.528 Sum_probs=219.9
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654434444566888999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999975 579999999999999999999999999999999999999999999999999987543211 112
Q ss_pred cccccCCCcccChhhHhhc----CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCCC---CCCHH
Q 012637 168 LHTQCGTPAYVAPEVLRKK----GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPP---WISTD 238 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 238 (459)
....+||+.|+|||++.+. +..+.++||||+||+||+|++|+.||...+..+.+..+.... +.+|. .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998752 223578999999999999999999999888877777776543 33343 36899
Q ss_pred HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPER--RITIQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~--R~t~~eil~hpw~~~ 268 (459)
+++||.+||..++.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876654 569999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=364.57 Aligned_cols=252 Identities=38% Similarity=0.685 Sum_probs=214.4
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|++++.||+|+||+||+|.+..+++.||+|++......... .....+|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999877544432 23345699999999999999999999999999999999
Q ss_pred cCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccc
Q 012637 92 VKGGELFAKVA-RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT 170 (459)
Q Consensus 92 ~~gg~L~~~i~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~ 170 (459)
+++++|.+++. .+.+++..+..++.||+.||.+||++||+||||||+||+++.++.++|+|||++... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 99999999997 589999999999999999999999999999999999999999999999999998743 112334456
Q ss_pred ccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc---hHHHHHHHHHhccCCCCC----CCCHHHHHHH
Q 012637 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE---NIMNMYRKVFKAEFVYPP----WISTDAKRLI 243 (459)
Q Consensus 171 ~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~----~~s~~~~~Li 243 (459)
.+||+.|+|||++......+.++||||||+++|+|++|..||... +...............+. ..+..+.+||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 778999999999983344468999999999999999999999987 333333333332221111 1248999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCccc
Q 012637 244 SKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=381.31 Aligned_cols=256 Identities=24% Similarity=0.427 Sum_probs=213.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 4568999999999999999999999999999999998754322 22345677899999999999999999987543
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...|+++|++ |++|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999998 7789888877889999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc------------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------ 228 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 228 (459)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 23456799999999999875555689999999999999999999998776554443332110
Q ss_pred -----------CCCC--------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 -----------FVYP--------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 -----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...| ...++.+.+||.+||.+||.+|||+.++++||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0011 1256778999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=368.22 Aligned_cols=253 Identities=37% Similarity=0.724 Sum_probs=229.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997665544445677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999866 67999999999999999999999999999999999999999999999999998754321 3
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..+....|..++..+.++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 35579999999999977655 48899999999999999999999988877777777777888888899999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 012637 249 SDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 249 ~dP~~R~-----t~~eil~hpw~~~ 268 (459)
.||.+|+ +++++++||||+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 9999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=383.02 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=213.6
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..+.|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3567999999999999999999999999999999986542 23345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 88 AMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||+++|+|... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 150 v~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDP 224 (353)
T ss_pred EEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--ccc
Confidence 9999999988543 34678889999999999999999999999999999999999999999999999764321 112
Q ss_pred cccccCCCcccChhhHhh----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH---HHHHHHH-hccCCCCCCCCHHH
Q 012637 168 LHTQCGTPAYVAPEVLRK----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIM---NMYRKVF-KAEFVYPPWISTDA 239 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s~~~ 239 (459)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .....+. ......+..++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 345679999999999753 234557899999999999999999999743322 2222222 22334456689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+||.+||..||++|||+.|+++||||....
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999998753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=384.51 Aligned_cols=250 Identities=21% Similarity=0.346 Sum_probs=205.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 34689999999999999999999999999999997532 245689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~ 238 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NAN 238 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-ccc
Confidence 999996 578887755 67999999999999999999999999999999999999999999999999999753221 122
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch-------HHHHHHHH---------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------IMNMYRKV--------------- 224 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i--------------- 224 (459)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.... ....+..+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 3345689999999999988776 489999999999999999998874321 00111111
Q ss_pred -----------HhccC----CCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 225 -----------FKAEF----VYPP-----WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 225 -----------~~~~~----~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..... ..|. .++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 01101 1111 146689999999999999999999999999999763
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=379.55 Aligned_cols=257 Identities=25% Similarity=0.464 Sum_probs=211.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4578999999999999999999999999999999998754322 22345678999999999999999999987543
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..+|+||||+++ .|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999976 5656554 458899999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------- 227 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 227 (459)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 2223456789999999999887765 8999999999999999999999887665554443321
Q ss_pred ---------cCC--------------C------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 228 ---------EFV--------------Y------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 228 ---------~~~--------------~------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
... . +...+..+++||.+||+.||.+|||+.++|+||||...+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 000 0 011356789999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=383.99 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=213.2
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-----EE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK-----KI 85 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 85 (459)
.|++.+.||+|+||.||+|.+..+|+.||||.+.... ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986432 22234567889999999999999999999998776 89
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||+.+ +|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 999999975 67777654 67999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh------------------
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------------------ 226 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------ 226 (459)
........||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22233456899999999998765556899999999999999999999988776554433321
Q ss_pred -----ccC---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 227 -----AEF---------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 227 -----~~~---------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
... ......++++.+||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223357889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=378.68 Aligned_cols=258 Identities=25% Similarity=0.465 Sum_probs=211.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 467899999999999999999999999999999999865432 233456778999999999999999999988643
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...|+||||+++ .|...+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 4555553 468999999999999999999999999999999999999999999999999997533
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------- 227 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 227 (459)
. .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 2233456799999999999887775 8899999999999999999999887654433222110
Q ss_pred ---------c-----CC---------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 228 ---------E-----FV---------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 228 ---------~-----~~---------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
. .. .+...+.++++||.+||..||.+|||+.|+++||||...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 01123567899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=374.49 Aligned_cols=256 Identities=23% Similarity=0.420 Sum_probs=215.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34579999999999999999999999999999999987542 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+||||++||+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 99999999999999876 6799999999999999999999985 799999999999999999999999999875432
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHH---------------------
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK--------------------- 223 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~--------------------- 223 (459)
......+||+.|+|||++.+..+. .++||||+||++|+|++|+.||...........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 122345799999999999876654 889999999999999999999986554332111
Q ss_pred -----------------------HHhcc-CCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 224 -----------------------VFKAE-FVYP-PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 224 -----------------------i~~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+.... ...+ ..++.++++||.+||+.||++|||+.|+++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00100 0111 1357889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=367.81 Aligned_cols=257 Identities=29% Similarity=0.525 Sum_probs=214.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
-.++|++.+.||.|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++......|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 3678999999999999999999999999999999986543222 23356789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 88 AMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
||||+++ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~ 158 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT 158 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CC
Confidence 9999975 78777754 5689999999999999999999999999999999999999999999999999875332 11
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc------------------
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------ 227 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 227 (459)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22334567899999999877655568999999999999999999999887765544332211
Q ss_pred -cCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 -EFVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 -~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
....| +.+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 2468889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=366.14 Aligned_cols=254 Identities=29% Similarity=0.471 Sum_probs=215.8
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999976655444445567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 9999999888753 3699999999999999999999999999999999999999999999999999864321 122
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH---HHHHH-HHhccCCCCCCCCHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM---NMYRK-VFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~-i~~~~~~~p~~~s~~~~~Li 243 (459)
....+||+.|+|||++.+..++ .++||||+||++|+|++|..||...... ..... ........+..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999877764 8899999999999999999999864321 11111 12222345667899999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 244 SKLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
.+||+.||.+||| ++|+++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=359.30 Aligned_cols=256 Identities=28% Similarity=0.535 Sum_probs=219.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc--HHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK--EFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+.|.+.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543322 2234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|+||++|++|.+.+.. +.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999998865 679999999999999999999999999999999999999999999999999987543221111
Q ss_pred -ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHHHH
Q 012637 167 -LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKRLI 243 (459)
Q Consensus 167 -~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li 243 (459)
......|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+... ....|..++.++.+||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1134568899999999988765 48999999999999999999999887665554444333 3445667899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCccc
Q 012637 244 SKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=366.14 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=205.2
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCCcceeEEEEEe-----C
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV---RHPNVVELREVMAT-----K 82 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 82 (459)
+|++.+.||+|+||.||+|.++.+|+.||+|.+........ ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 69999999999999999999999999999999875432221 223455677777766 69999999998864 3
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
..++++|||+++ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999986 78777754 35899999999999999999999999999999999999999999999999999765
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-----------c
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-----------E 228 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-----------~ 228 (459)
.. ........||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+....+.++... .
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 1223345789999999999877664 8999999999999999999999887665544443321 0
Q ss_pred C----------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 F----------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ~----------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
. ...+.++..+.+||.+||++||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=363.61 Aligned_cols=247 Identities=27% Similarity=0.454 Sum_probs=208.0
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCch
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL 97 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (459)
||+|+||.||++.++.+|+.||+|.+.+...........+..|+.+++.++||||+++++++.+...+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333334566799999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCC
Q 012637 98 FAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT 174 (459)
Q Consensus 98 ~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt 174 (459)
.+.+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... ........||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 888754 3588999999999999999999999999999999999999999999999999875432 2223345799
Q ss_pred CcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH----HHHHHHHHhccCCCC-CCCCHHHHHHHHHhcCC
Q 012637 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI----MNMYRKVFKAEFVYP-PWISTDAKRLISKLLVS 249 (459)
Q Consensus 175 ~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~ 249 (459)
+.|+|||++.+..+ +.++||||+||++|+|++|..||..... ..............+ ..+++++.+||.+||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999988775 4899999999999999999999976432 233333333333332 35799999999999999
Q ss_pred CCCCCCCH----HHHhcCccccc
Q 012637 250 DPERRITI----QSIMRVPWFRK 268 (459)
Q Consensus 250 dP~~R~t~----~eil~hpw~~~ 268 (459)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=359.41 Aligned_cols=255 Identities=32% Similarity=0.643 Sum_probs=220.7
Q ss_pred EEEe-eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEE
Q 012637 12 YEMG-RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 12 y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
|.+. +.||+|+||.|-.+.+..+|..||||++++... ....++.+|+.++..+ .|+||++++++|++++++|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 4443 689999999999999999999999999988732 2457889999999999 5999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---CeEEeecCCCcccccc---
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---DLKISDFGLSALPEQL--- 162 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---~lKl~DFGla~~~~~~--- 162 (459)
|-+.||.|...|.+ ..++|.+|.++.+.|++||.|||.+||+||||||||||..... -+|||||.|..-....
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999999999976 6799999999999999999999999999999999999997654 4899999997643221
Q ss_pred --cCCCccccccCCCcccChhhHh----hcCCCCCcchhhhHHHHHHHHhhCCCCCCCc---------------hHHHHH
Q 012637 163 --RNDGLLHTQCGTPAYVAPEVLR----KKGYDGSKADLWSCGVILYVLLAGFLPFQDE---------------NIMNMY 221 (459)
Q Consensus 163 --~~~~~~~~~~Gt~~y~APE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------------~~~~~~ 221 (459)
.....+.+.||+-.|||||++. ...++..++|.||||||||.||+|++||.+. =...++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 1223456789999999999974 2334458999999999999999999999753 134678
Q ss_pred HHHHhccCCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 222 RKVFKAEFVYPP--W--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 222 ~~i~~~~~~~p~--~--~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..|..+.+.+|. | +|.++++||+.+|..+|..|.++.++++|||++.-
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 889999999995 3 89999999999999999999999999999999853
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=353.35 Aligned_cols=252 Identities=26% Similarity=0.532 Sum_probs=218.3
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-CCEEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-KKKIFVAM 89 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 89 (459)
+|++.+.||.|++|.||+|.+..+++.||+|.+..+.... ...+.+.+|+.++++++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5999999999999999999999999999999997654332 245568899999999999999999998764 45789999
Q ss_pred eccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 90 EYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||+++++|.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999998864 3589999999999999999999999999999999999999999999999999976533 222
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISK 245 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 245 (459)
......|++.|+|||++.+..++ .++||||+||++|+|++|..||...+.......+..+.. ..+..+++.+.+||.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 33456789999999999877664 789999999999999999999988777666655555543 3456689999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 012637 246 LLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~ 266 (459)
||++||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=388.68 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=201.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC------CCcceeEEEEEeC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH------PNVVELREVMATK 82 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h------pnIv~l~~~~~~~ 82 (459)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996431 123345667777777754 4588899988764
Q ss_pred -CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCC-------------
Q 012637 83 -KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENE------------- 146 (459)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~------------- 146 (459)
.++|+|||++ |++|.+++.+ +.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5799999998 6678887765 789999999999999999999998 5999999999999998766
Q ss_pred ---CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHH
Q 012637 147 ---DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK 223 (459)
Q Consensus 147 ---~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 223 (459)
.+||+|||++.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|++||.+.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999886321 223456899999999999988775 899999999999999999999988665443332
Q ss_pred HHhccCCCC-----------------------C-------------------CCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 012637 224 VFKAEFVYP-----------------------P-------------------WISTDAKRLISKLLVSDPERRITIQSIM 261 (459)
Q Consensus 224 i~~~~~~~p-----------------------~-------------------~~s~~~~~Li~~~L~~dP~~R~t~~eil 261 (459)
+....-.+| + ..++.+.+||.+||..||++|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 211100000 0 0145577999999999999999999999
Q ss_pred cCcccccCC
Q 012637 262 RVPWFRKGF 270 (459)
Q Consensus 262 ~hpw~~~~~ 270 (459)
+||||...+
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998754
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.52 Aligned_cols=254 Identities=30% Similarity=0.487 Sum_probs=218.9
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+...+..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999977655444445567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 9999999887753 3699999999999999999999999999999999999999999999999999865322 122
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH----HHHHHhccCCCCCCCCHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM----YRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
.....|++.|+|||++.+..+. .++||||+||++|+|++|..||.+...... ...+......++..++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999877664 889999999999999999999987654332 23333444456667899999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 244 SKLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
.+||++||++||| +.++++||||+.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 9999999999999 889999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=373.59 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=205.7
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVM 79 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 79 (459)
.+-.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 344579999999999999999999752 355789999986432 222346788999999999 899999999988
Q ss_pred EeC-CEEEEEEeccCCCchHHHHhcC------------------------------------------------------
Q 012637 80 ATK-KKIFVAMEYVKGGELFAKVARG------------------------------------------------------ 104 (459)
Q Consensus 80 ~~~-~~~~lV~E~~~gg~L~~~i~~~------------------------------------------------------ 104 (459)
... ..+|+||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 654 4689999999999999888641
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCC
Q 012637 105 ---------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP 175 (459)
Q Consensus 105 ---------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~ 175 (459)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+..+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 37788899999999999999999999999999999999999999999999997543211111122344667
Q ss_pred cccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHH-HHHHhc-cCCCCCCCCHHHHHHHHHhcCCCCC
Q 012637 176 AYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMY-RKVFKA-EFVYPPWISTDAKRLISKLLVSDPE 252 (459)
Q Consensus 176 ~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~ 252 (459)
.|+|||++.+..+. .++|||||||+||+|++ |..||.+......+ ..+..+ ....|...++++.+||.+||..||.
T Consensus 241 ~y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 241 KWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred cccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 89999999877764 89999999999999997 99999876543333 333322 2344667899999999999999999
Q ss_pred CCCCHHHHhc
Q 012637 253 RRITIQSIMR 262 (459)
Q Consensus 253 ~R~t~~eil~ 262 (459)
+|||+.++++
T Consensus 320 ~RPs~~el~~ 329 (338)
T cd05102 320 ERPTFSALVE 329 (338)
T ss_pred hCcCHHHHHH
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=358.80 Aligned_cols=252 Identities=29% Similarity=0.507 Sum_probs=208.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986543222 234567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 91 YVKGGELFAKVAR----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 998 478777753 46899999999999999999999999999999999999999999999999998754321 12
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc------------------c
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------E 228 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~ 228 (459)
......|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234567899999999876554458899999999999999999999876543322211100 0
Q ss_pred C-----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 F-----------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
. .....+++++.+||.+||..||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=360.70 Aligned_cols=256 Identities=30% Similarity=0.489 Sum_probs=220.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
...+|++.+.||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.+.||||+++++.+......|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 3478999999999999999999999999999999997654332 3567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 88 AMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~--~~~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (296)
T ss_pred eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc--cccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999875432 1122
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---CCCCCCCCHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKRLIS 244 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~ 244 (459)
.....|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+.... ...|..++..+.+||.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 234578999999999987665 489999999999999999999998877654433333221 2234567889999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccC
Q 012637 245 KLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+||.++|.+|||+.++++||||...
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=368.83 Aligned_cols=259 Identities=32% Similarity=0.604 Sum_probs=235.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
+-...|....+||+|+||+|-+|..+.+.+.||||++.++-+.....++--..|-++|... +-|.+++++.+|++-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 4456789999999999999999999999999999999988776554555556788888887 578999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||+.||+|...|.. |++.|..|..|+..|+-||-|||++||++||||.+|||||.+|++||+|||+++. ....
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~~ 503 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIFD 503 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--cccC
Confidence 999999999999999987 9999999999999999999999999999999999999999999999999999973 2234
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
+....+.||||.|+|||++..++| +..+|+||+||+||+|++|.+||++++..++++.|......+|..+|.++.++..
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ick 582 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICK 582 (683)
T ss_pred CcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHH
Confidence 445678899999999999999888 5899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 245 KLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 245 ~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
..|...|.+|.. -.+|..||||+.
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhh
Confidence 999999999984 358999999985
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=353.58 Aligned_cols=255 Identities=30% Similarity=0.558 Sum_probs=218.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc------HHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK------EFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+|.+++.||.|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999999999999987543321 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
.++||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 679999999999999999999999999999999999999999999999999987654211
Q ss_pred C----CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 164 N----DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 164 ~----~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
. ........|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1112234688999999999877664 7899999999999999999999886655544444332 33456678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+.+||.+||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.70 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=193.9
Q ss_pred eeeecccCcEEEEEEEEc--CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CCEEEEEEe
Q 012637 15 GRLLGKGTFAKVYYGKQL--MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KKKIFVAME 90 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 90 (459)
+++||+|+||.||+|+++ .+++.||+|.+..... ...+.+|+.++++++||||+++++++.+ ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999976 4678999999865432 2346789999999999999999998854 567899999
Q ss_pred ccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe----cCCCCeEEeecCCC
Q 012637 91 YVKGGELFAKVAR----------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL----DENEDLKISDFGLS 156 (459)
Q Consensus 91 ~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl----~~~~~lKl~DFGla 156 (459)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 77776642 258999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccc-CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH---------HHHHHHHh
Q 012637 157 ALPEQLR-NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM---------NMYRKVFK 226 (459)
Q Consensus 157 ~~~~~~~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~~ 226 (459)
....... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||...... ..+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7654321 1122345678999999999987665568999999999999999999999643210 11111100
Q ss_pred ----------------------------ccCCC----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 227 ----------------------------AEFVY----------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 227 ----------------------------~~~~~----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
..... ....+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 01135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.61 Aligned_cols=252 Identities=29% Similarity=0.533 Sum_probs=208.0
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++.+...+|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 6999999999999999999999999999999997543222 233457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 91 YVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
|+++ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~--~~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC--CCCCc
Confidence 9975 67676643 6799999999999999999999999999999999999999999999999999975432 11222
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCC-CCchHHHHHHHHHhc----------------cC--
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPF-QDENIMNMYRKVFKA----------------EF-- 229 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~----------------~~-- 229 (459)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+..+.+..+.+. .+
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877655568999999999999999998885 444444433333211 00
Q ss_pred -----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 -----------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 -----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
...+.+++++.+||.+||..||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=360.81 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=214.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... ......++.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999986542 2334567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 99999999999876 789999999999999999999997 5999999999999999999999999999864322 22
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--------------------
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------------------- 227 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------- 227 (459)
..+.+|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345678999999999877665 48899999999999999999999765544332222110
Q ss_pred -----------------cCCCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 -----------------EFVYPP-WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 -----------------~~~~p~-~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
....|. .++.++.+||.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011111 257889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=361.27 Aligned_cols=258 Identities=34% Similarity=0.589 Sum_probs=225.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776554445677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC--
Q 012637 90 EYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN-- 164 (459)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~-- 164 (459)
||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999998865 4699999999999999999999999999999999999999999999999999864321110
Q ss_pred -------------------------CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHH
Q 012637 165 -------------------------DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN 219 (459)
Q Consensus 165 -------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~ 219 (459)
........||..|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 001123468899999999987766 489999999999999999999999888777
Q ss_pred HHHHHHhccCCCCCC--CCHHHHHHHHHhcCCCCCCCCC----HHHHhcCccccc
Q 012637 220 MYRKVFKAEFVYPPW--ISTDAKRLISKLLVSDPERRIT----IQSIMRVPWFRK 268 (459)
Q Consensus 220 ~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t----~~eil~hpw~~~ 268 (459)
.+..+......+|.. ++.++.+||.+||..||++||| ++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777766655555544 6899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=359.38 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=221.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
..+|++.+.||.|+||.||+|.+..+|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 35799999999999999999999999999999998754322 245678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 89 MEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
+||+++++|..++....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--~~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKR 172 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--cccC
Confidence 99999999999998888999999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---CCCCCCCCHHHHHHHHH
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKRLISK 245 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~ 245 (459)
...+|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+.......+.... ...|..+++.+.+||.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 345789999999999876664 88999999999999999999998877655444443322 23445678999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
||..||.+|||+.++++||||+..
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=347.75 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=220.9
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|.+.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4889999999999999999999999999999997654433 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999998865 46899999999999999999999999999999999999999999999999998755431 222
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-CCCCCCHHHHHHHHHh
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLISKL 246 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~ 246 (459)
....+|++.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+..+... .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3445789999999999877664 8899999999999999999999988877766666655443 3346789999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 012637 247 LVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~ 266 (459)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=384.74 Aligned_cols=255 Identities=30% Similarity=0.457 Sum_probs=225.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
-+.|.|+..||.|+||+||+|.++.++-..|.|+|... .....+...-||.||..|.||+||++++.|...+++||.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 35688899999999999999999999999999998643 344567778899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
.|||.||-....+-. ..|+|++++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+..... ...
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence 999999999888765 6799999999999999999999999999999999999999999999999999874322 222
Q ss_pred ccccccCCCcccChhhHh-----hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC---CCCCCCHH
Q 012637 167 LLHTQCGTPAYVAPEVLR-----KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV---YPPWISTD 238 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~ 238 (459)
.-.+.+|||.|||||++. ..+|+ .++|||||||.|.+|.-+.+|...-+++..+-+|.+.+++ -|..++..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 345678999999999975 35666 8999999999999999999999999999988888877653 35668999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+.+||.+||..||..||++++|++||||.+.
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999999999999999853
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=353.71 Aligned_cols=254 Identities=29% Similarity=0.479 Sum_probs=211.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.++.+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 57999999999999999999999999999999986543211 12345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||++++.|..++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 99999988877755 579999999999999999999999999999999999999999999999999997654321 122
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------cC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------------------EF 229 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 229 (459)
....|+..|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 33457889999999876554568999999999999999999999876654333222110 00
Q ss_pred CCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 VYP------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 ~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
..| +.++..+.+||.+||+++|++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=356.88 Aligned_cols=262 Identities=29% Similarity=0.398 Sum_probs=221.3
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+++....++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 44556678899999999999999999999999999999998654 333466788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+.+|+||||++|++|..++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999887753 578999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCccccccCCCcccChhhHhhcC----CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC---CCCC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKG----YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF---VYPP 233 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~ 233 (459)
. .........|++.|+|||++.... ..+.++|||||||++|+|++|..||...+....+.++..... ..+.
T Consensus 162 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 162 K--TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred c--cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCc
Confidence 2 112223456889999999985321 124689999999999999999999988776665555544322 2344
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.++.++.+||.+||..||++||+++++++||||..-
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 578899999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=356.89 Aligned_cols=256 Identities=32% Similarity=0.466 Sum_probs=220.1
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||.|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 46799999999999999999999889999999998643 333456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 999999999998865 46999999999999999999999999999999999999999999999999998654321 12
Q ss_pred ccccccCCCcccChhhHhhcC----CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC---CCCCCCCHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKG----YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF---VYPPWISTDA 239 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 239 (459)
......|++.|+|||++.... ..+.++||||+||++|+|++|..||...+.......+..... ..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 223457899999999986322 224689999999999999999999988877666666655432 3355688999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+||.+||..+|.+|||++++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.47 Aligned_cols=251 Identities=31% Similarity=0.481 Sum_probs=213.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-C-----CCcceeEEEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-H-----PNVVELREVMA 80 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-h-----pnIv~l~~~~~ 80 (459)
.+..+|.+.+.||+|+||.|-+|.+..|++.||||+++... ....+...|+.+|..|+ | -|+|+++++|.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 34458999999999999999999999999999999997542 35567778999999997 4 48999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC--CCeEEeecCC
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN--EDLKISDFGL 155 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~--~~lKl~DFGl 155 (459)
..+++|||+|.... .|+++++. .+++...++.+++||+.||.+||+.||||+|||||||||.+- ..|||+|||+
T Consensus 259 fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 99999999999965 89999976 468999999999999999999999999999999999999764 4799999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--------
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------- 227 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------- 227 (459)
|.... ... .+.+-++.|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|..-
T Consensus 338 Sc~~~----q~v-ytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 338 SCFES----QRV-YTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ccccC----Ccc-eeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 98532 223 378889999999999999996 8999999999999999999999998877666544310
Q ss_pred --------------------------------------------cCCCCCC-----------CCHHHHHHHHHhcCCCCC
Q 012637 228 --------------------------------------------EFVYPPW-----------ISTDAKRLISKLLVSDPE 252 (459)
Q Consensus 228 --------------------------------------------~~~~p~~-----------~s~~~~~Li~~~L~~dP~ 252 (459)
+...|+. -...+.+||.+||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0111200 123468999999999999
Q ss_pred CCCCHHHHhcCccccc
Q 012637 253 RRITIQSIMRVPWFRK 268 (459)
Q Consensus 253 ~R~t~~eil~hpw~~~ 268 (459)
+|+|+.++|+||||..
T Consensus 492 ~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTG 507 (586)
T ss_pred hcCCHHHHhcCccccc
Confidence 9999999999999984
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=354.85 Aligned_cols=256 Identities=30% Similarity=0.462 Sum_probs=217.7
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
-|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3788999999999999999999999999999986542 2345678889999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 91 YVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
|+++++|...+.. +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--ccccc
Confidence 9999999887754 6799999999999999999999999999999999999999999999999999875432 11223
Q ss_pred ccccCCCcccChhhHhh-----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---CCCCCCCCHHHH
Q 012637 169 HTQCGTPAYVAPEVLRK-----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAK 240 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~ 240 (459)
....|++.|+|||++.. ..+ +.++||||+||++|+|++|.+||...+.......+.... ...|..++.++.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 34578999999999842 223 468999999999999999999998877666555554432 234556789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012637 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTR 272 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~~ 272 (459)
+||.+||+.||.+|||++++++||||+.....
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 99999999999999999999999999875443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=352.90 Aligned_cols=252 Identities=31% Similarity=0.569 Sum_probs=222.8
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665554567789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 91 YVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
|+.|++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 9999999999976 4899999999999999999999999999999999999999999999999999875432 11334
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH---HHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI---MNMYRKVFKAEFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 246 (459)
...|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+. ..............|+.++.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678899999999987665 5899999999999999999999987663 33333333355667777899999999999
Q ss_pred cCCCCCCCCCH--HHHhcCccc
Q 012637 247 LVSDPERRITI--QSIMRVPWF 266 (459)
Q Consensus 247 L~~dP~~R~t~--~eil~hpw~ 266 (459)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=360.08 Aligned_cols=256 Identities=31% Similarity=0.503 Sum_probs=219.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
...+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 347899999999999999999999999999999999754332 23567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 88 AMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||++|++|.+++.+..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...... ...
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--~~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 171 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--ccC
Confidence 999999999999998888999999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---cCCCCCCCCHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EFVYPPWISTDAKRLIS 244 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~ 244 (459)
.....|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+... ....|..++..+.+||.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 234578999999999987666 48899999999999999999999876654332222221 12234567889999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccC
Q 012637 245 KLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+||..||.+|||++++++||||+..
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=375.18 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=207.3
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEc--CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQL--MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
.+..+|++.+.||+|+||.||+|... .++..||+|.+.... ...+|+.+++.++||||+++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 45568999999999999999999764 356789999886432 24579999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+|||++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999996 578888754 689999999999999999999999999999999999999999999999999997544322
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH---HHHHHHHHh--------------
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI---MNMYRKVFK-------------- 226 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~-------------- 226 (459)
.........||+.|+|||++.+..|. .++||||+||++|+|++|..||.+... ...+..+.+
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 22223346799999999999887775 889999999999999999999976432 111111111
Q ss_pred ---------------ccCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 227 ---------------AEFVYPP-----WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 227 ---------------~~~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+..|. .++.++.+||.+||..||++|||+.++|+||||.+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111111 246788999999999999999999999999999864
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=354.34 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=211.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+......|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3589999999999999999999999999999999865432 2335678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cccc
Confidence 999999999998865 7899999999999999999999999999999999999999999999999999875432 1122
Q ss_pred cccccCCCcccChhhHh---hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC-----CCCCHHH
Q 012637 168 LHTQCGTPAYVAPEVLR---KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP-----PWISTDA 239 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 239 (459)
.....|++.|+|||++. ...+ +.++||||+||++|+|++|..||...................+ ..++..+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred cccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 23457899999999985 2334 4789999999999999999999976554433333333332222 1357889
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPW 265 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw 265 (459)
.+||.+||..+|++|||++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=367.46 Aligned_cols=258 Identities=32% Similarity=0.516 Sum_probs=229.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+-.+.|+.-++||+|+||.|+-++-+.||+.||+|.+++.++....-.....+|-.||.+++.|.||.+-..|++.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44567888999999999999999999999999999999888876655566789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR-G--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+||..|.||+|.-+|-. | .++|..+++|+.+|+.||++||+.+|++|||||+|||||+.|+++|+|+|||.-+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~--- 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP--- 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC---
Confidence 99999999999777754 4 79999999999999999999999999999999999999999999999999998543
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH----HHHHHHHHhccCCCCCCCCHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI----MNMYRKVFKAEFVYPPWISTDA 239 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~ 239 (459)
.........||.+|||||++.+..|+ ..+|+|||||+||+|+.|+.||..... .++-+.+......+|..+|+++
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 33344556999999999999988875 899999999999999999999976432 2444556666778889999999
Q ss_pred HHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 240 KRLISKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
++|.+.+|..||.+|. +++++.+||||+.
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 9999999999999998 5779999999985
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=397.17 Aligned_cols=261 Identities=29% Similarity=0.477 Sum_probs=217.2
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-- 81 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (459)
.+..+.++|++.+.||+|+||+||+|.+..+++.||+|++....... .....+..|+.+++.++||||+++++++..
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 35678899999999999999999999999999999999997654433 345678899999999999999999998854
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-------CcEeccCCCCCeEecC-----
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSR-------GVSHRDLKPENLLLDE----- 144 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~-------gi~HrDlkp~NILl~~----- 144 (459)
...+||||||+++|+|.+++.. +.+++..++.++.||+.||.|||+. +|+||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4679999999999999998864 5799999999999999999999985 4999999999999964
Q ss_pred ------------CCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhc-CCCCCcchhhhHHHHHHHHhhCCCC
Q 012637 145 ------------NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK-GYDGSKADLWSCGVILYVLLAGFLP 211 (459)
Q Consensus 145 ------------~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~P 211 (459)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|..|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 23589999999975432 2233456799999999998643 2345899999999999999999999
Q ss_pred CCCchHH-HHHHHHHhccCCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 212 FQDENIM-NMYRKVFKAEFVYP-PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 212 f~~~~~~-~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
|...+.. .+...+... ...| ...+.++.+||.+||..+|.+|||+.++|+|||++..
T Consensus 243 F~~~~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 243 FHKANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcCCcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 9765543 333333332 3333 3478999999999999999999999999999999743
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.86 Aligned_cols=258 Identities=33% Similarity=0.611 Sum_probs=222.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999997665434445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc-----
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR----- 163 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~----- 163 (459)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999866 679999999999999999999999999999999999999999999999999986311000
Q ss_pred --------CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC--
Q 012637 164 --------NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-- 233 (459)
Q Consensus 164 --------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~-- 233 (459)
.........|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+.......|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0001123467889999999887665 58999999999999999999999988887777777666544443
Q ss_pred -CCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 012637 234 -WISTDAKRLISKLLVSDPERRIT---IQSIMRVPWFRK 268 (459)
Q Consensus 234 -~~s~~~~~Li~~~L~~dP~~R~t---~~eil~hpw~~~ 268 (459)
.++.++.+||.+||++||++||| +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 789999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=348.41 Aligned_cols=255 Identities=29% Similarity=0.502 Sum_probs=218.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++++.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987554333 4567899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 90 EYVKGGELFAKVAR----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 90 E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||+|+||++++++.+||+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999864 35899999999999999999999999999999999999999999999999998755432221
Q ss_pred --CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-CC-----CCCCH
Q 012637 166 --GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YP-----PWIST 237 (459)
Q Consensus 166 --~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~ 237 (459)
......+|++.|+|||++......+.++|+||+||++|+|++|..||...+....+.+....... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12234578999999999987634468999999999999999999999887766655555443221 11 24678
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.+.+|+.+||..||.+|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 89999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=353.05 Aligned_cols=255 Identities=30% Similarity=0.500 Sum_probs=222.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||.|+||.||+|.+..+++.||+|.+..+.. ......+.+|+.+++.++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999975532 223456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
||+++++|.+++..+++++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++...... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999997654321 2223
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCC-CCHHHHHHHHHhc
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPW-ISTDAKRLISKLL 247 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~Li~~~L 247 (459)
...|++.|+|||.+.+..++ .++||||+||++|+|++|..||...+.......+..... ..+.. ++.++.++|.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 45688999999999887754 899999999999999999999988776665555544422 33334 7889999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccC
Q 012637 248 VSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 248 ~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+|++|||++++++||||+..
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCC
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=352.11 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=211.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 46799999999999999999999999999999998654322 234678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--ccc
Confidence 999999999998865 68999999999999999999999999999999999999999999999999999754321 112
Q ss_pred cccccCCCcccChhhHhhc--CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC-----CCCCHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKK--GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP-----PWISTDAK 240 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~ 240 (459)
.....|++.|+|||.+... ...+.++||||+||++|+|++|..||...........+....+..+ ..++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 2345689999999998532 2224789999999999999999999976554433333322222222 23678999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcc
Q 012637 241 RLISKLLVSDPERRITIQSIMRVPW 265 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~hpw 265 (459)
+||++||..+|.+|||+++|++|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=363.87 Aligned_cols=253 Identities=21% Similarity=0.400 Sum_probs=206.3
Q ss_pred Eeeeeccc--CcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 14 MGRLLGKG--TFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 14 i~~~LG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
+.++||+| +|++||++.++.+|+.||+|.++.+... ....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56889999 7899999999999999999999765433 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC----
Q 012637 92 VKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN---- 164 (459)
Q Consensus 92 ~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~---- 164 (459)
+++|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999998854 4589999999999999999999999999999999999999999999999986543211111
Q ss_pred -CCccccccCCCcccChhhHhhc--CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-----------
Q 012637 165 -DGLLHTQCGTPAYVAPEVLRKK--GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV----------- 230 (459)
Q Consensus 165 -~~~~~~~~Gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~----------- 230 (459)
........++..|+|||++.+. .+ +.++||||+||++|+|++|..||..............+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234577889999999763 34 48899999999999999999999875544332222211100
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 231 -----------------------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 231 -----------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
....+++.+.+||.+||+.||++|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.31 Aligned_cols=254 Identities=33% Similarity=0.527 Sum_probs=214.9
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 6999999999999999999999999999999997654322 245678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 91 YVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
|+ |++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence 99 9999998854 569999999999999999999999999999999999999999999999999997654321 1223
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------cC
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------------------EF 229 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 229 (459)
....|++.|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 45678999999999876555568999999999999999999999876655444333221 00
Q ss_pred CC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 230 VY-----------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 230 ~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
.+ .+..+.++.+||.+||.+||.+|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 123578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=346.61 Aligned_cols=252 Identities=28% Similarity=0.560 Sum_probs=220.3
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|+||.||++.+..+|+.||+|.+........ ....+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 69999999999999999999999999999999976543332 44678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VEL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--hhh
Confidence 9999999998864 35899999999999999999999999999999999999999999999999999754321 111
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHHHHh
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISKL 246 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 246 (459)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+..+....+..+.. ..|..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223458899999999987665 4789999999999999999999988887777766665544 34566899999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 012637 247 LVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~ 266 (459)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=371.32 Aligned_cols=247 Identities=37% Similarity=0.728 Sum_probs=221.3
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
.++||.|.||+||-|.++.+|+.||||+|+|.++..... .++++|+.||+.+.||.||.+--.+++.++++.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 378999999999999999999999999999988765533 7899999999999999999999999999999999999988
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC---CCeEEeecCCCcccccccCCCccc
Q 012637 95 GELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN---EDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~---~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
.-|.-.+.. |+++|...+++..||+.||.|||-+||+|+||||||||+... -.+||||||+|++... ...-.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFRr 724 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFRR 724 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhhh
Confidence 766666643 899999999999999999999999999999999999999865 4699999999998653 34556
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC--C--CCHHHHHHHHH
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP--W--ISTDAKRLISK 245 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~~~Li~~ 245 (459)
+..|||.|.|||++.+++|+ ..-|+||.|||+|.-|+|..||.... ++..+|....+-+|+ | +++++.+||..
T Consensus 725 sVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 78999999999999999997 78999999999999999999997643 344567777777764 4 89999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccccc
Q 012637 246 LLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+|+..-.+|.|++..+.|||++.
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhc
Confidence 99999999999999999999985
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=376.95 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=204.3
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++++||||+++++++......|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35589999999999999999999999999999996421 234689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 88 AMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|||++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999996 578877754 46999999999999999999999999999999999999999999999999999765432222
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc--------hHHHHHHHHHhccC--------
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE--------NIMNMYRKVFKAEF-------- 229 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~--------~~~~~~~~i~~~~~-------- 229 (459)
......+||+.|+|||++.+..+. .++|||||||+||+|++|..|+... ....+.+.+.....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 223346799999999999887765 8999999999999999987654321 11222222222111
Q ss_pred ---------------------CCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 230 ---------------------VYPP-----WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 230 ---------------------~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 14568999999999999999999999999999974
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=351.55 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=211.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.+..+++.||+|.+..+. .......+.+|+.++++++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987543 2224467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++..... ....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----cccc
Confidence 99999988654 4689999999999999999999999999999999999999999999999999975432 2234
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH-------HHHHHHHHhcc-CCC-CCCCCHHHH
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI-------MNMYRKVFKAE-FVY-PPWISTDAK 240 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~~~ 240 (459)
..+||+.|+|||++.+..+ +.++||||+||++|+|++|..||..... ......+.... ... ....++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 5689999999999987766 4899999999999999999999965321 12222222221 111 234788999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 241 RLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+||.+||..||.+||+++++++||||+...
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=355.52 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=216.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999999999999986432 2334567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 90 EYVKGGELFAKVARG----RLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 90 E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999998888764 79999999999999999999997 599999999999999999999999999987542
Q ss_pred CCccccccCCCcccChhhHhhcCC-----CCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHH---HHhc-cCCCCCCC
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGY-----DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK---VFKA-EFVYPPWI 235 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~ 235 (459)
.....+..|++.|+|||.+.+... .+.++||||+||++|+|++|..||........+.. +... ....|+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 223345678999999999865432 25789999999999999999999977655443332 2222 23456668
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+.++.+||.+||..+|.+||+++++++||||...
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=349.32 Aligned_cols=256 Identities=29% Similarity=0.524 Sum_probs=214.7
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc-------cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-------KEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 699999999999999999999999999999998643211 1123467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
..++||||++|++|.+++.. +.+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999876 78999999999999999999999999999999999999999999999999999754432
Q ss_pred cCCCccccccCCCcccChhhHhhcC-CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCC----CC
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKG-YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPP----WI 235 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~ 235 (459)
..........|+..|+|||.+.... ..+.++|+||||+++|+|++|..||...........+... ....+. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233456899999999987654 2358899999999999999999999776554443333222 222232 35
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+.++.+||.+||.++|.+|||++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=360.20 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=219.5
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|.++.+||+|+||.||+|.++.+|+.+|||.+..+. ..+.+.+||.||++|+.|+||++|+.|.....+||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 677889999999999999999999999999886543 467788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 92 VKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
|..|+..+.++- ..++|+++..+++.-+.||+|||...-+|||||..|||++.+|..||+|||.|..+.. .-....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence 999999998864 6799999999999999999999999999999999999999999999999999975432 122345
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---CCCCCCCCHHHHHHHHHh
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKRLISKL 246 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~ 246 (459)
+..|||.|||||++..-+|+ .++||||||+...+|..|++||.+-.++..+.-|.... +.-|..+|.++.+||+.|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 78999999999999999998 88999999999999999999998877654333222221 223445789999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccC
Q 012637 247 LVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
|..+|++|.|+.++++|||+++.
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=348.31 Aligned_cols=254 Identities=27% Similarity=0.489 Sum_probs=215.0
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc---cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK---KEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+|++++.||+|+||+||+|.+ .+|+.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 58899999998754321 22335678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc---
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR--- 163 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~--- 163 (459)
++||++|++|.+++.+ +.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999876 689999999999999999999999999999999999999999999999999987542211
Q ss_pred -CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---cCCCCCCCCHHH
Q 012637 164 -NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EFVYPPWISTDA 239 (459)
Q Consensus 164 -~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 239 (459)
.........|++.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+... ....|..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11122345689999999999877664 8899999999999999999999876554433333322 223556689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.+||.+||.++|.+|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.13 Aligned_cols=247 Identities=38% Similarity=0.659 Sum_probs=218.6
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCch
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL 97 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (459)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+...+|+++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999876655444567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCc
Q 012637 98 FAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176 (459)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~ 176 (459)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ......+|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---cccccccCCcC
Confidence 999976 57899999999999999999999999999999999999999999999999999754321 12234578999
Q ss_pred ccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch--HHHHHHHHH--hccCCCCCCCCHHHHHHHHHhcCCCCC
Q 012637 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN--IMNMYRKVF--KAEFVYPPWISTDAKRLISKLLVSDPE 252 (459)
Q Consensus 177 y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~ 252 (459)
|+|||.+....++ .++|+||+|+++|+|++|..||.... ....+..+. ......|...++++.++|.+||..||.
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998776664 88999999999999999999998776 666666666 345666777799999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q 012637 253 RRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 253 ~R~t-----~~eil~hpw~~~ 268 (459)
+||| +.|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.54 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=210.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeC-----
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATK----- 82 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~----- 82 (459)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4789999999999999999999999999999999875432 224677899999998 799999999998653
Q ss_pred -CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 83 -KKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
..+|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 568999999999999998875 3689999999999999999999999999999999999999999999999999975
Q ss_pred cccccCCCccccccCCCcccChhhHhh-----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC--CC
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRK-----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF--VY 231 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~ 231 (459)
... ......+.+|++.|+|||++.. ..+ +.++||||+||++|+|++|..||................. ..
T Consensus 161 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 161 LDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred ccc--ccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 432 1223345679999999999863 234 4789999999999999999999987655544433333221 12
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 232 PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 232 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+..++.++.+||.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 23478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=352.59 Aligned_cols=248 Identities=30% Similarity=0.466 Sum_probs=203.9
Q ss_pred eecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHH---hcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR---LVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
.||+|+||.||+|.+..+++.||+|.+.+.............+|..+++ ...||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654432222223344544444 3479999999999999999999999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccccc
Q 012637 94 GGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172 (459)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~ 172 (459)
||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999988865 67999999999999999999999999999999999999999999999999998644321 223457
Q ss_pred CCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch---HHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCC
Q 012637 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN---IMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249 (459)
Q Consensus 173 Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 249 (459)
||+.|+|||.+......+.++||||+||++|+|++|..||.... ...............|+.+++++.+||.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643334588999999999999999999997532 222222223334556777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCccccc
Q 012637 250 DPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 250 dP~~R~-----t~~eil~hpw~~~ 268 (459)
||.+|+ |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=353.78 Aligned_cols=254 Identities=29% Similarity=0.465 Sum_probs=213.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999999999999986543322 24466789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||++++.|...... +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999988887755 56999999999999999999999999999999999999999999999999998754331 1223
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-------------------C
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-------------------F 229 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (459)
....|++.|+|||++.+....+.++||||+||++|+|++|.+||...+..+....+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345688999999998765555688999999999999999999998766544333322100 0
Q ss_pred C------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 V------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 ~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
. .++.++..+.+|+.+||..+|.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=355.76 Aligned_cols=259 Identities=31% Similarity=0.485 Sum_probs=214.0
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--CEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--KKI 85 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (459)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+........ ....+.+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999875433221 223456799999999999999999998755 578
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||+.+ +|.+.+.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999976 67777654 679999999999999999999999999999999999999999999999999997654321
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc----------------
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---------------- 227 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 227 (459)
.......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+.+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 22233456788999999876554568999999999999999999999988777665544321
Q ss_pred ---cCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 228 ---EFVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 228 ---~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+..+ .+.++++.+||.+||.+||++|||+++++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 01111 23588899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=352.81 Aligned_cols=240 Identities=18% Similarity=0.277 Sum_probs=208.7
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe----CCEEEEEEec
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT----KKKIFVAMEY 91 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 91 (459)
..||+|++|.||+|.. +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999986 789999999987655555556788899999999999999999999876 4578999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 92 VKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 92 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
++||+|.+++.. +.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 999999999976 678999999999999999999998 4999999999999999999999999999875432 112
Q ss_pred cccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHHHHHH
Q 012637 170 TQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKRLISK 245 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 245 (459)
...||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+.+..+... .+..|...++.+.+||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999976 344 58999999999999999999999998888877776543 344555689999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 012637 246 LLVSDPERRITIQSIMRV 263 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~h 263 (459)
||+.||++|||+.++++.
T Consensus 258 cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 258 CTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HhcCCcccCcCHHHHHHH
Confidence 999999999999999863
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=350.93 Aligned_cols=256 Identities=35% Similarity=0.680 Sum_probs=227.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 88 (459)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.++..........+.+|+.+++.+. ||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765555545677889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC--
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND-- 165 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~-- 165 (459)
|||+++++|.+.+.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999977 58999999999999999999999999999999999999999999999999998754432210
Q ss_pred ----------------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC
Q 012637 166 ----------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF 229 (459)
Q Consensus 166 ----------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 229 (459)
.......|+..|+|||++....+ +.++||||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12233457889999999887654 4889999999999999999999998887777777777777
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITI----QSIMRVPWF 266 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~----~eil~hpw~ 266 (459)
..|..+++.+.+||.+||+.+|.+|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=344.09 Aligned_cols=251 Identities=33% Similarity=0.496 Sum_probs=216.1
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||.|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 36899999999999999999999999999999999755322 456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 999999999998865 58999999999999999999999999999999999999999999999999998754431 11
Q ss_pred ccccccCCCcccChhhHhhc---CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC-----CCCCCHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKK---GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY-----PPWISTD 238 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~ 238 (459)
......|+..|+|||.+... .++ .++|||||||++|+|++|..||.+.+.......+....+.. +...+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 22345788999999998765 554 78999999999999999999998876655544444442222 2335788
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPW 265 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw 265 (459)
+.+||.+||..+|..|||+.+++.|||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=350.79 Aligned_cols=249 Identities=31% Similarity=0.483 Sum_probs=207.7
Q ss_pred eecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHH---HHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE---ISVMRLVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
.||+|+||.||+|.+..+++.||+|.+.+..............| +.+++...||||+++++++.+....|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987544322211222333 344555689999999999999999999999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccccc
Q 012637 94 GGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172 (459)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~ 172 (459)
||+|..++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 9999988865 6799999999999999999999999999999999999999999999999999875432 1223567
Q ss_pred CCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc---hHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCC
Q 012637 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE---NIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249 (459)
Q Consensus 173 Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 249 (459)
|++.|+|||++.+....+.++||||+||++|+|++|..||.+. ........+.......|...+.++.+||.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999975433458899999999999999999999876 3334444444455666777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccC
Q 012637 250 DPERRI-----TIQSIMRVPWFRKG 269 (459)
Q Consensus 250 dP~~R~-----t~~eil~hpw~~~~ 269 (459)
+|.+|| ++.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=348.31 Aligned_cols=256 Identities=26% Similarity=0.494 Sum_probs=214.9
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc---cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK---KEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+|+.++.||+|+||.||.|.+..+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488999999999999999999999999999999754321 22346788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeecCCCcccccccC-
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRN- 164 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~~~~~~- 164 (459)
|+||++|++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999998876 6799999999999999999999999999999999999998776 599999999875443211
Q ss_pred -CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHH-----hccCCCCCCCCHH
Q 012637 165 -DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF-----KAEFVYPPWISTD 238 (459)
Q Consensus 165 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~s~~ 238 (459)
........||..|+|||.+.+..+. .++||||+||++|+|++|..||...........+. ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112234688999999999876664 88999999999999999999997644322222221 1223455668899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=342.27 Aligned_cols=252 Identities=29% Similarity=0.534 Sum_probs=221.6
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||.|+||.||.+++..+++.+++|.+........ ....+.+|+.++++++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh-HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 69999999999999999999999999999999876554333 45678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 9999999999865 358999999999999999999999999999999999999999999999999997543321 13
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-CCCCCCHHHHHHHHHh
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLISKL 246 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~ 246 (459)
.....|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+..+....+..+.+. .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999999876654 7899999999999999999999988887777776655443 2355789999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 012637 247 LVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~ 266 (459)
|.++|.+|||+.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=345.96 Aligned_cols=256 Identities=27% Similarity=0.503 Sum_probs=214.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CCEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK--KEFMMEQIKREISVMRLVRHPNVVELREVMAT--KKKI 85 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (459)
..|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3689999999999999999999999999999998754322 22345678899999999999999999998865 4678
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc-
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR- 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~- 163 (459)
|+++||+++++|.+.+.. +.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999876 679999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (459)
.........|+..|+|||.+.+..++ .++||||+||++|+|++|+.||............... ....|..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 11122335688999999999876654 8899999999999999999999876655444433322 23446668899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
|| +||..+|++|||++++++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=343.30 Aligned_cols=248 Identities=29% Similarity=0.542 Sum_probs=216.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+.+.+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2245678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|+++|+|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999988854 45899999999999999999999999999999999999999999999999999755431 122
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-CCCCCCHHHHHHHHHh
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLISKL 246 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~ 246 (459)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+... .|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999987765 48999999999999999999999988877776666555443 4566889999999999
Q ss_pred cCCCCCCCCCHHHHhcC
Q 012637 247 LVSDPERRITIQSIMRV 263 (459)
Q Consensus 247 L~~dP~~R~t~~eil~h 263 (459)
|+.||.+|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=344.54 Aligned_cols=256 Identities=27% Similarity=0.528 Sum_probs=214.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CCEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL--KKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KKKI 85 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (459)
..|++++.||+|+||.||.|.+..+|+.||||.+..... ......+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999999864322 223345778899999999999999999998866 3578
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc-
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR- 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~- 163 (459)
|++|||++|++|.+++.. +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999866 678999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (459)
.........|+..|+|||++.+..+ +.++|||||||++|+|++|+.||............... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1112234568999999999987665 48899999999999999999999876555444443322 22345567888999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
+|.+||. +|++|||++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.02 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=208.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCC-----CcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMT-----GESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMA 80 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 80 (459)
.-.++|++++.||+|+||.||+|.+..+ ++.||+|.+...... ...+.+.+|+.+++.+ +||||+++++.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3456799999999999999999986544 357999999754322 2356788999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---------------------------------------------------------
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR--------------------------------------------------------- 103 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--------------------------------------------------------- 103 (459)
....+|+|||||++|+|.+++..
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999988743
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 104 --------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 104 --------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
.++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 147888999999999999999999999999999999999999999999999997543211111112
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHHHHHHh
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~ 246 (459)
+..+++.|+|||++.+..+ +.++||||+||++|+|++ |..||........+...... ....|...++++.+||.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 2345668999999987666 489999999999999997 99999876554433333333 3345667899999999999
Q ss_pred cCCCCCCCCCHHHHhcC
Q 012637 247 LVSDPERRITIQSIMRV 263 (459)
Q Consensus 247 L~~dP~~R~t~~eil~h 263 (459)
|+.||.+|||+.++++.
T Consensus 352 l~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 352 WNLEPTERPTFSQISQL 368 (374)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=352.39 Aligned_cols=258 Identities=31% Similarity=0.469 Sum_probs=215.9
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK--KEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765443 122345677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+ +|+|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 88999999763 6999999999999999999999999999999999999999999999999999765432 12
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc------------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------------ 228 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 228 (459)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+..+.+.++...-
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334578899999998765555689999999999999999999998776655444443210
Q ss_pred -----CC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 229 -----FV-----YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 229 -----~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
.. .....+.++.+||.+||.+||++|||+.++++||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 00 01224778999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=341.91 Aligned_cols=251 Identities=32% Similarity=0.539 Sum_probs=219.0
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|+||.||+|.+..+++.+|+|.+........ ....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH-HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 69999999999999999999999999999999987654433 45678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeecCCCcccccccCCC
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~~~~~~~~ 166 (459)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++..... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC---Cc
Confidence 9999999999965 2489999999999999999999999999999999999998654 589999999975432 12
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISK 245 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 245 (459)
......|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.... ...+..+++++.++|.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2234568999999999987665 488999999999999999999999887776666655443 34566689999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 012637 246 LLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~ 266 (459)
||.+||.+|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=348.78 Aligned_cols=256 Identities=28% Similarity=0.532 Sum_probs=218.2
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCCcceeEEEEEeCCEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR---HPNVVELREVMATKKKIFV 87 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 87 (459)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58889999999999999999999999999999875432 223567889999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 88 AMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||++|++|.+++..+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999997654321 22
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCC-CCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPP-WISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~-~~s~~~~~Li~~ 245 (459)
.....|++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.........+..... ..+. .++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 33457899999999987654446899999999999999999999988766554433332221 2222 267899999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
||+.||++|||+.+++.||||+...
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999998654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=346.19 Aligned_cols=252 Identities=29% Similarity=0.485 Sum_probs=211.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCC----
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKK---- 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~---- 83 (459)
.++|++.+.||+|+||.||+|.++.+++.||+|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5899999999999999999999999999999999875432 235688999999999 7999999999997644
Q ss_pred --EEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 84 --KIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
.+|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 48999999999999888753 47999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcC----CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC---
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG----YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF--- 229 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--- 229 (459)
..... .........|++.|+|||++.... ..+.++|||||||++|+|++|..||...........+.....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 75432 122233467899999999986422 224789999999999999999999987665555555544322
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
..+..++.++++||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=350.12 Aligned_cols=253 Identities=30% Similarity=0.551 Sum_probs=206.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||.||+|.++.+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 578999999999999999999999999999999987543221 123456899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+++ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SK 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--Cc
Confidence 999985 88888765 46899999999999999999999999999999999999999999999999998643211 11
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch-HHHHHHHHHhc------------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVFKA------------------ 227 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~------------------ 227 (459)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.. ..+....+...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12234578899999998765444588999999999999999999997654 22222221110
Q ss_pred -cCCC-----------CCCCC--HHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 228 -EFVY-----------PPWIS--TDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 228 -~~~~-----------p~~~s--~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.... .+.++ .++.++|.+||+++|++|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=352.82 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=204.8
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcC----------------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLM----------------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn 71 (459)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35789999999999999999997532 34579999987543 2234567889999999999999
Q ss_pred cceeEEEEEeCCEEEEEEeccCCCchHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 012637 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARG--------------------RLREDLARKYFQQLISAVDFCHSRGVS 131 (459)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--------------------~l~e~~~~~~~~qll~~L~~LH~~gi~ 131 (459)
|+++++++.+.+..|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999988542 256778899999999999999999999
Q ss_pred eccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh--CC
Q 012637 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA--GF 209 (459)
Q Consensus 132 HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~--G~ 209 (459)
||||||+|||++.++.+||+|||+++...............+++.|+|||++....+ +.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999975432211112233456788999999987665 489999999999999986 67
Q ss_pred CCCCCchHHHHHHHHHh---c-----cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 210 LPFQDENIMNMYRKVFK---A-----EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 210 ~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.||.+.+..+....+.. . ....|+.++..+.+||.+||..||.+|||+++|.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 88887665554433221 1 12335567899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=359.71 Aligned_cols=258 Identities=27% Similarity=0.501 Sum_probs=211.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 457899999999999999999999999999999999865432 223445677899999999999999999988543
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...|+||||+.+ +|.+.+... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999975 777776544 9999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------- 227 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 227 (459)
. ........|++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+....+..+...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 2223445789999999999887775 8999999999999999999999876544333322110
Q ss_pred ---------cC--------------CC-------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 228 ---------EF--------------VY-------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 228 ---------~~--------------~~-------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
.. .. +...++.+++||.+||+.||.+|||+.++|+||||+.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 00 00 1123567899999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=354.23 Aligned_cols=256 Identities=25% Similarity=0.461 Sum_probs=218.6
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.|.....||+|+||.||++.+..+++.||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44666788999999999999999999999999986532 223566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
||+++++|.+++..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~~~~ 176 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRK 176 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccccCc
Confidence 999999999998888899999999999999999999999999999999999999999999999999875432 122233
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---CCCCCCCCHHHHHHHHHh
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKRLISKL 246 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~ 246 (459)
...|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+....+..+.... ...+...+..+.+||.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 45789999999999876664 78999999999999999999998877665555443321 122234688999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccCCC
Q 012637 247 LVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
|..||.+|||++++++||||+....
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccCC
Confidence 9999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=341.09 Aligned_cols=253 Identities=28% Similarity=0.516 Sum_probs=217.2
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL--KKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999988999999999865432 2233456789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
+||+++++|.+++.+ +.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~---~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---cc
Confidence 999999999999876 56999999999999999999999999999999999999999999999999998754322 12
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh--ccCCCCCCCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--AEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~Li~~ 245 (459)
.....|++.|+|||.+......+.++|+||+||++|+|++|..||...........+.. .....|+.+++++.+|+.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987655235889999999999999999999987665444333333 2234566789999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 012637 246 LLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~ 266 (459)
||..+|.+|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=348.91 Aligned_cols=255 Identities=33% Similarity=0.525 Sum_probs=214.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 579999999999999999999999999999999865432 2224567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
||++++.+..+... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99999877766655 5799999999999999999999999999999999999999999999999999876543221 133
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---------------------
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--------------------- 227 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------------- 227 (459)
....|++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34578899999999987734468999999999999999999999876554333222110
Q ss_pred c-----------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 228 E-----------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 228 ~-----------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
. ..+|..++.++.+||.+||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=351.79 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=207.0
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK---- 83 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (459)
..++|++.+.||+|+||.||+|.+..+++.||||.+........ ....+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 46789999999999999999999999999999999865432221 2334568999999999999999999986653
Q ss_pred ----EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 84 ----KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 84 ----~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
..|+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 46999999975 67777655 378999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCC--CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--c-----
Q 012637 158 LPEQLRND--GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--E----- 228 (459)
Q Consensus 158 ~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~----- 228 (459)
........ .......+++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+.......+... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 54332111 12234567889999999876544458899999999999999999999887654433222210 0
Q ss_pred ------------CCCC-------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 ------------FVYP-------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ------------~~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
...| ...++.+.+||.+||..||.+|||++++++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.21 Aligned_cols=252 Identities=30% Similarity=0.584 Sum_probs=218.6
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CCEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KKKIFVA 88 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV 88 (459)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998765443 3345678899999999999999999997753 5678999
Q ss_pred EeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----hCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 89 MEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCH-----SRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH-----~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
|||+++++|.+++.. +.+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999988853 57899999999999999999999 99999999999999999999999999999986
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCH
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWIST 237 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 237 (459)
.... ........|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. ..|..++.
T Consensus 160 ~~~~--~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHD--SSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCC--cccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 5432 111344578999999999987665 4889999999999999999999998877776666665544 34567889
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
++.+|+.+||..+|.+|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=342.81 Aligned_cols=249 Identities=28% Similarity=0.485 Sum_probs=215.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... .+.+.+|+.+++.++||||+++++++.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 679999999999999999999998899999999865421 567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~--~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC--ccc
Confidence 99999999999864 57899999999999999999999999999999999999999999999999998754432 112
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---cCCCCCCCCHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EFVYPPWISTDAKRLIS 244 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~ 244 (459)
.....|++.|+|||++.+..++ .++||||+||++|+|++|..||...+.......+... ....+..++.++.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 2344588999999999887664 8899999999999999999999876655443333221 12234457789999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 012637 245 KLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+||++||++|||+.++++||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.51 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=219.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
..|+..+.||.|+||.||.|.+..+++.||+|++..... ......+.+|+.+++.+.||||+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 568889999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
||++||+|.+++..+++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 82 e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 159 (277)
T cd06640 82 EYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRN 159 (277)
T ss_pred ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--ccccc
Confidence 9999999999998889999999999999999999999999999999999999999999999999999754321 11223
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHHHHhcC
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~ 248 (459)
...|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+... ....+..++.++.+||.+||.
T Consensus 160 ~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred cccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 3468889999999987665 48999999999999999999999887766555444332 222334578889999999999
Q ss_pred CCCCCCCCHHHHhcCcccccC
Q 012637 249 SDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 249 ~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+|++||++.++++||||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCcccCcCHHHHHhChHhhhc
Confidence 999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=358.14 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=212.1
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK----- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (459)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4679999999999999999999999999999999986422 222456678899999999999999999887544
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
...|+++||+.+ +|...+..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999975 8888887789999999999999999999999999999999999999999999999999998754321
Q ss_pred cC-CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh---------------
Q 012637 163 RN-DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--------------- 226 (459)
Q Consensus 163 ~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 226 (459)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223457899999999986644446899999999999999999999987654332221110
Q ss_pred --------c---cCC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 227 --------A---EFV-----YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 227 --------~---~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
. ... ..+..++++.+||.+||+.+|.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000 0123578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=349.63 Aligned_cols=252 Identities=30% Similarity=0.535 Sum_probs=209.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|++.+.||.|+||.||+|.+..+|+.||||.+..+.... .....+.+|+.++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4899999999999999999999999999999986543222 233567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|+. ++|..++.. +.+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 578887754 56899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc------------------cC
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------EF 229 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~ 229 (459)
.....+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+......++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 334467889999999876655568899999999999999999999876654333222210 00
Q ss_pred CC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 VY-----------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 ~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.+ .+.+++++++||.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.51 Aligned_cols=247 Identities=32% Similarity=0.520 Sum_probs=211.0
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCch
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL 97 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (459)
||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765444333445567899999999999999999999999999999999999999
Q ss_pred HHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCC
Q 012637 98 FAKVAR-G--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT 174 (459)
Q Consensus 98 ~~~i~~-~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt 174 (459)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..... ........|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 988865 3 699999999999999999999999999999999999999999999999999875432 2222345678
Q ss_pred CcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH----HHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCC
Q 012637 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI----MNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250 (459)
Q Consensus 175 ~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 250 (459)
..|+|||++.+..+ +.++||||+||++|+|++|+.||..... ..+...+.......|..+++.+.+||.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999987665 4889999999999999999999977543 233333333445566678999999999999999
Q ss_pred CCCCC-----CHHHHhcCccccc
Q 012637 251 PERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 251 P~~R~-----t~~eil~hpw~~~ 268 (459)
|.+|| ++.++++||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=362.88 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=199.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
..+|++.+.||+|+||.||+|.+..+++.||+|+..+.. ...|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 457999999999999999999999999999999854322 34699999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 999965 77777754 5799999999999999999999999999999999999999999999999999974321 12
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCC-CCCCchH----------HHHHHHHHhc---cCCCC
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFL-PFQDENI----------MNMYRKVFKA---EFVYP 232 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~~~----------~~~~~~i~~~---~~~~p 232 (459)
......||+.|+|||++.+..+. .++||||+||++|+|+++.. +|..... ..+...+... ...+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 22346799999999999887764 89999999999999998544 4433211 0111111100 00011
Q ss_pred ------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 233 ------------------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 233 ------------------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999974
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=348.74 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=215.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCC-----cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTG-----ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 567999999999999999999876655 679999986432 2334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC
Q 012637 84 KIFVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
..|++|||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999998864 3478899999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHH
Q 012637 147 DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVF 225 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 225 (459)
.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999754322222223345678899999998876664 89999999999999998 999999888877777766
Q ss_pred hcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 226 KAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 226 ~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
... ...|..+++++.+|+.+||+.||.+|||+.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 543 34456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.02 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=212.3
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeC----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATK---- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~---- 82 (459)
..++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 46889999999999999999999999999999999865321 235677899999999 899999999998653
Q ss_pred -CEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 83 -KKIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
...|+||||++|++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999999999987752 57899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcC----CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---C
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG----YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---F 229 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~ 229 (459)
....... .......|++.|+|||++.... ..+.++||||+||++|+|++|+.||...........+.+.. .
T Consensus 176 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 176 AQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred hhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 7543211 1223456899999999986432 12578999999999999999999998876655544444332 2
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
..+...+..+.+||.+||+.+|.+|||+.+|++||||+
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=365.58 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=206.4
Q ss_pred ccCCEEEeeeecccCcEEEEEEEE-----cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQ-----LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (459)
-.++|++++.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 345899999999999999999964 34677899999864432 22346788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhcC---------------------------------------------------------
Q 012637 82 KKKIFVAMEYVKGGELFAKVARG--------------------------------------------------------- 104 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~--------------------------------------------------------- 104 (459)
....|+|||||+||+|.+++...
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999999999888531
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 105 -------------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 105 -------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 3678889999999999999999999999999999999999999999999999754322111
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc--CCCCCCCCHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE--FVYPPWISTDAKRL 242 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~L 242 (459)
.......+++.|+|||++.+..+. .++|||||||++|+|++ |..||........+.+..... ...|...+.++.+|
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 349 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI 349 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence 111223456789999999877764 89999999999999998 999998765443333333322 23455678899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcC
Q 012637 243 ISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~h 263 (459)
|.+||++||++|||+.++++.
T Consensus 350 i~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 350 MKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.82 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=215.3
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK---- 83 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (459)
+.++|++.+.||+|+||.||+|.+..+|+.||||.+.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 5789999999999999999999999999999999986532 22334566889999999999999999999987653
Q ss_pred --EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 --KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.+|+||||+ |++|..++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 469999999 77898888878999999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF------------ 229 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------ 229 (459)
......+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+....+..+.....
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 171 -----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred -----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 123446789999999997644456899999999999999999999987765544443322111
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 230 -------------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 230 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
...+.+++.+.++|.+||..||.+|||+.+++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 01135688899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=343.41 Aligned_cols=250 Identities=37% Similarity=0.684 Sum_probs=220.3
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCch
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL 97 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (459)
||.|+||.||+|.+..+|+.||+|++...........+.+.+|+.++++++||||+++++.+......|+++||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999776554445667889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC------CCcccc
Q 012637 98 FAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN------DGLLHT 170 (459)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~------~~~~~~ 170 (459)
.+++.+ +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999876 7899999999999999999999999999999999999999999999999999875332111 112234
Q ss_pred ccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCC--CHHHHHHHHHhcC
Q 012637 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI--STDAKRLISKLLV 248 (459)
Q Consensus 171 ~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~Li~~~L~ 248 (459)
.++++.|+|||.+....+ +.++||||||+++|+|++|..||........+..+..+....|... +..+.+||.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999987664 4889999999999999999999998888888877777666666655 8999999999999
Q ss_pred CCCCCCCCH---HHHhcCccccc
Q 012637 249 SDPERRITI---QSIMRVPWFRK 268 (459)
Q Consensus 249 ~dP~~R~t~---~eil~hpw~~~ 268 (459)
.+|.+|||+ .++++||||+.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999963
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=320.03 Aligned_cols=256 Identities=30% Similarity=0.547 Sum_probs=217.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|.-.++||+|.||+|++|++..+++.||+|.++.+.-. +.......+||.+++.++|.|||+++++..++.++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 4577788999999999999999999999999999765432 223456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||.. +|..+... |.+..+.++.++.|++.||.|||++++.||||||.|+|++.+|.+|++|||+|+.++-. -.-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEe
Confidence 99976 67666654 78999999999999999999999999999999999999999999999999999876532 222
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-----c-------------
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-----E------------- 228 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-----~------------- 228 (459)
.....-|.+|++|.++.+...++...|+||.|||+.++.. |++.|++.+..+....|.+. +
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3344568999999999998877789999999999999987 88999999988887777542 0
Q ss_pred --CCCC---------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 --FVYP---------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 --~~~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+.+| +.++..-++|+.++|.-+|..|+++++.++||||...
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 0111 1244557899999999999999999999999999753
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=339.94 Aligned_cols=255 Identities=32% Similarity=0.557 Sum_probs=215.6
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
||.+.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||++++++..+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999766543 3456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC-c-
Q 012637 91 YVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG-L- 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~-~- 167 (459)
|+++++|.+++.. +.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999976 468999999999999999999999999999999999999999999999999987654321111 1
Q ss_pred cccccCCCcccChhhHhhcC--CCCCcchhhhHHHHHHHHhhCCCCCCCch-HHHHHHHHH-hccCCCCCCC--CHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKG--YDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVF-KAEFVYPPWI--STDAKR 241 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~-~~~~~~p~~~--s~~~~~ 241 (459)
.....|++.|+|||.+.... ..+.++||||+|+++|+|++|..||.... .......+. ......|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999997654 13588999999999999999999997642 222222222 2233455554 899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
||.+||+.+|.+|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=358.48 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=219.5
Q ss_pred CccccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 012637 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 1 m~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
|.+....+.++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.+.||||+++++++.
T Consensus 6 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 6 LNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred hccceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence 3444445788999999999999999999999999999999998654222 224466788999999999999999998876
Q ss_pred eCCE------EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecC
Q 012637 81 TKKK------IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFG 154 (459)
Q Consensus 81 ~~~~------~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFG 154 (459)
.... .|+|+||+ |++|.+++..+++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 85 PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 6554 99999999 5699999988899999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-----
Q 012637 155 LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF----- 229 (459)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----- 229 (459)
++..... ......+++.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+....+..+.....
T Consensus 164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 9975432 133456889999999987654456899999999999999999999988766555444332100
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 230 --------------------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 230 --------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
......++++.+||.+||++||.+|||+.++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 00123588999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=347.02 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=210.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT----- 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~----- 81 (459)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3478999999999999999999999999999999986542 2335678899999998 79999999999853
Q ss_pred -CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 82 -KKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
...+|++|||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 5689999999999999998864 458999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCcccChhhHhh-----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-C-
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRK-----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-V- 230 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~- 230 (459)
..... ........|++.|+|||++.. ..+ +.++|||||||++|+|++|..||...........+..... .
T Consensus 170 ~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 54321 122345678999999999863 234 4789999999999999999999977665444433333221 1
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 231 YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 231 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.+..++.++.+||.+||..||.+|||+.+|++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=342.98 Aligned_cols=250 Identities=19% Similarity=0.280 Sum_probs=210.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..+|++.+.||+|+||.||+|.++ ..+..||+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 467999999999999999999865 356789999987542 223346688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999998865 579999999999999999999999999999999999999999999999999876432111
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
........+++.|+|||++.+..+. .++||||+||++|++++ |..||.+.+..+....+..+ ....|..++..+.+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 0111123456789999999877664 89999999999999775 99999988877766666544 23456668899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
++.+||+++|.+|||+++|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.13 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=219.2
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
=|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 377889999999999999999999999999998654322 235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccc
Q 012637 91 YVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT 170 (459)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~ 170 (459)
|+++++|..++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhcc
Confidence 999999999998888999999999999999999999999999999999999999999999999998754321 111233
Q ss_pred ccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCC
Q 012637 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKLLVS 249 (459)
Q Consensus 171 ~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~ 249 (459)
..|+..|+|||.+.+...+ .++|+||+||++|+|++|..||...+.......+.... ...+..++.++.++|.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 5688899999999776554 78999999999999999999998776655555544332 234556789999999999999
Q ss_pred CCCCCCCHHHHhcCcccccC
Q 012637 250 DPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 250 dP~~R~t~~eil~hpw~~~~ 269 (459)
+|.+||++.++++||||...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.07 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=207.7
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCE----
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKK---- 84 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 84 (459)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 4799999999999999999999999999999998654322 123356778999999995 6999999999887665
Q ss_pred -EEEEEeccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEeecCCC
Q 012637 85 -IFVAMEYVKGGELFAKVAR------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLS 156 (459)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~DFGla 156 (459)
.|+||||+++ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78777643 24799999999999999999999999999999999999998 899999999998
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-----CC-
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-----FV- 230 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----~~- 230 (459)
...... ........+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+.... ..
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 754321 1222334678899999998765444689999999999999999999998876655444332210 00
Q ss_pred -----------CC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 231 -----------YP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 231 -----------~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
.| +.+++++.+||.+||.+||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01 23688899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=369.21 Aligned_cols=258 Identities=33% Similarity=0.552 Sum_probs=238.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.-+...+++.+||-|+||.|-++........+|+|++++..+.+....+.+..|-+||..++.|.||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34556788899999999999999876665669999999888877777889999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+.||-|-||+|...+.. |.+.+..+++|+..+++|++|||++||++|||||||++|+.+|-+||.|||+|+... .+
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---cC
Confidence 99999999999999875 899999999999999999999999999999999999999999999999999998654 45
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKRLI 243 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li 243 (459)
...-|.||||.|+|||++.+++.+ .++|.|||||++||||+|.+||.+.+++..|..|.++ .+.+|..++..+.+||
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 566789999999999999999987 8999999999999999999999999999999999887 5678999999999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 244 SKLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
+++...+|.+|.. +.+|.+|.||..
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 9999999999985 899999999964
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=354.00 Aligned_cols=246 Identities=27% Similarity=0.449 Sum_probs=192.3
Q ss_pred eeeecccCcEEEEEEEEcC--CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE--eCCEEEEEEe
Q 012637 15 GRLLGKGTFAKVYYGKQLM--TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA--TKKKIFVAME 90 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E 90 (459)
+..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4789999999999999754 668899999865432 234678999999999999999999884 4578999999
Q ss_pred ccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe----cCCCCeEEeecCCC
Q 012637 91 YVKGGELFAKVAR----------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL----DENEDLKISDFGLS 156 (459)
Q Consensus 91 ~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl----~~~~~lKl~DFGla 156 (459)
|+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9976 66666531 248899999999999999999999999999999999999 56679999999999
Q ss_pred cccccccC-CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH---------HHHHHHHh
Q 012637 157 ALPEQLRN-DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM---------NMYRKVFK 226 (459)
Q Consensus 157 ~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~~ 226 (459)
+....... ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76543211 112334578999999999987655568999999999999999999999653211 00000000
Q ss_pred ----------------------------ccC----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 227 ----------------------------AEF----------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 227 ----------------------------~~~----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
..+ ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.56 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=211.3
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK----- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (459)
+.++|++.+.||.|+||.||+|.++.+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 46899999999999999999999999999999999865543 2346688999999999999999999876543
Q ss_pred ---------CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEee
Q 012637 83 ---------KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISD 152 (459)
Q Consensus 83 ---------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~D 152 (459)
...|+||||+++ +|...+..+.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 368999999974 8888888788999999999999999999999999999999999999984 56789999
Q ss_pred cCCCcccccccC-CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---
Q 012637 153 FGLSALPEQLRN-DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--- 228 (459)
Q Consensus 153 FGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--- 228 (459)
||++........ ........|++.|+|||++.+....+.++|||||||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999975432111 1122334688999999988664445689999999999999999999998766554443332110
Q ss_pred ----------------------CC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 229 ----------------------FV-----YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 229 ----------------------~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.. ..+.++.++.+||.+||++||.+|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 11346788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=344.28 Aligned_cols=248 Identities=32% Similarity=0.555 Sum_probs=205.4
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeC--CEEEEE
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATK--KKIFVA 88 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV 88 (459)
|++.+.||+|+||.||+|.+..+++.||+|.+.+...... .....+|+.+++++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999865432221 123457899999885 99999999999887 899999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+++ +|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||+++. +.+||+|||++..... ..
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence 999975 77777754 56899999999999999999999999999999999999999 9999999999975432 12
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc------------------c
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------E 228 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~ 228 (459)
......+++.|+|||.+....+.+.++||||+||++|+|++|..||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2233568899999998866555668999999999999999999999887765544433211 1
Q ss_pred CCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 FVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+.+| +.++.++.+||.+||.+||.+|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=345.96 Aligned_cols=252 Identities=29% Similarity=0.453 Sum_probs=203.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++.++|+||+++++++.+....|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 67999999999999999999999999999999986543222 2235678999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CCC
Confidence 9996 566665543 56889999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-HHHHHHHhc-------------------
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-NMYRKVFKA------------------- 227 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~------------------- 227 (459)
.....+++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+.. +.+..+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 234567899999999876543457899999999999999999999765432 211111100
Q ss_pred -c---CCCCC---------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 228 -E---FVYPP---------WISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 228 -~---~~~p~---------~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
. ...+. ..++++.+||.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00000 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=344.64 Aligned_cols=251 Identities=32% Similarity=0.537 Sum_probs=210.6
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||.|++|.||+|.+..+|+.||||.+....... ....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 5899999999999999999999999999999997653221 23456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 91 YVKGGELFAKVAR----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|+++ +|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++++++.+||+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9986 78777754 35899999999999999999999999999999999999999999999999999754321 11
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc------------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------------ 228 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 228 (459)
......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765555689999999999999999999998877665544432210
Q ss_pred CC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 FV-----------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.. ..+..++.+.++|.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=349.43 Aligned_cols=254 Identities=31% Similarity=0.456 Sum_probs=212.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--CEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--KKIF 86 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (459)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.++++++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 467999999999999999999999999999999997554332 2334567899999999999999999998877 8999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+||||+++ +|.+.+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 99999985 88887765 35899999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc----------------
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---------------- 228 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 228 (459)
........+++.|+|||.+.+....+.++||||+||++|+|++|..||...+....+.++...-
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1223345678899999998765555688999999999999999999998876655544432210
Q ss_pred ---------------CCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 ---------------FVYPPW-ISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ---------------~~~p~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
..+|.. +++.+.+||.+||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 012222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=340.90 Aligned_cols=246 Identities=34% Similarity=0.622 Sum_probs=209.4
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHH-HhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
+.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+||||+++++++...+.+|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 6799999999999999999999999999765443332333445555544 455899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 95 GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999876 6799999999999999999999999999999999999999999999999999874322 234568
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHHHHHHHHHhcCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTDAKRLISKLLVS 249 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~ 249 (459)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+.......+ ..+++++.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987764 5899999999999999999999998888777766655544332 34789999999999999
Q ss_pred CCCCCC---CHHHHhcCccccc
Q 012637 250 DPERRI---TIQSIMRVPWFRK 268 (459)
Q Consensus 250 dP~~R~---t~~eil~hpw~~~ 268 (459)
||++|| +++|++.||||+.
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 4579999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=339.07 Aligned_cols=252 Identities=31% Similarity=0.590 Sum_probs=216.8
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|+||.||+|.++.+|..||+|.+........ ..+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 68999999999999999999999999999999976543222 34567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC-eEEeecCCCcccccccCCC
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED-LKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~-lKl~DFGla~~~~~~~~~~ 166 (459)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||++++++. +||+|||++..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 9999999998865 25899999999999999999999999999999999999998864 69999999976542 112
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISK 245 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 245 (459)
......|++.|+|||++.+..+. .++|+||+||++++|++|..||...+.......+..... ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22345689999999998876654 889999999999999999999988777666655554433 2345578899999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 012637 246 LLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~ 266 (459)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=349.98 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=217.6
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457778899999999999999999999999999875432 224567899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
||+++++|.+++..+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... .....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhhh
Confidence 9999999999998888999999999999999999999999999999999999999999999999998754321 11122
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcC
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~ 248 (459)
...|+..|+|||.+.+..++ .++||||+||++|+|++|..||...........+.... ...+...+.++.++|.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 34688899999999877664 88999999999999999999998766555444333322 22334578889999999999
Q ss_pred CCCCCCCCHHHHhcCcccccC
Q 012637 249 SDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 249 ~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+|.+|||+.++++||||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=339.71 Aligned_cols=252 Identities=27% Similarity=0.539 Sum_probs=212.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765444555566788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 89 MEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+||+++|+|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 999999999887742 35899999999999999999999999999999999999999999999999998764321
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch--HHHHHHHHHhccCC-CC-CCCCHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN--IMNMYRKVFKAEFV-YP-PWISTDA 239 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~-~p-~~~s~~~ 239 (459)
........|++.|+|||.+.+..++ .++||||+||++|+|++|..||.... .......+...... .+ ...+..+
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1122345789999999999877664 88999999999999999999996543 23444444332221 12 2467889
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+||.+||..+|.+|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.19 Aligned_cols=245 Identities=35% Similarity=0.564 Sum_probs=216.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
.+.+.|.+...+|.|+|+.|..+.+..+++.+|+|++.+... ...+|+.++.+. +||||+++++++.+....
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 467889999999999999999999999999999999987622 234678776666 799999999999999999
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe-cCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL-DENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl-~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+|||++.|+.|.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999999999999999988766668888999999999999999999999999999999 58899999999999854432
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-HHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-NMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
..+.|-|..|+|||++...+|+ .++||||||++||+||+|+.||...... ++...+..+.+. .++|.++++||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred ---hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 5677889999999999988886 9999999999999999999999765444 555555554443 78999999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCccc
Q 012637 244 SKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
++||++||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.44 Aligned_cols=252 Identities=27% Similarity=0.470 Sum_probs=215.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++.+.....+|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4688999999999999999999999999999998765322 34567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||+++++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 99999999999865 678999999999999999999999 999999999999999999999999999987543211
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc-----hHHHHHHHHHhcc-CCCCCC-CCHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE-----NIMNMYRKVFKAE-FVYPPW-ISTDA 239 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~ 239 (459)
.....|++.|+|||.+.+..+. .++||||+||++|+|++|..||... ...+..+.+.... ...+.. +++++
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred -hhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1126788999999999877664 8899999999999999999999764 2333444433322 233333 78899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+||.+||..||++|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=344.63 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=209.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEE-----e
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMA-----T 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~-----~ 81 (459)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 56799999999999999999999999999999998764321 234677899999999 6999999999873 4
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
....|+||||++|++|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 5679999999999999887642 46899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCccccccCCCcccChhhHhhc----CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---cC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKK----GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EF 229 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~ 229 (459)
..... .........|++.|+|||++... ...+.++||||+||++|+|++|..||...+.......+... ..
T Consensus 172 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 172 AQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred eeccc--CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 75432 11223345799999999998532 11247899999999999999999999877654443333222 12
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
..|..++..+.+||.+||+.||.+|||+.++++||||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2344568889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=371.03 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=217.0
Q ss_pred eecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCc
Q 012637 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGE 96 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 96 (459)
+||+|.||+||.|+|..|....|||.+... +....+-+..||.+++.|+|.|||++.+.+..++.+-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999999999999999999643 22345568899999999999999999999999999999999999999
Q ss_pred hHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEeecCCCcccccccCCCccccc
Q 012637 97 LFAKVAR--GRL--REDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLSALPEQLRNDGLLHTQ 171 (459)
Q Consensus 97 L~~~i~~--~~l--~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~~~~~~~~~~~~~~~ 171 (459)
|.++++. |++ +|..+-+|.+||++||.|||++.|+|||||-+|+|++. .|.+||+|||-++.... -+....|.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9999976 888 89999999999999999999999999999999999974 69999999999986543 33445677
Q ss_pred cCCCcccChhhHhhc-CCCCCcchhhhHHHHHHHHhhCCCCCCCch-H-HHHHH-HHHhccCCCCCCCCHHHHHHHHHhc
Q 012637 172 CGTPAYVAPEVLRKK-GYDGSKADLWSCGVILYVLLAGFLPFQDEN-I-MNMYR-KVFKAEFVYPPWISTDAKRLISKLL 247 (459)
Q Consensus 172 ~Gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~-~~~~~-~i~~~~~~~p~~~s~~~~~Li~~~L 247 (459)
-||..|||||++... .-+|.++|||||||++.+|.||++||.... + ..+++ ...+..++.|..+|.++++||.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 799999999999743 234789999999999999999999997633 2 23332 2345567778889999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccCCCC
Q 012637 248 VSDPERRITIQSIMRVPWFRKGFTR 272 (459)
Q Consensus 248 ~~dP~~R~t~~eil~hpw~~~~~~~ 272 (459)
.++|.+||++.++|++||++.+..+
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred CCCcccCccHHHhccCcccccCCCC
Confidence 9999999999999999999877443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.76 Aligned_cols=246 Identities=27% Similarity=0.466 Sum_probs=204.4
Q ss_pred ccCCEEEeeee--cccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 8 LFGKYEMGRLL--GKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 8 ~~~~y~i~~~L--G~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
+.++|++.+.+ |+|+||.||++.++.++..+|+|++....... .|+.++..+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 45677777776 99999999999999999999999987543221 123333323 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~~~~ 162 (459)
.|+||||++|++|.+++.. +.+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 9999999999999999977 4899999999999999999999999999999999999999998 999999999875432
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH----HHHHHhccCCCCCCCCHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM----YRKVFKAEFVYPPWISTD 238 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~ 238 (459)
.....|++.|+|||++.+..+. .++||||+||++|+|++|..||........ ...........++.+++.
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 1234689999999999887765 889999999999999999999976543221 111123334455568999
Q ss_pred HHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPERRIT-IQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t-~~eil~hpw~~~ 268 (459)
+.+||.+||++||.+||+ ++++++||||.+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999996 699999999963
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.04 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=205.7
Q ss_pred CEEEeeeecccCcEEEEEEEEcC--CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--CEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLM--TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--KKIF 86 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (459)
+|++.+.||+|+||.||+|.+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999764322233345678899999999999999999999988 8899
Q ss_pred EEEeccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC----CCCeEEeecCCC
Q 012637 87 VAMEYVKGGELFAKVAR------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE----NEDLKISDFGLS 156 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~----~~~lKl~DFGla 156 (459)
+||||+++ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999986 55555432 36899999999999999999999999999999999999999 899999999999
Q ss_pred cccccccC-CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHH---------HHHHHH-
Q 012637 157 ALPEQLRN-DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN---------MYRKVF- 225 (459)
Q Consensus 157 ~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~---------~~~~i~- 225 (459)
........ .......++|+.|+|||++.+....+.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543222 1122345789999999998765544688999999999999999999997644321 000000
Q ss_pred -------------------------hccCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 226 -------------------------KAEFVYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 226 -------------------------~~~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.....++ ...+.++.++|.+||.+||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.80 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=218.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 4789999999999999999999988999999999864322 2245678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 89 MEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
+||+++++|.+++.+..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--~~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--cccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998754321 1222
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-c--CCCCCCCCHHHHHHHHH
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-E--FVYPPWISTDAKRLISK 245 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~--~~~p~~~s~~~~~Li~~ 245 (459)
....|++.|+|||.+....+ +.++||||+||++|++++|..||...+.......+... . ...+..++..+++||.+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 34568999999999987665 48899999999999999999999877655443333222 1 22233467889999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
||..+|.+||++.+++.||||+...
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=342.28 Aligned_cols=254 Identities=27% Similarity=0.476 Sum_probs=218.4
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|.-.+.||+|++|.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555689999999999999999999999999986432 2234567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccc
Q 012637 91 YVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT 170 (459)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~ 170 (459)
|++|++|.+++..+++++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++...... ......
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~ 174 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKS 174 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccccc
Confidence 999999999998888999999999999999999999999999999999999999999999999988643321 112234
Q ss_pred ccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC---CCCCCHHHHHHHHHhc
Q 012637 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY---PPWISTDAKRLISKLL 247 (459)
Q Consensus 171 ~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~Li~~~L 247 (459)
..|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+....... +..++..+.+||.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 568999999999987665 488999999999999999999998877766666655543222 2237889999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccCC
Q 012637 248 VSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 248 ~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
..+|++|||+.++++||||++..
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.85 Aligned_cols=253 Identities=26% Similarity=0.474 Sum_probs=216.7
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|.....||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......|++|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 44566899999999999999999999999998654322 245678999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccc
Q 012637 92 VKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ 171 (459)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~ 171 (459)
+++++|...+....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .......
T Consensus 100 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~ 177 (297)
T cd06659 100 LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSL 177 (297)
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccccce
Confidence 99999999887788999999999999999999999999999999999999999999999999998644321 1122346
Q ss_pred cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC---CCCCCCCHHHHHHHHHhcC
Q 012637 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF---VYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 172 ~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~L~ 248 (459)
+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+..... ..+..++..+.++|.+||+
T Consensus 178 ~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 178 VGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred ecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 78999999999987766 4899999999999999999999987776665555443322 2233578899999999999
Q ss_pred CCCCCCCCHHHHhcCcccccCC
Q 012637 249 SDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 249 ~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+|.+|||++++++||||.+..
T Consensus 257 ~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 257 REPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CCcccCcCHHHHhhChhhccCC
Confidence 9999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=359.24 Aligned_cols=240 Identities=29% Similarity=0.484 Sum_probs=209.4
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
+.+.+.||+|.||.||+|.... ...||+|.+....... +.+.+|+.+|++|+|+|||++++++.....+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 4567899999999999999643 3589999997654433 4566999999999999999999999998899999999
Q ss_pred cCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 92 VKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 92 ~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
++.|+|.+++.. +.+.......|+.||++|++||+++++|||||.+.|||++++..+||+|||||+... +...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~----d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG----DDEY 358 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC----CCce
Confidence 999999999986 578999999999999999999999999999999999999999999999999999432 2222
Q ss_pred ccccC---CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHH
Q 012637 169 HTQCG---TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLI 243 (459)
Q Consensus 169 ~~~~G---t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 243 (459)
...-| ...|.|||.+....++ .++||||+||+|+||+| |+.||.+.+..+..+.+.++ ..+.|..+|+++-+++
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHH
Confidence 22222 2359999999988876 89999999999999999 99999999999999988877 4677888999999999
Q ss_pred HHhcCCCCCCCCCHHHHh
Q 012637 244 SKLLVSDPERRITIQSIM 261 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil 261 (459)
..||..+|++|||++.+.
T Consensus 438 ~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhhCCcccCCCHHHHH
Confidence 999999999999998554
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=343.81 Aligned_cols=257 Identities=29% Similarity=0.486 Sum_probs=210.6
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 368999999999999999999999999999999986543222 2345678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEeecCCCcccccccC
Q 012637 89 MEYVKGGELFAKVAR-G--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~~~~~~~~ 164 (459)
|||+++ +|...+.. . .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999965 77777654 2 3688899999999999999999999999999999999985 567999999999754321
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc----------------
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---------------- 228 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 228 (459)
........|++.|+|||.+.+....+.++||||+||++|+|++|..||...+..+...++....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1122345678999999998765444589999999999999999999998776555444332110
Q ss_pred -----CC--------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 -----FV--------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 -----~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.. ..+.+++++.++|.+||+.+|++||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 113468889999999999999999999999999999754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=343.64 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=211.6
Q ss_pred cCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
-++|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 367999999999999999999853 345679999886432 334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeE
Q 012637 84 KIFVAMEYVKGGELFAKVARG--------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLK 149 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~--------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lK 149 (459)
..|+||||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+|||+++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 999999999999999988642 389999999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc
Q 012637 150 ISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE 228 (459)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 228 (459)
|+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999754321111122234467889999999876654 89999999999999998 999998888777777776655
Q ss_pred C-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 229 F-VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 229 ~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
. ..+..++.++.+|+.+||++||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3 345568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=333.38 Aligned_cols=252 Identities=35% Similarity=0.635 Sum_probs=221.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 689999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 91 YVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998864 569999999999999999999999999999999999999999999999999997654321
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLIS 244 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~ 244 (459)
......+|++.|+|||.+....+. .++|+||+|+++|+|++|..||...+............. ..|..++.++.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 233456789999999998877654 789999999999999999999988877776666655433 345568899999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 012637 245 KLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+||..+|.+|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=344.30 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=215.5
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 467999999999999999999999999999999986542 233457789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+++++|.+++.. +.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----S 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----h
Confidence 999999999998876 679999999999999999999997 6999999999999999999999999999864322 1
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-----------HHHHHHHhcc-CCCCCC
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-----------NMYRKVFKAE-FVYPPW 234 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~~ 234 (459)
.....+|+..|+|||++.+..+ +.++||||+||++|+|++|..||...... +....+.... ...+..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 2234578999999999977655 48899999999999999999999865431 2333333322 222222
Q ss_pred -CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 235 -ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 235 -~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
++.++.+||.+||++||.+|||+.|+++||||...
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 67889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.11 Aligned_cols=252 Identities=31% Similarity=0.591 Sum_probs=220.0
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++|||++++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999776543 2345789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 91 YVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
|+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....... ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--cccc
Confidence 9999999999876 789999999999999999999999999999999999999999999999999998654321 1123
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHH-hccCCCCCCCCHHHHHHHHHhcC
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF-KAEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
...|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+......+.. ......|..++..+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568999999999987664 588999999999999999999998766544333333 33445566789999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 012637 249 SDPERRITIQSIMRVPWF 266 (459)
Q Consensus 249 ~dP~~R~t~~eil~hpw~ 266 (459)
++|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=346.07 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=214.4
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
...+|.+.+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++.+....|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34679999999999999999999999999999999875544444455678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 88 AMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 88 V~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
||||+.| +|.+.+. .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 9999985 5656554 36799999999999999999999999999999999999999999999999999875332
Q ss_pred CccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-CCC-CCCCCHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-FVY-PPWISTDAKR 241 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~~~ 241 (459)
.....|++.|+|||++.+ ....+.++||||+||++|+|++|..||.+.+.......+.... ... +..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 124568899999999752 2233578999999999999999999998877655444443322 222 2236788999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
||.+||..||.+|||+.+++.||||...
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=341.70 Aligned_cols=261 Identities=30% Similarity=0.583 Sum_probs=236.5
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCC
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKK 83 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (459)
+.+-.+.|++.++||+|+|++|-+++.+.|.+.||+|+++++-+.+...++.++.|-.+.... +||.+|-++.+|+++.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 345678899999999999999999999999999999999998888777888888998888777 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.+++|.||++||+|.-.+.+ .+++|+.|++|-..|+.||.|||++||++||||.+|+|+|..|++||+|+|+++. ..
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GL 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CC
Confidence 99999999999999777765 7899999999999999999999999999999999999999999999999999973 33
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC--------chHHHHHHHHHhccCCCCCC
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD--------ENIMNMYRKVFKAEFVYPPW 234 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~~~p~~ 234 (459)
.......+.||||.|+|||++.+..| |..+|+|+|||++|+|++|+.||+- .+...+++-|...++..|..
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 45556788999999999999999887 6999999999999999999999952 33446677888888999999
Q ss_pred CCHHHHHHHHHhcCCCCCCCC------CHHHHhcCccccc
Q 012637 235 ISTDAKRLISKLLVSDPERRI------TIQSIMRVPWFRK 268 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~------t~~eil~hpw~~~ 268 (459)
+|-.+..+++.-|++||++|. .+.++..||||+.
T Consensus 482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 999999999999999999997 4789999999973
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=341.17 Aligned_cols=255 Identities=23% Similarity=0.278 Sum_probs=211.0
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3456789999999999999999998652 45679999985432 2223456789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeE
Q 012637 81 TKKKIFVAMEYVKGGELFAKVARG-----------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLK 149 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~-----------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lK 149 (459)
.....++||||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999988641 246778899999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc
Q 012637 150 ISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE 228 (459)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 228 (459)
|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999874332111111123456788999999987665 489999999999999999 799999887777666555543
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 229 -FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 229 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
...|...++.+.+|+.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34556688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.38 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=212.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE----eCCE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA----TKKK 84 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~----~~~~ 84 (459)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.++++++||||+++++++. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 47899999999999999999999999999999998754322 224566788999999999999999999875 3457
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||||+. ++|...+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999996 578888864 679999999999999999999999999999999999999999999999999987543211
Q ss_pred --CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh---------------
Q 012637 164 --NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--------------- 226 (459)
Q Consensus 164 --~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 226 (459)
........+|+..|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 111223457899999999987654456899999999999999999999987654433221111
Q ss_pred -----------ccCCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 227 -----------AEFVY-----PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 227 -----------~~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
..... .+..+.++.++|.+||+.+|.+|||++++++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00001 133688999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.05 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=212.5
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 467899999865432 224567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCe
Q 012637 84 KIFVAMEYVKGGELFAKVAR---------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDL 148 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~l 148 (459)
..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999864 237889999999999999999999999999999999999999999
Q ss_pred EEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc
Q 012637 149 KISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA 227 (459)
Q Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 227 (459)
||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998743221111122344567889999999877764 88999999999999998 99999887777777776655
Q ss_pred cCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 228 EFV-YPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 228 ~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
... .|..++..+.+|+.+||.+||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 443 34568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=341.77 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=212.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
+-.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345789999999999999999997652 345799999864432 2223457789999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEE
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-----------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI 150 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl 150 (459)
....|+||||+++|+|.+++.. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999999864 12456788999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-
Q 012637 151 SDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE- 228 (459)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~- 228 (459)
+|||+++...............++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+..+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999875432111111222345678999999987666 489999999999999998 899998887777666555443
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------Cccccc
Q 012637 229 FVYPPWISTDAKRLISKLLVSDPERRITIQSIMR------VPWFRK 268 (459)
Q Consensus 229 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~------hpw~~~ 268 (459)
...|...++.+.+++.+||+.||++|||+.++++ ||||+.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 3445567899999999999999999999999987 898863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.95 Aligned_cols=254 Identities=31% Similarity=0.558 Sum_probs=218.4
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--CEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--KKIFVA 88 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV 88 (459)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+.+. ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999999999999999765433 33467889999999999999999999999988 899999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999876 4899999999999999999999999999999999999999999999999999886544222112
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch-HHHHHHHHH--hccCCCCCCCCHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVF--KAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~Li~ 244 (459)
.....++..|+|||.+....+ +.++||||+|+++|+|++|..||.... .......+. ......|..++..+.+||.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999987664 489999999999999999999998765 222222222 2334456667999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 012637 245 KLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+||..||.+||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=334.63 Aligned_cols=255 Identities=27% Similarity=0.520 Sum_probs=215.6
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--CEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL--KKEFMMEQIKREISVMRLVRHPNVVELREVMATK--KKI 85 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (459)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999854321 2233456789999999999999999999998764 568
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
++++||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999998876 6799999999999999999999999999999999999999999999999999975432111
Q ss_pred -CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHH
Q 012637 165 -DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKR 241 (459)
Q Consensus 165 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 241 (459)
........|++.|+|||.+.+..++ .++||||+||++|+|++|..||.+........++... ....|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1122345689999999999876654 8899999999999999999999887665555544432 23457778999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+|.+||. +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=375.20 Aligned_cols=246 Identities=30% Similarity=0.514 Sum_probs=207.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEE-EEe---C--
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREV-MAT---K-- 82 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~-~~~---~-- 82 (459)
.+++|.+.|.+|||+.||+|.+...|..||+|.+-.. ++...+.+++||.+|++|+ |+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4688999999999999999999888899999987533 5667889999999999996 9999999993 221 1
Q ss_pred -CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 83 -KKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
-.++|.||||.||.|.+++.. .+|+|.++.+||.|+++||.+||... |+|||||-|||||..+|+.||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 247899999999999999974 67999999999999999999999998 999999999999999999999999998
Q ss_pred cccccccC--CC--c---cccccCCCcccChhhHh---hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh
Q 012637 157 ALPEQLRN--DG--L---LHTQCGTPAYVAPEVLR---KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK 226 (459)
Q Consensus 157 ~~~~~~~~--~~--~---~~~~~Gt~~y~APE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~ 226 (459)
+..-.... .+ . --...-||.|+|||++. +.+. +.|+|||+|||+||-||....||++.... .|..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEe
Confidence 74221110 00 0 01234699999999984 4444 58999999999999999999999887543 4567
Q ss_pred ccCCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 227 AEFVYPP--WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 227 ~~~~~p~--~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.|.+|+ ..+..+.+||+.||++||.+||++.+++.+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 7888876 589999999999999999999999998875
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=339.66 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=205.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHH-HHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV-MRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
++|++.+.||+|+||.||+|.+..+|+.||+|.+........ ...+..|+.+ ++.++||||+++++++......|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 469999999999999999999999999999999976543222 2344556665 6677999999999999999999999
Q ss_pred EeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 89 MEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
|||++| +|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 999975 66655532 4689999999999999999999998 999999999999999999999999999875432
Q ss_pred cCCCccccccCCCcccChhhHhhcC---CCCCcchhhhHHHHHHHHhhCCCCCCCc-hHHHHHHHHHh-ccCCCC-CCCC
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKG---YDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFK-AEFVYP-PWIS 236 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~-~~~~~p-~~~s 236 (459)
........|++.|+|||++.+.. ..+.++|+||+||++|+|++|..||... ...+.+..+.. .....| ..+|
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred --ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 11222356889999999986421 1247899999999999999999999752 22222223322 223333 3478
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.++.+||.+||..+|.+|||+.++++||||.+..
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=351.79 Aligned_cols=258 Identities=29% Similarity=0.445 Sum_probs=211.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK----- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (459)
+..+|.+.+.||+|+||+||+|.+..+++.||||.+........ ....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc-hhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45789999999999999999999999999999999875422222 245667899999999999999999987644
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
..+|+|+||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 578887765 6899999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh---------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--------------- 226 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 226 (459)
. ........|+..|+|||.+......+.++||||+||++|+|++|+.||.+.+....+..+..
T Consensus 161 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 K--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred C--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 1 12334556899999999987644456899999999999999999999987654332221110
Q ss_pred --------ccC--------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 227 --------AEF--------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 227 --------~~~--------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
... ...+.+++++.+||.+||+++|.+|||++++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 0123578899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.57 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=219.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.|++.+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765432 34567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+++++|.+++.. +.+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 99999999999976 789999999999999999999999 999999999999999999999999999997654321 12
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc---hHHHHHHHHHhc-cCCCCCC-CCHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE---NIMNMYRKVFKA-EFVYPPW-ISTDAKRL 242 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~L 242 (459)
.....|+..|+|||.+....+ +.++|+||||+++|+|++|..||... ...+....+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999887654 58999999999999999999999876 344444444433 2334445 78899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
|.+||.++|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=350.93 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=211.8
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK----- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (459)
..++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 458999999999999999999999999999999998754222 22345678899999999999999999988543
Q ss_pred -CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 -KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
...|++++++ |++|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 4578899887 77898888778899999999999999999999999999999999999999999999999999875322
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------- 228 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 228 (459)
......|++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+....
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 22345789999999998764444588999999999999999999998765544333322110
Q ss_pred ----------CCCC--------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 229 ----------FVYP--------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 229 ----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
...| ...++++.+||.+||++||.+|||+.+++.||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0011 125788999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=335.05 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=203.1
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (459)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999886432 2334567889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 96 ELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999865 3689999999999999999999999999999999999999999999999999875332110000111123
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHHHHhcCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISKLLVSDP 251 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 251 (459)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|...+..+.+|+.+||+++|
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999987665 488999999999999998 99999876665554444332 344566678999999999999999
Q ss_pred CCCCCHHHHhc
Q 012637 252 ERRITIQSIMR 262 (459)
Q Consensus 252 ~~R~t~~eil~ 262 (459)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=342.01 Aligned_cols=251 Identities=31% Similarity=0.525 Sum_probs=208.8
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|++.+.||.|++|.||+|.++.+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999997654322 2335677899999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 92 VKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 92 ~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
++ ++|.+++... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 5888888653 5899999999999999999999999999999999999999999999999999754321 1122
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--------------------
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-------------------- 228 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------- 228 (459)
....+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999998765444588999999999999999999998776544333322210
Q ss_pred ---------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 ---------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ---------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
....+.++.++.+||.+||++||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=362.13 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=216.4
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|.=.+.||.|+||.||.|++..+.+.||||.+.-+.-....-...|.+|++.|+.++|||+|.+.++|......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44568899999999999999999999999999765444444467789999999999999999999999999999999999
Q ss_pred cCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 92 VKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 92 ~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
|-| +-.|++. +.++.|.++..++.+.+.||.|||+.+.+|||||..|||+++.|.|||+|||.|.+..+ ..
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 976 5556553 47899999999999999999999999999999999999999999999999999987554 34
Q ss_pred cccCCCcccChhhHhh---cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-CCCCC-CCCHHHHHHHH
Q 012637 170 TQCGTPAYVAPEVLRK---KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-FVYPP-WISTDAKRLIS 244 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~Li~ 244 (459)
+.+|||.|||||++.- ..|+ -++|||||||+..+|.-.++|+...+.+..+.-|...+ +.++. .+|..+++|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 6789999999999862 3455 68999999999999999999998888776554454443 33332 36889999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 245 KLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.||++-|.+|||.+++|.|+|+...-
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCC
Confidence 99999999999999999999997643
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=345.29 Aligned_cols=257 Identities=21% Similarity=0.377 Sum_probs=213.7
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcC-------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCccee
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLM-------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVEL 75 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l 75 (459)
+.++..++|.+++.||+|+||.||+|.+.. ++..+|+|.+..+. .......+.+|+.+++.+ +||||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 455667899999999999999999998643 23579999997543 222346688899999999 79999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCC
Q 012637 76 REVMATKKKIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPE 138 (459)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~ 138 (459)
++++......|+||||+++|+|.+++... .++...+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99999999999999999999999998642 3788899999999999999999999999999999
Q ss_pred CeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchH
Q 012637 139 NLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENI 217 (459)
Q Consensus 139 NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~ 217 (459)
|||++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999999875432111111112234578999999987666 489999999999999998 9999988877
Q ss_pred HHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 218 MNMYRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 218 ~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+....+.... ...|..++.++.+||.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 77666655443 34566689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=340.38 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=211.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEc----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQL----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
...|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 467999999999999999999853 356789999986432 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC
Q 012637 85 IFVAMEYVKGGELFAKVAR------------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~------------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 9999999999999998842 2378889999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHH
Q 012637 147 DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVF 225 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 225 (459)
.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999975432221222234456778999999987665 489999999999999998 999998877666555554
Q ss_pred hcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 226 KAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 226 ~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
... ...|..+++.+.+++.+||++||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 333 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.10 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=212.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCC---CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.++|++.+.||+|+||.||+|.++.+ ...||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 36799999999999999999998654 4579999986543 233445678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|++|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999865 579999999999999999999999999999999999999999999999999998654211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
.........+++.|+|||.+.+..+. .++|||||||++|+|++ |..||...........+... ....+...+..+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111123346789999999877664 89999999999999998 99999877766666666544 23445567899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 012637 242 LISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~h 263 (459)
|+.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.30 Aligned_cols=247 Identities=30% Similarity=0.476 Sum_probs=206.2
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
...||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|+||+++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 468999999999999999999999999986543 22356788999999999999999999999999999999999999
Q ss_pred CchHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEeecCCCcccccccCCCccc
Q 012637 95 GELFAKVAR--GRL--REDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 95 g~L~~~i~~--~~l--~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
++|.+.+.. ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..... ......
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--~~~~~~ 167 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTE 167 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc--CCCccc
Confidence 999998865 455 88899999999999999999999999999999999986 67999999999875432 112223
Q ss_pred cccCCCcccChhhHhhcC-CCCCcchhhhHHHHHHHHhhCCCCCCCchHH--HHHH-HHHhccCCCCCCCCHHHHHHHHH
Q 012637 170 TQCGTPAYVAPEVLRKKG-YDGSKADLWSCGVILYVLLAGFLPFQDENIM--NMYR-KVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~-~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
...|++.|+|||++.... ..+.++||||+||++|+|++|..||...... .... .........|..+++++.+|+.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 345889999999986543 2358899999999999999999999754322 1111 12233345667789999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 012637 246 LLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~ 266 (459)
||.++|.+|||+.+++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.33 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=213.2
Q ss_pred eeecccCcEEEEEEEEcCC---CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q 012637 16 RLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYV 92 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (459)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+.+++.++|+||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8999999997654322 4577899999999999999999999999999999999999
Q ss_pred CCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 93 KGGELFAKVAR----------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 93 ~gg~L~~~i~~----------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
++++|.+++.. ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999865 56899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAK 240 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (459)
..........+++.|+|||.+....+ +.++|||||||++|+|++ |..||......+....+... ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122344567889999999987665 489999999999999999 69999998887777776643 3455677899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 012637 241 RLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+++.+||..||.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=356.23 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=210.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 87 (459)
...|++.+.||+||-+.||++... ..+.||+|.+... ..+.....-..+||..|.+| .|.+||+++++-..++.+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 456999999999999999999864 3456777766433 23455778899999999999 59999999999999999999
Q ss_pred EEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 88 AMEYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
||||-+ .+|...+.++ .++.-.++.|.+|++.++.++|+.||||.||||.|+|+- .|.+||+|||+|.........
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 999764 4888888763 344458999999999999999999999999999999986 789999999999876654444
Q ss_pred CccccccCCCcccChhhHhhcCCC----------CCcchhhhHHHHHHHHhhCCCCCCCc-hHHHHHHHHHhc--cCCCC
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYD----------GSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFKA--EFVYP 232 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~----------~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~--~~~~p 232 (459)
-...+.+||+.||+||.+....+. ++++||||||||||+|+.|++||..- +...-+..|... ++.+|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 556788999999999999754433 57899999999999999999999653 233334445443 34556
Q ss_pred CCCCHH-HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 233 PWISTD-AKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 233 ~~~s~~-~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..-+.. +.++++.||..||++|||+.++|+|||++.
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 544433 999999999999999999999999999974
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=346.53 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=209.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcE----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+-..+|++.+.||+|+||.||+|.+..+++. ||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3346799999999999999999998766664 8999986432 233456788999999999999999999998764
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..++++||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 57899999999999999875 468999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
............++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+....+....+... ....|+..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 32111112233456789999999877765 89999999999999997 99999887766554433332 23445678899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+++.+||..||.+|||+.+++.+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.14 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=213.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCC-----CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMT-----GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
+..++|++.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999988654 4789999986442 22234567899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEE
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-----------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI 150 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl 150 (459)
....|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999998853 23678889999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-c
Q 012637 151 SDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-E 228 (459)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~ 228 (459)
+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999875433221122234557889999999977665 488999999999999998 99999888777766665543 3
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 229 FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 229 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
...|...+.++.+||.+||+.+|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 34566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.62 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=213.4
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
....|.+.+.||+|+||.||+|.+..+++.||+|.+..+. .....+.+|+.+++.++||||+++++++.....+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 3457999999999999999999999999999999986442 124567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 88 AMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999999998864 3589999999999999999999999999999999999999999999999999975432111
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRL 242 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 242 (459)
. ......+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+.+..+... ....|..+++++.+|
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 0 11122345679999999877664 78999999999999998 99999988877776666543 345566789999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcC
Q 012637 243 ISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~h 263 (459)
|.+||..||++|||+.++++.
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHccCCcccCCCHHHHHHH
Confidence 999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=360.65 Aligned_cols=257 Identities=31% Similarity=0.545 Sum_probs=221.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.-|..++.||-|+||+|.+++...|...||+|.+.+..+........++.|-.||..-..+-||+||..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34778999999999999999999999999999999887777667788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC---
Q 012637 90 EYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND--- 165 (459)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~--- 165 (459)
||++||++..++.+ |-++|+.|++|+..|..|+++.|..|++||||||+|||||.+|++||+||||++-+......
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999888766 88999999999999999999999999999999999999999999999999999744311000
Q ss_pred -------------------------------------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC
Q 012637 166 -------------------------------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG 208 (459)
Q Consensus 166 -------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G 208 (459)
-..+..+||+.|+|||++...+|. ..+|+||.|||||+|+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhC
Confidence 012234599999999999999986 889999999999999999
Q ss_pred CCCCCCchHHHHHHHHHh--c--cCCCCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 012637 209 FLPFQDENIMNMYRKVFK--A--EFVYPPWISTDAKRLISKLLVSDPERRI---TIQSIMRVPWFRK 268 (459)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~--~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~---t~~eil~hpw~~~ 268 (459)
..||-..++.+...++.. . .+.+...+|+++.+||.++.. +++.|. .++++..||||+.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 999998877655443332 2 233334689999999998765 688887 4778999999985
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.44 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=210.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34789999999999999999999987 77889999886432 222345678899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---CeEEe
Q 012637 83 KKIFVAMEYVKGGELFAKVARG--------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---DLKIS 151 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---~lKl~ 151 (459)
...|+||||++|++|.+++... .+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999998652 488999999999999999999999999999999999998765 59999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cC
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EF 229 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~ 229 (459)
|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999975422111111112233567999999987766 489999999999999997 99999987776666555433 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..|..++..+.+++.+||+.+|++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4566789999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=332.54 Aligned_cols=250 Identities=28% Similarity=0.555 Sum_probs=212.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999987654444445677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 90 EYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
||+++|+|..++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999988753 45899999999999999999999999999999999999999999999999998754321
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch--HHHHHHHHHhccC-CCCC-CCCHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN--IMNMYRKVFKAEF-VYPP-WISTDAK 240 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~ 240 (459)
........|++.|+|||.+.+..+. .++||||+||++|+|++|..||.... .......+..+.. ..|. .++.++.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 1223345789999999999877765 88999999999999999999996543 3334444433322 2333 5788999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 012637 241 RLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~ 262 (459)
++|.+||.++|.+|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=337.19 Aligned_cols=251 Identities=27% Similarity=0.535 Sum_probs=212.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++||||+++++++...+..|++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36799999999999999999999999999999998765444444556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 89 MEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|||++|++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~-- 158 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-- 158 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc--
Confidence 999999999988752 4689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH--HHHHHHHHhccCC-C-CCCCCHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI--MNMYRKVFKAEFV-Y-PPWISTDA 239 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~~~ 239 (459)
........+|++.|+|||.+.+..+. .++||||+|+++|+|++|..||.+... ......+....+. . +..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 12223456789999999999877664 789999999999999999999976543 2333333332222 1 23478899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 012637 240 KRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+||.+||..||.+|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=336.80 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=208.1
Q ss_pred EEEeeeecccCcEEEEEEEEcCC---CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE----
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK---- 84 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 84 (459)
|.+++.||+|+||.||.|.+..+ +..||+|.+..+... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67899999999999999987653 478999998754333 3345678999999999999999999998865544
Q ss_pred --EEEEEeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCC
Q 012637 85 --IFVAMEYVKGGELFAKVAR-------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGL 155 (459)
Q Consensus 85 --~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGl 155 (459)
.+++|||+++|+|..++.. ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999888732 3589999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCC
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPP 233 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 233 (459)
++...............++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+.+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 975433211111222345678999999877665 489999999999999999 99999887777776666544 344567
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.++..+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=352.47 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=207.1
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 78 (459)
|.+-.++|++.+.||+|+||.||+|.+.. +++.||+|++..... ....+.+.+|+.+++++ +||||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 44556799999999999999999997543 457899999864432 22346678899999999 89999999998
Q ss_pred EEe-CCEEEEEEeccCCCchHHHHhc------------------------------------------------------
Q 012637 79 MAT-KKKIFVAMEYVKGGELFAKVAR------------------------------------------------------ 103 (459)
Q Consensus 79 ~~~-~~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------ 103 (459)
+.. ...+|++|||+++++|.+++..
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 754 4678999999999999988743
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCC
Q 012637 104 --------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP 175 (459)
Q Consensus 104 --------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~ 175 (459)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 257889999999999999999999999999999999999999999999999997543211111122344567
Q ss_pred cccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHH-HHhc-cCCCCCCCCHHHHHHHHHhcCCCCC
Q 012637 176 AYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRK-VFKA-EFVYPPWISTDAKRLISKLLVSDPE 252 (459)
Q Consensus 176 ~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~-i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~ 252 (459)
.|+|||++.+..+. .++||||+||+||+|++ |..||.+....+.+.. +... ....|...++++.+++.+||+.+|+
T Consensus 240 ~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 240 KWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred cccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 89999999887775 88999999999999998 9999987544333322 2222 2334556789999999999999999
Q ss_pred CCCCHHHHhcC
Q 012637 253 RRITIQSIMRV 263 (459)
Q Consensus 253 ~R~t~~eil~h 263 (459)
+|||++++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.10 Aligned_cols=246 Identities=40% Similarity=0.725 Sum_probs=220.4
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCch
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL 97 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (459)
||+|+||.||.+.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+.+...+|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999877655555667889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCc
Q 012637 98 FAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176 (459)
Q Consensus 98 ~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~ 176 (459)
.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|+..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999976 478999999999999999999999999999999999999999999999999997543211 22345568899
Q ss_pred ccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 012637 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRIT 256 (459)
Q Consensus 177 y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t 256 (459)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+.......|...+..+.++|.+||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999977655 4789999999999999999999988877777777777777888888999999999999999999999
Q ss_pred H---HHHhcCccc
Q 012637 257 I---QSIMRVPWF 266 (459)
Q Consensus 257 ~---~eil~hpw~ 266 (459)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.94 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=208.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcE--EEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGES--VAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (459)
+-.+.|++.+.||+|+||.||+|.+..++.. +|+|.+.. .........+.+|+.++.++ +||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3457899999999999999999999888765 57766542 22333456788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC
Q 012637 84 KIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
.+|+||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999999999988642 478999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHH
Q 012637 147 DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVF 225 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 225 (459)
.+||+|||++....... ......++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 99999999986322111 1111234567999999977665 489999999999999998 999998877777666554
Q ss_pred hc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012637 226 KA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVP 264 (459)
Q Consensus 226 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hp 264 (459)
.. ....|..+++++.+||.+||+.+|++|||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 43 2234455789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.96 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=206.5
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCc--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------CC
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGE--SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------KK 83 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~~ 83 (459)
|.+++.||+|+||.||+|.+..+++ .||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999887775 699999865432 33346778899999999999999999997643 23
Q ss_pred EEEEEEeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 84 KIFVAMEYVKGGELFAKVAR-------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
..+++|||+++|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999887632 34889999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccC-CCCCC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEF-VYPPW 234 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 234 (459)
................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+......+..+..+.. ..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 86532211111223356778999999987766 489999999999999999 8999988777777666665443 44566
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
++..+.++|.+||++||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=342.91 Aligned_cols=259 Identities=29% Similarity=0.517 Sum_probs=211.9
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK- 83 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~- 83 (459)
+....++|++.+.||+|+||.||+|.++.+|+.||+|.+........ ....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-FPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-chHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 45678899999999999999999999999999999999975432221 2345678999999999999999999987654
Q ss_pred ---------EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEee
Q 012637 84 ---------KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISD 152 (459)
Q Consensus 84 ---------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~D 152 (459)
.+|+|+||+++ ++...+.. ..+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 89999999987 56666654 4799999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---cC
Q 012637 153 FGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EF 229 (459)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~ 229 (459)
||++........ .......+++.|+|||.+.+....+.++||||+||++|+|++|++||...+....+..+... ..
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999976543211 12223356788999999876544568999999999999999999999877665544443321 00
Q ss_pred --C-------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 --V-------------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 --~-------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
. ....++..+.+||.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0 011367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=395.43 Aligned_cols=259 Identities=31% Similarity=0.526 Sum_probs=224.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.-||.-+..||.|.||.||.|.+..||+..|+|.+.-.... ......+.+|..++..++|||+|++|++-.+.+.+||.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34788899999999999999999999999999998654433 44567889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc--cCC
Q 012637 89 MEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL--RND 165 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~--~~~ 165 (459)
||||+||+|.+.++.++ .+|...+.|..|++.|+.|||+.|||||||||+||+|+.+|.+|++|||.|...... .-.
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999999998864 778889999999999999999999999999999999999999999999999754432 122
Q ss_pred CccccccCCCcccChhhHhhcC--CCCCcchhhhHHHHHHHHhhCCCCCCCc--hHHHHHHHHHhccCCCCCCCCHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKG--YDGSKADLWSCGVILYVLLAGFLPFQDE--NIMNMYRKVFKAEFVYPPWISTDAKR 241 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (459)
+.+....|||.|||||++.+.. -++.++|||||||+..||+||+.||..- +..-+|.--....+++|..+|++.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 3456678999999999997643 2357899999999999999999999753 33344444445567889899999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
||.+||..||++|+++.||++|.|-+.
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999998754
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=337.01 Aligned_cols=253 Identities=29% Similarity=0.439 Sum_probs=209.7
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CCEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KKKIFV 87 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (459)
++|+..+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 5799999999999999999999999999999998754322 345678899999999999999999998854 457999
Q ss_pred EEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 88 AMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
||||++|++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887642 56899999999999999999999999999999999999999999999999998743321
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc-----hHHHHHHHHHhcc-CCCC----
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE-----NIMNMYRKVFKAE-FVYP---- 232 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p---- 232 (459)
......++..|+|||.+.+..++ .++|||||||++|+|++|..||... ...+....+.... ...+
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 12234678899999999877664 8899999999999999999999865 2233333333211 1111
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 233 --PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 233 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...++.+.+||.+||.+||.+|||+.|+++||||++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=340.65 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=213.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCC-----CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMT-----GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
..+|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45688999999999999999987543 5789999987543 2334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC
Q 012637 84 KIFVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
..++++||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999988742 2478888999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHH
Q 012637 147 DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVF 225 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 225 (459)
.+||+|||+++...............+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999875433222222234456789999999987665 488999999999999998 899999888877777776
Q ss_pred hccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 226 KAEF-VYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 226 ~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.... ..|..++..+.+|+.+||+.+|.+||++.+|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 6543 3466789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=338.96 Aligned_cols=258 Identities=32% Similarity=0.594 Sum_probs=216.7
Q ss_pred CEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
.|++.+.||.|+||.||.|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 47899999999754332 222346778999999999 699999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-E 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-c
Confidence 999999999999999865 67999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccChhhHhhc-CCCCCcchhhhHHHHHHHHhhCCCCCCCch----HHHHHHHHHhccCCCCCCCCHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKK-GYDGSKADLWSCGVILYVLLAGFLPFQDEN----IMNMYRKVFKAEFVYPPWISTDA 239 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 239 (459)
.......+|++.|+|||.+... ...+.++||||+||++|+|++|..||...+ .......+......+|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1222345789999999998753 233578999999999999999999997432 33444445555566677789999
Q ss_pred HHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 012637 240 KRLISKLLVSDPERRI-----TIQSIMRVPWFRKG 269 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~-----t~~eil~hpw~~~~ 269 (459)
.+|+.+||..||.+|| ++++++.||||+..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.15 Aligned_cols=254 Identities=22% Similarity=0.404 Sum_probs=213.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCC-----cEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTG-----ESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMA 80 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 80 (459)
+-.++|++.+.||+|+||.||+|.+...+ ..+|+|.+..... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 44578999999999999999999876443 6899999875432 22345688999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD 143 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~ 143 (459)
....+|++|||+++|+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999998853 3588999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHH
Q 012637 144 ENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYR 222 (459)
Q Consensus 144 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 222 (459)
.++.+||+|||+++...............++..|+|||++.+..+. .++||||+||++|+|++ |..||...+..+.+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999865432111112223356789999998776664 88999999999999997 999999888777776
Q ss_pred HHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 223 KVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 223 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+.... ...|...+.++.+|+.+||..||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 665543 34456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=342.02 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=207.3
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK----- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (459)
..++|++.+.||+|+||.||+|.+..+++.||+|.+........ ....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 36899999999999999999999999999999999865433221 223567899999999999999999987443
Q ss_pred ---CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 83 ---KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
..+|+||||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 357999999976 56666543 579999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCC---------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc
Q 012637 158 LPEQLRND---------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE 228 (459)
Q Consensus 158 ~~~~~~~~---------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 228 (459)
........ .......|++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54322111 111234578899999998765444688999999999999999999999877765555443210
Q ss_pred C-----------------------CCC-------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 F-----------------------VYP-------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ~-----------------------~~p-------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
. ..+ ..+++++.+||.+||..||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 1244678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.90 Aligned_cols=253 Identities=24% Similarity=0.410 Sum_probs=207.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|++.+.||+|+||.||+|.+..+|+.||+|++..+........+++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999999765444455567789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 89 MEYVKGGELFAKVAR------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
|||++||+|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999988753 23456678899999999999999999999999999999999999999999999
Q ss_pred cccccccC----------------CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH
Q 012637 157 ALPEQLRN----------------DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM 220 (459)
Q Consensus 157 ~~~~~~~~----------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~ 220 (459)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521100 001123479999999999988776 4899999999999999999999987554433
Q ss_pred HHHH-HhccCCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 221 YRKV-FKAEFVY--PPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 221 ~~~i-~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.... ....... ...+++.+.+++.+||..||++|++..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2211 1111111 1247889999999999999999987655543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=340.34 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=214.5
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
...||+|+||.||+|.+..+|+.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 467999999999999999999999999985432 22356688999999999999999999999999999999999999
Q ss_pred CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCC
Q 012637 95 GELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT 174 (459)
Q Consensus 95 g~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt 174 (459)
++|.+.+..+++++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ........|+
T Consensus 102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~ 179 (292)
T cd06657 102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGT 179 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--cccccccccC
Confidence 99999887788999999999999999999999999999999999999999999999999988643321 1122345689
Q ss_pred CcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---cCCCCCCCCHHHHHHHHHhcCCCC
Q 012637 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EFVYPPWISTDAKRLISKLLVSDP 251 (459)
Q Consensus 175 ~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~~L~~dP 251 (459)
+.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.........+... .......+++++.++|.+||..||
T Consensus 180 ~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 180 PYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred ccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 99999999876655 48999999999999999999999887665544443322 122233478999999999999999
Q ss_pred CCCCCHHHHhcCcccccCCCC
Q 012637 252 ERRITIQSIMRVPWFRKGFTR 272 (459)
Q Consensus 252 ~~R~t~~eil~hpw~~~~~~~ 272 (459)
.+||++.++++||||.+...+
T Consensus 259 ~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 259 AQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred ccCcCHHHHhcChHHhccCCC
Confidence 999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=339.88 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=212.9
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.|...+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34777788999999999999999999999999997665544445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+.| +|.+.+.. ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.... .
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 99975 66666643 578999999999999999999999999999999999999999999999999986322 2
Q ss_pred cccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC--CCCCCCHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV--YPPWISTDAKRLI 243 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li 243 (459)
.....|++.|+|||++.. ....+.++||||+||++|+|++|..||...+.......+...... ....++..+++||
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 234578999999999852 233347899999999999999999999887665555444433221 1223678899999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 244 SKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+||+++|.+||++.+++.||||+..
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=331.54 Aligned_cols=246 Identities=25% Similarity=0.423 Sum_probs=208.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
..|++.+.||+|+||.||+|..+ ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56899999999999999999875 4568999988654332 245778999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+++|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999998864 5689999999999999999999999999999999999999999999999999875321111 01
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 245 (459)
.....++..|+|||++.+..+. .++||||+||++|+|++ |+.||...+..+....+..+. ...|...+.++.+|+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122345679999999876664 89999999999999999 999999888777777766543 33455678899999999
Q ss_pred hcCCCCCCCCCHHHHhc
Q 012637 246 LLVSDPERRITIQSIMR 262 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~ 262 (459)
||..+|.+|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=340.80 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=211.5
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEE
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELRE 77 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~ 77 (459)
++....++|++.+.||+|+||.||+|.+. .++..||+|.+..... ....+.+.+|+.+++++ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 44566678999999999999999999752 3556899999865432 23456788999999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecC
Q 012637 78 VMATKKKIFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFG 154 (459)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFG 154 (459)
++...+..|+||||+++|+|.+++... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999999998652 38999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc--CCC
Q 012637 155 LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE--FVY 231 (459)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~ 231 (459)
++................+++.|+|||.+.+..+. .++||||+||++|+|++ |..||.+......+....... ...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99754321111111223457789999999877664 89999999999999998 999998876655444443332 234
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 232 PPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 232 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
|...++++.+|+.+||.++|++|||+.++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=346.90 Aligned_cols=262 Identities=27% Similarity=0.393 Sum_probs=213.8
Q ss_pred cccCCEEE-eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHH-----------HHHHHHHHHHHHHhcCCCCcce
Q 012637 7 VLFGKYEM-GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF-----------MMEQIKREISVMRLVRHPNVVE 74 (459)
Q Consensus 7 ~~~~~y~i-~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~i~~Ei~il~~l~hpnIv~ 74 (459)
-+.+||.. .+.||+|+||+||+|.+..+++.||+|.+......... ....+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 35678875 57799999999999999999999999998654322210 1124678999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeec
Q 012637 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDF 153 (459)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DF 153 (459)
+++++......|+||||+.| +|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99999999999999999974 88888865 67999999999999999999999999999999999999999999999999
Q ss_pred CCCccccccc------------CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHH
Q 012637 154 GLSALPEQLR------------NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY 221 (459)
Q Consensus 154 Gla~~~~~~~------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~ 221 (459)
|++....... .........+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987544100 1112233457889999999976555568999999999999999999999887766554
Q ss_pred HHHHhcc--C-------------------C-------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 222 RKVFKAE--F-------------------V-------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 222 ~~i~~~~--~-------------------~-------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+.... . . ..+..+.++.+||.+||+++|.+|||+++++.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 4332210 0 0 012357889999999999999999999999999999854
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=355.33 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=207.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCC-----CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMT-----GESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVM 79 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~ 79 (459)
..-.++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+++++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34467889999999999999999987533 3579999986543 2223467889999999996 99999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc--------------------------------------------------------
Q 012637 80 ATKKKIFVAMEYVKGGELFAKVAR-------------------------------------------------------- 103 (459)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~-------------------------------------------------------- 103 (459)
.+...+|+|||||++|+|.+++..
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999887743
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe
Q 012637 104 -----------------------------------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL 142 (459)
Q Consensus 104 -----------------------------------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl 142 (459)
..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136788889999999999999999999999999999999
Q ss_pred cCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHH
Q 012637 143 DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMY 221 (459)
Q Consensus 143 ~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~ 221 (459)
+.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 9999999999999975432222122233457788999999987666 489999999999999997 99999876544333
Q ss_pred -HHHHhc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 222 -RKVFKA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 222 -~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..+..+ ....+..++.++.+|+.+||+.||++|||+.++.+.
T Consensus 350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 333322 234455688999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=329.64 Aligned_cols=250 Identities=30% Similarity=0.526 Sum_probs=219.0
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997654333 234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 91 YVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|+++++|..++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999988865 56899999999999999999999999999999999999999999999999999765432
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLIS 244 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~ 244 (459)
......|++.|+|||.+.+..+. .++|+||+|+++|+|++|+.||...+.......+....+ ..+...+.++.++|.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 33446789999999999877664 789999999999999999999998887766666555443 234557899999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 012637 245 KLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+||..+|.+|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=374.01 Aligned_cols=149 Identities=30% Similarity=0.621 Sum_probs=140.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876665666677889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
|||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999875 678999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=349.14 Aligned_cols=262 Identities=32% Similarity=0.471 Sum_probs=214.2
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe--C
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT--K 82 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~--~ 82 (459)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++++ +||||+++++++.. .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 3567899999999999999999999999999999999864322 222335577899999999 99999999998864 3
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
...|+||||+++ +|...+..+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999975 8988887778899999999999999999999999999999999999999999999999999755432
Q ss_pred cCC---CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-----------
Q 012637 163 RND---GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE----------- 228 (459)
Q Consensus 163 ~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 228 (459)
... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 223345689999999998765555688999999999999999999998765444333221110
Q ss_pred ----------------C----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 ----------------F----VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 ----------------~----~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
. ...+.++.++.+||.+||+.||.+|||+.++++|||++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112368899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=340.66 Aligned_cols=257 Identities=21% Similarity=0.378 Sum_probs=212.5
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcC-------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCccee
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLM-------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVEL 75 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l 75 (459)
+.....++|.+++.||+|+||.||+|.+.. ....||+|.+..... ......+.+|+.+++.+ +||||+++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 445566899999999999999999998632 345799999864322 22356788999999999 69999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCC
Q 012637 76 REVMATKKKIFVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPE 138 (459)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~ 138 (459)
++++.+...+|++|||+++|+|.+++.. ..++...+..++.||+.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 9999999999999999999999998854 24788899999999999999999999999999999
Q ss_pred CeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchH
Q 012637 139 NLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENI 217 (459)
Q Consensus 139 NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~ 217 (459)
|||++.++.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999975432211111222334568999999987665 489999999999999999 9999998877
Q ss_pred HHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 218 MNMYRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 218 ~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+.+..+.... ...|..++.++.+||.+||..||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 77766655443 34456678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.38 Aligned_cols=251 Identities=23% Similarity=0.279 Sum_probs=209.1
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCC----------------cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTG----------------ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 72 (459)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876544 4689999875432 2346778899999999999999
Q ss_pred ceeEEEEEeCCEEEEEEeccCCCchHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCe
Q 012637 73 VELREVMATKKKIFVAMEYVKGGELFAKVARG------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENL 140 (459)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NI 140 (459)
+++++++......+++|||+++++|..++... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99999999999999999999999999988652 589999999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh--CCCCCCCchHH
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA--GFLPFQDENIM 218 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~ 218 (459)
+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999875432221222234456788999999887655 489999999999999998 78899876666
Q ss_pred HHHHHHHhc--------cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 219 NMYRKVFKA--------EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 219 ~~~~~i~~~--------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..+...... ....|+..+.++.+|+.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 555544322 12334557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=339.81 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=216.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
..|...+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34788999999999999999999999999999997655444455677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||++| +|.+.+. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99986 6666664 36799999999999999999999999999999999999999999999999999864321
Q ss_pred cccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC--CCCCCHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY--PPWISTDAKRLI 243 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li 243 (459)
.....|++.|+|||.+.. .+..+.++||||+||++|+|++|..||...+.......+....... +..+++.+++||
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 234578999999999852 2334578999999999999999999998876666555555443322 234688899999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 244 SKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
.+||+.+|.+|||+.++++|||+.....
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhccCc
Confidence 9999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=342.57 Aligned_cols=259 Identities=28% Similarity=0.487 Sum_probs=213.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-CCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-KKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~ 85 (459)
.+.++|++.+.||.|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3567999999999999999999999999999999998654322 2234667899999999999999999999865 5689
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 86 FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|+++||+ +++|...+..+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 9999998 55888888878899999999999999999999999999999999999999999999999999874321
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh-------------------
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------------------- 226 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 226 (459)
......+++.|+|||.+.+....+.++||||+||++|+|++|..||........+..+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 223456788999999986644445899999999999999999999987654322211110
Q ss_pred -------ccCCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012637 227 -------AEFVYP-----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTR 272 (459)
Q Consensus 227 -------~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~~ 272 (459)
.....| +.++.++.++|.+||+.+|++|||+++++.||||.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 000111 3467899999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.90 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=197.2
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCC-CcEEEEEEe--------------eccccccHHHHHHHHHHHHHHHhcCCC
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMT-GESVAIKVI--------------NKDQLKKEFMMEQIKREISVMRLVRHP 70 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vAiK~i--------------~~~~~~~~~~~~~i~~Ei~il~~l~hp 70 (459)
..+.++|++.+.||+|+||+||+|..+.. +..++.|.+ .+...........+.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 34678999999999999999999876543 222333311 111111222455688999999999999
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC
Q 012637 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARG------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE 144 (459)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~ 144 (459)
||+++++++.+.+..|+|+|++.+ +|+.++..+ ......++.++.||+.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 999999999999999999999964 677766432 2346778899999999999999999999999999999999
Q ss_pred CCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCC-CCCCc--hHHHHH
Q 012637 145 NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFL-PFQDE--NIMNMY 221 (459)
Q Consensus 145 ~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~--~~~~~~ 221 (459)
+|.+||+|||++..+.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|.. ||... +....+
T Consensus 303 ~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999997654321 1122346799999999999887775 89999999999999999875 44332 111111
Q ss_pred HHHHhc----------------------cC-----CCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 222 RKVFKA----------------------EF-----VYP-----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 222 ~~i~~~----------------------~~-----~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+... .+ ..+ ..++.++.++|.+||+.||.+|||+.|+|+||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 111110 00 000 1246678889999999999999999999999999754
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=335.80 Aligned_cols=257 Identities=28% Similarity=0.511 Sum_probs=220.1
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..+.|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.++|+||+++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999998999999999975432 34567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 88 AMEYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
++||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--~ 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--K 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--h
Confidence 99999999999999874 7999999999999999999999999999999999999999999999999998644321 1
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-C--CCCCCCHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-V--YPPWISTDAKRL 242 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~~~L 242 (459)
.......|++.|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+..... . .+..++.++.+|
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 122345688999999999877664 889999999999999999999988776555444433322 1 222378899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
|.+||+++|.+|||+.+++.||||.....
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 99999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=335.93 Aligned_cols=252 Identities=32% Similarity=0.523 Sum_probs=210.5
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--CEEEEEE
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--KKIFVAM 89 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 89 (459)
|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++|||++++++++... ...|+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998654 2223345677899999999999999999999888 8999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+++ +|...+.. ..+++..++.++.||+.||+|||++|++|+||+|+||++++++.+||+|||++....... ...
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN-SAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC-ccc
Confidence 99985 78888765 479999999999999999999999999999999999999999999999999997654321 112
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC------------------
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF------------------ 229 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------------ 229 (459)
.....+++.|+|||.+.+....+.++||||+||++|+|++|+.||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 33456788999999877654446899999999999999999999988776555444432100
Q ss_pred -----CC-------CCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 -----VY-------PPW-ISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 -----~~-------p~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.. ... .++.+.++|.+||..+|.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=333.17 Aligned_cols=247 Identities=23% Similarity=0.416 Sum_probs=212.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
...|++.+.||.|+||.||+|.+.. ++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999977 89999999875432 2345688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 89 MEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--V 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--c
Confidence 999999999999965 46899999999999999999999999999999999999999999999999999754321 1
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLI 243 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 243 (459)
.......+++.|+|||++....+. .++|||||||++|+|++ |..||...+..+.+..+... ....|...++++.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 111233456789999999876664 88999999999999998 89999888777777666643 3345567899999999
Q ss_pred HHhcCCCCCCCCCHHHHhc
Q 012637 244 SKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~ 262 (459)
.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=330.89 Aligned_cols=249 Identities=20% Similarity=0.367 Sum_probs=209.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+-.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+.+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 44678999999999999999999864 567899998764332 2457889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
++|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999998864 468899999999999999999999999999999999999999999999999997643211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
. .......++..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ....+..++.++.+
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11122345678999999987665 478999999999999998 99999887776666655543 22333457899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
|+.+||.++|++|||++++.+
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=346.14 Aligned_cols=253 Identities=20% Similarity=0.340 Sum_probs=203.0
Q ss_pred eeeccc--CcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 16 RLLGKG--TFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 16 ~~LG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
..||+| +||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999987654333 345788999999999999999999999999999999999999
Q ss_pred CCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC----
Q 012637 94 GGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG---- 166 (459)
Q Consensus 94 gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~---- 166 (459)
+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999998865 358999999999999999999999999999999999999999999999998654321111100
Q ss_pred -ccccccCCCcccChhhHhhcC-CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC--------------
Q 012637 167 -LLHTQCGTPAYVAPEVLRKKG-YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-------------- 230 (459)
Q Consensus 167 -~~~~~~Gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 230 (459)
......++..|+|||++.+.. ..+.++||||+||++|+|++|..||.+................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011223566799999997642 2358899999999999999999999876544333222211110
Q ss_pred ---------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 231 ---------------------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 231 ---------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+..+++.+.+||++||..||++|||+.++++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 011256778999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=323.77 Aligned_cols=248 Identities=32% Similarity=0.529 Sum_probs=213.1
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|++.+.||+|++|.||+|.+..+++.|++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976543 245678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 91 YVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 91 ~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
|++|++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998764 799999999999999999999999999999999999999999999999999875443211 3
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-cCCCC--CCCCHHHHHHHHH
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-EFVYP--PWISTDAKRLISK 245 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p--~~~s~~~~~Li~~ 245 (459)
....|+..|+|||.+....+ +.++||||+|+++|+|++|..||...+........... ....+ ..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999987654 58899999999999999999999887554433333322 12222 2248899999999
Q ss_pred hcCCCCCCCCCHHHHhcCcc
Q 012637 246 LLVSDPERRITIQSIMRVPW 265 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw 265 (459)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=337.80 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=207.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCc--EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGE--SVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIF 86 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (459)
++|++.+.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.+++++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999887765 4688887532 2233456788999999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeE
Q 012637 87 VAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLK 149 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lK 149 (459)
+||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999988642 488899999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc
Q 012637 150 ISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE 228 (459)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 228 (459)
|+|||++....... ......++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+.
T Consensus 160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCcccccee---ccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999986322110 01112234579999999877664 89999999999999997 999999888877777665542
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 229 -FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 229 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
...|..++.++.+||.+||..+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33455689999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=345.71 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=209.0
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK----- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (459)
+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 467999999999999999999999999999999998754322 22345678999999999999999999998654
Q ss_pred -CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 -KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
..+|+|+||+.+ +|.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999975 665554 35799999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------------- 227 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 227 (459)
......|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2234567899999999876444468999999999999999999999987655444333221
Q ss_pred ---------cCCC--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 ---------EFVY--------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 ---------~~~~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.... .+..++++.+||.+||+.||.+|||+++++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 12367789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=330.81 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=207.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||.||+|.+. ++..+|+|++.+..... ..+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999875 56789999986543322 35678999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999875432110 01
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 245 (459)
.....++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+..+....+... ....|...+..+.+|+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1111234579999999877664 88999999999999999 89999887776666665544 334566689999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 012637 246 LLVSDPERRITIQSIMRV 263 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~h 263 (459)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=345.65 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=216.1
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-----EE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK-----KI 85 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 85 (459)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999999999999987542 12234567889999999999999999999987775 89
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|++|||+++ +|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999985 78888866 5899999999999999999999999999999999999999999999999999986543211
Q ss_pred -CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-------------
Q 012637 165 -DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV------------- 230 (459)
Q Consensus 165 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------- 230 (459)
........|++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+.+..+....-.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 012334568899999999987734458999999999999999999999988776655554331100
Q ss_pred ------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 231 ------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 231 ------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
..+.++.++.+||.+||+.+|.+|||++++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1123678899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=332.51 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=209.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCc----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGE----SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+...+|++.+.||+|+||+||+|.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 446789999999999999999999877776 48999986443 23345678899999999999999999999865
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 457899999999999999865 469999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (459)
............+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+.... ...+...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 22111111223346789999999877665 89999999999999998 999998876665555444432 3445568899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+++.+||..||++|||+.+++..
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=335.94 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=210.5
Q ss_pred cCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
.++|.+.+.||+|+||.||+|.+. .++..+|+|.+..... ...+.+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 467999999999999999999854 3456799998864432 23456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC
Q 012637 84 KIFVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
..++||||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999864 2378999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHH
Q 012637 147 DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVF 225 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 225 (459)
.+||+|||++................|++.|+|||++.+..+. .++||||+||++|+|++ |..||...+.......+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999754321111122344568889999999877664 78999999999999998 999998877777666665
Q ss_pred hccCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 226 KAEFV-YPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 226 ~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+... .+...+..+.+|+.+||++||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 54432 345578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=338.00 Aligned_cols=256 Identities=21% Similarity=0.385 Sum_probs=213.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEc-------CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQL-------MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELR 76 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~ 76 (459)
..+..++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3456678999999999999999999753 234579999986432 222356788999999999 899999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCC
Q 012637 77 EVMATKKKIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPEN 139 (459)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N 139 (459)
+++......|++|||+++|+|.+++... .++...+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999988642 36778899999999999999999999999999999
Q ss_pred eEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHH
Q 012637 140 LLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIM 218 (459)
Q Consensus 140 ILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 218 (459)
||++.++.+||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999755432222222334567889999999876664 88999999999999998 89999988887
Q ss_pred HHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 219 NMYRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 219 ~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+....+.... ...|..++.++.+||.+||.++|.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 7777665443 23455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=335.37 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=207.8
Q ss_pred CEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235799998865432 22346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCe
Q 012637 86 FVAMEYVKGGELFAKVAR-------------------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENL 140 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NI 140 (459)
|+++||+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999988753 2478889999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHH
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMN 219 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 219 (459)
|+++++.+||+|||++...............+++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999975432221112233456778999999877665 488999999999999998 999999887777
Q ss_pred HHHHHHhc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 220 MYRKVFKA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 220 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+...+... ....|...+.++.+|+.+||+++|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66554433 23446668899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=334.61 Aligned_cols=263 Identities=28% Similarity=0.430 Sum_probs=209.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCc----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-CC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGE----SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-KK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~ 83 (459)
...|++.+.||+|.||.||+|..+.++. .+|||.+..++-.. ......-||+.++|.++||||+.+..++.+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4579999999999999999997766543 68999986553222 233456699999999999999999999877 88
Q ss_pred EEEEEEeccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC----CCeEEeec
Q 012637 84 KIFVAMEYVKGGELFAKVAR------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN----EDLKISDF 153 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~----~~lKl~DF 153 (459)
++|+++||++. +|...|.- ..++...++.++.||+.|+.|||++.|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999987 77777742 458999999999999999999999999999999999999988 89999999
Q ss_pred CCCcccccccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH---------HHHHH
Q 012637 154 GLSALPEQLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM---------NMYRK 223 (459)
Q Consensus 154 Gla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~ 223 (459)
|+|+++...-.. ......+-|.+|+|||.+.+...++.++||||.|||+.||++-.+.|.+.... +....
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999987653221 13344567889999999999888889999999999999999988888653211 11122
Q ss_pred HHhc---------------------------cCC----CCC------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 224 VFKA---------------------------EFV----YPP------WISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 224 i~~~---------------------------~~~----~p~------~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
|..- .+. .+. .-++.+.+|+.+||+.||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 2110 000 011 135668999999999999999999999999999
Q ss_pred ccCCCCC
Q 012637 267 RKGFTRP 273 (459)
Q Consensus 267 ~~~~~~~ 273 (459)
.....+|
T Consensus 341 ~~d~lpp 347 (438)
T KOG0666|consen 341 TEDPLPP 347 (438)
T ss_pred ccCCCCC
Confidence 8765443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=334.27 Aligned_cols=250 Identities=20% Similarity=0.330 Sum_probs=209.6
Q ss_pred cCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
..+|.+.+.||+|+||.||+|... .++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 457899999999999999999743 35678999987643 2334567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC
Q 012637 84 KIFVAMEYVKGGELFAKVARG----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED 147 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~ 147 (459)
..|++|||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 999999999999999988652 3789999999999999999999999999999999999999999
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHh
Q 012637 148 LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFK 226 (459)
Q Consensus 148 lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 226 (459)
+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...+.......+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999998744321111112233457889999999877764 88999999999999998 9999988776666655554
Q ss_pred c-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 227 A-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 227 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+ ....|..+++.+.+||.+||..||.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4 33455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=347.21 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=205.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEE-----cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQ-----LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 78 (459)
+..-.++|++.+.||+|+||.||+|.+ ..+++.||||.+..... ......+.+|+.+++++ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 344567999999999999999999984 34678999999975432 22346788999999999 68999999998
Q ss_pred EEe-CCEEEEEEeccCCCchHHHHhcC-----------------------------------------------------
Q 012637 79 MAT-KKKIFVAMEYVKGGELFAKVARG----------------------------------------------------- 104 (459)
Q Consensus 79 ~~~-~~~~~lV~E~~~gg~L~~~i~~~----------------------------------------------------- 104 (459)
+.. ...+|++||||++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 754 45789999999999999887531
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 105 ---------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 105 ---------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
.++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 25777888999999999999999999999999999999999999999999997543211111122
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHH-HHHHHHhc-cCCCCCCCCHHHHHHHHHh
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMN-MYRKVFKA-EFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~ 246 (459)
+..+++.|+|||++.+..+. .++|||||||++|+|++ |..||....... ....+..+ ....|.+.++++.+++.+|
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 23456789999999877664 88999999999999997 999998754332 22222222 3345667889999999999
Q ss_pred cCCCCCCCCCHHHHhcC
Q 012637 247 LVSDPERRITIQSIMRV 263 (459)
Q Consensus 247 L~~dP~~R~t~~eil~h 263 (459)
|.+||.+|||+.+|++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=329.17 Aligned_cols=244 Identities=22% Similarity=0.323 Sum_probs=203.6
Q ss_pred eeecccCcEEEEEEEE--cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 16 RLLGKGTFAKVYYGKQ--LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
+.||+|+||.||+|.+ ..+++.+|+|++..... .....+.+.+|+.+++.+.||||+++++++. ....++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 3689999999999964 45788999999865432 3345677899999999999999999999875 456799999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC-Cccccc
Q 012637 94 GGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND-GLLHTQ 171 (459)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~-~~~~~~ 171 (459)
+|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++......... ......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999999865 67999999999999999999999999999999999999999999999999999754322111 011223
Q ss_pred cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCC
Q 012637 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKLLVS 249 (459)
Q Consensus 172 ~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~ 249 (459)
.+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++++.+||.+||++
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 44678999999876555 478999999999999998 999999877777666665543 456677899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 012637 250 DPERRITIQSIMR 262 (459)
Q Consensus 250 dP~~R~t~~eil~ 262 (459)
||.+|||+++|.+
T Consensus 238 ~p~~Rp~~~~i~~ 250 (257)
T cd05116 238 GVDERPGFAVVEL 250 (257)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=337.61 Aligned_cols=254 Identities=21% Similarity=0.372 Sum_probs=205.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 88 (459)
++|...+.||+|+||.||++.+..+++.||+|.+.+.... .....+.+|+.++.++. ||||+++++++......|++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4577788999999999999999999999999998754332 23566889999999996 99999999999999999999
Q ss_pred EeccCCC--chHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 89 MEYVKGG--ELFAKVA---RGRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 89 ~E~~~gg--~L~~~i~---~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
|||+.+. ++...+. .+.+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~- 160 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD- 160 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc-
Confidence 9998752 2333332 25799999999999999999999975 999999999999999999999999999864332
Q ss_pred cCCCccccccCCCcccChhhHhhc--CCCCCcchhhhHHHHHHHHhhCCCCCCCchH-HHHHHHHHhcc-CCCC----CC
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKK--GYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVFKAE-FVYP----PW 234 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~-~~~p----~~ 234 (459)
........|++.|+|||++.+. ...+.++||||+||++|+|++|..||..... .+....+.... ...+ ..
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 161 --SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred --CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 1222345689999999999766 2345899999999999999999999976542 22222222221 1111 23
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
++.++.+||.+||++||.+|||++++++||||+.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 7889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.19 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=209.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+.++++++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 34578999999999999999999974 4578999998754322 345788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999865 258999999999999999999999999999999999999999999999999997654211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
.. ......++..|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+.+.......+... ....+...+.++.+
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 11 0111122457999999887665 488999999999999999 99999988877776666544 23445667899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
++.+||+.+|.+||++.++.+
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.49 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=207.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||.||+|.+..+ ..||+|.+.+.... .+.+.+|+.+++.++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4467899999999999999999988655 46999998754332 246788999999999999999999875 45689
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999865 358999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
........++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+... ....+..++..+.+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 157 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred -cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 111223346678999999877666 489999999999999999 89999887776666655443 23345568899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
||.+||++||.+|||+.++++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.03 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=207.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||.||.|.+.. +..+|+|.+...... .+.+.+|+.++++++||||+++++++......|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 579999999999999999998643 456999998654332 245788999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 99999999999865 4689999999999999999999999999999999999999999999999999875422111 01
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 245 (459)
.....++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+..... ..+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1112345679999999876664 78999999999999998 9999988777666666655432 3345578999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 012637 246 LLVSDPERRITIQSIMRV 263 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~h 263 (459)
||.+||.+|||+.+|+++
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=328.77 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=207.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999865 5677999998765432 245789999999999999999999885 55689
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999864 358999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
. .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....|...+..+.+
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 157 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234 (260)
T ss_pred c-ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 11112234567999999876665 489999999999999999 99999887777766666543 34456668899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
|+.+||.++|.+|||++++.+
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=341.41 Aligned_cols=258 Identities=21% Similarity=0.373 Sum_probs=213.4
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCC-------CcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCccee
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMT-------GESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVEL 75 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l 75 (459)
++.+...+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3456667899999999999999999986432 2369999886432 223456788999999999 79999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCC
Q 012637 76 REVMATKKKIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPE 138 (459)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~ 138 (459)
++++.....+|++|||+++|+|.+++... .++...+..++.|++.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 99999999999999999999999988641 3677888999999999999999999999999999
Q ss_pred CeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchH
Q 012637 139 NLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENI 217 (459)
Q Consensus 139 NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~ 217 (459)
|||++.++.+||+|||+++...............++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999754322111112223345679999999877665 78999999999999998 8999998888
Q ss_pred HHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012637 218 MNMYRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVP 264 (459)
Q Consensus 218 ~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hp 264 (459)
.+.+..+.... ...|...+.++.+||.+||..+|.+|||+.+++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 77776665543 344566788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.26 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=212.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
..|...+.||+|+||.||+|+++.+++.||+|.+.............+.+|+.+++.++|||++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45888899999999999999999999999999987544444445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+.| +|.+.+. ...+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.....
T Consensus 95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 99975 6766654 25689999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC--CCCCCHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY--PPWISTDAKRLI 243 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li 243 (459)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+....... +..++..+.+||
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 224568899999999853 2223478999999999999999999998766554444444333221 235788899999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 244 SKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+||..+|.+||+++++++|||+...
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.73 Aligned_cols=258 Identities=33% Similarity=0.569 Sum_probs=215.3
Q ss_pred CEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
.|++.+.||+|+||.||+|.+. .+++.||||++.+.... .....+.+.+|+.+++.+ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998754332 223456778999999999 699999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||+++|+|.+.+.. +.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+... .
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence 999999999999998865 67999999999999999999999999999999999999999999999999998754322 1
Q ss_pred CCccccccCCCcccChhhHhhcC-CCCCcchhhhHHHHHHHHhhCCCCCCCch----HHHHHHHHHhccCCCCCCCCHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKG-YDGSKADLWSCGVILYVLLAGFLPFQDEN----IMNMYRKVFKAEFVYPPWISTDA 239 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 239 (459)
.......+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||.... .....+.+.......|..++.++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223356899999999987543 23578999999999999999999996432 23444455555666777789999
Q ss_pred HHHHHHhcCCCCCCCCC---HHHHhcCcccccC
Q 012637 240 KRLISKLLVSDPERRIT---IQSIMRVPWFRKG 269 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t---~~eil~hpw~~~~ 269 (459)
.+||.+||+.||++||| +.++|+||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5678999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=331.23 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=208.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcE----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+-.++|++.+.||+|+||+||+|.+..+++. ||+|.+.... .......+..|+.+++.+.||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3457899999999999999999999877774 6777764321 2234467788999999999999999999875 4
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...++++||+++|+|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 567899999999999999964 578999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (459)
............|+..|+|||.+.+..++ .++||||+||++|+|++ |..||.+.........+..+. ...|...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence 22222223344577789999999876664 89999999999999998 999998877666554444443 2334456788
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+++.+||..||.+|||+.++++.
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=328.51 Aligned_cols=252 Identities=22% Similarity=0.383 Sum_probs=210.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCc---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+.|++.+.||+|+||.||+|.++.+++ .||||.+.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999887765 59999986542 233456789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999998864 568999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcccccc---CCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 164 NDGLLHTQC---GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 164 ~~~~~~~~~---Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
......... ++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111112 24579999999877664 89999999999999886 99999887776666655433 23344567889
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+++.+||.++|.+||+++++++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=333.76 Aligned_cols=251 Identities=33% Similarity=0.550 Sum_probs=210.7
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765433 23456788899999999999999999999999999999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 92 VKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
+++ +|.+.+.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 986 77777755 489999999999999999999999999999999999999999999999999987554321 1223
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------cCC
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------------------EFV 230 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~~ 230 (459)
...++..|+|||.+.+....+.++||||+||++|+|++|+.||...+..+.+..+... ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3567889999999987634468999999999999999999999887765544433211 000
Q ss_pred C-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 231 Y-----------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 231 ~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+ .+.++.++.+||.+||.+||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 12367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.11 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=210.6
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4689999999999999999998753 67889999986543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCe
Q 012637 84 KIFVAMEYVKGGELFAKVARG-----------------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENL 140 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~-----------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NI 140 (459)
..|++|||+++|+|.+++... .+++..+..++.||+.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999999999988631 367888999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHH
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMN 219 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 219 (459)
+++.++.+||+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998754321111112223456789999999877764 89999999999999997 889998877777
Q ss_pred HHHHHHhccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 220 MYRKVFKAEF-VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 220 ~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
....+..+.. ..|..++.++.+||.+||+.+|.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7666665543 345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=356.32 Aligned_cols=253 Identities=23% Similarity=0.482 Sum_probs=220.6
Q ss_pred CCE-EEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc-ccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE--E
Q 012637 10 GKY-EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK--I 85 (459)
Q Consensus 10 ~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~--~ 85 (459)
+|| +....||+|+|-+||+|.|..+|-.||.-.+..+.+ ..+...++++.|+.+|+.|+||||+++|++|.+... +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 444 335789999999999999999999999776654443 345567899999999999999999999999987665 8
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecCC-CCeEEeecCCCccccc
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDEN-EDLKISDFGLSALPEQ 161 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~~-~~lKl~DFGla~~~~~ 161 (459)
.+|+|++.+|+|..+.++ ++++...++.|++||+.||.|||++. |+|||||.+||+|+.+ |.|||+|+|||++...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 899999999999999987 88999999999999999999999995 9999999999999876 9999999999997653
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC-chHHHHHHHHHhccCC--CCCCCCHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKAEFV--YPPWISTD 238 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~ 238 (459)
......+|||.|||||++. ..|+ ..+||||||+.+.||+|+.+||.. .++.++|+++..+..+ +..--+++
T Consensus 199 ----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 199 ----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred ----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 2334578999999999998 4676 899999999999999999999976 6788999999877432 22234889
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+++||.+||.. .+.|+|+.|+|+||||...
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 9999999999999999874
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=335.59 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=204.6
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCC--------------cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcce
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTG--------------ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVE 74 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~ 74 (459)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 359999987542 2334567889999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCchHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeE
Q 012637 75 LREVMATKKKIFVAMEYVKGGELFAKVARG-------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLL 141 (459)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NIL 141 (459)
+++++...+..|+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999999988542 3678889999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh--CCCCCCCchHHH
Q 012637 142 LDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA--GFLPFQDENIMN 219 (459)
Q Consensus 142 l~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~~ 219 (459)
++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999975432111111222345678999999887665 589999999999999988 778998766655
Q ss_pred HHHHHHh-----c---cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 220 MYRKVFK-----A---EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 220 ~~~~i~~-----~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
....+.. . ....++..++.+.+|+.+||..||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4443321 1 12234557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=329.01 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=212.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCc----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGE----SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+..++|++.+.||+|+||.||+|.++.+|+ .||+|.+..... ......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999877765 589998865532 3345678899999999999999999999987
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...++||||+++|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 789999999999999999875 469999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (459)
............++..|+|||.+....+. .++||||+||++|++++ |..||.+....+....+.... ...|...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 22111111222345689999999776664 89999999999999998 999999988777766666543 3456667899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+.+++.+||..||..|||+.++++
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=328.54 Aligned_cols=251 Identities=23% Similarity=0.396 Sum_probs=208.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCc---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.++|++.+.||+|+||.||+|.++.++. .+|+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999875544 799999865432 22456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999865 468999999999999999999999999999999999999999999999999997654321
Q ss_pred CCC-ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHH
Q 012637 164 NDG-LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAK 240 (459)
Q Consensus 164 ~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (459)
... ......++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+.+..+....+... ....+...++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 1111223567999999987665 489999999999999886 99999887766666555543 2233445788999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 012637 241 RLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+++.+||+++|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=338.83 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=206.1
Q ss_pred CEEEeeeecccCcEEEEEEEEcCC--CcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe----CC
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMT--GESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT----KK 83 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 83 (459)
+|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ........+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 9999999986432 2222345677899999999 59999999987533 25
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.+|+++||+. ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999986 578888765 67999999999999999999999999999999999999999999999999999754321
Q ss_pred cC--CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------
Q 012637 163 RN--DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------- 227 (459)
Q Consensus 163 ~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 227 (459)
.. ........||+.|+|||.+.+....+.++||||+||++|+|++|..||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999999876443458999999999999999999999876543333221110
Q ss_pred ------------c---CC---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 ------------E---FV---YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 ------------~---~~---~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
. .. ..+..+..+.+||.+||+.||.+|||+.+++.|||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00 012357889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=332.25 Aligned_cols=251 Identities=31% Similarity=0.560 Sum_probs=210.9
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997654 2222345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 92 VKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 92 ~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
+++ +|.+.+... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++...... .....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 985 899988764 7999999999999999999999999999999999999999999999999999754331 11233
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc------------------cCCC
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------EFVY 231 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~~ 231 (459)
...++..|+|||.+......+.++||||+||++|+|++|..||...+....+..+... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456788999999977644468999999999999999999999887765544433210 0011
Q ss_pred C-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 232 P-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 232 p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+ +.++.++.++|.+||..||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=320.83 Aligned_cols=253 Identities=28% Similarity=0.397 Sum_probs=206.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK----- 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (459)
-..||++.+.||+|||+.||++.+..+++.||+|.+.... ....+...+||...++++||||++++++....
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3468999999999999999999999999999999997654 33567889999999999999999998876433
Q ss_pred CEEEEEEeccCCCchHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecCCCCeEEeecCC
Q 012637 83 KKIFVAMEYVKGGELFAKVAR----G-RLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDENEDLKISDFGL 155 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~----~-~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~~~~lKl~DFGl 155 (459)
...|+++.|...|+|.+.+.. | -++|.++..||.+|++||++||+.. .+||||||.|||+.+.+..+|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 449999999999999998864 3 5999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCC-------ccccccCCCcccChhhHhhcCCC--CCcchhhhHHHHHHHHhhCCCCCCCchHH--HHHHHH
Q 012637 156 SALPEQLRNDG-------LLHTQCGTPAYVAPEVLRKKGYD--GSKADLWSCGVILYVLLAGFLPFQDENIM--NMYRKV 224 (459)
Q Consensus 156 a~~~~~~~~~~-------~~~~~~Gt~~y~APE~l~~~~~~--~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~i 224 (459)
++...-.-.+. .......|..|+|||.+.-+.+. +.++|||||||+||+|+.|..||+..-.. .+.-.+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 97543211111 01122358899999998755443 57999999999999999999999632110 011123
Q ss_pred HhccCCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 225 FKAEFVYPP--WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 225 ~~~~~~~p~--~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..+++.+|. .+|..+.+||+.||++||.+||++.+++.+
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 344555553 389999999999999999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=330.06 Aligned_cols=249 Identities=30% Similarity=0.501 Sum_probs=206.5
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCCcceeEEEEEeCCE----
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV---RHPNVVELREVMATKKK---- 84 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 84 (459)
|++.+.||+|+||.||+|.++.+++.||+|.+...... ......+.+|+.+++++ .||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 78899999999999999999889999999999754332 22334566788887766 59999999999988776
Q ss_pred -EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 85 -IFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+|++|||+++ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999985 78887765 358999999999999999999999999999999999999999999999999997653
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-----CC-----
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-----FV----- 230 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----~~----- 230 (459)
. ........+++.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+..+.+..+.... ..
T Consensus 159 ~---~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 F---EMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred C---CcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 2 122234457889999999987765 488999999999999999999999887766655554310 00
Q ss_pred ------C-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 231 ------Y-----------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 231 ------~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+ .+.+++.+.+||.+||++||.+||+++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=333.53 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=204.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcC----------------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLM----------------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 72 (459)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999986432 34569999986542 23345678899999999999999
Q ss_pred ceeEEEEEeCCEEEEEEeccCCCchHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCe
Q 012637 73 VELREVMATKKKIFVAMEYVKGGELFAKVARG------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENL 140 (459)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NI 140 (459)
+++++++......|+||||+++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999988652 266778999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh--CCCCCCCchHH
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA--GFLPFQDENIM 218 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~ 218 (459)
|++.++.+||+|||++................+++.|+|||...+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999975432111111223345678999999877665 489999999999999998 78999876655
Q ss_pred HHHHHHHh--------ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 219 NMYRKVFK--------AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 219 ~~~~~i~~--------~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+....... .....|..+++.+.+|+.+||+.||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54433211 112334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.92 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=201.5
Q ss_pred cCCE-EEeeeecccCcEEEEEEE----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--
Q 012637 9 FGKY-EMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-- 81 (459)
Q Consensus 9 ~~~y-~i~~~LG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (459)
.+|| ++.+.||+|+||+||++. ...+++.||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4677 999999999999998865 335788999999875422 2234567889999999999999999998765
Q ss_pred CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
...+|++|||+++++|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999975442
Q ss_pred ccCCC-ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH--HHH-------------HHHH
Q 012637 162 LRNDG-LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM--NMY-------------RKVF 225 (459)
Q Consensus 162 ~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~-------------~~i~ 225 (459)
..... ......++..|+|||.+....+ +.++|||||||++|+|++|..||...... +.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 11111 1122345667999999987665 48999999999999999999998653211 110 0010
Q ss_pred h-ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 226 K-AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 226 ~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
. .....|..++..+.+|+.+||+++|++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 112335567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=329.30 Aligned_cols=252 Identities=30% Similarity=0.526 Sum_probs=211.8
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK--KEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
||.+.+.||+|+||.||+|.+..++..+++|++..-... ......++.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888887888776542221 111234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 89 MEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+||+++++|.+.+.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999887752 56999999999999999999999999999999999999975 6799999999875432
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRL 242 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~L 242 (459)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.+.+.......+..+.. ..|..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 12223345688999999998776665 789999999999999999999988777666666554432 3455678999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCccc
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
|.+||..||.+||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.56 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=208.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~ 78 (459)
+.+-.++|.+++.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+|.++. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 3344567899999999999999999864 3557899999975432 223456889999999997 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC------------------------------------------------------
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVARG------------------------------------------------------ 104 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~------------------------------------------------------ 104 (459)
+.....+|+|||||++|+|.+++.+.
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 99999999999999999999988542
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCC
Q 012637 105 ---------------------------------------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPEN 139 (459)
Q Consensus 105 ---------------------------------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N 139 (459)
.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25667788899999999999999999999999999
Q ss_pred eEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHH
Q 012637 140 LLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIM 218 (459)
Q Consensus 140 ILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 218 (459)
||++.++.+||+|||+++............+..|++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9999999999999999975432111112223467889999999987665 488999999999999998 89999875554
Q ss_pred HHHHH-HHhc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 219 NMYRK-VFKA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 219 ~~~~~-i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.... +..+ ....|..++.++.+|+.+||.++|.+||++.+|++.
T Consensus 349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44333 3332 234566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=325.85 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=207.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.++++++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 4567899999999999999999986 46788999998755432 246788999999999999999999874 56789
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
++|||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999998864 468999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
........++..|+|||++....+ +.++||||+||++|+|++ |++||.+.+..+....+... ....+...+.++.+
T Consensus 157 -~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 157 -YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE 234 (260)
T ss_pred -cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111122345678999999987665 489999999999999999 99999888776666555443 23445567889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
||.+||..+|++|||++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=324.26 Aligned_cols=243 Identities=25% Similarity=0.352 Sum_probs=202.5
Q ss_pred eeecccCcEEEEEEEEcCCC---cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q 012637 16 RLLGKGTFAKVYYGKQLMTG---ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYV 92 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (459)
+.||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.+.||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876655 78999998765443 24567889999999999999999999876 45689999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC-cccc
Q 012637 93 KGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG-LLHT 170 (459)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~-~~~~ 170 (459)
++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 569999999999999999999999999999999999999999999999999998654321110 0111
Q ss_pred ccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcC
Q 012637 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 171 ~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~ 248 (459)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+.... ...|..++..+.+||.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 223467999999987665 489999999999999998 999998877766655554442 34566789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 012637 249 SDPERRITIQSIMR 262 (459)
Q Consensus 249 ~dP~~R~t~~eil~ 262 (459)
++|++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=323.71 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=210.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||.||+|.+. +++.||||.+...... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 44678999999999999999999975 5578999998754432 346789999999999999999999999989999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999865 368999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
........++..|+|||.+.+..+ +.++||||+||++|+|++ |+.||.+.+.......+... ....|...+.++.+
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111112234568999999987665 588999999999999998 99999888777776666544 23445667899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
++.+||..+|.+||+++++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=329.59 Aligned_cols=247 Identities=32% Similarity=0.499 Sum_probs=203.1
Q ss_pred EEeeeecccCcEEEEEEEEc----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 13 EMGRLLGKGTFAKVYYGKQL----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.+.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|+.++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999987 45678999999542 2333467889999999999999999999999988889999
Q ss_pred EeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 89 MEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+|||++|+|.+++... .+++.....++.||+.||.|||+++++|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999764 7999999999999999999999999999999999999999999999999999755211111
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLI 243 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li 243 (459)
.......+...|+|||.+....+ +.++||||||+++|+|++ |..||.+.+..+....+..+.. ..|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233456778999999988765 489999999999999999 7899998888777777755433 44566899999999
Q ss_pred HHhcCCCCCCCCCHHHHhc
Q 012637 244 SKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~ 262 (459)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=323.77 Aligned_cols=242 Identities=26% Similarity=0.458 Sum_probs=208.6
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.+.|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+....|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 56899999999999999999986 488999999865432 356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 89 MEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--- 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--- 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc---
Confidence 9999999999998752 6899999999999999999999999999999999999999999999999999754221
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLI 243 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 243 (459)
.....++..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ....|..+++++.+||
T Consensus 156 --~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 156 --QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred --cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 112334567999999876655 488999999999999997 99999888777666555443 3344566889999999
Q ss_pred HHhcCCCCCCCCCHHHHhc
Q 012637 244 SKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~ 262 (459)
.+||..+|.+|||+.++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=324.17 Aligned_cols=241 Identities=27% Similarity=0.446 Sum_probs=205.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEE-EeCCEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM-ATKKKIFV 87 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~l 87 (459)
..+|++.+.||+|+||.||+|.. .|..||+|.+..+. ..+.+.+|+.++++++||||+++++++ ...+..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 46899999999999999999975 48889999986432 235678999999999999999999875 45678999
Q ss_pred EEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 88 AMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+|||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~--- 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc---
Confidence 99999999999998652 488999999999999999999999999999999999999999999999999874322
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRL 242 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 242 (459)
......++..|+|||++....+. .++|||||||++|+|++ |..||...+..+....+..+ ....++.+++.+.++
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 155 --TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred --cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 11233456789999999877664 78999999999999997 99999988877776666544 234456689999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 012637 243 ISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~ 262 (459)
|.+||..+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=324.43 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=205.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|.+...... .+.+.+|+.+++.++|||++++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 3457899999999999999999987655 46999988654322 245778999999999999999999885 45689
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999865 248899999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
........++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+....+....+... ....|...+..+.+
T Consensus 157 -~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 157 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred -ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 111122345678999999877665 488999999999999999 99999988777666665543 23345568899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
|+.+||.+||.+|||++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=329.51 Aligned_cols=238 Identities=25% Similarity=0.360 Sum_probs=198.5
Q ss_pred eeecccCcEEEEEEEEcCCCc-------EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 16 RLLGKGTFAKVYYGKQLMTGE-------SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~-------~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+.||+|+||.||+|.+..++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999866544 48888875432 23456788899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC--------eEEeecCCCcc
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED--------LKISDFGLSAL 158 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~--------lKl~DFGla~~ 158 (459)
|||+++|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +|++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999999975 35899999999999999999999999999999999999987765 69999999864
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-CCCCCCchHHHHHHHHHhccCCCCCCCCH
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMNMYRKVFKAEFVYPPWIST 237 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 237 (459)
... .....|++.|+|||++.+....+.++||||+||++|+|++| ..||...+..... .........|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 321 23456889999999998755446889999999999999998 5777665554432 233445566767788
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
++.+||.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.69 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=199.5
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
+++.+|.| |.||.+++..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++......|++|||++
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 44444444 556666666799999999997653323 356789999999999999999999999999999999999999
Q ss_pred CCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC-----C
Q 012637 94 GGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN-----D 165 (459)
Q Consensus 94 gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~-----~ 165 (459)
+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999998865 4689999999999999999999999999999999999999999999999998864321111 1
Q ss_pred CccccccCCCcccChhhHhhc--CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---------------
Q 012637 166 GLLHTQCGTPAYVAPEVLRKK--GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--------------- 228 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------- 228 (459)
.......++..|+|||++... .+ +.++||||+||++|+|++|..||..............+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 122344578889999999753 34 478999999999999999999998754433221111110
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 -------------------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 -------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...+..++.++.+||.+||..||++|||++++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00111235678899999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=373.26 Aligned_cols=256 Identities=30% Similarity=0.506 Sum_probs=209.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------ 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (459)
....|+..+.||+||||.||+++++.+|..||||.|.... .......+.+|+.++.+|+|||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4456788899999999999999999999999999997654 34456789999999999999999999863100
Q ss_pred --------------------------------------------------------------------------------
Q 012637 82 -------------------------------------------------------------------------------- 81 (459)
Q Consensus 82 -------------------------------------------------------------------------------- 81 (459)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CEEEEEEeccCCCchHHHHhcCCCC--HHHHHHHHHHHHHHHHHHH
Q 012637 82 -------------------------K--------KKIFVAMEYVKGGELFAKVARGRLR--EDLARKYFQQLISAVDFCH 126 (459)
Q Consensus 82 -------------------------~--------~~~~lV~E~~~gg~L~~~i~~~~l~--e~~~~~~~~qll~~L~~LH 126 (459)
+ ..+||-||||+...|.+++.++.+. .+.++++|+||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 2379999999999999999887664 7899999999999999999
Q ss_pred hCCcEeccCCCCCeEecCCCCeEEeecCCCcccc----------------cccCCCccccccCCCcccChhhHhhcC--C
Q 012637 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPE----------------QLRNDGLLHTQCGTPAYVAPEVLRKKG--Y 188 (459)
Q Consensus 127 ~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~----------------~~~~~~~~~~~~Gt~~y~APE~l~~~~--~ 188 (459)
++||+||||||.||+|+++++|||+|||+|+... .....+..+..+||-.|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998621 011122445678999999999998766 2
Q ss_pred CCCcchhhhHHHHHHHHhhCCCCCCC-chHHHHHHHHHhccCCCCCC----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 189 DGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKAEFVYPPW----ISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 189 ~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+..|+|+||||||||||+ .||.. ......+..+.++.++.|.. --+....+|++||+.||.+||||.|+|++
T Consensus 795 Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 349999999999999998 46654 23344555666666666632 23456799999999999999999999999
Q ss_pred ccccc
Q 012637 264 PWFRK 268 (459)
Q Consensus 264 pw~~~ 268 (459)
.||..
T Consensus 872 ~llpp 876 (1351)
T KOG1035|consen 872 ELLPP 876 (1351)
T ss_pred cCCCc
Confidence 99963
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=331.08 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=210.9
Q ss_pred ccccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEE
Q 012637 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMA 80 (459)
Q Consensus 2 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 80 (459)
.++...-.+.|++.+.||+|+||.||+|.+..+++.||||.+.+..... ....+.+|+.++.++ .||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 3445566789999999999999999999999899999999997543222 234566778777666 4999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
+....|++|||+++ .|.+.+.. +.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 85 TDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred cCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 99999999999865 66665543 579999999999999999999997 599999999999999999999999999987
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcC---CCCCcchhhhHHHHHHHHhhCCCCCCCchH-HHHHHHHHhcc-CCCC
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKG---YDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVFKAE-FVYP 232 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~-~~~p 232 (459)
.... ........|++.|+|||.+.+.. ..+.++|||||||++|+|++|+.||..... .+.+..+.... ...+
T Consensus 164 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06618 164 RLVD---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240 (296)
T ss_pred hccC---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC
Confidence 5432 11223345788999999987543 234789999999999999999999976332 23344444332 2222
Q ss_pred C--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 233 P--WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 233 ~--~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
. .++.++.+||.+||..||.+|||++++++||||...
T Consensus 241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 2 368899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=321.48 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=204.7
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (459)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999877 999999998755432 24567889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 96 ELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999864 5689999999999999999999999999999999999999999999999999975432111111112234
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHHHHhcCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISKLLVSDP 251 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 251 (459)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+... ....|...+..+.+|+.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999877665 489999999999999999 89999887766655555433 234556688999999999999999
Q ss_pred CCCCCHHHHhcC
Q 012637 252 ERRITIQSIMRV 263 (459)
Q Consensus 252 ~~R~t~~eil~h 263 (459)
.+|||+.++++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=323.64 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=209.1
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCc---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+.|+..+.||+|+||.||+|.+..+++ .+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4578999999999999999999876665 79999986442 222356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999998864 578999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcc-ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHH
Q 012637 164 NDGLL-HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAK 240 (459)
Q Consensus 164 ~~~~~-~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (459)
..... .....++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+.... .+.+...+.++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11123457999999987666 489999999999999997 999998877777666665432 223344788999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 012637 241 RLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+|+.+||..+|.+||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=323.37 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=201.2
Q ss_pred eecccCcEEEEEEEEc--CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 17 LLGKGTFAKVYYGKQL--MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999765 345679999986542 2334567889999999999999999999885 4578999999999
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC-ccccc
Q 012637 95 GELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG-LLHTQ 171 (459)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~-~~~~~ 171 (459)
++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998854 579999999999999999999999999999999999999999999999999997543211110 11112
Q ss_pred cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHHHHhcCC
Q 012637 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISKLLVS 249 (459)
Q Consensus 172 ~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 249 (459)
.+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+....+....+..+ ....|+..++++.+||.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999987665 488999999999999996 99999988777666655543 3456677899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 012637 250 DPERRITIQSIMRV 263 (459)
Q Consensus 250 dP~~R~t~~eil~h 263 (459)
||++||++.++.+.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=325.69 Aligned_cols=242 Identities=23% Similarity=0.376 Sum_probs=200.8
Q ss_pred eeecccCcEEEEEEEEcCCCc--EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEecc
Q 012637 16 RLLGKGTFAKVYYGKQLMTGE--SVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEYV 92 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (459)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988876 46888875322 223456788999999999 8999999999999999999999999
Q ss_pred CCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCC
Q 012637 93 KGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGL 155 (459)
Q Consensus 93 ~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGl 155 (459)
++|+|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCC
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPP 233 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 233 (459)
+....... .......++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+.+..+... ....+.
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 86322111 1112234567999999977665 489999999999999997 99999887777766666543 223455
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.++.++.+|+.+||..||.+|||++++++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=322.19 Aligned_cols=243 Identities=25% Similarity=0.425 Sum_probs=205.1
Q ss_pred eeecccCcEEEEEEEEcC-CCc--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q 012637 16 RLLGKGTFAKVYYGKQLM-TGE--SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYV 92 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (459)
+.||+|++|.||+|.+.. .++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999776543 456788999999999999999999999988 8999999999
Q ss_pred CCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC-Ccc
Q 012637 93 KGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND-GLL 168 (459)
Q Consensus 93 ~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~-~~~ 168 (459)
++++|.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999876 35899999999999999999999999999999999999999999999999999765432111 111
Q ss_pred ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHHHHHH
Q 012637 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKRLISK 245 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 245 (459)
....++..|+|||.+....+. .++||||+||++|+|++ |..||...+..+....+... ....|...+..+.+|+.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577889999999877664 78999999999999998 99999887777766665532 223345578999999999
Q ss_pred hcCCCCCCCCCHHHHhc
Q 012637 246 LLVSDPERRITIQSIMR 262 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~ 262 (459)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=326.00 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=208.5
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcC----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-CC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLM----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-KK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~ 83 (459)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4789999999999999999999876 3578999988633 233345778899999999999999999998765 57
Q ss_pred EEEEEEeccCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecC
Q 012637 84 KIFVAMEYVKGGELFAKVAR---------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFG 154 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFG 154 (459)
..++++||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 89999999999999998854 348899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCC
Q 012637 155 LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYP 232 (459)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p 232 (459)
+++...............++..|+|||.+.+..+ +.++|||||||++|++++ |..||...+..+....+..+. +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 9975432111111122345678999999987766 488999999999999999 999999887777665554432 2344
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..+++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 557899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.92 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=218.8
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+.+.+..+...++..||+|.||+||+|++- ..||||+++.+....+ ..+.+++|+.++++-+|.||+-+.+++-.+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 346677888899999999999999999975 4599999988776665 778999999999999999999999999777
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
.. .||+.+|+|.+|+.++.- -+|.....+.|++|++.|+.|||.++|+|||||..||+|.+++.|||+||||++.-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 999999999999998864 578888999999999999999999999999999999999999999999999998755
Q ss_pred cccCCCccccccCCCcccChhhHhh---cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-----CC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRK---KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-----YP 232 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p 232 (459)
.......+....|...|||||++.. .+| +..+||||+||++|||++|.+||...+.++++-.+-++... .-
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 5444555666778899999999973 344 48899999999999999999999987777766555555221 11
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
...+.++++|+..||..+|++||++.+||.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 235679999999999999999999999987
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=320.94 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=208.9
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+....... ..+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 57999999999999999999875 47789999986544322 35778999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+++++|.+++.. +.++++.++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccc
Confidence 99999999998864 568999999999999999999999999999999999999999999999999987442211 111
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 245 (459)
.....++..|+|||.+.+..+. .++|||||||++|+|++ |..||...........+..+. ...|...+..+.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 1223345689999999876654 78999999999999998 999999887777776665542 23355578999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 012637 246 LLVSDPERRITIQSIMRV 263 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~h 263 (459)
||..+|++|||+.+++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=349.28 Aligned_cols=243 Identities=26% Similarity=0.464 Sum_probs=208.0
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+-++...-.+-||.|+.|.||+|+ ..++.||||.++. .-..+|+-|++|+||||+.|.++|.....+
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGR--LHNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeee--ccCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 3344444446779999999999998 5688999998742 112578899999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|||||||..|-|...++. +.++......+-.+|+.|+.|||.+.|+|||||.-||||..+..|||+|||-++....
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~--- 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD--- 264 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---
Confidence 999999999999999987 5788899999999999999999999999999999999999999999999999875433
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCCCCCHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPWISTDAKRL 242 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L 242 (459)
.......|||..|||||++.+.+.+ .++||||+||+||+||||..||.+-+...++-.+-.. .++.|..+++.++=|
T Consensus 265 ~STkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 265 KSTKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred hhhhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHH
Confidence 2344567999999999999988876 9999999999999999999999876554443222222 356778899999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCc
Q 012637 243 ISKLLVSDPERRITIQSIMRVP 264 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hp 264 (459)
|+.||+-.|..||++.+||.|-
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHH
Confidence 9999999999999999999993
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=320.26 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=209.7
Q ss_pred EEEeeeecccCcEEEEEEEEcCCC----cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTG----ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+++.+.||+|+||.||+|.+..++ ..||+|.+...... ...+.+..|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357889999999999999998766 89999999654322 145678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcC-C--CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 88 AMEYVKGGELFAKVARG-R--LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~-~--l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+|||+++++|.+.+... . +++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998652 2 99999999999999999999999999999999999999999999999999975543211
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRL 242 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 242 (459)
... ....+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+.... ...+...+.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 11236789999999966555 589999999999999998 899998877777776665543 34456689999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 012637 243 ISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~ 262 (459)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=325.77 Aligned_cols=251 Identities=21% Similarity=0.349 Sum_probs=210.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
..+|++.+.||+|+||.||+|+.+. +.+.||+|.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3679999999999999999999754 34679999886543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-C---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeec
Q 012637 84 KIFVAMEYVKGGELFAKVAR-G---------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDF 153 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~---------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DF 153 (459)
..|+||||+++|+|.+++.. . .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999865 3 5899999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccCC--
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFV-- 230 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~-- 230 (459)
|++...... .........+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.........+......
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 998643211 11122334567789999998876654 88999999999999998 89999877666666666544433
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 231 YPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 231 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+..++..+.+++.+||..+|.+|||+.+++++
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.49 Aligned_cols=243 Identities=26% Similarity=0.441 Sum_probs=203.0
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (459)
+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4799999999999986 468899999986543 2223456889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccC
Q 012637 96 ELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173 (459)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~G 173 (459)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 99998864 468999999999999999999999999999999999999999999999999986432111 111112244
Q ss_pred CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHHHHhcCCCC
Q 012637 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISKLLVSDP 251 (459)
Q Consensus 174 t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 251 (459)
++.|+|||++.+..+ +.++||||+||++|++++ |..||.+.+.......+... ....|..++..+.+|+.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 667999999977655 488999999999999998 99999887776665555544 234566789999999999999999
Q ss_pred CCCCCHHHHhcC
Q 012637 252 ERRITIQSIMRV 263 (459)
Q Consensus 252 ~~R~t~~eil~h 263 (459)
++|||+.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=318.57 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=210.9
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEe
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.+.+..||.|+.|+|++++.+.+|...|||.+.+.. +....++|.+.+.++.+.+ .|+||+.+++|..+..+++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445678999999999999999999999999997654 4456788999999988885 8999999999999999999999
Q ss_pred ccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
.+.. .+..++. .++++|..+-++...+++||.||.+ +||+|||+||+|||+|+.|++||||||++..+-. ...
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkA 247 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKA 247 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---ccc
Confidence 9853 2223333 3789999999999999999999986 5999999999999999999999999999975432 222
Q ss_pred cccccCCCcccChhhHhhc---CCCCCcchhhhHHHHHHHHhhCCCCCCCch-HHHHHHHHHhccCCC-CC--CCCHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKK---GYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVFKAEFVY-PP--WISTDAK 240 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~~~-p~--~~s~~~~ 240 (459)
.....|.+.|||||.+... .|+ ..+|||||||.|++|.||..||.+.+ ..+.+.++...+++. |. .+|+++.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 3456799999999998632 354 88999999999999999999999843 456677777765432 22 3899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 241 RLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+|+..||++|+.+||...++|+|||+..-
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 99999999999999999999999999753
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=327.49 Aligned_cols=249 Identities=32% Similarity=0.494 Sum_probs=206.0
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEe
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 90 (459)
|++.+.||+|+||+||+|.+..+++.||||.+....... ......+|+..+++++ ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 788999999999999999999999999999986543221 1223457999999998 9999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|+ +|+|.+.+.. ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 7788888765 2689999999999999999999999999999999999999999999999999975432 122
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------c
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-------------------E 228 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 228 (459)
.....|+..|+|||++......+.++|+||+|+++++|++|+.||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865444458999999999999999999999877655444332210 0
Q ss_pred CC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 229 FV-----------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 229 ~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.. ..+..+.++.+||.+||..||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=323.90 Aligned_cols=238 Identities=23% Similarity=0.325 Sum_probs=194.7
Q ss_pred eeecccCcEEEEEEEEcC------------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 16 RLLGKGTFAKVYYGKQLM------------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~------------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999997532 22358999876532 234456788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC-------eEEeecC
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED-------LKISDFG 154 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~-------lKl~DFG 154 (459)
..++||||+++|.|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888764 56999999999999999999999999999999999999987664 8999999
Q ss_pred CCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHh-hCCCCCCCchHHHHHHHHHhccCCCCC
Q 012637 155 LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLL-AGFLPFQDENIMNMYRKVFKAEFVYPP 233 (459)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (459)
++..... .....|++.|+|||.+......+.++||||+||++|+|+ .|..||......+.. ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 9864321 123467889999999875444568999999999999997 589999876654432 22333333344
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.01 Aligned_cols=244 Identities=20% Similarity=0.271 Sum_probs=192.5
Q ss_pred eeecccCcEEEEEEEEcC--CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 16 RLLGKGTFAKVYYGKQLM--TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999996432 44578888875432 23344567889999999999999999999999999999999999
Q ss_pred CCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 94 GGELFAKVARG------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 94 gg~L~~~i~~~------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
+|+|.+++... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998652 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCCcccChhhHhhc------CCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHh-ccCC-----CCCC
Q 012637 168 LHTQCGTPAYVAPEVLRKK------GYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFK-AEFV-----YPPW 234 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~------~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~-----~p~~ 234 (459)
.....+++.|+|||++... ...+.++||||+||++|+|++ |..||......+....... .... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233456789999998642 223578999999999999999 8899987766555444332 2222 2334
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+++...+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888899999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.02 Aligned_cols=228 Identities=25% Similarity=0.442 Sum_probs=193.1
Q ss_pred cCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCchHHH
Q 012637 21 GTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK 100 (459)
Q Consensus 21 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 100 (459)
|.||.||+|+++.+++.||+|.+.+.. ...+|...+....||||+++++++.+....|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997543 122455555566799999999999999999999999999999998
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccC
Q 012637 101 VAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179 (459)
Q Consensus 101 i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~A 179 (459)
+.+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||++..... ......+++.|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 865 5799999999999999999999999999999999999999999999999998764432 1234456788999
Q ss_pred hhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH--
Q 012637 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITI-- 257 (459)
Q Consensus 180 PE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~-- 257 (459)
||.+....+ +.++||||+||++|+|++|..||...... .. .......|.++++.+.+||.+||+.||.+|||+
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876666 47899999999999999999988643221 00 112345678899999999999999999999985
Q ss_pred ---HHHhcCccc
Q 012637 258 ---QSIMRVPWF 266 (459)
Q Consensus 258 ---~eil~hpw~ 266 (459)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=326.54 Aligned_cols=237 Identities=23% Similarity=0.333 Sum_probs=194.1
Q ss_pred eecccCcEEEEEEEEcCC------------------------CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc
Q 012637 17 LLGKGTFAKVYYGKQLMT------------------------GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 72 (459)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2358999886432 2234567889999999999999
Q ss_pred ceeEEEEEeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC----
Q 012637 73 VELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---- 146 (459)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---- 146 (459)
+++++++.+....|+||||+++|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988854 6799999999999999999999999999999999999998654
Q ss_pred ---CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHh-hCCCCCCCchHHHHHH
Q 012637 147 ---DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLL-AGFLPFQDENIMNMYR 222 (459)
Q Consensus 147 ---~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~ 222 (459)
.+|++|||++..... .....+++.|+|||.+.+....+.++||||+||++|+|+ +|..||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998853221 123457889999999876444468999999999999984 6999998766554432
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 223 KVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 223 ~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
........|...++++.+||.+||+.+|++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2333344555567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=345.49 Aligned_cols=255 Identities=26% Similarity=0.431 Sum_probs=217.2
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCc---E-EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEE
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGE---S-VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM 79 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 79 (459)
.+.+..++-.+.+.||+|+||.||+|..+..+. . ||+|....+..........+.+|.++|+.++|||||++||+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345566677788999999999999998776433 3 899998764434455678899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 80 ATKKKIFVAMEYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
.....+|+|||+|+||+|.+++.+. .++..+...|+.+.+.||+|||+++++||||-.+|+|++.++.+||+||||++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999999999873 49999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCcccccc-CCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccCC--CCC
Q 012637 158 LPEQLRNDGLLHTQC-GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFV--YPP 233 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~-Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~--~p~ 233 (459)
.-... ......+ -...|+|||.+....|+ .++||||+||++||+++ |..||.+.+..+...++....+. .|.
T Consensus 311 ~~~~~---~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 311 AGSQY---VMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS 386 (474)
T ss_pred CCcce---eeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence 43211 1111122 23579999999988664 99999999999999999 89999999999999998665543 455
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..+.++..++.+|+..||+.|||+.++.+
T Consensus 387 ~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 387 KTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 67888999999999999999999998876
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=318.52 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=206.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
++..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 456789999999999999999999864 55679999886432 124567889999999999999999999887 788
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 86 FVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
|++|||+++++|.+++.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999999865 35788899999999999999999999999999999999999999999999998754321
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAK 240 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (459)
. ........++..|+|||++....+ +.++|||||||++|++++ |..||.+.+.......+.... ...+...+.++.
T Consensus 156 ~-~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 156 E-YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233 (260)
T ss_pred C-cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHH
Confidence 1 111112335667999999987655 478999999999999998 999999877766665554432 234456889999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 012637 241 RLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+++.+||.++|++||++.++++
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.11 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=207.1
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCC---CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..+|.+.+.||+|+||.||+|.+... ...||||....... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 46799999999999999999987654 34699998864432 2345678899999999999999999999875 457
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999999999999975 358999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
.. ......+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..++..+.+
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 YY-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred ce-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 10 1112234568999999877666 488999999999999986 99999887776666555544 34556678999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 012637 242 LISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~h 263 (459)
||.+||..+|.+|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=328.14 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=206.5
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCc----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGE----SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
.+.|++.+.||+|+||.||+|.+..+|+ .||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4678999999999999999999887776 478888764432 22344678999999999999999999998654 4
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.++++||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 7899999999999999865 36899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAK 240 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (459)
..........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+.... +..++..+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 11112223446778999999987665 488999999999999997 999998866555444443332 334456788999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 012637 241 RLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+++.+||..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=320.24 Aligned_cols=244 Identities=18% Similarity=0.239 Sum_probs=193.0
Q ss_pred eeecccCcEEEEEEEEc--CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 16 RLLGKGTFAKVYYGKQL--MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46999999999999754 3567899998865432 2233468889999999999999999999999999999999999
Q ss_pred CCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 94 GGELFAKVARG------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 94 gg~L~~~i~~~------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
+|+|.+++... ..++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999988641 356778889999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCCcccChhhHhhcC------CCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHh-ccCCC--C---CC
Q 012637 168 LHTQCGTPAYVAPEVLRKKG------YDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFK-AEFVY--P---PW 234 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~--p---~~ 234 (459)
....+|++.|+|||++.+.. ..+.++||||+||++|+|++ |..||...+..+....... ..... | ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22356788999999986432 12578999999999999996 9999987665554333222 21212 1 23
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.++.+.+++.+|+ .+|.+|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 5788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=321.40 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=201.7
Q ss_pred eeecccCcEEEEEEEEcCCC------cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 16 RLLGKGTFAKVYYGKQLMTG------ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.||+|+||.||+|.+...+ +.+|+|.+.+... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46999999999999886544 6899998864321 123456888999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-----CeEEeecCCC
Q 012637 90 EYVKGGELFAKVAR--------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-----DLKISDFGLS 156 (459)
Q Consensus 90 E~~~gg~L~~~i~~--------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-----~lKl~DFGla 156 (459)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999998853 2378899999999999999999999999999999999999887 8999999998
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPW 234 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 234 (459)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+... .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75432111111223345788999999987665 589999999999999998 99999887766665554433 3455667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
++..+.+||.+||.++|.+||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=317.04 Aligned_cols=242 Identities=26% Similarity=0.440 Sum_probs=204.1
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
...+|++.+.||+|+||.||++. .+++.||+|.+..+. ..+.+.+|+.+++.++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 35789999999999999999986 578899999986432 235678899999999999999999998654 4799
Q ss_pred EEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 88 AMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999999999999865 35899999999999999999999999999999999999999999999999998743211
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRL 242 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 242 (459)
......+..|+|||.+.+..+ +.++|+||+||++|+|++ |..||...+..+....+..+. +..+..++..+.+|
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 122334567999999877665 488999999999999997 999999888777666655442 23345578999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcC
Q 012637 243 ISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~h 263 (459)
+.+||+.+|.+|||+.++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=322.92 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=200.5
Q ss_pred CEEEeeeecccCcEEEEEEEE----cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC--CE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQ----LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--KK 84 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 84 (459)
-|++.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368899999999999999974 4578899999986442 233456789999999999999999999998775 67
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.|+||||++|++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8999999999999999865 35899999999999999999999999999999999999999999999999999765322
Q ss_pred cCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch---------------HHHHHHHHHh
Q 012637 163 RND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN---------------IMNMYRKVFK 226 (459)
Q Consensus 163 ~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---------------~~~~~~~i~~ 226 (459)
... .......|+..|+|||++.+..+. .++||||+||++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 111 112234567789999999876654 88999999999999999877653211 0111111111
Q ss_pred c-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 227 A-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 227 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
. ....+..++..+.+||.+||++||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1 223345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=316.97 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=198.2
Q ss_pred eeecccCcEEEEEEEEcC---CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE-eCCEEEEEEec
Q 012637 16 RLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA-TKKKIFVAMEY 91 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 91 (459)
+.||+|+||.||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 3457999987532 22334567889999999999999999999765 45678999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC--CCc
Q 012637 92 VKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN--DGL 167 (459)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~--~~~ 167 (459)
+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999865 4567888899999999999999999999999999999999999999999999874322110 011
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 245 (459)
.....+++.|+|||.+.+..+. .++|||||||++|+|++ |.+||...+..+....+..+. ...|..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233457789999999876664 89999999999999999 577888777666665555443 33345578999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 012637 246 LLVSDPERRITIQSIMRV 263 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~h 263 (459)
||.++|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=320.42 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=205.1
Q ss_pred EEEeeeecccCcEEEEEEEEcC---CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-----
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK----- 83 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----- 83 (459)
|.+.++||+|+||.||+|.+.. +++.||||++..+... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998653 5789999999654333 334567889999999999999999999886532
Q ss_pred -EEEEEEeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCC
Q 012637 84 -KIFVAMEYVKGGELFAKVAR-------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGL 155 (459)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGl 155 (459)
..++++||+.+|+|..++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999877632 2478999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCC
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPP 233 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 233 (459)
++...............+++.|++||.+....+. .++|||||||++|+|++ |.+||.+.+..+.+..+.... ...++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 9754321111112233456789999999877664 78999999999999999 999998887777666655443 34456
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..+..+.+++.+||+++|++|||+.+++++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=320.65 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=198.9
Q ss_pred CCEEEeeeecccCcEEEEEEE----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CC
Q 012637 10 GKYEMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KK 83 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~ 83 (459)
.+|++.+.||+|+||.||+|. +..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999997 44578899999986442 3345678899999999999999999998643 45
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.+|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68999999999999999865 4689999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCcc-ccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH---------------HHHHH
Q 012637 162 LRNDGLL-HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM---------------YRKVF 225 (459)
Q Consensus 162 ~~~~~~~-~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~---------------~~~i~ 225 (459)
....... ....++..|+|||++.+..+ +.++||||+||++|+|++|..|+........ ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 1111011 11223446999999987665 4899999999999999998877654321100 01111
Q ss_pred hc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 226 KA--EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 226 ~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.. .+..+..++.++.+||.+||.++|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 11 223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=318.92 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=214.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT----- 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (459)
...+.|+-..++|+|.||.||+|+.+.+|+.||+|.+--+.-. +.+.....+|+.+|..|+|+|++.+++++.+
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 4567888899999999999999999999999999976433222 2233445689999999999999999987743
Q ss_pred ---CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 82 ---KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 82 ---~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
...+|+|+++|+. +|+-.+.. .+++..+++.++++|++||.|+|++.|+|||+||+|+||+.+|.+||+|||+|
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 3459999999986 77777754 57999999999999999999999999999999999999999999999999999
Q ss_pred cccccccC--CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh--cc----
Q 012637 157 ALPEQLRN--DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK--AE---- 228 (459)
Q Consensus 157 ~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~---- 228 (459)
+.+....+ .......+-|.+|++||.+.+...+|++.|||+.|||+.+|.++.+-|++.+....+..|.. +.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76643222 22344556699999999999888889999999999999999999999999877665544321 10
Q ss_pred -------------C---CCC-------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 229 -------------F---VYP-------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 229 -------------~---~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+ +.| -.-++++.+|+.+||..||.+|++++++++|.||.+..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 0 011 11356889999999999999999999999999998653
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=315.63 Aligned_cols=235 Identities=24% Similarity=0.312 Sum_probs=193.2
Q ss_pred eeecccCcEEEEEEEEcCCC----------cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 16 RLLGKGTFAKVYYGKQLMTG----------ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47999999999999998776 3578887754321 14677899999999999999999999887 778
Q ss_pred EEEEeccCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-------CeEEeecCCC
Q 012637 86 FVAMEYVKGGELFAKVAR-G-RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-------DLKISDFGLS 156 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-------~lKl~DFGla 156 (459)
|+||||+++|+|.+++.. . .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999875 3 689999999999999999999999999999999999999887 7999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhc-CCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccCCCCCC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKK-GYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVYPPW 234 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 234 (459)
..... .....++..|+|||++... ...+.++||||+||++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75332 2234577889999999866 234588999999999999999 688887765443322222 22223333
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
....+.+||.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.18 Aligned_cols=249 Identities=28% Similarity=0.532 Sum_probs=208.9
Q ss_pred CEEEeeeecccCcEEEEEEEEcC-CCcEEEEEEeecccc-------ccHHHHHHHHHHHHHHHh-cCCCCcceeEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLM-TGESVAIKVINKDQL-------KKEFMMEQIKREISVMRL-VRHPNVVELREVMAT 81 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~ 81 (459)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++++ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 788999999864321 223345567789988875 699999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCC
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGL 155 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGl 155 (459)
.+..|++|||++|++|.+.+.. ..+++..++.++.|++.||.|||+ .|++||||+|+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887632 469999999999999999999996 7899999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC-C-C
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY-P-P 233 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p-~ 233 (459)
+...... .......|+..|+|||.+.+..+ +.++|||||||++|+|++|..||...........+....... + .
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 9764332 13345678999999999987665 589999999999999999999998877766665555444332 2 2
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..++++.+||.+||+.||++|||+.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=314.58 Aligned_cols=244 Identities=18% Similarity=0.276 Sum_probs=192.8
Q ss_pred eeecccCcEEEEEEEEcCC--CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 16 RLLGKGTFAKVYYGKQLMT--GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
+.||+|+||.||+|..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 23566777654322 2245678899999999999999999999999999999999999
Q ss_pred CCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcc
Q 012637 94 GGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168 (459)
Q Consensus 94 gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~ 168 (459)
+|+|.+++.. ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999998864 23567788899999999999999999999999999999999999999999998632211111122
Q ss_pred ccccCCCcccChhhHhhcC------CCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc------CCCCCCC
Q 012637 169 HTQCGTPAYVAPEVLRKKG------YDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE------FVYPPWI 235 (459)
Q Consensus 169 ~~~~Gt~~y~APE~l~~~~------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~ 235 (459)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+.+.. ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 12468999999999999997 678998777666655544332 1223347
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
++.+.+++..|| .+|.+|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.51 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=202.7
Q ss_pred CCEEEeeeecccCcEEEEEEEEcC----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CC
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLM----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KK 83 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~ 83 (459)
..|++.+.||+|+||.||+|.... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 568889999999999999998653 4889999999755432 345678999999999999999999999877 66
Q ss_pred EEEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
..|++|||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 899999999999999999764 499999999999999999999999999999999999999999999999999986542
Q ss_pred ccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHH--------------HHHHHHh
Q 012637 162 LRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN--------------MYRKVFK 226 (459)
Q Consensus 162 ~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~--------------~~~~i~~ 226 (459)
.... .......++..|+|||.+....+ +.++||||+||++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 01112234567999999977665 488999999999999999999986543221 1111122
Q ss_pred c--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 227 A--EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 227 ~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
. ....+..++.++.+|+.+||.++|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2 22334557889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=317.72 Aligned_cols=253 Identities=16% Similarity=0.209 Sum_probs=191.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCC---CcEEEEEEeeccccc--cHHH------HHHHHHHHHHHHhcCCCCccee
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLK--KEFM------MEQIKREISVMRLVRHPNVVEL 75 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~--~~~~------~~~i~~Ei~il~~l~hpnIv~l 75 (459)
+..++|++.+.||+|+||+||+|.+..+ +..+|+|+....... .+.. ......++..++.+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4557899999999999999999998877 677888875432211 1100 0112233445566789999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEE
Q 012637 76 REVMATKK----KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI 150 (459)
Q Consensus 76 ~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl 150 (459)
+++..... ..|+++|++.. .+.+.+.. ...++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765543 45788888754 45555554 45789999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccC-----CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH-HH-----
Q 012637 151 SDFGLSALPEQLRN-----DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MN----- 219 (459)
Q Consensus 151 ~DFGla~~~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~----- 219 (459)
+|||+|+.+..... ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+. ..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999976532111 111223469999999999988776 4899999999999999999999987632 11
Q ss_pred ---HHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 220 ---MYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 220 ---~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
....+..+.... +..++.+.+++..|+..+|++||++++|++
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333333332 346889999999999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=323.88 Aligned_cols=254 Identities=31% Similarity=0.473 Sum_probs=207.1
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-C-CC----cceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-H-PN----VVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-h-pn----Iv~l~~~ 78 (459)
+-.+.+||.+.++||+|.||.|-.+.+..++..||||+++.- . ...+..+-||+++.++. + |+ +|++.++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--D--KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--H--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 346789999999999999999999999999999999998532 1 23455667999999994 2 32 7888899
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-----------
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE----------- 144 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~----------- 144 (459)
|+-.+++|||+|.+ |.++++++.. .+++.+.++.+.+||+.+++|||+++++|-||||||||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999988 6699999976 36999999999999999999999999999999999999943
Q ss_pred ---------CCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc
Q 012637 145 ---------NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE 215 (459)
Q Consensus 145 ---------~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 215 (459)
+..+||+|||.|+.... .-.+.+.|..|+|||++.+-+++ .++||||+||||+|+++|...|+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred ccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccC
Confidence 23589999999985432 22566789999999999999997 8999999999999999999999876
Q ss_pred hHHH---HHHHHHh------------------ccCCCCCC-------------------------CCHHHHHHHHHhcCC
Q 012637 216 NIMN---MYRKVFK------------------AEFVYPPW-------------------------ISTDAKRLISKLLVS 249 (459)
Q Consensus 216 ~~~~---~~~~i~~------------------~~~~~p~~-------------------------~s~~~~~Li~~~L~~ 249 (459)
...+ +.+.|.. +.+.+|.. ...++.+||++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 5332 3333221 11111100 122467999999999
Q ss_pred CCCCCCCHHHHhcCcccccC
Q 012637 250 DPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 250 dP~~R~t~~eil~hpw~~~~ 269 (459)
||.+|+|+.|+|.||||+..
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.38 Aligned_cols=256 Identities=18% Similarity=0.274 Sum_probs=181.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCC----CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEE---
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMT----GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREV--- 78 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~--- 78 (459)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+....... ....| .++...+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhc
Confidence 44568999999999999999999999988 9999999875432111 11111 1122222233222211
Q ss_pred ---EEeCCEEEEEEeccCCCchHHHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 012637 79 ---MATKKKIFVAMEYVKGGELFAKVARGRL---------------------REDLARKYFQQLISAVDFCHSRGVSHRD 134 (459)
Q Consensus 79 ---~~~~~~~~lV~E~~~gg~L~~~i~~~~l---------------------~e~~~~~~~~qll~~L~~LH~~gi~HrD 134 (459)
......+|+|+||+++++|.+++....+ .+..++.++.||+.||.|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456789999999999999988865321 2345678999999999999999999999
Q ss_pred CCCCCeEecC-CCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCC---------------------CCc
Q 012637 135 LKPENLLLDE-NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD---------------------GSK 192 (459)
Q Consensus 135 lkp~NILl~~-~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~---------------------~~~ 192 (459)
|||+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+....+. +.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999986 589999999999754321 12233466899999999976432211 245
Q ss_pred chhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC-------C--------------CCCCHHHHHHHHHhcCCCC
Q 012637 193 ADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY-------P--------------PWISTDAKRLISKLLVSDP 251 (459)
Q Consensus 193 ~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------p--------------~~~s~~~~~Li~~~L~~dP 251 (459)
+||||+||+||+|+++..|++.. .......+....... + ...+..+.+||.+||++||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 69999999999999988776542 222222222111110 0 1122345589999999999
Q ss_pred CCCCCHHHHhcCcccccCC
Q 012637 252 ERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 252 ~~R~t~~eil~hpw~~~~~ 270 (459)
++|||+.++|+||||+...
T Consensus 439 ~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 439 RQRISAKAALAHPYFDREG 457 (566)
T ss_pred ccCCCHHHHhCCcCcCCCC
Confidence 9999999999999998643
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=338.70 Aligned_cols=241 Identities=32% Similarity=0.499 Sum_probs=196.6
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC------
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK------ 83 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~------ 83 (459)
+-|...+.||+||||.||+++++.+|+.||||.+++..... ..+..-+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 56788899999999999999999999999999998754333 3567789999999999999999999866544
Q ss_pred EEEEEEeccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC--C--CeEEeecCC
Q 012637 84 KIFVAMEYVKGGELFAKVAR----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN--E--DLKISDFGL 155 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~--~--~lKl~DFGl 155 (459)
.-.+|||||.||+|+..+.+ .+|+|.+...++..+..||.|||++||+||||||+||++-.+ | .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 46799999999999999975 579999999999999999999999999999999999999533 3 369999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch-H----HHHHHHHHhc---
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-I----MNMYRKVFKA--- 227 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~----~~~~~~i~~~--- 227 (459)
|+-.+ .+....+..||+.|.+||++....+++..+|.||+||++|++.||.+||.... + .-++..+.+.
T Consensus 171 Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 98654 45577888999999999999976666789999999999999999999995422 1 1222222211
Q ss_pred -----------------cCCCCCCCCHHH----HHHHHHhcCCCCCCCC
Q 012637 228 -----------------EFVYPPWISTDA----KRLISKLLVSDPERRI 255 (459)
Q Consensus 228 -----------------~~~~p~~~s~~~----~~Li~~~L~~dP~~R~ 255 (459)
.+++|-.+++.+ ...|..+|.-+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 123333445543 4567778899999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=342.93 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=213.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
..-...+.||+|+||+||+|+-.. ....||||.++... +......++||+.++..++|||||++++++..++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 455678899999999999997543 33569999986443 34467889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-----------CC----CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeE
Q 012637 85 IFVAMEYVKGGELFAKVAR-----------GR----LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLK 149 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-----------~~----l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lK 149 (459)
+|||+||+..|+|-.++.. .. |+..+...++.||+.|++||-++.++||||..+|+|+.++-.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 9999999999999888752 12 77889999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc
Q 012637 150 ISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE 228 (459)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 228 (459)
|+||||++-.-..+.........-..+|||||.+....|. .++||||+||+|||+++ |..||.+.+..+.+..+..+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999853322211122122234589999999988875 89999999999999998 999999999999888887765
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 229 -FVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 229 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
...|..++.++.+|+..||+.+|++||++.||-.
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 4678889999999999999999999999999854
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.89 Aligned_cols=266 Identities=29% Similarity=0.476 Sum_probs=219.4
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc----cHHHHHHHHHHHHHHHhcCCCCcceeEEEEE-
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK----KEFMMEQIKREISVMRLVRHPNVVELREVMA- 80 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~- 80 (459)
.++.+||-+...||+|+|+.||+|.|....+.||+|+-...+-. ++...+...+|.+|++.|.||.||++|+++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 46788999999999999999999999999999999996543322 3345677889999999999999999999995
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC--CcEeccCCCCCeEecCC---CCeEEeecC
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSR--GVSHRDLKPENLLLDEN---EDLKISDFG 154 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~--gi~HrDlkp~NILl~~~---~~lKl~DFG 154 (459)
+...+|-|+|||+|.+|.-+++. .-++|.+|+.++.||++||.||.+. -|+|-||||.||||-.+ |.+||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 45678999999999999999987 5689999999999999999999987 59999999999999644 789999999
Q ss_pred CCcccccccCC-----CccccccCCCcccChhhHhh---cCCCCCcchhhhHHHHHHHHhhCCCCCCCchH-HHHHH--H
Q 012637 155 LSALPEQLRND-----GLLHTQCGTPAYVAPEVLRK---KGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYR--K 223 (459)
Q Consensus 155 la~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~---~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~--~ 223 (459)
|+++++....+ .+.....||-+|++||.+.- .+..+.++||||.|||+|..+.|+.||...-. .++++ .
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99987643222 12334579999999998742 23346899999999999999999999976433 23322 2
Q ss_pred HHh-ccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 224 VFK-AEFVYP--PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 224 i~~-~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
|.+ .+..+| +.+++++++||++||..--+.|+.+.++-.||||..+..
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 222 234444 568999999999999999999999999999999986543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=347.56 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=211.7
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCC-Cc----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMT-GE----SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~-~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
..-++.+.||+|+||.||.|..... |. .||||.+. +..+......+.+|..+|+.++|||||++++++.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 4577889999999999999987653 32 38888875 44456667889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 85 IFVAMEYVKGGELFAKVARG--------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
.+|++|||+||+|..++++. .++..+...++.|++.|+.||++++++||||..+|+||+....+||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999753 3888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccC--CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHH-HHHhccCCCC
Q 012637 157 ALPEQLRNDGLLHTQCG--TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYR-KVFKAEFVYP 232 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~G--t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~-~i~~~~~~~p 232 (459)
+.... .+.......+ ...|||||.+....+ +.++||||+||+|||+++ |..||.+.+..++.. -...+....|
T Consensus 850 rDiy~--~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 850 RDIYD--KDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP 926 (1025)
T ss_pred Hhhhh--chheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence 83221 1111111112 246999999998666 599999999999999999 999999988887776 4445577788
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..++..+.+|+..||+.+|++||++..|++
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 899999999999999999999999999997
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.72 Aligned_cols=253 Identities=30% Similarity=0.511 Sum_probs=221.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe-----C
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT-----K 82 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~-----~ 82 (459)
.+.|++.+++|.|.+|.||+++++.+++.+|+|+.+...-. -+.+..|.++++.+ .|||++.+++++.- +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 46799999999999999999999999999999998765432 35677899999988 69999999999854 5
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
+.+|||||||.||+..|+++. +++.|+.+..+++.++.|+.+||.+.++|||||-.|||++.+|.|||+|||.+...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 789999999999999999875 68999999999999999999999999999999999999999999999999999866
Q ss_pred ccccCCCccccccCCCcccChhhHhhcC-----CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC---C
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKG-----YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV---Y 231 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~-----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~ 231 (459)
.. .-+.-.|..|||.|||||++.... |+ ..+|+||||++..+|-.|.+|+-+..+...+.+|.+..++ -
T Consensus 174 ds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 174 DS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred ec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 54 334456788999999999997532 43 6799999999999999999999999888776666655432 2
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 232 PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 232 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
|...+..+.+||..||..|-.+||+..++++|||+..
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 3447889999999999999999999999999999984
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=314.41 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=194.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-EEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK-KIFVA 88 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV 88 (459)
+.|.-...||+|+||.||+|... +|..||||.+....... ..++.+|+.++.+++|||+|+++++|.+.+ ..++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 45677789999999999999864 44899999876543321 344899999999999999999999999998 59999
Q ss_pred EeccCCCchHHHHhc--C-CCCHHHHHHHHHHHHHHHHHHHhCC---cEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 89 MEYVKGGELFAKVAR--G-RLREDLARKYFQQLISAVDFCHSRG---VSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~-~l~e~~~~~~~~qll~~L~~LH~~g---i~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
+||++.|+|.+++.. + .+++.....|+.+++.||+|||+.. |+||||||+|||||.+.+.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999975 3 7899999999999999999999964 999999999999999999999999999643321
Q ss_pred cCCCccccc-cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch------HHHHHHHH-Hhc------c
Q 012637 163 RNDGLLHTQ-CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN------IMNMYRKV-FKA------E 228 (459)
Q Consensus 163 ~~~~~~~~~-~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~------~~~~~~~i-~~~------~ 228 (459)
.....+. .||.+|+|||.+.... .+.++||||+||+|.|+++|+.|.+... ..+..... ..+ +
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 2222333 8999999999998644 4589999999999999999998887532 22221111 111 1
Q ss_pred CCCC-CCCC--HH---HHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 229 FVYP-PWIS--TD---AKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 229 ~~~p-~~~s--~~---~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..+. ...+ .. +..+..+|++.+|.+||++.++.+
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1122 12 456888999999999999999754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=292.74 Aligned_cols=239 Identities=48% Similarity=0.848 Sum_probs=206.7
Q ss_pred CcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCchHHHH
Q 012637 22 TFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKV 101 (459)
Q Consensus 22 ~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 101 (459)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999976543322 567889999999999999999999999999999999999999999998
Q ss_pred hcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccCh
Q 012637 102 ARG-RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180 (459)
Q Consensus 102 ~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~AP 180 (459)
... .+++..+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++...... .......|++.|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 764 4899999999999999999999999999999999999999999999999999765432 133456788999999
Q ss_pred hhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC-chHHHHHHHHHhccCCCCCC---CCHHHHHHHHHhcCCCCCCCCC
Q 012637 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKAEFVYPPW---ISTDAKRLISKLLVSDPERRIT 256 (459)
Q Consensus 181 E~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~Li~~~L~~dP~~R~t 256 (459)
|.+....+. .++||||+|+++++|++|..||.. .................+.. ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999876664 799999999999999999999987 55555555555444433322 7889999999999999999999
Q ss_pred HHHHhcCccc
Q 012637 257 IQSIMRVPWF 266 (459)
Q Consensus 257 ~~eil~hpw~ 266 (459)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=305.00 Aligned_cols=254 Identities=28% Similarity=0.516 Sum_probs=210.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------C
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------K 82 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~ 82 (459)
-.||.-.+.+|.|+. .|-.|.|..++++||+|.+... ..+....++..+|..++..++|+||++++.+|.- .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 458888999999999 8899999999999999998766 3334456788999999999999999999999843 3
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
...|+||||+.. +|...+. -.+....+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+.-.
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~-- 169 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED-- 169 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC--
Confidence 468999999976 6666664 567888999999999999999999999999999999999999999999999997432
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---------------
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--------------- 227 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------- 227 (459)
.+-..+..+.|+.|.|||++.+.+|. ..+||||+||++.+|++|..-|.+.+..+.+.++...
T Consensus 170 -~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 170 -TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred -cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 23345566789999999999999865 8999999999999999999999987766555443211
Q ss_pred ---------c---C----CCCC-----------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 228 ---------E---F----VYPP-----------WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 228 ---------~---~----~~p~-----------~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+ + .+|. .-+..+++|+.+||..||++|+|++++|.|||++-++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 0 0 1111 1234589999999999999999999999999998554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.48 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=205.6
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEe
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.+-...||.|+||+|++..++.+|+..|||.|..... +....++..|.....+- +.||||++|+....++..||.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3345679999999999999999999999999976554 34567888888876555 79999999999999999999999
Q ss_pred ccCCCchHHH---H---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 91 YVKGGELFAK---V---ARGRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 91 ~~~gg~L~~~---i---~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
++.- +|..+ + ...+++|..+-.+.-..+.||.||.+ ..|+|||+||+|||++..|.+||||||++.....
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-- 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-- 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence 9964 33222 2 23679999999999999999999986 4899999999999999999999999999864332
Q ss_pred CCCccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCc-hHHHHHHHHHhccCCC---CC---C
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFKAEFVY---PP---W 234 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~---p~---~ 234 (459)
.-..+...|..+|||||.+.. .+|+ .++||||||++|||+.||..||..- +..+....+..++++. +. .
T Consensus 221 -SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 221 -SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred -HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 112234579999999999964 4565 8999999999999999999999764 3445555555555432 22 2
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+..+..+|.-||.+|-..||...+++++||++..
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 78899999999999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=317.68 Aligned_cols=254 Identities=28% Similarity=0.488 Sum_probs=211.7
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC------CCCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR------HPNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~------hpnIv~l~~~ 78 (459)
|.+|-.+|.+.-..|+|-|++|-.|.+...|..||||+|... +-+.+.=.+|+.||++|+ -.|+++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 567889999999999999999999999999999999999753 334555678999999995 3589999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeec
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVAR-G---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDF 153 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DF 153 (459)
|...+++|||+|-+.- .|.+.+.+ | +|....++.|++||+-||..|-..||+|.||||+|||++++ ..||||||
T Consensus 503 F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 9999999999998754 78888875 3 58889999999999999999999999999999999999987 46899999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC-
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP- 232 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p- 232 (459)
|.|.... .+......-+..|.|||++.+.+|+ .+.|+||.||.||+|.||+..|++.+..++++..+...-.+|
T Consensus 582 GSA~~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 582 GSASFAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred ccccccc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 9997543 2333344456789999999999997 899999999999999999999999887776654332110111
Q ss_pred ----------------------------------------------------CCCC-------HHHHHHHHHhcCCCCCC
Q 012637 233 ----------------------------------------------------PWIS-------TDAKRLISKLLVSDPER 253 (459)
Q Consensus 233 ----------------------------------------------------~~~s-------~~~~~Li~~~L~~dP~~ 253 (459)
+.++ ..+++||.+||..||.+
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0011 24689999999999999
Q ss_pred CCCHHHHhcCccccc
Q 012637 254 RITIQSIMRVPWFRK 268 (459)
Q Consensus 254 R~t~~eil~hpw~~~ 268 (459)
|.|+.++|+||||..
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999963
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.80 Aligned_cols=262 Identities=20% Similarity=0.274 Sum_probs=189.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEc----------------CCCcEEEEEEeeccccccH-H----------HHHHHHH
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQL----------------MTGESVAIKVINKDQLKKE-F----------MMEQIKR 59 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~----------------~~~~~vAiK~i~~~~~~~~-~----------~~~~i~~ 59 (459)
+-.++|++.+.||+|+||.||+|... ..++.||||.+........ . ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34678999999999999999999752 2456799999864321110 0 0112234
Q ss_pred HHHHHHhcCCCCc-----ceeEEEEEe--------CCEEEEEEeccCCCchHHHHhc--C--------------------
Q 012637 60 EISVMRLVRHPNV-----VELREVMAT--------KKKIFVAMEYVKGGELFAKVAR--G-------------------- 104 (459)
Q Consensus 60 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~--~-------------------- 104 (459)
|+.++.+++|.++ +++++++.. ....|+|+||+++++|.+++.. +
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777766554 666666542 3568999999999999887753 1
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChh
Q 012637 105 ---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181 (459)
Q Consensus 105 ---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE 181 (459)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .........+||.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeChh
Confidence 2345678899999999999999999999999999999999999999999999654321 111111234589999999
Q ss_pred hHhhcC--------------------CC-CCcchhhhHHHHHHHHhhCCC-CCCCchHH-----------HHHHHHHhcc
Q 012637 182 VLRKKG--------------------YD-GSKADLWSCGVILYVLLAGFL-PFQDENIM-----------NMYRKVFKAE 228 (459)
Q Consensus 182 ~l~~~~--------------------~~-~~~~DIwSlGvil~~ll~G~~-Pf~~~~~~-----------~~~~~i~~~~ 228 (459)
++.... |. ....||||+||++|+|++|.+ ||.+.... ..++.+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 986422 11 124799999999999999986 77542211 1112222333
Q ss_pred CCCC--CCCCHHHHHHHHHhcCCCC---CCCCCHHHHhcCcccccC
Q 012637 229 FVYP--PWISTDAKRLISKLLVSDP---ERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 ~~~p--~~~s~~~~~Li~~~L~~dP---~~R~t~~eil~hpw~~~~ 269 (459)
+.++ ...++.+.+|+.+||..+| .+|+|++|+|+||||...
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 3443 3478999999999999766 789999999999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=285.39 Aligned_cols=249 Identities=28% Similarity=0.513 Sum_probs=203.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeC--CE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATK--KK 84 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~--~~ 84 (459)
..++|++.+.+|+|.|+.|+.|.+..+++.++||++..- -.+.+++||.||+.|. ||||+++.++..++ ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 357899999999999999999999999999999998532 2467899999999996 99999999998765 44
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFGla~~~~~~~ 163 (459)
.-+++||+...+...+. ..++.-.++.|+.||+.||.|||++||+|||+||.|+++|.. ..++|+|+|||....
T Consensus 110 paLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH--- 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--- 184 (338)
T ss_pred chhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC---
Confidence 67999999886544333 458888999999999999999999999999999999999965 679999999998654
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC--chHHHHHHHHH-------------hcc
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD--ENIMNMYRKVF-------------KAE 228 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~--~~~~~~~~~i~-------------~~~ 228 (459)
+.........++.|--||.+..-..+...-|+||+||+|..|+..+-||-. .+..++. +|. +-.
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV-kIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-KIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH-HHHHHhChHHHHHHHHHHc
Confidence 334455667788899999998766666889999999999999999999842 2222221 111 111
Q ss_pred CCCC-------------C-----------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 229 FVYP-------------P-----------WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 229 ~~~p-------------~-----------~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+..+ + ..++++.+||.++|..|-.+|+|+.|++.||||..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111 1 15799999999999999999999999999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.50 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=217.6
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCC-Cc--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMT-GE--SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~-~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.++..+.+.||+|+||.|++|.++.. |+ .||||.+..+.... .+..+.+|+.+|.+|+|||++++|++..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 34567789999999999999988763 44 48999997665543 67889999999999999999999999977 789
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 86 FVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.||||+|++|+|.+++.+ +.|.......|+.||+.||.||.+++.|||||...|+||.....|||+||||.+.+...
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999999976 56888999999999999999999999999999999999999999999999999876543
Q ss_pred cCCCccccc-cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHH
Q 012637 163 RNDGLLHTQ-CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDA 239 (459)
Q Consensus 163 ~~~~~~~~~-~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (459)
.....+... .-...|+|||.+....++ .++|||++||++|||++ |..||.+....++++++-.+ ...-|+.++.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI 344 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence 222111111 123369999999988775 89999999999999999 89999999999998888654 456788899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
.+++..||..+|.+|||+..|.+.-+.+
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHHHH
Confidence 9999999999999999999997654443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=294.27 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=207.6
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----CEEE
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK-----KKIF 86 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~ 86 (459)
.+..+.||-|+||.||.+.|..+|+.||+|.+.. -..+--..+++.+|+.+|...+|.|++...++.... ..+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3456889999999999999999999999998742 222223457889999999999999999999987654 3478
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
++.|++.. +|...|.. ..++.+.++-+.+||+.||.|||+.||.||||||.|+|++.|..+||||||+|+..+.. ..
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~~ 211 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-DR 211 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-hh
Confidence 88998865 66666654 78999999999999999999999999999999999999999999999999999875532 22
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh-------------------
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------------------- 226 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 226 (459)
.......-|..|+|||++.+...++.++||||.|||+.||+..+..|...++.+.++.|..
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 2233345678999999999887777999999999999999999999988877665544421
Q ss_pred ----ccCCCCC-----------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 227 ----AEFVYPP-----------WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 227 ----~~~~~p~-----------~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+....|. .-..+...++..||.+||++|++.++.+.|++...+
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 1222221 123467889999999999999999999999998654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=311.51 Aligned_cols=243 Identities=28% Similarity=0.474 Sum_probs=204.2
Q ss_pred EEeeeecccCcEEEEEEEEcCC--Cc--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMT--GE--SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~--~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.+.+.||.|.||.||.|..... |+ .||||..+.+...+ ..+.+..|..+|+.++||||+++++++. ....|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--DTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--hHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEE
Confidence 3456899999999999986543 33 48999886544322 3678999999999999999999999996 5579999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||+++-|+|..++.. ..++......|++||+.||.|||+..++||||...|||+....-+||+||||++..+. +.
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed---~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED---DA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc---cc
Confidence 999999999999976 5789999999999999999999999999999999999999999999999999987653 22
Q ss_pred ccccccCCC--cccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHH
Q 012637 167 LLHTQCGTP--AYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRL 242 (459)
Q Consensus 167 ~~~~~~Gt~--~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 242 (459)
..+...|.. -|||||.+.-..+ +.++|||-|||.+||++. |..||.+-...+.+-.+.++ ..+.|+.+++.+..|
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl 624 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL 624 (974)
T ss_pred hhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence 333334433 4999999987666 489999999999999877 99999986665555555444 578899999999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 012637 243 ISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~ 262 (459)
+.+||..+|.+||++.+|..
T Consensus 625 mskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHhccCcccCCcHHHHHH
Confidence 99999999999999877643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.30 Aligned_cols=134 Identities=29% Similarity=0.481 Sum_probs=116.1
Q ss_pred ccccc-CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-----C---CCccee
Q 012637 5 RHVLF-GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-----H---PNVVEL 75 (459)
Q Consensus 5 ~~~~~-~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----h---pnIv~l 75 (459)
|-.|. +||.+.++||-|-|++||+|.|..+.+.||+|+.+... ...+....||.+|+.++ | .+||++
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 45666 89999999999999999999999999999999986543 24566778999999883 3 369999
Q ss_pred EEEEEe----CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEec
Q 012637 76 REVMAT----KKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLD 143 (459)
Q Consensus 76 ~~~~~~----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~ 143 (459)
++.|.. ..++|||+|+. |..|..+|.+ ..++...++.|++|++.||.|||+. ||+|-||||||||+.
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999964 57899999998 5577777765 6899999999999999999999975 999999999999993
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=310.54 Aligned_cols=203 Identities=29% Similarity=0.516 Sum_probs=184.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHH-----HHHHHHHHHHHhcC---CCCcceeEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMM-----EQIKREISVMRLVR---HPNVVELREV 78 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~-----~~i~~Ei~il~~l~---hpnIv~l~~~ 78 (459)
--+..|...+.||.|+||.|++|.++.+...|+||.|.|+++--...+ ..+..||+||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 345679999999999999999999999999999999998876544433 34788999999997 9999999999
Q ss_pred EEeCCEEEEEEecc-CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 79 MATKKKIFVAMEYV-KGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 79 ~~~~~~~~lV~E~~-~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
|++++++||+||-- +|.+||++|+. .+++|.++..+|+|++.|+++||++||+|||||-||+.++.+|-+||+|||.|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 99999999999975 46699999986 68999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ 213 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~ 213 (459)
... ..+...+..||..|.|||++.+..|-|.+-|||++||+||.++....||.
T Consensus 718 a~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 753 45667788999999999999999999999999999999999999988884
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.69 Aligned_cols=257 Identities=29% Similarity=0.450 Sum_probs=223.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.-.++|++...+|.|+||.||+|+|+.+++..|+|+++.+.-. ...-+..||-+++.++||||+.+++.+.....+|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 3457899999999999999999999999999999999876433 2455778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+.||||.||+|.+...- +.++|.++...++..+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+..... .-
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence 99999999999987754 8999999999999999999999999999999999999999999999999999864432 11
Q ss_pred CccccccCCCcccChhhHh---hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC-----CCCH
Q 012637 166 GLLHTQCGTPAYVAPEVLR---KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-----WIST 237 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~-----~~s~ 237 (459)
.......|||.|||||+-. ..+| ...+|||++|+...++---.+|-.+..++.......+..+..|. ..++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 2234568999999999863 3455 48999999999999998888888777777766666666666553 3688
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+-+|++.+|..||++|||++.+|+|||+...
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 89999999999999999999999999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=318.63 Aligned_cols=247 Identities=27% Similarity=0.426 Sum_probs=198.8
Q ss_pred EEeeeecccCcEE-EEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEe
Q 012637 13 EMGRLLGKGTFAK-VYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 13 ~i~~~LG~G~fg~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.-.+.+|.|+-|+ ||+|. ..|+.||||.+-.+ ....+.+||..|+.. .|||||++|..-.+.+..||.+|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred ccHHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3346889999987 79998 57889999987432 345678999999999 69999999999999999999999
Q ss_pred ccCCCchHHHHhcC-C----CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CC--CeEEeecCCCcccc
Q 012637 91 YVKGGELFAKVARG-R----LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NE--DLKISDFGLSALPE 160 (459)
Q Consensus 91 ~~~gg~L~~~i~~~-~----l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~--~lKl~DFGla~~~~ 160 (459)
.|.. +|.++++.. . ...-..+....|+++||++||+.+|+||||||.||||+. ++ ..+|+|||+++...
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9976 899999762 1 111456889999999999999999999999999999986 33 68999999998654
Q ss_pred ccc-CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-CCCCCCchHHHHHHHHHhccCCCCC---CC
Q 012637 161 QLR-NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMNMYRKVFKAEFVYPP---WI 235 (459)
Q Consensus 161 ~~~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~---~~ 235 (459)
... .-....+..||-+|+|||++..... ..++||+|+||++|+.++| ..||.+.-..+ .+|.++.+..-. .-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCc
Confidence 321 1223456779999999999987665 4799999999999988885 99998755433 345555554322 12
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
..++.+||.+||+++|..||++.++|.||+|.....
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek 775 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK 775 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence 238999999999999999999999999999986543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=301.38 Aligned_cols=243 Identities=26% Similarity=0.437 Sum_probs=212.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
......+||-|.||.||.|.++.-.-.||||.+..+.. ..+.+.+|..+|+.++|||+|++.++|..+..+|||.|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34556799999999999999998888999999865432 35778999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||..|.|.+++++ ..++.-....++.||.+|++||..++++||||...|+|+.++..+|++||||++++.. ..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DT 419 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Cc
Confidence 9999999999976 3477778889999999999999999999999999999999999999999999997653 12
Q ss_pred cccccCC---CcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHH
Q 012637 168 LHTQCGT---PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRL 242 (459)
Q Consensus 168 ~~~~~Gt---~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 242 (459)
+....|. .-|.|||-+....++ .++|||+|||+||++.| |-.||.+-+..+.|..+.++ ...-|..+++.+.+|
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYEL 498 (1157)
T ss_pred eecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHH
Confidence 2233333 359999999887775 89999999999999998 99999999998888777655 355688899999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 012637 243 ISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~ 262 (459)
++.||+.+|.+||+++||-+
T Consensus 499 MraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHhcCCcccCccHHHHHH
Confidence 99999999999999998854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=299.14 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=204.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
-.+..+++.||+|-||.|.++.- ..+..||+|.++.+...+ ....+.+||++|.+|+||||+++.++|..++.++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34678899999999999999985 336899999997654333 467899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 89 MEYVKGGELFAKVARGRL---REDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l---~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+||++.|+|-.++..... ......+++.||++|++||.+.+++||||.|.|+|+|.++++||+|||+++-.-.....
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999999977532 33456679999999999999999999999999999999999999999999843221111
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh--CCCCCCCchHHHHHHHHH---hc-----cCCCCCCC
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA--GFLPFQDENIMNMYRKVF---KA-----EFVYPPWI 235 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~--G~~Pf~~~~~~~~~~~i~---~~-----~~~~p~~~ 235 (459)
.......-..+|||||.+....+ +.++|+|++||++||+++ ...||...+..+...... .. -+..|+-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 11111223468999999987666 489999999999998654 789998887776655432 11 23456778
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+..+.+|+-+||..+-++|||++++..|
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 9999999999999999999999998543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.05 Aligned_cols=237 Identities=24% Similarity=0.360 Sum_probs=187.9
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
..|...+.||+|+||.||+|.+..++..||||.+...... ..+|+.++++++||||+++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3456677899999999999999999999999998643221 124688999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH---SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH---~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||+++|+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred eCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999986 4889999999999999999999 6799999999999999999888876 666543211
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch-----HHHHHHHHHhc-------cCCC---
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-----IMNMYRKVFKA-------EFVY--- 231 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~~-------~~~~--- 231 (459)
..+..||+.|+|||++.+..+. .++||||+||++|||++|+.||+... .....+..... +...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1234689999999999877764 89999999999999999999995421 11111111000 0000
Q ss_pred ---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 232 ---PPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 232 ---p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.....++.+++.+||+.||++|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112346789999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=308.39 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=216.6
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCc---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
..-.|.++||.|.||.|++|+.+..|+ .||||.++... .+.....+..|..||-+.+||||+++.++......+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345788999999999999999988775 59999986443 2334567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
||.|||+.|+|..+++. |.++.-++..+++.|++|+.||.+.|.+||||...|||++.+-.+|++||||++..+.. .
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd-~ 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-P 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC-C
Confidence 99999999999999975 78999999999999999999999999999999999999999999999999999976543 2
Q ss_pred CCccccccCC--CcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHH
Q 012637 165 DGLLHTQCGT--PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAK 240 (459)
Q Consensus 165 ~~~~~~~~Gt--~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (459)
.....+.-|. .+|.|||.+....+ +.++||||+||++||.++ |..||-+.+..+.++.|..+ ..+.|..++..+-
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 3334444443 46999999988776 489999999999997665 99999999998888888765 3444556899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 012637 241 RLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+|+..||++|-..||++.+|+.+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.01 Aligned_cols=254 Identities=26% Similarity=0.461 Sum_probs=202.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcC---CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (459)
.+...|.++++||.|.|++||+|.+.. .++.||+|.+.... ...++.+|+++|..+ .+.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 455679999999999999999999877 78899999986543 235688999999999 699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFGla~~~~~ 161 (459)
+...+||||.+..+..++... ++..+++.|++.++.||.++|.+||+||||||.|+|.+.. +.-.|+|||||...+.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999998887777754 6688899999999999999999999999999999999864 7789999999962110
Q ss_pred cc-------------------------------CCCcc-----------ccccCCCcccChhhHhhcCCCCCcchhhhHH
Q 012637 162 LR-------------------------------NDGLL-----------HTQCGTPAYVAPEVLRKKGYDGSKADLWSCG 199 (459)
Q Consensus 162 ~~-------------------------------~~~~~-----------~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlG 199 (459)
.. ..+.. ....|||+|+|||++...+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00000 0124999999999999888888999999999
Q ss_pred HHHHHHhhCCCCCCCch-----HHHHH--------HH---------HH------------------------hccC---C
Q 012637 200 VILYVLLAGFLPFQDEN-----IMNMY--------RK---------VF------------------------KAEF---V 230 (459)
Q Consensus 200 vil~~ll~G~~Pf~~~~-----~~~~~--------~~---------i~------------------------~~~~---~ 230 (459)
||+..++++..||-... ..++. ++ +. +.+. .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999994321 11110 00 00 0000 0
Q ss_pred ---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 231 ---YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 231 ---~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
.....+..+.+|+.+||..||.+|+|++++|+||||.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 0012456789999999999999999999999999997
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=258.96 Aligned_cols=207 Identities=25% Similarity=0.464 Sum_probs=172.9
Q ss_pred EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEec
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
.-+..||+|++|.|-+.++..+|+..|+|.+...- +....+++.+|+.+..+. .+|.+|.+|+.+.....+||.||.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 34578999999999999999999999999996443 233567788999997776 799999999999999999999999
Q ss_pred cCCCchHHHH----hc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 92 VKGGELFAKV----AR-GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 92 ~~gg~L~~~i----~~-~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+.. +|..+. .. +.++|..+-+++-.++.||.|||++ .|+|||+||+|||++.+|++|+||||.+..+. +
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~----d 201 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV----D 201 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh----h
Confidence 965 554333 23 5799999999999999999999987 89999999999999999999999999997543 2
Q ss_pred Ccccc-ccCCCcccChhhHh----hcCCCCCcchhhhHHHHHHHHhhCCCCCCC-chHHHHHHHHHhc
Q 012637 166 GLLHT-QCGTPAYVAPEVLR----KKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKA 227 (459)
Q Consensus 166 ~~~~~-~~Gt~~y~APE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~ 227 (459)
....+ ..|...|||||.+. ..+|+ -++||||||+.++||.+++.||+. .++.+.++++...
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 33333 57889999999985 34665 899999999999999999999975 4566666666554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.70 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=206.8
Q ss_pred CCEEEeeeecccCcEEEEEEEEcC---C----CcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLM---T----GESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT 81 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~---~----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (459)
.+..+.+.||+|+||.|++|.-.. . ...||||.+...... ...+.+..|+.+|+.+ .||||+.+.+++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 344677799999999999996431 1 356999998654433 4567899999999999 69999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC
Q 012637 82 KKKIFVAMEYVKGGELFAKVARGR-----------------LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE 144 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~ 144 (459)
.+.+++|+|||..|+|..+++..+ ++..+...+..||+.|++||++..++||||...|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 999999999999999999998766 899999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCcccccccCCCccccccCCC--cccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCch-HHHH
Q 012637 145 NEDLKISDFGLSALPEQLRNDGLLHTQCGTP--AYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDEN-IMNM 220 (459)
Q Consensus 145 ~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~--~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~-~~~~ 220 (459)
+..+||+|||+|+....... .......|+. .|||||.+....| +.++||||+||+|||+++ |..||.+-. ..++
T Consensus 454 ~~~~kIaDFGlar~~~~~~~-y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDY-YRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCEEEEccccceeccCCCCc-eEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 99999999999984332111 1112222333 3999999998666 489999999999999999 999999844 4555
Q ss_pred HHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 221 YRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 221 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
++.+..+. ...|..+++++.++++.||+.+|++||++.++.+
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 66555553 4678889999999999999999999999999876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=279.53 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=195.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCCcceeEEEEEeCC----
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL--VRHPNVVELREVMATKK---- 83 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~~~---- 83 (459)
....+.+.+|+|.||.||+|. .+++.||||++... ..+.+..|-+|.+. ++|+||+++++.-...+
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 345677899999999999998 56799999999633 33456667777665 48999999998765554
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeccCCCCCeEecCCCCeEEeecC
Q 012637 84 KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR---------GVSHRDLKPENLLLDENEDLKISDFG 154 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~---------gi~HrDlkp~NILl~~~~~lKl~DFG 154 (459)
.++||+||.+.|+|.+++..+-++.....+++..++.||+|||+. .|+|||||..|||+..|+...|+|||
T Consensus 282 eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 899999999999999999999999999999999999999999963 59999999999999999999999999
Q ss_pred CCcccccccCCCccccccCCCcccChhhHhhcCCCC-----CcchhhhHHHHHHHHhhCC------------CCCC----
Q 012637 155 LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG-----SKADLWSCGVILYVLLAGF------------LPFQ---- 213 (459)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~-----~~~DIwSlGvil~~ll~G~------------~Pf~---- 213 (459)
||..+......+.....+||.+|||||++.+.-... ...||||+|.+||||++.. +||+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999887666666677789999999999998754321 2589999999999999843 3443
Q ss_pred -CchHHHHHHHH--HhccCCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHH
Q 012637 214 -DENIMNMYRKV--FKAEFVYPPW-----ISTDAKRLISKLLVSDPERRITIQSI 260 (459)
Q Consensus 214 -~~~~~~~~~~i--~~~~~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~ei 260 (459)
.++..++...+ .+.++.+|.. -...+.+.+..||..||+-|.|+.=+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 13333333322 3445555542 23457899999999999999998644
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=250.39 Aligned_cols=212 Identities=43% Similarity=0.768 Sum_probs=186.4
Q ss_pred ecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCch
Q 012637 18 LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL 97 (459)
Q Consensus 18 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (459)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|+.+++.+.|++|+++++++......++++||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654322 346788999999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEeecCCCcccccccCCCccccccCC
Q 012637 98 FAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLSALPEQLRNDGLLHTQCGT 174 (459)
Q Consensus 98 ~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt 174 (459)
.+++... .++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999764 7999999999999999999999999999999999999999 89999999999975433211 13345578
Q ss_pred CcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012637 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254 (459)
Q Consensus 175 ~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 254 (459)
..|++||.+......+.++|+|++|+++++| ..+.+++.+||..||.+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999997752445889999999999999 678999999999999999
Q ss_pred CCHHHHhcCc
Q 012637 255 ITIQSIMRVP 264 (459)
Q Consensus 255 ~t~~eil~hp 264 (459)
|+++++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=272.51 Aligned_cols=247 Identities=25% Similarity=0.461 Sum_probs=191.9
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHH--hcCCCCcceeEEEEEe----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR--LVRHPNVVELREVMAT---- 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~--~l~hpnIv~l~~~~~~---- 81 (459)
+..+-.+.+.||+|.||.||+|. ..|+.||||++.... .....+|.+|.+ .|+|+||+.+++.--.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeecc--ccCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 34568899999999999999998 569999999996432 234556666665 5699999999976422
Q ss_pred CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeccCCCCCeEecCCCCeEEeec
Q 012637 82 KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR--------GVSHRDLKPENLLLDENEDLKISDF 153 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~--------gi~HrDlkp~NILl~~~~~lKl~DF 153 (459)
-..+|+|.+|-+.|+|+|++.+..++.+...+++..+++||+|||.. .|+|||||..|||+..+|..-|+|+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 35799999999999999999999999999999999999999999953 4999999999999999999999999
Q ss_pred CCCccccccc--CCCccccccCCCcccChhhHhhcC----CCC-CcchhhhHHHHHHHHhhC----------CCCCCC--
Q 012637 154 GLSALPEQLR--NDGLLHTQCGTPAYVAPEVLRKKG----YDG-SKADLWSCGVILYVLLAG----------FLPFQD-- 214 (459)
Q Consensus 154 Gla~~~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~----~~~-~~~DIwSlGvil~~ll~G----------~~Pf~~-- 214 (459)
|||-...... -+-.....+||.+|||||++...- +.. ..+||||+|.++||++-. .+||.+
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9996543321 122345789999999999996432 111 369999999999998752 578854
Q ss_pred ---chHHHHHHHHH--hccCCCCC-CCCHH----HHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 215 ---ENIMNMYRKVF--KAEFVYPP-WISTD----AKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 215 ---~~~~~~~~~i~--~~~~~~p~-~~s~~----~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
++.+++..-+. +..+..|. |-|.+ +..|++.||..||.-|.|+--|.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 44455544332 23344443 44443 457899999999999999877665
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=289.07 Aligned_cols=244 Identities=25% Similarity=0.398 Sum_probs=208.9
Q ss_pred EEeeeecccCcEEEEEEEEcCCCc----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGE----SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+..++||+|+||+||+|.....|+ +||||++......+ ....+..|+-+|.++.|||++++++++.... +-||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 446799999999999998876665 58999987554332 4567889999999999999999999997666 8899
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
++|+++|.|.++++. +.+.......|..||++||.|||.++++||||-..|+|+..-..+||.|||+|.+.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e- 854 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE- 854 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc-
Confidence 999999999999975 67888999999999999999999999999999999999999999999999999987653322
Q ss_pred ccccccC--CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHH
Q 012637 167 LLHTQCG--TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRL 242 (459)
Q Consensus 167 ~~~~~~G--t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 242 (459)
..+..| .+.|||-|.+....| +.++||||+||.+||++| |..|+.+....++-..+.++ +...|+..+.++-.+
T Consensus 855 -y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 855 -YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred -ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence 233333 456999999988777 489999999999999998 99999998888776655554 467788899999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 012637 243 ISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~ 262 (459)
+.+||..|+..||++.++..
T Consensus 933 mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHhccCcccCccHHHHHH
Confidence 99999999999999988755
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=261.98 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=202.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE-EEeCCE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV-MATKKK 84 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~-~~~~~~ 84 (459)
.+.+.|.|.++||+|.||.+.+|+++.+++.+++|.+.+.... ...+.+|..---.| .|.||+.-|++ |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4678899999999999999999999999999999999765433 34567777665455 59999998875 677888
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC--CCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE--NEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~--~~~lKl~DFGla~~~~~~ 162 (459)
+.+++|||+-|+|..-+...++-|.....++.||++|++|||+++++|||||.+||||-. ..++||||||+++..+
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 999999999999999998899999999999999999999999999999999999999953 3589999999987432
Q ss_pred cCCCccccccCCCcccChhhHhhcC---C-CCCcchhhhHHHHHHHHhhCCCCCCCchHH----HHHHHHHhc-cCCCCC
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKG---Y-DGSKADLWSCGVILYVLLAGFLPFQDENIM----NMYRKVFKA-EFVYPP 233 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~---~-~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~-~~~~p~ 233 (459)
...+..--+..|.|||++.... + ..+..|||.+||++|.+++|++||+....+ ..+.++... ....|.
T Consensus 175 ---~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 ---TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ---ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 2223333466899999876432 1 135689999999999999999999854322 122333332 234443
Q ss_pred ---CCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCccccc
Q 012637 234 ---WISTDAKRLISKLLVSDPERR---ITIQSIMRVPWFRK 268 (459)
Q Consensus 234 ---~~s~~~~~Li~~~L~~dP~~R---~t~~eil~hpw~~~ 268 (459)
.+|+.+..+.++-|.++|++| .++.......|...
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 379999999999999999999 66777777788754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.43 Aligned_cols=262 Identities=30% Similarity=0.481 Sum_probs=214.2
Q ss_pred cccCCE-EEeeeecccCcEEEEEEEEcCCCcEEEEEEeecc---ccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKY-EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
.+..+| .....+|.|++|.|+.+......+.++.|.+... ..........+..|..+-..+.|||++.....+.+.
T Consensus 314 ~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 314 GFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI 393 (601)
T ss_pred ccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence 345566 5678999999999999988877777777765421 112222334488899999999999998887777666
Q ss_pred CEEEEEEeccCCCchHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVARG-RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
...+-+||||++ +|+.++... .+...++..+|+||+.||.|||+.||.|||+||+|++++.+|.+||+|||.+..+..
T Consensus 394 ~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 394 DGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred ccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 666666999999 999999885 999999999999999999999999999999999999999999999999999998776
Q ss_pred ccCC--CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHH--HHHH-------hccCC
Q 012637 162 LRND--GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY--RKVF-------KAEFV 230 (459)
Q Consensus 162 ~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~--~~i~-------~~~~~ 230 (459)
.... -.....+|+.+|+|||++.+..|+...+||||+||+++.|.+|+.||......+.. .... .+...
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 5554 45667899999999999999999999999999999999999999999765443221 1111 11111
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 231 YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 231 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.-..++...+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 112368889999999999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=251.26 Aligned_cols=218 Identities=40% Similarity=0.673 Sum_probs=184.9
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999765433 2456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC-C-CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 92 VKGGELFAKVARG-R-LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 92 ~~gg~L~~~i~~~-~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
+++++|.+++... . +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 9999999999763 4 8999999999999999999999999999999999999999999999999988654322 11234
Q ss_pred cccCCCcccChhhH-hhcCCCCCcchhhhHHHHHHHHhhCCCCCCC-ch-HHHHHHHHHhccCCCCC
Q 012637 170 TQCGTPAYVAPEVL-RKKGYDGSKADLWSCGVILYVLLAGFLPFQD-EN-IMNMYRKVFKAEFVYPP 233 (459)
Q Consensus 170 ~~~Gt~~y~APE~l-~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~-~~~~~~~i~~~~~~~p~ 233 (459)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+ ...+.+.+..+.+...+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 56788899999998 444444 689999999999999999999987 44 44666666666544333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=301.37 Aligned_cols=200 Identities=16% Similarity=0.175 Sum_probs=147.4
Q ss_pred hcCC-CCcceeEEEE-------EeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 012637 66 LVRH-PNVVELREVM-------ATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDL 135 (459)
Q Consensus 66 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl 135 (459)
.++| +||+++++++ .....++.+|||+ +++|.+++.. +.+++.++..+++||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5777777776 3335678889987 5599999965 46999999999999999999999999999999
Q ss_pred CCCCeEecCC-------------------CCeEEeecCCCcccccccC--------------CCccccccCCCcccChhh
Q 012637 136 KPENLLLDEN-------------------EDLKISDFGLSALPEQLRN--------------DGLLHTQCGTPAYVAPEV 182 (459)
Q Consensus 136 kp~NILl~~~-------------------~~lKl~DFGla~~~~~~~~--------------~~~~~~~~Gt~~y~APE~ 182 (459)
||+||||+.. +.+|++|||+++....... .......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 4556666666643211000 000112468999999999
Q ss_pred HhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 012637 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLISKLLVSDPERRITIQSIM 261 (459)
Q Consensus 183 l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil 261 (459)
+.+..| +.++|||||||+||+|++|..|+..... ....+.....+ .+....+...+++.+||.+||.+|||+.|++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 988877 5899999999999999999998764321 11122111111 0111345678999999999999999999999
Q ss_pred cCcccccC
Q 012637 262 RVPWFRKG 269 (459)
Q Consensus 262 ~hpw~~~~ 269 (459)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-28 Score=237.30 Aligned_cols=255 Identities=35% Similarity=0.591 Sum_probs=213.0
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC-CcceeEEEEEeCCEEEEEEe
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP-NVVELREVMATKKKIFVAME 90 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 90 (459)
|.+.+.||.|+||.||++.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999987 88999999876555444567889999999999988 79999999988888999999
Q ss_pred ccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeecCCCcccccccCC
Q 012637 91 YVKGGELFAKVARG----RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRND 165 (459)
Q Consensus 91 ~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~~~~~~~ 165 (459)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999777664 699999999999999999999999999999999999999998 7999999999754432222
Q ss_pred C----ccccccCCCcccChhhHhhc--CCCCCcchhhhHHHHHHHHhhCCCCCCCchH----HHHHHHHHhccCC-CCCC
Q 012637 166 G----LLHTQCGTPAYVAPEVLRKK--GYDGSKADLWSCGVILYVLLAGFLPFQDENI----MNMYRKVFKAEFV-YPPW 234 (459)
Q Consensus 166 ~----~~~~~~Gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~-~p~~ 234 (459)
. .....+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34677899999999999874 3556899999999999999999999987763 4444444444333 2222
Q ss_pred CC--------HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 235 IS--------TDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 235 ~s--------~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 21 478999999999999999999999998777653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=227.91 Aligned_cols=157 Identities=22% Similarity=0.242 Sum_probs=128.0
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccccc
Q 012637 95 GELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172 (459)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~ 172 (459)
|+|.+++.. +.+++..++.++.|++.||.|||++| ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 688888874 46999999999999999999999999 999999999999999 999875432 1236
Q ss_pred CCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH-HHHHHHHHhccCCC-------CCCCCH--HHHHH
Q 012637 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVFKAEFVY-------PPWIST--DAKRL 242 (459)
Q Consensus 173 Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~L 242 (459)
||+.|||||++.+..|. .++||||+||++|+|++|..||..... ...+..+....... +..++. .+.+|
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887775 899999999999999999999976543 23333332221111 112333 69999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
|.+||..||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=265.11 Aligned_cols=238 Identities=33% Similarity=0.589 Sum_probs=207.7
Q ss_pred eecccCcEEEEEEEE---cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEecc
Q 012637 17 LLGKGTFAKVYYGKQ---LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVAMEYV 92 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 92 (459)
++|+|+||.|++++- ...|+.+|+|+..+......... .-..|..++..++ ||.+++++..++++++.|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998753 34678899999877655433222 4556888888886 999999999999999999999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccc
Q 012637 93 KGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ 171 (459)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~ 171 (459)
.||+|+..+.. ..+.+...+.|...++-+++++|+.||+|||+|++||+++.+|++|+.|||+++..-.. ...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh------hhc
Confidence 99999998876 67888899999999999999999999999999999999999999999999999854321 122
Q ss_pred cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCC
Q 012637 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDP 251 (459)
Q Consensus 172 ~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 251 (459)
|||..|||||++. +. ...+|.||+|+++|+|++|..||.. +....|.+.++..|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 44 3789999999999999999999988 667888899999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q 012637 252 ERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 252 ~~R~t-----~~eil~hpw~~~ 268 (459)
..|.- +.+|++|+||+.
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHhccCcchhHHHhccchhee
Confidence 99985 579999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=246.12 Aligned_cols=170 Identities=22% Similarity=0.249 Sum_probs=135.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcC-CCcEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCCcce-eEEEEEe
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLM-TGESVAIKVINKDQL--KKEFMMEQIKREISVMRLVRHPNVVE-LREVMAT 81 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~-l~~~~~~ 81 (459)
..+.++|.+.+.||+|+||+||+|++.. +++.||||.+..... ........+.+|+.+|+.++|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3577899999999999999999999876 778889998753311 12334567899999999999999985 4432
Q ss_pred CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC-CCCCeEecCCCCeEEeecCCCcccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDL-KPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl-kp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+..|+|||||+|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++++||+|||+|+.+.
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 468999999999999632 11 11 2568899999999999999999999 9999999999999999999998765
Q ss_pred cccCCCc------cccccCCCcccChhhHhh
Q 012637 161 QLRNDGL------LHTQCGTPAYVAPEVLRK 185 (459)
Q Consensus 161 ~~~~~~~------~~~~~Gt~~y~APE~l~~ 185 (459)
....... ..+.+|++.|+|||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4332222 246678999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=233.81 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=204.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCC-----cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEE-E
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTG-----ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM-A 80 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~ 80 (459)
+...|+++...+-+|.||.||.|..+... +.|-+|.+... ..+-....+..|-..+..+.|||++.+.++. +
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34467888889999999999999766432 34566665322 1233356678899999999999999999876 4
Q ss_pred eCCEEEEEEeccCCCchHHHHh-----c----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEe
Q 012637 81 TKKKIFVAMEYVKGGELFAKVA-----R----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKIS 151 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~-----~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~ 151 (459)
+....+.++.+..-|.|..++. . +.++..+...++.|+..|++|||+.||+|.||...|++||+.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 5567788888888889988776 1 237778889999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-C
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-F 229 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 229 (459)
|=.+++-.-+.+........-....||+||.+....|+ .++|+|||||+||||+| |+.|+-+-++.+++.-++.+. .
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 99998854433322222222234569999999998886 89999999999999999 999999999999888777663 4
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.-|-.+++++-.++.-||...|++||+++++..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 557789999999999999999999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=254.55 Aligned_cols=222 Identities=32% Similarity=0.604 Sum_probs=180.2
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
...-..|..+|++..|+||.||+++|+.+.+.+|+| ++++.+. .|- |+.....|.+|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn--ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN--ILTFAGNPFVV------------ 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc--cccccCCccee------------
Confidence 344568999999999999999999999999999994 4544321 111 44444555555
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc--
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL-- 162 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~-- 162 (459)
|+-...++. +.++.+. +.+++|+|+-||+|||+||+|+||+.-|++|++|||++..-...
T Consensus 136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 455555554 6777765 77999999999999999999999999999999999998532110
Q ss_pred ----------cCCCc-cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC
Q 012637 163 ----------RNDGL-LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY 231 (459)
Q Consensus 163 ----------~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 231 (459)
....+ ....||||.|+|||++...+| |.++|+|++|+|+|+++.|+.||.++++.+++.++......+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 00111 233599999999999999998 699999999999999999999999999999999999888887
Q ss_pred CCC---CCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 012637 232 PPW---ISTDAKRLISKLLVSDPERRI---TIQSIMRVPWFRK 268 (459)
Q Consensus 232 p~~---~s~~~~~Li~~~L~~dP~~R~---t~~eil~hpw~~~ 268 (459)
|.. .+++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 753 789999999999999999997 5678999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-25 Score=222.47 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=193.0
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCC-cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC----CCcceeEEEE-EeCCE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTG-ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH----PNVVELREVM-ATKKK 84 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 84 (459)
+|.+.+.||+|+||.||.|.+..++ +.+|+|+......... ..+..|+.++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998775 6799998765432221 157789999998863 6899999999 58889
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-----CCeEEeecCCC
Q 012637 85 IFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-----EDLKISDFGLS 156 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-----~~lKl~DFGla 156 (459)
-|+||+.+ |.+|.++... ++++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 6688887743 679999999999999999999999999999999999999865 35999999999
Q ss_pred cccccccCCC-------c-cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHH---HHHHHH
Q 012637 157 ALPEQLRNDG-------L-LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN---MYRKVF 225 (459)
Q Consensus 157 ~~~~~~~~~~-------~-~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~---~~~~i~ 225 (459)
+.+......+ . .....||..|+++.+..+... +...|+||++.++.+++.|.+||....... .+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8433211111 1 123349999999999988765 589999999999999999999997755322 222222
Q ss_pred hccCC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 226 KAEFV--YPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 226 ~~~~~--~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..... .....+..+..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22211 223345677777777777899999987777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-27 Score=254.25 Aligned_cols=259 Identities=32% Similarity=0.550 Sum_probs=221.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcC-CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLM-TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIF 86 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (459)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... ......+++..|..+.+.+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999999998754 44568888776543 23335677888999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHH-hcC--CCCHHHHHHHHHHHHHHHHHHH-hCCcEeccCCCCCeEecCCC-CeEEeecCCCccccc
Q 012637 87 VAMEYVKGGELFAKV-ARG--RLREDLARKYFQQLISAVDFCH-SRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQ 161 (459)
Q Consensus 87 lV~E~~~gg~L~~~i-~~~--~l~e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~~~ 161 (459)
++++|..|+++++.+ ... ..+...+..|+.|+..++.|+| ..|+.||||||+|.+++..+ ++|++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 653 6888899999999999999999 99999999999999999999 999999999998776
Q ss_pred -ccCCCccccccC-CCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH-HHHHHhc--cCCCC--CC
Q 012637 162 -LRNDGLLHTQCG-TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM-YRKVFKA--EFVYP--PW 234 (459)
Q Consensus 162 -~~~~~~~~~~~G-t~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~-~~~i~~~--~~~~p--~~ 234 (459)
.+........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||........ +..+... ..... ..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 566667788899 99999999999888999999999999999999999999987655432 2222222 21222 34
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
++..+.+++.++|..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7889999999999999999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=208.51 Aligned_cols=175 Identities=17% Similarity=0.209 Sum_probs=138.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHH------HHHHHHHHHhcCCCCcceeEEEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQ------IKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
++.++|++.+.||.|+||.||++.+ ++..+|+|++.......+..... +.+|+..+.++.||+|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 5789999999999999999999765 57789999997655444444444 579999999999999999999876
Q ss_pred eC--------CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEee
Q 012637 81 TK--------KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISD 152 (459)
Q Consensus 81 ~~--------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~D 152 (459)
.. +..+++|||++|.+|.+.. .+++. ...+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP---EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh---hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 44 3589999999999997763 23443 456999999999999999999999999999988 99999
Q ss_pred cCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHh
Q 012637 153 FGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLL 206 (459)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll 206 (459)
||.+....... .....+....|. .++|||||||.+..+.
T Consensus 178 fg~~~~~~e~~--------------a~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRK--------------AKDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchh--------------hHHHHHHHhHhc-ccccccceeEeehHHH
Confidence 99886432110 011144455676 8999999999877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=196.47 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=193.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH-PNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 84 (459)
-+..++|.+++.||.|+||.+|+|.+..+|+.||||+=.... .. .++..|..+.+.|++ ..|..+..+..+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CC----cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 356789999999999999999999999999999999864332 22 356679999999965 678888888888889
Q ss_pred EEEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC---CCeEEeecCCCccc
Q 012637 85 IFVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN---EDLKISDFGLSALP 159 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~---~~lKl~DFGla~~~ 159 (459)
-.+|||+. |.+|.++.. ..+++...+.-++-|++.-++|+|.++++||||||+|+|..-+ ..+.++|||||+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 668877764 3789999999999999999999999999999999999999755 46999999999865
Q ss_pred ccccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH---HHHHHHHHhccCCC
Q 012637 160 EQLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI---MNMYRKVFKAEFVY 231 (459)
Q Consensus 160 ~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~ 231 (459)
...... .......||-.|.+--...+... +..-|+=|+|.+|.++.-|.+||++-.. .+-+.+|.......
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 433221 12233468999998777665544 3789999999999999999999998544 34566666655555
Q ss_pred C-----CCCCHHHHHHHHHhcCCCCCCCCC
Q 012637 232 P-----PWISTDAKRLISKLLVSDPERRIT 256 (459)
Q Consensus 232 p-----~~~s~~~~~Li~~~L~~dP~~R~t 256 (459)
| ..+|.++.-.|.-|-..--++-|.
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 5 347888888887776665555555
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=202.03 Aligned_cols=141 Identities=21% Similarity=0.263 Sum_probs=113.1
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHH-----------------------HHHHHHHHHHHHHhcCCCC
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF-----------------------MMEQIKREISVMRLVRHPN 71 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~i~~Ei~il~~l~hpn 71 (459)
...||+|+||.||+|.+. +|+.||||+++.+...... ......+|+.+++++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321110 0123456999999998888
Q ss_pred cceeEEEEEeCCEEEEEEeccCCCchHHH-HhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeccCCCCCeEecCCCCeE
Q 012637 72 VVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFC-HSRGVSHRDLKPENLLLDENEDLK 149 (459)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~~~~qll~~L~~L-H~~gi~HrDlkp~NILl~~~~~lK 149 (459)
+.....+.... .+|||||++|+++... +..+.+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75544433222 3899999999877654 4457899999999999999999999 799999999999999998 57899
Q ss_pred EeecCCCccc
Q 012637 150 ISDFGLSALP 159 (459)
Q Consensus 150 l~DFGla~~~ 159 (459)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=200.77 Aligned_cols=211 Identities=22% Similarity=0.368 Sum_probs=175.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 87 (459)
.-.|+++++||+|+||..+.|.+..++++||||.=.... ...+++.|.+..+.| ..++|...|.+....-+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 347999999999999999999999999999999754322 235788899999999 57999999999988888999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-----CeEEeecCCCcccc
Q 012637 88 AMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-----DLKISDFGLSALPE 160 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-----~lKl~DFGla~~~~ 160 (459)
|||+. |-+|.|+..- .+++...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .+-++|||+|+...
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99998 6688777753 6899999999999999999999999999999999999997543 48999999998654
Q ss_pred cccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc---hHHHHHHHHHh
Q 012637 161 QLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE---NIMNMYRKVFK 226 (459)
Q Consensus 161 ~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~ 226 (459)
..... .......||-+||+--...+...+ ..-|+=|||-+++++|-|.+||++- +..+-|++|-.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 32221 122344699999998888877664 7899999999999999999999874 44555666643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=195.22 Aligned_cols=142 Identities=19% Similarity=0.284 Sum_probs=116.0
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc-----------------------HHHHHHHHHHHHHHHhcCCCC
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK-----------------------EFMMEQIKREISVMRLVRHPN 71 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~i~~Ei~il~~l~hpn 71 (459)
.+.||+|+||.||+|.+. +|+.||||+++...... ........+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999998652110 001233568999999999999
Q ss_pred cceeEEEEEeCCEEEEEEeccCCCchHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeE
Q 012637 72 VVELREVMATKKKIFVAMEYVKGGELFA-KVARGRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLK 149 (459)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lK 149 (459)
|.....+.... .|+||||++|+++.. .+..+++++..+..++.|++.+|.++|+ +||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 86655544333 489999999985543 3556788999999999999999999999 9999999999999999 89999
Q ss_pred EeecCCCcccc
Q 012637 150 ISDFGLSALPE 160 (459)
Q Consensus 150 l~DFGla~~~~ 160 (459)
|+|||+|....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=202.93 Aligned_cols=234 Identities=27% Similarity=0.319 Sum_probs=152.7
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC----------CCcceeEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH----------PNVVELREVMA 80 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h----------pnIv~l~~~~~ 80 (459)
.+..++.||.|+++.||.+.+..||+.+|+|++...........+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35678899999999999999999999999999875553333456778777766665432 12333333321
Q ss_pred ---------eC---C-----EEEEEEeccCCCchHHHHhc----CCC---CHHHH-HHHHHHHHHHHHHHHhCCcEeccC
Q 012637 81 ---------TK---K-----KIFVAMEYVKGGELFAKVAR----GRL---REDLA-RKYFQQLISAVDFCHSRGVSHRDL 135 (459)
Q Consensus 81 ---------~~---~-----~~~lV~E~~~gg~L~~~i~~----~~l---~e~~~-~~~~~qll~~L~~LH~~gi~HrDl 135 (459)
.. + ..+++|+-+. ++|.+.+.- ... ....+ ..+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2366777774 477666542 222 12233 344589999999999999999999
Q ss_pred CCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcC-------CCCCcchhhhHHHHHHHHhhC
Q 012637 136 KPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG-------YDGSKADLWSCGVILYVLLAG 208 (459)
Q Consensus 136 kp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-------~~~~~~DIwSlGvil~~ll~G 208 (459)
+|+|++++.+|.++|+||+.....+. .......+..|.+||...... ..+.+.|.|+||+++|.|.+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987754322 111133457899999876531 124789999999999999999
Q ss_pred CCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012637 209 FLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254 (459)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 254 (459)
..||........... .+..-..++..++.||.++|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999987654322110 222222688999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=233.04 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=184.4
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccc--cccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQ--LKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.|...+.||++.|=+|.+|++. .|. |+||++-+.. +.-. ...+..+|++ ...++|||++.+.-+.++....|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~-~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLR-PFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCch-HHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 6889999999999999999863 344 9999986543 2222 2334445666 6777999999999999999999999
Q ss_pred EeccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC-
Q 012637 89 MEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG- 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~-l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~- 166 (459)
-+|... .|+|++..++ +.+-+.+.|+.||+.||.-||..||+|+|||.||||++.-..+.|+||..-+..- ...++
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY-LPeDNP 177 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY-LPEDNP 177 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc-CCCCCc
Confidence 999976 8999998765 6778899999999999999999999999999999999999999999998664211 01111
Q ss_pred -----ccccccCCCcccChhhHhhcC----------CCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccCC
Q 012637 167 -----LLHTQCGTPAYVAPEVLRKKG----------YDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFV 230 (459)
Q Consensus 167 -----~~~~~~Gt~~y~APE~l~~~~----------~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~ 230 (459)
...|..--.+|.|||.+.... .-+++.||||+||+++||++ |.+||.-..... ...+...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a----Yr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA----YRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh----HhccCcc
Confidence 223333344699999986522 12467899999999999988 899995322211 1111111
Q ss_pred CC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 231 YP-----PWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 231 ~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.| .--+..+++||..|++.||.+|.++++.|+-
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11 1135679999999999999999999999985
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-23 Score=188.17 Aligned_cols=191 Identities=18% Similarity=0.232 Sum_probs=143.8
Q ss_pred EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHH-HHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEe
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF-MMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.+...|++|+||+|+++.. .+.+++.+.+......... ....+.+|+++|++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4578999999999998874 6788887777544332211 1235789999999995 5889999886 34799999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC-CCCCeEecCCCCeEEeecCCCcccccccCC----
Q 012637 91 YVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDL-KPENLLLDENEDLKISDFGLSALPEQLRND---- 165 (459)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl-kp~NILl~~~~~lKl~DFGla~~~~~~~~~---- 165 (459)
|+.|.+|......+ ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........-
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999987544221 2357899999999999999999999 799999999999999999999854421110
Q ss_pred C-------ccccccCCCcccChhhHhhc-CCCCCcchhhhHHHHHHHHhhCCCCCCCc
Q 012637 166 G-------LLHTQCGTPAYVAPEVLRKK-GYDGSKADLWSCGVILYVLLAGFLPFQDE 215 (459)
Q Consensus 166 ~-------~~~~~~Gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 215 (459)
. ...-...++.|++|+.-.-. ..+-...++++.|+-+|.++|+..|+-+.
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 01122368899999976533 22225678889999999999999887543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=187.87 Aligned_cols=135 Identities=18% Similarity=0.217 Sum_probs=110.1
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-----CCCCcceeEEEEEeCC---EEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-----RHPNVVELREVMATKK---KIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 86 (459)
.+.||+|+||.||. ++.++.. +||++...... ..+.+.+|+.+++.+ .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 57899999999995 7777666 69998764322 345789999999999 5799999999999874 444
Q ss_pred -EEEec--cCCCchHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcEeccCCCCCeEecCC----CCeEEeecCCCc
Q 012637 87 -VAMEY--VKGGELFAKVARGRLREDLARKYFQQLISAV-DFCHSRGVSHRDLKPENLLLDEN----EDLKISDFGLSA 157 (459)
Q Consensus 87 -lV~E~--~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L-~~LH~~gi~HrDlkp~NILl~~~----~~lKl~DFGla~ 157 (459)
+|+|| +.+|+|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++.. ++++|+||+-+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 558999999988777777 35678888777 99999999999999999999743 479999955443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=193.89 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=178.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCc-----------------------------------EEEEEEeecccc--c
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGE-----------------------------------SVAIKVINKDQL--K 49 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~-----------------------------------~vAiK~i~~~~~--~ 49 (459)
..++.|+|++.||+|.-+.||.|+....|. +.|||.+-.-.. .
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 446779999999999999999987543210 245665422111 1
Q ss_pred cHHHHHHHHHHHH------HH--------Hh--------cCCCCcceeEEEEEe--------------------------
Q 012637 50 KEFMMEQIKREIS------VM--------RL--------VRHPNVVELREVMAT-------------------------- 81 (459)
Q Consensus 50 ~~~~~~~i~~Ei~------il--------~~--------l~hpnIv~l~~~~~~-------------------------- 81 (459)
.....+.+.+|.. .+ +. -+|||||++...|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 1222333333321 11 11 259999999876532
Q ss_pred -CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec--CCC--CeEEeecCCC
Q 012637 82 -KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD--ENE--DLKISDFGLS 156 (459)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~--~~~--~lKl~DFGla 156 (459)
+..+|+||...+. +|..++-.+..+-...+-++.|+++|+.|||++||.|||+|.+|||+. +++ .+.|+|||.+
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 3458999987765 888888888888899999999999999999999999999999999994 333 5899999987
Q ss_pred cccccccC----CCccccccCCCcccChhhHhhcC-----CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHH-HHH-
Q 012637 157 ALPEQLRN----DGLLHTQCGTPAYVAPEVLRKKG-----YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYR-KVF- 225 (459)
Q Consensus 157 ~~~~~~~~----~~~~~~~~Gt~~y~APE~l~~~~-----~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~-~i~- 225 (459)
-..+..+- ..-....-|.-.-||||+....+ .+-.++|.|++|-+.||++....||.....+.+-. ...
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe 472 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE 472 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence 53322110 00111234566789999986432 11258999999999999999999998744332211 111
Q ss_pred hccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCc
Q 012637 226 KAEFVYPPWISTDAKRLISKLLVSDPERRITIQ---SIMRVP 264 (459)
Q Consensus 226 ~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~---eil~hp 264 (459)
..-+..|..+++.+++|+..+|++||.+|++.. .+++..
T Consensus 473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHH
Confidence 122456677999999999999999999999843 455543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=208.54 Aligned_cols=239 Identities=19% Similarity=0.279 Sum_probs=184.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
-..+|.|.+.||+|+||+||.|.+.. |+.||+|+=.......-+...+++.-++ .+ --+.|..++..+.-.+..++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCccee
Confidence 35689999999999999999999876 9999999977666655545544444333 11 13456666666666778899
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-------CCCeEEeecCCCccc
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-------NEDLKISDFGLSALP 159 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-------~~~lKl~DFGla~~~ 159 (459)
|+||.+.|+|.+++.. +.+++..+.++..|++.-|++||..||||+||||+|+||.. +--|+|+|||.|--+
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 9999999999999986 67999999999999999999999999999999999999953 245999999999766
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-----CCCCC
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-----VYPPW 234 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~~p~~ 234 (459)
............++|-.+-.+|+..+.++. ..+|.|.+.-+++.||.|++-= ...+.. .++..
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~~~Ry 919 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTNFPRY 919 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceeccccchhh
Confidence 555455577788999999999999999986 8999999999999999995421 122211 12222
Q ss_pred CC-HHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 235 IS-TDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 235 ~s-~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+. .-..+|+..+|++|-..=|.+.+|..
T Consensus 920 ~~~~~W~~~F~~lLN~~~~~~p~l~~lr~ 948 (974)
T KOG1166|consen 920 WKRDMWNKFFDLLLNPDCDTLPNLQELRT 948 (974)
T ss_pred hhHHHHHHHHHHHhCcCcccchhHHHHHH
Confidence 22 23467889999965555555555543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=184.24 Aligned_cols=142 Identities=18% Similarity=0.239 Sum_probs=114.7
Q ss_pred EEEeeeecccCcEEEEEEE-EcCCCcEEEEEEeecccccc---------------------HHHHHHHHHHHHHHHhcCC
Q 012637 12 YEMGRLLGKGTFAKVYYGK-QLMTGESVAIKVINKDQLKK---------------------EFMMEQIKREISVMRLVRH 69 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~-~~~~~~~vAiK~i~~~~~~~---------------------~~~~~~i~~Ei~il~~l~h 69 (459)
|++.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8899999999999999999 77899999999997543210 0012346789999999975
Q ss_pred CC--cceeEEEEEeCCEEEEEEeccCCCchHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeccCCCCCeEecCC
Q 012637 70 PN--VVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRG-VSHRDLKPENLLLDEN 145 (459)
Q Consensus 70 pn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~l~e~~~~~~~~qll~~L~~LH~~g-i~HrDlkp~NILl~~~ 145 (459)
.+ +.++++. ...|+||||++|++|.... ....+.+..+..++.|++.+|.+||++| |+||||||+||+++ +
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 33 3444432 2358999999998886654 3456677778899999999999999999 99999999999999 8
Q ss_pred CCeEEeecCCCcc
Q 012637 146 EDLKISDFGLSAL 158 (459)
Q Consensus 146 ~~lKl~DFGla~~ 158 (459)
+.++|+|||+|..
T Consensus 185 ~~i~LiDFg~a~~ 197 (237)
T smart00090 185 GKVVIIDVSQSVE 197 (237)
T ss_pred CCEEEEEChhhhc
Confidence 8999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.8e-20 Score=170.22 Aligned_cols=137 Identities=23% Similarity=0.381 Sum_probs=116.7
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH-----HHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE-----FMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+.||+|++|.||+|.+ +|..|++|+......... .....+.+|+.++..+.|++|.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999986 778899998754333221 123467889999999999999888888778888999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 91 YVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998865322 7889999999999999999999999999999999 88999999999874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-21 Score=177.49 Aligned_cols=241 Identities=21% Similarity=0.385 Sum_probs=190.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
++...+..+|...-.|..|+|+. .|..+++|++........ ....+..|.-.|+-..||||+.+++.+.++.++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 34455667888899999999985 456677788765443322 345577888889999999999999999999999999
Q ss_pred EeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecCCCCeEE--eecCCCccccc
Q 012637 89 MEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDENEDLKI--SDFGLSALPEQ 161 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~~~~lKl--~DFGla~~~~~ 161 (459)
..|++-|+|+..+..+ -+...++.+++..++.|++|||+.. |----|....+++|++-+.+| +|--++-
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---- 341 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---- 341 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee----
Confidence 9999999999999874 2677889999999999999999974 444467888999999866555 3432221
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCC--CCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHH--hccCCCCCCCCH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYD--GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF--KAEFVYPPWIST 237 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~--~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 237 (459)
.. ....-.|.||+||.+..++.+ -.++|+||+.|+|++|.|...||.+-++++.=-++. .-...+|+.++.
T Consensus 342 qe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 342 QE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred ec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 00 122347899999999877654 357999999999999999999999988876544443 235678999999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHh
Q 012637 238 DAKRLISKLLVSDPERRITIQSIM 261 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil 261 (459)
....|++-|++.||.+||.+..|.
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999987653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=166.82 Aligned_cols=133 Identities=23% Similarity=0.376 Sum_probs=109.6
Q ss_pred eecccCcEEEEEEEEcCCCcEEEEEEeecccccc-----HHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK-----EFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
.||+|+||.||+|. .+|..|++|......... .....++.+|+.+++.+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 567899999865432221 11246678999999999988766655555667778999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 92 VKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999888754321 7899999999999999999999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-21 Score=191.20 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=170.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCC---CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEE-------
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE------- 77 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~------- 77 (459)
....+.+.+..+.++++.+....-..+ .+.+.-+..+.+ +........+++-.+.-..|-+..-+.+
T Consensus 242 ~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~ 318 (516)
T KOG1033|consen 242 ESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFE 318 (516)
T ss_pred ccccccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhh
Confidence 344556666777777776665543332 233443433222 2123344556677766665444333333
Q ss_pred EE-----EeCCEEEEEEeccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCe
Q 012637 78 VM-----ATKKKIFVAMEYVKGGELFAKVARG----RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDL 148 (459)
Q Consensus 78 ~~-----~~~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~l 148 (459)
.+ ....++||.|++|.-.+|.+++.+. ..+......++.|+..|++| +|.+|||+||.||++..++.+
T Consensus 319 ~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~ 395 (516)
T KOG1033|consen 319 SSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQL 395 (516)
T ss_pred hccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhh
Confidence 11 1134689999999999999999753 35566789999999999999 999999999999999999999
Q ss_pred EEeecCCCccccccc----CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHH
Q 012637 149 KISDFGLSALPEQLR----NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRK 223 (459)
Q Consensus 149 Kl~DFGla~~~~~~~----~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~ 223 (459)
||+|||+.+...... .........||+.||+||.+.+..|. .++||||||+||++++. =..+|.... .+..
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d 471 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFERIA---TLTD 471 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHHHH---hhhh
Confidence 999999987544322 12234566899999999999998885 99999999999999997 233332211 1122
Q ss_pred HHhccCCCCCCC-CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 224 VFKAEFVYPPWI-STDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 224 i~~~~~~~p~~~-s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+..+.++.-.+. -+.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 472 ~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 472 IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 222322211122 3456689999999999999988777777775
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=167.76 Aligned_cols=139 Identities=20% Similarity=0.323 Sum_probs=110.6
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH-------------------HHHHHHHHHHHHHHhcCCCC-
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE-------------------FMMEQIKREISVMRLVRHPN- 71 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-------------------~~~~~i~~Ei~il~~l~hpn- 71 (459)
|.+.+.||+|+||.||+|.+. +|+.||||++........ .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 889999999999999999874 899999999865431000 01123678999999998774
Q ss_pred -cceeEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEE
Q 012637 72 -VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI 150 (459)
Q Consensus 72 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl 150 (459)
+...++ ....++||||++|++|...... ..+..++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2456899999999988665421 346778899999999999999999999999999999999999
Q ss_pred eecCCCcccc
Q 012637 151 SDFGLSALPE 160 (459)
Q Consensus 151 ~DFGla~~~~ 160 (459)
+|||++....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=185.99 Aligned_cols=139 Identities=22% Similarity=0.302 Sum_probs=113.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-----KEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
..|...+.||+|+||+||+|.... ..+++|+....... .....+.+.+|+.+++.++|++|+....+..+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345678999999999999998643 34455543222111 11224568899999999999999988887777778
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 85 IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
.++||||++|++|.+.+. ....++.|++.+|.+||++|++||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999988875 457799999999999999999999999999999 678999999999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=159.41 Aligned_cols=138 Identities=21% Similarity=0.308 Sum_probs=101.7
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHH---------------------HHHHHHHHHHhcCCC--C
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME---------------------QIKREISVMRLVRHP--N 71 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~---------------------~i~~Ei~il~~l~hp--n 71 (459)
++.||+|+||+||+|.+. +|+.||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 8999999998754322111111 124567777776443 3
Q ss_pred cceeEEEEEeCCEEEEEEeccCCCchHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeE
Q 012637 72 VVELREVMATKKKIFVAMEYVKGGELFA-KVARGRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLK 149 (459)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lK 149 (459)
+.++++. ...++||||++|+.+.. .+...... ..++.++.+++.++.++|+ .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4555543 23689999999954321 12111111 6788999999999999999 9999999999999999 99999
Q ss_pred EeecCCCccc
Q 012637 150 ISDFGLSALP 159 (459)
Q Consensus 150 l~DFGla~~~ 159 (459)
|+|||.+...
T Consensus 155 liDfg~a~~~ 164 (187)
T cd05119 155 IIDVPQAVEI 164 (187)
T ss_pred EEECcccccc
Confidence 9999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=177.30 Aligned_cols=199 Identities=24% Similarity=0.357 Sum_probs=156.1
Q ss_pred HHhcCCCCcceeEEEEEeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc-EeccCCCCCe
Q 012637 64 MRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGV-SHRDLKPENL 140 (459)
Q Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi-~HrDlkp~NI 140 (459)
|+.+.|.|+.++++.+.+....++|.+||+-|+|.+.+.. -.++.-....+.+.|+.||.|||.-.| +|+.++..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999976 456777788889999999999998866 9999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCC------CCCcchhhhHHHHHHHHhhCCCCCCC
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY------DGSKADLWSCGVILYVLLAGFLPFQD 214 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~------~~~~~DIwSlGvil~~ll~G~~Pf~~ 214 (459)
++|..-.+||+|||+..+..........+...-..-|.|||.+..... -+.+.||||+|++++++++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999886542111111111222345999999986422 24579999999999999999999976
Q ss_pred c----hHHHHHHHHHh-ccCCC-CC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 215 E----NIMNMYRKVFK-AEFVY-PP-----WISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 215 ~----~~~~~~~~i~~-~~~~~-p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
. .+.++...+.+ +...+ |. ...+++..++.+||..+|..||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 3 22345555555 22212 21 23457899999999999999999998865
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=160.06 Aligned_cols=137 Identities=19% Similarity=0.311 Sum_probs=106.3
Q ss_pred eeec-ccCcEEEEEEEEcCCCcEEEEEEeecccc-----c-----cHHHHHHHHHHHHHHHhcCCCCc--ceeEEEEEeC
Q 012637 16 RLLG-KGTFAKVYYGKQLMTGESVAIKVINKDQL-----K-----KEFMMEQIKREISVMRLVRHPNV--VELREVMATK 82 (459)
Q Consensus 16 ~~LG-~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~-----~~~~~~~i~~Ei~il~~l~hpnI--v~l~~~~~~~ 82 (459)
..|| .|+.|+||.+.. .+..+++|.+..... . .......+.+|+.++..+.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 677777887764 378899998864321 0 11223567899999999998775 6777664332
Q ss_pred -C---EEEEEEeccCC-CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 83 -K---KIFVAMEYVKG-GELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 83 -~---~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
. ..++|||+++| .+|.+.+..+.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2 23599999998 6888888777777654 5789999999999999999999999999999999999999887
Q ss_pred c
Q 012637 158 L 158 (459)
Q Consensus 158 ~ 158 (459)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.2e-19 Score=188.77 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=212.6
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
-.+.+.+.+-+-+|+++.+..+.-..+|...++|+..+.........+.+..+-.++-...+|-++....-+--....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45678888899999999999999888888888887655433222223444455555555566777766555556778999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc----
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL---- 162 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~---- 162 (459)
+++|..|++|...+.. +..+++.++.+...+..+++|||+..+.|||++|.|+|...+|..+++|||........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999999987 77999999999999999999999999999999999999999999999999843221100
Q ss_pred -------------------------cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH
Q 012637 163 -------------------------RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI 217 (459)
Q Consensus 163 -------------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~ 217 (459)
..........||+.|.+||.+.+... +..+|+|+.|+++++.++|.+||.....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 00011233468999999999988764 6899999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCC---CCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCcccccC
Q 012637 218 MNMYRKVFKAEFVYPP---WISTDAKRLISKLLVSDPERRITIQ---SIMRVPWFRKG 269 (459)
Q Consensus 218 ~~~~~~i~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~R~t~~---eil~hpw~~~~ 269 (459)
...++.+......+|. ..+.++++++.++|..+|.+|..+. +...||||+..
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 9999999998887764 4799999999999999999999877 99999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=143.28 Aligned_cols=132 Identities=22% Similarity=0.297 Sum_probs=112.9
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CCcceeEEEEEeCCEEEEEEec
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH--PNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 91 (459)
+.+.||+|.++.||++... +..+++|.+..... ...+.+|+.+++.+.| +++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999964 37899999865432 3467889999999976 5899999988888899999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 92 VKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR---GVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~---gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
++|+.+... +......++.+++.+|.++|.. +++|+|++|+||+++.++.+++.|||++..
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877543 5566778899999999999985 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-16 Score=162.33 Aligned_cols=257 Identities=19% Similarity=0.238 Sum_probs=193.9
Q ss_pred cccCCEEEeeeecc--cCcEEEEEEEE--cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGK--GTFAKVYYGKQ--LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~--G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (459)
++...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-... .........=.+|+.-.+.+ .|+|.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccccc
Confidence 34456778889999 99999999988 889999999973221 11111122234677777777 59999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHH----HHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecC
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLIS----AVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFG 154 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~----~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFG 154 (459)
.+..|+-+|+|. .+|..+... .-+++..++.++.+... ||.++|+.+++|-|+||.||+...+ ...+++|||
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 999999999996 577777765 44899999999999999 9999999999999999999999999 899999999
Q ss_pred CCcccccccCCCc---cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc--hHHHHHHHHHhccC
Q 012637 155 LSALPEQLRNDGL---LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE--NIMNMYRKVFKAEF 229 (459)
Q Consensus 155 la~~~~~~~~~~~---~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~ 229 (459)
+...+....-... .....|...|++||.+.+. .+...||+|+|.+..+-.+|..++... +.-..++.+. ...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~ 345 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPL 345 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cch
Confidence 9876543221111 1122577789999998754 358899999999999888876655433 1111111111 001
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+-...+.++...+..|++.+|..|++.+.+++|+++..
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 111234667777999999999999999999999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.5e-16 Score=162.74 Aligned_cols=145 Identities=22% Similarity=0.371 Sum_probs=102.6
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc--------------------------c-----HHHHHH
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK--------------------------K-----EFMMEQ 56 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--------------------------~-----~~~~~~ 56 (459)
++..|+. +.||+|++|+||+|+.+.+|+.||||++.+.-.. + ....+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 4556776 8999999999999999888999999999754100 0 012233
Q ss_pred HHHHHHHHHhc----------CCCCcceeEEEEEe-CCEEEEEEeccCCCchHHH--Hhc-C----CCCHHHHHHHHHHH
Q 012637 57 IKREISVMRLV----------RHPNVVELREVMAT-KKKIFVAMEYVKGGELFAK--VAR-G----RLREDLARKYFQQL 118 (459)
Q Consensus 57 i~~Ei~il~~l----------~hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--i~~-~----~l~e~~~~~~~~ql 118 (459)
+.+|+..++.. .+.+.+.+-.++.+ .+..++||||++|+.+.+. +.. + .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 44444444333 13333333333322 4557799999999999764 333 3 36677777788887
Q ss_pred HHHHHHHHhCCcEeccCCCCCeEecCCC----CeEEeecCCCcccc
Q 012637 119 ISAVDFCHSRGVSHRDLKPENLLLDENE----DLKISDFGLSALPE 160 (459)
Q Consensus 119 l~~L~~LH~~gi~HrDlkp~NILl~~~~----~lKl~DFGla~~~~ 160 (459)
+ ..|++|+|+||.||+++.+| .+++.|||++....
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 6 48999999999999999988 99999999987543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-15 Score=153.89 Aligned_cols=141 Identities=21% Similarity=0.284 Sum_probs=96.5
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeecccccc---------------------------H----HHHH------HHH
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK---------------------------E----FMME------QIK 58 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---------------------------~----~~~~------~i~ 58 (459)
+.||.|++|+||+|+. .+|+.||||+....-... . .... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999986 479999999985431100 0 0001 133
Q ss_pred HHHHHHHhcC-----CCCcceeEEEEEeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 012637 59 REISVMRLVR-----HPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLIS-AVDFCHSRGV 130 (459)
Q Consensus 59 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~-~L~~LH~~gi 130 (459)
+|...+.++. +++|.-..-+....+..++||||++|++|.+.... .... ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4555554442 34332222222334557999999999999877643 2222 2345555555 4788999999
Q ss_pred EeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 131 SHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 131 ~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+|+|+||.||+++.+|.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999997554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=149.92 Aligned_cols=252 Identities=17% Similarity=0.186 Sum_probs=191.4
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEc-CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeC
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQL-MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATK 82 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (459)
..-..++|.++..||.|.|+.|+..... .++..|++|...+........+. -..|+.+...+ .|.+++.++..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccc
Confidence 3456788999999999999999988755 67889999988665444332222 24577777776 599999999888888
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFGla~~~~ 160 (459)
...|+-.|||.++++...+.- ..+.++..+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||..+.+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 889999999999987666533 578899999999999999999999999999999999999886 889999999987422
Q ss_pred cccCCCccccccCCCccc-ChhhHhhcCCCCCcchhhhHHHHHHHHhhCC-CCCCCchHHHHHHHHHhccCCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYV-APEVLRKKGYDGSKADLWSCGVILYVLLAGF-LPFQDENIMNMYRKVFKAEFVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~-APE~l~~~~~~~~~~DIwSlGvil~~ll~G~-~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (459)
. .. ....++-+++ .+|++........++|++|||.-+.+.++|. +++.+... ..+..+.....+.....
T Consensus 419 ~--~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 F--SS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----LTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred e--ec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----eeeecccccCCCchHHh
Confidence 1 01 1112333445 3555544444468999999999999998875 33333222 23344555555556688
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+..+...++.+++..|+.+.++..|+=|
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchh
Confidence 9999999999999999999999888655
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.51 E-value=2e-14 Score=105.64 Aligned_cols=59 Identities=54% Similarity=0.829 Sum_probs=47.3
Q ss_pred CCcCCChhhHhhhcCCCCCCCccccccC----cccceeecCCCHHHHHHHHHHHHhhcCcEEEE
Q 012637 309 SPKFFNAFEFISSMSSGFDLSNLFENKK----KTGSMFTSRYSARHIMEKIEGVAKGMNFKVAK 368 (459)
Q Consensus 309 ~~~~~~~~~~~~~~s~~~~~s~~~~~~~----~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~ 368 (459)
.|..+|||++|| +|+|+|||+||+... ++.+||+|+.+|+.|+++||++|+.+|++|++
T Consensus 1 ~p~~lNAFdiIS-~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 1 KPKSLNAFDIIS-LSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --EE--HHHHHC-TSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CCccccHHHHHH-hccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 367899999997 999999999997643 46899999999999999999999999999985
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.9e-13 Score=139.84 Aligned_cols=218 Identities=17% Similarity=0.272 Sum_probs=153.9
Q ss_pred EEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCchHHHHhcCCCC
Q 012637 28 YGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLR 107 (459)
Q Consensus 28 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~ 107 (459)
.|..+.++.+|.|.+.+.+.. ...+.+.+-+.-|+.++||||+++++.++..+.+|+|+|-+.. |..++++ +.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--hH
Confidence 466778999999999876543 3456678888999999999999999999999999999999864 4455544 33
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhc
Q 012637 108 EDLARKYFQQLISAVDFCH-SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186 (459)
Q Consensus 108 e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 186 (459)
......-++||+.||.||| ..+++|++|.-..|+++..|..||++|-++........ ......---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 7778888999999999997 56899999999999999999999999998764332211 00111111236777765433
Q ss_pred CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-----HHh
Q 012637 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQ-----SIM 261 (459)
Q Consensus 187 ~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~-----eil 261 (459)
. ...|.|-|||++++++.|.++- . .+...+..++.....+-.+-+--.+..||... -.+
T Consensus 181 ~---~s~D~~~Lg~li~el~ng~~~~--~-----------~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~ 244 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNGSLLT--K-----------TDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRL 244 (690)
T ss_pred c---cchhhhhHHHHHHHHhCcccCc--c-----------hhhhccCccchhHHHHHHHHhccccccccchhhHHHHHHh
Confidence 2 4579999999999999994332 1 11222333444444555444544555555422 233
Q ss_pred cCcccccCC
Q 012637 262 RVPWFRKGF 270 (459)
Q Consensus 262 ~hpw~~~~~ 270 (459)
-|+||++.+
T Consensus 245 ~~gff~n~f 253 (690)
T KOG1243|consen 245 LGGFFRNDF 253 (690)
T ss_pred ccccccchH
Confidence 488888765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-13 Score=123.14 Aligned_cols=127 Identities=18% Similarity=0.258 Sum_probs=97.0
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcc-eeEEEEEeCCEEEEEEeccC
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVV-ELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~ 93 (459)
.+.|+.|.++.||++... ++.|++|+...... ......+|+.+++.+.+.+++ +++.+. ....++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 467899999999999853 78899999754421 112356899999998655544 455443 334589999999
Q ss_pred CCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 94 GGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGV-----SHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 94 gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi-----~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9877543 11123467899999999999985 9999999999999 6789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.9e-13 Score=122.55 Aligned_cols=140 Identities=18% Similarity=0.214 Sum_probs=104.8
Q ss_pred eeeecccCcEEEEEEEEcC------CCcEEEEEEeecccc---------------c----cHHHHHH----HHHHHHHHH
Q 012637 15 GRLLGKGTFAKVYYGKQLM------TGESVAIKVINKDQL---------------K----KEFMMEQ----IKREISVMR 65 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~---------------~----~~~~~~~----i~~Ei~il~ 65 (459)
...||.|--+.||.|.... .+..+|||+...... . +...... ..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 357899999743210 0 0011222 349999999
Q ss_pred hcCC--CCcceeEEEEEeCCEEEEEEeccCCCchH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeccCCCCCeE
Q 012637 66 LVRH--PNVVELREVMATKKKIFVAMEYVKGGELF-AKVARGRLREDLARKYFQQLISAVDFC-HSRGVSHRDLKPENLL 141 (459)
Q Consensus 66 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~-~~i~~~~l~e~~~~~~~~qll~~L~~L-H~~gi~HrDlkp~NIL 141 (459)
++.. -++.+++++ ..-++||||+.++.+. ..+....+++..+..++.|++.+|..| |+.||+|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9953 567777765 4578999999876443 234444567777888899999999999 8999999999999999
Q ss_pred ecCCCCeEEeecCCCccc
Q 012637 142 LDENEDLKISDFGLSALP 159 (459)
Q Consensus 142 l~~~~~lKl~DFGla~~~ 159 (459)
++ ++.+.|+|||.|-..
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 97 578999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.7e-13 Score=131.20 Aligned_cols=198 Identities=17% Similarity=0.266 Sum_probs=138.9
Q ss_pred hcCCCCcceeEEEEEeC-----CEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEec
Q 012637 66 LVRHPNVVELREVMATK-----KKIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRG--VSHR 133 (459)
Q Consensus 66 ~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~g--i~Hr 133 (459)
.+.|.|||++|.++.+. ....++.||+..|++..++++ ..+....-++|+-||++||.|||+.. |+|+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 44699999999988543 458899999999999998865 35888889999999999999999984 9999
Q ss_pred cCCCCCeEecCCCCeEEeecCCCcccccccC--CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCC
Q 012637 134 DLKPENLLLDENEDLKISDFGLSALPEQLRN--DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLP 211 (459)
Q Consensus 134 Dlkp~NILl~~~~~lKl~DFGla~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P 211 (459)
.+..+-|++..+|-+|++----...-..... ........|-++|.|||.-..... ..++|||++|....+|..|..-
T Consensus 203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHheec
Confidence 9999999999999888852111110000000 001112246788999997554443 3679999999999999887643
Q ss_pred -CCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 212 -FQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 212 -f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
-.+.+....-..+.+.-+.. -...-+.++.+||+..|..||++.+++-||.+-
T Consensus 282 ~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 282 STNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred cCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 22222111111111111111 122245799999999999999999999999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-11 Score=108.33 Aligned_cols=134 Identities=21% Similarity=0.318 Sum_probs=104.1
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHH-----HHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFM-----MEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~-----~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
..+++|+-+.+|.+.. -|..+.+|.=.+.....+.. ..+..+|.++++++.--.|.-..-+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999864 45557777644333333322 3556889999999976666666666668888899999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 91 YVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
|++|-.|.+.+... ...+++.+-.-+.-||.+||+|+||.++||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888765 245667777788889999999999999999998655 99999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.9e-11 Score=113.23 Aligned_cols=140 Identities=22% Similarity=0.272 Sum_probs=108.3
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CCcceeEEEEEeC---CEEEEEEe
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH--PNVVELREVMATK---KKIFVAME 90 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E 90 (459)
+.||.|..+.||++... +|+.+++|........ .....+.+|+.+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999864 3689999997654321 123467899999999965 4467777776654 36789999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 012637 91 YVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS------------------------------------------- 127 (459)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~------------------------------------------- 127 (459)
|++|..+.+.+..+.+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999888765543457777777888888888888874
Q ss_pred -------------CCcEeccCCCCCeEecC--CCCeEEeecCCCcc
Q 012637 128 -------------RGVSHRDLKPENLLLDE--NEDLKISDFGLSAL 158 (459)
Q Consensus 128 -------------~gi~HrDlkp~NILl~~--~~~lKl~DFGla~~ 158 (459)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.8e-10 Score=102.92 Aligned_cols=144 Identities=21% Similarity=0.276 Sum_probs=110.2
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHH-----HHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF-----MMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
....|-+|+-+.|+.+. ..|+.+.||.=-......+. ...+.++|++++.+|.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 56788999999999998 57888888864333333222 235678999999999766666656667778888899
Q ss_pred EeccCC-CchHHHHhc--CCCCHH-HHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC---eEEeecCCCccc
Q 012637 89 MEYVKG-GELFAKVAR--GRLRED-LARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED---LKISDFGLSALP 159 (459)
Q Consensus 89 ~E~~~g-g~L~~~i~~--~~l~e~-~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~---lKl~DFGla~~~ 159 (459)
|||++| .++.+++.. ..-.++ ....++++|-+.+.-||.++|+|+||..+||++..+|+ +-+.|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999988 366666654 222333 33789999999999999999999999999999987653 589999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.1e-10 Score=115.14 Aligned_cols=210 Identities=20% Similarity=0.301 Sum_probs=155.9
Q ss_pred cEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE----eCCEEEEEEeccCC-Cch
Q 012637 23 FAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA----TKKKIFVAMEYVKG-GEL 97 (459)
Q Consensus 23 fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~----~~~~~~lV~E~~~g-g~L 97 (459)
-.+.|+|....+|..|++|.+.-.+.... .....-+.+++++.|+|||++.+++. .+..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999999954332221 12334577899999999999999986 34679999999886 466
Q ss_pred HHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 98 FAKVA----------------RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 98 ~~~i~----------------~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.++.- ..+.+|..+|.|+.||..||.++|+.|...+-|.|.+||++.+-+++|+.-|...+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 55431 12478999999999999999999999999999999999999888899987776554332
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCC-CCchHHHH-HHHHHhccCCCCCCCCHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPF-QDENIMNM-YRKVFKAEFVYPPWISTDA 239 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~-~~~i~~~~~~~p~~~s~~~ 239 (459)
+. + |.+... .+-|.=.||.+++.|.||..-= ........ .+.+. ...|.++
T Consensus 446 ---d~------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D~ 498 (655)
T KOG3741|consen 446 ---DP------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTDL 498 (655)
T ss_pred ---CC------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHHH
Confidence 10 0 122221 3568889999999999996542 12222222 22222 3468899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+++|.-+...++++ -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999987 688999876
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.1e-10 Score=102.64 Aligned_cols=127 Identities=23% Similarity=0.358 Sum_probs=85.6
Q ss_pred EEEEEEEcCCCcEEEEEEeecccc-----------------------ccHHHHHHHHHHHHHHHhcCCC--CcceeEEEE
Q 012637 25 KVYYGKQLMTGESVAIKVINKDQL-----------------------KKEFMMEQIKREISVMRLVRHP--NVVELREVM 79 (459)
Q Consensus 25 ~V~~a~~~~~~~~vAiK~i~~~~~-----------------------~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~ 79 (459)
.||.|.. .+|..+|+|+...... ..........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899986 5678999999743210 1111235678999999999765 567776553
Q ss_pred EeCCEEEEEEeccC--CCchHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 80 ATKKKIFVAMEYVK--GGELFAKVARGRLREDLARKYFQQLISAVDF-CHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 80 ~~~~~~~lV~E~~~--gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~-LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
.-++||||++ |..+.. +....++.+....++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.|
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2369999998 655533 333333355677888889886655 579999999999999999977 9999999988
Q ss_pred cc
Q 012637 157 AL 158 (459)
Q Consensus 157 ~~ 158 (459)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 63
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=4e-09 Score=102.29 Aligned_cols=130 Identities=16% Similarity=0.151 Sum_probs=94.9
Q ss_pred EEEEEEcCCCcEEEEEEeecccccc---H-----HHHHHHHHHHHHHHhcCCCC--cceeEEEEEe-----CCEEEEEEe
Q 012637 26 VYYGKQLMTGESVAIKVINKDQLKK---E-----FMMEQIKREISVMRLVRHPN--VVELREVMAT-----KKKIFVAME 90 (459)
Q Consensus 26 V~~a~~~~~~~~vAiK~i~~~~~~~---~-----~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~~-----~~~~~lV~E 90 (459)
|..+. ..|+.|.||......... . .......+|...+.+|..-+ ++.++.+.+. ....++|+|
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44543 467889999764322110 0 01113678999998885333 3444555543 245789999
Q ss_pred ccCCC-chHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-------CCCeEEeecCCCc
Q 012637 91 YVKGG-ELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-------NEDLKISDFGLSA 157 (459)
Q Consensus 91 ~~~gg-~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-------~~~lKl~DFGla~ 157 (459)
++++. +|.+++.. ...++.....++.++...+.-||.+||+|+|++|.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99986 78888753 45677788899999999999999999999999999999985 4679999999885
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3e-10 Score=118.95 Aligned_cols=152 Identities=22% Similarity=0.370 Sum_probs=111.8
Q ss_pred HHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCcccccccC------CCcc-ccccCCCcccChhhHhhcCCC
Q 012637 118 LISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN------DGLL-HTQCGTPAYVAPEVLRKKGYD 189 (459)
Q Consensus 118 ll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~------~~~~-~~~~Gt~~y~APE~l~~~~~~ 189 (459)
.+.|+.|+|.. +++|+.|.|++|.++.+|.+||+.|+++........ +... .-..-...|.|||++... ..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~~ 186 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-TN 186 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-cc
Confidence 34899999975 899999999999999999999999998754322100 0000 001123469999999874 45
Q ss_pred CCcchhhhHHHHHHHHh-hCCCCCCCchHHHHHHHHH----hccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012637 190 GSKADLWSCGVILYVLL-AGFLPFQDENIMNMYRKVF----KAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVP 264 (459)
Q Consensus 190 ~~~~DIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hp 264 (459)
+.++|++|+||++|.+. .|+.-+...+....+.... .+.+.++..+++++++=|.++|..++..||++.+++.-|
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 68999999999999998 5655555443322222111 112344567899999999999999999999999999999
Q ss_pred ccccCC
Q 012637 265 WFRKGF 270 (459)
Q Consensus 265 w~~~~~ 270 (459)
||..+.
T Consensus 267 ff~D~~ 272 (700)
T KOG2137|consen 267 FFSDPG 272 (700)
T ss_pred ccCCch
Confidence 998754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.8e-08 Score=96.71 Aligned_cols=233 Identities=18% Similarity=0.232 Sum_probs=151.8
Q ss_pred EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE------EEeCC-E
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV------MATKK-K 84 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~------~~~~~-~ 84 (459)
.+++.||+|+-+.+|-.-. -+..| .|++.+...... .+.+..|... .||-+-.-+.| ..+.+ .
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~V-AKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQV-AKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch--hhchh-heeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4578899999999996531 22234 488765432211 1123333333 56643321111 12233 3
Q ss_pred EEEEEeccCCCch-HHHHhc----CC---CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 85 IFVAMEYVKGGEL-FAKVAR----GR---LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 85 ~~lV~E~~~gg~L-~~~i~~----~~---l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
+-+.|..++|..- .++... .. ...+.+.+..+.|+.+.+.||..|-.-+|+.++|+|+.+++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7888999888632 222221 22 456788899999999999999999999999999999999999999985543
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCC----CCCcchhhhHHHHHHHHhhC-CCCCCCc-------hHHHHHHHH
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY----DGSKADLWSCGVILYVLLAG-FLPFQDE-------NIMNMYRKV 224 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~----~~~~~DIwSlGvil~~ll~G-~~Pf~~~-------~~~~~~~~i 224 (459)
.+. .++.......|.+.|.+||.-.-... .+...|-|.|||++|++|.| +.||.+- ++.+ ..|
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~I 239 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDI 239 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhh
Confidence 321 24444555679999999998652221 13568999999999999886 9999752 2222 112
Q ss_pred Hhc-----------cCCCC---CC--CCHHHHHHHHHhcCC--CCCCCCCHHH
Q 012637 225 FKA-----------EFVYP---PW--ISTDAKRLISKLLVS--DPERRITIQS 259 (459)
Q Consensus 225 ~~~-----------~~~~p---~~--~s~~~~~Li~~~L~~--dP~~R~t~~e 259 (459)
..+ ..+.| +| ++++++.|..+|+.. +|.-|||++.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111 11111 22 689999999999975 4678999653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.2e-08 Score=91.03 Aligned_cols=125 Identities=18% Similarity=0.272 Sum_probs=93.0
Q ss_pred CCcEEEEEEeecccccc----HHHHHHHHHHHHHHHhcCC--CCcceeEEEEEeC----CEEEEEEeccCCC-chHHHHh
Q 012637 34 TGESVAIKVINKDQLKK----EFMMEQIKREISVMRLVRH--PNVVELREVMATK----KKIFVAMEYVKGG-ELFAKVA 102 (459)
Q Consensus 34 ~~~~vAiK~i~~~~~~~----~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~ 102 (459)
.++.|-+|........+ ........+|...+..|.. =.+.+.+.+.+.. ...++|+|+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221111 1123457789998888853 3355666666543 3468999999985 7888887
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---CeEEeecCCCcc
Q 012637 103 R-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---DLKISDFGLSAL 158 (459)
Q Consensus 103 ~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---~lKl~DFGla~~ 158 (459)
. ...+......++.++...+.-||.+||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 5 3477778889999999999999999999999999999999887 899999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.77 E-value=8.1e-08 Score=89.36 Aligned_cols=141 Identities=20% Similarity=0.279 Sum_probs=95.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHH------HHHHHHHHHHhcC---CCCcceeEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME------QIKREISVMRLVR---HPNVVELRE 77 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~------~i~~Ei~il~~l~---hpnIv~l~~ 77 (459)
++.++|.+.+.+-......|.+.. .+|+.+.+|.........+.... ...+++..+.++. -.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 567889999999998888887776 67899999987643322221111 1233444444442 233333333
Q ss_pred EEE-----eCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEee
Q 012637 78 VMA-----TKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISD 152 (459)
Q Consensus 78 ~~~-----~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~D 152 (459)
+.+ -....+++|||++|-+|.+... ++++ +...|..++.-||+.|++|+|.+|.|++++.++ +++.|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh---cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 222 2245668999999988765532 3332 445677889999999999999999999999555 99999
Q ss_pred cCCCc
Q 012637 153 FGLSA 157 (459)
Q Consensus 153 FGla~ 157 (459)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.7e-08 Score=93.50 Aligned_cols=137 Identities=23% Similarity=0.365 Sum_probs=104.1
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccc-------cccH------------HHHHHHHHHHHHHHhcCCC--
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQ-------LKKE------------FMMEQIKREISVMRLVRHP-- 70 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~------------~~~~~i~~Ei~il~~l~hp-- 70 (459)
+.++..||-|--|.||.|.+. .|.++|||.=.... .... -......+|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467899999999999999974 78999999742110 0000 0124468999999999654
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEE
Q 012637 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI 150 (459)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl 150 (459)
.|.+.+++ +.-.+||||++|-+|... ++....+..++..|+.-+.-.-..|++|+|+.+=||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 77777765 456799999999777442 2345556667777777777777999999999999999999999999
Q ss_pred eecCCCc
Q 012637 151 SDFGLSA 157 (459)
Q Consensus 151 ~DFGla~ 157 (459)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9997664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.8e-07 Score=85.45 Aligned_cols=137 Identities=14% Similarity=0.148 Sum_probs=99.1
Q ss_pred cccCcEEEEEEEEcCCCcEEEEEEeeccc---cccHHHHHHHHHHHHHHHhcCC--CCcceeEEEEEe----CCEEEEEE
Q 012637 19 GKGTFAKVYYGKQLMTGESVAIKVINKDQ---LKKEFMMEQIKREISVMRLVRH--PNVVELREVMAT----KKKIFVAM 89 (459)
Q Consensus 19 G~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~----~~~~~lV~ 89 (459)
|+||-+.|+.... .|+.+=+|.-.... ...+.-...+.+|+..++.|.. -.+.+....... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5689999998763 45567788653111 0101123568899999999853 235555422211 23478999
Q ss_pred eccCC-CchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC--eEEeecCCCc
Q 012637 90 EYVKG-GELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED--LKISDFGLSA 157 (459)
Q Consensus 90 E~~~g-g~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~--lKl~DFGla~ 157 (459)
|-++| -+|.+++..+ +.++..-..++.++...+.-||+.|+.|+|+.+.|||++.+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97765 4888887664 4577777899999999999999999999999999999987777 9999998665
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.4e-09 Score=110.10 Aligned_cols=236 Identities=19% Similarity=0.175 Sum_probs=165.7
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC-cceeEEEEEeCCEEEEEEe
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN-VVELREVMATKKKIFVAME 90 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E 90 (459)
|.....+++|+++++++.+...+...+ .+++... ..+.-++.+|.+++||| .+..++-++.+...+++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 445567889999999999987776665 6766433 23456899999999999 7788888888899999999
Q ss_pred ccCCC-chHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 91 YVKGG-ELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 91 ~~~gg-~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
+|.++ +-...+. .-.+.+-+.....+.-+.+++++|+.-=+||| ||+..+ +..|..||+......... .
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~ 386 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K 386 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---c
Confidence 99987 2222111 11233444555666777899999998778998 777664 789999999886544321 3
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC------CCCCHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP------PWISTDAKR 241 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p------~~~s~~~~~ 241 (459)
..+..+|+.++|||+.....+. ...|.||+|+-..+|--|-+|-..+-.. ...+ ......| .|-+..-++
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~-g~~p~s~~L~~~~aw~~~~~~~ 462 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMI-GNGPNSPMLTDKSAWSPVFHRD 462 (829)
T ss_pred cccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCCC-CCCCCccccchhhhcCcccccC
Confidence 4566799999999999888876 7899999999877888887776441110 0000 0000011 111122234
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+...|+...|..|+..-.++.|.+|..
T Consensus 463 ~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 463 FPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CcccccCCCCCCCcchhhHHHHHHhcc
Confidence 777899999999999999988887764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.7e-07 Score=93.11 Aligned_cols=137 Identities=22% Similarity=0.336 Sum_probs=92.0
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccc---------------------------cccH----HHHHH------HH
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQ---------------------------LKKE----FMMEQ------IK 58 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------------------------~~~~----~~~~~------i~ 58 (459)
+.|+.++-|+||.|+.+ +|+.||||+....- +.-. ...+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67899999999999974 59999999974321 0000 01122 23
Q ss_pred HHHHHHHhc-----CCCCcceeEEEEEeCCEEEEEEeccCCCchHHH--HhcCCCC-----HHHHHHHHHHHHHHHHHHH
Q 012637 59 REISVMRLV-----RHPNVVELREVMATKKKIFVAMEYVKGGELFAK--VARGRLR-----EDLARKYFQQLISAVDFCH 126 (459)
Q Consensus 59 ~Ei~il~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~l~-----e~~~~~~~~qll~~L~~LH 126 (459)
+|..-+.++ ..|+|.=..-+++-.+.-.++|||++|-.+.+. +....++ +.-++.++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 344444443 134443333344445677899999999888776 3444444 344444555444
Q ss_pred hCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 127 ~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..|++|.|.+|.||+++.+|.+-+.|||+.....
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 3899999999999999999999999999986543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2e-06 Score=81.13 Aligned_cols=137 Identities=17% Similarity=0.222 Sum_probs=100.3
Q ss_pred eecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---------------------HHHHHHHHHHHHHHhcC--CCCcc
Q 012637 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---------------------FMMEQIKREISVMRLVR--HPNVV 73 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---------------------~~~~~i~~Ei~il~~l~--hpnIv 73 (459)
.|+.|--+.||+|.. .++..||+|++......-. .......+|..-|+++. +=.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566788889999985 5688999999854322111 11233578888888884 45566
Q ss_pred eeEEEEEeCCEEEEEEeccCCC-chHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEe
Q 012637 74 ELREVMATKKKIFVAMEYVKGG-ELFAKVARGRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKIS 151 (459)
Q Consensus 74 ~l~~~~~~~~~~~lV~E~~~gg-~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~ 151 (459)
+.+.+. .-.+||||+... .-.-.+..-++..+++..++.+++..+.-|-. .|++|+||+.=|||+. +|.+.|+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI 208 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII 208 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence 666665 356999999654 11223333344555799999999999988876 8999999999999999 8899999
Q ss_pred ecCCCccc
Q 012637 152 DFGLSALP 159 (459)
Q Consensus 152 DFGla~~~ 159 (459)
|||-|...
T Consensus 209 D~~QaV~~ 216 (268)
T COG1718 209 DVSQAVTI 216 (268)
T ss_pred ECcccccc
Confidence 99988643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.4e-06 Score=81.03 Aligned_cols=132 Identities=17% Similarity=0.133 Sum_probs=84.7
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--CcceeEEEEEeCCEEEEEEeccC
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP--NVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
..||+|.-+.||+. .|..+++|...... ....+.+|.++++.+..- .+.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25567889875422 123568899999998643 35777888888888899999999
Q ss_pred CCc-hH--------------HH-------HhcC---CCCHH-HHHHHHHHH----------HH-HHHHHH----hCCcEe
Q 012637 94 GGE-LF--------------AK-------VARG---RLRED-LARKYFQQL----------IS-AVDFCH----SRGVSH 132 (459)
Q Consensus 94 gg~-L~--------------~~-------i~~~---~l~e~-~~~~~~~ql----------l~-~L~~LH----~~gi~H 132 (459)
|.. +. .. +..- ..+.. ....+..++ .. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 10 11 1110 01100 011111111 11 112222 124789
Q ss_pred ccCCCCCeEecCCCCeEEeecCCCc
Q 012637 133 RDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 133 rDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999886
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=96.33 Aligned_cols=204 Identities=19% Similarity=0.188 Sum_probs=144.4
Q ss_pred HHHHHHHHHHHhcCCCCcceeEEEEEeCCEE----EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012637 55 EQIKREISVMRLVRHPNVVELREVMATKKKI----FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG 129 (459)
Q Consensus 55 ~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~----~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~g 129 (459)
....-|+..+.+..|+|++.++.|....... .+..|+|++-++...+.. +.++.+.++.+..+++.||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3345567777888999999999987654333 345678999999888876 88999999999999999999999996
Q ss_pred cEeccCCCC---CeEecCCCCeEEe--ecCCCcccccccCCCccccccCCCcccChhhHhhcCCC-CCcchhhhHHHHHH
Q 012637 130 VSHRDLKPE---NLLLDENEDLKIS--DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD-GSKADLWSCGVILY 203 (459)
Q Consensus 130 i~HrDlkp~---NILl~~~~~lKl~--DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~-~~~~DIwSlGvil~ 203 (459)
..|.-+... +--.+..+...++ ||+.+..... ........-+..+.|||......+. ....|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 666655555 4444556667776 8887764332 1122233345678889988765543 23369999999999
Q ss_pred HHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 204 VLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 204 ~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+..|..+-.-... .... .+........+++.+|+.-++++|+++.+++.|||.+.+.
T Consensus 384 ~~~~~~~i~~~~~~---~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAV---PVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhcCcccccccc---hhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 98887544211100 0000 1111222678899999999999999999999999998653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=5e-06 Score=79.48 Aligned_cols=134 Identities=17% Similarity=0.146 Sum_probs=84.3
Q ss_pred eecccCc-EEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEeccCC
Q 012637 17 LLGKGTF-AKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVAMEYVKG 94 (459)
Q Consensus 17 ~LG~G~f-g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (459)
.|..|.. +.||++.. .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4455555 78999874 34688889875432 234668999998883 45566788887777778999999999
Q ss_pred CchHHHH----------------hc-CCCCH-----H-HHHHHHHH-----------------------HHHHHHHH---
Q 012637 95 GELFAKV----------------AR-GRLRE-----D-LARKYFQQ-----------------------LISAVDFC--- 125 (459)
Q Consensus 95 g~L~~~i----------------~~-~~l~e-----~-~~~~~~~q-----------------------ll~~L~~L--- 125 (459)
..|.... .. ..++. . .......+ +...+..|
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7654221 00 11110 0 00000000 11111222
Q ss_pred ----HhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 126 ----HSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 126 ----H~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999987789999998863
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=1e-05 Score=75.87 Aligned_cols=136 Identities=22% Similarity=0.251 Sum_probs=82.5
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--CcceeEEEE---EeCCEEEEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP--NVVELREVM---ATKKKIFVAM 89 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lV~ 89 (459)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4789999999999998644 59999987543 2456778899999888533 355666643 3345689999
Q ss_pred eccCCCchHH----------------HHh---cC--C---CCHHH------HHHH---------------HHHHHH-HHH
Q 012637 90 EYVKGGELFA----------------KVA---RG--R---LREDL------ARKY---------------FQQLIS-AVD 123 (459)
Q Consensus 90 E~~~gg~L~~----------------~i~---~~--~---l~e~~------~~~~---------------~~qll~-~L~ 123 (459)
++++|..+.. .+. .. . +.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 111 10 0 00000 0000 011122 233
Q ss_pred HHH-------hCCcEeccCCCCCeEec-CCCCeEEeecCCCc
Q 012637 124 FCH-------SRGVSHRDLKPENLLLD-ENEDLKISDFGLSA 157 (459)
Q Consensus 124 ~LH-------~~gi~HrDlkp~NILl~-~~~~lKl~DFGla~ 157 (459)
.++ ...++|+|+.|.|||++ .++.+-|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24699999999999999 66777899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-05 Score=88.81 Aligned_cols=142 Identities=20% Similarity=0.349 Sum_probs=90.2
Q ss_pred eeeecccCcEEEEEEEEcCCC--cEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCc--ceeEEEEEeC---CEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTG--ESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNV--VELREVMATK---KKIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~ 86 (459)
.+.|+.|.++.+|+......+ ..+++|+........ ....+.+|+.+|+.+. |++| .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 578899999999998764432 467777754332211 1245779999999995 6665 7777777654 4689
Q ss_pred EEEeccCCCchHH--------------------HHhc-CCC----------------CHHHHHHHHHH------------
Q 012637 87 VAMEYVKGGELFA--------------------KVAR-GRL----------------REDLARKYFQQ------------ 117 (459)
Q Consensus 87 lV~E~~~gg~L~~--------------------~i~~-~~l----------------~e~~~~~~~~q------------ 117 (459)
+||||++|..+.+ .+.. ..+ .+..+..+..|
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999864211 1110 011 01223222222
Q ss_pred ---HHHHHHHHHh-----------CCcEeccCCCCCeEecCC-CC-eEEeecCCCcc
Q 012637 118 ---LISAVDFCHS-----------RGVSHRDLKPENLLLDEN-ED-LKISDFGLSAL 158 (459)
Q Consensus 118 ---ll~~L~~LH~-----------~gi~HrDlkp~NILl~~~-~~-lKl~DFGla~~ 158 (459)
+...+.+|.. ..++|+|++|.|||++.+ +. .-|.||.++++
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 1223455632 259999999999999853 33 57999999875
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.2e-05 Score=84.35 Aligned_cols=138 Identities=20% Similarity=0.282 Sum_probs=87.7
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeecccccc----------------------------HHHHHHHHHHHHHH---
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK----------------------------EFMMEQIKREISVM--- 64 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~----------------------------~~~~~~i~~Ei~il--- 64 (459)
+.||.-+.|.||+|+.+. |+.||||+-+..--.. +...+.+..|+.-.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 689999999999999865 9999999964321000 01122233333222
Q ss_pred -------HhcCCCC------cceeEEEEEeCCEEEEEEeccCCCchHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012637 65 -------RLVRHPN------VVELREVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLISAVDFCHSRG 129 (459)
Q Consensus 65 -------~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~--~i~~~~l~e~~~~~~~~qll~~L~~LH~~g 129 (459)
+.+.|-+ |.++| +.-.+...++||||+|..+.| .+.+..++...+.....+... +-|=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 2223444 22322 223456789999999986644 555666666544433333322 2223468
Q ss_pred cEeccCCCCCeEecC----CCCeEEeecCCCcc
Q 012637 130 VSHRDLKPENLLLDE----NEDLKISDFGLSAL 158 (459)
Q Consensus 130 i~HrDlkp~NILl~~----~~~lKl~DFGla~~ 158 (459)
++|+|=+|.||+++. ++.+.+-|||+...
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 999999999999994 57899999999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.6e-07 Score=105.62 Aligned_cols=211 Identities=15% Similarity=0.102 Sum_probs=149.5
Q ss_pred HHHHHHHHHHHhcCCCCcceeEEEEE--eCCEEEEEEeccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh
Q 012637 55 EQIKREISVMRLVRHPNVVELREVMA--TKKKIFVAMEYVKGGELFAKVARG-----RLREDLARKYFQQLISAVDFCHS 127 (459)
Q Consensus 55 ~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~~L~~LH~ 127 (459)
+-...|...++...|+++.....-.. +....|.+++||.+|.+++.|.+| .+.+..+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33455666667778999887766553 345679999999999999998763 34555555566666888888886
Q ss_pred CC-----cEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHH
Q 012637 128 RG-----VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVIL 202 (459)
Q Consensus 128 ~g-----i~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil 202 (459)
.. .+|++||+-|.+|..+.++|++++|+.++..+ .........++|.|++|++...-.+. .++|+|..|+.+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSL 1430 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHH
Confidence 52 79999999999999999999999999984322 12233455678899999999887775 559999999999
Q ss_pred HHHhhCCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 203 YVLLAGFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 203 ~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
|....|..||-......+...+.... ...+...|.++......+|-..-..||.-...+..+.|..
T Consensus 1431 y~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 99999988874333222221111111 2233334555555666666666678888888888777754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.2e-05 Score=71.28 Aligned_cols=128 Identities=20% Similarity=0.318 Sum_probs=92.6
Q ss_pred CCEEEeeeecccCc-EEEEEEEEcCCCcEEEEEEeec---c-------cccc-H-------HHHHHHHHHHHHHHhcC--
Q 012637 10 GKYEMGRLLGKGTF-AKVYYGKQLMTGESVAIKVINK---D-------QLKK-E-------FMMEQIKREISVMRLVR-- 68 (459)
Q Consensus 10 ~~y~i~~~LG~G~f-g~V~~a~~~~~~~~vAiK~i~~---~-------~~~~-~-------~~~~~i~~Ei~il~~l~-- 68 (459)
..++..+.||.|+- |.||+++ ..|+.||+|++.. . .... + ....-+..|.++.-+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 9999998 5788999999321 0 1110 0 22345778888877774
Q ss_pred -CCCc--ceeEEEEEeC------------------CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 012637 69 -HPNV--VELREVMATK------------------KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127 (459)
Q Consensus 69 -hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~ 127 (459)
+.++ |++|+++.-. ...-||-||++... .++. .=+.+|.+-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHHH
Confidence 4456 9999987322 12457888877643 2233 334577888889999
Q ss_pred CCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 128 RGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 128 ~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
.||+-+|+++.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999986 3489999964
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.4e-05 Score=70.10 Aligned_cols=131 Identities=20% Similarity=0.292 Sum_probs=96.5
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeecccc-------------ccHHHHHHHHHHHHHHHhcC------CCCccee
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-------------KKEFMMEQIKREISVMRLVR------HPNVVEL 75 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~i~~Ei~il~~l~------hpnIv~l 75 (459)
...||+|+.=.||.- ......+||+...... .......+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999888843 3445678899876650 01112355667777776666 7889999
Q ss_pred EEEEEeCCEEEEEEeccCC------CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---
Q 012637 76 REVMATKKKIFVAMEYVKG------GELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE--- 146 (459)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~g------g~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~--- 146 (459)
+++.+++.-.-+|+|.+.. -+|.+++..+.+++ .+. ..|-.-..||-+++|+.+|++|.||++..++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999998643 26888888788877 333 3444556788899999999999999997542
Q ss_pred -CeEEee
Q 012637 147 -DLKISD 152 (459)
Q Consensus 147 -~lKl~D 152 (459)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=4e-05 Score=68.75 Aligned_cols=129 Identities=26% Similarity=0.392 Sum_probs=92.4
Q ss_pred EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcce-eEEEEEeCCEEEEEEec
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVE-LREVMATKKKIFVAMEY 91 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~-l~~~~~~~~~~~lV~E~ 91 (459)
+..+.||+|.+|.||++. ..|..+|+|+-..+. ....+..|.++|..+.-.++-. +|.+. ..++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence 345789999999999998 467799999875443 2356889999999998766644 44443 23455999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCC-CCCeEecCCCCeEEeecCCCcc
Q 012637 92 VKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLK-PENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlk-p~NILl~~~~~lKl~DFGla~~ 158 (459)
+.|-.|......+ . ++-...+++.---|-..||-|..|. |...++..++.+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998886655432 1 2223345556556677899999986 5555555566999999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.6e-05 Score=72.48 Aligned_cols=73 Identities=10% Similarity=0.100 Sum_probs=45.9
Q ss_pred eeeecccCcE-EEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC---CcceeEEEEEeC---CEEEE
Q 012637 15 GRLLGKGTFA-KVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP---NVVELREVMATK---KKIFV 87 (459)
Q Consensus 15 ~~~LG~G~fg-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 87 (459)
++.|+.|+.. .||.. +..+.+|+..... ....+.+|..+++.+... .+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777776 48875 2357778754321 234688999999888532 344555443332 24589
Q ss_pred EEeccCCCch
Q 012637 88 AMEYVKGGEL 97 (459)
Q Consensus 88 V~E~~~gg~L 97 (459)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999999655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.80 E-value=6.2e-05 Score=52.46 Aligned_cols=43 Identities=23% Similarity=0.447 Sum_probs=36.5
Q ss_pred CCeEEEEEEEEEe-CceEEEEEEecCCChHHHHHHhhhhhhhhcc
Q 012637 385 GPLSVIAEVFEVA-PEVAVVEFSKSSGDTLEYAKFCEEDVRPALK 428 (459)
Q Consensus 385 ~~l~~~~~i~~~~-~~~~~v~~~k~~Gd~le~~~~~~~~l~~~l~ 428 (459)
..+.|.+||+++. ++++.|+|+|.+||.+.|+++|. +|-..|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~-~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCS-KILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHH-HHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHH-HHHHHcc
Confidence 5689999999997 89999999999999999999999 6766553
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00066 Score=69.52 Aligned_cols=79 Identities=15% Similarity=0.192 Sum_probs=55.0
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeecccc--cc--HHHHHHHHHHHHHHHhcC---CCCcceeEEEEEeCCEEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL--KK--EFMMEQIKREISVMRLVR---HPNVVELREVMATKKKIFV 87 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~--~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 87 (459)
.+.||.|.+..||++.+...++.|.||.-..... .. ....++...|...|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4789999999999999854446899998531110 01 113456777888888863 3457777776 4566889
Q ss_pred EEeccCCC
Q 012637 88 AMEYVKGG 95 (459)
Q Consensus 88 V~E~~~gg 95 (459)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00012 Score=67.31 Aligned_cols=97 Identities=19% Similarity=0.203 Sum_probs=79.4
Q ss_pred HHHHHHHHhcCC-CCcceeEEEEEeCCEEEEEEeccCCCchHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 012637 58 KREISVMRLVRH-PNVVELREVMATKKKIFVAMEYVKGGELFAK----VARGRLREDLARKYFQQLISAVDFCHS---RG 129 (459)
Q Consensus 58 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~----i~~~~l~e~~~~~~~~qll~~L~~LH~---~g 129 (459)
..|.-+|+.+++ +++++++|++- -++|.||...+++... ..-..-+......++.+++..+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 69999999983 3678899987766421 111346788899999999999999998 45
Q ss_pred cEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 130 VSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 130 i~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
+.-.|++|+|+-++++|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 89999999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00059 Score=64.62 Aligned_cols=135 Identities=16% Similarity=0.222 Sum_probs=80.6
Q ss_pred eeeecccCcEEEEEEEEcC-CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC-cceeEEEEEeCCEEEEEEecc
Q 012637 15 GRLLGKGTFAKVYYGKQLM-TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN-VVELREVMATKKKIFVAMEYV 92 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~ 92 (459)
.+.|..|-...+|++.... .++.|++|+....... .-...+|+.+++.+...+ ..+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4678888889999987533 3578999987543211 112347999999885433 344444332 2 3799999
Q ss_pred CCCchHH--------------H---Hhc--CCCC-----------HHHHHHHHHHH------------------------
Q 012637 93 KGGELFA--------------K---VAR--GRLR-----------EDLARKYFQQL------------------------ 118 (459)
Q Consensus 93 ~gg~L~~--------------~---i~~--~~l~-----------e~~~~~~~~ql------------------------ 118 (459)
+|..+.. . +.. .... .+.+..+...+
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 9865411 1 111 0110 11222222111
Q ss_pred -HHHHH-HHH----hCCcEeccCCCCCeEecC-CCCeEEeecCCCc
Q 012637 119 -ISAVD-FCH----SRGVSHRDLKPENLLLDE-NEDLKISDFGLSA 157 (459)
Q Consensus 119 -l~~L~-~LH----~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~ 157 (459)
+..|. .+. ..+++|+|+.|.|||++. ++.+.|+||-.|.
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11111 111 236999999999999998 5789999999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0011 Score=65.62 Aligned_cols=78 Identities=8% Similarity=0.046 Sum_probs=55.1
Q ss_pred EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC---CCcceeEEEEEe---CCEEE
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH---PNVVELREVMAT---KKKIF 86 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~ 86 (459)
.-.+.||.|..+.||.... ++..+.+|... ... . ...+.+|...|+.+.- -.+.++++++.. .+..|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~-~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMAR-SFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEec-ccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3456899999999999863 23357778743 211 1 2357789999998843 367888877754 36789
Q ss_pred EEEeccCCCch
Q 012637 87 VAMEYVKGGEL 97 (459)
Q Consensus 87 lV~E~~~gg~L 97 (459)
+|||+++|+.+
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00028 Score=67.99 Aligned_cols=132 Identities=15% Similarity=0.153 Sum_probs=78.9
Q ss_pred eecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEEeccCCC
Q 012637 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV-VELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 95 (459)
.+..|-.+.+|+.. .+++.+++|........ ..-...+|..+++.+...++ .+++... . -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 45678888899887 45678889976432111 10124679999999864333 3444433 2 36899999986
Q ss_pred chHH--------------H---HhcCC-----CC-HHHHHHHHHHHH---------HHHHHHHh--------CCcEeccC
Q 012637 96 ELFA--------------K---VARGR-----LR-EDLARKYFQQLI---------SAVDFCHS--------RGVSHRDL 135 (459)
Q Consensus 96 ~L~~--------------~---i~~~~-----l~-e~~~~~~~~qll---------~~L~~LH~--------~gi~HrDl 135 (459)
.+.. . +..-. ++ ...+..+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 1 11111 11 122334333331 11222211 25899999
Q ss_pred CCCCeEecCCCCeEEeecCCCcc
Q 012637 136 KPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 136 kp~NILl~~~~~lKl~DFGla~~ 158 (459)
.|.||++++++ +.|.||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 89999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00066 Score=66.70 Aligned_cols=135 Identities=17% Similarity=0.208 Sum_probs=83.2
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--CcceeEE------EEEeCCEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP--NVVELRE------VMATKKKIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 86 (459)
.+.|..|.-..+|+... .+..+++|+.... . ...+..|+.+++.+.+. .+.+++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56777888889998863 4457899987541 1 24567788888888432 2445443 223456779
Q ss_pred EEEeccCCCchHH--------------HHhc--CCCC---------H---HHHH--------HHHHHHHHHHHHHHh---
Q 012637 87 VAMEYVKGGELFA--------------KVAR--GRLR---------E---DLAR--------KYFQQLISAVDFCHS--- 127 (459)
Q Consensus 87 lV~E~~~gg~L~~--------------~i~~--~~l~---------e---~~~~--------~~~~qll~~L~~LH~--- 127 (459)
++++|++|..+.. .+.. ..+. . .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999865411 1110 0010 0 0000 011112233444443
Q ss_pred ----CCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 128 ----RGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 128 ----~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
.+++|+|+.|.|||+++++.+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0011 Score=65.80 Aligned_cols=136 Identities=19% Similarity=0.186 Sum_probs=81.2
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--CcceeEEE------EEeCCEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP--NVVELREV------MATKKKIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~------~~~~~~~~ 86 (459)
.+.++.|.-..+|++.. ++..+++|+..... . .+.+..|+.++..|... .+.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677887789998863 34467889875421 1 12355677777777422 24444431 12346789
Q ss_pred EEEeccCCCchH--------------HHHhc--CCCCH-------HHHH----------------HHHHHHHHHHHHHH-
Q 012637 87 VAMEYVKGGELF--------------AKVAR--GRLRE-------DLAR----------------KYFQQLISAVDFCH- 126 (459)
Q Consensus 87 lV~E~~~gg~L~--------------~~i~~--~~l~e-------~~~~----------------~~~~qll~~L~~LH- 126 (459)
+++||++|..+. ..+.. ..++. ...+ .....+...++++.
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999985431 01111 11100 0000 00112233455553
Q ss_pred ------hCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 127 ------SRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 127 ------~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
..+++|+|+++.||+++.++.+.|.||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2689999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0017 Score=64.00 Aligned_cols=75 Identities=16% Similarity=0.148 Sum_probs=48.5
Q ss_pred eeeecccCcEEEEEEEEcC------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC-cceeEEEEEeCCEEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLM------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN-VVELREVMATKKKIFV 87 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l 87 (459)
++.|..|--..||++.... +++.|++|+...... ......+|..+++.+...+ ..+++.++. . .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 3567777777899887533 267899999754321 1224568999998885333 345555543 2 35
Q ss_pred EEeccCCCch
Q 012637 88 AMEYVKGGEL 97 (459)
Q Consensus 88 V~E~~~gg~L 97 (459)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0048 Score=61.37 Aligned_cols=134 Identities=16% Similarity=0.213 Sum_probs=75.4
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--CcceeEE------EEEeCCEEEE
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP--NVVELRE------VMATKKKIFV 87 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~l 87 (459)
+.|+.|....+|+... ++..+++|++.. . . .+.+..|+.+++.|... .+.+.+. +....+..++
T Consensus 28 ~~l~~G~~n~~y~v~t--~~g~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 28 KGIAEGIENSNFFLTT--TQGEYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred chhccccccceEEEEe--CCCcEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 5566777789998874 234788998751 1 1 12344566666665321 2333332 2234567899
Q ss_pred EEeccCCCchH-----------HH---Hhc--CCCC------------HHHHH-----------HHHHHHH-HHHHHHH-
Q 012637 88 AMEYVKGGELF-----------AK---VAR--GRLR------------EDLAR-----------KYFQQLI-SAVDFCH- 126 (459)
Q Consensus 88 V~E~~~gg~L~-----------~~---i~~--~~l~------------e~~~~-----------~~~~qll-~~L~~LH- 126 (459)
++||++|..+. .. +.. ..++ ...+. ..+.+.+ ..++.+.
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 99999986431 11 111 0110 00011 1111111 1122222
Q ss_pred ------hCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 127 ------SRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 127 ------~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
..|++|+|+.|.|||++.+...-|.||+.+.
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999966656899999886
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00023 Score=69.62 Aligned_cols=135 Identities=16% Similarity=0.253 Sum_probs=97.4
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc-------c--------HHH----HHHHHHHHHHHHhcC-C-C
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-------K--------EFM----MEQIKREISVMRLVR-H-P 70 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------~--------~~~----~~~i~~Ei~il~~l~-h-p 70 (459)
|.++.+||-|--+-||.+.+ ..|.+.++|.-...+.. . ..+ .-...+|...|+.|. | -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67889999999999999987 57889999964221110 0 000 122468999999984 3 3
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEE
Q 012637 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI 150 (459)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl 150 (459)
-|.+.++ .+.-++|||++.|-.|...-. ...+..++..|..-+--|-.+|++|+|..-=||++++++.+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 3555554 456789999999977644321 1224456666777777888999999999999999999999999
Q ss_pred eecCCC
Q 012637 151 SDFGLS 156 (459)
Q Consensus 151 ~DFGla 156 (459)
+||--.
T Consensus 244 IDFPQm 249 (465)
T KOG2268|consen 244 IDFPQM 249 (465)
T ss_pred eechHh
Confidence 999643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0039 Score=62.79 Aligned_cols=77 Identities=13% Similarity=0.120 Sum_probs=50.5
Q ss_pred eecccCcEEEEEEEEcCCCcEEEEEEeecc-c-ccc--HHHHHHHHHHHHHHHhcC--CC-CcceeEEEEEeCCEEEEEE
Q 012637 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKD-Q-LKK--EFMMEQIKREISVMRLVR--HP-NVVELREVMATKKKIFVAM 89 (459)
Q Consensus 17 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~-~~~--~~~~~~i~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 89 (459)
.+|.|....||++.+...++.|+||.-..- + ... +-..++..-|..+|+... -| .+.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997544468999974311 1 010 122456667888887763 34 45555544 566677999
Q ss_pred eccCCC
Q 012637 90 EYVKGG 95 (459)
Q Consensus 90 E~~~gg 95 (459)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0049 Score=61.60 Aligned_cols=140 Identities=21% Similarity=0.290 Sum_probs=99.1
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc----------------------ccHHHH-HHHHHHHHHHHhcCCC
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL----------------------KKEFMM-EQIKREISVMRLVRHP 70 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~----------------------~~~~~~-~~i~~Ei~il~~l~hp 70 (459)
|-..|..|--+.||.|.. .+|..+|||++..+-+ ....++ -...+|++-|++++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445778899999999875 6788899999743211 111222 2356888888888755
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCC-chHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeccCCCCCeEecCCCCe
Q 012637 71 NVVELREVMATKKKIFVAMEYVKGG-ELFAKVARGRLREDLARKYFQQLISAVDFC-HSRGVSHRDLKPENLLLDENEDL 148 (459)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg-~L~~~i~~~~l~e~~~~~~~~qll~~L~~L-H~~gi~HrDlkp~NILl~~~~~l 148 (459)
.|.-.--+.. . .-.|||+|+... --.-.+....++...++.+.+|++.-+.-| |..+++|.||.-=|+|+. +|.|
T Consensus 227 GIP~PePIlL-k-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL-K-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCCCceee-e-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 5432222221 1 235899999642 223345556788999999999999998887 567999999999999997 6789
Q ss_pred EEeecCCCc
Q 012637 149 KISDFGLSA 157 (459)
Q Consensus 149 Kl~DFGla~ 157 (459)
.|+|-+-+-
T Consensus 304 yiIDVSQSV 312 (520)
T KOG2270|consen 304 YIIDVSQSV 312 (520)
T ss_pred EEEEccccc
Confidence 999988764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0021 Score=66.53 Aligned_cols=165 Identities=19% Similarity=0.225 Sum_probs=106.3
Q ss_pred HHHHHHHHHHhcCCCCcceeEEEEEe-CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 012637 56 QIKREISVMRLVRHPNVVELREVMAT-KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRD 134 (459)
Q Consensus 56 ~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrD 134 (459)
++.-....++.+.|+|...++++... .....+|||++.. +|.+....+.+..... + .+|+.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~----------~----~~~~~~-- 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESL----------L----AHGVLH-- 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhh----------c----ccccce--
Confidence 45566788999999999999988754 3458899999954 7888876654322111 1 222222
Q ss_pred CCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC
Q 012637 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD 214 (459)
Q Consensus 135 lkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~ 214 (459)
-| .++++| -+++ .. .+. .++++||||+|.++.++.-|..-|..
T Consensus 91 ---~~-------~~~~td-~~~t------~~---~~~-----------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 ---LN-------IIYITD-HFLT------KY---PSP-----------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ---eh-------hhhccc-cccc------cC---CCC-----------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 12 233333 1111 00 111 12489999999999999999887766
Q ss_pred chHHHHHHHHHhccCCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCc
Q 012637 215 ENIMNMYRKVFKAEFVYP------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274 (459)
Q Consensus 215 ~~~~~~~~~i~~~~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~~~~ 274 (459)
....+....+.+-..... ..++.-...++.+|+-..|..||...++++++-|...+..+.
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~~t 205 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKDLT 205 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhhhh
Confidence 555444443332211100 114556778999999999999999999999999987654443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0064 Score=59.41 Aligned_cols=30 Identities=27% Similarity=0.502 Sum_probs=25.6
Q ss_pred CcEeccCCCCCeEecCCCC-eEEeecCCCcc
Q 012637 129 GVSHRDLKPENLLLDENED-LKISDFGLSAL 158 (459)
Q Consensus 129 gi~HrDlkp~NILl~~~~~-lKl~DFGla~~ 158 (459)
.++|+|++|.|||++.++. .-|.||+.+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0093 Score=59.17 Aligned_cols=143 Identities=16% Similarity=0.181 Sum_probs=82.8
Q ss_pred EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CCcceeEEEEEeCC--EEEEE
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH--PNVVELREVMATKK--KIFVA 88 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~lV 88 (459)
.+.+....|.--.+|...+. ++.+.+. ... ............+|..+++.+.- --+...++++.+.. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34445544444456666543 7888888 321 12222245567789999988753 23344555555544 67999
Q ss_pred EeccCCCch------------------HHHHhc-CC--------------CCHHHHHHHHHHH--------------HHH
Q 012637 89 MEYVKGGEL------------------FAKVAR-GR--------------LREDLARKYFQQL--------------ISA 121 (459)
Q Consensus 89 ~E~~~gg~L------------------~~~i~~-~~--------------l~e~~~~~~~~ql--------------l~~ 121 (459)
|+|++|..+ .+.+.. .. ....++..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999998322 111110 00 0111111122221 222
Q ss_pred HHHHHhC--------CcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 122 VDFCHSR--------GVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 122 L~~LH~~--------gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
..+++.+ .++|+|+.+.||+++.++-+=+.||+++.+-
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3444432 4899999999999999998999999999753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.022 Score=56.20 Aligned_cols=29 Identities=31% Similarity=0.638 Sum_probs=25.8
Q ss_pred CCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 128 RGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 128 ~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.031 Score=57.34 Aligned_cols=77 Identities=19% Similarity=0.158 Sum_probs=52.1
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc-ccH---HHHHHHHHHHHHHHhcC---CCCcceeEEEEEeCCEEE
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKE---FMMEQIKREISVMRLVR---HPNVVELREVMATKKKIF 86 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 86 (459)
-.+.||.|....||+..+ .++.|+||.-..... ... ....+...|...|+.+. ..++.+++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 367899999999999886 345789997542111 011 12345556777777663 247888888765 4467
Q ss_pred EEEeccCC
Q 012637 87 VAMEYVKG 94 (459)
Q Consensus 87 lV~E~~~g 94 (459)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999987
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.016 Score=59.08 Aligned_cols=78 Identities=18% Similarity=0.210 Sum_probs=53.3
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeecc-cccc--HHHHHHHHHHHHHHHhcC--CC-CcceeEEEEEeCCEEEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKD-QLKK--EFMMEQIKREISVMRLVR--HP-NVVELREVMATKKKIFVA 88 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~--~~~~~~i~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV 88 (459)
.+.||.|.-.-||++.+...++.|+||.-..- +... +-..++..-|..+|+... -| .+.+++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 57899999999999998444578999964311 1111 123567778889988773 34 45556544 56667899
Q ss_pred EeccCC
Q 012637 89 MEYVKG 94 (459)
Q Consensus 89 ~E~~~g 94 (459)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999965
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.032 Score=56.34 Aligned_cols=135 Identities=17% Similarity=0.254 Sum_probs=80.6
Q ss_pred eeeecccCcEEEEEEEEcC----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLM----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV-VELREVMATKKKIFVAM 89 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~ 89 (459)
.+.|..|--..+|++.... +++.|.+|+..... ...+++ .+|..+++.+..-++ .++++.+.. . .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 4566668888999986432 34689999876532 122333 579999998854443 355565532 2 578
Q ss_pred eccCCCchHH----------H-------HhcCCC-------CHHHHHHHHHHHH-----------------HHHHH----
Q 012637 90 EYVKGGELFA----------K-------VARGRL-------REDLARKYFQQLI-----------------SAVDF---- 124 (459)
Q Consensus 90 E~~~gg~L~~----------~-------i~~~~l-------~e~~~~~~~~qll-----------------~~L~~---- 124 (459)
||++|..|.. . +....+ ..+.+..++.++. ..+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 9998765521 1 111111 1123333332221 11111
Q ss_pred HH----hCCcEeccCCCCCeEecC-CCCeEEeecCCCc
Q 012637 125 CH----SRGVSHRDLKPENLLLDE-NEDLKISDFGLSA 157 (459)
Q Consensus 125 LH----~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~ 157 (459)
+. ...++|+|+++.|||+++ ++.+.++||..|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11 236899999999999986 4789999999886
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.056 Score=53.57 Aligned_cols=29 Identities=21% Similarity=0.263 Sum_probs=27.4
Q ss_pred CcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 129 GVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 129 gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
+++|+|+.++|+|++.++.+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999876
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.068 Score=53.63 Aligned_cols=135 Identities=15% Similarity=0.251 Sum_probs=79.0
Q ss_pred eeeecccCcEEEEEEEEcCC---CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEEe
Q 012637 15 GRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV-VELREVMATKKKIFVAME 90 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E 90 (459)
.+.|..|--..+|++..... +..|.+|+.....- ..++ -.+|..+++.+..-++ .++++++. .+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 45565577788998865432 34799998754321 1222 2478999998865444 45555552 22 5889
Q ss_pred ccCCCchHH----------H-------HhcCCCC-------HHHHHHHHHHHH----------------------HHHH-
Q 012637 91 YVKGGELFA----------K-------VARGRLR-------EDLARKYFQQLI----------------------SAVD- 123 (459)
Q Consensus 91 ~~~gg~L~~----------~-------i~~~~l~-------e~~~~~~~~qll----------------------~~L~- 123 (459)
|++|..|.. . +....++ ...+..|+.++- .-+.
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998764411 1 1111111 123333333321 1111
Q ss_pred ---HHHhCC----cEeccCCCCCeEecC-CCCeEEeecCCCc
Q 012637 124 ---FCHSRG----VSHRDLKPENLLLDE-NEDLKISDFGLSA 157 (459)
Q Consensus 124 ---~LH~~g----i~HrDlkp~NILl~~-~~~lKl~DFGla~ 157 (459)
.+.+.+ ++|.|+.|.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 121222 799999999999975 5789999999886
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.018 Score=58.39 Aligned_cols=62 Identities=23% Similarity=0.252 Sum_probs=47.1
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeccCCCCCeEecCC
Q 012637 84 KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC-HSRGVSHRDLKPENLLLDEN 145 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~L-H~~gi~HrDlkp~NILl~~~ 145 (459)
...++-+|..|-++..++.....+|...+.++.--+.|+--+ --.+++|.|++|.||++--+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 456777889998888888877778776666666666665433 45689999999999999644
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.025 Score=56.58 Aligned_cols=89 Identities=22% Similarity=0.356 Sum_probs=62.4
Q ss_pred HhcCCCCcceeEEEE-EeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEe
Q 012637 65 RLVRHPNVVELREVM-ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLL 142 (459)
Q Consensus 65 ~~l~hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl 142 (459)
+.+..++..+.+-+- ....+.|++|++- |+.+ ..+.. -...++..+|.+.++-+.-+..+ ..-|||+.-.||||
T Consensus 280 ~~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 280 RECGSVFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred hhccchhhhcceEEecCCceEEEEEEecC-Ccee-eeeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 334455555555444 3445677888865 3333 22222 23456778889888888777765 68999999999999
Q ss_pred cCCCCeEEeecCCCcc
Q 012637 143 DENEDLKISDFGLSAL 158 (459)
Q Consensus 143 ~~~~~lKl~DFGla~~ 158 (459)
+ +|++.|+||-++++
T Consensus 356 d-~GnvtLIDfklsRl 370 (488)
T COG5072 356 D-EGNVTLIDFKLSRL 370 (488)
T ss_pred e-cCceEEEEeeeeec
Confidence 9 99999999999984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.45 Score=47.53 Aligned_cols=70 Identities=17% Similarity=0.088 Sum_probs=42.5
Q ss_pred CcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--CcceeE---E--EEEeCCEEEEEEeccCC
Q 012637 22 TFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP--NVVELR---E--VMATKKKIFVAMEYVKG 94 (459)
Q Consensus 22 ~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~---~--~~~~~~~~~lV~E~~~g 94 (459)
.-..||+... .+|..+++|+....... ...+..|+..+..|... .++... + +...++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 3456888864 45678999988543322 24566788888777321 122221 1 22335678899999988
Q ss_pred Cc
Q 012637 95 GE 96 (459)
Q Consensus 95 g~ 96 (459)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 53
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.13 Score=50.62 Aligned_cols=75 Identities=15% Similarity=0.178 Sum_probs=47.4
Q ss_pred EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCCcceeEEEEEeCCEEEEEE
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR---HPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+-.+.++.|....+|... .+++.+.+|+-.... ...+..|..-|+.|. --.+.+.+.+....+..|++|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345678999999999887 788899999876221 123556777777773 445778898888777789999
Q ss_pred eccCCC
Q 012637 90 EYVKGG 95 (459)
Q Consensus 90 E~~~gg 95 (459)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.2 Score=51.36 Aligned_cols=76 Identities=16% Similarity=0.263 Sum_probs=45.2
Q ss_pred EeeeecccCcEEEEEEEEcCC-CcE-----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc-ceeEEEEEeCCEEE
Q 012637 14 MGRLLGKGTFAKVYYGKQLMT-GES-----VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV-VELREVMATKKKIF 86 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~-~~~-----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 86 (459)
..+.|..|--..+|++..... +.. |.+.+.... ....++ -.+|+.+++.+...++ .++++.+. -+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~----~g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFG----DF 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEec-cHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence 345666688889999875332 122 444432111 111111 2579999999965444 55666653 26
Q ss_pred EEEeccCCCch
Q 012637 87 VAMEYVKGGEL 97 (459)
Q Consensus 87 lV~E~~~gg~L 97 (459)
++.||++|..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 99999998765
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.65 E-value=1 Score=52.16 Aligned_cols=30 Identities=30% Similarity=0.537 Sum_probs=26.1
Q ss_pred CCcEeccCCCCCeEecCCC--CeE-EeecCCCc
Q 012637 128 RGVSHRDLKPENLLLDENE--DLK-ISDFGLSA 157 (459)
Q Consensus 128 ~gi~HrDlkp~NILl~~~~--~lK-l~DFGla~ 157 (459)
.+++|.|+.+.|||++.++ .+. |.|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 555 99999875
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.063 Score=49.16 Aligned_cols=28 Identities=21% Similarity=0.336 Sum_probs=25.4
Q ss_pred cEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 130 VSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 130 i~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
.+|+|+.|+||+++++| ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 59999999999998777 99999999874
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.34 E-value=0.083 Score=52.26 Aligned_cols=51 Identities=24% Similarity=0.352 Sum_probs=36.8
Q ss_pred HHHHHHHHHHHHHHHHHHh----CCcEeccCCCCCeEecCCC------------------CeEEeecCCCccc
Q 012637 109 DLARKYFQQLISAVDFCHS----RGVSHRDLKPENLLLDENE------------------DLKISDFGLSALP 159 (459)
Q Consensus 109 ~~~~~~~~qll~~L~~LH~----~gi~HrDlkp~NILl~~~~------------------~lKl~DFGla~~~ 159 (459)
+-++.++.|++.-.-.+-+ .+.+|-||||+|||+-+.. ..+|.||.+|.+.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 4578888998776544433 3699999999999996543 2567788777653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 459 | ||||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-57 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-56 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-56 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-55 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-55 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-55 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-54 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-54 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-54 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-54 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-54 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-54 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-54 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-54 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-54 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-53 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-53 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-51 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-51 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-47 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-47 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-46 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-46 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-46 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-43 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-41 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-41 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-40 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-40 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-40 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-40 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-40 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-40 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-39 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-39 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-39 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-38 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-38 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-38 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-38 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-38 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-38 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-38 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-38 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-38 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-38 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-38 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-37 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-37 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-37 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-37 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-37 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-37 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-37 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-37 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-37 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-37 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-37 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-37 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-37 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-37 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-37 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-37 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-37 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-37 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-37 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-37 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-37 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-37 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-36 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-36 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-36 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-36 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-36 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-36 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-36 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-35 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-35 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-35 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-35 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-35 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-35 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-35 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-35 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-35 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-35 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-35 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-34 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-34 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-34 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-34 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-34 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-34 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-34 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-34 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-34 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-34 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-34 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-34 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-34 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-33 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-33 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-33 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-33 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-33 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-33 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-33 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-33 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-33 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-33 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-33 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-33 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-33 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-33 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-33 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-33 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-32 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-32 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-32 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-32 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-32 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-32 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-32 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-32 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-32 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-32 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-32 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-32 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-32 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-32 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-32 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-32 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-32 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-32 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-31 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-31 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-31 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-31 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-31 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-31 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-31 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-31 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-31 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-31 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-31 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-31 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-31 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-31 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-31 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-31 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-31 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-31 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-31 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-31 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-31 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-31 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-31 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-31 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-31 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-31 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-31 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-31 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-31 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-31 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-31 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-31 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-31 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-31 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-31 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-31 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-31 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-31 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-31 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-31 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-31 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-31 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-31 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-31 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-31 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-31 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-31 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-31 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-31 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-30 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-30 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-30 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-30 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-30 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-30 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-30 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-30 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-30 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-30 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-30 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-30 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-30 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-30 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-30 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-30 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-30 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-30 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-30 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-30 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-30 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-30 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-30 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-30 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-30 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-30 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-30 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-30 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-30 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-30 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-29 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-29 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-29 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-29 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-29 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-29 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-29 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-29 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-29 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-29 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-29 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-29 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-29 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-29 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-29 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-29 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-29 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-29 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-29 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-29 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-29 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-29 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-29 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-29 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-29 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-29 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-29 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-29 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-29 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-29 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-29 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-29 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-28 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-28 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-28 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-28 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-28 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-28 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-28 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-28 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-27 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-27 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-26 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-26 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-26 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-26 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-26 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-26 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-25 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-25 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-25 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-25 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-24 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-24 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-24 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-24 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-23 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-23 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-23 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-23 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-23 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-23 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-23 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-23 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-23 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-23 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-23 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-23 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-22 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-21 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-21 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-21 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-21 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-21 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-21 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-21 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-21 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-21 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-21 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-21 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-21 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-21 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-21 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-21 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-20 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-20 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-20 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-20 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-20 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-20 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-20 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-20 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-20 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-20 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-20 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-16 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-14 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-04 |
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 510 bits (1316), Expect = e-180
Identities = 134/471 (28%), Positives = 225/471 (47%), Gaps = 60/471 (12%)
Query: 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREI 61
+ + V G Y +G LG GTF KV GK +TG VA+K++N+ +++ ++ +I+REI
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 62 SVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLIS 120
++L RHP++++L +V++T IF+ MEYV GGELF GRL E +R+ FQQ++S
Sbjct: 68 QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
VD+CH V HRDLKPEN+LLD + + KI+DFGLS + + L T CG+P Y AP
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAP 184
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ + Y G + D+WS GVILY LL G LPF D+++ +++K+ F P +++
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVA-----FSITQHDDD---------GD 286
L+ +L DP +R TI+ I WF++ + + +S T DD+
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFEC 304
Query: 287 DDQAATEKTENDRHNNQ---------EEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKK 337
++ N H + + + + + + S S D +L +
Sbjct: 305 SEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPE 364
Query: 338 TGSM---------------------------------FTSRYSARHIMEKIEGVAKGMNF 364
S+ IM ++ K +++
Sbjct: 365 RVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDY 424
Query: 365 KVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEY 415
+ V + +R+R + + ++++V +++F + LE
Sbjct: 425 EWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 475 bits (1226), Expect = e-169
Identities = 115/274 (41%), Positives = 172/274 (62%), Gaps = 4/274 (1%)
Query: 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREI 61
+ + V G Y +G LG GTF KV G+ +TG VA+K++N+ +++ ++ +IKREI
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 62 SVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLIS 120
++L RHP++++L +V++T F+ MEYV GGELF GR+ E AR+ FQQ++S
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
AVD+CH V HRDLKPEN+LLD + + KI+DFGLS + + L T CG+P Y AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAP 179
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ + Y G + D+WSCGVILY LL G LPF DE++ +++K+ F P +++
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
L+ +L DP +R TI+ I WF++ +
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 476 bits (1227), Expect = e-169
Identities = 97/292 (33%), Positives = 150/292 (51%), Gaps = 7/292 (2%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME-QIKREISVMRL 66
L GKY MG LLG+G++ KV T A+K++ K +L++ E +K+EI ++R
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 67 VRHPNVVELREVM--ATKKKIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLISAV 122
+RH NV++L +V+ K+K+++ MEY G E+ V R A YF QLI +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
++ HS+G+ H+D+KP NLLL LKIS G++ D T G+PA+ PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 183 LR-KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKR 241
+ G K D+WS GV LY + G PF+ +NI ++ + K + P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 242 LISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAF-SITQHDDDGDDDQAAT 292
L+ +L +P +R +I+ I + WFRK A I D D ++ T
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMT 294
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-168
Identities = 92/305 (30%), Positives = 159/305 (52%), Gaps = 6/305 (1%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
+++ + LG+G + +V +T E+VA+K+++ + E IK+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 62
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCH 126
H NVV+ ++ +EY GGELF + + E A+++F QL++ V + H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
G++HRD+KPENLLLDE ++LKISDFGL+ + + LL+ CGT YVAPE+L+++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFKAEFVYPPW--ISTDAKRLI 243
+ D+WSCG++L +LAG LP+ + Y + + PW I + L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 244 SKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNNQ 303
K+LV +P RITI I + W+ K + + ++ +++ +
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSP 302
Query: 304 EEKVS 308
S
Sbjct: 303 VNSAS 307
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 469 bits (1210), Expect = e-167
Identities = 91/269 (33%), Positives = 151/269 (56%), Gaps = 6/269 (2%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
+++ + LG+G + +V +T E+VA+K+++ + E IK+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 62
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCH 126
H NVV+ ++ +EY GGELF + + E A+++F QL++ V + H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
G++HRD+KPENLLLDE ++LKISDFGL+ + + LL+ CGT YVAPE+L+++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFKAEFVYPPW--ISTDAKRLI 243
+ D+WSCG++L +LAG LP+ + Y + + PW I + L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 244 SKLLVSDPERRITIQSIMRVPWFRKGFTR 272
K+LV +P RITI I + W+ K +
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 469 bits (1210), Expect = e-165
Identities = 115/358 (32%), Positives = 170/358 (47%), Gaps = 23/358 (6%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
++ +Y+ + +G G F + +T E VA+K I + + E ++RE
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLI 119
I R +RHPN+V +EV+ T + + MEY GGEL+ + GR ED AR +FQQL+
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENE--DLKISDFGLSALPEQLRNDGLLHTQCGTPAY 177
S V +CHS + HRDLK EN LLD + LKI DFG S + GTPAY
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAY 183
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK----VFKAEFVYPP 233
+APEVL ++ YDG AD+WSCGV LYV+L G PF+D YRK + ++ P
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 234 --WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAA 291
IS + LIS++ V+DP RI+I I WF K + + +Q
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPM 303
Query: 292 TEKTENDRHNNQEEKVS-SPKFFNAFEFISSMSSGFDLSNLFENKKKTGSM-FTSRYS 347
+ ++ + + + F M+ DL + ++ + S
Sbjct: 304 QSLDTIMQIISEATIPAVRNRCLDDF-----MTDNLDLDDDMDDFDSESEIDIDSSGE 356
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 461 bits (1188), Expect = e-162
Identities = 122/289 (42%), Positives = 180/289 (62%), Gaps = 7/289 (2%)
Query: 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREI 61
+RH+ G Y + LG+G+F KV T + VA+K I++ LKK M +++REI
Sbjct: 3 ISKRHI--GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 62 SVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLIS 120
S ++L+RHP++++L +V+ T I + +EY GGELF V + R+ ED R++FQQ+I
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
A+++CH + HRDLKPENLLLD+N ++KI+DFGLS + + L T CG+P Y AP
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAP 176
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
EV+ K Y G + D+WSCG++LYV+L G LPF DE I N+++KV +V P ++S A+
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQ 289
LI +++V+DP +RITIQ I R PWF + D
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRI 285
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 452 bits (1164), Expect = e-159
Identities = 95/263 (36%), Positives = 134/263 (50%), Gaps = 4/263 (1%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+Y GR LGKG FAK + T E A K++ K L K E++ EIS+ R + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSR 128
+VV +FV +E + L R L E AR Y +Q++ + H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
V HRDLK NL L+E+ ++KI DFGL+ E + CGTP Y+APEVL KKG+
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248
+ D+WS G I+Y LL G PF+ + Y ++ K E+ P I+ A LI K+L
Sbjct: 193 SF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 249 SDPERRITIQSIMRVPWFRKGFT 271
+DP R TI ++ +F G+
Sbjct: 252 TDPTARPTINELLNDEFFTSGYI 274
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 452 bits (1164), Expect = e-159
Identities = 95/263 (36%), Positives = 134/263 (50%), Gaps = 4/263 (1%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+Y GR LGKG FAK + T E A K++ K L K E++ EIS+ R + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSR 128
+VV +FV +E + L R L E AR Y +Q++ + H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
V HRDLK NL L+E+ ++KI DFGL+ E + CGTP Y+APEVL KKG+
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248
+ D+WS G I+Y LL G PF+ + Y ++ K E+ P I+ A LI K+L
Sbjct: 219 SF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 249 SDPERRITIQSIMRVPWFRKGFT 271
+DP R TI ++ +F G+
Sbjct: 278 TDPTARPTINELLNDEFFTSGYI 300
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 445 bits (1147), Expect = e-157
Identities = 87/266 (32%), Positives = 152/266 (57%), Gaps = 5/266 (1%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+++G LLGKG+FA VY + + TG VAIK+I+K + K M+++++ E+ + ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLISAVDFCHS 127
P+++EL +++ +E GE+ K E+ AR + Q+I+ + + HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
G+ HRDL NLLL N ++KI+DFGL+ + +T CGTP Y++PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRSA 188
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLL 247
+ G ++D+WS G + Y LL G PF + + N KV A++ P ++S +AK LI +LL
Sbjct: 189 H-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 248 VSDPERRITIQSIMRVPWFRKGFTRP 273
+P R+++ S++ P+ + +
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRNSSTK 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 442 bits (1138), Expect = e-155
Identities = 94/296 (31%), Positives = 151/296 (51%), Gaps = 31/296 (10%)
Query: 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF--------- 52
V +Y + +GKG++ V A+KV++K +L ++
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 53 --------------MMEQIKREISVMRLVRHPNVVELREVM--ATKKKIFVAMEYVKGGE 96
+EQ+ +EI++++ + HPNVV+L EV+ + +++ E V G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 97 LFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156
+ L ED AR YFQ LI +++ H + + HRD+KP NLL+ E+ +KI+DFG+S
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLR--KKGYDGSKADLWSCGVILYVLLAGFLPFQD 214
+ +D LL GTPA++APE L +K + G D+W+ GV LY + G PF D
Sbjct: 185 NEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 215 ENIMNMYRKVFKAEFVYP--PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
E IM ++ K+ +P P I+ D K LI+++L +PE RI + I PW +
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 438 bits (1130), Expect = e-154
Identities = 96/271 (35%), Positives = 154/271 (56%), Gaps = 6/271 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
+R +++GR LGKG F VY ++ +A+KV+ K QL+KE + Q++REI
Sbjct: 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISA 121
+ +RHPN++ + +K+I++ +E+ GEL+ ++ + GR E + + ++L A
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181
+ +CH R V HRD+KPENLL+ +LKI+DFG S LR T CGT Y+ PE
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPE 182
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKR 241
++ K +D K DLW GV+ Y L G PF + +R++ + +PP++S +K
Sbjct: 183 MIEGKTHDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241
Query: 242 LISKLLVSDPERRITIQSIMRVPWFRKGFTR 272
LISKLL P +R+ ++ +M PW + R
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 433 bits (1115), Expect = e-152
Identities = 89/276 (32%), Positives = 152/276 (55%), Gaps = 6/276 (2%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
++R +E+GR LGKG F VY ++ + +A+KV+ K QL+K + Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISA 121
+ +RHPN++ L ++++ +EY G ++ ++ + + E Y +L +A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181
+ +CHS+ V HRD+KPENLLL +LKI+DFG S R CGT Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKR 241
++ + +D K DLWS GV+ Y L G PF+ Y+++ + EF +P +++ A+
Sbjct: 178 MIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 242 LISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFS 277
LIS+LL +P +R ++ ++ PW ++P
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 427 bits (1100), Expect = e-149
Identities = 113/287 (39%), Positives = 177/287 (61%), Gaps = 5/287 (1%)
Query: 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV 63
+ G Y + + +GKG FAKV + ++TG VAIK+I+K QL ++++ RE+ +
Sbjct: 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRI 67
Query: 64 MRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAV 122
M+++ HPN+V+L EV+ T+K +++ MEY GGE+F VA GR++E AR F+Q++SAV
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
+CH + + HRDLK ENLLLD + ++KI+DFG S G L CG P Y APE+
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPYAAPEL 184
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
+ K YDG + D+WS GVILY L++G LPF +N+ + +V + ++ P ++STD + L
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQ 289
+ + LV +P +R T++ IM+ W G + + D D +
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQK 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 412 bits (1060), Expect = e-143
Identities = 84/281 (29%), Positives = 140/281 (49%), Gaps = 20/281 (7%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQ---IKR 59
++R +Y +G LLGKG F V+ G +L VAIKVI ++++ +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 60 EISVMRLVR----HPNVVELREVMATKKKIFVAMEY-VKGGELFAK-VARGRLREDLARK 113
E++++ V HP V+ L + T++ + +E + +LF +G L E +R
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 114 YFQQLISAVDFCHSRGVSHRDLKPENLLLD-ENEDLKISDFGLSALPEQLRNDGLLHTQC 172
+F Q+++A+ CHSRGV HRD+K EN+L+D K+ DFG AL D
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDFD 199
Query: 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP 232
GT Y PE + + Y A +WS G++LY ++ G +PF+ + +++ +AE +P
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFP 253
Query: 233 PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
+S D LI + L P R +++ I+ PW +
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-142
Identities = 83/322 (25%), Positives = 147/322 (45%), Gaps = 16/322 (4%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME----- 55
+ KY LG G F V+ + V +K I K+++ ++ +E
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 56 QIKREISVMRLVRHPNVVELREVMATKKKIFVAME-YVKGGELFAK-VARGRLREDLARK 113
++ EI+++ V H N++++ ++ + + ME + G +LFA RL E LA
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 114 YFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG 173
F+QL+SAV + + + HRD+K EN+++ E+ +K+ DFG +A E+ L +T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---GKLFYTFCG 191
Query: 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP 233
T Y APEVL Y G + ++WS GV LY L+ PF + + +A P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY 245
Query: 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATE 293
+S + L+S LL PERR T++ ++ PW + + + +
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
Query: 294 KTENDRHNNQEEKVSSPKFFNA 315
+ + + + + +
Sbjct: 306 ASLEMGNRSLSDVAQAQELCGG 327
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 409 bits (1053), Expect = e-142
Identities = 86/288 (29%), Positives = 142/288 (49%), Gaps = 18/288 (6%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMM---EQIKR 59
+E+ L +Y++G LLG G F VY G ++ VAIK + KD++ + ++
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 60 EISVMRLVRH--PNVVELREVMATKKKIFVAMEYVKG-GELFAK-VARGRLREDLARKYF 115
E+ +++ V V+ L + + +E + +LF RG L+E+LAR +F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 116 QQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRNDGLLHTQCGT 174
Q++ AV CH+ GV HRD+K EN+L+D N +LK+ DFG AL + D + GT
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGT 211
Query: 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW 234
Y PE +R Y G A +WS G++LY ++ G +PF+ + ++ + + +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR 265
Query: 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHD 282
+S++ + LI L P R T + I PW + I H
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS 313
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 389 bits (1000), Expect = e-134
Identities = 59/318 (18%), Positives = 131/318 (41%), Gaps = 51/318 (16%)
Query: 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF--------- 52
+E+ Y + R L +G F K+ ++ + A+K K L+K+
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 53 -----MMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELF--------- 98
+ K E+ ++ +++ + ++ ++++ EY++ +
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 99 AKVARGRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSA 157
K + + + + ++++ + H+ + + HRD+KP N+L+D+N +K+SDFG S
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 158 LPEQLRNDGLLHTQCGTPAYVAPEVL-RKKGYDGSKADLWSCGVILYVLLAGFLPFQDE- 215
D + GT ++ PE + Y+G+K D+WS G+ LYV+ +PF +
Sbjct: 201 YMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 216 NIMNMYRKVFKAEFVYP-------------------PWISTDAKRLISKLLVSDPERRIT 256
+++ ++ + YP ++S + + L +P RIT
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 257 IQSIMRVPWFRKGFTRPV 274
+ ++ W +
Sbjct: 317 SEDALKHEWLADTNIEDL 334
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-113
Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 13/267 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y++ LGKG F+ V TG A K+IN +L ++++RE + R ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHP 65
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+V L + + + ++ + V GGELF VAR E A QQ++ ++ +CHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HR+LKPENLLL + +K++DFGL+ ++ + H GTP Y++PEVL+K
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY--PPW--ISTDAKRL 242
Y D+W+CGVILY+LL G+ PF DE+ +Y ++ + Y P W ++ +AK L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKG 269
I +L +P++RIT ++VPW
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNR 268
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-112
Identities = 96/316 (30%), Positives = 164/316 (51%), Gaps = 22/316 (6%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-----KKEFMMEQIKREIS 62
L +Y M + LG G +V + T + VAIK+I+K + ++ ++ EI
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISA 121
+++ + HP +++++ + ++ +E ++GGELF K V RL+E + YF Q++ A
Sbjct: 68 ILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 122 VDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV 178
V + H G+ HRDLKPEN+LL +E+ +KI+DFG S + L L+ T CGTP Y+
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYL 183
Query: 179 APEVLR---KKGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVFKAEFVY--P 232
APEVL GY D WS GVIL++ L+G+ PF + +++ ++ ++ +
Sbjct: 184 APEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 233 PW--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQA 290
W +S A L+ KLLV DP+ R T + +R PW + + + +++
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQ 302
Query: 291 ATEKTENDRHNNQEEK 306
+ R +E +
Sbjct: 303 VLAQPSTSRKRPREGE 318
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-112
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+E +LG+G F +V + + AIK I + K I E+ ++ + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLLASLNHQ 62
Query: 71 NVVELREV-------------MATKKKIFVAMEYVKGGELFAKVARGR--LREDLARKYF 115
VV + K +F+ MEY + G L+ + + D + F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 116 QQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ------------LR 163
+Q++ A+ + HS+G+ HRDLKP N+ +DE+ ++KI DFGL+ +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK 223
+ L + GT YVA EVL G+ K D++S G+I + ++ +N+ +K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK 240
Query: 224 VFKAEFVYPPW----ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270
+ +PP K++I L+ DP +R ++++ W
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-110
Identities = 100/267 (37%), Positives = 150/267 (56%), Gaps = 16/267 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+ +LG G F++V+ KQ +TG+ A+K I K ++ ++ EI+V++ ++H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHE 66
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+V L ++ + ++ M+ V GGELF + + RG E A QQ++SAV + H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRDLKPENLL +EN + I+DFGLS + + +G++ T CGTP YVAPEVL +K
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQK 182
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY--PPW--ISTDAKRL 242
Y D WS GVI Y+LL G+ PF +E ++ K+ + + + P W IS AK
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKG 269
I LL DP R T + + PW
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 328 bits (844), Expect = e-110
Identities = 94/275 (34%), Positives = 146/275 (53%), Gaps = 21/275 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK-----EFMMEQIKREISVMR 65
KY+ ++G+G + V TG A+K++ + E + E +RE ++R
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 66 -LVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVD 123
+ HP+++ L + + +F+ + ++ GELF + L E R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVL 183
F H+ + HRDLKPEN+LLD+N +++SDFG S L L CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 184 R------KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW- 234
+ GY G + DLW+CGVIL+ LLAG PF + M R + + +F P W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 235 -ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
S+ K LIS+LL DPE R+T + ++ P+F +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 324 bits (834), Expect = e-110
Identities = 92/271 (33%), Positives = 141/271 (52%), Gaps = 16/271 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y + +G+G++ +V Q T A K I K ++ ++ K+EI +M+ + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSLDHP 66
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N++ L E I++ ME GGELF + V + RE A + + ++SAV +CH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
V+HRDLKPEN L + LK+ DFGL+A + ++ T+ GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLEGL 183
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTDAKRL 242
Y G + D WS GV++YVLL G+ PF + K+ + F W +S A+ L
Sbjct: 184 -Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
I +LL P++RIT + WF K +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-109
Identities = 96/271 (35%), Positives = 151/271 (55%), Gaps = 13/271 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y++ LGKG F+ V TG A K+IN +L ++++RE + R ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHP 88
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+V L + + + ++ + V GGELF VAR E A QQ++ ++ +CHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HR+LKPENLLL + +K++DFGL+ ++ + H GTP Y++PEVL+K
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY--PPW--ISTDAKRL 242
Y D+W+CGVILY+LL G+ PF DE+ +Y ++ + Y P W ++ +AK L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
I +L +P++RIT ++VPW
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-109
Identities = 91/282 (32%), Positives = 143/282 (50%), Gaps = 22/282 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK------EFMMEQIKREISVM 64
YE +LG+G + V T + A+K+I+ + + E +E+ ++
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 65 R-LVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAV 122
R + HPN+++L++ T F+ + +K GELF + L E RK + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
H + HRDLKPEN+LLD++ ++K++DFG S QL L CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 194
Query: 183 LR------KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW 234
+ GY G + D+WS GVI+Y LLAG PF M M R + +F P W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 235 --ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
S K L+S+ LV P++R T + + P+F++ V
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-108
Identities = 100/266 (37%), Positives = 150/266 (56%), Gaps = 14/266 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y + +LGKG+F +V K +T + A+KVINK K + I RE+ +++ + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHP 81
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+++L E++ ++ E GGELF + + R R E A + +Q+ S + + H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRDLKPEN+LL +++ D+KI DFGLS + + + + GT Y+APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTDAKRL 242
Y K D+WS GVILY+LL+G PF +N ++ ++V F P W IS DAK L
Sbjct: 199 -Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRK 268
I K+L P RIT + PW +K
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = e-107
Identities = 93/278 (33%), Positives = 154/278 (55%), Gaps = 22/278 (7%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-----KKEFMMEQIKREIS 62
L +Y M + LG G +V + T + VAI++I+K + ++ ++ EI
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISA 121
+++ + HP +++++ + ++ +E ++GGELF K V RL+E + YF Q++ A
Sbjct: 193 ILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 122 VDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV 178
V + H G+ HRDLKPEN+LL +E+ +KI+DFG S + L L+ T CGTP Y+
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYL 308
Query: 179 APEVLR---KKGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVFKAEFVY--P 232
APEVL GY D WS GVIL++ L+G+ PF + +++ ++ ++ +
Sbjct: 309 APEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367
Query: 233 PW--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
W +S A L+ KLLV DP+ R T + +R PW +
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-107
Identities = 87/270 (32%), Positives = 143/270 (52%), Gaps = 18/270 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+ R LG G F V+ ++ +G IK INKD+ + MEQI+ EI V++ + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHP 80
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKV-----ARGRLREDLARKYFQQLISAVDFC 125
N++++ EV +++ ME +GGEL ++ L E + +Q+++A+ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 126 HSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
HS+ V H+DLKPEN+L + +KI DFGL+ L ++D GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEV 197
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP--PW-ISTDA 239
++ K D+WS GV++Y LL G LPF ++ + +K E Y ++ A
Sbjct: 198 FKRD-V-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 240 KRLISKLLVSDPERRITIQSIMRVPWFRKG 269
L+ ++L DPERR + ++ WF++
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-104
Identities = 99/272 (36%), Positives = 156/272 (57%), Gaps = 14/272 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y++ LGKG F+ V +++ G+ A +IN +L ++++RE + RL++HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHP 70
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+V L + ++ + ++ + V GGELF VAR E A QQ++ AV CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDG-LLHTQCGTPAYVAPEVLRK 185
V HR+LKPENLLL + +K++DFGL+ ++ + GTP Y++PEVLRK
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY--PPW--ISTDAKR 241
Y G DLW+CGVILY+LL G+ PF DE+ +Y+++ + + P W ++ +AK
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 242 LISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
LI+K+L +P +RIT ++ PW T
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-104
Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 20/274 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y + + +G G +KV+ + AIK +N ++ + ++ + EI+ + ++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 86
Query: 71 N--VVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHS 127
+ ++ L + T + I++ ME +L + + + + Y++ ++ AV H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
G+ H DLKP N L+ + LK+ DFG++ + + +Q GT Y+ PE ++
Sbjct: 146 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 188 YD----------GSKADLWSCGVILYVLLAGFLPFQD--ENIMNMYRKV-FKAEFVYPPW 234
K+D+WS G ILY + G PFQ I ++ + E +P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
D + ++ L DP++RI+I ++ P+ +
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-103
Identities = 96/276 (34%), Positives = 146/276 (52%), Gaps = 16/276 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFM---MEQIKREISVMRLV 67
YEMG LG G FA V +Q TG+ A K I K +L E+I+RE++++R +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCH 126
RHPN++ L ++ K + + +E V GGELF + L ED A ++ +Q++ V + H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 127 SRGVSHRDLKPENLLL----DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
S+ ++H DLKPEN++L N +K+ DFG++ + GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEI 182
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTD 238
+ + G +AD+WS GVI Y+LL+G PF E + +F + S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
AK I +LLV DP+RR+TI + W + R V
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-102
Identities = 104/267 (38%), Positives = 156/267 (58%), Gaps = 18/267 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+E+ LG+G + VY KQ T + A+KV+ K K + ++ EI V+ + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-----KIVRTEIGVLLRLSHP 108
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+++L+E+ T +I + +E V GGELF + V +G E A +Q++ AV + H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRDLKPENLL + LKI+DFGLS + + + L+ T CGTP Y APE+LR
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFKAEFVY--PPW--ISTDAKR 241
Y G + D+WS G+I Y+LL GF PF DE M+R++ E+ + P W +S +AK
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 242 LISKLLVSDPERRITIQSIMRVPWFRK 268
L+ KL+V DP++R+T ++ PW
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = e-102
Identities = 82/283 (28%), Positives = 153/283 (54%), Gaps = 18/283 (6%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMM--EQIK 58
M ++ + YE+ ++GKG F+ V TG+ A+K+++ + + E +K
Sbjct: 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 59 REISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLR----EDLARK 113
RE S+ +++HP++VEL E ++ +++ E++ G +L + V R E +A
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 114 YFQQLISAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHT 170
Y +Q++ A+ +CH + HRD+KP +LL + + +K+ FG++ + + +
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGG 192
Query: 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--E 228
+ GTP ++APEV++++ Y G D+W CGVIL++LL+G LPF ++ + K +
Sbjct: 193 RVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYK 250
Query: 229 FVYPPW--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269
W IS AK L+ ++L+ DP RIT+ + PW ++
Sbjct: 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 304 bits (779), Expect = e-100
Identities = 86/310 (27%), Positives = 142/310 (45%), Gaps = 52/310 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFM--MEQIKREISVMRLVR 68
KY + +G+G++ V + T AIK++NK+++++ +E+IK E+ +M+ +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLR-------------------- 107
HPN+ L EV ++ I + ME GG L K
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 108 --------------------EDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL--DEN 145
E L +Q+ SA+ + H++G+ HRD+KPEN L +++
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 146 EDLKISDFGLSAL--PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD-GSKADLWSCGVIL 202
++K+ DFGLS + T+ GTP +VAPEVL G K D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 203 YVLLAGFLPFQDENIMNMYRKVFKAE--FVYPPW--ISTDAKRLISKLLVSDPERRITIQ 258
++LL G +PF N + +V + F P + +S A+ L+S LL + + R
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326
Query: 259 SIMRVPWFRK 268
++ PW +
Sbjct: 327 RALQHPWISQ 336
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-100
Identities = 96/282 (34%), Positives = 146/282 (51%), Gaps = 16/282 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMM---EQIKREISVMRLV 67
Y+ G LG G FA V ++ TG A K I K + K E I+RE+S+++ +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCH 126
+HPNV+ L EV K + + +E V GGELF + L E+ A ++ +Q+++ V + H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 127 SRGVSHRDLKPENLLL----DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
S ++H DLKPEN++L +KI DFGL+ ++ GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 188
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTD 238
+ + G +AD+WS GVI Y+LL+G PF + V EF + S
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQ 280
AK I +LLV DP++R+TIQ ++ PW + T+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAS 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 61/311 (19%), Positives = 114/311 (36%), Gaps = 51/311 (16%)
Query: 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV 63
+ + + +LG+G A V+ G+ TG+ AIKV N + ++ RE V
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEV 60
Query: 64 MRLVRHPNVVELREVM--ATKKKIFVAMEYVKGGELFAK-VARGR---LREDLARKYFQQ 117
++ + H N+V+L + T + + ME+ G L+ L E +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENED----LKISDFGLSALPEQLRNDGLLHTQCG 173
++ ++ G+ HR++KP N++ ED K++DFG + +L +D + G
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYG 177
Query: 174 TPAYVAPEVLRKKGYD-------GSKADLWSCGVILYVLLAGFLPFQD----ENIMNMYR 222
T Y+ P++ + G+ DLWS GV Y G LPF+ +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 223 KVFKAEFV-------------------------YPPWISTDAKRLISKLLVSDPERRITI 257
K+ + + +++ +L +D E+
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 258 QSIMRVPWFRK 268
Sbjct: 298 DQFFAETSDIL 308
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-100
Identities = 88/276 (31%), Positives = 140/276 (50%), Gaps = 23/276 (8%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRH 69
YE+ +G G+++ T A+K+I+K + EI ++ R +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQH 75
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSR 128
PN++ L++V K ++V E +KGGEL K + + E A + V++ H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 129 GVSHRDLKPENLLLDENED----LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
GV HRDLKP N+L + ++I DFG + +GLL T C T +VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLE 193
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPF---QDENIMNMYRKVFKAEFVY--PPW--IST 237
++GYD + D+WS GV+LY +L G+ PF D+ + ++ +F W +S
Sbjct: 194 RQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
AK L+SK+L DP +R+T ++R PW P
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-100
Identities = 71/345 (20%), Positives = 138/345 (40%), Gaps = 27/345 (7%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
Y + + +G G +KV+ + AIK +N ++ + ++ + EI+ + ++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQ 113
Query: 70 PN--VVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCH 126
+ ++ L + T + I++ ME +L + + + + Y++ ++ AV H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
G+ H DLKP N L+ + LK+ DFG++ + + +Q G Y+ PE ++
Sbjct: 173 QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 187 GYD----------GSKADLWSCGVILYVLLAGFLPFQD--ENIMNMYRKV-FKAEFVYPP 233
K+D+WS G ILY + G PFQ I ++ + E +P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATE 293
D + ++ L DP++RI+I ++ P+ + T PV ++
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ-THPVNQMAKGTTEE------MKY 344
Query: 294 KTENDRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKT 338
N + + S S FE K+
Sbjct: 345 VLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGK 389
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-100
Identities = 101/282 (35%), Positives = 154/282 (54%), Gaps = 14/282 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y + +LGKG+F +V K +T + A+KVINK K + I RE+ +++ + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHP 81
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+++L E++ ++ E GGELF + + R R E A + +Q+ S + + H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRDLKPEN+LL +++ D+KI DFGLS + + + + GT Y+APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPPW--ISTDAKRL 242
Y K D+WS GVILY+LL+G PF +N ++ ++V + F P W IS DAK L
Sbjct: 199 -Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDD 284
I K+L P RIT + PW +K + S +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLES 298
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-100
Identities = 90/271 (33%), Positives = 142/271 (52%), Gaps = 16/271 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLV 67
Y++G LG G FA V ++ TG A K I K Q + E+I+RE+S++R V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCH 126
H NV+ L +V + + + +E V GGELF + L E+ A + +Q++ V++ H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 127 SRGVSHRDLKPENLLL----DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
++ ++H DLKPEN++L +K+ DFGL+ ++ + GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEI 189
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTD 238
+ + G +AD+WS GVI Y+LL+G PF + + +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKG 269
AK I KLLV + +R+TIQ +R PW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPV 279
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-100
Identities = 93/340 (27%), Positives = 155/340 (45%), Gaps = 29/340 (8%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLV 67
Y++G LG G FA V ++ TG A K I K Q + E+I+RE+S++R V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCH 126
HPN++ L +V + + + +E V GGELF + L E+ A + +Q++ V++ H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 127 SRGVSHRDLKPENLLL----DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
++ ++H DLKPEN++L +K+ DFGL+ ++ + GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEI 189
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTD 238
+ + G +AD+WS GVI Y+LL+G PF + + +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTEND 298
AK I KLLV + +R+TIQ +R PW + + EN
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPV-----------DTQQAMVRRESVVNLENF 297
Query: 299 RHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKT 338
+ + F+ + ++ +
Sbjct: 298 KKQYVRRRWK--LSFSIVSLCNHLTRSLMKKVHLRTSEDL 335
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-100
Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 20/274 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y + + +G G +KV+ + AIK +N ++ + ++ + EI+ + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 67
Query: 71 N--VVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHS 127
+ ++ L + T + I++ ME +L + + + + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
G+ H DLKP N L+ + LK+ DFG++ + + +Q GT Y+ PE ++
Sbjct: 127 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 188 YD----------GSKADLWSCGVILYVLLAGFLPFQD--ENIMNMYRKV-FKAEFVYPPW 234
K+D+WS G ILY + G PFQ I ++ + E +P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
D + ++ L DP++RI+I ++ P+ +
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 1e-98
Identities = 95/282 (33%), Positives = 146/282 (51%), Gaps = 28/282 (9%)
Query: 11 KYEMG---RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
Y++ + LG+G+F+ + ++ A+K+I+K ++EI+ ++L
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 68 R-HPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFC 125
HPN+V+L EV + F+ ME + GGELF + + E A ++L+SAV
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 126 HSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
H GV HRDLKPENLL ++N ++KI DFG + L ++ L T C T Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------IMNMYRKVFKA--EFVYPP 233
L + GYD DLWS GVILY +L+G +PFQ + + + +K+ K F
Sbjct: 181 LNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 234 W--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
W +S +AK LI LL DP +R+ + + W + G
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 309 bits (792), Expect = 1e-98
Identities = 85/336 (25%), Positives = 129/336 (38%), Gaps = 44/336 (13%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
G +EM LG G F V TGE VAIK ++ K E+ EI +M+ + H
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNH 71
Query: 70 PNVVELREVMATKKKI------FVAMEYVKGGELFAK-VARGR---LREDLARKYFQQLI 119
PNVV REV +K+ +AMEY +GG+L L+E R +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENED---LKISDFGLSALPEQLRNDGLLHTQCGTPA 176
SA+ + H + HRDLKPEN++L KI D G + +L L GT
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGTLQ 188
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWIS 236
Y+APE+L +K Y D WS G + + + GF PF + + + +
Sbjct: 189 YLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 237 TD------------------------AKRLISKLLVSDPERRITIQSIMRVPWFRKGFTR 272
D +R + +L+ +R T V F+
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL-DS 306
Query: 273 PVAFSITQHDDDGDDDQAATEKTENDRHNNQEEKVS 308
++ + + TEN+ N + +
Sbjct: 307 ILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQ 342
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = 1e-98
Identities = 99/281 (35%), Positives = 157/281 (55%), Gaps = 13/281 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ R+LGKG+F +V K +TG+ A+KVI+K Q+K++ E + RE+ +++ + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+++L E K ++ E GGELF + ++R R E A + +Q++S + + H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRDLKPENLLL ++ +++I DFGLS + + GT Y+APEVL
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVLHGT 203
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPPW--ISTDAKRL 242
Y K D+WS GVILY+LL+G PF N ++ +KV K + F P W +S AK L
Sbjct: 204 -Y-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDD 283
I K+L P RI+ + + W + ++ + D+
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 4e-98
Identities = 79/271 (29%), Positives = 132/271 (48%), Gaps = 17/271 (6%)
Query: 11 KYEM-GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
Y + + LG+G FA V TG+ A K + K + ++ +I EI+V+ L +
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKS 87
Query: 70 -PNVVELREVMATKKKIFVAMEYVKGGELFAKVA---RGRLREDLARKYFQQLISAVDFC 125
P V+ L EV +I + +EY GGE+F+ + E+ + +Q++ V +
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 126 HSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
H + H DLKP+N+LL D+KI DFG+S ++ + L GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMGTPEYLAPEI 204
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTD 238
L + D+W+ G+I Y+LL PF E+ Y + + ++ + +S
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKG 269
A I LLV +PE+R T + + W ++
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 299 bits (766), Expect = 4e-98
Identities = 64/323 (19%), Positives = 118/323 (36%), Gaps = 51/323 (15%)
Query: 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV 63
+ + + +LG+G A V+ G+ TG+ AIKV N + ++ RE V
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEV 60
Query: 64 MRLVRHPNVVELREVM--ATKKKIFVAMEYVKGGELFAK-VARGR---LREDLARKYFQQ 117
++ + H N+V+L + T + + ME+ G L+ L E +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENED----LKISDFGLSALPEQLRNDGLLHTQCG 173
++ ++ G+ HR++KP N++ ED K++DFG + +L +D + G
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYG 177
Query: 174 TPAYVAPEVLRKKGYD-------GSKADLWSCGVILYVLLAGFLPFQD----ENIMNMYR 222
T Y+ P++ + G+ DLWS GV Y G LPF+ +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 223 KVFKAEFV-------------------------YPPWISTDAKRLISKLLVSDPERRITI 257
K+ + + +++ +L +D E+
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 258 QSIMRVPWFRKGFTRPVAFSITQ 280
FS+ Q
Sbjct: 298 DQFFAETSDILHRMVIHVFSLQQ 320
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 4e-97
Identities = 90/294 (30%), Positives = 146/294 (49%), Gaps = 39/294 (13%)
Query: 11 KYEMGR-LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR- 68
Y++ +LG+G A+V L+T + A+K+I K ++ RE+ ++ +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQG 69
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHS 127
H NV+EL E + + ++ E ++GG + + R E A Q + SA+DF H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 128 RGVSHRDLKPENLLL---DENEDLKISDFGLSAL-----PEQLRNDGLLHTQCGTPAYVA 179
+G++HRDLKPEN+L ++ +KI DF L + + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 180 PEVLRK-----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN--------------- 219
PEV+ YD + DLWS GVILY+LL+G+ PF +
Sbjct: 190 PEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 220 MYRKVFKA--EFVYPPW--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269
++ + + EF W IS AK LISKLLV D ++R++ +++ PW +
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 1e-96
Identities = 100/282 (35%), Positives = 157/282 (55%), Gaps = 14/282 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y+ + LG G + +V + +T AIK+I K + ++ E++V++L+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHP 96
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLISAVDFCHSRG 129
N+++L + K+ ++ ME KGGELF + + R + E A +Q++S V + H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRDLKPENLLL +++ +KI DFGLSA+ N + + GT Y+APEVLRKK
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLRKK 213
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPPW--ISTDAKRL 242
Y K D+WS GVIL++LLAG+ PF + + RKV K + F P W +S AK L
Sbjct: 214 -Y-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDD 284
I ++L D +RRI+ Q + PW ++ ++ + +
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 1e-96
Identities = 76/339 (22%), Positives = 138/339 (40%), Gaps = 31/339 (9%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY + LG+G F V+ + + ++ K + + +K+EIS++ + RH
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIARHR 61
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARG-RLREDLARKYFQQLISAVDFCHSR 128
N++ L E + +++ + E++ G ++F + L E Y Q+ A+ F HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 129 GVSHRDLKPENLLL--DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ H D++PEN++ + +KI +FG + QL+ P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTDAKRL 242
+ D+WS G ++YVLL+G PF E + + A F + IS +A
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
+ +LLV + + R+T ++ PW + + +T R
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLK---------------QKIERVSTKVIRTLKHRRYY 282
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSM 341
+ IS + + K K S+
Sbjct: 283 HTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVASI 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 1e-96
Identities = 86/352 (24%), Positives = 157/352 (44%), Gaps = 34/352 (9%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y++ LG G F V+ + TG K IN + +K EIS+M + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHP 108
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAK-VARG-RLREDLARKYFQQLISAVDFCHSR 128
++ L + K ++ + +E++ GGELF + A ++ E Y +Q + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 129 GVSHRDLKPENLLL--DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ H D+KPEN++ + +KI DFGL+ +L D ++ T + APE++ ++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTDAKRL 242
G D+W+ GV+ YVLL+G PF E+ + + V + EF + +S +AK
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
I LL +P +R+T+ + PW + D + + + R
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKG-------------DHSNLTSRIPSSRYNKIRQKI 331
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSARHIMEK 354
+E+ P A I++ SS L +++ + ++ S + + + +
Sbjct: 332 KEKYADWPAPQPAIGRIANFSS------LRKHRPQEYQIYDSYFDRKEAVPR 377
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 6e-96
Identities = 96/353 (27%), Positives = 163/353 (46%), Gaps = 49/353 (13%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHP 70
++LG G KV T E A+K++ + +RE+ + R + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 71 NVVELREV----MATKKKIFVAMEYVKGGELFAK-VARGRLR--EDLARKYFQQLISAVD 123
++V + +V A +K + + ME + GGELF++ RG E A + + + A+
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 124 FCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
+ HS ++HRD+KPENLL N LK++DFG + + + L T C TP YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAP 232
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------EFVYPPW 234
EVL + YD D+WS GVI+Y+LL G+ PF + + + + EF P W
Sbjct: 233 EVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 235 --ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAAT 292
+S + K LI LL ++P +R+TI M PW + P +
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP----------QTPLHTSRV 341
Query: 293 EKTENDRHNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSR 345
K + +R + +E+++S +++M ++ + + + + + R
Sbjct: 342 LKEDKERWEDVKEEMTS--------ALATMRVDYEQIKIKKIEDASNPLLLKR 386
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 7e-96
Identities = 100/291 (34%), Positives = 149/291 (51%), Gaps = 23/291 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFM----------MEQIKRE 60
Y R LG G + +V K+ AIKVI K Q K E+I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 61 ISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARGRLREDLARKYFQQLI 119
IS+++ + HPN+++L +V KK ++ E+ +GGELF + + R + E A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 120 SAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
S + + H + HRD+KPEN+LL + ++KI DFGLS D L + GT
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAY 213
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPPW 234
Y+APEVL+KK Y K D+WSCGVI+Y+LL G+ PF +N ++ +KV K + F + W
Sbjct: 214 YIAPEVLKKK-Y-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 235 --ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDD 283
IS +AK LI +L D +R T + + W +K
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCG 322
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 2e-95
Identities = 97/328 (29%), Positives = 149/328 (45%), Gaps = 27/328 (8%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y++ LG G F V+ + TG + A K + + E +++EI M ++RHP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRHP 214
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSR 128
+V L + ++ + E++ GGELF KVA ++ ED A +Y +Q+ + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 129 GVSHRDLKPENLLL--DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
H DLKPEN++ + +LK+ DFGL+A L + GT + APEV K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTDAKRL 242
G D+WS GV+ Y+LL+G PF EN R V + IS D K
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNN 302
I KLL++DP R+TI + PW +T + G D Q + + R +
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPW------------LTPGNAPGRDSQIPSSRYTKIRDSI 438
Query: 303 QEEKVSSPKFFNAFEFISSMSSGFDLSN 330
+ + + P+ IS+ SS
Sbjct: 439 KTKYDAWPEPLPPLGRISNYSSLRKHRP 466
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 4e-94
Identities = 92/283 (32%), Positives = 141/283 (49%), Gaps = 33/283 (11%)
Query: 11 KYEMGR-LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVR 68
Y++ + +LG G KV TG+ A+K++ ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK--------ARQEVDHHWQASG 80
Query: 69 HPNVVELREV----MATKKKIFVAMEYVKGGELFAK-VARGRLR--EDLARKYFQQLISA 121
P++V + +V K+ + + ME ++GGELF++ RG E A + + + +A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 122 VDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV 178
+ F HS ++HRD+KPENLL +++ LK++DFG + Q L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYV 196
Query: 179 APEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------EFVYP 232
APEVL + YD D+WS GVI+Y+LL GF PF + + + F P
Sbjct: 197 APEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 233 PW--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
W +S DAK+LI LL +DP R+TI M PW + P
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 5e-94
Identities = 85/268 (31%), Positives = 134/268 (50%), Gaps = 17/268 (6%)
Query: 11 KYEMGRL--LGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
Y + + LG G F +V+ ++ TG +A K+I +K + E++K EISVM +
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLD 144
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAK-VARG-RLREDLARKYFQQLISAVDFCH 126
H N+++L + +K I + MEYV GGELF + + L E + +Q+ + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 127 SRGVSHRDLKPENLLL--DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
+ H DLKPEN+L + + +KI DFGL+ + + L GTP ++APEV+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPEFLAPEVVN 261
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW--ISTDAK 240
D+WS GVI Y+LL+G PF +N + + + IS +AK
Sbjct: 262 YDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 241 RLISKLLVSDPERRITIQSIMRVPWFRK 268
ISKLL+ + RI+ ++ PW
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSD 348
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-90
Identities = 48/302 (15%), Positives = 95/302 (31%), Gaps = 54/302 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-- 68
G +LG+ TGES + V + ++Q+K E+ +RL+R
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 69 -----------------------HPNVVELREVMATK--KKIFVAME------YVKGGEL 97
++ +R F G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 98 FAKVARGRLREDLARKY-FQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156
+ + + AR Q+I + H G+ H L+P +++LD+ + ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 157 ALPEQLRNDGLLHTQCGTPAYVAPEVL----------RKKGYDGSKADLWSCGVILYVLL 206
DG + + PE+ ++ D W+ G+++Y +
Sbjct: 254 ------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 207 AGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
LP + + +F++ I + L+ L E R+ M P +
Sbjct: 308 CADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 267 RK 268
+
Sbjct: 364 EQ 365
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 5e-87
Identities = 86/264 (32%), Positives = 146/264 (55%), Gaps = 8/264 (3%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
++ G++LG+G+F+ V ++L T AIK++ K + KE + + RE VM + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
V+L +K++ + Y K GEL + + G E R Y +++SA+++ H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
HRDLKPEN+LL+E+ ++I+DFG + + ++ GT YV+PE+L +K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250
S +DLW+ G I+Y L+AG PF+ N +++K+ K E+ +P A+ L+ KLLV D
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 251 PERRITI------QSIMRVPWFRK 268
+R+ + P+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 8e-84
Identities = 77/283 (27%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVRH 69
+ + R+L +G FA VY + + +G A+K + +E I +E+ M+ L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS---NEEEKNRAIIQEVCFMKKLSGH 85
Query: 70 PNVVEL-------REVMATKKKIFVAMEYVKGGELF----AKVARGRLREDLARKYFQQL 118
PN+V+ +E T + F+ + + G+L +RG L D K F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 119 ISAVDFCHSRG--VSHRDLKPENLLLDENEDLKISDFGLSALP----------EQLRNDG 166
AV H + + HRDLK ENLLL +K+ DFG + ++
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 167 LLHTQCGTPAYVAPEV--LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV 224
T+ TP Y PE+ L G K D+W+ G ILY+L PF+D + ++
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RI 261
Query: 225 FKAEFVYPPW--ISTDAKRLISKLLVSDPERRITIQSIMRVPW 265
++ PP T LI +L +PE R++I ++
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-83
Identities = 70/271 (25%), Positives = 136/271 (50%), Gaps = 17/271 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
YE+ +G G++ + ++ G+ + K ++ + + + + E++++R ++HP
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 65
Query: 71 NVVELRE--VMATKKKIFVAMEYVKGGELFAKVARGR-----LREDLARKYFQQLISAVD 123
N+V + + T +++ MEY +GG+L + + +G L E+ + QL A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 124 FCHSRGVS-----HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV 178
CH R HRDLKP N+ LD +++K+ DFGL+ + + T GTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYM 183
Query: 179 APEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWIST 237
+PE + + Y+ K+D+WS G +LY L A PF + + K+ + +F P S
Sbjct: 184 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242
Query: 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
+ +I+++L R +++ I+ P +
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 2e-83
Identities = 75/305 (24%), Positives = 145/305 (47%), Gaps = 8/305 (2%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY + +G+G+F K K G IK IN ++ + E+ +RE++V+ ++HP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHP 83
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHS 127
N+V+ RE +++ M+Y +GG+LF ++ +ED +F Q+ A+ H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
R + HRD+K +N+ L ++ +++ DFG++ + L GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISKL 246
Y+ +K+D+W+ G +LY L F+ ++ N+ K+ F S D + L+S+L
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 247 LVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDRHNNQEEK 306
+P R ++ SI+ + K + ++ + + + + +
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQN 320
Query: 307 VSSPK 311
S
Sbjct: 321 SISVM 325
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 3e-83
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 24/280 (8%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y + LG+G F+ V + L G A+K I + + E+ +RE + RL HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHP 86
Query: 71 NVVELREV----MATKKKIFVAMEYVKGGELF-----AKVARGRLREDLARKYFQQLISA 121
N++ L K + ++ + + K G L+ K L ED +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP-------EQLRNDGLLHTQCGT 174
++ H++G +HRDLKP N+LL + + D G Q Q T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 175 PAYVAPEVLRKKGYD--GSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVFKAEFVY 231
+Y APE+ + + + D+WS G +LY ++ G P+ + + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 232 PPW--ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269
P S+ +L++ ++ DP +R I ++ +
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 6e-83
Identities = 72/294 (24%), Positives = 119/294 (40%), Gaps = 44/294 (14%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVRH 69
++LG G+ V + + G VA+K + D + EI ++ H
Sbjct: 16 LVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDH 68
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVAR--------GRLREDLARKYFQQLISA 121
PNV+ T + +++A+E L V +E +Q+ S
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 122 VDFCHSRGVSHRDLKPENLLLD-------------ENEDLKISDFGLSAL--PEQLRNDG 166
V HS + HRDLKP+N+L+ EN + ISDFGL Q
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 167 LLHTQCGTPAYVAPEVLRKKGYD------GSKADLWSCGVILYVLL-AGFLPFQDE---- 215
L+ GT + APE+L + D++S G + Y +L G PF D+
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 216 -NIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
NI+ + + + ++ + +A LIS+++ DP +R T ++R P F
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-82
Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 52/281 (18%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHP 70
++LG G KV T E A+K++ + +RE+ + R + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 71 NVVELREV----MATKKKIFVAMEYVKGGELFAK-VARGRLR--EDLARKYFQQLISAVD 123
++V + +V A +K + + ME + GGELF++ RG E A + + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 124 FCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
+ HS ++HRD+KPENLL N LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------EFVYPPW 234
E +K YD D+WS GVI+Y+LL G+ PF + + + + EF P W
Sbjct: 169 ETTGEK-YD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 235 --ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
+S + K LI LL ++P +R+TI M PW + P
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-81
Identities = 61/261 (23%), Positives = 113/261 (43%), Gaps = 11/261 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
++ LG G++ +V+ + G A+K + ++ S ++ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSR 128
V L + +++ E G L L E Y + + A+ HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
G+ H D+KP N+ L K+ DFGL +L G Q G P Y+APE+L+ Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQ-GSY 232
Query: 189 DGSKADLWSCGVILYVLLAGF-LPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLL 247
+ AD++S G+ + + LP E + + EF +S++ + ++ +L
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 248 VSDPERRITIQSIMRVPWFRK 268
DP+ R T ++++ +P R+
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-80
Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 36/277 (12%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
++ L+G G F +V+ K + G++ IK + + E+ +RE+ + + H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVN 65
Query: 72 VVELRE----------------VMATKKKIFVAMEYVKGGELFAKVAR---GRLREDLAR 112
+V + K +F+ ME+ G L + + +L + LA
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 113 KYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172
+ F+Q+ VD+ HS+ + +RDLKP N+ L + + +KI DFGL L+NDG
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSK 182
Query: 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVY 231
GT Y++PE + + Y + DL++ G+IL LL F+ R +
Sbjct: 183 GTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG-----II 236
Query: 232 PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
K L+ KLL PE R I+R K
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-79
Identities = 68/285 (23%), Positives = 115/285 (40%), Gaps = 27/285 (9%)
Query: 2 EEERHVLFGK--YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKR 59
EE V+ GK + +LG G + Y + + VA+K I + R
Sbjct: 14 EETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC------FSFADR 66
Query: 60 EISVMR-LVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQ 116
E+ ++R HPNV+ ++ ++A+E L V + Q
Sbjct: 67 EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQ 125
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENED-----LKISDFGLSA-LPEQLRNDGLLHT 170
Q S + HS + HRDLKP N+L+ ISDFGL L +
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 171 QCGTPAYVAPEVLR---KKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMY--RKV 224
GT ++APE+L K+ D++S G + Y +++ G PF
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
Query: 225 FKAEFVYPPW-ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
+ ++P A+ LI K++ DP++R + + +++ P+F
Sbjct: 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 4e-78
Identities = 47/301 (15%), Positives = 78/301 (25%), Gaps = 48/301 (15%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
K ++ L G + V+ + + E A+KV +E++ +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 71 NVVELREVM--------------------------ATKKKIFVAMEYVKG-----GELFA 99
+ E R+ + M
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 100 KV--ARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157
V RG QLI S+G+ H P+NL + + L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD-GSKADLWSCGVILYVLLAGFLPF--QD 214
Y E L + W G+ +Y + FLPF
Sbjct: 243 KVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 215 ENIMNMYRKVFKAEFVYPPW-------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
I +++ + K LI + L D RR+ M P F
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 268 K 268
+
Sbjct: 358 Q 358
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 8e-78
Identities = 89/262 (33%), Positives = 154/262 (58%), Gaps = 12/262 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+++ R LG G+F +V+ + G A+KV+ K+ + + +E E ++ +V HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
++ + ++IF+ M+Y++GGELF+ + + R +A+ Y ++ A+++ HS+ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+RDLKPEN+LLD+N +KI+DFG + + +T CGTP Y+APEV+ K Y+
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 182
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250
S D WS G+++Y +LAG+ PF D N M Y K+ AE +PP+ + D K L+S+L+ D
Sbjct: 183 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 251 PERRI-----TIQSIMRVPWFR 267
+R+ + + PWF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 7e-77
Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 12/262 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
++ + LG G+F +V K +G A+K+++K ++ K +E E +++ V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
+V+L +++ MEYV GGE+F+ + R GR E AR Y Q++ ++ HS +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+RDLKPENLL+D+ ++++DFG + R G T CGTP +APE++ KGY+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250
+ D W+ GV++Y + AG+ PF + + +Y K+ + +P S+D K L+ LL D
Sbjct: 218 A-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PERRI-----TIQSIMRVPWFR 267
+R + I WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 9e-77
Identities = 48/295 (16%), Positives = 98/295 (33%), Gaps = 43/295 (14%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL----- 66
G +LG+ TGES + V + ++Q+K E+ +RL
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 67 -----------------VRHPNVVELREVMATKKKIFVAMEYV-----------KGGELF 98
V+ P ++ V ++ ++V + G L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 99 AKV-ARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157
+ L + Q+I + H G+ H L+P +++LD+ + ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH-L 258
Query: 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSK----ADLWSCGVILYVLLAGFLPFQ 213
+ + + P A +L + + D W+ G+ +Y + LP
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 214 DENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
D+ + +F++ I + L+ L E R+ M P + +
Sbjct: 319 DDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 3e-76
Identities = 75/275 (27%), Positives = 133/275 (48%), Gaps = 16/275 (5%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+ + + +G+G F++VY L+ G VA+K + L +EI +++ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELF-----AKVARGRLREDLARKYFQQLISAVDF 124
PNV++ ++ + +E G+L K + + E KYF QL SA++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
HSR V HRD+KP N+ + +K+ D GL H+ GTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIH 209
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDE--NIMNMYRKVFKAEFVYPPW----ISTD 238
+ GY+ K+D+WS G +LY + A PF + N+ ++ +K+ + + YPP S +
Sbjct: 210 ENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEE 266
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
++L++ + DPE+R + + V T
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-73
Identities = 87/263 (33%), Positives = 147/263 (55%), Gaps = 13/263 (4%)
Query: 16 RLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQL-KKEFMMEQIKREISVMRLVRHPN 71
R+LGKG + KV+ +++ TG+ A+KV+ K + + K E +++ V+HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
+V+L T K+++ +EY+ GGELF ++ R G ED A Y ++ A+ H +G+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+RDLKPEN++L+ +K++DFGL E + + + HT CGT Y+APE+L + G++
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250
+ D WS G ++Y +L G PF EN K+ K + PP+++ +A+ L+ KLL +
Sbjct: 201 A-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRN 259
Query: 251 PERRI-----TIQSIMRVPWFRK 268
R+ + P+FR
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRH 282
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 234 bits (597), Expect = 3e-73
Identities = 44/288 (15%), Positives = 98/288 (34%), Gaps = 35/288 (12%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQ-----LMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
+ LLG+G FA+VY Q + +KV + ++ Q+ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER---LK 122
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR------GRLREDLARKYFQQLI 119
++ + + E G L + + + L + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 120 SAVDFCHSRGVSHRDLKPENLLL-----------DENEDLKISDFGLSALPEQLRNDGLL 168
++ H + H D+KP+N +L D + L + D G S + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMNMYRKVFKA 227
+C T + E+L K ++ + D + +Y +L G ++ ++E +F+
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 228 EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR---VPWFRKGFTR 272
W +L + ++R F++ +T
Sbjct: 302 LPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 4e-73
Identities = 75/273 (27%), Positives = 140/273 (51%), Gaps = 10/273 (3%)
Query: 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREI 61
+E V F +E+ R +GKG+F KV ++ T + A+K +NK + + + + +E+
Sbjct: 7 DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66
Query: 62 SVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLIS 120
+M+ + HP +V L ++ +F+ ++ + GG+L + + +E+ + + +L+
Sbjct: 67 QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
A+D+ ++ + HRD+KP+N+LLDE+ + I+DF ++A L + + T GT Y+AP
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAP 183
Query: 181 EVLRKKGYDG-SKA-DLWSCGVILYVLLAGFLPF---QDENIMNMYRKVFKAEFVYPPWI 235
E+ + G S A D WS GV Y LL G P+ + + YP
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243
Query: 236 STDAKRLISKLLVSDPERRI-TIQSIMRVPWFR 267
S + L+ KLL +P++R + + P+
Sbjct: 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-72
Identities = 89/258 (34%), Positives = 147/258 (56%), Gaps = 9/258 (3%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+LLGKGTF KV ++ TG A+K++ K+ + + + E V++ RHP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRD 134
+ T ++ MEY GGELF ++R E+ AR Y +++SA+++ HSR V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKAD 194
+K ENL+LD++ +KI+DFGL E + + + T CGTP Y+APEVL Y + D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VD 187
Query: 195 LWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERR 254
W GV++Y ++ G LPF +++ ++ + E +P +S +AK L++ LL DP++R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 255 I-----TIQSIMRVPWFR 267
+ + +M +F
Sbjct: 248 LGGGPSDAKEVMEHRFFL 265
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-72
Identities = 86/262 (32%), Positives = 153/262 (58%), Gaps = 13/262 (4%)
Query: 16 RLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
++LG+G+F KV+ K++ + A+KV+ K LK + K E ++ V HP +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFI 88
Query: 73 VELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVS 131
V+L T+ K+++ +++++GG+LF ++++ E+ + Y +L A+D HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS 191
+RDLKPEN+LLDE +K++DFGLS E + ++ ++ CGT Y+APEV+ ++G+ S
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 192 KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDP 251
AD WS GV+++ +L G LPFQ ++ + KA+ P ++S +A+ L+ L +P
Sbjct: 207 -ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 252 ERRI-----TIQSIMRVPWFRK 268
R+ ++ I R +F
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFST 287
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 3e-71
Identities = 89/255 (34%), Positives = 143/255 (56%), Gaps = 6/255 (2%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
++LGKG+F KV+ + T + AIK + KD + + +E E V+ L HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
+ TK+ +F MEY+ GG+L + + A Y ++I + F HS+G+ +R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD++ +KI+DFG+ E + D +T CGTP Y+APE+L + Y+ S
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-V 199
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D WS GV+LY +L G PF ++ ++ + YP W+ +AK L+ KL V +PE+
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 254 RITIQS-IMRVPWFR 267
R+ ++ I + P FR
Sbjct: 260 RLGVRGDIRQHPLFR 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-71
Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 34/289 (11%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+E + LG+G F V+ K + + AIK I + E++ RE+ + + HP
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHP 63
Query: 71 NVVELREV------------MATKKKIFVAMEYVKGGELFAKVARGR----LREDLARKY 114
+V + K +++ M+ + L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 115 FQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL----------PEQLRN 164
F Q+ AV+F HS+G+ HRDLKP N+ ++ +K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM-YRK 223
Q GT Y++PE + Y K D++S G+IL+ LL PF +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239
Query: 224 VFKAEF-VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271
V +F ++ +L P R +I+ F
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 6e-71
Identities = 87/258 (33%), Positives = 133/258 (51%), Gaps = 9/258 (3%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVE 74
+++GKG+F KV + A+KV+ K + K+ + I E +V+ + V+HP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L T K++ ++Y+ GGELF + R E AR Y ++ SA+ + HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLKPEN+LLD + ++DFGL E + ++ T CGTP Y+APEVL K+ YD +
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT-V 220
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W G +LY +L G PF N MY + P I+ A+ L+ LL D +
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 280
Query: 254 RI----TIQSIMRVPWFR 267
R+ I +F
Sbjct: 281 RLGAKDDFMEIKSHVFFS 298
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 6e-71
Identities = 90/260 (34%), Positives = 145/260 (55%), Gaps = 11/260 (4%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
R+LGKG+F KV + TG+ A+KV+ KD + ++ +E E ++ L HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L T ++F ME+V GG+L + + R E AR Y ++ISA+ F H +G+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD K++DFG+ E + N T CGTP Y+APE+L++ Y +
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEMLYGPA-V 205
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W+ GV+LY +L G PF+ EN +++ + E VYP W+ DA ++ + +P
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265
Query: 254 RI------TIQSIMRVPWFR 267
R+ +I+R P+F+
Sbjct: 266 RLGSLTQGGEHAILRHPFFK 285
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-70
Identities = 81/259 (31%), Positives = 139/259 (53%), Gaps = 10/259 (3%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
+LGKG+F KV ++ T E A+K++ KD + ++ +E E V+ L + P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L T +++ MEYV GG+L + + GR +E A Y ++ + F S+G+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N++LD +KI+DFG+ E + + T CGTP Y+APE++ + Y S
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-V 202
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W+ GV+LY +LAG PF+ E+ +++ + + YP +S +A + L+ P +
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 262
Query: 254 RI-----TIQSIMRVPWFR 267
R+ + I +FR
Sbjct: 263 RLGCGPEGERDIKEHAFFR 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-70
Identities = 86/268 (32%), Positives = 146/268 (54%), Gaps = 16/268 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE+ +++G+G F +V + T + A+K+++K ++ K E +M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVS 131
VV+L + +++ MEY+ GG+L ++ + E AR Y +++ A+D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ--CGTPAYVAPEVLRKKGYD 189
HRD+KP+N+LLD++ LK++DFG ++ +G++ GTP Y++PEVL+ +G D
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 190 ---GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV--FKAEFVYP--PWISTDAKRL 242
G + D WS GV LY +L G PF ++++ Y K+ K +P IS +AK L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 243 ISKLLVSDPERRIT---IQSIMRVPWFR 267
I L +D E R+ ++ I R +F+
Sbjct: 308 ICAFL-TDREVRLGRNGVEEIKRHLFFK 334
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 3e-69
Identities = 93/259 (35%), Positives = 148/259 (57%), Gaps = 10/259 (3%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
+LLGKGTF KV K+ TG A+K++ K+ + + + E V++ RHP + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHR 133
+ T ++ MEY GGELF ++R ED AR Y +++SA+D+ HS + V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK ENL+LD++ +KI+DFGL E +++ + T CGTP Y+APEVL Y +
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-V 330
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W GV++Y ++ G LPF +++ ++ + E +P + +AK L+S LL DP++
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 390
Query: 254 RI-----TIQSIMRVPWFR 267
R+ + IM+ +F
Sbjct: 391 RLGGGSEDAKEIMQHRFFA 409
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 7e-69
Identities = 81/269 (30%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
R++G+G++AKV + T A+KV+ K+ + + ++ ++ E V HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L T+ ++F +EYV GG+L + R +L E+ AR Y ++ A+++ H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD +K++D+G+ E LR T CGTP Y+APE+LR + Y S
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 191
Query: 194 DLWSCGVILYVLLAGFLPF---------QDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244
D W+ GV+++ ++AG PF +++ + + + P +S A ++
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 245 KLLVSDPERRI------TIQSIMRVPWFR 267
L DP+ R+ I P+FR
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 9e-68
Identities = 91/365 (24%), Positives = 148/365 (40%), Gaps = 43/365 (11%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
E + V + R+LGKG F +V + TG+ A K + K ++KK E
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELF---AKVARGRLREDLARKYFQQLI 119
++ V VV L TK + + + + GG+L + + E A Y ++
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179
++ H + +RDLKPEN+LLD++ ++ISD GL+ + + + GT Y+A
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMA 353
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN----IMNMYRKVFKAEFVYPPWI 235
PEV++ + Y S D W+ G +LY ++AG PFQ + R V + Y
Sbjct: 354 PEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 236 STDAKRLISKLLVSDPERRI-----TIQSIMRVPWFR---------KGFTRPVAFSITQH 281
S A+ L S+LL DP R+ + + + P F+ P
Sbjct: 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAI 472
Query: 282 D--DDGDDDQAATEKTENDRHNNQEEKVSSPKFFNAFEFISS---------MSSGFDLSN 330
D D +Q +T K +Q+ F+ F S + F N
Sbjct: 473 YCKDVLDIEQFSTVKGVELEPTDQD-------FYQKFATGSVPIPWQNEMVETECFQELN 525
Query: 331 LFENK 335
+F
Sbjct: 526 VFGLD 530
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-67
Identities = 80/269 (29%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
R++G+G++AKV + T A++V+ K+ + + ++ ++ E V HP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L T+ ++F +EYV GG+L + R +L E+ AR Y ++ A+++ H RG+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N+LLD +K++D+G+ E LR T CGTP Y+APE+LR + Y S
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 234
Query: 194 DLWSCGVILYVLLAGFLPF---------QDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244
D W+ GV+++ ++AG PF +++ + + + P +S A ++
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294
Query: 245 KLLVSDPERRI------TIQSIMRVPWFR 267
L DP+ R+ I P+FR
Sbjct: 295 SFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-67
Identities = 81/259 (31%), Positives = 139/259 (53%), Gaps = 10/259 (3%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVE 74
+LGKG+F KV ++ T E A+K++ KD + ++ +E E V+ L + P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHR 133
L T +++ MEYV GG+L + + GR +E A Y ++ + F S+G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKA 193
DLK +N++LD +KI+DFG+ E + + T CGTP Y+APE++ + Y S
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-V 523
Query: 194 DLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPER 253
D W+ GV+LY +LAG PF+ E+ +++ + + YP +S +A + L+ P +
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 583
Query: 254 RI-----TIQSIMRVPWFR 267
R+ + I +FR
Sbjct: 584 RLGCGPEGERDIKEHAFFR 602
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-67
Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 22/274 (8%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E+ +++G+G F++V K TG+ A+K++NK + K + + E V+
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRG 129
+ +L + +++ MEY GG+L +++ R+ ++AR Y +++ A+D H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ--CGTPAYVAPEVLRKKG 187
HRD+KP+N+LLD ++++DFG +LR DG + + GTP Y++PE+L+ G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 188 YD------GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV--FKAEFVYP---PWIS 236
G + D W+ GV Y + G PF ++ Y K+ +K P +
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 237 TDAKRLISKLLVSDPERRIT---IQSIMRVPWFR 267
+A+ I +LL PE R+ P+F
Sbjct: 300 EEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFF 332
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-67
Identities = 80/272 (29%), Positives = 141/272 (51%), Gaps = 20/272 (7%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E+ +++G+G F +V K + A+K++NK ++ K + E V+
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRG 129
+ L +++ M+Y GG+L +++ RL E++AR Y +++ A+D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ--CGTPAYVAPEVLR--- 184
HRD+KP+N+L+D N ++++DFG +L DG + + GTP Y++PE+L+
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 185 --KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV--FKAEFVYPPW---IST 237
K Y G + D WS GV +Y +L G PF E+++ Y K+ K F +P +S
Sbjct: 253 GGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 238 DAKRLISKLLVSDPER--RITIQSIMRVPWFR 267
+AK LI +L+ S R + I+ + P+F
Sbjct: 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 4e-67
Identities = 80/279 (28%), Positives = 132/279 (47%), Gaps = 17/279 (6%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
E + + + R+LG+G F +V+ + TG+ A K +NK +LKK + E
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELF-----AKVARGRLREDLARKYFQQ 117
++ V +V L TK + + M + GG++ +E A Y Q
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY 177
++S ++ H R + +RDLKPEN+LLD++ +++ISD GL+ E GTP +
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGF 355
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN----MYRKVFKAEFVYPP 233
+APE+L + YD S D ++ GV LY ++A PF+ + ++V + YP
Sbjct: 356 MAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD 414
Query: 234 WISTDAKRLISKLLVSDPERRI-----TIQSIMRVPWFR 267
S +K LL DPE+R+ + + P FR
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-66
Identities = 86/271 (31%), Positives = 150/271 (55%), Gaps = 21/271 (7%)
Query: 16 RLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQL-KKEFMMEQIKREISVMRLVRH-P 70
++LG G + KV+ +++ TG+ A+KV+ K + +K E + E V+ +R P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG 129
+V L T+ K+ + ++Y+ GGELF +++ R E + Y +++ A++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL-HTQCGTPAYVAPEVLR--KK 186
+ +RD+K EN+LLD N + ++DFGLS E + ++ + CGT Y+AP+++R
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPF----QDENIMNMYRKVFKAEFVYPPWISTDAKRL 242
G+D + D WS GV++Y LL G PF + + + R++ K+E YP +S AK L
Sbjct: 238 GHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 243 ISKLLVSDPERRI-----TIQSIMRVPWFRK 268
I +LL+ DP++R+ I +F+K
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-63
Identities = 81/266 (30%), Positives = 132/266 (49%), Gaps = 18/266 (6%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV---RHPNV 72
R++G+G F +VY ++ TG+ A+K ++K ++K + E ++ LV P +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 73 VELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVS 131
V + T K+ ++ + GG+L +++ G E R Y ++I ++ H+R V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK-GYDG 190
+RDLKP N+LLDE+ ++ISD GL+ + H GT Y+APEVL+K YD
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMN---MYRKVFKAEFVYPPWISTDAKRLISKLL 247
S AD +S G +L+ LL G PF+ + + R P S + + L+ LL
Sbjct: 371 S-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 248 VSDPERRI-----TIQSIMRVPWFRK 268
D RR+ Q + P+FR
Sbjct: 430 QRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-59
Identities = 48/283 (16%), Positives = 99/283 (34%), Gaps = 34/283 (12%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
++ +G G F V+ + + G AIK K ++ + L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFC 125
+VV A + + EY GG L ++ +E + Q+ + +
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 126 HSRGVSHRDLKPENLLLDENEDL-------------------KISDFGLSALPEQLRNDG 166
HS + H D+KP N+ + KI D G
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR------IS 185
Query: 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK 226
+ G ++A EVL++ KAD+++ + + ++ + + ++ +
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---GDQWHEIRQ 242
Query: 227 AEF-VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
P +S + L+ ++ DPERR + ++++
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-55
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 23/265 (8%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+G+G+F +V+ K TG A+K + + + E E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPR 111
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGV 130
+V L + + + ME ++GG L + + G L ED A Y Q + +++ H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 131 SHRDLKPENLLLDEN-EDLKISDFGLSALPEQLRNDGLLHTQC------GTPAYVAPEVL 183
H D+K +N+LL + + DFG + L+ DGL + GT ++APEV+
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN-MYRKV--FKAEFVYPPWISTDAK 240
K D +K D+WS ++ +L G P+ + PP +
Sbjct: 229 MGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 241 RLISKLLVSDPERRITIQSIMRVPW 265
+ I + L +P R + + R
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVG 312
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-53
Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 45/294 (15%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KYE L+G+G++ V + TG VAIK + K + REI +++ +RH
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-REIKLLKQLRHE 84
Query: 71 NVVELREVMATKKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
N+V L EV KK+ ++ E+V ++ L + +KY Q+I+ + FCH
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTILD---DLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVL-R 184
S + HRD+KPEN+L+ ++ +K+ DFG + L + T Y APE+L
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV---YDDEVATRWYRAPELLVG 198
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA----------------- 227
Y G D+W+ G ++ + G F ++ ++ +
Sbjct: 199 DVKY-GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 228 --EFVYPPW------------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
P +S L K L DP++R ++ +F+
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-53
Identities = 80/297 (26%), Positives = 140/297 (47%), Gaps = 52/297 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KYE +G+GT+ V+ K T E VA+K + D + + REI +++ ++H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHK 61
Query: 71 NVVELREVMATKKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
N+V L +V+ + KK+ + E+ K + G L ++ + + QL+ + FCH
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-----YVAPE 181
SR V HRDLKP+NLL++ N +LK+++FGL+ R G + +C + Y P+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLA------RAFG-IPVRCYSAEVVTLWYRPPD 171
Query: 182 VL-RKKGYDGSKADLWSCGVILYVLLAGFLP-FQDENIMNMYRKVFKA-----EFVYP-- 232
VL K Y + D+WS G I L P F ++ + +++F+ E +P
Sbjct: 172 VLFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 233 ----------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
P ++ + L+ LL +P +RI+ + ++ P+F
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 67/262 (25%), Positives = 123/262 (46%), Gaps = 18/262 (6%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
++ + + + +G G+F V+ + G VA+K++ + E + + RE++
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAE-RVNEFLREVA 86
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV 122
+M+ +RHPN+V + + + EY+ G L+ + + RE L + ++L A
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER--RRLSMAY 144
Query: 123 DFC------HSRGVS--HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT 174
D H+R HR+LK NLL+D+ +K+ DFGLS + + GT
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGT 202
Query: 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF--VYP 232
P ++APEVLR + + K+D++S GVIL+ L P+ + N + V P
Sbjct: 203 PEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261
Query: 233 PWISTDAKRLISKLLVSDPERR 254
++ +I ++P +R
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKR 283
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 45/294 (15%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KYE +G+G++ V+ + TG+ VAIK + + + REI +++ ++HP
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-REIRMLKQLKHP 62
Query: 71 NVVELREVMATKKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
N+V L EV K+++ + EY + + E L + Q + AV+FCH
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLH---ELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVL-R 184
HRD+KPEN+L+ ++ +K+ DFG + L + T Y +PE+L
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY---YDDEVATRWYRSPELLVG 176
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA----------------- 227
Y G D+W+ G + LL+G + ++ ++ + K
Sbjct: 177 DTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235
Query: 228 --EFVYPPW------------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
P IS A L+ L DP R+T + ++ P+F
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-52
Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 18/271 (6%)
Query: 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
+ + +LGKGT+ VY G+ L +AIK I + + + EI++ + ++
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK 77
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELF----AKVARGRLREDLARKYFQQLISAVDF 124
H N+V+ + I + ME V GG L +K + E Y +Q++ + +
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 125 CHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRN-DGLLHTQCGTPAYVAPEV 182
H + HRD+K +N+L++ LKISDFG S +L + T GT Y+APE+
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEI 194
Query: 183 LRK--KGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMN-MYR-KVFKAEFVYPPWIST 237
+ K +GY G AD+WS G + + G PF + M++ +FK P +S
Sbjct: 195 IDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253
Query: 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
+AK I K DP++R ++ + +
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKV 284
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 52/296 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY +G+GT+ VY + GE+ A+K I ++ + I REIS+++ ++H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-REISILKELKHS 60
Query: 71 NVVELREVMATKKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
N+V+L +V+ TKK++ + E++ K V G L A+ + QL++ + +CH
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-----YVAPE 181
R V HRDLKP+NLL++ +LKI+DFGL+ R G + + T Y AP+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLA------RAFG-IPVRKYTHEIVTLWYRAPD 170
Query: 182 VL-RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-----EFVYP--- 232
VL K Y + D+WS G I ++ G F + + ++F+ +P
Sbjct: 171 VLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 233 ---------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
+ L+SK+L DP +RIT + + +F+
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 61/263 (23%), Positives = 121/263 (46%), Gaps = 19/263 (7%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
+G+ +G G+F VY GK G+ VA+K++N + ++ K E+ V+R RH N+
Sbjct: 27 TVGQRIGSGSFGTVYKGK--WHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNI 82
Query: 73 VELREVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLISAVDFCHSRGV 130
+ T ++ + ++ +G L+ + + +Q +D+ H++ +
Sbjct: 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD- 189
HRDLK N+ L E+ +KI DFGL+ + G+ ++APEV+R + +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 190 -GSKADLWSCGVILYVLLAGFLPFQDEN--------IMNMYRKVFKAEFVYPPWISTDAK 240
++D+++ G++LY L+ G LP+ + N + ++ K
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV--RSNCPKRMK 259
Query: 241 RLISKLLVSDPERRITIQSIMRV 263
RL+++ L + R + I+
Sbjct: 260 RLMAECLKKKRDERPSFPRILAE 282
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 75/297 (25%), Positives = 140/297 (47%), Gaps = 30/297 (10%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
+E + F + E+G L+GKG F +VY+G+ GE VAI++I+ ++ ++ ++ KRE+
Sbjct: 26 QEWDIPFEQLEIGELIGKGRFGQVYHGR--WHGE-VAIRLIDIERDNED-QLKAFKREVM 81
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLIS 120
R RH NVV + + + KG L++ + A+ L + R+ Q+++
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGTPAY 177
+ + H++G+ H+DLK +N+ D + I+DFGL + + R + L Q G +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 178 VAPEVLRKKGYDGS--------KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF 229
+APE++R+ D +D+++ G I Y L A PF+ +++
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT---QPAEAIIWQMGT 257
Query: 230 VY-PPWISTDAKRLISKLLVS----DPERRITIQSIM----RVPWFRKGFTRPVAFS 277
P + IS +L+ + E R T +M ++P + + P F
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-51
Identities = 77/303 (25%), Positives = 128/303 (42%), Gaps = 56/303 (18%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+++ LG GT+A VY G TG VA+K + D ++ I REIS+M+ ++H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAI-REISLMKELKHE 63
Query: 71 NVVELREVMATKKKIFVAMEYV----KG--GELFAKVARGRLREDLARKYFQQLISAVDF 124
N+V L +V+ T+ K+ + E++ K L +L + + QL+ + F
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-----YVA 179
CH + HRDLKP+NLL+++ LK+ DFGL+ R G + + Y A
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLA------RAFG-IPVNTFSSEVVTLWYRA 176
Query: 180 PEVL-RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF------------- 225
P+VL + Y + D+WSCG IL ++ G F N + +F
Sbjct: 177 PDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 226 -------KAEFVY--------------PPWISTDAKRLISKLLVSDPERRITIQSIMRVP 264
+ + + LL +P+ R++ + + P
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 265 WFR 267
WF
Sbjct: 296 WFA 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-51
Identities = 78/297 (26%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY+ +G+GT+ VY K G VA+K I D + I REIS+++ + HP
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI-REISLLKELHHP 79
Query: 71 NVVELREVMATKKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
N+V L +V+ +++ + + E++ K + L++ + Y QL+ V CH
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEKDLKK---VLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-----YVAPE 181
+ HRDLKP+NLL++ + LK++DFGL+ R G + + T Y AP+
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLA------RAFG-IPVRSYTHEVVTLWYRAPD 189
Query: 182 VL-RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------- 227
VL K Y + D+WS G I ++ G F + K+F
Sbjct: 190 VLMGSKKY-STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 228 ------EFVYPPW-----------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
+ + + + L+S +L DP +RI+ + M P+F+
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-51
Identities = 78/306 (25%), Positives = 125/306 (40%), Gaps = 69/306 (22%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI---NKDQLKKEFMMEQIKREISVMRLV 67
+YE LG+G FA VY + T + VAIK I ++ + K + REI +++ +
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL-REIKLLQEL 69
Query: 68 RHPNVVELREVMATKKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVD 123
HPN++ L + K I + +++ + K L + Y + ++
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA------- 176
+ H + HRDLKP NLLLDEN LK++DFGL+ G+P
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPNRAYTHQV 173
Query: 177 ----YVAPEVLR-KKGYDGSKADLWSCGVILYVLLAG--FLPFQDENIMNMYRKVFKA-- 227
Y APE+L + Y D+W+ G IL LL FLP + ++ ++F+
Sbjct: 174 VTRWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLG 230
Query: 228 ---EFVYP-----------------------PWISTDAKRLISKLLVSDPERRITIQSIM 261
E +P D LI L + +P RIT +
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
Query: 262 RVPWFR 267
++ +F
Sbjct: 291 KMKYFS 296
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 55/261 (21%), Positives = 92/261 (35%), Gaps = 18/261 (6%)
Query: 23 FAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82
Q E L M+ +I M N V + + K
Sbjct: 74 LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK 133
Query: 83 KKIFVAMEYVKGGELFAKVARGR----LREDLARKYFQQLISAVDFCHSRGVSHRDLKPE 138
+++ M+ + L + R + F Q+ AV+F HS+G+ HRDLKP
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPS 193
Query: 139 NLLLDENEDLKISDFGLSA----------LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
N+ ++ +K+ DFGL + + Q GT Y++PE + Y
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLISKLL 247
K D++S G+IL+ LL F + + V +F + ++ +L
Sbjct: 254 S-HKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDML 310
Query: 248 VSDPERRITIQSIMRVPWFRK 268
P R I+ F
Sbjct: 311 SPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 17/67 (25%), Positives = 31/67 (46%), Gaps = 2/67 (2%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+E + +G+G F V+ K + + AIK I +E E++ RE+ + + HP
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHP 64
Query: 71 NVVELRE 77
+V
Sbjct: 65 GIVRYFN 71
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 78/295 (26%), Positives = 134/295 (45%), Gaps = 49/295 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE--FMMEQIKREISVMRLVR 68
Y LG+GT+A VY GK +T VA+K I +L+ E I RE+S+++ ++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI-REVSLLKDLK 58
Query: 69 HPNVVELREVMATKKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQLISAVDF 124
H N+V L +++ T+K + + EY+ K + + + + QL+ + +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQ---YLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVL 183
CH + V HRDLKP+NLL++E +LK++DFGL+ A + + T Y P++L
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---YDNEVVTLWYRPPDIL 172
Query: 184 -RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-----EFVYP----- 232
Y ++ D+W G I Y + G F + +F+ E +P
Sbjct: 173 LGSTDY-STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 233 --------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
P + +D L++KLL + RI+ + M+ P+F
Sbjct: 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 80/306 (26%), Positives = 135/306 (44%), Gaps = 66/306 (21%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y LG+GT+ +VY +T E+VAIK I + ++ I RE+S+++ ++H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI-REVSLLKELQHR 93
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKV--ARGRLREDLARKYFQQLISAVDFCHSR 128
N++EL+ V+ ++ + EY + +L K + + + + QLI+ V+FCHSR
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DL-KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 129 GVSHRDLKPENLLLDENED-----LKISDFGLSALPEQLRNDGLLHTQCGTPA------- 176
HRDLKP+NLLL ++ LKI DFGL+ R G P
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R-------AFGIPIRQFTHEI 198
Query: 177 ----YVAPEVL-RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF------ 225
Y PE+L + Y + D+WS I +L F ++ ++ K+F
Sbjct: 199 ITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257
Query: 226 --------------KAEF----------VYPPWISTDAKRLISKLLVSDPERRITIQSIM 261
K F V + + L++ +L DP +RI+ ++ +
Sbjct: 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 262 RVPWFR 267
P+F
Sbjct: 318 EHPYFS 323
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-50
Identities = 66/268 (24%), Positives = 112/268 (41%), Gaps = 30/268 (11%)
Query: 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
+ + E+ ++G+G F V K + VAIK I + +K F E+ + V
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAF-----IVELRQLSRVN 59
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC--- 125
HPN+V+L A + + MEY +GG L+ + + +
Sbjct: 60 HPNIVKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAA--HAMSWCLQCSQGV 115
Query: 126 ---HSR---GVSHRDLKPENLLLDEN-EDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV 178
HS + HRDLKP NLLL LKI DFG + + G+ A++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWM 170
Query: 179 APEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD--ENIMNMYRKVFKAE-FVYPPWI 235
APEV Y K D++S G+IL+ ++ PF + + V +
Sbjct: 171 APEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 236 STDAKRLISKLLVSDPERRITIQSIMRV 263
+ L+++ DP +R +++ I+++
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-50
Identities = 76/263 (28%), Positives = 135/263 (51%), Gaps = 16/263 (6%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+ +GKG+F +V+ G T + VAIK+I+ ++ + E E I++EI+V+ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPY 81
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVS 131
V + K+++ MEY+ GG + G L E ++++ +D+ HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 132 HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL-HTQCGTPAYVAPEVLRKKGYDG 190
HRD+K N+LL E+ ++K++DFG++ QL + + +T GTP ++APEV+++ YD
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD- 197
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-----WISTDAKRLISK 245
SKAD+WS G+ L G P + + M + +F PP + S K +
Sbjct: 198 SKADIWSLGITAIELARGEPPHSELHPM---KVLFLIPKNNPPTLEGNY-SKPLKEFVEA 253
Query: 246 LLVSDPERRITIQSIMRVPWFRK 268
L +P R T + +++ + +
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILR 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-50
Identities = 62/271 (22%), Positives = 126/271 (46%), Gaps = 19/271 (7%)
Query: 10 GKYE-MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
G++ +G+G+F VY G T VA + +L K ++ K E +++ ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ 83
Query: 69 HPNVVEL----REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVD 123
HPN+V + KK I + E + G L + R ++ + R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 124 FCHSRG--VSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
F H+R + HRDLK +N+ + +KI D GL+ L+ GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 199
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKAE--FVYPPWIST 237
E+ ++ YD D+++ G+ + + P+ + +N +YR+V +
Sbjct: 200 EMY-EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
+ K +I + + + R +I+ ++ +F++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 5e-49
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 53/307 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIK--REISVMR--- 65
+YE +G G + VY + +G VA+K + I RE++++R
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 66 LVRHPNVVELREVMATKK-----KIFVAMEYV----KGGELFAKVARGRLREDLARKYFQ 116
HPNVV L +V AT + K+ + E+V + K L + + +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETIKDLMR 127
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCG 173
Q + +DF H+ + HRDLKPEN+L+ +K++DFGL+ + L
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP------VVV 181
Query: 174 TPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-----E 228
T Y APEVL + Y + D+WS G I + F + + K+F E
Sbjct: 182 TLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 229 FVYP----------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
+P P + +L+ ++L +P +RI+ ++ +
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300
Query: 267 RKGFTRP 273
K P
Sbjct: 301 HKDEGNP 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-48
Identities = 60/272 (22%), Positives = 114/272 (41%), Gaps = 33/272 (12%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE----FMMEQIKREISVMRLVR 68
E + +GKG F V+ G+ + VAIK + + E ++ +RE+ +M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLISAVDFCH 126
HPN+V+L + ME+V G+L+ ++ + + + +++
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SRGVS--HRDLKPENLLLDENED-----LKISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179
++ HRDL+ N+ L ++ K++DFGLS + + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMA 194
Query: 180 PEVL--RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY------ 231
PE + ++ Y KAD +S +ILY +L G PF + + + F
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE---YSYGKIKFINMIREEGLRPT 250
Query: 232 -PPWISTDAKRLISKLLVSDPERRITIQSIMR 262
P + +I DP++R I++
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-48
Identities = 71/266 (26%), Positives = 145/266 (54%), Gaps = 17/266 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+ +G+G+ V ++ +G VA+K+++ L+K+ E + E+ +MR +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHF 102
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
NVVE+ + ++++V ME+++GG L V++ RL E+ + ++ A+ + H++GV
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVAPEVLRKKGYD 189
HRD+K +++LL + +K+SDFG A Q+ D + GTP ++APEV+ + Y
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI------STDAKRLI 243
++ D+WS G+++ ++ G P+ ++ + + + + PP + S + +
Sbjct: 220 -TEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDSPPPKLKNSHKVSPVLRDFL 275
Query: 244 SKLLVSDPERRITIQSIMRVPWFRKG 269
++LV DP+ R T Q ++ P+ +
Sbjct: 276 ERMLVRDPQERATAQELLDHPFLLQT 301
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-48
Identities = 68/264 (25%), Positives = 125/264 (47%), Gaps = 21/264 (7%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLVRHPN 71
+ ++G G F KVY G+ VA+K D + +E +++E + +++HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVS 131
++ LR V + + + ME+ +GG L ++ R+ D+ + Q+ +++ H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 132 ---HRDLKPENLLLDE--------NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
HRDLK N+L+ + N+ LKI+DFGL+ + + + G A++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAP 183
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKAE-FVYPPWISTD 238
EV+R + +D+WS GV+L+ LL G +PF+ + + Y P
Sbjct: 184 EVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 239 AKRLISKLLVSDPERRITIQSIMR 262
+L+ DP R + +I+
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILD 266
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 76/266 (28%), Positives = 135/266 (50%), Gaps = 17/266 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY +G+G VY + TG+ VAI+ +N L+++ E I EI VMR ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNP 77
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
N+V + +++V MEY+ GG L V + E ++ + A++F HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL-LHTQCGTPAYVAPEVLRKKGYD 189
HRD+K +N+LL + +K++DFG A Q+ + T GTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI------STDAKRLI 243
K D+WS G++ ++ G P+ +EN + R ++ P + S + +
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGTPELQNPEKLSAIFRDFL 250
Query: 244 SKLLVSDPERRITIQSIMRVPWFRKG 269
++ L D E+R + + +++ + +
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQFLKIA 276
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-47
Identities = 57/274 (20%), Positives = 107/274 (39%), Gaps = 27/274 (9%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
+ + F + L + +++ G+ G + +KV+ E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTR-KSRDFNEECP 59
Query: 63 VMRLVRHPNVVELREVMAT--KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
+R+ HPNV+ + + + ++ G L+ V + + Q +
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLY-NVLHEGTNFVVDQS--QAVKF 116
Query: 121 AVD------FCHSRG--VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172
A+D F H+ + L ++++DE+ +IS + + +
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRM 169
Query: 173 GTPAYVAPEVLRKKGYDGS--KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF- 229
PA+VAPE L+KK D + AD+WS V+L+ L+ +PF D + M + KV
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
Query: 230 -VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
PP IS +L+ + DP +R I+
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-47
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 53/300 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQL-MTGESVAIKVINKDQLKKEFMMEQIKREISVMR---L 66
+YE +G+G + KV+ + L G VA+K + ++ + I RE++V+R
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLET 70
Query: 67 VRHPNVVELREVMAT-----KKKIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQ 117
HPNVV L +V + K+ + E+V KV + + + Q
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQ 128
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS---ALPEQLRNDGLLHTQCGT 174
L+ +DF HS V HRDLKP+N+L+ + +K++DFGL+ + L + T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS------VVVT 182
Query: 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA-----EF 229
Y APEVL + Y + DLWS G I + F+ + ++ K+ E
Sbjct: 183 LWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 230 VYP----------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
+P I K L+ K L +P +RI+ S + P+F+
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-46
Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 26/273 (9%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+E+ LG G F KVY K TG A KVI K E +E EI ++ HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHP 76
Query: 71 NVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSR 128
+V+L K+++ +E+ GG + L E + +Q++ A++F HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH-TQCGTPAYVAPEV----- 182
+ HRDLK N+L+ D++++DFG+SA + + GTP ++APEV
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-------WI 235
++ YD KAD+WS G+ L + P + N M R + K PP W
Sbjct: 194 MKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSDPPTLLTPSKW- 248
Query: 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
S + + + L +PE R + ++ P+
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 65/262 (24%), Positives = 117/262 (44%), Gaps = 27/262 (10%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINK--DQLKKEFMMEQIKREISVMRLVRHP 70
G +LGKG F + TGE + +K + + ++ ++ F+ +E+ VMR + HP
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL-----KEVKVMRCLEHP 67
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLISAVDFCHSR 128
NV++ V+ K++ EY+KGG L K + + + + S + + HS
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND------------GLLHTQCGTPA 176
+ HRDL N L+ EN+++ ++DFGL+ L + +T G P
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWIS 236
++APE++ + YD K D++S G++L ++ D M + F +
Sbjct: 188 WMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF-LDRYCP 245
Query: 237 TDAKRLISKLLVS----DPERR 254
+ + V DPE+R
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKR 267
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 75/343 (21%), Positives = 136/343 (39%), Gaps = 61/343 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KYE +G+GTF +V+ + TG+ VA+K + + K+ F + + REI +++L++H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHE 76
Query: 71 NVVELREVMATKK--------KIFVAMEYV----KGGELFAKVARGRLREDLARKYFQQL 118
NVV L E+ TK I++ ++ G + ++ Q L
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQML 133
Query: 119 ISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQC-GTPA 176
++ + + H + HRD+K N+L+ + LK++DFGL+ A + +T T
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 177 YVAPEVLR-KKGYDGSKADLWSCGVILYVLLAG----------------F---------- 209
Y PE+L ++ Y G DLW G I+ +
Sbjct: 194 YRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 210 ------LP-FQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
++ ++ ++ K A LI KLLV DP +RI +
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 263 VPWFRKGFTRPVAFSI----TQHDDDGDDDQAATEKTENDRHN 301
+F + P+ + + H + A + + H+
Sbjct: 312 HDFFW---SDPMPSDLKGMLSTHLTSMFEYLAPPRRKHHHHHH 351
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 25/271 (9%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+ R +G G+F VY+ + + E VAIK ++ + + I +E+ ++ +RHP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 71 NVVELREVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
N ++ R + ++ MEY G +V + L+E + + + HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQL--RNDGLLHTQCGTPAYVAPEV---LR 184
+ HRD+K N+LL E +K+ DFG ++ + N + GTP ++APEV +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPAN-----SFVGTPYWMAPEVILAMD 226
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP------WISTD 238
+ YD K D+WS G+ L P + N M ++ P W S
Sbjct: 227 EGQYD-GKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPALQSGHW-SEY 281
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKG 269
+ + L P+ R T + +++ + +
Sbjct: 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 34/284 (11%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
YE+ ++G G A V E VAIK IN ++ + M+++ +EI M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPN 74
Query: 72 VVELREVMATKKKIFVAMEYVKGGELF---------AKVARGRLREDLARKYFQQLISAV 122
+V K ++++ M+ + GG + + G L E ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC------GTPA 176
++ H G HRD+K N+LL E+ ++I+DFG+SA L G + GTP
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA---FLATGGDITRNKVRKTFVGTPC 191
Query: 177 YVAPEVL-RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN-MY----------RKV 224
++APEV+ + +GYD KAD+WS G+ L G P+ M +
Sbjct: 192 WMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 225 FKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
+ + + + +++IS L DPE+R T ++R +F+K
Sbjct: 251 VQDKEMLKKY-GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-45
Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 33/273 (12%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+++ LG+G++ VY TG+ VAIK + ++ + ++I +EIS+M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDL--QEIIKEISIMQQCDSP 84
Query: 71 NVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSR 128
+VV+ +++ MEY G + ++ L ED Q + +++ H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQL------RNDGLLHTQCGTPAYVAPEV 182
HRD+K N+LL+ K++DFG++ QL RN T GTP ++APEV
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDTMAKRN-----TVIGTPFWMAPEV 196
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP-------WI 235
+++ GY+ AD+WS G+ + G P+ D + M R +F PP W
Sbjct: 197 IQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPM---RAIFMIPTNPPPTFRKPELW- 251
Query: 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
S + + + LV PE+R T +++ P+ R
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-44
Identities = 50/132 (37%), Positives = 77/132 (58%), Gaps = 6/132 (4%)
Query: 309 SPKFFNAFEFISSMSSGFDLSNLFENKK---KTGSMFTSRYSARHIMEKIEGVAKGMNFK 365
P NAFE I+ +S G +LS LF+ ++ K + F SR I+ IE VA M FK
Sbjct: 3 GPLMMNAFEMIT-LSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 366 VAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEEDVRP 425
++FK RL G S + G L+V+ E++EVAP + +V+ K++G+TLEY KF ++ +
Sbjct: 62 S-HTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK-LCS 119
Query: 426 ALKDIVWTWQGD 437
L++I+W
Sbjct: 120 KLENIIWRATEG 131
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 3e-44
Identities = 33/126 (26%), Positives = 63/126 (50%), Gaps = 7/126 (5%)
Query: 309 SPKFFNAFEFISSMSSGFDLSNLFEN--KKKTGSMFTSRYSARHIMEKIEGVAKGMNFKV 366
+ NAF+ IS S GF+LS LF + K F S ++A ++E++E + N V
Sbjct: 2 GARRMNAFDIIS-GSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTV 60
Query: 367 AKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEEDVRPA 426
AK + + +++ EG+KG +++ E+ ++ E+ ++E K + +RP
Sbjct: 61 AKKETWGMKI----EGQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116
Query: 427 LKDIVW 432
++V
Sbjct: 117 FVELVH 122
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-44
Identities = 61/291 (20%), Positives = 119/291 (40%), Gaps = 47/291 (16%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
+ +GKG + +V+ G GE+VA+K+ + +K + E E+ ++RH N+
Sbjct: 11 TLLECVGKGRYGEVWRGS--WQGENVAVKIF-SSRDEKSWFRET---ELYNTVMLRHENI 64
Query: 73 VEL----REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR 128
+ + ++++ Y + G L+ + L + + S + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 129 --------GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL--HTQCGTPAYV 178
++HRDLK +N+L+ +N I+D GL+ + Q N + + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 179 APEVLRKKGYDGS-----KADLWSCGVILYVLLAGF----------LPFQDEN-----IM 218
APEVL + + D+W+ G++L+ + PF D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 219 NMYRKVFKAEF---VYPPWISTDAKRLISKLLV----SDPERRITIQSIMR 262
+M + V + + W S ++KL+ +P R+T I +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 81/305 (26%), Positives = 129/305 (42%), Gaps = 68/305 (22%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y +++G G+F VY K +GE VAIK + +D+ K RE+ +MR + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHC 107
Query: 71 NVVELREVMAT------KKKIFVAMEYVKGGELFAKVARGRLR------EDLARKYFQQL 118
N+V LR + + + + ++YV E +VAR R + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 119 ISAVDFCHSRGVSHRDLKPENLLLDENED-LKISDFGLSALPEQLRNDGLLHTQCGTPAY 177
++ + HS G+ HRD+KP+NLLLD + LK+ DFG + + L+ + +Y
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------K--QLVRGEPNV-SY 216
Query: 178 V------APEV-LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK---- 226
+ APE+ Y S D+WS G +L LL G F ++ ++ ++ K
Sbjct: 217 ICSRYYRAPELIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 227 -------------AEFVYPPW------------ISTDAKRLISKLLVSDPERRITIQSIM 261
EF +P +A L S+LL P R+T
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 262 RVPWF 266
+F
Sbjct: 336 AHSFF 340
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 10 GKYEMGRLLGKG--TFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
G YE+ ++GKG V + TGE V ++ IN + E M+ ++ E+ V +L
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE-MVTFLQGELHVSKLF 83
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGG---ELFAKVARGRLREDLARKYFQQLISAVDF 124
HPN+V R +++V ++ G +L + E Q ++ A+D+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG--------LLHTQCGTPA 176
H G HR +K ++L+ + + +S + + + G
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSVKVLP 200
Query: 177 YVAPEVLR--KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM 220
+++PEVL+ +GYD +K+D++S G+ L G +PF+D M
Sbjct: 201 WLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQM 245
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-43
Identities = 74/301 (24%), Positives = 131/301 (43%), Gaps = 59/301 (19%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVRH 69
Y++ R LG+G +++V+ + E V +K++ + KK IKREI ++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRGG 90
Query: 70 PNVVELREVM--ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
PN++ L +++ + + E+V + K L + R Y +++ A+D+CHS
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKALDYCHS 148
Query: 128 RGVSHRDLKPENLLLD-ENEDLKISDFGL--SALPEQLRNDGLLHTQCGTPAYVAPEVL- 183
G+ HRD+KP N+++D E+ L++ D+GL P Q N + + + PE+L
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-----RVASRYFKGPELLV 203
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPF--------------------QDENIMNMYRK 223
+ YD S D+WS G +L ++ PF + ++ Y
Sbjct: 204 DYQMYDYS-LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 224 VFKAEFV-------YPPW-----------ISTDAKRLISKLLVSDPERRITIQSIMRVPW 265
F W +S +A + KLL D + R+T + M P+
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 266 F 266
F
Sbjct: 323 F 323
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-43
Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 16/256 (6%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE-ISVMRL 66
FG Y + RL+G+G VY + + VA+K++++ +++RE + RL
Sbjct: 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL 91
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFC 125
+ P+VV + + +++V M + G +L A + R G L A +Q+ SA+D
Sbjct: 92 -QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGL-SALPEQLRNDGLLHTQC--GTPAYVAPEV 182
H+ G +HRD+KPEN+L+ ++ + DFG+ SA ++ L GT Y+APE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE----KLTQLGNTVGTLYYMAPER 206
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTD 238
+ +AD+++ +LY L G P+Q + + M + P P I
Sbjct: 207 FSESHATY-RADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVA 264
Query: 239 AKRLISKLLVSDPERR 254
+I++ + +PE R
Sbjct: 265 FDAVIARGMAKNPEDR 280
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 80/305 (26%), Positives = 133/305 (43%), Gaps = 69/305 (22%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y +++G G+F V+ K + + E VAIK + +D+ RE+ +MR+V+HP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHP 92
Query: 71 NVVELREVMAT------KKKIFVAMEYV-----KGGELFAKVARGRLREDLARKYFQQLI 119
NVV+L+ + + + + +EYV + +AK + + L + Y QL+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLL 151
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENED-LKISDFGLS-ALPEQLRNDGLLHTQCGTPAY 177
++ + HS G+ HRD+KP+NLLLD LK+ DFG + L N +Y
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN----------VSY 201
Query: 178 V------APEV-LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK---- 226
+ APE+ Y + D+WS G ++ L+ G F E+ ++ ++ K
Sbjct: 202 ICSRYYRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260
Query: 227 -------------AEFVYPPW------------ISTDAKRLISKLLVSDPERRITIQSIM 261
E +P DA LIS+LL P R+T +
Sbjct: 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320
Query: 262 RVPWF 266
P+F
Sbjct: 321 CHPFF 325
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 73/259 (28%), Positives = 121/259 (46%), Gaps = 16/259 (6%)
Query: 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREI-SVM 64
++ +Y++ LG G + VY + + VAIK I +KE +++ +RE+ +
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVA-RGRLREDLARKYFQQLISAVD 123
+L H N+V + +V ++ MEY++G L + G L D A + Q++ +
Sbjct: 67 QLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQC--GTPAYVAP 180
H + HRD+KP+N+L+D N+ LKI DFG++ AL E L T GT Y +P
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLGTVQYFSP 181
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-----IMNMYRKVFKAEFVYPPWI 235
E + + D D++S G++LY +L G PF E I ++ V I
Sbjct: 182 EQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240
Query: 236 STDAKRLISKLLVSDPERR 254
+I + D R
Sbjct: 241 PQSLSNVILRATEKDKANR 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 81/281 (28%), Positives = 137/281 (48%), Gaps = 34/281 (12%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVR 68
G +E+ L+G GT+ +VY G+ + TG+ AIKV++ ++E +IK+EI++++
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE----EIKQEINMLKKYSH 79
Query: 69 HPNVVEL------REVMATKKKIFVAMEYVKGG---ELFAKVARGRLREDLARKYFQQLI 119
H N+ + ++++ ME+ G +L L+E+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL-RNDGLLHTQCGTPAYV 178
+ H V HRD+K +N+LL EN ++K+ DFG+SA QL R G +T GTP ++
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWM 196
Query: 179 APEVLRKK-----GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP 233
APEV+ YD K+DLWS G+ + G P D + M R +F P
Sbjct: 197 APEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRNPAP 252
Query: 234 ------WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
W S + I LV + +R + +M+ P+ R
Sbjct: 253 RLKSKKW-SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 24/278 (8%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV-MRLVRHP 70
E +G GT +V+ + TG +A+K + + K+E ++I ++ V ++ P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN--KRILMDLDVVLKSHDCP 84
Query: 71 NVVELREVMATKKKIFVAMEYVKGG-ELFAKVARGRLREDLARKYFQQLISAVDFCHS-R 128
+V+ T +F+AME + E K +G + E + K ++ A+ +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVL----- 183
GV HRD+KP N+LLDE +K+ DFG+S +L +D G AY+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKAEFVYPP------WIS 236
K YD +AD+WS G+ L L G P+++ + + KV + E PP S
Sbjct: 202 TKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---PPLLPGHMGFS 257
Query: 237 TDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
D + + L D +R ++ + ++ T V
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 4e-41
Identities = 58/254 (22%), Positives = 101/254 (39%), Gaps = 24/254 (9%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQL-MTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
++ G+YE+ + G +Y + G V +K + E E +
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQ-AMAMAERQFLA 134
Query: 66 LVRHPNVVELREV-----MATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
V HP++V++ ++ MEYV G L + +L A Y +++
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAIAYLLEILP 193
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
A+ + HS G+ + DLKPEN++L E + LK+ D G + G L GTP + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINS---FGYL---YGTPGFQAP 246
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240
E++R + D+++ G L L + + E
Sbjct: 247 EIVRTGPTVAT--DIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYG 298
Query: 241 RLISKLLVSDPERR 254
RL+ + + DP +R
Sbjct: 299 RLLRRAIDPDPRQR 312
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 69/262 (26%), Positives = 125/262 (47%), Gaps = 17/262 (6%)
Query: 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE-ISVM 64
L +YE+G +LG G ++V+ + L VA+KV+ D + + +RE +
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 65 RLVRHPNVVEL----REVMATKKKIFVAMEYVKGGELFAKVA-RGRLREDLARKYFQQLI 119
L HP +V + ++ MEYV G L V G + A +
Sbjct: 68 ALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQC--GTPA 176
A++F H G+ HRD+KP N+++ +K+ DFG++ A+ + + + T GT
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS--GNSVTQTAAVIGTAQ 184
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP---- 232
Y++PE R D +++D++S G +LY +L G PF ++ +++ + + + + P
Sbjct: 185 YLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 233 PWISTDAKRLISKLLVSDPERR 254
+S D ++ K L +PE R
Sbjct: 244 EGLSADLDAVVLKALAKNPENR 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 47/291 (16%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
+M + +GKG + +V+ GK GE VA+KV + + E EI L+RH N+
Sbjct: 40 QMVKQIGKGRYGEVWMGK--WRGEKVAVKVF-FTTEEASWFRET---EIYQTVLMRHENI 93
Query: 73 VEL----REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR 128
+ + + ++++ +Y + G L+ + L K +S + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 129 --------GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN--DGLLHTQCGTPAYV 178
++HRDLK +N+L+ +N I+D GL+ N D +T+ GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 179 APEVLRKKGYDGS-----KADLWSCGVILYVLLAGF----------LPFQDENIMNMYRK 223
PEVL + AD++S G+IL+ + LP+ D + +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 224 VFKAEFVY----PP----WISTDAKRLISKLLV----SDPERRITIQSIMR 262
+ P W S + R + KL+ +P R+T + +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 64/291 (21%), Positives = 127/291 (43%), Gaps = 47/291 (16%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
+ +GKG F +V+ GK GE VA+K+ + ++ + E EI ++RH N+
Sbjct: 45 VLQESIGKGRFGEVWRGK--WRGEEVAVKIF-SSREERSWFREA---EIYQTVMLRHENI 98
Query: 73 VEL----REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR 128
+ + T ++++ +Y + G LF + R + + K S + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 129 --------GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN--DGLLHTQCGTPAYV 178
++HRDLK +N+L+ +N I+D GL+ + + D + + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 179 APEVLRKKGYDGS-----KADLWSCGVILYVLLAGF----------LPFQDE-----NIM 218
APEVL +AD+++ G++ + + LP+ D ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 219 NMYRKVFKAEF---VYPPWISTDAKRLISKLLV----SDPERRITIQSIMR 262
M + V + + + W S +A R+++K++ ++ R+T I +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 7e-40
Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 11/246 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E LG G V+ +G +A K+I+ + K + QI RE+ V+ P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPY 92
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
+V + +I + ME++ GG L K A GR+ E + K +I + + +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 130 -VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
+ HRD+KP N+L++ ++K+ DFG+S QL D + ++ GT +Y++PE L+ Y
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSG---QL-IDSMANSFVGTRSYMSPERLQGTHY 207
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLV 248
++D+WS G+ L + G P + + + L
Sbjct: 208 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 249 SDPERR 254
+ R
Sbjct: 267 FGMDSR 272
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 62/286 (21%), Positives = 122/286 (42%), Gaps = 29/286 (10%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV-MRLVRHP 70
+ +G+G + V +G+ +A+K I E +Q+ ++ V MR P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCP 81
Query: 71 NVVELREVMATKKKIFVAMEYVKGG-----ELFAKVARGRLREDLARKYFQQLISAVDFC 125
+V+ + + ++ ME + + V + E++ K + A++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 126 HS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVL- 183
+ HRD+KP N+LLD + ++K+ DFG+S QL + G Y+APE +
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERID 198
Query: 184 ---RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP------- 233
++GYD ++D+WS G+ LY L G P+ +++ ++ + PP
Sbjct: 199 PSASRQGYD-VRSDVWSLGITLYELATGRFPYPK--WNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 234 --WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFS 277
+ S ++ L D +R + +++ P+ R V +
Sbjct: 256 REF-SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVA 300
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 65/280 (23%), Positives = 123/280 (43%), Gaps = 27/280 (9%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV-MRLVRHP 70
E LG+G + V + + +G+ +A+K I +E +++ ++ + MR V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ--KRLLMDLDISMRTVDCP 66
Query: 71 NVVELREVMATKKKIFVAMEYVKGG--ELFAKVAR--GRLREDLARKYFQQLISAVDFCH 126
V + + +++ ME + + + +V + ED+ K ++ A++ H
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 127 S-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV--- 182
S V HRD+KP N+L++ +K+ DFG+S L +D G Y+APE
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINP 183
Query: 183 -LRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKAEFVYPP------W 234
L +KGY K+D+WS G+ + L P+ ++V + P +
Sbjct: 184 ELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SPQLPADKF 239
Query: 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
S + S+ L + + R T +M+ P+F ++
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 71/328 (21%), Positives = 119/328 (36%), Gaps = 81/328 (24%)
Query: 11 KYE-MGRLLGKGTFAKVYYG--KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
+E G +G+GT+ VY K + A+K I + REI+++R +
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLREL 75
Query: 68 RHPNVVELREVMATK--KKIFVAMEYV---------KGGELFAKVARGRLREDLARKYFQ 116
+HPNV+ L++V + +K+++ +Y A +L + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENED----LKISDFGLS---ALPEQLRNDGLLH 169
Q++ + + H+ V HRDLKP N+L+ +KI+D G + P L+ L
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLD 193
Query: 170 TQCGTPAYVAPEVL-RKKGYDGSKADLWSCGVILYVLLAG-------------------- 208
T Y APE+L + Y D+W+ G I LL
Sbjct: 194 PVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252
Query: 209 -----------------------------FLPFQDENIMNMYRKVFKAEFVYPPWISTDA 239
F+ N + + + A
Sbjct: 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK--VKPDSKA 310
Query: 240 KRLISKLLVSDPERRITIQSIMRVPWFR 267
L+ KLL DP +RIT + M+ P+F
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 61/293 (20%), Positives = 122/293 (41%), Gaps = 47/293 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
++ + +G F V+ + + E VA+K+ Q K+ + E E+ + ++H
Sbjct: 25 PLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIF-PIQDKQSWQNEY---EVYSLPGMKHE 78
Query: 71 NVVEL----REVMATKKKIFVAMEYVKGGELF--------AKVARGRLREDLAR--KYFQ 116
N+++ + + +++ + + G L + + E +AR Y
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
+ I + H +SHRD+K +N+LL N I+DFGL+ E ++ G H Q GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 177 YVAPEVLRKKGYDGS----KADLWSCGVILYVLLAGF-----------LPFQDE-----N 216
Y+APEVL + D+++ G++L+ L + LPF++E +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 217 IMNMYRKVFKAEF---VYPPWISTDAKRLISKLLVS----DPERRITIQSIMR 262
+ +M V + + W ++ + + D E R++ +
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 39/255 (15%), Positives = 82/255 (32%), Gaps = 38/255 (14%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
+ G+Y + G + + VA+ ++ + + ++++ +
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
+ P V + +V+ T+ V E+++GG L +VA A + Q L +A D H
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSPVGAIRAMQSLAAAADAAH 146
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
GV+ P + + + D+ + PA +
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA----- 179
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP-------PWISTDA 239
+ D+ G LY LL P + + + + P I
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 240 KRLISKLLVSDPERR 254
+ ++ + D R
Sbjct: 237 SAVAARSVQGDGGIR 251
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 59/300 (19%), Positives = 111/300 (37%), Gaps = 40/300 (13%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
++ L+G+G + VY G + VA+KV ++ F+ E + I + L+ H N+
Sbjct: 16 KLLELIGRGRYGAVYKGS--LDERPVAVKVF-SFANRQNFINE---KNIYRVPLMEHDNI 69
Query: 73 VEL-----REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
R + + + MEY G L ++ + + + + + H+
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 128 ---------RGVSHRDLKPENLLLDENEDLKISDFGLS------ALPEQLRNDGLLHTQC 172
+SHRDL N+L+ + ISDFGLS L D ++
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 173 GTPAYVAPEVLR------KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK 226
GT Y+APEVL + D+++ G+I + + + Y+ F+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 227 AEFVYPP-------WISTDAKRL-ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSI 278
E P +S + +R + + +++ + W + R A
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 77/314 (24%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL---V 67
++++ R+ G+GTF V GK+ TG SVAIK + +D + RE+ +M+ +
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVL 76
Query: 68 RHPNVVELREVMATKKK-------IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQ-- 116
HPN+V+L+ T + + V MEYV + + R R + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 117 --QLISAVDFCH--SRGVSHRDLKPENLLLD-ENEDLKISDFGLSALPEQLRNDGLLHTQ 171
QLI ++ H S V HRD+KP N+L++ + LK+ DFG + + L ++
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA------K--KLSPSE 186
Query: 172 CGTPAYV------APEV-LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV 224
AY+ APE+ + Y + D+WS G I ++ G F+ +N ++
Sbjct: 187 PNV-AYICSRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244
Query: 225 FK-----------------AEFVYP-----PW----------ISTDAKRLISKLLVSDPE 252
+ + PW + +A L+S LL PE
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 253 RRITIQSIMRVPWF 266
R+ + P+F
Sbjct: 305 ERMKPYEALCHPYF 318
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 71/335 (21%), Positives = 123/335 (36%), Gaps = 96/335 (28%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY +G+ LG G+F V + +G+ A+K + +D K RE+ +M+++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHV 60
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLR----------------------- 107
N+++L + T +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 108 -EDLAR-----------------KYFQ-QLISAVDFCHSRGVSHRDLKPENLLLDENED- 147
+ L + + QL AV F HS G+ HRD+KP+NLL++ ++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 148 LKISDFGLSALPEQLRNDGLLHTQCGTPAYV------APEV-LRKKGYDGSKADLWSCGV 200
LK+ DFG + + L+ ++ AY+ APE+ L Y DLWS G
Sbjct: 181 LKLCDFGSA------K--KLIPSEPSV-AYICSRFYRAPELMLGATEYT-PSIDLWSIGC 230
Query: 201 ILYVLLAGFLPFQDENIMNMYRKVFK-----------------AEFVYP-----PWIS-- 236
+ L+ G F E ++ ++ + E +P W
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290
Query: 237 -----TDAKRLISKLLVSDPERRITIQSIMRVPWF 266
+ A L+ ++L +P+ RI M P+F
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 77/295 (26%), Positives = 131/295 (44%), Gaps = 49/295 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y +G G + V +GE VAIK ++ + E ++ RE+ +++ ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 71 NVVELREVMATKKK------IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
NV+ L +V ++ M ++ +L K+ + E+ + Q++ + +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ-CGTPAYVAPEV- 182
HS GV HRDLKP NL ++E+ +LKI DFGL+ R+ T T Y APEV
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMTGYVVTRWYRAPEVI 195
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AEFV------ 230
L Y+ + D+WS G I+ +L G F+ ++ ++ ++ K EFV
Sbjct: 196 LSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 231 -----------YP--------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
P P S A L+ K+L D ++R+T + P+F
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 72/317 (22%), Positives = 131/317 (41%), Gaps = 61/317 (19%)
Query: 1 MEEERHVLFG-------KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFM 53
++ G +Y +G+G + V + VAIK I+ + +
Sbjct: 11 AAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTY 68
Query: 54 MEQIKREISVMRLVRHPNVVELREVMATK-----KKIFVAMEYVKGGELFAKVARGRLRE 108
++ REI ++ RH N++ + +++ K +++ + + +L K+ + +
Sbjct: 69 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLS 126
Query: 109 DLARKYFQ-QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167
+ YF Q++ + + HS V HRDLKP NLLL+ DLKI DFGL+ + + +
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 168 LHTQCGTPAYV------APEV-LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM 220
T+ YV APE+ L KGY S D+WS G IL +L+ F ++ ++
Sbjct: 187 FLTE-----YVATRWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQ 240
Query: 221 YRKVFK------AEFVYP-------------------------PWISTDAKRLISKLLVS 249
+ E + P + A L+ K+L
Sbjct: 241 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 300
Query: 250 DPERRITIQSIMRVPWF 266
+P +RI ++ + P+
Sbjct: 301 NPHKRIEVEQALAHPYL 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 48/295 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y + +G G + V TG VAIK + + E ++ RE+ +++ +RH
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMRHE 84
Query: 71 NVVELREVM------ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
NV+ L +V ++ M ++ G +L + +L ED + Q++ + +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ-CGTPAYVAPEV- 182
H+ G+ HRDLKP NL ++E+ +LKI DFGL+ R T T Y APEV
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMTGYVVTRWYRAPEVI 197
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AEFVYP---- 232
L Y + D+WS G I+ ++ G F+ + ++ +++ K AEFV
Sbjct: 198 LNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 233 ---------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266
S A L+ K+LV D E+R+T + P+F
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 85/339 (25%), Positives = 133/339 (39%), Gaps = 61/339 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+++ LLG+G + V TGE VAIK I K + REI +++ +H
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHFKHE 69
Query: 71 NVVELREVM-----ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQ-QLISAVDF 124
N++ + + ++++ E + +L +V ++ D +YF Q + AV
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGL--SALPEQLRNDGLLHTQCGTPAYV---- 178
H V HRDLKP NLL++ N DLK+ DFGL N Q G +V
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 179 --APEV-LRKKGYDGSKADLWSCGVILYVLLAG---F-----------------LPFQDE 215
APEV L Y + D+WSCG IL L F P D
Sbjct: 188 YRAPEVMLTSAKYSRA-MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 216 NI--------------MNMYRKV-FKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSI 260
++ + MY + F P ++ L+ ++LV DP +RIT +
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMF---PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 261 MRVPWFRKGFTR---PVAFSITQHDDDGDDDQAATEKTE 296
+ P+ + P I + D + A +
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKD 342
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 68/304 (22%), Positives = 128/304 (42%), Gaps = 55/304 (18%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ + +G G V + +VAIK ++ + + ++ RE+ +M+ V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 71 NVVELREVM------ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
N++ L V + +++ ME + L +V + L + Q++ +
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
HS G+ HRDLKP N+++ + LKI DFGL+ ++ T Y APEV+
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV-------------------- 224
GY + D+WS G I+ ++ G + F + ++ + KV
Sbjct: 200 GMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 225 ----------------------FKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
F A+ + ++ A+ L+SK+LV D +RI++ ++
Sbjct: 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318
Query: 263 VPWF 266
P+
Sbjct: 319 HPYI 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 69/304 (22%), Positives = 130/304 (42%), Gaps = 55/304 (18%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ + +G G V + +VAIK ++ + + ++ RE+ +M+ V H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 71 NVVELREVMA------TKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDF 124
N++ L V + +++ ME + L +V + L + Q++ +
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
HS G+ HRDLKP N+++ + LKI DFGL+ ++ T Y APEV+
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AEFV-------- 230
GY + D+WS G I+ ++ + F + ++ + KV + EF+
Sbjct: 237 GMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295
Query: 231 -----------------YP-----------PWISTDAKRLISKLLVSDPERRITIQSIMR 262
+P ++ A+ L+SK+LV DP +RI++ ++
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355
Query: 263 VPWF 266
P+
Sbjct: 356 HPYI 359
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 69/298 (23%), Positives = 128/298 (42%), Gaps = 50/298 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ +G G + V TG VA+K ++ + ++ RE+ +++ ++H
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 71 NVVELREVM------ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQ-QLISAVD 123
NV+ L +V +++ + G +L + + + D ++ Q++ +
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ-CGTPAYVAPEV 182
+ HS + HRDLKP NL ++E+ +LKI DFGL+ R+ T T Y APE+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------RHTADEMTGYVATRWYRAPEI 200
Query: 183 -LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AEFV----- 230
L Y+ + D+WS G I+ LL G F + ++ + + + AE +
Sbjct: 201 MLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 231 ------------YP--------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
P + A L+ K+LV D ++RIT + +F +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 67/308 (21%), Positives = 123/308 (39%), Gaps = 62/308 (20%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y + LG G V+ + VAIK K L ++ REI ++R + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 71 NVVELREVMATKKK--------------IFVAMEYVKGGELFAKVARGRLREDLARKYFQ 116
N+V++ E++ +++ EY+ +L + +G L E+ AR +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMY 127
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLD-ENEDLKISDFGLSALPEQLRNDGLLHTQCGTP 175
QL+ + + HS V HRDLKP NL ++ E+ LKI DFGL+ + + + ++
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE---- 183
Query: 176 AYV------APEV-LRKKGYDGSKADLWSCGVILYVLLAG--FLPFQD------------ 214
+ +P + L Y D+W+ G I +L G
Sbjct: 184 -GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 215 --------ENIMNMYRKVFKAEFVYP--------PWISTDAKRLISKLLVSDPERRITIQ 258
+ ++++ + + P P IS +A + ++L P R+T +
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301
Query: 259 SIMRVPWF 266
+ P+
Sbjct: 302 EALSHPYM 309
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 54/306 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME--------QIKREIS 62
Y + R + G++ V G G VAIK + + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 63 VMRLVRHPNVVELREVMATK-----KKIFVAMEYVKGGELFA--KVARGRLREDLARKYF 115
++ HPN++ LR++ K+++ E + +L R + + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140
Query: 116 QQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP 175
++ + H GV HRDL P N+LL +N D+ I DF L+ + D
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHYVTHR 197
Query: 176 AYVAPEV-LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK------AE 228
Y APE+ ++ KG+ D+WS G ++ + F+ N K+ + E
Sbjct: 198 WYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 229 FV------------------YP--------PWISTDAKRLISKLLVSDPERRITIQSIMR 262
V P P A LI+K+L +P+RRI+ + +R
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
Query: 263 VPWFRK 268
P+F
Sbjct: 317 HPYFES 322
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+YE+ L+G G++ V + VAIK I + ++I REI+++ + H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNRLNHD 112
Query: 71 NVVELREVMATK-----KKIFVAMEYVKGGELFAKV--ARGRLREDLARKYFQQLISAVD 123
+VV++ +++ K +++V +E + K+ L E + L+ V
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPA------ 176
+ HS G+ HRDLKP N L++++ +K+ DFGL+ + + L
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 177 ------------YV------APEV-LRKKGYDGSKA-DLWSCGVIL 202
+V APE+ L ++ Y ++A D+WS G I
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 72/337 (21%), Positives = 126/337 (37%), Gaps = 81/337 (24%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
+ +YE+ +++GKG+F +V + VA+K++ ++ Q EI ++
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEH 149
Query: 67 VRH------PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLR---EDLARKYFQQ 117
+R NV+ + E + I + E + L+ + + + + L RK+
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 118 LISAVDFCHSRGVSHRDLKPENLLLDENE--DLKISDFGLSALPEQLRNDGLLHTQCGTP 175
++ +D H + H DLKPEN+LL + +K+ DFG S Q ++T +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSR 263
Query: 176 AYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ--DEN-----IMNM-------- 220
Y APEV+ Y D+WS G IL LL G+ DE ++ +
Sbjct: 264 FYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322
Query: 221 -----YRKVFKAEFVYPPWISTDAKR---------------------------------- 241
K F + YP + +
Sbjct: 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382
Query: 242 -----LISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
+ + L DP R+T +R PW R+ +P
Sbjct: 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 79/330 (23%), Positives = 130/330 (39%), Gaps = 77/330 (23%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVRH 69
KYE+ + LGKG + V+ TGE VA+K I D + ++ REI ++ L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELSGH 68
Query: 70 PNVVELREVMATK--KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQ-QLISAVDFCH 126
N+V L V+ + +++ +Y+ +L V R + E + ++Y QLI + + H
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA---------- 176
S G+ HRD+KP N+LL+ +K++DFGLS +R
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 177 ---YV------APEV-LRKKGYDGSKA-DLWSCGVILYVLLAG---F------------- 209
YV APE+ L Y +K D+WS G IL +L G F
Sbjct: 187 LTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 210 -------------------------------LPFQDENIMNMYRKVFKAEFVYPPWISTD 238
+ ++ + K + + +
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRK 268
A L+ KLL +P +RI+ ++ P+
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKD---QLKKEFMMEQIKREISVMRLVRH 69
+G +G+G F +V+ G+ VA+K + LK +F+ +E +++ H
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-----QEARILKQYSH 171
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHS 127
PN+V L V K+ I++ ME V+GG+ F + RLR + + +++ S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY----VAPEVL 183
+ HRDL N L+ E LKISDFG+S + DG+ G APE L
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 184 RKKGYDGSKADLWSCGVILY-VLLAGFLPFQD-------ENIMNMYR 222
Y S++D+WS G++L+ G P+ + E + R
Sbjct: 288 NYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR 333
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 75/353 (21%), Positives = 125/353 (35%), Gaps = 92/353 (26%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTG-ESVAIKVI-NKDQLKKEFMMEQIKREISVM 64
L +YE+ LG+GTF KV G VA+K+I N + E + EI+V+
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-----YREAARLEINVL 70
Query: 65 RLVRHP------NVVELREVMATKKKIFVAME------YVKGGELFAKVARGRLREDLAR 112
+ ++ V + + + +A E + E + R
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF----EFLKENNFQPYPLPHVR 126
Query: 113 KYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-------------------DLKISDF 153
QL A+ F H ++H DLKPEN+L +E ++++DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ 213
G SA + T T Y PEV+ + G+ D+WS G IL+ GF FQ
Sbjct: 187 G-SATFDHEH----HTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQ 240
Query: 214 DEN-------IM--------NMYRKVFKAEFVY---PPWISTDAKR-------------- 241
+ +M + K ++ Y W +
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300
Query: 242 ------------LISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHD 282
L+ ++L DP +RIT+ + P+F +F +++
Sbjct: 301 LQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y + L+G+G++ VY T ++VAIK +N + ++I REI+++ ++
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNRLKSD 85
Query: 71 NVVELREVMATK-----KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQ-QLISAVDF 124
++ L +++ ++++ +E +L + K L+ +F
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGL--SALPEQLRNDGLLHTQCGTPA------ 176
H G+ HRDLKP N LL+++ +K+ DFGL + E+ N + P
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 177 ------YV------APEV-LRKKGYDGSKA-DLWSCGVILYVLLAG 208
+V APE+ L ++ Y +K+ D+WS G I LL
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFAELLNM 248
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 81/339 (23%), Positives = 126/339 (37%), Gaps = 92/339 (27%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTG-ESVAIKVI-NKDQLKKEFMMEQIKREISVM 64
VL +YE+ LG+G F KV G VA+K++ N D+ E + EI V+
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR-----YCEAARSEIQVL 65
Query: 65 RLVRHP------NVVELREVMATKKKIFVAME------YVKGGELFAKVARGRLREDLAR 112
+ V++ E I + E Y + + R D R
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY----DFIKENGFLPFRLDHIR 121
Query: 113 KYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-------------------DLKISDF 153
K Q+ +V+F HS ++H DLKPEN+L +++ D+K+ DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ 213
G SA + T T Y APEV+ G+ D+WS G IL GF F
Sbjct: 182 G-SATYDDEH----HSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFP 235
Query: 214 DEN-------IM--------NMYRKVFKAEFVY---PPWISTDAKR-------------- 241
+ + +M +K K ++ + W +
Sbjct: 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295
Query: 242 ------------LISKLLVSDPERRITIQSIMRVPWFRK 268
LI K+L DP +RIT++ ++ P+F
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 66/366 (18%), Positives = 134/366 (36%), Gaps = 85/366 (23%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR- 68
+Y + R LG G F+ V+ K ++ VA+K++ + E + EI +++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVND 74
Query: 69 ----------HPNVVELREV----MATKKKIFVAMEYVKGGELFAKVAR---GRLREDLA 111
++++L + + + E V G L A + + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 112 RKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENED------LKISDFGLSALPEQLRN 164
++ +QL+ +D+ H R G+ H D+KPEN+L++ + +KI+D G + ++
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------- 216
+ + Q T Y +PEVL + AD+WS +++ L+ G F+ +
Sbjct: 194 NSI---Q--TREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 217 -----IMNM--------------YRKVFKAEFVYPPWISTDAKRL--------------- 242
I+ + R F + + L
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 243 ------ISKLLVSDPERRITIQSIMRVPWFRKG-FTRPVAFSITQHDDDGDDDQAATEKT 295
+S +L DP +R ++ PW + + + G D E+
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEV 367
Query: 296 ENDRHN 301
+ + +
Sbjct: 368 RDHKRH 373
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 32/227 (14%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE-FMMEQIKREISVMRLVRHPN 71
M LG G + +VY G +VA+K + +D ++ E F+ +E +VM+ ++HPN
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-----KEAAVMKEIKHPN 277
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC------ 125
+V+L V + ++ E++ G L LRE + + +
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNL-----LDYLREC--NRQEVSAVVLLYMATQISSA 330
Query: 126 ----HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV--- 178
+ HR+L N L+ EN +K++DFGLS +L G +
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWT 386
Query: 179 APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
APE L + K+D+W+ GV+L+ + G P+ ++ +Y +
Sbjct: 387 APESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 13/211 (6%)
Query: 13 EMGRLLGKGTFAKVYYGK-QLMTGES--VAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+ LG G+F V G+ +G++ VA+K + D L + M+ RE++ M + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHS 127
N++ L V + + E G L + +G +Y Q+ + + S
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP---AYVAPEVLR 184
+ HRDL NLLL + +KI DFGL Q ND Q A+ APE L+
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLK 197
Query: 185 KKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ + +D W GV L+ + G P+
Sbjct: 198 TRTFS-HASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 34/225 (15%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
++ + +GKG F V G G VA+K I D + F+ E SVM +RH N+
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFL-----AEASVMTQLRHSNL 76
Query: 73 VELREVMATKKK--IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS-AVDFCH--- 126
V+L V ++K +++ EY+ G L R R R L L+ ++D C
Sbjct: 77 VQLLGV-IVEEKGGLYIVTEYMAKGSLV-DYLRSRGRSVLGGD---CLLKFSLDVCEAME 131
Query: 127 ---SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV---AP 180
HRDL N+L+ E+ K+SDFGL+ ++ G L P V AP
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAP 183
Query: 181 EVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
E LR+K + +K+D+WS G++L+ + G +P+ + ++ +V
Sbjct: 184 EALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 76/343 (22%), Positives = 126/343 (36%), Gaps = 96/343 (27%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI-NKDQLKKEFMMEQIKREISVMR 65
+YE+ L+GKG+F +V + E VAIK+I NK + Q + E+ ++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA-----FLNQAQIEVRLLE 105
Query: 66 LVRHP------NVVELREVMATKKKIFVAME------YVKGGELFAKVARGRLREDLARK 113
L+ +V L+ + + + E Y +L + +L RK
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY----DLLRNTNFRGVSLNLTRK 161
Query: 114 YFQQLISAVDFCHSR--GVSHRDLKPENLLL--DENEDLKISDFGLSALPEQLRNDGLLH 169
+ QQ+ +A+ F + + H DLKPEN+LL + +KI DFG S+ ++
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL----GQRIY 216
Query: 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------IMNM-- 220
+ Y +PEVL YD D+WS G IL + G F N I+ +
Sbjct: 217 QYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 221 -----------YRKVF---KAEFVYPPWISTDAKR------------------------- 241
+ F + + + D KR
Sbjct: 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335
Query: 242 ----------------LISKLLVSDPERRITIQSIMRVPWFRK 268
LI ++L DP+ RI ++ +F+K
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/279 (22%), Positives = 117/279 (41%), Gaps = 42/279 (15%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKD---QLKKEFMMEQIKREISVMR 65
+ ++LG G F VY G + GE VAIK + + + KE + E VM
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-----DEAYVMA 72
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVD 123
V +P+V L + + + + + G L + + + + + Q+ ++
Sbjct: 73 SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG-TP-AYVAPE 181
+ R + HRDL N+L+ + +KI+DFGL+ L + H + G P ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALE 189
Query: 182 VLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKAEFVYPP------- 233
+ + Y ++D+WS GV ++ ++ G P+ + + K E + P
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 234 -------WISTDAKR-----LISKL--LVSDPERRITIQ 258
W+ R LI + + DP+R + IQ
Sbjct: 249 YMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/343 (17%), Positives = 115/343 (33%), Gaps = 98/343 (28%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI-NKDQLKKEFMMEQIKREISVMR 65
+L + + R +G GTF +V + + + A+KV+ N + K E +++
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK-----YTRSAKIEADILK 86
Query: 66 LVRH-----PNVVELREVMATKKKIFVAME------YVKGGELFAKVARGRLREDLARKY 114
+++ N+V+ + + E Y E+ + + + Y
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY----EIITRNNYNGFHIEDIKLY 142
Query: 115 FQQLISAVDFCHSRGVSHRDLKPENLLLDENE-------------------------DLK 149
+++ A+++ ++H DLKPEN+LLD+ +K
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 150 ISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGF 209
+ DFG A + + T Y APEV+ G+D +D+WS G +L L G
Sbjct: 203 LIDFG-CATFKSDY----HGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGS 256
Query: 210 LPFQDEN-------IM--------NMYRKVFKA----------------------EFVYP 232
L F+ + NM + K +
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 233 PWISTDAKR---------LISKLLVSDPERRITIQSIMRVPWF 266
+ + +L DP R + +++ +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 30/225 (13%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE-FMMEQIKREISVMRLVRHPN 71
+ LG+G F +V+ G T VAIK + + E F+ +E VM+ +RH
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL-----QEAQVMKKLRHEK 323
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC------ 125
+V+L V +++ I++ EY+ G L L+ + + +L VD
Sbjct: 324 LVQLYAV-VSEEPIYIVTEYMSKGSL-----LDFLKGE--TGKYLRLPQLVDMAAQIASG 375
Query: 126 ----HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAP 180
HRDL+ N+L+ EN K++DFGL+ L E N+ P + AP
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAP 433
Query: 181 EVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
E + K+D+WS G++L + G +P+ + +V
Sbjct: 434 EAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 10 GKYE-------MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKEFMMEQIKREI 61
GK+ + +G G F V+ G + + VAIK I + + +++F+ E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFI-----EEA 54
Query: 62 SVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLI 119
VM + HP +V+L V + I + E+++ G L + + RG + +
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--PA- 176
+ + V HRDL N L+ EN+ +K+SDFG++ D + GT P
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFPVK 170
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ +PEV Y SK+D+WS GV+++ V G +P+++
Sbjct: 171 WASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
+ LG+G F +V+ G T VAIK + + E ++ E VM+ +RH +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 241
Query: 73 VELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC------- 125
V+L V +++ I++ EY+ G L L+ + + +L VD
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSL-----LDFLKGE--TGKYLRLPQLVDMAAQIASGM 293
Query: 126 ---HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP-AYVAPE 181
HRDL+ N+L+ EN K++DFGL+ L E N+ P + APE
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPE 351
Query: 182 VLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
+ K+D+WS G++L + G +P+ + +V
Sbjct: 352 AALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGES----VAIKVINK---DQLKKEFMMEQIKREISVMRL 66
+++G G F +VY G + VAIK + ++ + +F+ E +M
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-----GEAGIMGQ 102
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDF 124
H N++ L V++ K + + EY++ G L F + G + + + + +
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV---APE 181
+ HRDL N+L++ N K+SDFGLS + E + +T G + APE
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPE 220
Query: 182 VLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD-------ENIMNMYR 222
+ + + S +D+WS G++++ V+ G P+ + + I + +R
Sbjct: 221 AISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 13 EMGRLLGKGTFAKVYYGK----QLMTGESVAIKVI--NKDQLKKEFMMEQIKREISVMRL 66
+ + LGKG F V + Q TGE VA+K + + ++ ++F REI +++
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-----REIEILKS 67
Query: 67 VRHPNVVELREV--MATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAV 122
++H N+V+ + V A ++ + + MEY+ G L + + + R+ +Y Q+ +
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGT--P-AYV 178
++ ++ HRDL N+L++ +KI DFGL+ LP+ + + P +
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ---DKEFFKVKEPGESPIFWY 184
Query: 179 APEVLRKKGYDGSKADLWSCGVILY 203
APE L + + +D+WS GV+LY
Sbjct: 185 APESLTESKFS-VASDVWSFGVVLY 208
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINK---DQLKKEFMMEQIKREISVMRL 66
+ +++G G +V YG+ + G+ VAIK + ++ +++F+ E S+M
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-----SEASIMGQ 106
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDF 124
HPN++ L V+ + + EY++ G L F + G+ + + + + +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV---APE 181
G HRDL N+L+D N K+SDFGLS + E + +T G + APE
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPE 224
Query: 182 VLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ + + S +D+WS GV+++ VL G P+ +
Sbjct: 225 AIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWN 257
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 27/228 (11%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINK---DQLKKEFMMEQIKREISVMRLV 67
+ +++G G F +V G+ + + SVAIK + ++ +++F+ E S+M
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-----GEASIMGQF 103
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFC 125
HPN++ L V+ K + + EY++ G L F + + + + S + +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV---APEV 182
G HRDL N+L++ N K+SDFGL + E + +T G + +PE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKIPIRWTSPEA 221
Query: 183 LRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD-------ENIMNMYR 222
+ + + S +D+WS G++L+ V+ G P+ + + + YR
Sbjct: 222 IAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 18/220 (8%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE-FMMEQIKREISVMRLVRHPN 71
M LG G + +VY G +VA+K + +D ++ E F+ +E +VM+ ++HPN
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-----KEAAVMKEIKHPN 70
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFA---KVARGRLREDLARKYFQQLISAVDFCHSR 128
+V+L V + ++ E++ G L + R + + Q+ SA+++ +
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--PA-YVAPEVLRK 185
HRDL N L+ EN +K++DFGLS +L G P + APE L
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 186 KGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
+ K+D+W+ GV+L+ + G P+ ++ +Y +
Sbjct: 187 NKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 41/214 (19%)
Query: 13 EMGRLLGKGTFAKVYYGK----QLMTGESVAIKVI--NKDQLKKEFMMEQIKREISVMRL 66
+ + LGKG F V + Q TGE VA+K + + ++ ++F REI +++
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-----REIEILKS 98
Query: 67 VRHPNVVELREV--MATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAV 122
++H N+V+ + V A ++ + + MEY+ G L + + + R+ +Y Q+ +
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 123 DFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYV--- 178
++ ++ HRDL N+L++ +KI DFGL+ LP+ Y
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ------------DKEYYKVKE 206
Query: 179 ---------APEVLRKKGYDGSKADLWSCGVILY 203
APE L + + +D+WS GV+LY
Sbjct: 207 PGESPIFWYAPESLTESKFS-VASDVWSFGVVLY 239
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-24
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 25/223 (11%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKEFMMEQIKREISVMRLVRHPNV 72
+ + LG G F V GK VA+K+I + + + EF +E M + HP +
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFF-----QEAQTMMKLSHPKL 65
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
V+ V + + I++ EY+ G L + + L + + + F S
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--PA-YVAPEVLRKKG 187
HRDL N L+D + +K+SDFG++ D + GT P + APEV
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVSSVGTKFPVKWSAPEVFHYFK 181
Query: 188 YDGSKADLWSCGVILY-VLLAGFLPFQD-------ENIMNMYR 222
Y SK+D+W+ G++++ V G +P+ + +R
Sbjct: 182 YS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 29/201 (14%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV 72
++ + +GKG F V G G VA+K I D + F+ E SVM +RH N+
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFL-----AEASVMTQLRHSNL 248
Query: 73 VELREVMATKKK--IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS-AVDFC---- 125
V+L V ++K +++ EY+ G L + R R R L L+ ++D C
Sbjct: 249 VQLLGV-IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLG---GDCLLKFSLDVCEAME 303
Query: 126 --HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA-YVAPEV 182
HRDL N+L+ E+ K+SDFGL+ ++ G L P + APE
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEA 357
Query: 183 LRKKGYDGSKADLWSCGVILY 203
LR+K + +K+D+WS G++L+
Sbjct: 358 LREKKFS-TKSDVWSFGILLW 377
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKD---QLKKEFMMEQIKREISVMR 65
+ ++LG G F VY G + GE VAIK + + + KE + E VM
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-----DEAYVMA 72
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVD 123
V +P+V L + + + + + G L + + + + + Q+ ++
Sbjct: 73 SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG-TP-AYVAPE 181
+ R + HRDL N+L+ + +KI+DFGL+ L + H + G P ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALE 189
Query: 182 VLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ + Y ++D+WS GV ++ ++ G P+
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDG 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 13 EMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
+ R LG+G F KV + TGE VA+K + + + +K+EI ++R +
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLY 81
Query: 69 HPNVVELREV--MATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDF 124
H N+V+ + + I + ME++ G L + + ++ KY Q+ +D+
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYV---AP 180
SR HRDL N+L++ +KI DFGL+ A+ + + + V AP
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET---DKEYYTVKDDRDSPVFWYAP 198
Query: 181 EVLRKKGYDGSKADLWSCGVILY 203
E L + + +D+WS GV L+
Sbjct: 199 ECLMQSKFY-IASDVWSFGVTLH 220
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 25/224 (11%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKEFMMEQIKREISVMRLVRHPN 71
+ LG G F V YGK VAIK+I + + + EF+ E VM + H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI-----EEAKVMMNLSHEK 80
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
+V+L V ++ IF+ EY+ G L + + R R + + + + A+++ S+
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--PA-YVAPEVLRKK 186
HRDL N L+++ +K+SDFGLS D + G+ P + PEVL
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 187 GYDGSKADLWSCGVILY-VLLAGFLPFQD-------ENIMNMYR 222
+ SK+D+W+ GV+++ + G +P++ E+I R
Sbjct: 197 KFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 39/213 (18%)
Query: 13 EMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQ--IKREISVMRL 66
+ LGKG F V + TG VA+K QL+ +Q +REI +++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK-----QLQHSGPDQQRDFQREIQILKA 80
Query: 67 VRHPNVVELREV-MATKKK-IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS-AVD 123
+ +V+ R V ++ + + MEY+ G L R L+ AR +L+ +
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL-----RDFLQRHRARLDASRLLLYSSQ 135
Query: 124 FC------HSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQ-----LRNDGLLHTQ 171
C SR HRDL N+L++ +KI+DFGL+ LP +R G
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS--- 192
Query: 172 CGTP-AYVAPEVLRKKGYDGSKADLWSCGVILY 203
P + APE L + ++D+WS GV+LY
Sbjct: 193 ---PIFWYAPESLSDNIFS-RQSDVWSFGVVLY 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 56/230 (24%), Positives = 102/230 (44%), Gaps = 37/230 (16%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE-FMMEQIKREISVMRLVRHPN 71
++ LG G F +V+ G VA+K + + + + F+ E ++M+ ++H
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQR 69
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKY-FQQLIS-AVDFCH--- 126
+V L V T++ I++ EY++ G L L+ K +L+ A
Sbjct: 70 LVRLYAV-VTQEPIYIITEYMENGSL-----VDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 127 ---SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV---AP 180
R HRDL+ N+L+ + KI+DFGL+ +L D + G + AP
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLA----RLIEDNEYTAREGAKFPIKWTAP 179
Query: 181 EVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD-------ENIMNMYR 222
E + + K+D+WS G++L ++ G +P+ +N+ YR
Sbjct: 180 EAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 33/205 (16%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKEFMMEQIKREISVMRLVRHPN 71
++ + LG G F +V+ + VA+K + + + F+ E +VM+ ++H
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL-----AEANVMKTLQHDK 244
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH----- 126
+V+L V TK+ I++ E++ G L L+ D Q L +DF
Sbjct: 245 LVKLHAV-VTKEPIYIITEFMAKGSL-----LDFLKSD--EGSKQPLPKLIDFSAQIAEG 296
Query: 127 -----SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV--- 178
R HRDL+ N+L+ + KI+DFGL+ ++ D + G +
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWT 352
Query: 179 APEVLRKKGYDGSKADLWSCGVILY 203
APE + + K+D+WS G++L
Sbjct: 353 APEAINFGSFT-IKSDVWSFGILLM 376
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 13 EMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
+ R LG+G F KV TGE VA+K + D + K+EI ++R +
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILRTLY 91
Query: 69 HPNVVELREV--MATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
H ++++ + A + + MEYV G L + R + + QQ+ + + H
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPE-----QLRNDGLLHTQCGTP-AYVA 179
++ HRDL N+LLD + +KI DFGL+ A+PE ++R DG P + A
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PVFWYA 205
Query: 180 PEVLRKKGYDGSKADLWSCGVILY 203
PE L++ + +D+WS GV LY
Sbjct: 206 PECLKEYKFY-YASDVWSFGVTLY 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 48/203 (23%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKD---QLKKEFMMEQIKREISVMR 65
++LG G F V+ G + GES V IKVI Q + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-----DHMLAIG 70
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVD 123
+ H ++V L + + + +Y+ G L + RG L L + Q+ +
Sbjct: 71 SLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--P-AYVAP 180
+ G+ HR+L N+LL ++++DFG++ L L D P ++A
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTPIKWMAL 186
Query: 181 EVLRKKGYDGSKADLWSCGVILY 203
E + Y ++D+WS GV ++
Sbjct: 187 ESIHFGKYT-HQSDVWSYGVTVW 208
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 6e-23
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINK---DQLKKEFMMEQIKREISVMRL 66
E+GR +G+G F V+ G + +VAIK D ++++F+ +E MR
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-----QEALTMRQ 72
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDF 124
HP++V+L V T+ +++ ME GEL F +V + L Y QL +A+ +
Sbjct: 73 FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG------TPAYV 178
S+ HRD+ N+L+ N+ +K+ DFGLS + + G
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWM---- 184
Query: 179 APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
APE + + + S +D+W GV ++ +L+ G PFQ
Sbjct: 185 APESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQG 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINK---DQLKKEFMMEQIKREISVMRL 66
E+GR +G+G F V+ G + +VAIK D ++++F+ +E MR
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-----QEALTMRQ 447
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDF 124
HP++V+L V T+ +++ ME GEL F +V + L Y QL +A+ +
Sbjct: 448 FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCG-TPA-YVAPEV 182
S+ HRD+ N+L+ N+ +K+ DFGLS + + G P ++APE
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPES 563
Query: 183 LRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ + + S +D+W GV ++ +L+ G PFQ
Sbjct: 564 INFRRFT-SASDVWMFGVCMWEILMHGVKPFQG 595
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 2e-22
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 18 LGKGTFAKVYYGKQLMTGES--VAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNV 72
LG G F V G M + VAIKV+ + +E M RE +M + +P +
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-----REAQIMHQLDNPYI 398
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
V L V + + + ME GG L F R + + Q+ + + +
Sbjct: 399 VRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 131 SHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGT--P-AYVAPEVLRKK 186
HR+L N+LL KISDFGLS AL +D + P + APE + +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFR 514
Query: 187 GYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ S++D+WS GV ++ L G P++
Sbjct: 515 KFS-SRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 18 LGKGTFAKVYYGKQLMTGES--VAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNV 72
LG G F V G M + VAIKV+ + +E M RE +M + +P +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-----REAQIMHQLDNPYI 72
Query: 73 VELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRGV 130
V L V + + + ME GG L F R + + Q+ + + +
Sbjct: 73 VRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--P-AYVAPEVLRKKG 187
HRDL N+LL KISDFGLS +D + P + APE + +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 188 YDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ S++D+WS GV ++ L G P++
Sbjct: 190 FS-SRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGES--VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+ LG G F V G M VA+K++ + + +++ E +VM+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-LKDELLAEANVMQQLDNPY 79
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH----- 126
+V + + + + ME + G L L+++ K +
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPL-----NKYLQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 127 -SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--P-AYVAPEV 182
HRDL N+LL KISDFGLS ++ Q P + APE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPEC 191
Query: 183 LRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ + SK+D+WS GV+++ G P++
Sbjct: 192 INYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINK---DQLKKEFMMEQIKREISVMRL 66
+ R+LG+G F +VY G +VA+K K K++FM E +M+
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-----SEAVIMKN 69
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDF 124
+ HP++V+L ++ ++ ++ ME GEL + + + L+ Y Q+ A+ +
Sbjct: 70 LDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT--P-AYVAPE 181
S HRD+ N+L+ E +K+ DFGLS E D + T P +++PE
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE----DEDYYKASVTRLPIKWMSPE 184
Query: 182 VLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD-------ENIMNMYR 222
+ + + + +D+W V ++ +L G PF + R
Sbjct: 185 SINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 38/243 (15%)
Query: 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGES---VAIKVINK---DQLKKEFMME 55
++ ++G+G F VY+G L A+K +N+ +F+
Sbjct: 21 GPSSLIV----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-- 74
Query: 56 QIKREISVMRLVRHPNVVELREVMATKKK-IFVAMEYVKGGELFAKVARGRLREDLARKY 114
E +M+ HPNV+ L + + V + Y+K G+L R +R +
Sbjct: 75 ---TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPT 126
Query: 115 FQQLIS-AVDFCH------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167
+ LI + S+ HRDL N +LDE +K++DFGL+ + +
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDKEY 183
Query: 168 LHTQCGTPAYV-----APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMY 221
T A + A E L+ + + +K+D+WS GV+L+ ++ G P+ D N ++
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242
Query: 222 RKV 224
+
Sbjct: 243 VYL 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 34/232 (14%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVMRL 66
++G+G F VY+G L A+K +N+ +F+ E +M+
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-----TEGIIMKD 146
Query: 67 VRHPNVVELREVMA-TKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS-AVDF 124
HPNV+ L + ++ V + Y+K G+L R +R + + LI +
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQV 201
Query: 125 CH------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV 178
S+ HRDL N +LDE +K++DFGL+ + + T A +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDKEFDSVHNKTGAKL 258
Query: 179 -----APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
A E L+ + + +K+D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 259 PVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 61/235 (25%), Positives = 108/235 (45%), Gaps = 40/235 (17%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVMRL 66
R++GKG F VY+G+ + ++ AIK +++ Q + F+ RE +MR
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-----REGLLMRG 78
Query: 67 VRHPNVVELREVMATKK-KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC 125
+ HPNV+ L +M + V + Y+ G+L +R + LI F
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL-----LQFIRSPQRNPTVKDLI---SFG 130
Query: 126 H--SRGVS--------HRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTP 175
+RG+ HRDL N +LDE+ +K++DFGL+ + + Q
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA---RDILDREYYSVQQHRH 187
Query: 176 AYV-----APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
A + A E L+ + +K+D+WS GV+L+ +L G P++ + ++ +
Sbjct: 188 ARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 61/241 (25%), Positives = 96/241 (39%), Gaps = 43/241 (17%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES---VAIKVINKD----QLKKEFMMEQIKREISVMR 65
+GR+LGKG F V + S VA+K++ D +EF+ RE + M+
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-----REAACMK 80
Query: 66 LVRHPNVVEL------REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLI 119
HP+V +L V + ++K G+L A + R+ E+ Q L+
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 120 S-AVDFCH------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ-----LRNDGL 167
VD SR HRDL N +L E+ + ++DFGLS
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 168 LHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRK 223
L P V A E L Y +D+W+ GV ++ ++ G P+ +Y
Sbjct: 201 L------P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 224 V 224
+
Sbjct: 252 L 252
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 62/228 (27%)
Query: 14 MGRLLGKGTFAKVYYGKQLMTGES--VAIKVINKDQLKKEFMMEQIK---REISVM-RLV 67
++G+G F +V + G AIK ++K+ + + E+ V+ +L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIK-----RMKEYASKDDHRDFAGELEVLCKLG 83
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKY--------FQQ 117
HPN++ L + +++A+EY G L F + +R + QQ
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 118 LISAVDFCH----------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167
L+ F + HRDL N+L+ EN KI+DFGLS R
Sbjct: 144 LLH---FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQE- 193
Query: 168 LHTQCGTPAYV------------APEVLRKKGYDGSKADLWSCGVILY 203
YV A E L Y + +D+WS GV+L+
Sbjct: 194 --------VYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 48/225 (21%), Positives = 84/225 (37%), Gaps = 37/225 (16%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES-------VAIKVINKD--QLKKEFMMEQIKREISV 63
LG+GTF K++ G + G+ V +KV++K + F S+
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF-----EAASM 65
Query: 64 MRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISA 121
M + H ++V V + + E+VK G L + K + + + +QL +A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDL--------KISDFGLSALPEQLRNDGLLHTQCG 173
+ F + H ++ +N+LL ED K+SD G+S + +
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------I---TVLPKDI 176
Query: 174 TPAYV---APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQD 214
+ PE + D WS G L+ + G P
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 54/246 (21%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
M R LG+G+F VY G K ++ E VAIK +N+ + + EF+ E SVM
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-----NEASVM 82
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKY--FQQLIS 120
+ +VV L V++ + V ME + G+L + + R + + ++I
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 121 -AVD------FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN--------- 164
A + + ++ HRDL N ++ E+ +KI DFG++ R+
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRK 196
Query: 165 --DGLLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIM 218
GLL P V +PE L+ + + +D+WS GV+L+ + P+Q +
Sbjct: 197 GGKGLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 219 NMYRKV 224
+ R V
Sbjct: 248 QVLRFV 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 59/240 (24%), Positives = 95/240 (39%), Gaps = 42/240 (17%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGES---VAIKVINKD----QLKKEFMMEQIKREISVMR 65
+G++LG+G F V G + VA+K + D + +EF+ E + M+
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-----SEAACMK 91
Query: 66 LVRHPNVVEL-----REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLIS 120
HPNV+ L K V + ++K G+L + RL Q L+
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 121 -AVDFCH------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ-----LRNDGLL 168
VD +R HRDL N +L ++ + ++DFGLS +
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 169 HTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
P V A E L + Y SK+D+W+ GV ++ + G P+ MY +
Sbjct: 212 ------P--VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 44/224 (19%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
G+ LG G F KV L+ ++ VA+K++ ++ M E+ V+
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-----SELKVL 80
Query: 65 -RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL------------FAKVARGRLREDLA 111
L H N+V L V EY G+L +K + + +D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 112 RKYFQQLIS-------AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164
+ L+S + F S+ HRDL N+LL KI DFGL+ ++N
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKN 197
Query: 165 DG--LLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY 203
D ++ P V APE + Y ++D+WS G+ L+
Sbjct: 198 DSNYVVKGNARLP--VKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 52/219 (23%)
Query: 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKD--QLKKEFMMEQIKREISVMRLVRHPNVV 73
L+G G F KVY G L G VA+K + Q +EF + EI + RHP++V
Sbjct: 45 FLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEF-----ETEIETLSFCRHPHLV 98
Query: 74 EL------REVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLI-------- 119
L R M I + +Y+ G L+ L +
Sbjct: 99 SLIGFCDERNEM-----ILI-YKYM---------ENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 120 ----SA--VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL-PEQLRNDGLLH--T 170
+A + + H+R + HRD+K N+LLDEN KI+DFG+S E H T
Sbjct: 144 ICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE----LDQTHLST 199
Query: 171 QC-GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG 208
GT Y+ PE KG K+D++S GV+L+ +L
Sbjct: 200 VVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCA 237
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 55/227 (24%), Positives = 85/227 (37%), Gaps = 54/227 (23%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
+ G+ LG G F KV L ++ VA+K++ K+ M E+ +M
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-----SELKIM 103
Query: 65 -RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISA 121
L +H N+V L + V EY G+L F + L D A S
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 122 ---VDFCH----------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168
+ F S+ HRD+ N+LL KI DFGL+ R+ +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD---I 214
Query: 169 HTQCGTPAYV------------APEVLRKKGYDGSKADLWSCGVILY 203
Y+ APE + Y ++D+WS G++L+
Sbjct: 215 MN---DSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 74/379 (19%), Positives = 125/379 (32%), Gaps = 134/379 (35%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
+ G+Y + R LG G F+ V+ + + VA+KV+ + E EI +++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKS 89
Query: 67 VR-----HPN---VVELRE------------VMATKKKIFVAMEYVKGGELFAKVARGRL 106
VR PN VV+L + M + V ++ + K L
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE----VLGHHLL--KWIIKSNYQGL 143
Query: 107 REDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLL----------------------- 142
+K QQ++ +D+ H++ + H D+KPEN+LL
Sbjct: 144 PLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 143 --------------------------DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
E +KI+D G + + + T
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQ 258
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ---------DENIMNM------- 220
Y + EVL GY+ + AD+WS + + L G F+ DE+ + +
Sbjct: 259 YRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317
Query: 221 ----------YRKVF---KAEFVY----PPWISTD---------------AKRLISKLLV 248
Y K F K + + PW + + +L
Sbjct: 318 VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377
Query: 249 SDPERRITIQSIMRVPWFR 267
PE+R T +R PW
Sbjct: 378 LIPEKRATAAECLRHPWLN 396
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 36/237 (15%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
+ R LG G F +VY G + S VA+K + + +Q + +F+ E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-----MEALII 87
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAV 122
H N+V V F+ ME + GG+L F + R R + + L A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 123 DFCH------SRGVSHRDLKPEN-LLLDENEDL--KISDFGLSALPEQLRNDGLLHTQCG 173
D HRD+ N LL KI DFG++ R + + G
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS---YYRKG 202
Query: 174 TPAYV-----APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
A + PE + + SK D WS GV+L+ + G++P+ ++ + V
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 47/224 (20%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
LG+ F KVY G GE VAIK + L++EF E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-----HEAMLR 66
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--F--AKVARGRLREDLARKYFQQLIS 120
++HPNVV L V+ + + + Y G+L F + + + + +
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 121 AVDFCH-------------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ-----L 162
DF H S V H+DL N+L+ + ++KISD GL L
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 163 RNDGLLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY 203
+ LL P + APE + + +D+WS GV+L+
Sbjct: 187 LGNSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLW 221
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 8e-19
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 54/227 (23%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK--DQLKKEFMMEQIKREISVMR 65
+ R LG+G F KV+ L + VA+K + +K+F RE ++
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-----REAELLT 72
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL----------FAKVARGRLREDLARKYF 115
++H ++V+ V + + EY+K G+L + G+ R+
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 116 QQLIS-AVDFCH------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLL 168
Q++ A S+ HRDL N L+ N +KI DFG+S R+ +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RD---V 183
Query: 169 HTQCGTPAYV------------APEVLRKKGYDGSKADLWSCGVILY 203
++ T Y PE + + + +++D+WS GVIL+
Sbjct: 184 YS---TDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILW 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 63/236 (26%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
E G++LG G F KV + VA+K++ + ++ M E+ +M
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-----SELKMM 102
Query: 65 -RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISA 121
+L H N+V L I++ EY G+L + + R + ED Q+ +
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 122 ------------VDFCH----------SRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159
+ F + + HRDL N+L+ + +KI DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA--- 219
Query: 160 EQLRNDGLLHTQCGTPAYV------------APEVLRKKGYDGSKADLWSCGVILY 203
R+ + + YV APE L + Y K+D+WS G++L+
Sbjct: 220 ---RD---IMS---DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 36/237 (15%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
+ R LG G F +VY G + S VA+K + + +Q + +F+ E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-----MEALII 128
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAV 122
H N+V V F+ +E + GG+L F + R R + + L A
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 123 DFCH------SRGVSHRDLKPEN-LLLDENEDL--KISDFGLSALPEQLRNDGLLHTQCG 173
D HRD+ N LL KI DFG++ + R + + G
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAG---YYRKG 243
Query: 174 TPAYV-----APEVLRKKGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKV 224
A + PE + + SK D WS GV+L+ + G++P+ ++ + V
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 43/222 (19%), Positives = 89/222 (40%), Gaps = 45/222 (20%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK--DQLKKEFMMEQIKREISVMR 65
+ LG+G F KV+ L+ + VA+K + + + +++F RE ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-----REAELLT 98
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQ-QLISAV 122
+++H ++V V + + + EY++ G+L F + + + +
Sbjct: 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 123 DFCH-------------SRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQ----LRN 164
HRDL N L+ + +KI DFG+S + +
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 165 DGLLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY 203
+L P + PE + + + +++D+WS GV+L+
Sbjct: 219 RTML------P--IRWMPPESILYRKFT-TESDVWSFGVVLW 251
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 67/238 (28%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
+G+ LG+G F KV L VA+K++ + ++ + E +V+
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-----SEFNVL 80
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISA- 121
+ V HP+V++L + + + +EY K G L F + +R L + S
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 122 ------------VDFCH----------SRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159
+ F + HRDL N+L+ E +KISDFGLS
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS--- 197
Query: 160 EQLRN-----------DGLLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY 203
R+ G + P V A E L Y +++D+WS GV+L+
Sbjct: 198 ---RDVYEEDSYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 50/227 (22%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES-----VAIKVINKD---QLKKEFMMEQIKREIS 62
+G+ LG+G F +V L + VA+K++ D + + + E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-----SEME 126
Query: 63 VM-RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKY----- 114
+M + +H N++ L ++V +EY G L + + R E
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 115 ---FQQLIS-AVDFCH------SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ--- 161
+ L+S A S+ HRDL N+L+ E+ +KI+DFGL+
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 162 --LRNDGLLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY 203
+G L P V APE L + Y ++D+WS GV+L+
Sbjct: 247 YKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 63/236 (26%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
E R +G+G F +V+ L+ E VA+K++ + ++ +F RE ++M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-----REAALM 104
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL------------FAKVARGRLREDLAR 112
+PN+V+L V A K + + EY+ G+L +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 113 KYFQQLISAVDFCH-------------SRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159
+S + R HRDL N L+ EN +KI+DFGLS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS--- 221
Query: 160 EQLRNDGLLHTQCGTPAYV------------APEVLRKKGYDGSKADLWSCGVILY 203
RN +++ Y PE + Y +++D+W+ GV+L+
Sbjct: 222 ---RN---IYS---ADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLW 267
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 50/227 (22%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES-----VAIKVINK---DQLKKEFMMEQIKREIS 62
+G+ LG+G F +V + + VA+K++ ++ + + E+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-----SEME 92
Query: 63 VM-RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKY----- 114
+M + +H N++ L ++V +EY G L + + R E
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 115 ---FQQLIS-AVD------FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ--- 161
F+ L+S + S+ HRDL N+L+ EN +KI+DFGL+
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 162 --LRNDGLLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY 203
+G L P V APE L + Y ++D+WS GV+++
Sbjct: 213 YKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 61/232 (26%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES---VAIKVINK---DQLKKEFMMEQIKREISVM 64
++G+ LG+G F +V + + VA+K++ + + M E+ ++
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-----SELKIL 84
Query: 65 -RLVRHPNVVELREV-MATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKY------ 114
+ H NVV L + V +E+ K G L + + R
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 115 --FQQLIS-AVD------FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN- 164
+ LI + F SR HRDL N+LL E +KI DFGL+ R+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RDI 198
Query: 165 ----------DGLLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY 203
D L P + APE + + Y ++D+WS GV+L+
Sbjct: 199 YKDPDYVRKGDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 6e-18
Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 49/221 (22%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIK------VINKDQLKKEFMMEQIKREISVMRL 66
G +G+G F VY G + +VA+K I ++LK++F +EI VM
Sbjct: 34 VGGNKMGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEELKQQF-----DQEIKVMAK 86
Query: 67 VRHPNVVELREV---MATKKKIFVAMEYVKGG----ELFAKVARG------RLR--EDLA 111
+H N+VEL + V Y+ G L R + + A
Sbjct: 87 CQHENLVEL--LGFSSDGDDLCLV-YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 112 RKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL-PEQLRNDGLLH- 169
++F H HRD+K N+LLDE KISDFGL+ +
Sbjct: 144 N--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK----FAQTVM 191
Query: 170 -TQ-CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG 208
++ GT AY+APE LR G K+D++S GV+L ++ G
Sbjct: 192 TSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITG 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 62/233 (26%)
Query: 13 EMGRLLGKGTFAKVYYG--KQLMTGES-----VAIKVINK---DQLKKEFMMEQIKREIS 62
+G+ LG+G F +V + + VA+K++ ++ + + E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-----SEME 138
Query: 63 VM-RLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKY----- 114
+M + +H N++ L ++V +EY G L + + R E
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 115 ---FQQLIS-AVD------FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164
F+ L+S + S+ HRDL N+L+ EN +KI+DFGL+ R+
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RD 252
Query: 165 -----------DGLLHTQCGTPAYV---APEVLRKKGYDGSKADLWSCGVILY 203
+G L P V APE L + Y ++D+WS GV+++
Sbjct: 253 INNIDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 54/240 (22%), Positives = 96/240 (40%), Gaps = 40/240 (16%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+ +G+ +G G F ++ GK L T E VAIK+ + Q+ E + +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQLHLEYRFYKQLGS 63
Query: 70 -PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYF--------QQLIS 120
+ ++ K + +E + G L L + R + QLIS
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL-GPSL------EDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 121 AVDFCHSRGVSHRDLKPENLLL--DENEDLK---ISDFGLSALPEQLRN-DGLLHTQ--- 171
+++ HS+ + +RD+KPEN L+ N+ + I DF L+ + + + H
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK---EYIDPETKKHIPYRE 173
Query: 172 ----CGTPAYVAPEVLRKKGYDGS-KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK 226
GT Y++ G + S + DL + G + L G LP+Q + + K
Sbjct: 174 HKSLTGTARYMSINTH--LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 17 LLGKGTFAKVYYGKQLMTGESVAIKVINKD---QLKKEFMMEQIKREISVMRLVRHPNVV 73
+LG+G F KVY G +L G VA+K + ++ + +F + E+ ++ + H N++
Sbjct: 37 ILGRGGFGKVYKG-RLADGTLVAVKRLKEERTQGGELQF-----QTEVEMISMAVHRNLL 90
Query: 74 ELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAV----------D 123
LR T + + Y+ G + A R R + ++ A+ D
Sbjct: 91 RLRGFCMTPTERLLVYPYMANGSV-ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD 149
Query: 124 FCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH--TQ-CGTPAYVAP 180
C + + HRD+K N+LLDE + + DFGL+ +L + H T GT ++AP
Sbjct: 150 HCDPK-IIHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAP 204
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAG 208
E L G K D++ GV+L L+ G
Sbjct: 205 EYLS-TGKSSEKTDVFGYGVMLLELITG 231
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 38/238 (15%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR- 68
K+ +GR +G G+F ++Y G + T E VAIK+ N Q+ E + R+++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQG 61
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYF--------QQLIS 120
+ +R + M+ + G L L +RK Q+I+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSL------EDLFNFCSRKLSLKTVLMLADQMIN 114
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENED---LKISDFGLSALPEQLRN-DGLLHTQ----- 171
V+F HS+ HRD+KP+N L+ + I DFGL+ + R+ H
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---KYRDTSTHQHIPYRENK 171
Query: 172 --CGTPAYVAPEVLRKKGYDGS-KADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK 226
GT Y + G + S + DL S G +L L G LP+Q +K K
Sbjct: 172 NLTGTARYASVNTH--LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 50/249 (20%), Positives = 97/249 (38%), Gaps = 40/249 (16%)
Query: 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKRE 60
M + +V+ Y++GR +G+G+F ++ G L+ + VAIK + Q++ E
Sbjct: 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDE 55
Query: 61 ISVMRLVRH-PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYF---- 115
+L+ + + + ++ + G L L + RK+
Sbjct: 56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL------EDLLDLCGRKFSVKTV 108
Query: 116 ----QQLISAVDFCHSRGVSHRDLKPENLLLDENEDLK-----ISDFGLSALPEQLRN-D 165
+Q+++ V H + + +RD+KP+N L+ + DFG+ R+
Sbjct: 109 AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---FYRDPV 165
Query: 166 GLLHTQ-------CGTPAYVAPEVLRKKGYDGS-KADLWSCGVILYVLLAGFLPFQDENI 217
H GT Y++ G + S + DL + G + L G LP+Q
Sbjct: 166 TKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223
Query: 218 MNMYRKVFK 226
+K +
Sbjct: 224 ATNKQKYER 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 41/241 (17%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+Y +GR +G G+F +Y G + GE VAIK + Q+ E + ++++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQG 63
Query: 70 -PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYF--------QQLIS 120
+ +R A + ME + G L L +RK+ Q+IS
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSL------EDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENED---LKISDFGLSALPEQLRND-GLLHTQ----- 171
+++ HS+ HRD+KP+N L+ + + I DFGL+ ++ R+ H
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA---KKYRDARTHQHIPYRENK 173
Query: 172 --CGTPAYVAPEVLRKKGYDGS-KADLWSCGVILYVLLAGFLPFQ---DENIMNMYRKVF 225
GT Y + G + S + DL S G +L G LP+Q Y ++
Sbjct: 174 NLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
Query: 226 K 226
+
Sbjct: 232 E 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 46/256 (17%), Positives = 90/256 (35%), Gaps = 49/256 (19%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
++ +G+ +G G F +Y E A V+ + + + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG----PLFSELKFYQRVAK 92
Query: 70 PNVVELREVMATKKKIFVAMEYVKG-GELFAKVARGR------LREDLARKYFQ------ 116
+ ++ + + K+ ++ + G G K R L DL K
Sbjct: 93 KDCIK--KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQ-KISGQNGTFK 149
Query: 117 ---------QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI--SDFGLS--------- 156
+++ +++ H H D+K NLLL ++ +D+GLS
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 157 -ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS-KADLWSCGVILYVLLAGFLPFQD 214
E N H GT + + + KG S ++D+ G + L G LP++
Sbjct: 210 KQYQE---NPRKGHN--GTIEFTSLDAH--KGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262
Query: 215 ENIMNMYRKVFKAEFV 230
+ + K +
Sbjct: 263 NLKDPVAVQTAKTNLL 278
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 5e-15
Identities = 32/191 (16%), Positives = 62/191 (32%), Gaps = 47/191 (24%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVI-----NKDQLKKEFMMEQIKREISVMR 65
K + +G+G F +V+ + + VAIK+I + + E+I EI + +
Sbjct: 21 KLQRCEKIGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 66 LV---------RHPNVVELREV------------------------------MATKKKIF 86
+ R + L V ++F
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDEN 145
+ +E+ GG ++ A+ QL +++ + HRDL N+LL +
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 146 EDLKISDFGLS 156
K+
Sbjct: 199 SLKKLHYTLNG 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 37/252 (14%), Positives = 81/252 (32%), Gaps = 47/252 (18%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV-MRLVR 68
++++ + +Y T + K LK + ++ E + R +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 69 HPNVVELREVMATKKKIFVAMEYVKG--------------------GELFAKVARGRLRE 108
++ + +A+ G + L E
Sbjct: 102 PL---QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSE 158
Query: 109 DLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI--SDFGLS---------- 156
+ +L+ A++F H H ++ EN+ +D + ++ + +G +
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
Query: 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS-KADLWSCGVILYVLLAGFLPFQD- 214
A E G +++ ++ KG S ++DL S G + L GFLP+ +
Sbjct: 219 AYVEG-SRSPH----EGDLEFISMDLH--KGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271
Query: 215 --ENIMNMYRKV 224
M +K
Sbjct: 272 LPNTEDIMKQKQ 283
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 43/256 (16%), Positives = 87/256 (33%), Gaps = 55/256 (21%)
Query: 10 GKYEMGRLLGKGTFAKVYYG-----KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM 64
+++G +G+G F +Y + + + +KV D + E+
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GPLFTELKFY 87
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARG-----RLREDLARKYFQ--- 116
+ P ++ K + V + G + R DL K ++
Sbjct: 88 QRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANA 146
Query: 117 -------------QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI--SDFGLSALPEQ 161
+++ +++ H H D+K NLLL+ ++ D+GL+ +
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA---YR 203
Query: 162 LRNDGLLHTQ---------CGTPAYVAPEVLRKKGYDGS-KADLWSCGVILYVLLAGFLP 211
+G +H GT + + + G S + DL G + L G LP
Sbjct: 204 YCPEG-VHKAYAADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
Query: 212 FQD---ENIMNMYRKV 224
++D + K+
Sbjct: 261 WEDNLKDPKYVRDSKI 276
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 1e-08
Identities = 66/438 (15%), Positives = 140/438 (31%), Gaps = 112/438 (25%)
Query: 45 KDQLKKEFMMEQIKREISVMRLVRHPNVVEL-----REVMATK-KKIFVAMEYVKGGELF 98
+ +L++ + + + V+ V++ + ++ T+ K++ + +
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
Query: 99 AKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158
L D + + + +DL P E L + LS +
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYL---------DCRPQDL-PR-------EVLTTNPRRLSII 333
Query: 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM 218
E +R DGL K + K L ++ L +
Sbjct: 334 AESIR-DGLATWD------------NWKHVNCDK---------LTTIIESSLNVLEPAE- 370
Query: 219 NMYRKVFKAEFVYPP--WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG--FTRPV 274
YRK+F V+PP I T L+S + + + ++ + +P
Sbjct: 371 --YRKMFDRLSVFPPSAHIPTI---LLSLIWFDVIKS--DVMVVV-NKLHKYSLVEKQPK 422
Query: 275 AFSITQHDDDGDDDQAATEKTENDR--HNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLF 332
+I+ + K EN+ H + + + PK FD +L
Sbjct: 423 ESTISIPSIYLE----LKVKLENEYALHRSIVDHYNIPK-------------TFDSDDLI 465
Query: 333 ENKKKTGSMFTSRYSARHI---MEKIEGVAKGMNFKVAKVKDF-----KIRLRGDSEGRK 384
+Y HI ++ IE + F++ + DF KIR +
Sbjct: 466 PPY-------LDQYFYSHIGHHLKNIEHPERMTLFRMVFL-DFRFLEQKIRHDSTAWNAS 517
Query: 385 GP-LSVIAE-------VFEVAPEVAVVEFSKSSGDTLEYAKFCEED-VRPALKDIVWTWQ 435
G L+ + + + + P ++ + L++ EE+ + D++ +
Sbjct: 518 GSILNTLQQLKFYKPYICDNDP-----KYERLVNAILDFLPKIEENLICSKYTDLL---R 569
Query: 436 GDNINKVEG--EDCEMQL 451
+ + E E+ Q+
Sbjct: 570 IALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 8e-04
Identities = 50/457 (10%), Positives = 112/457 (24%), Gaps = 180/457 (39%)
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181
+DF + +++L + + +F + + ++
Sbjct: 7 MDF----ETGEHQYQYKDILSVFEDAF-VDNFDCKDVQDMPKS----------------- 44
Query: 182 VLRKKGYD---GSKADLWSCGVILYVLLA------------------GFL--PFQDEN-- 216
+L K+ D SK + + + LL+ FL P + E
Sbjct: 45 ILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ 104
Query: 217 ---IMNMY----RKVFKAEFVYPP---WISTDAKRLISKLLVSDPERRITIQ-------- 258
+ MY +++ V+ +L LL P + + I
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT 164
Query: 259 ----SIMRVPWFRKGFTRPVAF--SITQHDDDGD--------------DDQAATEKTEND 298
+ + + F ++ + + + ++ + N
Sbjct: 165 WVALDVCLSYKVQCKMDFKI-FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 299 RHNNQEEK---------------------VSSPKFFNAFEFISSMSSGFDLSNLFENKKK 337
+ + V + K +NAF K
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL----------------SCK 267
Query: 338 TGSMFTSRYSA----------RHIMEKIEGVAKGMN-------F-KVAKVKDFKIRLRGD 379
+ T+R+ HI ++ + + K + +
Sbjct: 268 I--LLTTRFKQVTDFLSAATTTHI--SLDHHSMTLTPDEVKSLLLKYLDCRPQDLP---- 319
Query: 380 SEGRKG-PL--SVIAEVFEVAPEV----------AVVEFSKSSGDTLE-------YAKFC 419
E P S+IAE + +SS + LE + +
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS 379
Query: 420 --EEDVR--PALKDIVWTWQGDNINKVEGEDCEMQLS 452
L ++W V D + ++
Sbjct: 380 VFPPSAHIPTILLSLIW-------FDVIKSDVMVVVN 409
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
Q+ ++F SR HRDL N+LL E +KI DFGL+ + D +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKDPDYVRKGDARL 257
Query: 177 YV---APEVLRKKGYDGSKADLWSCGVILY 203
+ APE + + Y ++D+WS GV+L+
Sbjct: 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 29/150 (19%), Positives = 53/150 (35%), Gaps = 10/150 (6%)
Query: 13 EMGRLLGKGTFAKVYYGK-QLMTGESVAIKVINKDQLKKEFMMEQIK---REISVM-RLV 67
++G+ LG+G F +V + + V K LK+ + + E+ ++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSELKILIHIG 83
Query: 68 RHPNVVELREVMATKKK-IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH 126
H NVV L + V +E+ K G L + R + + Y +
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---RSKRNEFVPYKTKGARFRQGKD 140
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLS 156
G DLK + ++ S F
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEE 170
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-05
Identities = 13/80 (16%), Positives = 28/80 (35%), Gaps = 1/80 (1%)
Query: 343 TSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVA-PEVA 401
TS +M +I V N + + F + + + EV ++ +
Sbjct: 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLN 93
Query: 402 VVEFSKSSGDTLEYAKFCEE 421
V F + SG ++ + +
Sbjct: 94 GVRFKRISGTSIAFKNIASK 113
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 29/156 (18%), Positives = 53/156 (33%), Gaps = 23/156 (14%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+G+L+G+G + V+ +K F + KR+ +
Sbjct: 92 DAIGKLMGEGKESAVFNCYSE-KFGECVVKF--HKVGHTSFKKVKEKRDYGDLHFSVLAI 148
Query: 72 VVELREVMATK-------------KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQL 118
E A + + V ME + EL+ +R + + +
Sbjct: 149 RSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR------VRVENPDEVLDMI 202
Query: 119 ISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFG 154
+ V + RG+ H DL N+L+ E + I DF
Sbjct: 203 LEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 237
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 30/170 (17%), Positives = 55/170 (32%), Gaps = 31/170 (18%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGE--SVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
MG ++ G A V+Y + G+ ++A+K+ + EF +R
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETS--EFDKMDEYLYGDERFDMRR 106
Query: 70 PNVVELREVMATK---------------------KKIFVAMEYVKGGELFA---KVARGR 105
+ E + K K + ME++ EL A
Sbjct: 107 ISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE 166
Query: 106 LREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFG 154
L+E F ++ V + + H DL N++ + + D G
Sbjct: 167 LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK--VYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 459 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.35 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.84 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.65 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.27 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.27 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.06 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.31 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.72 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.52 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.61 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.05 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.86 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-69 Score=534.44 Aligned_cols=259 Identities=33% Similarity=0.621 Sum_probs=240.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|+.++|||||++++++++.+.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999877654444567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||+||+|++++.+ +.++|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..........
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999999999999976 8999999999999999999999999999999999999999999999999999987654444455
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLL 247 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 247 (459)
..+.||||.|||||++.+.+|. .++|||||||+||+|++|++||.+.+..+++.++....+.+|..+|+++++||.+||
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL 269 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLL 269 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHS
T ss_pred ccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHc
Confidence 6788999999999999998875 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHH------HhcCccccc
Q 012637 248 VSDPERRITIQS------IMRVPWFRK 268 (459)
Q Consensus 248 ~~dP~~R~t~~e------il~hpw~~~ 268 (459)
++||++|||++| |++||||+.
T Consensus 270 ~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 270 VLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred cCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 999999999988 588999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-69 Score=522.47 Aligned_cols=258 Identities=45% Similarity=0.851 Sum_probs=223.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|++.+.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 58999999999999999999999999999999999887766655667899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||| +|+|++++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---CCc
Confidence 9999 6799998865 7899999999999999999999999999999999999999999999999999986432 334
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLL 247 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 247 (459)
..+.||||.|||||++.+..|++.++|||||||+||+|++|++||.+.+...+++.+..+.+.+|..+|+++++||.+||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 247 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 247 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHS
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 56789999999999999998888899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccCC
Q 012637 248 VSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 248 ~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
++||++|||++|+++||||+...
T Consensus 248 ~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 248 IVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp CSSGGGSCCHHHHHHCHHHHTTC
T ss_pred cCChhHCcCHHHHHcCcccccCC
Confidence 99999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-66 Score=520.58 Aligned_cols=255 Identities=26% Similarity=0.449 Sum_probs=231.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998654433 345789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
|||+||+|++++..++++|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... ......
T Consensus 151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 228 (346)
T 4fih_A 151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 228 (346)
T ss_dssp CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBC
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCccc
Confidence 999999999999989999999999999999999999999999999999999999999999999999986543 233456
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC---CCCCCCCHHHHHHHHHh
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF---VYPPWISTDAKRLISKL 246 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~~ 246 (459)
+.||||.|||||++.+.+|. .++|||||||+||+|++|++||.+.+..+.+..+..... ..+..+|+++++||.+|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 78999999999999988874 899999999999999999999999998888888876532 22345899999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccCC
Q 012637 247 LVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
|+.||++|||++|+|+||||++..
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-67 Score=523.63 Aligned_cols=258 Identities=29% Similarity=0.548 Sum_probs=228.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ..+.+.+|+.+|++|+|||||++++++++.+.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4699999999999999999999999999999999987765443 567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 89 MEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
||||+||+|++++.. ..++|..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--V 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--H
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--c
Confidence 999999999999964 35799999999999999999999999999999999999999999999999999865431 1
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCCCHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWISTDAKRLIS 244 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~ 244 (459)
....+.||||.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..+++.++..+.+ ..+..+|+++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 234567899999999999998885 899999999999999999999999999999999888775 456679999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 245 KLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+||++||++|||++|+|+||||++..
T Consensus 259 ~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHccCChhHCcCHHHHhcCHHhhcCC
Confidence 99999999999999999999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-66 Score=511.90 Aligned_cols=255 Identities=33% Similarity=0.631 Sum_probs=226.2
Q ss_pred CCEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
++|++++.||+|+||+||+|++. .+++.||||++++...... ...++.+|+.+|++++|||||++++++.+.+.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999999984 4688999999987654322 1235778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+|||||+||+|++++.+ +.++|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CC
Confidence 99999999999999976 7899999999999999999999999999999999999999999999999999985432 23
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
....+.||||.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+..+++..+.+..+.+|..+|+++++||.+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 345678999999999999988886 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCC-----HHHHhcCccccc
Q 012637 246 LLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 246 ~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
||++||++||| ++|+++||||+.
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999999998 589999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-65 Score=522.11 Aligned_cols=255 Identities=26% Similarity=0.457 Sum_probs=231.9
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998664433 346789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
|||+||+|++++..++++|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... ......
T Consensus 228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 305 (423)
T 4fie_A 228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 305 (423)
T ss_dssp ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCBC
T ss_pred eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcccc
Confidence 999999999999889999999999999999999999999999999999999999999999999999986543 233456
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---CCCCCCCCHHHHHHHHHh
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKRLISKL 246 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~ 246 (459)
+.||||.|||||++.+..|. .++|||||||+||+|++|++||.+.+..+.+..+.... +..+..+|+++++||.+|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 78999999999999988874 89999999999999999999999999888888877653 233456899999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccCC
Q 012637 247 LVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
|..||++|||++|+|+||||++..
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-64 Score=491.29 Aligned_cols=255 Identities=24% Similarity=0.475 Sum_probs=221.7
Q ss_pred cccCCE-EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe----
Q 012637 7 VLFGKY-EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT---- 81 (459)
Q Consensus 7 ~~~~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~---- 81 (459)
...+|| ++.+.||+|+||+||+|.++.++..||+|++.+...... ..+.+.+|+.+|++++|||||++++++.+
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 345676 788899999999999999999999999999987655433 46789999999999999999999999875
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecC-CCCeEEeecCCCc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDE-NEDLKISDFGLSA 157 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~-~~~lKl~DFGla~ 157 (459)
...+|||||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++| |+||||||+||||+. +|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 3568999999999999999976 78999999999999999999999999 999999999999985 7999999999997
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc-hHHHHHHHHHhccC--CCCCC
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFKAEF--VYPPW 234 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~--~~p~~ 234 (459)
.. ......+.||||.|||||++.+ .| +.++|||||||+||+|+||+.||.+. +...++..+..+.. .++..
T Consensus 181 ~~----~~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 181 LK----RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GC----CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred eC----CCCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 53 2344567899999999999875 46 48999999999999999999999764 44556666655432 34456
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.++++++||.+||.+||++|||++|+|+||||+.
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 8899999999999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-63 Score=517.45 Aligned_cols=409 Identities=32% Similarity=0.581 Sum_probs=314.2
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
.+....++|.+++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45678899999999999999999999999999999999998654433334567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.+|+|||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~-- 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-- 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc--
Confidence 99999999999999999976 689999999999999999999999999999999999999999999999999998643
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 242 (459)
......+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+..+..+.+..|..+++++.+|
T Consensus 168 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 246 (476)
T 2y94_A 168 -DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL 246 (476)
T ss_dssp -TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred -ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence 2334567899999999999998887778999999999999999999999999988999999988888899999999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCCCCCcccccccCCC-------------C----CCchhHhh-hhh-c-------
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDD-------------D----GDDDQAAT-EKT-E------- 296 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~~~~~~~~~~~~~~~~~-------------~----~~~~~~~~-~~~-~------- 296 (459)
|.+||..||.+|||++++++||||+................ . ..+..... ... .
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y 326 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAY 326 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-------------------------
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHH
Confidence 99999999999999999999999987543211000000000 0 00000000 000 0
Q ss_pred -----ccccccc----------------c--cccCCCcCCChhhHhh-----hcCCC--CCCCccccccCcccceeecCC
Q 012637 297 -----NDRHNNQ----------------E--EKVSSPKFFNAFEFIS-----SMSSG--FDLSNLFENKKKTGSMFTSRY 346 (459)
Q Consensus 297 -----~~~~~~~----------------~--~~~~~~~~~~~~~~~~-----~~s~~--~~~s~~~~~~~~~~trf~s~~ 346 (459)
+....++ . .....|.......-.+ ++++. ......+..+.++..++.|+.
T Consensus 327 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~ 406 (476)
T 2y94_A 327 HLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQS 406 (476)
T ss_dssp ------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEECS
T ss_pred HHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccCC
Confidence 0000000 0 0000000000000000 00000 001111223346789999999
Q ss_pred CHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEeCceEEEEEEecCCChHHH
Q 012637 347 SARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEY 415 (459)
Q Consensus 347 ~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~le~ 415 (459)
.|.+||..|..+++.+|+.|++.+.+.|++....+.....+.|.+++|++.++.+||||++..|+.++|
T Consensus 407 ~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 407 RPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp CHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred CHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 999999999999999999999999999999753333345577999999999999999999999999886
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-63 Score=495.68 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=222.1
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.+.|++.+.||+|+||+||+|+++.+|+.||||+++++... .+|+.+|+.++|||||++++++.+.+.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999876432 3699999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~~~~~~~~ 166 (459)
||||+||+|++++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999999976 7899999999999999999999999999999999999999988 69999999998654322111
Q ss_pred ---ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC---CCCCCCCHHHH
Q 012637 167 ---LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF---VYPPWISTDAK 240 (459)
Q Consensus 167 ---~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 240 (459)
...+.||||.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+...++.++..... ..|+.+|+++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 22346899999999999998885 899999999999999999999998887777777776654 35778999999
Q ss_pred HHHHHhcCCCCCCCCCHHHH-------------hcCcccccC
Q 012637 241 RLISKLLVSDPERRITIQSI-------------MRVPWFRKG 269 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~ei-------------l~hpw~~~~ 269 (459)
+||.+||++||.+|||+.|+ ++|||+...
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999999999999998 578998653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-62 Score=496.53 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=224.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------C
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------K 82 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~ 82 (459)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 46899999999999999999999999999999999765433 3345778899999999999999999999764 3
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+.+|||||||+ |+|++++.. +++++..++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67999999996 579998876 7899999999999999999999999999999999999999999999999999986532
Q ss_pred c--cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC--------
Q 012637 162 L--RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY-------- 231 (459)
Q Consensus 162 ~--~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 231 (459)
. .......+.|||+.|||||++.+..+++.++||||+||++|+|++|++||.+.+..+.+..|.......
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2 123345678999999999999988777899999999999999999999999998888777765432111
Q ss_pred -----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 232 -----------------------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 232 -----------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+.+|+++.+||.+||..||.+|||++|+|+||||+..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 12468999999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-61 Score=512.03 Aligned_cols=259 Identities=30% Similarity=0.494 Sum_probs=228.2
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHH---HHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEF---MMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
.+..++|+++++||+|+||+||+|+++.+|+.||||++.+..+.... ......+++.+++.++|||||++++++++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 45678999999999999999999999999999999999876543222 222334456677778999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+.+|||||||+||+|++++.+ +.++|..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~- 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS- 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC-
Confidence 999999999999999999976 889999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch---HHHHHHHHHhccCCCCCCCCHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN---IMNMYRKVFKAEFVYPPWISTD 238 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~ 238 (459)
.....+.||||.|||||++.+...++.++|||||||+||+|++|.+||.+.+ ...++..+....+.+|..+|++
T Consensus 344 ---~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 ---KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp ---SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ---CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 2345678999999999999754334589999999999999999999997643 4466777888888999999999
Q ss_pred HHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
+++||.+||+.||.+|++ ++||++||||+.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999999999999999998 799999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-60 Score=478.15 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=210.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (459)
.+.++|++.+.||+|+||+||+|+++ .+++.||||.+.+... ..++.+|+.+|+.+ +||||+++++++.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 35688999999999999999999875 4678999999865431 24578999999998 699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFGla~~~~~ 161 (459)
+++|+|||||+||+|.+++. ++++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999999984 69999999999999999999999999999999999999877 8999999999974332
Q ss_pred cc--------------------------CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC-
Q 012637 162 LR--------------------------NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD- 214 (459)
Q Consensus 162 ~~--------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~- 214 (459)
.. ......+.||||.|||||++.+..+++.++||||+||++|+|++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 10 112234568999999999998877667999999999999999999999954
Q ss_pred chHHHHHHHHHh--------------------------------------ccC----------------CCCCCCCHHHH
Q 012637 215 ENIMNMYRKVFK--------------------------------------AEF----------------VYPPWISTDAK 240 (459)
Q Consensus 215 ~~~~~~~~~i~~--------------------------------------~~~----------------~~p~~~s~~~~ 240 (459)
.+..+.+..+.. ... .....+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 333333222211 000 01124789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 241 RLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+||.+||+.||++|||++|+|+||||+.
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=468.67 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=202.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-----
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK----- 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----- 83 (459)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 356999999999999999999999999999999997553 3345578899999999999999999999987544
Q ss_pred -------EEEEEEeccCCCchHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEee
Q 012637 84 -------KIFVAMEYVKGGELFAKVAR-GR---LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISD 152 (459)
Q Consensus 84 -------~~~lV~E~~~gg~L~~~i~~-~~---l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~D 152 (459)
.+|+|||||+||+|.+++.. +. .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999976 33 45567899999999999999999999999999999999999999999
Q ss_pred cCCCcccccccCC----------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH-HHHH
Q 012637 153 FGLSALPEQLRND----------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMY 221 (459)
Q Consensus 153 FGla~~~~~~~~~----------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~ 221 (459)
||+|+........ ....+.||||.|||||++.+..|+ .++|||||||+||+|++ ||.+... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999865432111 123456899999999999988875 89999999999999996 8876432 2233
Q ss_pred HHHHhccCCCCC---CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 222 RKVFKAEFVYPP---WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 222 ~~i~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+... .+|+ ..++.+.+||.+||++||.+|||+.|+++||||+.
T Consensus 238 ~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 238 TDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 333332 3332 25677899999999999999999999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=498.56 Aligned_cols=256 Identities=34% Similarity=0.602 Sum_probs=233.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+.+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999997653 2235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC--CCeEEeecCCCccccccc
Q 012637 88 AMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN--EDLKISDFGLSALPEQLR 163 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~--~~lKl~DFGla~~~~~~~ 163 (459)
|||||+||+|++++.. +.++|.+++.|++||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--- 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 308 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC---
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc---
Confidence 9999999999999964 689999999999999999999999999999999999999854 899999999998654
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTDA 239 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (459)
......+.|||+.|||||++.+.+|. .++|||||||+||+|++|.+||.+.+..+.+..+....+.++ ..+|+++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 33455678999999999999998874 899999999999999999999999999999999988876655 3589999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
++||.+||..||.+|||++|+|+||||+...
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 9999999999999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-60 Score=464.02 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=222.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
+-.++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|++++|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 33467999999999999999999875 36788999999654 33456789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR--------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED 147 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~ 147 (459)
.+.+|||||||+||+|.+++.. ..+++.++..++.||+.||.|||+++|+||||||+|||++.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 9999999999999999999964 25999999999999999999999999999999999999999999
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHh
Q 012637 148 LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFK 226 (459)
Q Consensus 148 lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 226 (459)
+||+|||+|+..............+||+.|||||++.+..|+ .++||||+||+||||+| |+.||.+.+..+++..+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999865433222233446799999999999988875 89999999999999998 9999999998888888877
Q ss_pred cc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 227 AE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 227 ~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+. ...|..+|+++.+||.+||+.||++|||+++| |+|++.
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 65 46678899999999999999999999999999 567753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=459.50 Aligned_cols=251 Identities=20% Similarity=0.317 Sum_probs=213.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
..+|.+.+.||+|+||+||+|+.. .+++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 457999999999999999999865 36889999999653 3345678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC
Q 012637 84 KIFVAMEYVKGGELFAKVAR----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED 147 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~ 147 (459)
.+|||||||++|+|.+++.. +++++.++..++.|++.||.|||+++|+||||||+||||+.+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 99999999999999998854 35899999999999999999999999999999999999999999
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHh
Q 012637 148 LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFK 226 (459)
Q Consensus 148 lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 226 (459)
+||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..+.+..+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999865443333334567899999999999988875 89999999999999999 9999999888888888776
Q ss_pred c-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 227 A-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 227 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+ .+..|..+++++.+||.+||+.||++|||++||+++
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5 466788899999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=454.58 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=207.0
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+.+-.+++++++.||+|+||+||+|++. ..||||+++.... .....+.+.+|+.+|++++|||||++++++. .+.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence 3455678999999999999999999853 3599999865443 3345678999999999999999999999875 456
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
+|||||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 8999999999999999964 67999999999999999999999999999999999999999999999999999876543
Q ss_pred cCCCccccccCCCcccChhhHhhcC--CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC------CCCCC
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKG--YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF------VYPPW 234 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------~~p~~ 234 (459)
.......+.+||+.|||||++.+.. .++.++|||||||+||+|+||+.||.+.+.......+..... ..++.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence 3344456779999999999997532 235899999999999999999999988665444433333222 23456
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+++++.+||.+||+.||++|||+.||+++
T Consensus 266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp SCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999988654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-58 Score=454.01 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=222.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
+-...+++.+.||+|+||+||+|... .+++.||||++.... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 44578999999999999999999853 467899999996543 22235678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE 144 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~ 144 (459)
.+.+|||||||++|+|.+++.. +.+++..+..++.||+.||+|||+++|+||||||+||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 9999999999999999999853 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHH
Q 012637 145 NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRK 223 (459)
Q Consensus 145 ~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~ 223 (459)
++++||+|||+|+............+.+||+.|||||++.+..|+ .++||||+||+||||+| |..||.+.+..++...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876544334445567899999999999988875 89999999999999998 8999999998888888
Q ss_pred HHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 224 VFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 224 i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+..+. .+.|+.+++++.+|+.+||+.||++|||+.||+++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77654 45677899999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=450.22 Aligned_cols=262 Identities=42% Similarity=0.811 Sum_probs=241.9
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
.....++|++.+.||+|+||.||+|.+..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 456789999999999999999999999999999999999876543 3356778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||||++||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~--- 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT--- 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS---
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC---
Confidence 9999999999999999865 789999999999999999999999999999999999999999999999999997543
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
......+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+..+....+..+.+..|..+++++.+||
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 23345678999999999999998888789999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 244 SKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+||..||.+|||++|+++||||+...
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=448.32 Aligned_cols=260 Identities=35% Similarity=0.653 Sum_probs=231.2
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
.+..++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999876544444566788999999988 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+|||||+||+|..++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999974322
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++..+......+|.++++++.+||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 22344567999999999999988775 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCH------HHHhcCccccc
Q 012637 244 SKLLVSDPERRITI------QSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t~------~eil~hpw~~~ 268 (459)
.+||..||.+||++ ++|++||||+.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999998 89999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=451.40 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=217.5
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCC-----CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMT-----GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH-PNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~ 78 (459)
+.+-.++|++++.||+|+||+||+|.+..+ ++.||||.+..... ....+.+.+|+.+|+++.| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 344567899999999999999999997654 46799999975432 2345678999999999965 999999999
Q ss_pred EEe-CCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCe
Q 012637 79 MAT-KKKIFVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENL 140 (459)
Q Consensus 79 ~~~-~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NI 140 (459)
+.+ .+.+|||||||++|+|.+++.. ..+++..+..|+.||+.||+|||+++|+||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 4679999999999999999863 2389999999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHH-
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIM- 218 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~- 218 (459)
|++.++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999865432222233456899999999999988875 89999999999999998 99999886643
Q ss_pred HHHHHHHhc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 219 NMYRKVFKA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 219 ~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+...+..+ .+..|..+++++.+||.+||+.||++|||+.+|++|
T Consensus 296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 344444443 456788899999999999999999999999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=440.63 Aligned_cols=258 Identities=34% Similarity=0.637 Sum_probs=235.3
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 46789999999999999999999999999999999986543333335678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||||++||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCC
Confidence 9999999999999876 7899999999999999999999999999999999999999999999999999975322 223
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 246 (459)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..+......+|..+++++.+||.+|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 4557799999999999988776 489999999999999999999999999999999999888999999999999999999
Q ss_pred cCCCCCCCC-----CHHHHhcCccccc
Q 012637 247 LVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 247 L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
|..||.+|| +++++++||||+.
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999999 8999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=433.34 Aligned_cols=256 Identities=34% Similarity=0.703 Sum_probs=234.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45688999999999999999999999999999999998654333233567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 99999999999999976 789999999999999999999999999999999999999999999999999997543
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|+.+++++.+||.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 158 DVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 223467899999999999887775 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----CHHHHhcCccccc
Q 012637 246 LLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 246 ~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
||..||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 9999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=445.18 Aligned_cols=262 Identities=45% Similarity=0.852 Sum_probs=233.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
...+++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45679999999999999999999999999999999999765433332345788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||+ +|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.... .
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~---~ 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---D 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT---T
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc---C
Confidence 9999999 6788888765 789999999999999999999999999999999999999999999999999998643 2
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......+..+....+..|..+|+++.+||.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 33456779999999999998887767899999999999999999999998776666666666667788889999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 245 KLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
+||..||.+|||++|+++||||+...+
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHcCCChhHCcCHHHHHhChhhccCCc
Confidence 999999999999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=440.22 Aligned_cols=260 Identities=33% Similarity=0.627 Sum_probs=234.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
....++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 35678999999999999999999999999999999999875433222345678899999887 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++..+......+|.++++++.+||
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 22334577999999999999987774 89999999999999999999999999999999999998899999999999999
Q ss_pred HHhcCCCCCCCCCHH-HHhcCccccc
Q 012637 244 SKLLVSDPERRITIQ-SIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~-eil~hpw~~~ 268 (459)
.+||..||.+||++. +|++||||+.
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHhcCCHhHcCCChHHHHcCccccC
Confidence 999999999999998 9999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=436.54 Aligned_cols=260 Identities=35% Similarity=0.616 Sum_probs=233.3
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
...+.++|++++.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 34677899999999999999999999999999999999987543221 124578899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC----CeEEeecCCC
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE----DLKISDFGLS 156 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~----~lKl~DFGla 156 (459)
...+|+||||++||+|++++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999976 6899999999999999999999999999999999999998877 7999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP---- 232 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p---- 232 (459)
..... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+....+.++
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eEcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 76432 233456789999999999988776 4899999999999999999999999999999888888877665
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+++++++||.+||.+||.+|||++|+++||||+.
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 468999999999999999999999999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=432.42 Aligned_cols=260 Identities=30% Similarity=0.586 Sum_probs=234.2
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
.+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45578999999999999999999999999999999999987766666778889999999988 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 9999999999999999876 7899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC---------chHHHHHHHHHhccCCCCCC
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD---------ENIMNMYRKVFKAEFVYPPW 234 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~ 234 (459)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .....++..+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 2234556799999999999998777 4899999999999999999999975 33445667778888889999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 012637 235 ISTDAKRLISKLLVSDPERRITI------QSIMRVPWFRK 268 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~------~eil~hpw~~~ 268 (459)
+++++.+||.+||+.||.+||++ +++++||||+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 89999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=442.89 Aligned_cols=259 Identities=29% Similarity=0.578 Sum_probs=230.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
+-.++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 4567899999999999999999999999999999999887665555566788999999887 899999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+|||||+||+|..++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 206 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 206 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--C
Confidence 999999999999999876 7899999999999999999999999999999999999999999999999999974322 2
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc---------hHHHHHHHHHhccCCCCCCC
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE---------NIMNMYRKVFKAEFVYPPWI 235 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~ 235 (459)
.....+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||... ....++..+....+.+|..+
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 285 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred CCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence 3345678999999999999988774 8999999999999999999999642 23456777888889999999
Q ss_pred CHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPERRITI------QSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~------~eil~hpw~~~ 268 (459)
++++.+||.+||+.||.+||++ ++|++||||+.
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999985 89999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=437.21 Aligned_cols=260 Identities=31% Similarity=0.570 Sum_probs=234.6
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
.+..++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45678999999999999999999999999999999999876443333456788999999988 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+++..+......+|..+++++.+||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 2234556799999999999988777 489999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 244 SKLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
.+||..||.+||+ +++|++||||+.
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999994 699999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=435.12 Aligned_cols=257 Identities=32% Similarity=0.626 Sum_probs=236.4
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
....++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 35678999999999999999999999999999999999766443333456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+..+...+|..+++++.+||.
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23467899999999999987775 899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 245 KLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 245 ~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
+||+.||.+||+ +++|++||||+.
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999998 999999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=419.55 Aligned_cols=256 Identities=30% Similarity=0.488 Sum_probs=227.6
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..++|++.+.||+|+||+||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 4578999999999999999999999999999999997654433 3567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 88 AMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--cccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999975443 2223
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---cCCCCCCCCHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EFVYPPWISTDAKRLIS 244 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~ 244 (459)
....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+... ....|..+++.+.+||.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 4566899999999999988774 8999999999999999999999988776655554433 23445678999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccC
Q 012637 245 KLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+||+.||.+|||++|+++||||+..
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHccCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=431.37 Aligned_cols=260 Identities=35% Similarity=0.693 Sum_probs=232.2
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
....+.++|++.+.||+|+||.||+|.++.+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 34556778999999999999999999999999999999998765533 34567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---CeEEeecCCCccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---DLKISDFGLSALP 159 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---~lKl~DFGla~~~ 159 (459)
..|+|||||+||+|++.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999998865 6799999999999999999999999999999999999998654 5999999999765
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC----CC
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP----WI 235 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~ 235 (459)
.. .......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+..+.+.+|. .+
T Consensus 182 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 182 ND---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp TT---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred cC---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 42 2334567899999999999887775 8999999999999999999999999988888888888776653 37
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
++++.+||.+||..||.+|||+.++++||||..
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=442.28 Aligned_cols=259 Identities=36% Similarity=0.688 Sum_probs=231.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
+.+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 456688999999999999999999999999999999998765433 3456789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec---CCCCeEEeecCCCccccc
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD---ENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~---~~~~lKl~DFGla~~~~~ 161 (459)
|+|||||+||+|++.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999998865 7899999999999999999999999999999999999998 468899999999976543
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC----CCCH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP----WIST 237 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 237 (459)
........+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+..+.+.+|. .+++
T Consensus 166 --~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 166 --EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp --TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred --CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 22334567899999999999887774 8999999999999999999999999999999998888766553 4799
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=433.79 Aligned_cols=260 Identities=33% Similarity=0.584 Sum_probs=227.3
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHH-HHhcCCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISV-MRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 84 (459)
....++|++.+.||+|+||+||+|+++.+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3556789999999999999999999999999999999988766555455667778877 577899999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||||++||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLI 243 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 243 (459)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++..+......+|+.+++++.+||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 23345677999999999999988775 89999999999999999999999999999999999988889999999999999
Q ss_pred HHhcCCCCCCCCCH----HHHhcCccccc
Q 012637 244 SKLLVSDPERRITI----QSIMRVPWFRK 268 (459)
Q Consensus 244 ~~~L~~dP~~R~t~----~eil~hpw~~~ 268 (459)
.+||+.||.+||++ ++|++||||+.
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999986 69999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=426.02 Aligned_cols=264 Identities=34% Similarity=0.625 Sum_probs=226.3
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 357899999999999999999999999999999999997554322 235688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+|||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999999999976 5799999999999999999999999999999999999999999999999999986554333
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-HHHHHHHhccCCCC--CCCCHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-NMYRKVFKAEFVYP--PWISTDAKR 241 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~ 241 (459)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++++.+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence 344556789999999999998877668899999999999999999999875543 33333333333333 348999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
||.+||..||.+|||++|+++||||+....
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 999999999999999999999999986543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=441.60 Aligned_cols=261 Identities=32% Similarity=0.553 Sum_probs=229.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 44678999999999999999999999999999999997643322212344778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
+|||||+||+|.+++..+++++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|....... ..
T Consensus 146 lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EE
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997543211 11
Q ss_pred ccccccCCCcccChhhHhhcC---CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCCC--CCCHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKG---YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYPP--WISTDA 239 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 239 (459)
...+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||.+.+....+.++.... +.+|. .+|+++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 234679999999999998655 13589999999999999999999999999998888887642 44554 689999
Q ss_pred HHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012637 240 KRLISKLLVSDPER--RITIQSIMRVPWFRK 268 (459)
Q Consensus 240 ~~Li~~~L~~dP~~--R~t~~eil~hpw~~~ 268 (459)
++||.+||..+|.+ |++++||++||||+.
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 99999999999988 999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=422.15 Aligned_cols=254 Identities=27% Similarity=0.529 Sum_probs=229.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 5789999999999999999999999999999999986442 234568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC--CCCeEEeecCCCccccccc
Q 012637 88 AMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE--NEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~--~~~lKl~DFGla~~~~~~~ 163 (459)
|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 9999999999999976 36999999999999999999999999999999999999997 78999999999986532
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTDA 239 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (459)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+....+.++ +.+|+++
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 233456789999999999987655 4899999999999999999999999998888888888877665 3689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+||.+||..||.+|||+.|+++||||+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=433.81 Aligned_cols=262 Identities=28% Similarity=0.540 Sum_probs=233.7
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+.+.+..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34567789999999999999999999999999999999999866543333456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+.+|+||||+.||+|..++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~- 166 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP- 166 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc-
Confidence 999999999999999999976 589999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCcccChhhHhhc---CCCCCcchhhhHHHHHHHHhhCCCCCCC---chHHHHHHHHHhccCCCCCCC
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKK---GYDGSKADLWSCGVILYVLLAGFLPFQD---ENIMNMYRKVFKAEFVYPPWI 235 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~---~~~~~~~DIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~p~~~ 235 (459)
......+.+||+.|+|||++... +| +.++|||||||++|+|++|..||.. ......+..+......+|..+
T Consensus 167 --~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~ 243 (384)
T 4fr4_A 167 --RETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243 (384)
T ss_dssp --TTCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTS
T ss_pred --CCCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcC
Confidence 23445678999999999999742 34 5899999999999999999999974 345566677777788889999
Q ss_pred CHHHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPERRIT-IQSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t-~~eil~hpw~~~ 268 (459)
++++.+||.+||..||.+||+ ++++++||||+.
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 999999999999999999998 999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=418.46 Aligned_cols=260 Identities=36% Similarity=0.630 Sum_probs=223.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc-----------------------HHHHHHHHHHHH
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK-----------------------EFMMEQIKREIS 62 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~i~~Ei~ 62 (459)
....++|++.+.||+|+||.||+|.+..+|+.||||++.+..... ....+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 456789999999999999999999999999999999997654321 112356889999
Q ss_pred HHHhcCCCCcceeEEEEEe--CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCe
Q 012637 63 VMRLVRHPNVVELREVMAT--KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENL 140 (459)
Q Consensus 63 il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NI 140 (459)
+++.++||||+++++++.+ ...+|+||||+++++|.+++..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 9999999999999999987 67899999999999998877778899999999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCC--CCCcchhhhHHHHHHHHhhCCCCCCCchHH
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY--DGSKADLWSCGVILYVLLAGFLPFQDENIM 218 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~ 218 (459)
|++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+..
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 999999999999999976442 2223455689999999999976542 357899999999999999999999998888
Q ss_pred HHHHHHHhccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 219 NMYRKVFKAEFVYP--PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 219 ~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
.....+.......| +.+++++.+||.+||..||.+|||+.|+++||||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 77777776655554 46899999999999999999999999999999996
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=428.40 Aligned_cols=264 Identities=30% Similarity=0.665 Sum_probs=224.8
Q ss_pred CccccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc--HHHHHHHHHHHHHHHhcCCCCcceeEEE
Q 012637 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK--EFMMEQIKREISVMRLVRHPNVVELREV 78 (459)
Q Consensus 1 m~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 78 (459)
|.+....+.++|++.+.||+|+||+||+|.++.+|+.||||++....... ....+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 94 (351)
T 3c0i_A 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94 (351)
T ss_dssp -----CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCCCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34455677789999999999999999999999999999999997543221 1124578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC---eEE
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED---LKI 150 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~---lKl 150 (459)
+.+.+.+|+|||||+||+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence 9999999999999999999887753 24899999999999999999999999999999999999987655 999
Q ss_pred eecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC
Q 012637 151 SDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV 230 (459)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 230 (459)
+|||++..... ........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.. ...+..+..+.+.
T Consensus 175 ~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 175 GGFGVAIQLGE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYK 250 (351)
T ss_dssp CCCTTCEECCT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCC
T ss_pred ecCcceeEecC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCC
Confidence 99999976543 2223446789999999999988776 489999999999999999999998864 4556666666665
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 231 YP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 231 ~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+ ..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 54 458999999999999999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=411.28 Aligned_cols=258 Identities=28% Similarity=0.484 Sum_probs=218.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|++.+.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 468999999999999999999999999999999998655433 2456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVA-RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~-~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||++++.+..... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 157 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCSC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--cccc
Confidence 99998754444444 37899999999999999999999999999999999999999999999999999976532 2233
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCC-CCCchHHHHHHHHHhcc------------------
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLP-FQDENIMNMYRKVFKAE------------------ 228 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~------------------ 228 (459)
....+||+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+..+....+....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 45668999999999998877556999999999999999988777 56666666555554310
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 -----------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 -----------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...++.+++++++||.+||+.||.+|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01123478899999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=411.51 Aligned_cols=263 Identities=33% Similarity=0.664 Sum_probs=234.8
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
++....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 45677899999999999999999999999999999999997654443334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
..|+||||+++|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 99999999999999999876 7899999999999999999999999999999999999999999999999999864332
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 242 (459)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++++.+|
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred ---ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 22345679999999999987766 48999999999999999999999999999888888888888999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
|.+||..||.+|||++|+++||||+....
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 99999999999999999999999986543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=420.28 Aligned_cols=260 Identities=33% Similarity=0.626 Sum_probs=223.7
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeecccccc-HHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLKK-EFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
.+..++|++.+.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456789999999999999999999986 689999999998754322 2234567899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999999976 789999999999999999999999999999999999999999999999999997533
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAK 240 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (459)
. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|+.+++++.
T Consensus 173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 173 H--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred c--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2 2223456789999999999988776 489999999999999999999999999888888999888899999999999
Q ss_pred HHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 241 RLISKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
+||.+||..||.+|| +++++++||||+.
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 999999999999999 8999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=441.23 Aligned_cols=259 Identities=36% Similarity=0.639 Sum_probs=225.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999998765444445567789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|..... .
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence 99999999999999876 789999999999999999999998 9999999999999999999999999999975322 2
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
.....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 2344567899999999999887774 899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 245 KLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 245 ~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
+||..||.+|| |++++++||||+.
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999999999 9999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=418.90 Aligned_cols=259 Identities=36% Similarity=0.609 Sum_probs=229.7
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456789999999999999999999999999999999976543211 1246788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC----CeEEeecCCCc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE----DLKISDFGLSA 157 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~----~lKl~DFGla~ 157 (459)
..+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999999976 6799999999999999999999999999999999999999887 89999999998
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----C
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----P 233 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 233 (459)
.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+....+..+ .
T Consensus 167 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 6532 2234567899999999999877764 899999999999999999999999888888777777666554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+++.+.+||.+||.+||.+|||++++++||||+.
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 58999999999999999999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=423.29 Aligned_cols=257 Identities=41% Similarity=0.723 Sum_probs=215.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||+||+|++..+++.||||++.+..... +.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 34689999999999999999999999999999999997654433 45779999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC--eEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED--LKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~--lKl~DFGla~~~~~~~ 163 (459)
+||||++||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 99999999999999865 78999999999999999999999999999999999999987765 9999999997432
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH----HHHHHHHHhccCCCCC--CCCH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI----MNMYRKVFKAEFVYPP--WIST 237 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~ 237 (459)
........+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+. ......+....+..|. .+++
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 222334568999999999999888876669999999999999999999987543 4455556666666665 4799
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
++.+||.+||..||.+|||++|+++||||....
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 999999999999999999999999999997654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=421.06 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=195.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC----EE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK----KI 85 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 85 (459)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+..+.+++|||||++++++.+.+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 5799999999999999999986 689999999975431 1122345777778899999999999997653 68
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 86 FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR--------GVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~--------gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
|||||||+||+|.+++...+++++.+..++.|++.||+|||++ ||+||||||+||||+.++++||+|||+|+
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999999999989999999999999999999999987 99999999999999999999999999998
Q ss_pred ccccccC--CCccccccCCCcccChhhHhhcCC-----CCCcchhhhHHHHHHHHhhCCCCCCCc---------------
Q 012637 158 LPEQLRN--DGLLHTQCGTPAYVAPEVLRKKGY-----DGSKADLWSCGVILYVLLAGFLPFQDE--------------- 215 (459)
Q Consensus 158 ~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~--------------- 215 (459)
....... .....+.+||+.|||||++.+... .+.++|||||||+||||+||..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 6543221 112335689999999999976421 236899999999999999997765321
Q ss_pred hHHHHHHHHHhccC--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 216 NIMNMYRKVFKAEF--VYPPW-----ISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 216 ~~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
....+...+..... ..|.. .+..+.+|+.+||+.||++|||+.||++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22333333333322 23322 22467899999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=412.52 Aligned_cols=259 Identities=29% Similarity=0.471 Sum_probs=215.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+..+.++|++.+.||+|+||+||+|.+. +|+.||+|++...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 4578899999999999999999999985 5899999999755332 2245678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
+|+||||+++ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~- 171 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI- 171 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS-
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC-
Confidence 9999999986 77777754 4699999999999999999999999999999999999999999999999999986532
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCC----------
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFV---------- 230 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~---------- 230 (459)
........+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+... ...
T Consensus 172 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 172 -PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp -CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred -CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 2233445689999999999987555568999999999999999999999886655544444321 000
Q ss_pred ------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 231 ------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 231 ------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+.+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 11236789999999999999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=437.47 Aligned_cols=261 Identities=29% Similarity=0.536 Sum_probs=226.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 44678999999999999999999999999999999997643322222334788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+|||||+||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~ 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-G 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-C
Confidence 99999999999999976 68999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccChhhHhh----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCCCC---C
Q 012637 165 DGLLHTQCGTPAYVAPEVLRK----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYPPW---I 235 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~---~ 235 (459)
.......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+..+.+.++... .+.+|.. +
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 112334689999999999972 233458999999999999999999999999998888888653 3555543 8
Q ss_pred CHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPER--RITIQSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~--R~t~~eil~hpw~~~ 268 (459)
|+++++||++||..+|++ |++++|+++||||+.
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999988888 999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=425.82 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=212.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCC-
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKK- 83 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~- 83 (459)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 456789999999999999999999999999999999986542 33445677889999999997 999999999997554
Q ss_pred -EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 -KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.+|+|||||++ +|...+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 84 RDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp SCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred CEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 79999999984 8999998889999999999999999999999999999999999999999999999999999754321
Q ss_pred -------------------cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHH
Q 012637 163 -------------------RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK 223 (459)
Q Consensus 163 -------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 223 (459)
.........+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122344568999999999998755556899999999999999999999999887766665
Q ss_pred HHhcc-----------------------------------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 012637 224 VFKAE-----------------------------------------------FVYPPWISTDAKRLISKLLVSDPERRIT 256 (459)
Q Consensus 224 i~~~~-----------------------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t 256 (459)
+...- ...+..+++++.+||.+||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 54210 0011257899999999999999999999
Q ss_pred HHHHhcCcccccC
Q 012637 257 IQSIMRVPWFRKG 269 (459)
Q Consensus 257 ~~eil~hpw~~~~ 269 (459)
++|+|+||||+.-
T Consensus 323 ~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 323 ANDALKHPFVSIF 335 (388)
T ss_dssp HHHHTTSTTTTTT
T ss_pred HHHHhCCHHHHHh
Confidence 9999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=405.80 Aligned_cols=265 Identities=43% Similarity=0.838 Sum_probs=229.0
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
..+.+..++|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 35678889999999999999999999999999999999999765433333456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999999975 7899999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKR 241 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 241 (459)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+....+..+.......|..++.++.+
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22334568999999999998877666899999999999999999999999888888888888888888889999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
||.+||+.||.+|||++++++||||+...
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=421.07 Aligned_cols=256 Identities=33% Similarity=0.617 Sum_probs=223.1
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATK 82 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (459)
....+.++|++.+.||+|+||.||+|.++.+|+.||||++.+.... ..+|+.++.++ +||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 3446778999999999999999999999999999999999865432 24688888887 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-C---CeEEeecCCCc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-E---DLKISDFGLSA 157 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~---~lKl~DFGla~ 157 (459)
..+|+|||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+..+ + .+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999999999876 679999999999999999999999999999999999998543 3 49999999998
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC---chHHHHHHHHHhccCCCC--
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD---ENIMNMYRKVFKAEFVYP-- 232 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~p-- 232 (459)
.... ......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+ .+..+++..+..+.+..+
T Consensus 169 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 169 QLRA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp ECBC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred cCcC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 6543 23345677999999999999887765 899999999999999999999986 456677778877776654
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 233 --PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 233 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+|+++.+||.+||..||.+|||++++++||||...
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4589999999999999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=405.25 Aligned_cols=262 Identities=35% Similarity=0.706 Sum_probs=235.1
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
++....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 35567889999999999999999999999999999999997654333323467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
..|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 99999999999999999876 7899999999999999999999999999999999999999999999999999864332
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRL 242 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 242 (459)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|+.++.++.+|
T Consensus 167 ---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 167 ---LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp ---SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred ---cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence 223456899999999999887664 8999999999999999999999998888888888888888899999999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
|.+||..||.+|||++++++||||+...
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 9999999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=399.01 Aligned_cols=259 Identities=36% Similarity=0.694 Sum_probs=231.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 457899999999999999999999999999999999998665433 3457788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC---eEEeecCCCccccc
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED---LKISDFGLSALPEQ 161 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~---lKl~DFGla~~~~~ 161 (459)
|+||||++|++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999888865 78999999999999999999999999999999999999987665 99999999975432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWIST 237 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (459)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+..+....| ..+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 223345689999999999988776 4899999999999999999999999988888888877766555 35799
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
++.+||.+||++||.+|||++++++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=431.27 Aligned_cols=260 Identities=27% Similarity=0.495 Sum_probs=225.3
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 45688999999999999999999999999999999997654333333455789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+||||++||+|.+++.+ ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~- 216 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG- 216 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-
Confidence 99999999999999976 479999999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccCCCcccChhhHhh------cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cCCCC---C
Q 012637 165 DGLLHTQCGTPAYVAPEVLRK------KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EFVYP---P 233 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p---~ 233 (459)
.....+.+||+.|+|||++.. ....+.++|||||||++|+|++|+.||.+.+..+.+.++... ...+| .
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 112235689999999999974 122358999999999999999999999999988888887653 23444 5
Q ss_pred CCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCccccc
Q 012637 234 WISTDAKRLISKLLVSDPERR---ITIQSIMRVPWFRK 268 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R---~t~~eil~hpw~~~ 268 (459)
.+|+++++||.+||. +|.+| ++++||++||||+.
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 689999999999999 99998 59999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=406.19 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=213.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|++.+.||+|+||+||+|.+ .+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 689999999997554322 1235677999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||+++ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence 999986 88888865 6799999999999999999999999999999999999999999999999999975432 122
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cC---------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EF--------------- 229 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~--------------- 229 (459)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 3345689999999999987655568999999999999999999999988776665554331 00
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 230 ------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 230 ------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+..+++++.+||.+||..||.+|||++|+++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 011347899999999999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=405.33 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=215.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 46899999999999999999999999999999999876543 33345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSD 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--ccc
Confidence 9999999999988875 6799999999999999999999999999999999999999999999999999976542 222
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------- 227 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 227 (459)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3446689999999999987555568999999999999999999999988766554443221
Q ss_pred --cCCCC----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 228 --EFVYP----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 228 --~~~~p----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
....+ +.+++++.+||.+||..||.+|||++++++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 00111 347889999999999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=453.47 Aligned_cols=259 Identities=31% Similarity=0.573 Sum_probs=235.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
+..++|++.+.||+|+||+||+|+++.+++.||||++.+.........+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4578899999999999999999999999999999999865443333456778899999988 799999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||++||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 999999999999999976 8899999999999999999999999999999999999999999999999999974322 2
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLIS 244 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 244 (459)
.....+.+||+.|+|||++.+..| +.++|||||||+||+|++|..||.+.+..+++..+....+.+|..+++++.+||.
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 334567799999999999988877 4899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCH-----HHHhcCccccc
Q 012637 245 KLLVSDPERRITI-----QSIMRVPWFRK 268 (459)
Q Consensus 245 ~~L~~dP~~R~t~-----~eil~hpw~~~ 268 (459)
+||+.||.+||++ ++|++||||+.
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999997 99999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=401.51 Aligned_cols=261 Identities=36% Similarity=0.577 Sum_probs=238.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45679999999999999999999999999999999998776666666778899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc--Cc
Confidence 99999999999998876 7899999999999999999999999999999999999999999999999999976542 12
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+.+..+.......|..+++.+.+||.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 23345679999999999987766 48999999999999999999999999888888888888888899999999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
||..||.+|||++++++||||....
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HcccChhhCcCHHHHhhChheecCC
Confidence 9999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=421.48 Aligned_cols=260 Identities=22% Similarity=0.390 Sum_probs=218.4
Q ss_pred ccCCEEEeeeeccc--CcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 8 LFGKYEMGRLLGKG--TFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 8 ~~~~y~i~~~LG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..++|++.+.||+| +||+||+|+++.+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 45789999999999 9999999999999999999999876543 34567889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 86 FVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
|+|||||++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999999865 57999999999999999999999999999999999999999999999999998643221
Q ss_pred c-----CCCccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-------
Q 012637 163 R-----NDGLLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------- 228 (459)
Q Consensus 163 ~-----~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------- 228 (459)
. ........+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.+.......+..+.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 1 1122334589999999999987 344 589999999999999999999998755443332221111
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 ---------------------------------------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 ---------------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 11344578999999999999999999999999999999854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=442.18 Aligned_cols=260 Identities=30% Similarity=0.470 Sum_probs=231.5
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
..+..++|++.+.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 34667889999999999999999999999999999999987654333334667899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-G--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+|+||||++||+|.+++.. + .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999999875 2 499999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch----HHHHHHHHHhccCCCCCCCCH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN----IMNMYRKVFKAEFVYPPWIST 237 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~ 237 (459)
.....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+ ...+...+......+|..+|+
T Consensus 339 ---~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~ 414 (576)
T 2acx_A 339 ---GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414 (576)
T ss_dssp ---TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ---CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCH
Confidence 2334567999999999999887764 89999999999999999999998753 456667777777788889999
Q ss_pred HHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 238 DAKRLISKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
++.+||.+||..||.+|| +++|+++||||+.
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999999999999 7999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=411.83 Aligned_cols=257 Identities=29% Similarity=0.481 Sum_probs=206.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||.||+|.++.+|+.||+|++....... ....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 578999999999999999999999999999999997654221 234677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 89 MEYVKGGELFAKVAR-------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
|||++| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999985 88888754 3589999999999999999999999999999999999999999999999999976532
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------- 228 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 228 (459)
........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 161 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 --PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp --CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred --CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 22234456899999999999875545689999999999999999999999988776666554310
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 229 ---------------------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 229 ---------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
...+..+++++.+||.+||+.||.+|||++|+++||||+..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 011224788999999999999999999999999999998644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=433.62 Aligned_cols=261 Identities=37% Similarity=0.636 Sum_probs=229.0
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH----------HHHHHHHHHHHHHHhcCCCCcce
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE----------FMMEQIKREISVMRLVRHPNVVE 74 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~i~~Ei~il~~l~hpnIv~ 74 (459)
...+.++|++++.||+|+||+||+|.++.+++.||+|++.+...... ...+.+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34577899999999999999999999999999999999986543321 23467889999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---CeEE
Q 012637 75 LREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---DLKI 150 (459)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---~lKl 150 (459)
+++++.+...+|+|||||+||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999998865 7899999999999999999999999999999999999999876 6999
Q ss_pred eecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC
Q 012637 151 SDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV 230 (459)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 230 (459)
+|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+..+.+..+..+.+.
T Consensus 191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986542 334456789999999999874 44 58999999999999999999999999999999999888776
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 231 YP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 231 ~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
++ ..+|+++++||.+||.+||.+|||++|+|+||||+...
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 65 46899999999999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=419.04 Aligned_cols=257 Identities=28% Similarity=0.572 Sum_probs=228.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 456899999999999999999999999999999999976532 23456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC--CCCeEEeecCCCcccccc
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE--NEDLKISDFGLSALPEQL 162 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~--~~~lKl~DFGla~~~~~~ 162 (459)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|.....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 99999999999999975 37999999999999999999999999999999999999984 47899999999986432
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTD 238 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (459)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......++ ..++++
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 204 --DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred --CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 334456689999999999988766 4899999999999999999999999988888888877665544 357999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+.+||.+||..||.+|||+.++++||||+...
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=409.52 Aligned_cols=262 Identities=36% Similarity=0.574 Sum_probs=238.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999999999999999998776666666778999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc--Cc
Confidence 99999999999998876 7899999999999999999999999999999999999999999999999999976542 12
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......+.+..+....+..|..+++.+.+||.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23345689999999999988766 48999999999999999999999998888888888888888899999999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
||..||.+|||++++++||||.....
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HccCChhHCcCHHHHhcCccccCCCc
Confidence 99999999999999999999987653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=437.64 Aligned_cols=260 Identities=37% Similarity=0.642 Sum_probs=232.5
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+..+.++|++.+.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999999999999999999987655443345778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe---cCCCCeEEeecCCCcccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPE 160 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl---~~~~~lKl~DFGla~~~~ 160 (459)
+|+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|....
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999998865 789999999999999999999999999999999999999 467899999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWIS 236 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 236 (459)
........+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..+....+..+.+.++ ..+|
T Consensus 181 ---~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 181 ---ASKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp ---CCCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred ---cccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence 2334456789999999999976 45 5899999999999999999999999999988888888766543 2479
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+++++||.+||++||.+|||++++++||||+..
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=438.11 Aligned_cols=260 Identities=30% Similarity=0.461 Sum_probs=231.3
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+..++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 34568899999999999999999999999999999999876544333456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 86 FVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
|+||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999998864 259999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc----hHHHHHHHHHhccCCCCCCCC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE----NIMNMYRKVFKAEFVYPPWIS 236 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s 236 (459)
. ......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+. ....+...+......+|..++
T Consensus 341 ~--~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 341 A--GQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp T--TCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred C--CCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 2 12223456999999999999987775 8999999999999999999999875 346677788888888899999
Q ss_pred HHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 237 TDAKRLISKLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
+++.+||.+||++||.+||+ +++|++||||+.
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99999999999999999996 589999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=414.31 Aligned_cols=256 Identities=37% Similarity=0.701 Sum_probs=205.3
Q ss_pred ccccCCEEEe---eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEe
Q 012637 6 HVLFGKYEMG---RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMAT 81 (459)
Q Consensus 6 ~~~~~~y~i~---~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (459)
..+.++|++. +.||+|+||.||+|.++.+|+.||||++.+. ....+.+|+.+++.+. ||||+++++++.+
T Consensus 4 ~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp CHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 5677899996 8899999999999999999999999999654 2345678999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---CeEEeecCCCc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---DLKISDFGLSA 157 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---~lKl~DFGla~ 157 (459)
....|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 9999999999999999999976 6799999999999999999999999999999999999998766 79999999997
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch-------HHHHHHHHHhccCC
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------IMNMYRKVFKAEFV 230 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~ 230 (459)
.... ......+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+ ..+....+..+.+.
T Consensus 158 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 158 LKPP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp ECCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred ecCC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 5432 23344567899999999999887775 89999999999999999999998643 34566777777666
Q ss_pred CCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 231 YPP----WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 231 ~p~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
++. .+++++.+||.+||.+||.+|||++++++||||+...
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 553 4899999999999999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=405.57 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=213.3
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc--HHHHHHHHHHHHHHHhcC---CCCcceeEEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK--EFMMEQIKREISVMRLVR---HPNVVELREVM 79 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~ 79 (459)
+..+.++|++.+.||+|+||+||+|++..+|+.||||++....... ......+.+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 5677899999999999999999999999999999999997543211 111234567888877764 99999999999
Q ss_pred EeCC-----EEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEe
Q 012637 80 ATKK-----KIFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKIS 151 (459)
Q Consensus 80 ~~~~-----~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~ 151 (459)
.... .+|+||||+.+ +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 8765 68999999975 999988763 39999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV- 230 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~- 230 (459)
|||+|..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999986432 3334567899999999999887774 8999999999999999999999998887776665432100
Q ss_pred --------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 231 --------------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 231 --------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 013478899999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=403.60 Aligned_cols=259 Identities=33% Similarity=0.645 Sum_probs=205.6
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45789999999999999999999999999999999976543333335678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 88 AMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--H 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC--C
Confidence 9999999999999876 57999999999999999999999999999999999999999999999999999764421 1
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+....+..|..++.++.+||.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence 22335679999999999987665 48999999999999999999999987766666666566677788899999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
||..||.+|||++++++||||...
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=396.49 Aligned_cols=256 Identities=36% Similarity=0.634 Sum_probs=229.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..+.++|++.+.||+|+||.||+|.+..++..||+|.+.+..... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 346678999999999999999999999999999999997654433 35688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe---cCCCCeEEeecCCCccccc
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl---~~~~~lKl~DFGla~~~~~ 161 (459)
|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~- 160 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK- 160 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc-
Confidence 999999999999998865 779999999999999999999999999999999999999 788999999999997543
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC----CCCH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP----WIST 237 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 237 (459)
........+||+.|+|||++.+. .+.++|||||||++|+|++|..||...+..+....+..+....|. .+++
T Consensus 161 --~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 161 --PGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp --TTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred --CccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 23344567899999999998754 458999999999999999999999999888888888888777664 5899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+.+||.+||++||.+|||+.++++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=411.68 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=211.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
....++|++.+.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 45678999999999999999999999999999999999765432 22445678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec-----CCCCeEEeecCCCccc
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD-----ENEDLKISDFGLSALP 159 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~-----~~~~lKl~DFGla~~~ 159 (459)
|+||||++| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...
T Consensus 109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999999985 89888876 6799999999999999999999999999999999999995 4455999999999755
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC---------
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV--------- 230 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--------- 230 (459)
.. ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 188 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 188 GI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred CC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 32 2223445688999999999987665569999999999999999999999998877666655432100
Q ss_pred --CC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 231 --YP-------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 231 --~p-------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+ ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 00 1167899999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=430.64 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=213.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++++.||+|+||+||+|.+..+|+.||||++.+.. ......+++.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 45689999999999999999999999999999999997653 3344567889999999999999999999999654
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..+|+||||++++ |...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCCC-HHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 5689999999875 555554 469999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-----------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF----------- 229 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 229 (459)
........+||+.|+|||++.+..|. .++|||||||++|+|++|+.||.+.+..+.+..+...--
T Consensus 216 ---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 ---TSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ---CCcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 23345567899999999999988775 899999999999999999999999887766665543100
Q ss_pred ----------------CC----CCC-----------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 230 ----------------VY----PPW-----------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 230 ----------------~~----p~~-----------~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+ |.. .++++++||.+||..||.+|||++|+|+||||+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 00 000 156799999999999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=406.37 Aligned_cols=260 Identities=35% Similarity=0.608 Sum_probs=230.4
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34567889999999999999999999999999999999976543221 124678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC----CeEEeecCCC
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE----DLKISDFGLS 156 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~----~lKl~DFGla 156 (459)
...+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999976 6799999999999999999999999999999999999999888 7999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP---- 232 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p---- 232 (459)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 75432 223345679999999999987776 4899999999999999999999999888888888877666554
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+++.+.+||.+||.+||.+|||++++++||||+.
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 468999999999999999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=431.21 Aligned_cols=256 Identities=38% Similarity=0.655 Sum_probs=222.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.+.++|++++.||+|+||+||+|+++.++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+|
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 456689999999999999999999999999999999986543322 2456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC---CCeEEeecCCCcccccc
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN---EDLKISDFGLSALPEQL 162 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~---~~lKl~DFGla~~~~~~ 162 (459)
+|||||+||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|.....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~- 191 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN- 191 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT-
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC-
Confidence 99999999999998865 789999999999999999999999999999999999999764 4599999999986543
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTD 238 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (459)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+..+.+..+..+.+.++ ..+|++
T Consensus 192 --~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 192 --QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp --TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred --CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 234456789999999999864 45 5899999999999999999999999999999888888776654 247999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+.+||.+||++||.+|||+.++|+||||+.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=396.79 Aligned_cols=263 Identities=34% Similarity=0.630 Sum_probs=226.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 46789999999999999999999999999999999997654332 3567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999999876 57999999999999999999999999999999999999999999999999999865433223
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-HHHHHHHhccCCCC--CCCCHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-NMYRKVFKAEFVYP--PWISTDAKRL 242 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~L 242 (459)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++++.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 33456789999999999988776667899999999999999999999876543 23333333322222 3589999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
|.+||..||.+|||++++++||||+....
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 99999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=401.56 Aligned_cols=253 Identities=26% Similarity=0.480 Sum_probs=223.6
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
.|...+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888999999999999999999999999999997654332 3567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccc
Q 012637 91 YVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT 170 (459)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~ 170 (459)
|++|++|.+++...++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--Ccccccc
Confidence 99999999999888999999999999999999999999999999999999999999999999999975443 1222345
Q ss_pred ccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC---CCCCCCHHHHHHHHHhc
Q 012637 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV---YPPWISTDAKRLISKLL 247 (459)
Q Consensus 171 ~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L 247 (459)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+...... .+..+++.+.+||.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 6899999999999877664 8999999999999999999999988877776666554322 22347899999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccC
Q 012637 248 VSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 248 ~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..||.+|||++++++||||...
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGC
T ss_pred cCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=410.03 Aligned_cols=254 Identities=22% Similarity=0.391 Sum_probs=219.2
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-----CCCcceeEE
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-----HPNVVELRE 77 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----hpnIv~l~~ 77 (459)
.++..+.++|++.+.||+|+||+||+|++..+++.||||++... ........+|+.+++.+. ||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 45678889999999999999999999999999999999999643 223456778999999996 999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC----------
Q 012637 78 VMATKKKIFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---------- 144 (459)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---------- 144 (459)
++...+..|+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 88999999763 4999999999999999999999999999999999999975
Q ss_pred ---------------CCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCC
Q 012637 145 ---------------NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGF 209 (459)
Q Consensus 145 ---------------~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~ 209 (459)
++.+||+|||+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSS
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCC
Confidence 78999999999975332 23456899999999999988775 8999999999999999999
Q ss_pred CCCCCchHHHHHHHHHhccCCCC--------------------------C--------------------CCCHHHHHHH
Q 012637 210 LPFQDENIMNMYRKVFKAEFVYP--------------------------P--------------------WISTDAKRLI 243 (459)
Q Consensus 210 ~Pf~~~~~~~~~~~i~~~~~~~p--------------------------~--------------------~~s~~~~~Li 243 (459)
.||.+.+..+....+.......| . ..++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 99998877666555443222211 1 1236788999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccc
Q 012637 244 SKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
.+||+.||.+|||++|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999995
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=432.03 Aligned_cols=258 Identities=38% Similarity=0.661 Sum_probs=226.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.+.++|++.+.||+|+||+||+|.+..+|+.||||++.+...... ....+.+|+.+++.++||||+++++++.+...+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 466789999999999999999999999999999999976443222 2467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec---CCCCeEEeecCCCcccccc
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD---ENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~---~~~~lKl~DFGla~~~~~~ 162 (459)
+|||||+||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-
Confidence 99999999999998865 7899999999999999999999999999999999999995 456799999999986532
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTD 238 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (459)
.......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+..+.+..+..+.+.++ ..+|++
T Consensus 177 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 177 --NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp --C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred --CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 233456789999999999976 35 5899999999999999999999999999888888887765543 247999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+++||.+||.+||.+|||+.++|+||||+...
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999999999999998653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=413.75 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=216.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 35688999999999999999999999999999999996543 3344567889999999999999999999999765
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..+|+||||+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 8899999988899999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-----------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF----------- 229 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 229 (459)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+.+..+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 234568999999999998744456899999999999999999999998877666555533110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 230 --------------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 230 --------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..++..++++.+||.+||..||.+|||++++++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 1224568999999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=410.11 Aligned_cols=255 Identities=40% Similarity=0.709 Sum_probs=209.0
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 456778999999999999999999999999999999997543 234677899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CCCeEEeecCCCccccc
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NEDLKISDFGLSALPEQ 161 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~~lKl~DFGla~~~~~ 161 (459)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999876 67999999999999999999999999999999999999975 88999999999986432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHH-HHHHHHhccCCCC----CCCC
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN-MYRKVFKAEFVYP----PWIS 236 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~~~p----~~~s 236 (459)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..... .+..+.......+ ..++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 204 ---QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ---ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 223456789999999999988776 489999999999999999999998765443 5666666554433 3478
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.++.+||.+||..||++|||+.++++||||...
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=401.26 Aligned_cols=259 Identities=33% Similarity=0.615 Sum_probs=216.3
Q ss_pred cccCCEEEe-eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 7 VLFGKYEMG-RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 7 ~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
.+.++|++. +.||+|+||.||+|.+..+++.||||++.+.... ....+.+|+.+++++ +||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 466789995 7899999999999999999999999999765322 235678999999985 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC---eEEeecCCCcccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED---LKISDFGLSALPE 160 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~---lKl~DFGla~~~~ 160 (459)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999999976 78999999999999999999999999999999999999998776 9999999997543
Q ss_pred cccC-----CCccccccCCCcccChhhHhh-----cCCCCCcchhhhHHHHHHHHhhCCCCCCCch--------------
Q 012637 161 QLRN-----DGLLHTQCGTPAYVAPEVLRK-----KGYDGSKADLWSCGVILYVLLAGFLPFQDEN-------------- 216 (459)
Q Consensus 161 ~~~~-----~~~~~~~~Gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-------------- 216 (459)
.... .......+||+.|+|||++.. ..+ +.++|||||||++|+|++|..||.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 2111 112335679999999999975 334 489999999999999999999998753
Q ss_pred -HHHHHHHHHhccCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 217 -IMNMYRKVFKAEFVYP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 217 -~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...++..+....+.+| ..+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345666667766666 3589999999999999999999999999999999853
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=395.38 Aligned_cols=255 Identities=34% Similarity=0.618 Sum_probs=218.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+....|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 45688999999999999999999999999999999998664332 2467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe---cCCCCeEEeecCCCcc
Q 012637 87 VAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSAL 158 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl---~~~~~lKl~DFGla~~ 158 (459)
+||||++||+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999988743 579999999999999999999999999999999999999 4567899999999976
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC---CCC
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP---PWI 235 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p---~~~ 235 (459)
... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..+
T Consensus 177 ~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 177 FKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp -------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred cCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence 543 223456689999999999864 44 5899999999999999999999999888877776665544433 237
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
++++.+||.+||++||.+|||+.|+++||||+.
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 899999999999999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=424.52 Aligned_cols=261 Identities=27% Similarity=0.419 Sum_probs=199.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT----- 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (459)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+. .......+++.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 3558999999999999999999999999999999999654 2344456788999999999999999999999843
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...+|+||||+. |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 367999999985 688888876 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCC-------------------------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh--------
Q 012637 161 QLRND-------------------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-------- 207 (459)
Q Consensus 161 ~~~~~-------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-------- 207 (459)
..... ......+||+.|+|||++......+.++|||||||+||+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 21110 133456899999999987655545689999999999999998
Q ss_pred ---CCCCCCCchH--------------------HHHHHHHHhc----------------------c---------CCCCC
Q 012637 208 ---GFLPFQDENI--------------------MNMYRKVFKA----------------------E---------FVYPP 233 (459)
Q Consensus 208 ---G~~Pf~~~~~--------------------~~~~~~i~~~----------------------~---------~~~p~ 233 (459)
|.+||.+.+. .+.+..+... . ....+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7778866542 1111111100 0 00113
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 468999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=409.14 Aligned_cols=262 Identities=34% Similarity=0.573 Sum_probs=222.0
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK--KEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 457899999999999999999999999999999999765432 223456789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 012637 86 FVAMEYVKGGELFAKVAR-----------------------------------------GRLREDLARKYFQQLISAVDF 124 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----------------------------------------~~l~e~~~~~~~~qll~~L~~ 124 (459)
|+|||||+||+|.+++.. ..+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999998851 124678899999999999999
Q ss_pred HHhCCcEeccCCCCCeEecCCC--CeEEeecCCCcccccccCCC--ccccccCCCcccChhhHhhc-CCCCCcchhhhHH
Q 012637 125 CHSRGVSHRDLKPENLLLDENE--DLKISDFGLSALPEQLRNDG--LLHTQCGTPAYVAPEVLRKK-GYDGSKADLWSCG 199 (459)
Q Consensus 125 LH~~gi~HrDlkp~NILl~~~~--~lKl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~-~~~~~~~DIwSlG 199 (459)
||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 89999999998654322221 23466899999999999752 3345899999999
Q ss_pred HHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 200 VILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP----WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 200 vil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
|++|+|++|..||.+.+..+....+.......+. .+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999998888887777776554432 379999999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=407.37 Aligned_cols=267 Identities=26% Similarity=0.451 Sum_probs=225.6
Q ss_pred ccccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 2 EEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 2 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
...+..+.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 34567889999999999999999999999999999999999987766666667789999999999999999999999876
Q ss_pred CC----EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 82 KK----KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 82 ~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
.. ..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 54 45999999999999999975 78999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC---
Q 012637 157 ALPEQLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP--- 232 (459)
Q Consensus 157 ~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 232 (459)
......... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 765432211 223346799999999999887764 899999999999999999999999888777666665544332
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 233 -PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 233 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+++++.+||.+||..||.+||++.+++.|+|++..
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 4589999999999999999999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=407.16 Aligned_cols=257 Identities=28% Similarity=0.495 Sum_probs=211.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+++|++.+.||+|+||+||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 478999999999999999999999999999999996543211 122345799999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||++| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 999985 88887765 4699999999999999999999999999999999999999999999999999975432 222
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc------------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------------ 228 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 228 (459)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 34456899999999999875555689999999999999999999999988777666554310
Q ss_pred -CCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 229 -FVY-----------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 229 -~~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+.+ ++.+++++.+||.+||+.||.+|||++|+++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 001 124688999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=407.65 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=218.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------ 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (459)
..++|++.+.||+|+||.||+|++..+|+.||+|++........ ....+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-chHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 46899999999999999999999999999999999866543322 23456789999999999999999999987
Q ss_pred --CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 82 --KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
.+.+|+||||++| +|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999986 66666654 679999999999999999999999999999999999999999999999999997
Q ss_pred cccccc--CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCC-
Q 012637 158 LPEQLR--NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW- 234 (459)
Q Consensus 158 ~~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~- 234 (459)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......++.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 654221 22234566899999999999876555689999999999999999999999988777666654432221111
Q ss_pred -------------------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 235 -------------------------------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 235 -------------------------------~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.++++.+||.+||..||.+|||++|+++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 26789999999999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=413.73 Aligned_cols=255 Identities=33% Similarity=0.535 Sum_probs=222.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH-----HHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE-----FMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
.+.++|++.+.||+|+||.||+|.++.+|+.||||++.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 356789999999999999999999999999999999987643221 123356789999999999999999999999
Q ss_pred CCEEEEEEeccCCC-chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 82 KKKIFVAMEYVKGG-ELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 82 ~~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
.+.+|+||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999776 99999976 58999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHH
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDA 239 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 239 (459)
.. .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++++
T Consensus 181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKEL 251 (335)
T ss_dssp CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHH
T ss_pred CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHH
Confidence 32 33445678999999999999888767899999999999999999999976332 2334455666789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+||.+||.+||.+|||++++++||||+...
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 9999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=417.21 Aligned_cols=252 Identities=33% Similarity=0.618 Sum_probs=209.3
Q ss_pred cccCCEEEe-eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHH-hcCCCCcceeEEEEEe---
Q 012637 7 VLFGKYEMG-RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVRHPNVVELREVMAT--- 81 (459)
Q Consensus 7 ~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~-~l~hpnIv~l~~~~~~--- 81 (459)
.+.++|.+. +.||+|+||+||+|.++.+|+.||||++... ..+.+|+.++. ..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 456778887 7999999999999999999999999999642 24568888874 4589999999999876
Q ss_pred -CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CCCeEEeecC
Q 012637 82 -KKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NEDLKISDFG 154 (459)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~~lKl~DFG 154 (459)
...+|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 6789999999999999999976 25999999999999999999999999999999999999998 7899999999
Q ss_pred CCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH----HHHHHHHhccCC
Q 012637 155 LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM----NMYRKVFKAEFV 230 (459)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~ 230 (459)
++..... .....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+.. .....+..+.+.
T Consensus 210 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 210 FAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 9975432 2334577999999999999877765 8999999999999999999999875432 234455556555
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 231 YP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 231 ~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+| ..+++++.+||.+||..||.+|||++++++||||....
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 54 34899999999999999999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=416.65 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=210.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++.+.||+|+||.||+|.++.+|+.||||++.+. .......+.+.+|+.+|+.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 4678999999999999999999999999999999999754 23444567889999999999999999999999766
Q ss_pred -CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 -KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..+|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 679999999975 99999877 569999999999999999999999999999999999999999999999999998654
Q ss_pred cccCC--------------------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-----------C
Q 012637 161 QLRND--------------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-----------F 209 (459)
Q Consensus 161 ~~~~~--------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-----------~ 209 (459)
..... ......+||+.|+|||++......+.++||||+||++|+|++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 32111 2246678999999999976555456999999999999999984 4
Q ss_pred CCCCCchH-----------------HHHHHHHH------------------------hccCCCC-------CCCCHHHHH
Q 012637 210 LPFQDENI-----------------MNMYRKVF------------------------KAEFVYP-------PWISTDAKR 241 (459)
Q Consensus 210 ~Pf~~~~~-----------------~~~~~~i~------------------------~~~~~~p-------~~~s~~~~~ 241 (459)
++|.+.+. .+.+..+. ......+ +.+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44444320 11111111 1011111 347999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
||.+||..||.+|||++|+|+||||+..
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=400.89 Aligned_cols=264 Identities=34% Similarity=0.610 Sum_probs=227.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc-HHHHHHHHHHHHHHHhcCCCCcceeEEEE--EeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK-EFMMEQIKREISVMRLVRHPNVVELREVM--ATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~--~~~~ 83 (459)
.+.++|++++.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 36789999999999999999999999999999999997653321 22356789999999999999999999998 4556
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..|+||||++++ |.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999987 5555543 679999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcC-CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKG-YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDA 239 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 239 (459)
............||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+....+..|..+++++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 333334445667999999999997643 2357899999999999999999999999988888888888888888999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
.+||.+||..||.+|||++++++||||+....
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=411.36 Aligned_cols=253 Identities=33% Similarity=0.557 Sum_probs=218.6
Q ss_pred cCCEEE--eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 9 FGKYEM--GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 9 ~~~y~i--~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 162 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 345666 6789999999999999999999999999976532 23467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe--cCCCCeEEeecCCCcccccc
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL--DENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl--~~~~~lKl~DFGla~~~~~~ 162 (459)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~- 241 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP- 241 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT-
T ss_pred EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC-
Confidence 99999999999998864 469999999999999999999999999999999999999 5678899999999986542
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTD 238 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (459)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+.......+ +.++++
T Consensus 242 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 242 --REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp --TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred --ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence 233445689999999999987665 4899999999999999999999999988888888877765544 358999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+.+||.+||.+||.+|||++|+++||||+.
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 999999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=406.67 Aligned_cols=257 Identities=35% Similarity=0.639 Sum_probs=226.4
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-----KEFMMEQIKREISVMRLV-RHPNVVELREVMAT 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (459)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 457899999999999999999999999999999999764321 122356788999999999 79999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
.+..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999999876 689999999999999999999999999999999999999999999999999997544
Q ss_pred cccCCCccccccCCCcccChhhHhhc-----CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC---
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKK-----GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP--- 232 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 232 (459)
. .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..+.+..+
T Consensus 252 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 252 P---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred C---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 2 2334567899999999999743 2235789999999999999999999999888887777777665544
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 233 -PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 233 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
..+++++.+||.+||..||.+|||++++++||||+
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 35789999999999999999999999999999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=405.44 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=221.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----C
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK-----K 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 83 (459)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 479999999999999999999999999999999997433 334557788999999999999999999999765 4
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 84 KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
..|+||||+.| +|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 79999999985 89999988899999999999999999999999999999999999999999999999999998654322
Q ss_pred C-CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--------------
Q 012637 164 N-DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-------------- 228 (459)
Q Consensus 164 ~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------- 228 (459)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 2234556899999999998766655689999999999999999999999877655554443210
Q ss_pred --------C---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 229 --------F---------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 229 --------~---------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
. ..++.+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 0 01134789999999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=395.09 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=223.2
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 56788999999999999999999999999999999999977666666677889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 164 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET- 164 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-
Confidence 9999999999999999976 78999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-----CCCCCCHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-----YPPWISTD 238 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~ 238 (459)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.............. .++.+++.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp ----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred cccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 1122345679999999999988776 48899999999999999999999998877665555444322 34568999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
+.++|.+||.+||.+||+..+.+.+.|..
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999999999767777777654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=403.19 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=217.6
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 56799999999999999999999999999999999875543 33345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||||+++++|.++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PGE 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--Ccc
Confidence 9999999999888764 7899999999999999999999999999999999999999999999999999975443 223
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------------- 227 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 227 (459)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 3456689999999999987655568999999999999999999999987766554443321
Q ss_pred cCCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 228 EFVYP------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 228 ~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
....| +.+++++.+||.+||..||.+|||++|+++||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 01111 246899999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=397.23 Aligned_cols=256 Identities=38% Similarity=0.694 Sum_probs=225.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 45778999999999999999999999999999999999765322 235678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe---cCCCCeEEeecCCCccccc
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl---~~~~~lKl~DFGla~~~~~ 161 (459)
|+||||++|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~- 160 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ- 160 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC-
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC-
Confidence 999999999999998865 789999999999999999999999999999999999999 778999999999997532
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWIST 237 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 237 (459)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+..+.+..+ ..+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 161 ---NGIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp ---CBTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ---CCccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 2234456899999999999877664 899999999999999999999999888888888877655443 45789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
++.+||.+||..||.+|||++++++||||...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=400.37 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=207.3
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
..+.++|++.+.||+|+||+||+|++..+|+.||||++......... .....+|+..+..+ +||||+++++++.+.+.
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 34557899999999999999999999999999999998665433333 33444555555554 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
+|+||||+ +++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~- 209 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT- 209 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc-
Confidence 99999999 5688887765 5699999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC--CCCCCCCHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF--VYPPWISTDAK 240 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~ 240 (459)
.......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+..... .+..... .++..+++++.
T Consensus 210 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 210 --AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELR 282 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTTSCHHHH
T ss_pred --CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccCCCHHHH
Confidence 223445679999999999876 45 589999999999999999977665543322 2222211 23456899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 241 RLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+||.+||++||.+|||++++++||||+.
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=391.53 Aligned_cols=258 Identities=36% Similarity=0.650 Sum_probs=224.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
++.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 456789999999999999999999999999999999976543221 12467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC----CeEEeecCCCcc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE----DLKISDFGLSAL 158 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~----~lKl~DFGla~~ 158 (459)
..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999999965 7899999999999999999999999999999999999999877 899999999975
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CC
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PW 234 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 234 (459)
... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+ ..
T Consensus 162 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 162 IEA---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ccC---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 432 222345679999999999987766 4899999999999999999999999888887777776655544 45
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 7899999999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=389.50 Aligned_cols=253 Identities=19% Similarity=0.291 Sum_probs=215.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++........ ....+.+|+.++..+ +||||+++++++.+.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 456889999999999999999999999999999999986544333 346678999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC---------------
Q 012637 86 FVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN--------------- 145 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~--------------- 145 (459)
|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999999865 569999999999999999999999999999999999999854
Q ss_pred ----CCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHH
Q 012637 146 ----EDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY 221 (459)
Q Consensus 146 ----~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~ 221 (459)
..+||+|||++..... ....+||+.|+|||++.+....+.++|||||||++|+|++|.+|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred cCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 4799999999975432 224569999999999987655557999999999999999999887665432
Q ss_pred HHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 222 RKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 222 ~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+.... ...|..+++++.+||.+||.+||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2333333 35567799999999999999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=390.32 Aligned_cols=262 Identities=32% Similarity=0.577 Sum_probs=227.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc------cHHHHHHHHHHHHHHHhcC-CCCcceeEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK------KEFMMEQIKREISVMRLVR-HPNVVELRE 77 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~i~~Ei~il~~l~-hpnIv~l~~ 77 (459)
...+.++|++.+.||+|+||.||+|.++.+|+.||||++...... .....+.+.+|+.+++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 345789999999999999999999999999999999999765311 1234567889999999995 999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 78 VMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
++.+....|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999976 68999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhh-----cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRK-----KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY 231 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 231 (459)
..... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...+.......+.......
T Consensus 172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 172 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 75432 233456689999999999863 2233589999999999999999999999988888877777766554
Q ss_pred CC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 232 PP----WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 232 p~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+. .++.++.+||.+||..||.+|||++++++||||+..
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 42 478999999999999999999999999999999854
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=406.59 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=214.6
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc--HHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK--EFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
....++|++.+.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345789999999999999999999999999999999997543222 112346789999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
..|+||||+++ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999987 78887765 4699999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-----CC-----
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-----VY----- 231 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~~----- 231 (459)
........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+.+..+..... .+
T Consensus 165 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 165 --PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp --CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 223345678999999999997765556899999999999999999999999887777666654210 00
Q ss_pred ------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 232 ------------------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 232 ------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 03457899999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=401.23 Aligned_cols=260 Identities=24% Similarity=0.416 Sum_probs=213.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CCcceeEEEEEeCC
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH--PNVVELREVMATKK 83 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~ 83 (459)
.+..++|++.+.||+|+||.||+|.+ .+++.||||++...... ....+.+.+|+.+++.++| |||+++++++.+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 34567899999999999999999998 56899999999765443 3356778999999999976 99999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.+|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|......
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999999 567899999976 6899999999999999999999999999999999999997 688999999999866543
Q ss_pred cCCCccccccCCCcccChhhHhhc----------CCCCCcchhhhHHHHHHHHhhCCCCCCCch-HHHHHHHHHh--ccC
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKK----------GYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVFK--AEF 229 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~--~~~ 229 (459)
.........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.. .......+.. ...
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 333334567899999999999751 233588999999999999999999998743 2233333332 234
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+|...+.++.+||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 5677788999999999999999999999999999999854
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=401.41 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=221.0
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998765555555678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+.| +|.+.+. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 99985 7777764 36899999999999999999999999999999999999999999999999999975432
Q ss_pred cccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC--CCCCCCHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV--YPPWISTDAKRLI 243 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li 243 (459)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+...... .+..+++.+.+||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 235689999999999863 223358999999999999999999999988776666555554332 2345799999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 244 SKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 244 ~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+||+.||.+|||++++++||||....
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999999999999999999997643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=394.99 Aligned_cols=265 Identities=27% Similarity=0.414 Sum_probs=216.7
Q ss_pred CccccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 012637 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 1 m~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
|.-.+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 2 m~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 78 (320)
T 2i6l_A 2 MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILG 78 (320)
T ss_dssp ----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence 5566778899999999999999999999999999999999998654 3345677889999999999999999999873
Q ss_pred --------------eCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec-CC
Q 012637 81 --------------TKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD-EN 145 (459)
Q Consensus 81 --------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~-~~ 145 (459)
+....|+||||++ |+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 4578999999998 5999999889999999999999999999999999999999999999997 56
Q ss_pred CCeEEeecCCCccccccc-CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHH
Q 012637 146 EDLKISDFGLSALPEQLR-NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKV 224 (459)
Q Consensus 146 ~~lKl~DFGla~~~~~~~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i 224 (459)
+.+||+|||++....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 799999999998654221 1223345678999999999876444568999999999999999999999988776665555
Q ss_pred HhccCC------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 225 FKAEFV------------------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 225 ~~~~~~------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...... .++.+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 432110 124579999999999999999999999999999999853
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=401.61 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=209.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC---
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK--- 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (459)
.+.++|++.+.||+|+||.||+|+++.+|+.||||++..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 456889999999999999999999999999999999976542 224567899999999999999999999986543
Q ss_pred ------------------------------------------------------EEEEEEeccCCCchHHHHhcC----C
Q 012637 84 ------------------------------------------------------KIFVAMEYVKGGELFAKVARG----R 105 (459)
Q Consensus 84 ------------------------------------------------------~~~lV~E~~~gg~L~~~i~~~----~ 105 (459)
.+|+|||||+||+|.+++... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 389999999999999999762 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC----------CCccccccCCC
Q 012637 106 LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN----------DGLLHTQCGTP 175 (459)
Q Consensus 106 l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~----------~~~~~~~~Gt~ 175 (459)
.++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 56677999999999999999999999999999999999999999999999986543211 12234567999
Q ss_pred cccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC-CCCCCHHHHHHHHHhcCCCCCCC
Q 012637 176 AYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY-PPWISTDAKRLISKLLVSDPERR 254 (459)
Q Consensus 176 ~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~Li~~~L~~dP~~R 254 (459)
.|+|||++.+..+ +.++|||||||++|+|++|..|+.. .......+....... +...++++.+||.+||++||.+|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999998776 4899999999999999999877532 222223333322211 12357888999999999999999
Q ss_pred CCHHHHhcCccccc
Q 012637 255 ITIQSIMRVPWFRK 268 (459)
Q Consensus 255 ~t~~eil~hpw~~~ 268 (459)
||++++++||||+.
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=399.85 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=223.7
Q ss_pred ccccCCEEEe-eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCC
Q 012637 6 HVLFGKYEMG-RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKK 83 (459)
Q Consensus 6 ~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (459)
..+.++|.+. +.||+|+||.||+|.+..+|+.||+|++.+...... ....+.+|+.+++.+ +||||+++++++.+..
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 3567789998 899999999999999999999999999976543332 245688999999999 5699999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CCCeEEeecCCCc
Q 012637 84 KIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NEDLKISDFGLSA 157 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~~lKl~DFGla~ 157 (459)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 99999999999999998854 67999999999999999999999999999999999999998 7899999999998
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----C
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----P 233 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 233 (459)
.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.......+ .
T Consensus 183 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 183 KIGH---ACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp EC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred ccCC---ccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 6542 2233456899999999999887764 899999999999999999999999888887777766554443 3
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 478999999999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=406.80 Aligned_cols=257 Identities=26% Similarity=0.470 Sum_probs=209.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC---
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK--- 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (459)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 457899999999999999999999999999999999976432 3345677889999999999999999999997665
Q ss_pred ---EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 84 ---KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
.+|+||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 89999999986 6777774 579999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-----------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF----------- 229 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 229 (459)
. .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2234456899999999999987775 899999999999999999999999887766655543210
Q ss_pred -----------CC--------------CCC------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 230 -----------VY--------------PPW------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 230 -----------~~--------------p~~------~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
.+ |.. .++++++||.+||..||.+|||++|+++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 000 156789999999999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=406.16 Aligned_cols=251 Identities=29% Similarity=0.452 Sum_probs=211.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT----- 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (459)
...++|++++.||+|+||+||+|.+..+|+.||||++..+... ..+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4568999999999999999999999999999999998755322 2379999999999999999999844
Q ss_pred ---------------------------------CCEEEEEEeccCCCchHHHHh----c-CCCCHHHHHHHHHHHHHHHH
Q 012637 82 ---------------------------------KKKIFVAMEYVKGGELFAKVA----R-GRLREDLARKYFQQLISAVD 123 (459)
Q Consensus 82 ---------------------------------~~~~~lV~E~~~gg~L~~~i~----~-~~l~e~~~~~~~~qll~~L~ 123 (459)
...+|+||||++| +|.+.+. . +.+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999986 6665553 2 67999999999999999999
Q ss_pred HHHhCCcEeccCCCCCeEec-CCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHH
Q 012637 124 FCHSRGVSHRDLKPENLLLD-ENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVIL 202 (459)
Q Consensus 124 ~LH~~gi~HrDlkp~NILl~-~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil 202 (459)
|||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++||||+||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999998 688999999999985432 23344668899999999998766556899999999999
Q ss_pred HHHhhCCCCCCCchHHHHHHHHHhc-----------------cCC------------CCCCCCHHHHHHHHHhcCCCCCC
Q 012637 203 YVLLAGFLPFQDENIMNMYRKVFKA-----------------EFV------------YPPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 203 ~~ll~G~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
|+|++|..||.+.+..+.+..+... ... +|...++++.+||.+||..||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998877666555421 011 34557899999999999999999
Q ss_pred CCCHHHHhcCccccc
Q 012637 254 RITIQSIMRVPWFRK 268 (459)
Q Consensus 254 R~t~~eil~hpw~~~ 268 (459)
|||+.|+++||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=407.67 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=202.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK---- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (459)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 34589999999999999999999999999999999996543 2334567788999999999999999999998654
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..+|+|+||+ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 6689999999 6799999888899999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc------------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------ 228 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 228 (459)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+.+..+....
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 23456899999999999875455689999999999999999999999988766655543310
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 -----------FVY--------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 -----------~~~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
... .+..++++.+||.+||..||.+|||++++|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 001 12468899999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=407.36 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=214.1
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC--CCCcceeEEEEEeCCEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR--HPNVVELREVMATKKKIFV 87 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~l 87 (459)
.+|++.+.||+|+||.||+|.+.. ++.||||++...... ....+.+.+|+.+|+.++ ||||+++++++...+.+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 459999999999999999999864 899999999876543 345678899999999996 5999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 668899999876 6899999999999999999999999999999999999995 6899999999998654332222
Q ss_pred ccccccCCCcccChhhHhhc----------CCCCCcchhhhHHHHHHHHhhCCCCCCCch-HHHHHHHHHhc--cCCCCC
Q 012637 167 LLHTQCGTPAYVAPEVLRKK----------GYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVFKA--EFVYPP 233 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~--~~~~p~ 233 (459)
.....+||+.|+|||++.+. ...+.++|||||||+||+|++|..||.+.. ....+..+... ...+|.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 34567899999999999752 234589999999999999999999998743 33344444433 345677
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+.+.++.+||.+||..||.+|||+.++++||||+..
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 789999999999999999999999999999999854
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=389.44 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=228.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 34578999999999999999999999999999999997654333 3567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
+||||++|++|.+++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 174 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QI 174 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BC
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--cc
Confidence 9999999999999998899999999999999999999999999999999999999999999999999999764432 12
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISK 245 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 245 (459)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.... ...+..++..+.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 23456799999999999887765 89999999999999999999999887776666555443 34556789999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
||.+||.+|||++++++||||....
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCC
Confidence 9999999999999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=410.68 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=214.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc------CCCCcceeEEEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV------RHPNVVELREVMA 80 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l------~hpnIv~l~~~~~ 80 (459)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 45678999999999999999999999999999999997542 2345677888888887 5779999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC--eEEeecCC
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED--LKISDFGL 155 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~--lKl~DFGl 155 (459)
....+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 588888865 34999999999999999999999999999999999999999987 99999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC------
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF------ 229 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------ 229 (459)
|.... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+..+....-
T Consensus 249 a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 249 SCYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CEETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ceecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 96432 23446789999999999998877 4899999999999999999999999887666554432100
Q ss_pred --------------C---------------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCC
Q 012637 230 --------------V---------------------------------------YPPWISTDAKRLISKLLVSDPERRIT 256 (459)
Q Consensus 230 --------------~---------------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t 256 (459)
. .+...++++.+||.+||+.||.+|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0 01123788999999999999999999
Q ss_pred HHHHhcCcccccCCCC
Q 012637 257 IQSIMRVPWFRKGFTR 272 (459)
Q Consensus 257 ~~eil~hpw~~~~~~~ 272 (459)
++|+|+||||+.....
T Consensus 403 a~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 403 PGQALRHPWLRRRLPK 418 (429)
T ss_dssp HHHHHTSTTTC-----
T ss_pred HHHHhCChhhccCCCC
Confidence 9999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=385.80 Aligned_cols=253 Identities=24% Similarity=0.457 Sum_probs=217.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe----CCE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT----KKK 84 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 84 (459)
...|++.+.||+|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345999999999999999999999999999999997655443 346778999999999999999999999875 467
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEec-CCCCeEEeecCCCcccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLD-ENEDLKISDFGLSALPE 160 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~-~~~~lKl~DFGla~~~~ 160 (459)
+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999999977 78999999999999999999999999 99999999999998 78999999999997432
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch-HHHHHHHHHhcc--CCCCCCCCH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVFKAE--FVYPPWIST 237 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~--~~~p~~~s~ 237 (459)
.......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.. ....+..+.... ...+...++
T Consensus 184 ----~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 184 ----ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 2334456799999999998743 4 589999999999999999999998744 444444444332 223455789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
++.+||.+||..||.+|||++++++||||+.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=393.51 Aligned_cols=259 Identities=25% Similarity=0.445 Sum_probs=215.6
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+..++|++.+.||+|+||+||+|.+ +|+.||||++...... ....+.+.+|+.++++++||||+++++++.+...+
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 45678999999999999999999986 6889999999765543 33457788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 86 FVAMEYVKGGELFAKVARGR----LREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~----l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
|+||||++||+|.+++.... +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999997633 999999999999999999999999 999999999999999999999999999754
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHH--hccCCCCCCCCH
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVF--KAEFVYPPWIST 237 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 237 (459)
.. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+. ......|..+++
T Consensus 190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 190 AS--TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cc--cccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 32 1222345689999999999988776 489999999999999999999999988877766553 334567788999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc--CcccccCC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMR--VPWFRKGF 270 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~--hpw~~~~~ 270 (459)
++.+||.+||..||.+|||++++++ .+|++...
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999998 57776543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=414.64 Aligned_cols=258 Identities=34% Similarity=0.648 Sum_probs=209.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc-----HHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK-----EFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.+..... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 35689999999999999999999999999999999998754321 112335789999999999999999999985
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---CeEEeecCCCc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---DLKISDFGLSA 157 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---~lKl~DFGla~ 157 (459)
.+..|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 5568999999999999998865 6899999999999999999999999999999999999997654 59999999998
Q ss_pred ccccccCCCccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-HHHHHHHhccCCCC--
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-NMYRKVFKAEFVYP-- 232 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p-- 232 (459)
.... .....+.+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+.... .....+..+.+..+
T Consensus 291 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 291 ILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred ecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 6542 334456789999999999863 222347899999999999999999999865432 33444555544443
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 233 --PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 233 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 357999999999999999999999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=401.33 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=220.6
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+.+..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 4567789999999999999999999999999999999997653 33456788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
+|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999999976 7899999999999999999999996 9999999999999999999999999999754322
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHH--------------------
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYR-------------------- 222 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~-------------------- 222 (459)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+......
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 23356899999999999887764 89999999999999999999998766543321
Q ss_pred ----------------------HHHhccC-CCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 223 ----------------------KVFKAEF-VYP-PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 223 ----------------------~i~~~~~-~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+..... ..+ ..++.++.+||.+||..||.+|||++++++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 1111111 112 2368899999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=403.07 Aligned_cols=261 Identities=32% Similarity=0.569 Sum_probs=222.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLV-RHPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (459)
.-.++|++.+.||+|+||.||+|++. .+|+.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34579999999999999999999985 58999999999754321 111234567899999999 79999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999999976 789999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhc-CCCCCcchhhhHHHHHHHHhhCCCCCCCc----hHHHHHHHHHhccCCCCCCC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKK-GYDGSKADLWSCGVILYVLLAGFLPFQDE----NIMNMYRKVFKAEFVYPPWI 235 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~ 235 (459)
.. ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+......+|..+
T Consensus 211 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 21 11223456899999999999853 23358899999999999999999999743 34555666667777888889
Q ss_pred CHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
+..+.+||.+||..||.+|| |++++++||||+.
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999999999999999 9999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=395.55 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=218.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC---
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK--- 82 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--- 82 (459)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 456789999999999999999999999999999999996432 334556788999999999999999999988654
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
...|+||||+. |+|.+.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 78999999997 489999988899999999999999999999999999999999999999999999999999997654
Q ss_pred cccCC--------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-----
Q 012637 161 QLRND--------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA----- 227 (459)
Q Consensus 161 ~~~~~--------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----- 227 (459)
..... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 22111 11234579999999999876555568999999999999999999999988765544433210
Q ss_pred -------------------cCC--------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 -------------------EFV--------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 -------------------~~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
... .++.+++++.+||.+||..||.+|||++++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 113578999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=395.89 Aligned_cols=264 Identities=34% Similarity=0.647 Sum_probs=215.8
Q ss_pred CccccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcCCCCccee
Q 012637 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-----KEFMMEQIKREISVMRLVRHPNVVEL 75 (459)
Q Consensus 1 m~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~hpnIv~l 75 (459)
|.--+..+.++|++.+.||+|+||.||+|.+..+++.||||++.+.... .......+.+|+.+++.++||||+++
T Consensus 1 M~~~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp -CCCCHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred CccchhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 3333456778999999999999999999999999999999999765432 11223457899999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC---eEEe
Q 012637 76 REVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED---LKIS 151 (459)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~---lKl~ 151 (459)
++++.... .|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 99997665 8999999999999998876 68999999999999999999999999999999999999987665 9999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-HHHHHHHhcc
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-NMYRKVFKAE 228 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~ 228 (459)
|||++..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .....+..+.
T Consensus 160 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 160 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp CCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred cCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 9999975432 222345679999999999853 223358999999999999999999999765432 3333444444
Q ss_pred CCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 229 FVYP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 229 ~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
...+ ..+++++.+||.+||..||.+|||++++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 4332 457999999999999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=407.43 Aligned_cols=253 Identities=30% Similarity=0.461 Sum_probs=209.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC--
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK-- 83 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-- 83 (459)
.....+|++.+.||+|+||+||+|++..+++ ||+|.+..+... ..+|+.+++.++||||+++++++....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 4556789999999999999999999987766 888887654322 236999999999999999999995543
Q ss_pred ----EEEEEEeccCCCchHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec-CCCCeEEeecC
Q 012637 84 ----KIFVAMEYVKGGELFAKVA----RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD-ENEDLKISDFG 154 (459)
Q Consensus 84 ----~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~-~~~~lKl~DFG 154 (459)
.+|+||||++++.+..... .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 3899999999865433322 36799999999999999999999999999999999999999 78999999999
Q ss_pred CCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc-------
Q 012637 155 LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------- 227 (459)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------- 227 (459)
+|+.... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+.+..+.+.
T Consensus 188 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 188 SAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp TCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9976432 223345688999999999987665568999999999999999999999998876665554431
Q ss_pred ----------cCC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 ----------EFV------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 ----------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
... +++.+++++.+||.+||+.||.+|||+.|+++||||+.-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 011 233478999999999999999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=393.74 Aligned_cols=251 Identities=25% Similarity=0.465 Sum_probs=211.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEe--CCE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMAT--KKK 84 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 84 (459)
..++|++++.||+|+||+||+|.+..+++.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999996432 256789999999997 9999999999988 678
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~~~~~ 163 (459)
.++||||+++++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT--
T ss_pred eEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC--
Confidence 999999999999988885 499999999999999999999999999999999999999776 899999999975432
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc-hHHHHHHH-------------HHhccC
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRK-------------VFKAEF 229 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~-------------i~~~~~ 229 (459)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +..+.... +.....
T Consensus 184 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 233456789999999999987555568999999999999999999999542 22111111 111111
Q ss_pred CC------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 230 VY------------------------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 230 ~~------------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.. +..+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 11 11278999999999999999999999999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=386.56 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=201.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.++...++.++||||+++++++.+.+..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 4568999999999999999999999999999999999754322 223344555666688889999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 87 VAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+||||++| +|.+++.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999986 77665532 5799999999999999999999998 99999999999999999999999999997644
Q ss_pred cccCCCccccccCCCcccChhhHh---hcCCCCCcchhhhHHHHHHHHhhCCCCCCC-chHHHHHHHH-HhccCCCC-CC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLR---KKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKV-FKAEFVYP-PW 234 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i-~~~~~~~p-~~ 234 (459)
. .......+||+.|+|||++. .....+.++||||+||++|+|++|..||.. .......... .......+ ..
T Consensus 162 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 162 D---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred c---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 3 22234457999999999973 233345899999999999999999999986 3333333333 33333333 35
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 8999999999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=386.49 Aligned_cols=258 Identities=27% Similarity=0.523 Sum_probs=224.6
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CCEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KKKI 85 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (459)
..++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 3579999999999999999999999999999999998665433 346778999999999999999999998754 6789
Q ss_pred EEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeccCCCCCeEecCCCCeEEeecCC
Q 012637 86 FVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRG-----VSHRDLKPENLLLDENEDLKISDFGL 155 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~g-----i~HrDlkp~NILl~~~~~lKl~DFGl 155 (459)
|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999998864 23999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCC
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPW 234 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 234 (459)
+..... ........+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+..+.. ..|..
T Consensus 163 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeecc--ccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 875432 11223356799999999999887664 899999999999999999999999888877777776655 55667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+++++.+||.+||+.||.+|||++++++|||+..+
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 89999999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=398.77 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=215.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE-
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI- 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~- 85 (459)
.+.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 456899999999999999999999999999999999976433 344567888999999999999999999999877655
Q ss_pred -----EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 86 -----FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 86 -----~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
|+||||+. ++|.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIM-GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEcccc-ccHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999998 4777776 3569999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc------------
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------ 228 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 228 (459)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 196 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 196 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred c-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2 23456799999999999874445689999999999999999999999988766655553310
Q ss_pred -----------C--------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 -----------F--------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 -----------~--------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
. ..++.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0123468999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=388.31 Aligned_cols=259 Identities=29% Similarity=0.409 Sum_probs=218.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 35678999999999999999999999999999999998754322 245788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999998864 679999999999999999999999999999999999999999999999999976432211
Q ss_pred CCCccccccCCCcccChhhHh----hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC---CCCCCC
Q 012637 164 NDGLLHTQCGTPAYVAPEVLR----KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV---YPPWIS 236 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s 236 (459)
......+||+.|+|||++. .....+.++|||||||++|+|++|..||...+.......+...... .+..++
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence 1223457999999999985 2233358999999999999999999999998877776666655432 345578
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.++.+||.+||..||.+|||++++++||||+..
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 999999999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=393.46 Aligned_cols=257 Identities=23% Similarity=0.409 Sum_probs=214.0
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
....+.++|++.+.||+|+||+||+|.+..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred cccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 35677899999999999999999999999999999999997654333 2456779999999999999999999998765
Q ss_pred --EEEEEEeccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe----cCCCCeEEeec
Q 012637 84 --KIFVAMEYVKGGELFAKVARG----RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL----DENEDLKISDF 153 (459)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl----~~~~~lKl~DF 153 (459)
..|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 889999999999999999752 39999999999999999999999999999999999999 77888999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhh-------cCCCCCcchhhhHHHHHHHHhhCCCCCCC----chHHHHHH
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK-------KGYDGSKADLWSCGVILYVLLAGFLPFQD----ENIMNMYR 222 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-------~~~~~~~~DIwSlGvil~~ll~G~~Pf~~----~~~~~~~~ 222 (459)
|+|..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.. ....+...
T Consensus 161 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 161 GAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TTCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CCceecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 99976432 233445689999999999873 23345899999999999999999999964 22344444
Q ss_pred HHHhccC-------------------CCC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012637 223 KVFKAEF-------------------VYP------PWISTDAKRLISKLLVSDPERRITIQSIMRVPW 265 (459)
Q Consensus 223 ~i~~~~~-------------------~~p------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw 265 (459)
.+..+.+ ..| ..++..+.+||.+||+.||++|||++|+++||-
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 5544322 111 123557889999999999999999999999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=385.74 Aligned_cols=256 Identities=38% Similarity=0.674 Sum_probs=225.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++........ ..+.+.+|+.++++++||||+++++++.+....|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 456799999999999999999999999999999999976543322 3467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC---CCeEEeecCCCcccccc
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN---EDLKISDFGLSALPEQL 162 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~---~~lKl~DFGla~~~~~~ 162 (459)
+||||+++++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~- 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC-
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC-
Confidence 99999999999888865 789999999999999999999999999999999999999764 4699999999975432
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTD 238 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (459)
........||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..+....+..+.+..+ ..++++
T Consensus 177 --~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 177 --NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp --CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred --CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 2233455789999999998764 4 5899999999999999999999999888888777777665443 357999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+.+||.+||.+||.+|||+.++++||||+.
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 999999999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=390.74 Aligned_cols=255 Identities=29% Similarity=0.460 Sum_probs=215.5
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEE-cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC------Cccee
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQ-LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP------NVVEL 75 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp------nIv~l 75 (459)
..+..+.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|+ +|+++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 45678889999999999999999999998 568899999999643 23456788999999988765 49999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC--------
Q 012637 76 REVMATKKKIFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-------- 144 (459)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-------- 144 (459)
++++.+.+.+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 88999988763 5899999999999999999999999999999999999987
Q ss_pred -----------CCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCC
Q 012637 145 -----------NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQ 213 (459)
Q Consensus 145 -----------~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~ 213 (459)
++.+||+|||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCC
Confidence 67899999999975322 23456899999999999887775 89999999999999999999999
Q ss_pred CchHHHHHHHHHhccCCCC--------------------------------------------CCCCHHHHHHHHHhcCC
Q 012637 214 DENIMNMYRKVFKAEFVYP--------------------------------------------PWISTDAKRLISKLLVS 249 (459)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~Li~~~L~~ 249 (459)
..+..+....+.......| ...++++.+||.+||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 8776654443322111111 11246788999999999
Q ss_pred CCCCCCCHHHHhcCccccc
Q 012637 250 DPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 250 dP~~R~t~~eil~hpw~~~ 268 (459)
||.+|||++|+++||||+.
T Consensus 316 dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDL 334 (339)
T ss_dssp STTTSCCHHHHTTSGGGGG
T ss_pred CcccccCHHHHhcCHHHHH
Confidence 9999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=413.53 Aligned_cols=248 Identities=17% Similarity=0.227 Sum_probs=205.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHH---HHHhcCCCCcceeE-------EE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS---VMRLVRHPNVVELR-------EV 78 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~---il~~l~hpnIv~l~-------~~ 78 (459)
.++|++.+.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999999999999999998665544446678899995 45555799999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCCchHHHHhc-CCCCH-------HHHHHHHHHHHHHHHHHHhCCcEec
Q 012637 79 MATKKK-----------------IFVAMEYVKGGELFAKVAR-GRLRE-------DLARKYFQQLISAVDFCHSRGVSHR 133 (459)
Q Consensus 79 ~~~~~~-----------------~~lV~E~~~gg~L~~~i~~-~~l~e-------~~~~~~~~qll~~L~~LH~~gi~Hr 133 (459)
+.+.+. .|+||||+ +|+|.+++.. +.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 6799999975 45555 7888899999999999999999999
Q ss_pred cCCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhc-----------CCCCCcchhhhHHHHH
Q 012637 134 DLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK-----------GYDGSKADLWSCGVIL 202 (459)
Q Consensus 134 Dlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-----------~~~~~~~DIwSlGvil 202 (459)
||||+|||++.+|.+||+|||+|... .....+.+| +.|+|||++.+. .+ +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 99999999999999999999999742 223456678 999999999887 55 4899999999999
Q ss_pred HHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 203 YVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 203 ~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
|+|++|..||.+.+.......+ ...+..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999876544332222 2234678999999999999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=402.14 Aligned_cols=258 Identities=22% Similarity=0.507 Sum_probs=225.4
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH--------------HHHHHHHHHHHHHHhcCCC
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE--------------FMMEQIKREISVMRLVRHP 70 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~--------------~~~~~i~~Ei~il~~l~hp 70 (459)
+..+.++|++.+.||+|+||.||+|.+ +|+.||+|++........ ...+.+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 456779999999999999999999998 899999999975433211 0126788999999999999
Q ss_pred CcceeEEEEEeCCEEEEEEeccCCCchHHH------Hhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCe
Q 012637 71 NVVELREVMATKKKIFVAMEYVKGGELFAK------VAR---GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENL 140 (459)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------i~~---~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NI 140 (459)
||+++++++.+.+..|+||||++||+|.++ +.. +.+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999988 543 579999999999999999999999 9999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhc-CCCCCcchhhhHHHHHHHHhhCCCCCCCchH-H
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK-GYDGSKADLWSCGVILYVLLAGFLPFQDENI-M 218 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~ 218 (459)
|++.++.+||+|||++..... ......+||+.|+|||++.+. .+.+.++|||||||++|+|++|..||...+. .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999999999999999975432 234456799999999999876 4443389999999999999999999998776 6
Q ss_pred HHHHHHHhccCCCC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 219 NMYRKVFKAEFVYP-------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 219 ~~~~~i~~~~~~~p-------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+....+.......| ..+++++.+||.+||..||.+|||++++++||||+.
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 77777777766666 568999999999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=392.63 Aligned_cols=267 Identities=22% Similarity=0.365 Sum_probs=202.5
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCc---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
..+..++|++++.||+|+||.||+|.+..++. .||||++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH-HHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH-HHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34567789999999999999999999887765 899999976543333 45778999999999999999999999987
Q ss_pred CCEE------EEEEeccCCCchHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCe
Q 012637 82 KKKI------FVAMEYVKGGELFAKVARG-------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDL 148 (459)
Q Consensus 82 ~~~~------~lV~E~~~gg~L~~~i~~~-------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~l 148 (459)
.... |+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7665 9999999999999988541 59999999999999999999999999999999999999999999
Q ss_pred EEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc
Q 012637 149 KISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA 227 (459)
Q Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 227 (459)
||+|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 99999999865432222223345578899999999887764 89999999999999999 99999988877777666654
Q ss_pred c-CCCCCCCCHHHHHHHHHhcCCCCCCCCC-------HHHHhcCcccccCCCCC
Q 012637 228 E-FVYPPWISTDAKRLISKLLVSDPERRIT-------IQSIMRVPWFRKGFTRP 273 (459)
Q Consensus 228 ~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t-------~~eil~hpw~~~~~~~~ 273 (459)
. ...|+.+++++.+||.+||..||.+||| ++++++|||+......|
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 3 5567779999999999999999999999 78889999998754443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=405.48 Aligned_cols=250 Identities=30% Similarity=0.438 Sum_probs=207.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC------
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK------ 82 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 82 (459)
..+|++.+.||+|+||.||+|++..+|+.||||++..+... ..+|+.+|+.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 44799999999999999999999999999999998754321 23799999999999999999988542
Q ss_pred CEEEEEEeccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecCCC
Q 012637 83 KKIFVAMEYVKGGELFAKVA-----RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLS 156 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFGla 156 (459)
..+++||||+++ .|...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 247799999987 4544443 2679999999999999999999999999999999999999965 56899999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---------
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--------- 227 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------- 227 (459)
+.... .......+||+.|+|||++.+....+.++|||||||+||+|++|+.||.+.+..+.+..+.+.
T Consensus 205 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 85432 223345689999999999987644568999999999999999999999988766555544331
Q ss_pred --------cCC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 --------EFV------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 --------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+. +++.+++++.+||.+||..||.+|||+.|+++||||...
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111 223568999999999999999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=385.75 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=216.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 356789999999999999999999999999999999976532 245788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+||||+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 9999999999999986 368999999999999999999999999999999999999999999999999999754431
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---CCCCCCCCHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKR 241 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 241 (459)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.... +..|..+++++.+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 1223456799999999999887764 89999999999999999999998877665544444332 2334557999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 242 LISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
||.+||..||.+|||+.++++||||+..
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=386.79 Aligned_cols=256 Identities=28% Similarity=0.474 Sum_probs=214.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEe----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMAT---- 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~---- 81 (459)
...++|++.+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 4578999999999999999999999999999999999755332 24678999999999 89999999999987
Q ss_pred --CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 82 --KKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
...+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 5689999999999999999875 57999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHh-----hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC-
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLR-----KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV- 230 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~- 230 (459)
...... .......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||.+.+.......+......
T Consensus 177 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 177 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred eecCcC--ccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 765431 12234567999999999996 3334 58899999999999999999999988776665555544322
Q ss_pred -CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 231 -YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 231 -~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 234579999999999999999999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=401.67 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=207.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC--------CCCcceeE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR--------HPNVVELR 76 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--------hpnIv~l~ 76 (459)
+..+.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++ ||||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 456789999999999999999999999999999999999743 234567889999999985 78899999
Q ss_pred EEEE----eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCC--
Q 012637 77 EVMA----TKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENE-- 146 (459)
Q Consensus 77 ~~~~----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~-- 146 (459)
+++. ....+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9987 5678999999995 455555543 4699999999999999999999999 999999999999999776
Q ss_pred -----------------------------------------------CeEEeecCCCcccccccCCCccccccCCCcccC
Q 012637 147 -----------------------------------------------DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179 (459)
Q Consensus 147 -----------------------------------------------~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~A 179 (459)
.+||+|||+|..... .....+||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccC
Confidence 799999999975432 2345689999999
Q ss_pred hhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch------HHHHHHHHHh--c------------------------
Q 012637 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN------IMNMYRKVFK--A------------------------ 227 (459)
Q Consensus 180 PE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~------~~~~~~~i~~--~------------------------ 227 (459)
||++.+..+. .++|||||||+||+|++|..||...+ .......+.. +
T Consensus 262 PE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 262 LEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred ChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999988775 89999999999999999999997643 1122221111 0
Q ss_pred ----------------cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 228 ----------------EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 228 ----------------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
.+..+...++++.+||.+||+.||.+|||++|+++||||+
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111222356788999999999999999999999999996
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=398.34 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=219.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEc-------CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQL-------MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV 78 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 78 (459)
+..++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 45678999999999999999999975 345679999997553 334567889999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeE
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLL 141 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NIL 141 (459)
+.+.+.+|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 99999999999999999999998752 3789999999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHH
Q 012637 142 LDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNM 220 (459)
Q Consensus 142 l~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~ 220 (459)
++.+|.+||+|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999855432222233445678899999999887764 89999999999999999 9999999887777
Q ss_pred HHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 221 YRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 221 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+..+..+. ...|..+++++.+||.+||..||.+|||+.|++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76666553 45667789999999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=390.13 Aligned_cols=262 Identities=28% Similarity=0.466 Sum_probs=197.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+..++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 35578999999999999999999999999999999998654322 2346688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 86 FVAMEYVKGGELFAKVAR---------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999998862 45999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc---CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC----
Q 012637 157 ALPEQLR---NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF---- 229 (459)
Q Consensus 157 ~~~~~~~---~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---- 229 (459)
....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.................
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 7543211 112234567999999999997633345899999999999999999999988665544443333221
Q ss_pred ------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 230 ------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 230 ------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+..+++++.+||.+||..||.+|||++++++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1223578899999999999999999999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=391.44 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=214.1
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE---
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK--- 84 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 84 (459)
+.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 5689999999999999999999999999999999997643 234456778899999999999999999999987654
Q ss_pred ---EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 ---IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ---~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+|+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 101 FYDFYLVMPFMQT-DLQKIMG-LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCCEEEEECCSE-EGGGTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred ceeEEEEeccccC-CHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 5999999984 8877764 4699999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------- 228 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 228 (459)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+.+..
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 23356799999999999874445689999999999999999999999887666555443210
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 229 ------------------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 229 ------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...++.+++++.+||.+||..||.+|||++++++||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01224578999999999999999999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=400.37 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=223.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEE-----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGK-----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
.+..++|++.+.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456789999999999999999999 45678899999986432 2334557889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC---CeE
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR--------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE---DLK 149 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~---~lK 149 (459)
+....|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999875 2489999999999999999999999999999999999999655 499
Q ss_pred EeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc
Q 012637 150 ISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE 228 (459)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 228 (459)
|+|||+|+..............+||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999765443333344556789999999999887765 89999999999999998 999999998888887777654
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 229 -FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 229 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
...|..+++.+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4556678999999999999999999999999999988754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=404.64 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=196.4
Q ss_pred ccccCCEEE-eeeecccCcEEEEEEEEc--CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-
Q 012637 6 HVLFGKYEM-GRLLGKGTFAKVYYGKQL--MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT- 81 (459)
Q Consensus 6 ~~~~~~y~i-~~~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~- 81 (459)
..+.+.|++ +++||+|+||+||+|+++ .+++.||||++...... ..+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 345667888 568999999999999976 57899999999765432 356789999999999999999999954
Q ss_pred -CCEEEEEEeccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe----cCCC
Q 012637 82 -KKKIFVAMEYVKGGELFAKVAR----------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL----DENE 146 (459)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~----------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl----~~~~ 146 (459)
...+|+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 7899999999976 77776642 249999999999999999999999999999999999999 6778
Q ss_pred CeEEeecCCCccccccc-CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-------
Q 012637 147 DLKISDFGLSALPEQLR-NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM------- 218 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~------- 218 (459)
.+||+|||+|+...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 99999999998654321 1123456789999999999988665568999999999999999999999765431
Q ss_pred --HHHHHHHhc-cCC-C------------------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 012637 219 --NMYRKVFKA-EFV-Y------------------------------------PPWISTDAKRLISKLLVSDPERRITIQ 258 (459)
Q Consensus 219 --~~~~~i~~~-~~~-~------------------------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~ 258 (459)
+.+..+... ..+ . ....++.+.+||.+||..||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 222222110 000 0 011277899999999999999999999
Q ss_pred HHhcCcccccCC
Q 012637 259 SIMRVPWFRKGF 270 (459)
Q Consensus 259 eil~hpw~~~~~ 270 (459)
|+|+||||+...
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999998653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=392.87 Aligned_cols=261 Identities=25% Similarity=0.442 Sum_probs=210.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc--------ccHHHHHHHHHHHHHHHhcCCCCcceeEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL--------KKEFMMEQIKREISVMRLVRHPNVVELRE 77 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 77 (459)
..+.++|++.+.||+|+||.||+|.+.. |+.||||++..... ......+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3567999999999999999999999854 99999999865322 23344578999999999999999999999
Q ss_pred EEEe-----CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEE
Q 012637 78 VMAT-----KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKI 150 (459)
Q Consensus 78 ~~~~-----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl 150 (459)
++.. ...+|+||||++| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9854 3479999999985 77777765 46999999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--
Q 012637 151 SDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-- 228 (459)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-- 228 (459)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 176 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999974332 2233456899999999999874545689999999999999999999999987766655543210
Q ss_pred ----------------------C--------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 229 ----------------------F--------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 229 ----------------------~--------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
. ..++..++.+.+||.+||..||.+|||++++++||||+..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0 012346889999999999999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=391.66 Aligned_cols=255 Identities=31% Similarity=0.587 Sum_probs=221.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---HHHHHHHHHHHHHHhcC--CCCcceeEEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLVR--HPNVVELREVM 79 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~--hpnIv~l~~~~ 79 (459)
+..+.++|++.+.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 45778999999999999999999999999999999999976543220 01234567999999996 59999999999
Q ss_pred EeCCEEEEEEeccCC-CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec-CCCCeEEeecCCC
Q 012637 80 ATKKKIFVAMEYVKG-GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD-ENEDLKISDFGLS 156 (459)
Q Consensus 80 ~~~~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~-~~~~lKl~DFGla 156 (459)
.+.+..++|||++.+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999986 899999875 7899999999999999999999999999999999999999 7899999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWIS 236 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 236 (459)
..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+.......+..++
T Consensus 198 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~ 267 (320)
T 3a99_A 198 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVS 267 (320)
T ss_dssp EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCC
T ss_pred ccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCC
Confidence 75432 233456799999999999888776688999999999999999999997653 23445666778899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+++.+||.+||..||.+|||++++++||||+..
T Consensus 268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 999999999999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=380.46 Aligned_cols=254 Identities=29% Similarity=0.512 Sum_probs=208.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------ 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (459)
+.++|++.+.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 457899999999999999999999999999999999643 2345778899999999999999999998865
Q ss_pred -------CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEee
Q 012637 82 -------KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISD 152 (459)
Q Consensus 82 -------~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~D 152 (459)
....|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 4678999999999999999975 3588999999999999999999999999999999999999999999999
Q ss_pred cCCCccccccc------------CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC-chHHH
Q 012637 153 FGLSALPEQLR------------NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMN 219 (459)
Q Consensus 153 FGla~~~~~~~------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~ 219 (459)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||.. .+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99997643211 11223456799999999999876555689999999999999998 6654 33444
Q ss_pred HHHHHHhccCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 220 MYRKVFKAEFVYPP----WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 220 ~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
....+......+|+ ..++.+.+||.+||..||.+|||++++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 55555555444443 35677999999999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=384.67 Aligned_cols=263 Identities=29% Similarity=0.444 Sum_probs=215.6
Q ss_pred Ccccccc-ccCCEEEeeeecccCcEEEEEEEEc-CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCCccee
Q 012637 1 MEEERHV-LFGKYEMGRLLGKGTFAKVYYGKQL-MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV---RHPNVVEL 75 (459)
Q Consensus 1 m~~~~~~-~~~~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l 75 (459)
|.+.+.. ..++|++.+.||+|+||.||+|.+. .+|+.||+|++........ ....+.+|+.+++.+ +||||+++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEee
Confidence 4444443 3488999999999999999999996 6789999999975432211 112355778777766 89999999
Q ss_pred EEEEE-----eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC
Q 012637 76 REVMA-----TKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED 147 (459)
Q Consensus 76 ~~~~~-----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~ 147 (459)
++++. ....+|+||||++ |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 99987 5678999999998 589888865 34999999999999999999999999999999999999999999
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc
Q 012637 148 LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA 227 (459)
Q Consensus 148 lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 227 (459)
+||+|||++...... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccCC---CCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999999999865422 233456799999999999887764 8999999999999999999999998877666655431
Q ss_pred c---------------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 E---------------------------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 ~---------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
. ...+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 01224578999999999999999999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=386.40 Aligned_cols=256 Identities=24% Similarity=0.383 Sum_probs=219.4
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCc---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
+.+..++|++.+.||+|+||+||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34567899999999999999999999987665 49999997543 23345678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
.+..|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999999964 58999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCC-ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCC
Q 012637 160 EQLRNDG-LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWIS 236 (459)
Q Consensus 160 ~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 236 (459)
....... ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+... ....|..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 4321111 22234567889999999887764 89999999999999999 99999998888877777655 445667789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+++.+||.+||..||.+|||+.++++.
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=390.91 Aligned_cols=257 Identities=27% Similarity=0.369 Sum_probs=202.7
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE--
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK-- 84 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 84 (459)
...++|++.+.||+|+||.||+|.+..+|+.||||++..+.... ....+|+..++.++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45689999999999999999999999999999999986553322 234567888889999999999999866433
Q ss_pred -----EEEEEeccCCCchHHH---Hhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcEeccCCCCCeEecC-CCCeEEee
Q 012637 85 -----IFVAMEYVKGGELFAK---VAR-GRLREDLARKYFQQLISAVDFCH--SRGVSHRDLKPENLLLDE-NEDLKISD 152 (459)
Q Consensus 85 -----~~lV~E~~~gg~L~~~---i~~-~~l~e~~~~~~~~qll~~L~~LH--~~gi~HrDlkp~NILl~~-~~~lKl~D 152 (459)
+|+||||++++.+... ... ..+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 8999999998643322 222 67999999999999999999999 999999999999999997 89999999
Q ss_pred cCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC---
Q 012637 153 FGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF--- 229 (459)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--- 229 (459)
||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.+...
T Consensus 176 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 176 FGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999986543 22334567999999999997766556999999999999999999999999887766665543100
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 230 -----------------------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 230 -----------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
..+...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 11122567899999999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=394.53 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=215.6
Q ss_pred ccccCCEEEeeeecccCcEEEEEEE-----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGK-----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVM 79 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 79 (459)
.+..++|++++.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4567899999999999999999999 55677899999997543 233456789999999999 799999999999
Q ss_pred EeCC-EEEEEEeccCCCchHHHHhcCC-----------------------------------------------------
Q 012637 80 ATKK-KIFVAMEYVKGGELFAKVARGR----------------------------------------------------- 105 (459)
Q Consensus 80 ~~~~-~~~lV~E~~~gg~L~~~i~~~~----------------------------------------------------- 105 (459)
.+.+ .+|+|||||+||+|.+++....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8754 4999999999999999987522
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccccc
Q 012637 106 --------------LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ 171 (459)
Q Consensus 106 --------------l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~ 171 (459)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 899999999999999999999999999999999999999999999999999865432222234456
Q ss_pred cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHH-HHHh-ccCCCCCCCCHHHHHHHHHhcC
Q 012637 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYR-KVFK-AEFVYPPWISTDAKRLISKLLV 248 (459)
Q Consensus 172 ~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~-~i~~-~~~~~p~~~s~~~~~Li~~~L~ 248 (459)
.||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+...... .+.. .....|..+++++.+||.+||.
T Consensus 256 ~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp EECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 789999999999987765 89999999999999998 999998866443333 3332 2455677899999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 012637 249 SDPERRITIQSIMRV 263 (459)
Q Consensus 249 ~dP~~R~t~~eil~h 263 (459)
.||.+|||++++++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=402.29 Aligned_cols=251 Identities=18% Similarity=0.199 Sum_probs=195.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc--CCCCcceeE-------EEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV--RHPNVVELR-------EVMAT 81 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l--~hpnIv~l~-------~~~~~ 81 (459)
+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 499999999999999999999999999999999887655555677888896655555 699988755 55544
Q ss_pred C-----------------CEEEEEEeccCCCchHHHHhc--CCCCHHHH------HHHHHHHHHHHHHHHhCCcEeccCC
Q 012637 82 K-----------------KKIFVAMEYVKGGELFAKVAR--GRLREDLA------RKYFQQLISAVDFCHSRGVSHRDLK 136 (459)
Q Consensus 82 ~-----------------~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~------~~~~~qll~~L~~LH~~gi~HrDlk 136 (459)
. ..+|+|||||+ |+|.+++.. ..+++... ..++.||+.||+|||++||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3 34899999999 799999975 34444444 5666999999999999999999999
Q ss_pred CCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCCC
Q 012637 137 PENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQD 214 (459)
Q Consensus 137 p~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~~ 214 (459)
|+|||++.+|.+||+|||+|..... ......||+.|+|||++.+ ..+ +.++|||||||+||+|++|..||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999985432 2224567799999999976 455 5899999999999999999999987
Q ss_pred chHHHH--HHH-----HHhccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 215 ENIMNM--YRK-----VFKAEFVYP--PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 215 ~~~~~~--~~~-----i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
...... +.. .....+.+| +.+++.+.+||.+||+.||++|||+.++++||||+.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 643210 000 001122222 468999999999999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=387.37 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=212.0
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCC-cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC------cceeE
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTG-ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN------VVELR 76 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn------Iv~l~ 76 (459)
.+..+.++|++.+.||+|+||+||+|.+..++ +.||+|++... ....+.+.+|+.+++.++|++ ++.++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 35678899999999999999999999998877 68999999643 224567788999999997665 99999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe-----------
Q 012637 77 EVMATKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL----------- 142 (459)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl----------- 142 (459)
+++...+..|+||||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 5566666644 369999999999999999999999999999999999999
Q ss_pred --------cCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC
Q 012637 143 --------DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD 214 (459)
Q Consensus 143 --------~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~ 214 (459)
+.++.+||+|||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCC
Confidence 5678999999999975322 23456899999999999887775 899999999999999999999998
Q ss_pred chHHHHHHHHHhccCCCC--------------------------------------------CCCCHHHHHHHHHhcCCC
Q 012637 215 ENIMNMYRKVFKAEFVYP--------------------------------------------PWISTDAKRLISKLLVSD 250 (459)
Q Consensus 215 ~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~Li~~~L~~d 250 (459)
.+..+....+.......| ...++++.+||.+||..|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 776554443322111111 112457889999999999
Q ss_pred CCCCCCHHHHhcCccccc
Q 012637 251 PERRITIQSIMRVPWFRK 268 (459)
Q Consensus 251 P~~R~t~~eil~hpw~~~ 268 (459)
|.+|||++++++||||+.
T Consensus 322 P~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAG 339 (355)
T ss_dssp TTTSCCHHHHTTSGGGGG
T ss_pred hhhCcCHHHHhcChhhcC
Confidence 999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=393.02 Aligned_cols=254 Identities=29% Similarity=0.440 Sum_probs=213.5
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CC-----CcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HP-----NVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hp-----nIv~l~~~ 78 (459)
+..+.++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ |+ +|++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 456789999999999999999999999999999999999743 234566788999998885 55 49999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcEeccCCCCCeEec--CCCCeEEe
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCH--SRGVSHRDLKPENLLLD--ENEDLKIS 151 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH--~~gi~HrDlkp~NILl~--~~~~lKl~ 151 (459)
+...+.+|+||||+++ +|.+++.. +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999975 89998865 45999999999999999999999 57999999999999995 47889999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY 231 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 231 (459)
|||+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 204 DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 204 DFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp CCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eccCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999975432 23457899999999999988775 89999999999999999999999988776666554321000
Q ss_pred C------------------------------------C-C---------------------------CCHHHHHHHHHhc
Q 012637 232 P------------------------------------P-W---------------------------ISTDAKRLISKLL 247 (459)
Q Consensus 232 p------------------------------------~-~---------------------------~s~~~~~Li~~~L 247 (459)
| + . .++++.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0 0 0 0136899999999
Q ss_pred CCCCCCCCCHHHHhcCcccccC
Q 012637 248 VSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 248 ~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+.||++|||++|+|+||||+..
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=374.24 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=220.0
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
..+-.++|++.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3345578999999999999999999986 57889999997654433 457899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999999965 56999999999999999999999999999999999999999999999999999754322
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAK 240 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (459)
. ........||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+... ....|...++++.
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 160 Q-YTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 237 (269)
T ss_dssp H-HHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred c-cccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHH
Confidence 1 1122345678889999999887765 89999999999999999 99999998888887777665 3445667899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 012637 241 RLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+||.+||+.||.+|||+.++++|
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=387.85 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=221.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 345689999999999999999999987 456899999997543 3335677899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR-------------------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDL 135 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl 135 (459)
+.+..|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999865 56999999999999999999999999999999
Q ss_pred CCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCC
Q 012637 136 KPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQD 214 (459)
Q Consensus 136 kp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~ 214 (459)
||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999765433222233456789999999999887764 89999999999999999 9999999
Q ss_pred chHHHHHHHHHhccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 215 ENIMNMYRKVFKAEF-VYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 215 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+..+....+..+.. ..|..+++++.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 888887777766553 4567899999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=392.44 Aligned_cols=256 Identities=21% Similarity=0.383 Sum_probs=223.3
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCC-------CcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMT-------GESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELR 76 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~ 76 (459)
+.+..++|++++.||+|+||+||+|.+..+ +..||+|++.... .......+.+|+.+++++ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 345668999999999999999999997643 3579999997553 333567789999999999 999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCC
Q 012637 77 EVMATKKKIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPEN 139 (459)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N 139 (459)
+++.+.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 9999999999999999999999999753 39999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHH
Q 012637 140 LLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIM 218 (459)
Q Consensus 140 ILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 218 (459)
||++.++.+||+|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999865443322334455678999999999887664 89999999999999999 99999998888
Q ss_pred HHHHHHHhc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 219 NMYRKVFKA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 219 ~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+....+... ....|..+++++.+||.+||..||.+|||+.+++++
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 887777655 345567789999999999999999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=374.95 Aligned_cols=256 Identities=17% Similarity=0.263 Sum_probs=214.5
Q ss_pred CccccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEE
Q 012637 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVM 79 (459)
Q Consensus 1 m~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 79 (459)
|...+.++.++|++.+.||+|+||.||+|.+..+|+.||||++...... +.+.+|+.+++.+ +|+||+++++++
T Consensus 1 Ms~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp -----CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred CCCcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 6777889999999999999999999999999999999999998754322 3467899999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC-----eEEee
Q 012637 80 ATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED-----LKISD 152 (459)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~-----lKl~D 152 (459)
.+....|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred CCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 9999999999999 9999999975 46999999999999999999999999999999999999988776 99999
Q ss_pred cCCCcccccccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc---hHHHHHHHH
Q 012637 153 FGLSALPEQLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE---NIMNMYRKV 224 (459)
Q Consensus 153 FGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i 224 (459)
||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. .....+..+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 9999865432221 12345689999999999988776 48999999999999999999999873 333444444
Q ss_pred HhccCC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 225 FKAEFV-----YPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 225 ~~~~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
...... .++.+++++.+||.+||..||.+|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 332221 224689999999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=385.69 Aligned_cols=256 Identities=32% Similarity=0.602 Sum_probs=212.4
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---HHHHHHHHHHHHHHhc----CCCCcceeE
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLV----RHPNVVELR 76 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l----~hpnIv~l~ 76 (459)
.+..+.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 345778899999999999999999999999999999999976543321 1223456799999999 899999999
Q ss_pred EEEEeCCEEEEEEec-cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec-CCCCeEEeec
Q 012637 77 EVMATKKKIFVAMEY-VKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD-ENEDLKISDF 153 (459)
Q Consensus 77 ~~~~~~~~~~lV~E~-~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~-~~~~lKl~DF 153 (459)
+++.+.+..|+|||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 789999999976 6799999999999999999999999999999999999999 8899999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP 233 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 233 (459)
|++..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+......++.
T Consensus 185 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~ 254 (312)
T 2iwi_A 185 GSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA 254 (312)
T ss_dssp SSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCT
T ss_pred chhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcc
Confidence 99975432 233456799999999999887776668999999999999999999997643 23445667788
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+++++.+||.+||..||.+|||++++++||||+..
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 899999999999999999999999999999999854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=375.78 Aligned_cols=253 Identities=29% Similarity=0.448 Sum_probs=210.3
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
|.....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3334499999999999999999999999999976532 2346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-CCCeEEeecCCCcccccccCCC
Q 012637 92 VKGGELFAKVARG----RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-NEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 92 ~~gg~L~~~i~~~----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-~~~lKl~DFGla~~~~~~~~~~ 166 (459)
+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--CC
Confidence 9999999998753 4679999999999999999999999999999999999997 899999999999754321 22
Q ss_pred ccccccCCCcccChhhHhhcC-CCCCcchhhhHHHHHHHHhhCCCCCCCchHH--HHHH-HHHhccCCCCCCCCHHHHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKG-YDGSKADLWSCGVILYVLLAGFLPFQDENIM--NMYR-KVFKAEFVYPPWISTDAKRL 242 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~-~i~~~~~~~p~~~s~~~~~L 242 (459)
......||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...... .... .........|..+++++.+|
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence 234567999999999997643 2358999999999999999999999754322 2222 12233455677899999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
|.+||.+||.+|||++++++||||+..
T Consensus 259 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999999854
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=382.03 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=220.2
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM 79 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 79 (459)
..+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3455679999999999999999999984 456889999997543 334567789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 012637 80 ATKKKIFVAMEYVKGGELFAKVARG-------------------------RLREDLARKYFQQLISAVDFCHSRGVSHRD 134 (459)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrD 134 (459)
.+.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 9999999999999999999998752 289999999999999999999999999999
Q ss_pred CCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCC
Q 012637 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQ 213 (459)
Q Consensus 135 lkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~ 213 (459)
|||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999755432222223345678899999999887664 89999999999999999 999999
Q ss_pred CchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 214 DENIMNMYRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 214 ~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+.......+.... ...|..+++++.+||.+||..||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 887777766665543 45567789999999999999999999999999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=379.81 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=212.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+..++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 34568999999999999999999999999999999998543 344567889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||++||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999976 679999999999999999999999999999999999999999999999999997643221
Q ss_pred CC------------CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHH-----HHHHHHh
Q 012637 164 ND------------GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN-----MYRKVFK 226 (459)
Q Consensus 164 ~~------------~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-----~~~~i~~ 226 (459)
.. ....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||....... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~- 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL- 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-
Confidence 11 111256899999999999887765 89999999999999999999987532210 011111
Q ss_pred ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 227 AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 227 ~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
....|+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 -DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12346778999999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=370.37 Aligned_cols=250 Identities=28% Similarity=0.512 Sum_probs=206.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc-HHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK-EFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
+-.++|++.+.||+|+||.||+|.+. |+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34689999999999999999999974 8899999987543322 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cEeccCCCCCeEecC--------CCCeEEeecC
Q 012637 86 FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRG---VSHRDLKPENLLLDE--------NEDLKISDFG 154 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~g---i~HrDlkp~NILl~~--------~~~lKl~DFG 154 (459)
|+||||++|++|.+++..+++++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999998889999999999999999999999999 999999999999986 7789999999
Q ss_pred CCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--CCCC
Q 012637 155 LSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--FVYP 232 (459)
Q Consensus 155 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p 232 (459)
++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.... ...|
T Consensus 162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred cccccccc----cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 99754321 22356799999999999887764 89999999999999999999999887776666555443 3456
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..+++++.+||.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 6789999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=370.64 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=218.7
Q ss_pred CccccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 012637 1 MEEERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 1 m~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
|.....+..++|++.+.||+|+||.||+|.+. ++.||+|++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 1 m~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp ---CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred CCCcCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 67778888999999999999999999999974 8899999997654333 34567899999999999999999999998
Q ss_pred eC--CEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecCCCCeEEeec
Q 012637 81 TK--KKIFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDENEDLKISDF 153 (459)
Q Consensus 81 ~~--~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~~~~lKl~DF 153 (459)
+. ...|+||||++||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 87 7899999999999999999863 4899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhcCCCC--CcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc--cC
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG--SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA--EF 229 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~--~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~ 229 (459)
|++.... ....+||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 158 ~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 158 DVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230 (271)
T ss_dssp GSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC
Confidence 9875322 23457899999999998765542 2799999999999999999999988877776665544 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..|..+++++.+||.+||+.||.+|||++++++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5667799999999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=393.99 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=217.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+-.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 345678999999999999999999999999999999986442 233456688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999999999875 469999999999999999999999999999999999999999999999999997532211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 241 (459)
.........+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 346 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111123356789999999877664 89999999999999998 99999998877766665544 35567778999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 012637 242 LISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~ 262 (459)
||.+||+.||.+|||++++++
T Consensus 347 li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 347 LMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=387.38 Aligned_cols=255 Identities=34% Similarity=0.607 Sum_probs=186.9
Q ss_pred ccccccCCEEEee-eecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-
Q 012637 4 ERHVLFGKYEMGR-LLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT- 81 (459)
Q Consensus 4 ~~~~~~~~y~i~~-~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~- 81 (459)
++..+.++|++.+ .||+|+||+||+|.++.+|+.||||++.... .. .......++.+.||||+++++++..
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~---~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KA---RQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HH---HHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HH---HHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 4557889999965 6999999999999999999999999996532 11 1222334667799999999999976
Q ss_pred ---CCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC---CCeEEee
Q 012637 82 ---KKKIFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN---EDLKISD 152 (459)
Q Consensus 82 ---~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~---~~lKl~D 152 (459)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 55689999999999999999763 69999999999999999999999999999999999999864 5599999
Q ss_pred cCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH----HHHHHhcc
Q 012637 153 FGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM----YRKVFKAE 228 (459)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~ 228 (459)
||++.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+...... ...+....
T Consensus 175 fg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 175 FGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp CTTCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred cccceecc----ccccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 99997543 2234567899999999999776664 789999999999999999999987654433 22222233
Q ss_pred CCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 229 FVYP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 229 ~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
...| ..+++++.+||.+||..||.+|||++++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 3333 35799999999999999999999999999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=382.41 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=211.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
.++.++|++.+.||+|+||.||+|.+..+|+.||||++...... +.+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 35667899999999999999999999999999999999755332 2477899999999 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC-----eEEeecCCCc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED-----LKISDFGLSA 157 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~-----lKl~DFGla~ 157 (459)
.|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 9999999874 68999999999999999999999999999999999999999887 9999999998
Q ss_pred ccccccCCC-----ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC---chHHHHHHHHHhccC
Q 012637 158 LPEQLRNDG-----LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD---ENIMNMYRKVFKAEF 229 (459)
Q Consensus 158 ~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~ 229 (459)
......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ ....+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 654322111 1246789999999999998776 4899999999999999999999987 444455555544433
Q ss_pred CCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 230 VYP-----PWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 230 ~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..| ...+ ++.+||.+||..||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 333 2234 9999999999999999999998876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=384.87 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=217.2
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 78 (459)
+.+-.++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3455679999999999999999999973 466789999997543 222346788999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecc
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVARG------------------------RLREDLARKYFQQLISAVDFCHSRGVSHRD 134 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrD 134 (459)
+...+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 99999999999999999999999752 278999999999999999999999999999
Q ss_pred CCCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCC
Q 012637 135 LKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQ 213 (459)
Q Consensus 135 lkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~ 213 (459)
|||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999865443222233456688999999999887764 89999999999999998 999998
Q ss_pred CchHHHHHHHHHhc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 214 DENIMNMYRKVFKA--EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 214 ~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
+......+...... ....|..+++++.+||.+||..||.+|||+.++++|..-
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 87654444444333 344567789999999999999999999999999998543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.58 Aligned_cols=257 Identities=23% Similarity=0.288 Sum_probs=222.8
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEE
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREV 78 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 78 (459)
.+.+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34566789999999999999999999887 467889999997543 22345578899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVAR-----------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED 147 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~ 147 (459)
+.+.+..|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 9999999999999999999998864 35799999999999999999999999999999999999999999
Q ss_pred eEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHh
Q 012637 148 LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFK 226 (459)
Q Consensus 148 lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 226 (459)
+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 999999999865433222233445678999999999887764 89999999999999999 8999999888877777766
Q ss_pred ccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 227 AEF-VYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 227 ~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
... ..|..+++++.+||.+||..||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 543 4567789999999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=371.50 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=216.9
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+.+..++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++.+.+.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 3455679999999999999999999875 67789999997654433 457899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
+|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999999999976 68999999999999999999999999999999999999999999999999999754322
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAK 240 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (459)
. ........||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+.......+.... ...|...++.+.
T Consensus 174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (283)
T 3gen_A 174 E-YTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251 (283)
T ss_dssp H-HHSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred c-cccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHH
Confidence 1 1122344578889999999987764 89999999999999998 999999988887777776653 445667899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 012637 241 RLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+||.+||+.||.+|||+.++++|
T Consensus 252 ~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 252 TIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=387.65 Aligned_cols=254 Identities=24% Similarity=0.476 Sum_probs=208.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-----------CCCcce
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-----------HPNVVE 74 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----------hpnIv~ 74 (459)
.+..++|++.+.||+|+||+||+|.+..+++.||||++..+. ...+.+.+|+.+++++. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 345679999999999999999999999999999999997542 23456788999999886 899999
Q ss_pred eEEEEEeCC----EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEec---
Q 012637 75 LREVMATKK----KIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLD--- 143 (459)
Q Consensus 75 l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~--- 143 (459)
+++++...+ .+++||||+ |++|.+++.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999997654 899999999 8899998865 4699999999999999999999998 999999999999995
Q ss_pred ---CCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH---
Q 012637 144 ---ENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI--- 217 (459)
Q Consensus 144 ---~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~--- 217 (459)
..+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 344799999999975432 2345689999999999998776 4899999999999999999999986542
Q ss_pred ---HHHHHHHH------------------------------------------hccCCCCCCCCHHHHHHHHHhcCCCCC
Q 012637 218 ---MNMYRKVF------------------------------------------KAEFVYPPWISTDAKRLISKLLVSDPE 252 (459)
Q Consensus 218 ---~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~Li~~~L~~dP~ 252 (459)
......+. .....++...++++.+||.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 11111111 112223334567889999999999999
Q ss_pred CCCCHHHHhcCcccccCC
Q 012637 253 RRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 253 ~R~t~~eil~hpw~~~~~ 270 (459)
+|||++|+++||||+...
T Consensus 324 ~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TCBCHHHHHTCGGGTTCT
T ss_pred ccCCHHHHhhChhhhccc
Confidence 999999999999998643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=379.13 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=217.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEE-----cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQ-----LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 78 (459)
..+..++|++++.||+|+||.||+|.+ ..+++.||+|++..... ....+.+.+|+.+++++ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 445668999999999999999999985 45778999999975532 23457789999999999 99999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCC
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVARG-------------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPEN 139 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N 139 (459)
+.+.+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 99999999999999999999998753 38999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHH
Q 012637 140 LLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIM 218 (459)
Q Consensus 140 ILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 218 (459)
||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999865443222233455678899999999887764 89999999999999999 99999886654
Q ss_pred HHHHHHHhc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 219 NMYRKVFKA--EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 219 ~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
......... ....+..+++++.+||.+||.+||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 433333332 233456789999999999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=375.59 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=212.6
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCC-------cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTG-------ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREV 78 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 78 (459)
.+..++|++.+.||+|+||+||+|.+..++ ..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 355789999999999999999999998877 4699999965432 234678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC--------e
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED--------L 148 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~--------l 148 (459)
+.+.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999763 4999999999999999999999999999999999999998887 9
Q ss_pred EEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-CCCCCCchHHHHHHHHHhc
Q 012637 149 KISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMNMYRKVFKA 227 (459)
Q Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~ 227 (459)
||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++| .+||...+.... ......
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYED 233 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHT
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhc
Confidence 9999999974322 23456899999999998744446899999999999999995 556655554433 344445
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 228 EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 228 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
....|...++++.+||.+||+.||.+|||+.++++|
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 566777789999999999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.14 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=217.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+..++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 455689999999999999999999875 56789999997654433 4578999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999999999875 459999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (459)
........||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+.......+.... ...|...++.+.+
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -hhcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 1122334567789999999887765 89999999999999999 999999988877777666554 3445668999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 012637 242 LISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~h 263 (459)
||.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.65 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=211.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC--CCCcceeEEEEEeCCE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR--HPNVVELREVMATKKK 84 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~~~ 84 (459)
+..++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 44567999999999999999999985 5899999999765443 335678899999999997 5999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence 999999 667899999876 6899999999999999999999999999999999999996 5899999999998654432
Q ss_pred CCCccccccCCCcccChhhHhhc----------CCCCCcchhhhHHHHHHHHhhCCCCCCCch-HHHHHHHHHhc--cCC
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKK----------GYDGSKADLWSCGVILYVLLAGFLPFQDEN-IMNMYRKVFKA--EFV 230 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~----------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~--~~~ 230 (459)
........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ...
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 260 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence 22233456899999999999752 233578999999999999999999998743 22333333332 334
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 231 YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 231 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+|...+.++.+||.+||..||.+|||+.++++||||+...
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 5667899999999999999999999999999999998643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=375.46 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=210.7
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
...+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 35678999999999999999999999999999999999876655665678899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 86 FVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~ 188 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE-K 188 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc-c
Confidence 999999999999999976 78999999999999999999999999999999999999999999999999999754432 1
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---CCCCCCCCHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKR 241 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 241 (459)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.... ...++.+++++.+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 122345679999999999987666 489999999999999999999999887765444443322 1345678999999
Q ss_pred HHHHhcCCCCCCCC-CHHHHhcC
Q 012637 242 LISKLLVSDPERRI-TIQSIMRV 263 (459)
Q Consensus 242 Li~~~L~~dP~~R~-t~~eil~h 263 (459)
||.+||.+||.+|| |++++++.
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHHhccCCHHHHHHhHHHHHHH
Confidence 99999999999999 78877753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=383.98 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=214.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcE----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
.+..++|++.+.||+|+||+||+|.+..+++. ||+|.+....... ....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34567999999999999999999999988876 6777764332111 1234668999999999999999999986
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
....|+||||+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 4568999999999999999875 57999999999999999999999999999999999999999999999999999876
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCH
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWIST 237 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (459)
.............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|..+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence 543333344556788899999999887764 89999999999999999 99999988777776666655 4456677899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
++.+||.+||..||.+|||+.++++|
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=371.89 Aligned_cols=254 Identities=27% Similarity=0.394 Sum_probs=207.6
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCC---CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
..+..++|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 356778999999999999999999998754 4569999986432 334567789999999999999999999998 4
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
.+..|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 5678999999999999999975 36999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCH
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWIST 237 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 237 (459)
.... ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+.... ...|+.+++
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred Cccc-ccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 4321 1122344578899999999887764 89999999999999996 999999877776666665543 456778999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
++.+||.+||..||.+|||+.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=379.39 Aligned_cols=255 Identities=22% Similarity=0.391 Sum_probs=219.0
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEc-------CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQL-------MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELRE 77 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~ 77 (459)
.+..++|++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 455689999999999999999999986 467789999997543 333567789999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCe
Q 012637 78 VMATKKKIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENL 140 (459)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NI 140 (459)
++.+.+.+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 999999999999999999999999753 389999999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHH
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMN 219 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~ 219 (459)
|++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999755432211223344678899999999887664 89999999999999999 999999988887
Q ss_pred HHHHHHhcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 220 MYRKVFKAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 220 ~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
....+.... ...|..+++++.+||.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777666553 45567789999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=380.90 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=218.1
Q ss_pred cccccCCEEEeeeecccCcEEEEEEE-----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGK-----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM 79 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 79 (459)
+.+..++|++.+.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 45677899999999999999999999 56788899999996432 233456788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC---CCe
Q 012637 80 ATKKKIFVAMEYVKGGELFAKVARG--------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN---EDL 148 (459)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~---~~l 148 (459)
.+....|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999999753 38999999999999999999999999999999999999954 469
Q ss_pred EEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc
Q 012637 149 KISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA 227 (459)
Q Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 227 (459)
||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 99999999754332222233456789999999999887764 89999999999999998 99999988887777766655
Q ss_pred c-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 228 E-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 228 ~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
. ...+..+++.+.+||.+||..||.+|||+.++++|+|+..
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 3 4456678999999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=381.51 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=208.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEE----EEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESV----AIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+..++|++.+.||+|+||+||+|.+..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998888765 667664322 222346788999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
. .++|+||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999875 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|...+.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 33332233345678899999999987775 89999999999999999 99999987776666655544 34566778999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=372.85 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=198.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+..+..+++.++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 45679999999999999999999999999999999997654322 23344555566788889999999999999999999
Q ss_pred EEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 87 VAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+||||+ ++.+..... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC--
Confidence 999999 555555544 36899999999999999999999995 999999999999999999999999999975432
Q ss_pred CCCccccccCCCcccChhhHhh----cCCCCCcchhhhHHHHHHHHhhCCCCCCC-chHHHHHHHHHhccCC-CC--CCC
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRK----KGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKAEFV-YP--PWI 235 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~-~p--~~~ 235 (459)
.......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.. .........+...... .| ..+
T Consensus 178 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 178 -DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred -CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence 222345679999999999952 22335899999999999999999999987 3444555555544332 23 347
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
++++.+||.+||..||.+|||++++++||||+.
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 999999999999999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=372.19 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=209.1
Q ss_pred cccccCCEEEeeeecccCcEEEEEEE----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
..+..++|++.+.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35667899999999999999999998 5678999999998654 3334567899999999999999999999985
Q ss_pred e--CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 81 T--KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 81 ~--~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
. ...+|+||||+++|+|.+++.. .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 4568999999999999999976 45999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH----------------H
Q 012637 157 ALPEQLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM----------------N 219 (459)
Q Consensus 157 ~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----------------~ 219 (459)
......... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 865432111 122334577789999999988774 8999999999999999999998764322 1
Q ss_pred HHHHHH-hccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 220 MYRKVF-KAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 220 ~~~~i~-~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
....+. ......|..+++++.+||.+||..||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111222 22445667799999999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=378.43 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=218.0
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCc-----EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEE
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGE-----SVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELRE 77 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~ 77 (459)
+..+..++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 344567899999999999999999999987665 79999997543 233457789999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe
Q 012637 78 VMATKKKIFVAMEYVKGGELFAKVAR---------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL 142 (459)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl 142 (459)
++.+.+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999999999998863 357999999999999999999999999999999999999
Q ss_pred cCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHH
Q 012637 143 DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMY 221 (459)
Q Consensus 143 ~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~ 221 (459)
+.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999865433222223445678899999999887765 89999999999999998 99999886654444
Q ss_pred HHHHhc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 222 RKVFKA--EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 222 ~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..+... ....|...++++.+||.+||+.||.+|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 444333 234566789999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=364.25 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=218.7
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+-.++|++.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 445678999999999999999999986 67899999997654432 4678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999999999975 569999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (459)
........||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+.......+..+. ...|...++.+.+
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 159 -YTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 236 (267)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -ccccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHH
Confidence 1122345678899999999887764 89999999999999999 999999988887777776653 3456678999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 012637 242 LISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~h 263 (459)
||.+||..||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=370.58 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=222.1
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
++.+..++|++.+.||+|+||.||+|.+..+++.||+|++..+.. ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 456678899999999999999999999999999999999975432 3467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999999975 459999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
.. .........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|..+++.
T Consensus 163 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 3kfa_A 163 GD-TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240 (288)
T ss_dssp SS-SSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CC-ccccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHH
Confidence 21 11223345678899999999887764 89999999999999999 99999988777666665544 34566778999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+||.+||..||.+|||++++++.
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=368.62 Aligned_cols=255 Identities=27% Similarity=0.514 Sum_probs=207.3
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 45678999999999999999999999999999999999876555566677889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 86 FVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998853 569999999999999999999999999999999999999999999999999997544
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch--HHHHHHHHHhccCCC--CCCCC
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN--IMNMYRKVFKAEFVY--PPWIS 236 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~~--p~~~s 236 (459)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.. .......+....+.. +..++
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred CC--CccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence 31 2223456799999999999887664 89999999999999999999997643 334444554443322 24579
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+++.+||.+||..||.+|||+.+++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=376.30 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=215.3
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEE-----cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQ-----LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVM 79 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 79 (459)
.+..++|++++.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45568999999999999999999985 3577899999997543 233456788999999999 799999999998
Q ss_pred EeCC-EEEEEEeccCCCchHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeE
Q 012637 80 ATKK-KIFVAMEYVKGGELFAKVARGR-----------------LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLL 141 (459)
Q Consensus 80 ~~~~-~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NIL 141 (459)
...+ .+|+||||++||+|.+++.... +++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 5999999999999999997632 899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHH-
Q 012637 142 LDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMN- 219 (459)
Q Consensus 142 l~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~- 219 (459)
++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+...
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 999999999999999865432222233456789999999999887765 89999999999999998 999998765433
Q ss_pred HHHHHHhc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 220 MYRKVFKA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 220 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
....+..+ ....|..+++++.+||.+||..||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333333 345667789999999999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=377.52 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=208.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEE----EEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESV----AIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+..++|++.+.||+|+||.||+|.+..+++.| |+|.+..... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 45689999999999999999999999888866 5555543221 12346788999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
. .++|+||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 8899999999999999865 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (459)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+.... ...|+.++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999987775 89999999999999999 999999887777666665543 4566778999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+||.+||..||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999974
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=366.97 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=210.9
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHH----HHHHHHHHHHHHhcCCCCcceeEEEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFM----MEQIKREISVMRLVRHPNVVELREVMA 80 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~----~~~i~~Ei~il~~l~hpnIv~l~~~~~ 80 (459)
+.+..++|++.+.||+|+||.||+|.+..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 4566789999999999999999999999999999999997654332222 167889999999999999999999997
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecCCCC-----eEEe
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDENED-----LKIS 151 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~~~~-----lKl~ 151 (459)
+.. ++||||+++|+|.+.+.. ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 666 699999999999998855 57999999999999999999999999 999999999999998876 9999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhhc-CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH--HHHHHhc-
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK-GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM--YRKVFKA- 227 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~--~~~i~~~- 227 (459)
|||++.... ......+||+.|+|||++... ...+.++|||||||++|+|++|..||...+.... ...+...
T Consensus 172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 999997432 234456899999999998432 2235789999999999999999999987543322 3333322
Q ss_pred -cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 228 -EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 228 -~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
....|..+++++.+||.+||+.||.+|||++++++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 34556778999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=367.30 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=217.6
Q ss_pred cccCCEEEee-eecccCcEEEEEEEEc--CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGR-LLGKGTFAKVYYGKQL--MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~-~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+..++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4456788887 9999999999999864 467889999997643 334567889999999999999999999999 556
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 79999999999999999864 5699999999999999999999999999999999999999999999999999976532
Q ss_pred ccC-CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHH
Q 012637 162 LRN-DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTD 238 (459)
Q Consensus 162 ~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (459)
... ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+. ...|+.++++
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence 111 1112334578999999999877664 89999999999999998 999999888777776666553 4567789999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPW 265 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw 265 (459)
+.+||.+||..||.+|||+.++++|.+
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999999854
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=378.64 Aligned_cols=251 Identities=21% Similarity=0.259 Sum_probs=203.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC---
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK--- 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (459)
+-.++|++.+.||+|+||+||+|++. ++.||||++..... ......+|+.+++.++||||+++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 34568999999999999999999864 79999999965421 2344567999999999999999999998743
Q ss_pred -EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEeccCCCCCeEecCCCCeEEee
Q 012637 84 -KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR----------GVSHRDLKPENLLLDENEDLKISD 152 (459)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~----------gi~HrDlkp~NILl~~~~~lKl~D 152 (459)
.+|+|||||++|+|.+++..+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred ceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 479999999999999999988999999999999999999999999 999999999999999999999999
Q ss_pred cCCCcccccccCCCccccccCCCcccChhhHhhcCCC----CCcchhhhHHHHHHHHhhCCCCCCCch------------
Q 012637 153 FGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD----GSKADLWSCGVILYVLLAGFLPFQDEN------------ 216 (459)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~----~~~~DIwSlGvil~~ll~G~~Pf~~~~------------ 216 (459)
||+|...............+||+.|+|||++.+.... +.++|||||||++|+|++|..||.+..
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999765543333334557899999999999863221 357899999999999999999997532
Q ss_pred ----HHHHHHHHHhccC--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 217 ----IMNMYRKVFKAEF--VYPPW-----ISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 217 ----~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.......+..... ..+.. .++++.+||.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222222222211 11111 23459999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=377.45 Aligned_cols=257 Identities=22% Similarity=0.369 Sum_probs=192.3
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCCcceeEEEEEeCC
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS-VMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~ 83 (459)
+.+..++|++.+.||+|+||.||+|.++.+|+.||||++..... ......+.+|+. +++.++||||+++++++.+.+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 44667899999999999999999999999999999999976532 223345556666 777889999999999999999
Q ss_pred EEEEEEeccCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 84 KIFVAMEYVKGGELFAKVA------RGRLREDLARKYFQQLISAVDFCHSR-GVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~~~~qll~~L~~LH~~-gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
..|+||||++| +|.+++. .+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999986 6766654 46799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHh----hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-HHHHHHHhccC-C
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLR----KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-NMYRKVFKAEF-V 230 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~-~ 230 (459)
..... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.. +....+..+.. .
T Consensus 174 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 174 GQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp CC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred eeccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 76432 12233457999999999983 3444 48999999999999999999999875432 22222222211 1
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 231 YP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 231 ~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+ ..+++++.+||.+||..||.+|||+.++++||||..
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 11 347899999999999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=368.99 Aligned_cols=254 Identities=25% Similarity=0.462 Sum_probs=199.9
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
.+.+..++|++.+.||+|+||+||+|.+. ..||+|++..... .....+.+.+|+.+++.++||||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 35678899999999999999999999853 3599999975543 334567789999999999999999999965 566
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
..++||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 78999999999999999854 5799999999999999999999999999999999999999999999999999976543
Q ss_pred ccCCCccccccCCCcccChhhHh---hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHH-HHHHHHhccCC-----CC
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLR---KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN-MYRKVFKAEFV-----YP 232 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~~-----~p 232 (459)
..........+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+... ....+...... .+
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 33333445668999999999996 3334 478999999999999999999998755443 33333333322 22
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..+++++.+||.+||..||.+|||+.++++.
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 3578999999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=375.88 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=214.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEE--EEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESV--AIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (459)
+-.++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 44579999999999999999999999998865 999986432 222446688999999999 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC
Q 012637 84 KIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999998753 599999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHH
Q 012637 147 DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVF 225 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 225 (459)
.+||+|||++...... .......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998743321 122344678899999999877664 89999999999999998 999999988888777666
Q ss_pred hc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 226 KA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 226 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+ ....|..+++++.+||.+||..||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54 345566789999999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=371.59 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=206.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcC---CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+..++|++++.||+|+||.||+|.+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345689999999999999999998765 5568999999765433 334567899999999999999999999997755
Q ss_pred -----EEEEEEeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEe
Q 012637 84 -----KIFVAMEYVKGGELFAKVAR-------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKIS 151 (459)
Q Consensus 84 -----~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~ 151 (459)
..|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 35999999999999998832 469999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cC
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EF 229 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~ 229 (459)
|||++................|++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 99999765432222223345678899999999887764 89999999999999999 99999988777776666554 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 230 VYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 230 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..|..+++++.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5567789999999999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=365.39 Aligned_cols=248 Identities=28% Similarity=0.465 Sum_probs=213.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe----
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT---- 81 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~---- 81 (459)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 346678999999999999999999999999999999997543 245689999999999999999998864
Q ss_pred ------------CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC
Q 012637 82 ------------KKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 82 ------------~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
...+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence 4568999999999999999964 5799999999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHh
Q 012637 147 DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFK 226 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~ 226 (459)
.+||+|||++..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||... ......+..
T Consensus 160 ~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~ 233 (284)
T 2a19_B 160 QVKIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD 233 (284)
T ss_dssp EEEECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred CEEECcchhheeccc---cccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence 999999999975432 2233456799999999999887764 8999999999999999999988532 223333333
Q ss_pred ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 227 AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 227 ~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
. ..+..+++++.+||.+||..||.+|||+.++++|+|.-.
T Consensus 234 ~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 G--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp T--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred c--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 2 346678999999999999999999999999999988754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=363.31 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=207.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEE-EEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREV-MATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~-~~~~~~~ 85 (459)
.+.++|++.+.||+|+||.||+|++..+|+.||||++....... .+.+|+.+++.++|++++..+.. .......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-----HHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 46789999999999999999999999999999999987654332 47789999999998876665554 4778899
Q ss_pred EEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe---cCCCCeEEeecCCCcccc
Q 012637 86 FVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALPE 160 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl---~~~~~lKl~DFGla~~~~ 160 (459)
|+||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 899999997 3679999999999999999999999999999999999999 488999999999998654
Q ss_pred cccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch---HHHHHHHHHhccCCCC
Q 012637 161 QLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN---IMNMYRKVFKAEFVYP 232 (459)
Q Consensus 161 ~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p 232 (459)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ....+..+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 32211 12345689999999999988776 489999999999999999999998632 2223333333322233
Q ss_pred -----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 233 -----PWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 233 -----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
..+++++.+||.+||+.||.+|||++++++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 6689999999999999999999999998863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=364.79 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=212.8
Q ss_pred cccCCEEEee-eecccCcEEEEEEEE--cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGR-LLGKGTFAKVYYGKQ--LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~-~LG~G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+-.++|++.+ .||+|+||.||+|.+ ..+++.||||++...... ....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 3346899998 999999999999954 567889999999765332 23457789999999999999999999999 667
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999999999999976 56999999999999999999999999999999999999999999999999999754322
Q ss_pred cCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHH
Q 012637 163 RND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDA 239 (459)
Q Consensus 163 ~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (459)
... .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+.... ...|..+++++
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111 112234567899999999877664 89999999999999999 999999988877776666543 45667799999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 012637 240 KRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+||.+||+.||.+|||+.++++
T Consensus 250 ~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 250 YDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=367.19 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=208.6
Q ss_pred cccCCEEEeeeecccCcEEEEEEE----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+...+|++.+.||+|+||.||+|+ +..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999999 56789999999997553222 346788999999999999999999999876
Q ss_pred --CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 83 --KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
..+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 679999999999999999854 5799999999999999999999999999999999999999999999999999976
Q ss_pred cccccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch---------------HHHHHH
Q 012637 159 PEQLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN---------------IMNMYR 222 (459)
Q Consensus 159 ~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---------------~~~~~~ 222 (459)
....... .......||+.|+|||++.+..+. .++|||||||++|+|++|..|+.... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 5432111 223455788899999999887765 89999999999999999999864332 112222
Q ss_pred HHHh-ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 223 KVFK-AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 223 ~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+.. .....|+.+++++.+||.+||..||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2222 234566789999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=381.79 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=206.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+..++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 44568999999999999999999987 467789999996543 3334567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999999976 3799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 162 LRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 162 ~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
.... .......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..++..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278 (373)
T ss_dssp --------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 2111 111223457789999999987765 89999999999999998 99999988887777666554 34445668999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+||.+||+.||.+|||+.++++.
T Consensus 279 l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 279 LYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCcChhhCcCHHHHHHH
Confidence 9999999999999999999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=363.40 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=202.7
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEE-EEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREV-MATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~-~~~~~~ 84 (459)
..+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+.. +.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 34678999999999999999999999999999999987654332 246789999999988776666554 477889
Q ss_pred EEEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe---cCCCCeEEeecCCCccc
Q 012637 85 IFVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALP 159 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl---~~~~~lKl~DFGla~~~ 159 (459)
.|+||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 899999987 3689999999999999999999999999999999999999 78899999999999865
Q ss_pred ccccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH---HHHHHHHHhccCCC
Q 012637 160 EQLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI---MNMYRKVFKAEFVY 231 (459)
Q Consensus 160 ~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~ 231 (459)
...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+. ...+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 432221 12345689999999999998776 4899999999999999999999976432 12233333332223
Q ss_pred C-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 232 P-----PWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 232 p-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
| ..+++++.+||.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 3 567999999999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=369.99 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=211.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCC----cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTG----ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+...+|++.+.||+|+||+||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 45678999999999999999999987654 359999997543 233456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+..|+||||+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999999999865 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCC-ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCH
Q 012637 161 QLRNDG-LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWIST 237 (459)
Q Consensus 161 ~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (459)
...... ......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 321111 12233567899999999877764 89999999999999999 99999988887777776655 3455667899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+.+||.+||+.||.+|||+.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=387.00 Aligned_cols=255 Identities=24% Similarity=0.416 Sum_probs=210.1
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
.+..+.++|++.+.||+|+||+||+|++..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 35677899999999999999999999999999999999997654333 2456779999999999999999999998765
Q ss_pred --EEEEEEeccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe----cCCCCeEEeec
Q 012637 84 --KIFVAMEYVKGGELFAKVARG----RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL----DENEDLKISDF 153 (459)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl----~~~~~lKl~DF 153 (459)
..|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 789999999999999999752 39999999999999999999999999999999999999 77788999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhc-------CCCCCcchhhhHHHHHHHHhhCCCCCCC----chHHHHHH
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK-------GYDGSKADLWSCGVILYVLLAGFLPFQD----ENIMNMYR 222 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-------~~~~~~~DIwSlGvil~~ll~G~~Pf~~----~~~~~~~~ 222 (459)
|+|..... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.. ....+...
T Consensus 161 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 161 GAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GGCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CCceEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 99976433 2233456899999999998752 1224789999999999999999999964 22334444
Q ss_pred HHHhccCC-------------------CC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 223 KVFKAEFV-------------------YP------PWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 223 ~i~~~~~~-------------------~p------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+..+.+. .| ..++..+.+||.+||..||++|||+.+++++
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 55443221 11 1134568899999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=359.56 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=216.0
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
.++.+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++. .
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 345677789999999999999999999975 5678999999765432 356789999999999999999999986 4
Q ss_pred CEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 83 KKIFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
+..|+||||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 5689999999999999999752 7999999999999999999999999999999999999999999999999999764
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCH
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWIST 237 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (459)
.... ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+... ....|..+++
T Consensus 160 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 160 EDNE-YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (279)
T ss_dssp SSSC-EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCcc-cccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccH
Confidence 3211 1122344578899999999876664 89999999999999999 99999998887777766654 3345667899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
++.+||.+||..||.+|||++++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=369.82 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=211.9
Q ss_pred cccccCCE-EEeeeecccCcEEEEEEEE----cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEE
Q 012637 5 RHVLFGKY-EMGRLLGKGTFAKVYYGKQ----LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM 79 (459)
Q Consensus 5 ~~~~~~~y-~i~~~LG~G~fg~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 79 (459)
.+++.++| ++++.||+|+||+||+|.. ..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 45677777 9999999999999988753 4578999999997653 334567789999999999999999999999
Q ss_pred Ee--CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 80 AT--KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 80 ~~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
.+ ...+|+||||+++|+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 87 4789999999999999999998889999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH---------------HHH
Q 012637 158 LPEQLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM---------------NMY 221 (459)
Q Consensus 158 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------------~~~ 221 (459)
........ .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...... ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 65432111 123345688899999999887765 8999999999999999999999765322 111
Q ss_pred HHHHh-ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 222 RKVFK-AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 222 ~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..+.. .....|..+++++.+||.+||..||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11222 234556778999999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=373.39 Aligned_cols=254 Identities=15% Similarity=0.187 Sum_probs=201.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcC---CCcEEEEEEeeccccccHH---H-----HHHHHHHHHHHHhcCCCCcceeE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEF---M-----MEQIKREISVMRLVRHPNVVELR 76 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~---~-----~~~i~~Ei~il~~l~hpnIv~l~ 76 (459)
..++|++++.||+|+||.||+|.+.. ++..||+|++......... . ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999987 8889999999765321110 1 12356889999999999999999
Q ss_pred EEEEe----CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC--CeE
Q 012637 77 EVMAT----KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE--DLK 149 (459)
Q Consensus 77 ~~~~~----~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~--~lK 149 (459)
+++.. ....|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99988 78999999999 9999999976 5899999999999999999999999999999999999999887 999
Q ss_pred EeecCCCcccccccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc--hHHHHHH
Q 012637 150 ISDFGLSALPEQLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE--NIMNMYR 222 (459)
Q Consensus 150 l~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~--~~~~~~~ 222 (459)
|+|||+|+........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999765432211 12245689999999999988766 48999999999999999999999652 2222221
Q ss_pred HHHhccCCCC---------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 223 KVFKAEFVYP---------PWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 223 ~i~~~~~~~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.........| ..+++++.+||.+||..||.+|||++++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111111122 2688999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=385.47 Aligned_cols=244 Identities=27% Similarity=0.452 Sum_probs=211.3
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-E
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK-K 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 84 (459)
.+..++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|++++||||+++++++.... .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 355678999999999999999999864 7899999997653 2356789999999999999999999987665 7
Q ss_pred EEEEEeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-G--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+|+||||+++|+|.+++.. + .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999975 3 379999999999999999999999999999999999999999999999999974322
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDA 239 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (459)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++
T Consensus 342 -----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 342 -----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 415 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred -----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 12234678899999999887765 89999999999999998 99999987777666666554 456677899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 012637 240 KRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+||.+||..||.+|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.08 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=209.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
..++|++.+.||+|+||.||+|.+ .+|+.||||.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 568999999999999999999996 4789999999865432 235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 88 AMEYVKGGELFAKVARG-----RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999988652 4899999999999999999999999999999999999999999999999999754432
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH------H-HHHHhccC------
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM------Y-RKVFKAEF------ 229 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~------~-~~i~~~~~------ 229 (459)
.........+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+....+. . ........
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 233334456799999999999887764 899999999999999999999976443211 0 11111111
Q ss_pred CC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012637 230 VY----PPWISTDAKRLISKLLVSDPERRITIQSIMRVPW 265 (459)
Q Consensus 230 ~~----p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw 265 (459)
.. ++..+..+.+|+.+||..||++|||+.+++++..
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 1123566889999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.65 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=210.9
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCc---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE-E
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI-F 86 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 86 (459)
.|++.+.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57778999999999999999766555 79999986432 334567889999999999999999999999876655 9
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc-
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR- 163 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~- 163 (459)
+||||+.+|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 578999999999999999999999999999999999999999999999999997543221
Q ss_pred -CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHH
Q 012637 164 -NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAK 240 (459)
Q Consensus 164 -~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (459)
.........||+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+.......+.... ...|..+++.+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 12233455788999999999887764 89999999999999999 566676666666655555443 455667899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 012637 241 RLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+||.+||..||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=360.20 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=211.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcC---CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
.+..++|++.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 4556899999999999999999998754 34469999987653 23345778999999999999999999999865
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 457999999999999999965 469999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
... ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ....|..+++.
T Consensus 165 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 165 DED-YYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred ccc-ccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 321 1122345678899999999887764 89999999999999998 99999876665555555444 34556778999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+||.+||..||.+|||+.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=362.57 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=209.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCC---cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEE-EeCCE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTG---ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVM-ATKKK 84 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~~~ 84 (459)
..+|++.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++ ...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 457999999999999999999976543 358999986532 344567789999999999999999999985 55678
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999965 56899999999999999999999999999999999999999999999999999765332
Q ss_pred cC--CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccC-CCCCCCCHH
Q 012637 163 RN--DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEF-VYPPWISTD 238 (459)
Q Consensus 163 ~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~ 238 (459)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++ |.+||.+.+..+....+..... ..|..+++.
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 21 1223345678899999999887765 89999999999999999 7788887776666555555443 446678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+||.+||.+||.+|||+.++++.
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=385.31 Aligned_cols=249 Identities=22% Similarity=0.383 Sum_probs=214.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+..++|++.+.||+|+||+||+|.+. ++..||||++...... .+.+.+|+.+|+.++||||+++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 455678999999999999999999985 5678999999765432 457889999999999999999999986 6679
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 86 FVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999999975 37999999999999999999999999999999999999999999999999999864321
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAK 240 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (459)
.. .......+|+.|+|||++....+. .++|||||||+||+|++ |..||.+.+..+....+..+ ....|..+++++.
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred ce-eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 112234567889999999887765 89999999999999999 99999998888777776654 3455677899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 012637 241 RLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+||.+||..||.+|||+++|++
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=393.09 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=218.5
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.+...+|++.+.||+|+||.||+|.++.++..||||++..+... .+.+.+|+.+|++++||||+++++++.+...+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 34456899999999999999999999999999999999765432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 86 FVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999999975 45999999999999999999999999999999999999999999999999999864321
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAK 240 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 240 (459)
.........+++.|+|||++....+. .++|||||||+||+|++ |..||.+.+..+.+..+... ....|..+++++.
T Consensus 372 -~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 372 -TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449 (495)
T ss_dssp -CEECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -ceeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11112234567889999999887764 89999999999999999 99999988777766665544 3455777999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 012637 241 RLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+||.+||+.||.+|||+.+|++.
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCcChhHCcCHHHHHHH
Confidence 99999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=375.17 Aligned_cols=253 Identities=15% Similarity=0.193 Sum_probs=201.4
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCC-----CcEEEEEEeeccccccHH---H-----HHHHHHHHHHHHhcCCCCcce
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMT-----GESVAIKVINKDQLKKEF---M-----MEQIKREISVMRLVRHPNVVE 74 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~---~-----~~~i~~Ei~il~~l~hpnIv~ 74 (459)
..++|++++.||+|+||.||+|.+..+ ++.||||++......... . ...+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345999999999999999999998765 588999998765321110 0 122445677788889999999
Q ss_pred eEEEEEeC----CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec--CCC
Q 012637 75 LREVMATK----KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD--ENE 146 (459)
Q Consensus 75 l~~~~~~~----~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~--~~~ 146 (459)
+++++... ...|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 5689999999 9999999875 5799999999999999999999999999999999999999 889
Q ss_pred CeEEeecCCCcccccccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHH
Q 012637 147 DLKISDFGLSALPEQLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY 221 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~ 221 (459)
.+||+|||+|+........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999999765432221 11234569999999999988776 48999999999999999999999864322111
Q ss_pred HHHHh----c-------cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 222 RKVFK----A-------EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 222 ~~i~~----~-------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..... . ....+..+++++.+||.+||..||.+|||+.+|++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11110 0 01112567999999999999999999999999887
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=364.34 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=206.8
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcC-CCc--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLM-TGE--SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+..++|++.+.||+|+||+||+|.+.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 345689999999999999999998654 333 69999997665545456778999999999999999999999998765
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.++||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 8999999999999998865 5799999999999999999999999999999999999999999999999999976533
Q ss_pred ccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc--CCCCCCCCH
Q 012637 162 LRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE--FVYPPWIST 237 (459)
Q Consensus 162 ~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~ 237 (459)
.... .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+.... ...+..+++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2111 122345678899999999887664 89999999999999999 999999988888777776553 344567899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
++.+||.+||..||.+|||+.+++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.66 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=200.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCCcceeEEEEEe--
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL--VRHPNVVELREVMAT-- 81 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~-- 81 (459)
..+.++|++.+.||+|+||+||+|.+ +|+.||||++.... .....+|..++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 46788999999999999999999986 68999999986542 2344566777666 799999999998654
Q ss_pred --CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeccCCCCCeEecCCCCeEEe
Q 012637 82 --KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH--------SRGVSHRDLKPENLLLDENEDLKIS 151 (459)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH--------~~gi~HrDlkp~NILl~~~~~lKl~ 151 (459)
...+|+||||+++|+|.+++..+.+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 356899999999999999998889999999999999999999999 9999999999999999999999999
Q ss_pred ecCCCcccccccCC--CccccccCCCcccChhhHhhcCCC-----CCcchhhhHHHHHHHHhhC----------CCCCCC
Q 012637 152 DFGLSALPEQLRND--GLLHTQCGTPAYVAPEVLRKKGYD-----GSKADLWSCGVILYVLLAG----------FLPFQD 214 (459)
Q Consensus 152 DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~-----~~~~DIwSlGvil~~ll~G----------~~Pf~~ 214 (459)
|||+|......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999754332111 112345899999999999876332 2589999999999999999 889865
Q ss_pred ch----HHHHHHHHHhccC---CCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 215 EN----IMNMYRKVFKAEF---VYPP-----WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 215 ~~----~~~~~~~i~~~~~---~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.. ............. ..|. ..++++.+||.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 32 1222223222211 2221 134679999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=360.25 Aligned_cols=244 Identities=26% Similarity=0.436 Sum_probs=205.4
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-CE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK-KK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-~~ 84 (459)
.+..++|++.+.||+|+||.||+|.+ +|+.||+|++..+. ..+.+.+|+.+++.++||||+++++++... +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 45678999999999999999999986 48899999997543 245688999999999999999999987544 57
Q ss_pred EEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 IFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.|+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999999998752 389999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDA 239 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (459)
......+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+..+....+..+ ....|..+++.+
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 -----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred -----cccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 12344688999999999887764 89999999999999998 99999987776666665544 345667789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 012637 240 KRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+||.+||..||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=382.81 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=198.1
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (459)
..+.+.|.+.+.||+|+||+||.+ ...+|+.||||++..+. .+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred hhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 456678888999999999999875 45789999999986542 24567899999876 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-----------
Q 012637 85 IFVAMEYVKGGELFAKVARGRL--------REDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN----------- 145 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l--------~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~----------- 145 (459)
+|+|||||. |+|.+++..... ++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 999999996 599999976432 233457899999999999999999999999999999754
Q ss_pred --CCeEEeecCCCcccccccCC--CccccccCCCcccChhhHhh------cCCCCCcchhhhHHHHHHHHhh-CCCCCCC
Q 012637 146 --EDLKISDFGLSALPEQLRND--GLLHTQCGTPAYVAPEVLRK------KGYDGSKADLWSCGVILYVLLA-GFLPFQD 214 (459)
Q Consensus 146 --~~lKl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~------~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~ 214 (459)
+.+||+|||+|......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.+
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 48999999999865432111 12345689999999999975 1334689999999999999999 9999987
Q ss_pred chHHHHHHHHHhccCCCCC-------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 215 ENIMNMYRKVFKAEFVYPP-------WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 215 ~~~~~~~~~i~~~~~~~p~-------~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..... ..+.......+. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 65433 233444333322 13578999999999999999999999999999964
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=368.36 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=211.4
Q ss_pred cCCEEEeeeecccCcEEEEEEE----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE--eC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA--TK 82 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~ 82 (459)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+.+.+|+.++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 4689999999999999999999 56789999999997542 334567899999999999999999999886 56
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
..+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 779999999999999999975 569999999999999999999999999999999999999999999999999998654
Q ss_pred cccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH---------------HHHHHH
Q 012637 161 QLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM---------------NMYRKV 224 (459)
Q Consensus 161 ~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~---------------~~~~~i 224 (459)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 32111 12234568889999999988766 48999999999999999999999765432 122222
Q ss_pred Hh-ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 225 FK-AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 225 ~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.. .....|..+++++.+||.+||.+||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22 2345567789999999999999999999999999765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=368.06 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=205.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE----eCCE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA----TKKK 84 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~----~~~~ 84 (459)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 46899999999999999999999999999999998653 2334567889999999999999999999986 3457
Q ss_pred EEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
.|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999998864 56999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCC-------ccccccCCCcccChhhHhhcCC--CCCcchhhhHHHHHHHHhhCCCCCCCchHH--HHHHHHHh-c
Q 012637 160 EQLRNDG-------LLHTQCGTPAYVAPEVLRKKGY--DGSKADLWSCGVILYVLLAGFLPFQDENIM--NMYRKVFK-A 227 (459)
Q Consensus 160 ~~~~~~~-------~~~~~~Gt~~y~APE~l~~~~~--~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~i~~-~ 227 (459)
....... ......||+.|+|||++..... .+.++|||||||++|+|++|..||...... .....+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 3211110 1123468999999999875432 257999999999999999999999542111 11111111 1
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012637 228 EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVP 264 (459)
Q Consensus 228 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hp 264 (459)
....++.+++++.+||.+||+.||.+|||+++++++-
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 2333456899999999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=382.01 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=211.3
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+.+..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ +.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 34556789999999999999999999864 467999999765432 2467899999999999999999999866 67
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 8999999999999999964 4699999999999999999999999999999999999999999999999999986542
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDA 239 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (459)
. .........||+.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|+.+++.+
T Consensus 333 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 410 (452)
T 1fmk_A 333 N-EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 410 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred C-ceecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 1 11122334577899999999887764 89999999999999999 99999998887777776655 345677899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+||.+||..||.+|||++++++.
T Consensus 411 ~~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=383.52 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=195.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+|.+.+.||+|+||+|+. ....+|+.||||++..+.... +.+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~------~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSF------ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEE------CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHH------HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 499999999999999764 445789999999997654322 45799999999 7999999999999999999999
Q ss_pred eccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---C--CCeEEeecCCCcccccc
Q 012637 90 EYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---N--EDLKISDFGLSALPEQL 162 (459)
Q Consensus 90 E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~--~~lKl~DFGla~~~~~~ 162 (459)
|||.| +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|......
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99974 999998763 4666678899999999999999999999999999999953 2 35789999999765432
Q ss_pred cC-CCccccccCCCcccChhhHhhc--CCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccCCC---CCCC
Q 012637 163 RN-DGLLHTQCGTPAYVAPEVLRKK--GYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFVY---PPWI 235 (459)
Q Consensus 163 ~~-~~~~~~~~Gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~ 235 (459)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||................... +...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 11 1233456899999999999742 223478999999999999999 999997665444322222111111 1223
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
+..+.+||.+||+.||.+|||++++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 566899999999999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=374.22 Aligned_cols=246 Identities=15% Similarity=0.215 Sum_probs=201.7
Q ss_pred cccCCEEEeeeecccCcEEEEEE-----EEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCCcceeEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYG-----KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR---HPNVVELREV 78 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~ 78 (459)
+..++|++.+.||+|+||+||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34578999999999999999999 467889999999997542 235677888888886 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC--------
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVA------RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-------- 144 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-------- 144 (459)
+...+..|+|||||+||+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999999996 256999999999999999999999999999999999999998
Q ss_pred ---CCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHH
Q 012637 145 ---NEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY 221 (459)
Q Consensus 145 ---~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~ 221 (459)
++.+||+|||+|...............+||+.|+|||++.+..|. .++|||||||++|+|++|..||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 899999999999765443344455677899999999999988764 899999999999999999999965432110
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 222 RKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 222 ~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.........+.++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 294 ---~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 ---KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ---EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ---eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 000111122457789999999999999999765544443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=359.26 Aligned_cols=233 Identities=30% Similarity=0.589 Sum_probs=193.2
Q ss_pred ccccCCEEEe-eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHH-HhcCCCCcceeEEEEEe--
Q 012637 6 HVLFGKYEMG-RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRHPNVVELREVMAT-- 81 (459)
Q Consensus 6 ~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~-- 81 (459)
..+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3567788887 8899999999999999999999999999642 2456788888 66699999999999987
Q ss_pred --CCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CCCeEEeec
Q 012637 82 --KKKIFVAMEYVKGGELFAKVARG---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NEDLKISDF 153 (459)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~~lKl~DF 153 (459)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 77899999999999999999762 5999999999999999999999999999999999999998 789999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHH----HHhccC
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK----VFKAEF 229 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~----i~~~~~ 229 (459)
|++..... ..+ +.++|||||||++|+|++|..||.+.+....... +.....
T Consensus 165 g~a~~~~~------------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 165 GFAKETTG------------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp TTCEECTT------------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred cccccccc------------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 99863221 123 4789999999999999999999987655433211 112223
Q ss_pred CCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 230 VYP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 230 ~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
..| ..+++++.+||.+||..||.+|||++++++||||+....
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 333 457999999999999999999999999999999986543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=369.22 Aligned_cols=245 Identities=15% Similarity=0.222 Sum_probs=202.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCC--------CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcce------
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMT--------GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVE------ 74 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~------ 74 (459)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47999999999999999999999874 889999999754 24678999999999999987
Q ss_pred ---------eEEEEEe-CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeE
Q 012637 75 ---------LREVMAT-KKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLL 141 (459)
Q Consensus 75 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NIL 141 (459)
+++++.. ....|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777766 78999999999 9999999975 57999999999999999999999999999999999999
Q ss_pred ecCCC--CeEEeecCCCcccccccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC
Q 012637 142 LDENE--DLKISDFGLSALPEQLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD 214 (459)
Q Consensus 142 l~~~~--~lKl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~ 214 (459)
++.++ .+||+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 9999999999765432211 12234589999999999988766 4899999999999999999999987
Q ss_pred ch--HHHHHHHH---HhccCCCC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 215 EN--IMNMYRKV---FKAEFVYP------PWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 215 ~~--~~~~~~~i---~~~~~~~p------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.. ........ ......++ ..+++++.+||.+||..||.+|||++++++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 53 22222222 22222211 1368999999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=364.89 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=198.3
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc--CCCCcceeEEEEEeC--
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV--RHPNVVELREVMATK-- 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l--~hpnIv~l~~~~~~~-- 82 (459)
.+.++|++.+.||+|+||.||+|.+. |+.||||++.... .....+|..++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 45678999999999999999999874 8999999986432 12334455555554 899999999999887
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeccCCCCCeEecCCCCeEEee
Q 012637 83 --KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR--------GVSHRDLKPENLLLDENEDLKISD 152 (459)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~--------gi~HrDlkp~NILl~~~~~lKl~D 152 (459)
..+|+||||+++|+|.+++....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 7899999999999999999888999999999999999999999999 999999999999999999999999
Q ss_pred cCCCcccccccCC--CccccccCCCcccChhhHhhcCCCCC-----cchhhhHHHHHHHHhhC----------CCCCCCc
Q 012637 153 FGLSALPEQLRND--GLLHTQCGTPAYVAPEVLRKKGYDGS-----KADLWSCGVILYVLLAG----------FLPFQDE 215 (459)
Q Consensus 153 FGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~-----~~DIwSlGvil~~ll~G----------~~Pf~~~ 215 (459)
||+|......... ....+.+||+.|+|||++.+..+... ++|||||||++|+|++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 9999754332111 11235689999999999987665522 38999999999999999 7777543
Q ss_pred h-----HHHHHHHHHhc--cCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 216 N-----IMNMYRKVFKA--EFVYPP-----WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 216 ~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
. .......+... ....|. .+++++.+||.+||+.||.+|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1 12222222111 122222 245669999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.22 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=187.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEE-------
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMA------- 80 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~------- 80 (459)
..+|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 45899999999999999999999999999999998554 2334567889999999996 999999999984
Q ss_pred -eCCEEEEEEeccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEecCCCCeEEeec
Q 012637 81 -TKKKIFVAMEYVKGGELFAKVAR----GRLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLDENEDLKISDF 153 (459)
Q Consensus 81 -~~~~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~~~~~lKl~DF 153 (459)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 4456899999996 588887753 57999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccccCC----------CccccccCCCcccChhhHh---hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH
Q 012637 154 GLSALPEQLRND----------GLLHTQCGTPAYVAPEVLR---KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM 220 (459)
Q Consensus 154 Gla~~~~~~~~~----------~~~~~~~Gt~~y~APE~l~---~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~ 220 (459)
|++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 999765432111 1112557999999999983 3334 5799999999999999999999987655443
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 221 YRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 221 ~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
.... .....+...+..+.+||.+||+.||.+|||+.++++|.+-
T Consensus 262 ~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 262 VNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3221 1223345578889999999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=358.10 Aligned_cols=241 Identities=27% Similarity=0.469 Sum_probs=197.9
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
-.++|++.+.||+|+||.||+|.+ +++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+ ..|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 357899999999999999999986 47899999986432 34578899999999999999999998763 4799
Q ss_pred EEeccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcEeccCCCCCeEecCCCC-eEEeecCCCccc
Q 012637 88 AMEYVKGGELFAKVARG----RLREDLARKYFQQLISAVDFCHS---RGVSHRDLKPENLLLDENED-LKISDFGLSALP 159 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~----~l~e~~~~~~~~qll~~L~~LH~---~gi~HrDlkp~NILl~~~~~-lKl~DFGla~~~ 159 (459)
||||++||+|.+++... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999999763 37899999999999999999999 89999999999999998887 799999999754
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch--HHHHHHHHHh-ccCCCCCCCC
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN--IMNMYRKVFK-AEFVYPPWIS 236 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~-~~~~~p~~~s 236 (459)
.. ......||+.|+|||++.+..+. .++|||||||++|+|++|..||.... .......+.. .....+..++
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC
T ss_pred cc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC
Confidence 32 12345799999999999877664 89999999999999999999997532 2222222322 2344556789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+.+||.+||+.||.+|||+++++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999884
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=373.11 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=201.7
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCC---cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEE-eCCEEE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTG---ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMA-TKKKIF 86 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~ 86 (459)
+|++.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++. ..+..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 5899999999999999999876543 468999986432 3335678899999999999999999999864 456889
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999999975 4689999999999999999999999999999999999999999999999999975432211
Q ss_pred C--CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHH
Q 012637 165 D--GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAK 240 (459)
Q Consensus 165 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (459)
. .......||+.|+|||++.+..+. .++|||||||++|+|++ |.+||.+.+..+....+..+. ...|..+++.+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 112334678899999999887764 89999999999999999 788998776655555555443 345667899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 012637 241 RLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+||.+||..||.+|||+.+++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999885
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=364.45 Aligned_cols=262 Identities=22% Similarity=0.316 Sum_probs=196.0
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe---
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--- 81 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--- 81 (459)
..+..++|++.+.||+|+||.||+|.+ +++.||||++...... ......|+..++.++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 346789999999999999999999975 7899999999754311 1112234444556899999999986542
Q ss_pred --CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeccCCCCCeEecCCCCeEE
Q 012637 82 --KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR---------GVSHRDLKPENLLLDENEDLKI 150 (459)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~---------gi~HrDlkp~NILl~~~~~lKl 150 (459)
...+|+|||||++|+|.+++.....++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 34689999999999999999888889999999999999999999999 9999999999999999999999
Q ss_pred eecCCCccccccc------CCCccccccCCCcccChhhHhhcC------CCCCcchhhhHHHHHHHHhhCCCCCCCc-hH
Q 012637 151 SDFGLSALPEQLR------NDGLLHTQCGTPAYVAPEVLRKKG------YDGSKADLWSCGVILYVLLAGFLPFQDE-NI 217 (459)
Q Consensus 151 ~DFGla~~~~~~~------~~~~~~~~~Gt~~y~APE~l~~~~------~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~ 217 (459)
+|||+|....... ........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||... ..
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999997543211 122233567999999999997631 1236799999999999999997765321 10
Q ss_pred ----------------HHHHHHHHhc---cCCCCCC------CCHHHHHHHHHhcCCCCCCCCCHHHHhc------Cccc
Q 012637 218 ----------------MNMYRKVFKA---EFVYPPW------ISTDAKRLISKLLVSDPERRITIQSIMR------VPWF 266 (459)
Q Consensus 218 ----------------~~~~~~i~~~---~~~~p~~------~s~~~~~Li~~~L~~dP~~R~t~~eil~------hpw~ 266 (459)
.......... ...+|.. .++++.+||.+||..||.+|||+.|+++ ++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 0111111111 2223332 3347999999999999999999999954 6787
Q ss_pred ccCCCC
Q 012637 267 RKGFTR 272 (459)
Q Consensus 267 ~~~~~~ 272 (459)
++....
T Consensus 322 ~~~~~~ 327 (336)
T 3g2f_A 322 RNKSVS 327 (336)
T ss_dssp C-----
T ss_pred hcccCC
Confidence 765443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=362.94 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=203.0
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccc-ccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999985 689999999875432 233356778999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 91 YVKGGELFAKVAR----GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999998863 459999999999999999999999999999999999999999999999999997654322222
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHH----HHHHHHhccC-----------CC
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMN----MYRKVFKAEF-----------VY 231 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~-----------~~ 231 (459)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||....... ....+..... ..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23456799999999998754 4 589999999999999999999998754322 2222221111 11
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 232 PPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 232 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+...+..+.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12245678999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=366.76 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=206.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
...++|++.+.||+|+||.||+|.+ .+|+.||||++....... ....+.+|+.+++.++||||+++++++.+.+..|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 5568999999999999999999985 478999999997653221 1235789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 87 VAMEYVKGGELFAKVARG-----RLREDLARKYFQQLISAVDFCHSR---GVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~-----~l~e~~~~~~~~qll~~L~~LH~~---gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
+||||+++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 999999999999999752 399999999999999999999999 999999999999999999999999999986
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH----HHHHHHHhccC-----
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM----NMYRKVFKAEF----- 229 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~----- 229 (459)
.... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...........
T Consensus 184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 5422 2223344569999999999987776 48999999999999999999999632211 00111111100
Q ss_pred ----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 230 ----------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 230 ----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
..+...+..+.+|+.+||+.||.+|||+.++++|.+-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0111124678999999999999999999999998653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=387.22 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=211.0
Q ss_pred cCCEEEee-eecccCcEEEEEEEEcC--CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGR-LLGKGTFAKVYYGKQLM--TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~-~LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.++|.+.+ .||+|+||.||+|.++. ++..||||++...... ...+.+.+|+.+|+.++||||+++++++.. +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 34566666 89999999999998764 5567999999764322 235678899999999999999999999976 569
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+|||||++|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999999864 569999999999999999999999999999999999999999999999999998653221
Q ss_pred CC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHH
Q 012637 164 ND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAK 240 (459)
Q Consensus 164 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 240 (459)
.. .......+|+.|+|||++.+..+. .++|||||||+||+|++ |..||.+.+..+....+..+. ...|..+++++.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 11 112233467899999999887775 89999999999999998 999999988888777776653 456778999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHh---cCcccc
Q 012637 241 RLISKLLVSDPERRITIQSIM---RVPWFR 267 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t~~eil---~hpw~~ 267 (459)
+||.+||..||.+|||+.+++ ++.|+.
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999985 455554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.92 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=215.6
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+.+..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 44566789999999999999999999864 467999999765432 2467899999999999999999999866 67
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999999964 4699999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDA 239 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (459)
.. ........+++.|+|||++....+. .++|||||||+||+|++ |..||.+....+....+..+ ....|..++.++
T Consensus 416 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 493 (535)
T 2h8h_A 416 NE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 493 (535)
T ss_dssp HH-HHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred Cc-eecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 11 0112234567889999999887764 89999999999999999 99999998887777777655 345567899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+||.+||..||++|||+++|++.
T Consensus 494 ~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=389.64 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=207.7
Q ss_pred EEE-eeeecccCcEEEEEEEE--cCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 12 YEM-GRLLGKGTFAKVYYGKQ--LMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 12 y~i-~~~LG~G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
+.+ .+.||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.. ...|+|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 444 35899999999999955 45678999999975433 22345678999999999999999999999965 458999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC-CC
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN-DG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~-~~ 166 (459)
|||+++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999999999976 6799999999999999999999999999999999999999999999999999976543211 11
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLIS 244 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~ 244 (459)
......||+.|+|||++.+..+. .++|||||||+||+|++ |..||.+.+..+....+..+. ...|..+++++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22334578899999999887775 89999999999999998 999999988888777776653 4567789999999999
Q ss_pred HhcCCCCCCCCCHHHHhc
Q 012637 245 KLLVSDPERRITIQSIMR 262 (459)
Q Consensus 245 ~~L~~dP~~R~t~~eil~ 262 (459)
+||..||++|||++++++
T Consensus 607 ~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHTCSSTTTSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=378.15 Aligned_cols=244 Identities=18% Similarity=0.262 Sum_probs=197.9
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcC---------CCCcc
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-----KEFMMEQIKREISVMRLVR---------HPNVV 73 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~---------hpnIv 73 (459)
..++|++.+.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999997 7899999999865431 1123466789999998886 78888
Q ss_pred eeEEEEE------------------------------eCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 012637 74 ELREVMA------------------------------TKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVD 123 (459)
Q Consensus 74 ~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~ 123 (459)
++.+++. +...+|+|||||++|++.+.+.++.+++..++.++.||+.||.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 7777643 2788999999999998888777788999999999999999999
Q ss_pred HHH-hCCcEeccCCCCCeEecCCC--------------------CeEEeecCCCcccccccCCCccccccCCCcccChhh
Q 012637 124 FCH-SRGVSHRDLKPENLLLDENE--------------------DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182 (459)
Q Consensus 124 ~LH-~~gi~HrDlkp~NILl~~~~--------------------~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~ 182 (459)
||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhh
Confidence 999 99999999999999999887 899999999986542 24589999999999
Q ss_pred HhhcCCCCCcchhhhHHHH-HHHHhhCCCCCCCchH-HHHHHHHHhc-cCCC------CCCCCHHHHHHHHHhcCCCCCC
Q 012637 183 LRKKGYDGSKADLWSCGVI-LYVLLAGFLPFQDENI-MNMYRKVFKA-EFVY------PPWISTDAKRLISKLLVSDPER 253 (459)
Q Consensus 183 l~~~~~~~~~~DIwSlGvi-l~~ll~G~~Pf~~~~~-~~~~~~i~~~-~~~~------p~~~s~~~~~Li~~~L~~dP~~ 253 (459)
+.+.. +.++||||+|++ .+++++|..||.+... ......+... .... ++.+|+++.+||.+||+.|
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 98665 589999998776 7789999999965332 1222233311 1111 1236788999999999977
Q ss_pred CCCHHHHh-cCcccc
Q 012637 254 RITIQSIM-RVPWFR 267 (459)
Q Consensus 254 R~t~~eil-~hpw~~ 267 (459)
|++|+| +||||+
T Consensus 324 --sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDLLCQHSLFK 336 (336)
T ss_dssp --SHHHHHHHCGGGC
T ss_pred --CHHHHHhcCCCcC
Confidence 999999 999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=359.00 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=208.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEE----EcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGK----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+..++|++.+.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 455689999999999999999998 4568999999999754 233456789999999999999999999998654
Q ss_pred C--EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 83 K--KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 83 ~--~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
+ .+|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 78999999999999999976 4699999999999999999999999999999999999999999999999999986
Q ss_pred cccccCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH----------------HHH
Q 012637 159 PEQLRND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM----------------NMY 221 (459)
Q Consensus 159 ~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~----------------~~~ 221 (459)
....... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...... .+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 5432111 112334577889999999887664 8999999999999999999998654211 111
Q ss_pred HHHHh-ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 222 RKVFK-AEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 222 ~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..+.. .....|..+++++.+||.+||..||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11221 234556778999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=361.42 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=209.8
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
...+..++|++.+.||+|+||.||+|.+.. .||+|++........ ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNED-QLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCC-CCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHH-HHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345667899999999999999999998753 499999875432221 2245678999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVARG--RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.+|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 999999999999999999763 599999999999999999999999999999999999998 78999999999875432
Q ss_pred c---cCCCccccccCCCcccChhhHhhc--------CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC
Q 012637 162 L---RNDGLLHTQCGTPAYVAPEVLRKK--------GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV 230 (459)
Q Consensus 162 ~---~~~~~~~~~~Gt~~y~APE~l~~~--------~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 230 (459)
. ..........||+.|+|||++... ...+.++|||||||++|+|++|..||...+.......+......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 1 122233455799999999999752 22357899999999999999999999998887777666655433
Q ss_pred C--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 231 Y--PPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 231 ~--p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
. +..++.++.+||.+||..||.+|||+.++++.
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2 23478899999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=358.91 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=204.1
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCCcceeEEEEEeCC-
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL--VRHPNVVELREVMATKK- 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~~~- 83 (459)
.+.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 3457899999999999999999997 58999999996432 2456788999887 78999999999998876
Q ss_pred ---EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeccCCCCCeEecCCCCeEEee
Q 012637 84 ---KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCH--------SRGVSHRDLKPENLLLDENEDLKISD 152 (459)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH--------~~gi~HrDlkp~NILl~~~~~lKl~D 152 (459)
.+|+||||+++|+|.+++...++++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 8999999999999999998889999999999999999999999 89999999999999999999999999
Q ss_pred cCCCcccccccCC--CccccccCCCcccChhhHhhcCCCC-----CcchhhhHHHHHHHHhhC----------CCCCCCc
Q 012637 153 FGLSALPEQLRND--GLLHTQCGTPAYVAPEVLRKKGYDG-----SKADLWSCGVILYVLLAG----------FLPFQDE 215 (459)
Q Consensus 153 FGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~-----~~~DIwSlGvil~~ll~G----------~~Pf~~~ 215 (459)
||++......... ......+||+.|+|||++.+..... .++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9999765432111 0234557999999999997653221 579999999999999999 8899764
Q ss_pred -----hHHHHHHHHHhccC--CCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 216 -----NIMNMYRKVFKAEF--VYPP-----WISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 216 -----~~~~~~~~i~~~~~--~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
........+..... ..|. ..+..+.+||.+||..||.+|||+.++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23333333333222 2222 123578899999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=372.64 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=208.8
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CCcceeEEEEEeCCE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH-PNVVELREVMATKKK 84 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 84 (459)
..+.++|++++.||+|+||.||+|.+..+++.||||++....... .+.+|+.+++.++| ++|..+..++.....
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 356789999999999999999999999999999999987654332 36789999999976 566677777788999
Q ss_pred EEEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEe---cCCCCeEEeecCCCccc
Q 012637 85 IFVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLL---DENEDLKISDFGLSALP 159 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl---~~~~~lKl~DFGla~~~ 159 (459)
.|+||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99999999 899999997 4689999999999999999999999999999999999999 68899999999999865
Q ss_pred ccccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch---HHHHHHHHHhccC--
Q 012637 160 EQLRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN---IMNMYRKVFKAEF-- 229 (459)
Q Consensus 160 ~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~-- 229 (459)
...... ......+||+.|+|||++.+..+. .++|||||||+||+|++|..||.+.. ....+..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 432211 122366899999999999987764 89999999999999999999998743 2333433332221
Q ss_pred ---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 230 ---VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 230 ---~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..+..++.++.+||.+||..||.+||++.+|++
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 122567899999999999999999999998765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=375.93 Aligned_cols=246 Identities=19% Similarity=0.223 Sum_probs=194.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CCc---------ce------
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH-PNV---------VE------ 74 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnI---------v~------ 74 (459)
.|.+++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.| +|. +.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 48899999999999999999999999999999875443333345778999999999987 321 11
Q ss_pred ------eEEEEEe-----CCEEEEEEeccCCCchHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 012637 75 ------LREVMAT-----KKKIFVAMEYVKGGELFAKVA--------RGRLREDLARKYFQQLISAVDFCHSRGVSHRDL 135 (459)
Q Consensus 75 ------l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~--------~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl 135 (459)
+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.||+.||+|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 1111111 23467778766 568888874 245788899999999999999999999999999
Q ss_pred CCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHh----------hcCCCCCcchhhhHHHHHHHH
Q 012637 136 KPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR----------KKGYDGSKADLWSCGVILYVL 205 (459)
Q Consensus 136 kp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~----------~~~~~~~~~DIwSlGvil~~l 205 (459)
||+|||++.++.+||+|||+++.... ...+.+| +.|+|||++. ...+ +.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHH
Confidence 99999999999999999999875433 2456788 9999999994 2223 4799999999999999
Q ss_pred hhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 206 LAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 206 l~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
++|+.||.+.+.......+. .....+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 311 ltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999998876544333222 223457899999999999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=384.96 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=213.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCC---CcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+..++|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4567899999999999999999998654 4579999986432 3345577899999999999999999999984 56
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
..|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 68999999999999999975 3689999999999999999999999999999999999999999999999999986533
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDA 239 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 239 (459)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+. ...|+.+++.+
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 21 1122345678899999999887764 89999999999999997 999999988887777776553 55678899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+||.+||..||.+|||+.++++.
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=395.27 Aligned_cols=256 Identities=31% Similarity=0.451 Sum_probs=206.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-----
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT----- 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (459)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 45689999999999999999999999999999999986542 33456778999999999999999999998765
Q ss_pred -CCEEEEEEeccCCCchHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC---eEEeec
Q 012637 82 -KKKIFVAMEYVKGGELFAKVAR-G---RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED---LKISDF 153 (459)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~---lKl~DF 153 (459)
.+..|+|||||+||+|.+++.. + .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 6778999999999999999976 2 5999999999999999999999999999999999999998775 999999
Q ss_pred CCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHH---------HH
Q 012637 154 GLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYR---------KV 224 (459)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---------~i 224 (459)
|++..... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+......+. .+
T Consensus 169 G~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 169 GYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred cccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 99986532 2334556899999999999877764 89999999999999999999997643221110 00
Q ss_pred -----HhccC------CCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 225 -----FKAEF------VYP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 225 -----~~~~~------~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+.. ..| ..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00111 111 125678999999999999999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.18 Aligned_cols=225 Identities=15% Similarity=0.221 Sum_probs=192.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
++.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 67789999999999999999999999999999999998776665666788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
+||||++|++|.+++..+. ...++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999999997654 556788899999999999999999999999999999999999998543
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHH---HHHhccCC----CCCCCCHHH
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYR---KVFKAEFV----YPPWISTDA 239 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~~~~----~p~~~s~~~ 239 (459)
|++| .+.++|||||||++|+|++|..||.+.+...... +....... .++.+++++
T Consensus 175 ----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 3332 3589999999999999999999998765432110 11111111 235689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+||.+||+.||.+| |+.++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999 99999884
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=388.12 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=203.8
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcC-CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLM-TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+..+.++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 44677999999999999999999999976 78999999986532 3334567889999999999999999999998765
Q ss_pred E-----EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 84 K-----IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 84 ~-----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
. .|+||||++|++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 5 7999999999999887755 89999999999999999999999999999999999999975 999999999975
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHH
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTD 238 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (459)
... ....+||+.|+|||++.+. + +.++|||||||+||+|++|..||.+....... ........++.
T Consensus 231 ~~~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~ 296 (681)
T 2pzi_A 231 INS------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDS 296 (681)
T ss_dssp TTC------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHH
T ss_pred ccc------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHH
Confidence 432 1456899999999999765 3 58999999999999999999998763211000 00000114678
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
+.+||.+||.+||.+||+..+.+.|+|+.
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999999999885
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.40 Aligned_cols=232 Identities=14% Similarity=0.114 Sum_probs=163.9
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccc-------cHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEEEE
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK-------KEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 87 (459)
..++.|++|.+..++....|+.||+|++.++... .+...+.+.+|+.+|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4577899999999998899999999999765321 223356799999999999 79999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||||+|++|.+++.+ +++++. .++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCc
Confidence 9999999999999987 677764 4789999999999999999999999999999999999999999986543 233
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 246 (459)
...+.|||+.|||||++.+.. ..++|+||+|++++.|.++..||. ..... .|.. ...+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHH
Confidence 456789999999999998653 367999999999998877654431 11111 1111 11255677778
Q ss_pred cCCCCCCCCCHHHHhcCcccc
Q 012637 247 LVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~~ 267 (459)
+..+|..|+.......++|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 888888888877777777764
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=244.08 Aligned_cols=127 Identities=39% Similarity=0.686 Sum_probs=115.4
Q ss_pred CCcCCChhhHhhhcCCCCCCCccccccC---cccceeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCC
Q 012637 309 SPKFFNAFEFISSMSSGFDLSNLFENKK---KTGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKG 385 (459)
Q Consensus 309 ~~~~~~~~~~~~~~s~~~~~s~~~~~~~---~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 385 (459)
.|..+|||++|| +|+|+|||+||+... +++|||+|+.+|+.|+++|+++|+.+||+|++++ +++++++..+|+||
T Consensus 3 ~p~~lNAFdiIs-~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~-~~vkl~~~~~grkG 80 (143)
T 2ehb_D 3 GPLMMNAFEMIT-LSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRN-FKTRLEGLSSIKAG 80 (143)
T ss_dssp CCEECCHHHHHT-TCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESS-SEEEEEECCSSGGG
T ss_pred CccccCHHHHHH-HCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcC-cEEEEEEecCCCcc
Confidence 467899999998 999999999998653 7899999999999999999999999999999875 58999998999999
Q ss_pred CeEEEEEEEEEeCceEEEEEEecCCChHHHHHHhhhhhhhhccCceeeccCCC
Q 012637 386 PLSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEEDVRPALKDIVWTWQGDN 438 (459)
Q Consensus 386 ~l~~~~~i~~~~~~~~~v~~~k~~Gd~le~~~~~~~~l~~~l~d~v~~~~~~~ 438 (459)
.|++.+|||+|+|+++||||||++||++||+++|+ +|++.|+||||+|+++.
T Consensus 81 ~l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~-~Lr~~L~diV~~~~~~~ 132 (143)
T 2ehb_D 81 QLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYK-KLCSKLENIIWRATEGI 132 (143)
T ss_dssp CCEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHH-HHHHHSTTTBCC-----
T ss_pred eEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHH-HHHHHhhcceecCCCCC
Confidence 99999999999999999999999999999999998 89999999999999855
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=226.33 Aligned_cols=120 Identities=28% Similarity=0.484 Sum_probs=104.8
Q ss_pred CCcCCChhhHhhhcCCCCCCCccccc--cCcccceeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCC
Q 012637 309 SPKFFNAFEFISSMSSGFDLSNLFEN--KKKTGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGP 386 (459)
Q Consensus 309 ~~~~~~~~~~~~~~s~~~~~s~~~~~--~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 386 (459)
.|..+|||++|| +|+|+|||+||+. ..+++|||+|+.||+.|+++||++|+.+||+|++++.. ++..+|+||.
T Consensus 2 ~~~~lNAFdiIs-~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~----~~~~~g~kG~ 76 (123)
T 2zfd_B 2 GARRMNAFDIIS-GSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW----GMKIEGQKGN 76 (123)
T ss_dssp --CCCCHHHHHH-TSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT----EEEEEEGGGT
T ss_pred CcccccHHHHHH-HCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc----cccccCCCcc
Confidence 356799999999 9999999999975 33679999999999999999999999999999988653 4445788999
Q ss_pred eEEEEEEEEEeCceEEEEEEecCCChHHHHHHhhhhhhhhccCceee
Q 012637 387 LSVIAEVFEVAPEVAVVEFSKSSGDTLEYAKFCEEDVRPALKDIVWT 433 (459)
Q Consensus 387 l~~~~~i~~~~~~~~~v~~~k~~Gd~le~~~~~~~~l~~~l~d~v~~ 433 (459)
|++.+|||+|+|+++||||||++||++||++||.++|++.|+||||+
T Consensus 77 l~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 77 FAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 99999999999999999999999999999998876899999999994
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=276.81 Aligned_cols=189 Identities=21% Similarity=0.230 Sum_probs=147.4
Q ss_pred EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH-----HHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE-----FMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
...+.||+|+||.||+|. ..++.+|+|.......... ...+++.+|+.++++++||||+++..+.......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 456799999999999994 6788999998765443322 224568999999999999999965555557777899
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC-
Q 012637 88 AMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG- 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~- 166 (459)
|||||+|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999875 6789999999999999999999999999999998 99999999998654321111
Q ss_pred ----ccccccCCCcccChhhHhh--cCCCCCcchhhhHHHHHHHHhhCCCCCC
Q 012637 167 ----LLHTQCGTPAYVAPEVLRK--KGYDGSKADLWSCGVILYVLLAGFLPFQ 213 (459)
Q Consensus 167 ----~~~~~~Gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~~ll~G~~Pf~ 213 (459)
...+.+||+.|||||++.. .+|. ..+|+||.++-..+.+-++.+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 1246789999999999986 5564 67899999988888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=229.16 Aligned_cols=147 Identities=20% Similarity=0.292 Sum_probs=118.5
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---------------HHHHHHHHHHHHHHhcCCCCcceeE
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---------------FMMEQIKREISVMRLVRHPNVVELR 76 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~i~~Ei~il~~l~hpnIv~l~ 76 (459)
|.+++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+|++++| +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 44559999999999999999 8899999999964322110 134678899999999994 5555
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 77 EVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
+++.. +..|+||||++||+|.+ +. . ..+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~---~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR---V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC---C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc---h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 55543 45699999999999988 42 1 34567999999999999999999999999999999 999999999998
Q ss_pred cccccccCCCccccccCCCcccChhhHhh
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRK 185 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 185 (459)
. ++..|+|||.+..
T Consensus 240 ~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 240 V---------------EVGEEGWREILER 253 (282)
T ss_dssp E---------------ETTSTTHHHHHHH
T ss_pred e---------------ECCCCCHHHHHHH
Confidence 6 2456899999853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.4e-23 Score=196.09 Aligned_cols=139 Identities=19% Similarity=0.294 Sum_probs=110.3
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcE--EEEEEeeccccc---------------------cHHHHHHHHHHHHHHHhcC
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGES--VAIKVINKDQLK---------------------KEFMMEQIKREISVMRLVR 68 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~~~---------------------~~~~~~~i~~Ei~il~~l~ 68 (459)
|++.+.||+|+||.||+|.+..+|+. ||||++...... .......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998888999 999997543211 0112246789999999998
Q ss_pred CCCc--ceeEEEEEeCCEEEEEEeccCC-C----chHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeccCCCCCe
Q 012637 69 HPNV--VELREVMATKKKIFVAMEYVKG-G----ELFAKVARGRLREDLARKYFQQLISAVDFCH-SRGVSHRDLKPENL 140 (459)
Q Consensus 69 hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NI 140 (459)
|++| ..++++ ...|+||||+.+ | .|.+.... .++..+..++.||+.||.||| ++||+||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8764 444443 246899999942 3 56655432 345678899999999999999 99999999999999
Q ss_pred EecCCCCeEEeecCCCcc
Q 012637 141 LLDENEDLKISDFGLSAL 158 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~ 158 (459)
|++. .++|+|||+|..
T Consensus 203 Ll~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EESS--SEEECCCTTCEE
T ss_pred EEcC--cEEEEECccccc
Confidence 9998 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=180.75 Aligned_cols=138 Identities=15% Similarity=0.199 Sum_probs=102.6
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc---------------cHHH----HHHHHHHHHHHHhcCCCCc
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK---------------KEFM----MEQIKREISVMRLVRHPNV 72 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~~----~~~i~~Ei~il~~l~hpnI 72 (459)
|++++.||.|+||.||+|.+ .+|+.||||+++..... .... .-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999998 47999999997543211 0001 1123567888888865554
Q ss_pred ceeEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC-----
Q 012637 73 VELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED----- 147 (459)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~----- 147 (459)
.-..-+.... .+|||||++|++|.... ..+.+..++.||+.+|.+||++||+||||||.|||++.+|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~-----~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVS-----SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhc-----ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 3222222222 37999999998885543 22346778999999999999999999999999999998773
Q ss_pred -----eEEeecCCCc
Q 012637 148 -----LKISDFGLSA 157 (459)
Q Consensus 148 -----lKl~DFGla~ 157 (459)
+.|+||+-+-
T Consensus 249 ~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 249 SITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECCCTTCE
T ss_pred ccccceEEEEeCCcc
Confidence 8899999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.2e-13 Score=128.73 Aligned_cols=140 Identities=19% Similarity=0.155 Sum_probs=113.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFV 87 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 87 (459)
++.|++...+|.|+++.||++.. .++.+++|+........ ...+.+|+.+++.+. +.++.+++++..+.+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 46799999999999999999974 47899999986432111 134788999999994 6788899999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 012637 88 AMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS---------------------------------------- 127 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~---------------------------------------- 127 (459)
||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999999876531 222345788899999999998
Q ss_pred -------------------CCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 128 -------------------RGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 128 -------------------~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
.+++|+|++|.|||+++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.6e-12 Score=120.58 Aligned_cols=135 Identities=13% Similarity=0.157 Sum_probs=103.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC--cceeEEEEEeCCEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN--VVELREVMATKKKIF 86 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~ 86 (459)
...|.+....+.|..+.||++.. .+|+.+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 45678765555677799999964 567889999976431 134678999999985444 566889888888899
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 012637 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRG------------------------------------- 129 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~g------------------------------------- 129 (459)
+||||++|.+|. .. ... ...++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999999998883 21 122 2356778888888888754
Q ss_pred ---------------------cEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 130 ---------------------VSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 130 ---------------------i~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999886
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.22 E-value=9e-11 Score=98.22 Aligned_cols=87 Identities=17% Similarity=0.233 Sum_probs=77.4
Q ss_pred eeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEe-CceEEEEEEecCCChHHHHHHh
Q 012637 341 MFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVA-PEVAVVEFSKSSGDTLEYAKFC 419 (459)
Q Consensus 341 rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~k~~Gd~le~~~~~ 419 (459)
..+|+.+|++|+..|++++..+|+.++.++.+.+++.......++.+.|.+||+++. +++++|+|+|.+||.+.|+++|
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 567889999999999999999999999988889999864444567899999999995 8999999999999999999999
Q ss_pred hhhhhhhcc
Q 012637 420 EEDVRPALK 428 (459)
Q Consensus 420 ~~~l~~~l~ 428 (459)
. +|...|+
T Consensus 112 ~-~il~~L~ 119 (120)
T 3ose_A 112 S-KIANELK 119 (120)
T ss_dssp H-HHHHHCC
T ss_pred H-HHHHHhc
Confidence 9 7877664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.8e-11 Score=120.85 Aligned_cols=140 Identities=19% Similarity=0.311 Sum_probs=107.2
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEEEEee--ccccccHHHHHHHHHHHHHHHhcC--CCCcceeEEEEEeC---CEEE
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVIN--KDQLKKEFMMEQIKREISVMRLVR--HPNVVELREVMATK---KKIF 86 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~~ 86 (459)
-.+.|+.|.++.||++.. .+..+++|+.. ...... ....+.+|+.+++.+. +..+.+++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 467899999999999874 35688889775 322111 1346788999999996 45688899888776 4589
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 012637 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS--------------------------------------- 127 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~--------------------------------------- 127 (459)
+||||++|..+.+.. ...+++.....++.++...|..||+
T Consensus 118 ~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999998774421 1357888889999999999999997
Q ss_pred -------------------CCcEeccCCCCCeEecCCCC--eEEeecCCCcc
Q 012637 128 -------------------RGVSHRDLKPENLLLDENED--LKISDFGLSAL 158 (459)
Q Consensus 128 -------------------~gi~HrDlkp~NILl~~~~~--lKl~DFGla~~ 158 (459)
.+++|+|++|.|||++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997754 69999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.9e-11 Score=119.29 Aligned_cols=187 Identities=19% Similarity=0.219 Sum_probs=124.8
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCC--cceeEEEEEeCC---EEEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPN--VVELREVMATKK---KIFVA 88 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~lV 88 (459)
.+.++.|....||++. ..+++|+.... .....+.+|..+|+.+ .+.. +.+.+....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999863 56889986432 2356788999999988 4433 445554443333 35899
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 012637 89 MEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS----------------------------------------- 127 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~----------------------------------------- 127 (459)
||+++|..|..... ..++.++...++.|+...|..||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999988865332 457888888899999999999986
Q ss_pred -----------------CCcEeccCCCCCeEecC--CCCeEEeecCCCcccccccCCCcccccc--CCC----------c
Q 012637 128 -----------------RGVSHRDLKPENLLLDE--NEDLKISDFGLSALPEQLRNDGLLHTQC--GTP----------A 176 (459)
Q Consensus 128 -----------------~gi~HrDlkp~NILl~~--~~~lKl~DFGla~~~~~~~~~~~~~~~~--Gt~----------~ 176 (459)
..++|+|++|.||+++. ++.+.|+||+.+..-.....-....... ..+ +
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 13799999999999998 5568999999986432110000000000 000 1
Q ss_pred ccC-hhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc
Q 012637 177 YVA-PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE 215 (459)
Q Consensus 177 y~A-PE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~ 215 (459)
... |+...... ...+.|++|.++|.+.+|..||...
T Consensus 254 ~~~~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 254 HKDIPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp CSCHHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred CCCcHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHHHHH
Confidence 112 23222211 1268999999999999998887443
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.85 E-value=5.1e-09 Score=87.49 Aligned_cols=86 Identities=17% Similarity=0.198 Sum_probs=75.3
Q ss_pred eecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEe-CceEEEEEEecCCChHHHHHHhh
Q 012637 342 FTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVA-PEVAVVEFSKSSGDTLEYAKFCE 420 (459)
Q Consensus 342 f~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~k~~Gd~le~~~~~~ 420 (459)
.+|+.+|++|+..|..+++.+|+.++.++.+.+++.......+..+.|.+||+++. .+++.|+|+|.+||.+.|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 56788999999999999999999999888898888653333457899999999994 78999999999999999999999
Q ss_pred hhhhhhcc
Q 012637 421 EDVRPALK 428 (459)
Q Consensus 421 ~~l~~~l~ 428 (459)
+|-..|+
T Consensus 113 -~IL~eLk 119 (126)
T 1v5s_A 113 -KIANELK 119 (126)
T ss_dssp -HHHHHTT
T ss_pred -HHHHHHh
Confidence 7777776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=3.4e-07 Score=89.27 Aligned_cols=133 Identities=20% Similarity=0.225 Sum_probs=96.9
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC---CcceeEEEEE-eCCEEEEEEe
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP---NVVELREVMA-TKKKIFVAME 90 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E 90 (459)
.+.++.|....||+. |..+++|+... ......+.+|..+|+.+.+. .|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999988 57788898522 22456788999999999642 3566666664 4556789999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 012637 91 YVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSR------------------------------------------ 128 (459)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~------------------------------------------ 128 (459)
|++|..+.... -..++......++.|+...|..||+.
T Consensus 94 ~i~G~~l~~~~-~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDG-MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHH-HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhh-hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99998876532 13455556666666666666666642
Q ss_pred ------------------CcEeccCCCCCeEecC---CCCe-EEeecCCCcc
Q 012637 129 ------------------GVSHRDLKPENLLLDE---NEDL-KISDFGLSAL 158 (459)
Q Consensus 129 ------------------gi~HrDlkp~NILl~~---~~~l-Kl~DFGla~~ 158 (459)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999997 4554 8999998864
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=3.5e-07 Score=73.77 Aligned_cols=89 Identities=15% Similarity=0.274 Sum_probs=75.0
Q ss_pred ccceeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEeCceEEEEEEecCCC------
Q 012637 338 TGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGD------ 411 (459)
Q Consensus 338 ~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd------ 411 (459)
+.-...|...|.+|+..|..+++.+|+.|+..+.+.|++.-........+.|.+++|++.++.+++||++..||
T Consensus 8 W~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~ 87 (106)
T 4eai_A 8 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGG 87 (106)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSS
T ss_pred ceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCC
Confidence 44567888899999999999999999999999999999975333333568999999999999999999999994
Q ss_pred --hHHHHHHhhhhhhhhc
Q 012637 412 --TLEYAKFCEEDVRPAL 427 (459)
Q Consensus 412 --~le~~~~~~~~l~~~l 427 (459)
.++|-++|. .+-..|
T Consensus 88 ~~~~~F~d~ca-~li~~l 104 (106)
T 4eai_A 88 SHTIEFFEMCA-NLIKIL 104 (106)
T ss_dssp CHHHHHHHHHH-HHHHHC
T ss_pred cCcEeHHHHHH-HHHHHH
Confidence 899999998 554444
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=8.4e-07 Score=84.27 Aligned_cols=132 Identities=16% Similarity=0.198 Sum_probs=95.9
Q ss_pred ecccCc-EEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEeccCCC
Q 012637 18 LGKGTF-AKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIFVAMEYVKGG 95 (459)
Q Consensus 18 LG~G~f-g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (459)
+..|.. +.||+......+..+.+|+-... ....+.+|..+|+.+. +-.|.+++.+..+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 334444 46898887777788999986432 2456788999999884 444778899999999999999999998
Q ss_pred chHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------------
Q 012637 96 ELFAKVARGRLREDLARKYFQQLISAVDFCHSR----------------------------------------------- 128 (459)
Q Consensus 96 ~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~----------------------------------------------- 128 (459)
.+.+..... ......+..++...|.-||+.
T Consensus 106 ~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 106 TAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp EHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 776654321 122334555566666666631
Q ss_pred -----------CcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 129 -----------GVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 129 -----------gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
.++|+|+.|.|||++.++.+-|.||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999999877778999998863
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.2e-06 Score=73.29 Aligned_cols=77 Identities=13% Similarity=0.204 Sum_probs=63.5
Q ss_pred ccceeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEeCceEEEEEEecCCChHH
Q 012637 338 TGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLE 414 (459)
Q Consensus 338 ~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~le 414 (459)
+.-...|+..|.+|+..|..+++.+|+.|++.+.+.|++.-........+.|.+++|++.++.+||||++..||+.|
T Consensus 5 WhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 5 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 44566788899999999999999999999999999999975333222358999999999999999999999999866
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.1e-06 Score=88.63 Aligned_cols=79 Identities=15% Similarity=0.105 Sum_probs=50.6
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeecccc-ccH---HHHHHHHHHHHHHHhcCC--CC-cceeEEEEEeCCEEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL-KKE---FMMEQIKREISVMRLVRH--PN-VVELREVMATKKKIFV 87 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~i~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~l 87 (459)
.+.||.|..+.||++....+++.|++|....... ... ...+++..|..+++.+.. |. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5789999999999997666678999998653211 000 012456779999988742 33 4455544 4455689
Q ss_pred EEeccCCC
Q 012637 88 AMEYVKGG 95 (459)
Q Consensus 88 V~E~~~gg 95 (459)
||||++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.7e-06 Score=73.66 Aligned_cols=78 Identities=13% Similarity=0.200 Sum_probs=64.9
Q ss_pred cccceeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEeCceEEEEEEecCCChHH
Q 012637 337 KTGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLE 414 (459)
Q Consensus 337 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~le 414 (459)
++.-...|+..|.+|+..|..+++.+|+.|++.+.+.|++.-..+.....+.|.+++|++.++.+||||++..||+.|
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 566778888999999999999999999999999999999975322222358999999999999999999999999766
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=8.4e-07 Score=87.98 Aligned_cols=82 Identities=17% Similarity=0.184 Sum_probs=56.4
Q ss_pred EEeeee-cccCcEEEEEEEEcC------CCcEEEEEEeeccc---cccHHHHHHHHHHHHHHHhcC-C--CCcceeEEEE
Q 012637 13 EMGRLL-GKGTFAKVYYGKQLM------TGESVAIKVINKDQ---LKKEFMMEQIKREISVMRLVR-H--PNVVELREVM 79 (459)
Q Consensus 13 ~i~~~L-G~G~fg~V~~a~~~~------~~~~vAiK~i~~~~---~~~~~~~~~i~~Ei~il~~l~-h--pnIv~l~~~~ 79 (459)
...+.| +.|....+|+..... +++.+++|+..... ... ...+.+|+.+++.+. + -.+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 345778 899999999886531 26688999865432 101 124678999998884 3 3577788877
Q ss_pred EeC---CEEEEEEeccCCCch
Q 012637 80 ATK---KKIFVAMEYVKGGEL 97 (459)
Q Consensus 80 ~~~---~~~~lV~E~~~gg~L 97 (459)
.+. +..|+||||++|..+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 655 357899999998654
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.24 E-value=8.9e-06 Score=67.32 Aligned_cols=79 Identities=13% Similarity=0.223 Sum_probs=61.4
Q ss_pred ccceeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEeCceEEEEEEecCCChHHHH
Q 012637 338 TGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLEYA 416 (459)
Q Consensus 338 ~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~le~~ 416 (459)
+.-...|+..|.+|+..|..+++.+|+.|++.+.+.|++..........+.+.+++|++.++.+|+||+...||..|..
T Consensus 8 W~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~ 86 (130)
T 4eag_A 8 WHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG 86 (130)
T ss_dssp EEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred eeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence 4445667788999999999999999999999989999997533443456889999999999999999999999976544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.5e-05 Score=78.00 Aligned_cols=134 Identities=17% Similarity=0.207 Sum_probs=78.8
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-----CCCcceeE-E--EEEeCCEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-----HPNVVELR-E--VMATKKKIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 86 (459)
.+.|+.|..+.||++.. .+..+++|+.... . ..+..|..+++.|. .|.++... + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 34567778899999875 3345999998652 1 23344556665552 24444310 0 223577899
Q ss_pred EEEeccCCCchH--------------HHHhc--CCC--C-----------HH--------H-------------------
Q 012637 87 VAMEYVKGGELF--------------AKVAR--GRL--R-----------ED--------L------------------- 110 (459)
Q Consensus 87 lV~E~~~gg~L~--------------~~i~~--~~l--~-----------e~--------~------------------- 110 (459)
++|||++|..+. ..+.. ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986431 11111 111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------hCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 111 ----ARKYFQQLISAVDFCH-------------SRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 111 ----~~~~~~qll~~L~~LH-------------~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
+..+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223344566665 3689999999999999888899999999875
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=4.3e-06 Score=70.81 Aligned_cols=90 Identities=12% Similarity=0.118 Sum_probs=72.0
Q ss_pred cccceeecCCCHHHHHHHHHHHHhhcCcEEEEe---------cCcEEEEEeccCCC-----CCCeEEEEEEEEEeCceEE
Q 012637 337 KTGSMFTSRYSARHIMEKIEGVAKGMNFKVAKV---------KDFKIRLRGDSEGR-----KGPLSVIAEVFEVAPEVAV 402 (459)
Q Consensus 337 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~---------~~~~i~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~ 402 (459)
++.-..-|+..|.+||..|..|++.+|+.|++. +.+.|++.-..+.. ...+.|.+++|++.++.+|
T Consensus 12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL 91 (137)
T 2qrd_A 12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 91 (137)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence 455667788899999999999999999999988 78888886432211 2358899999999999999
Q ss_pred EEEEecCCC---------------h----HHHHHHhhhhhhhhc
Q 012637 403 VEFSKSSGD---------------T----LEYAKFCEEDVRPAL 427 (459)
Q Consensus 403 v~~~k~~Gd---------------~----le~~~~~~~~l~~~l 427 (459)
|||+...|+ . ++|-.+|. +|-..|
T Consensus 92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca-~Li~eL 134 (137)
T 2qrd_A 92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCA-MLVCKL 134 (137)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHH-HHHHHH
T ss_pred EEEEecCCccccccCccccccCCccccccccHHHHHH-HHHHHH
Confidence 999999999 5 88888887 554444
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00014 Score=70.86 Aligned_cols=75 Identities=13% Similarity=0.192 Sum_probs=60.2
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCCcceeEEEEEeCCEEEEEEec
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR---HPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+.+.+....+..|+||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 57789999999999874 5778999987543 1345778999998883 36688899988888899999999
Q ss_pred cCCCch
Q 012637 92 VKGGEL 97 (459)
Q Consensus 92 ~~gg~L 97 (459)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.82 E-value=0.0001 Score=64.38 Aligned_cols=89 Identities=17% Similarity=0.201 Sum_probs=70.5
Q ss_pred cccceeecCCCHHHHHHHHHHHHhhcCcEEEEec---CcEEEEEeccCC---------CCCCeEEEEEEEEEeCceEEEE
Q 012637 337 KTGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVK---DFKIRLRGDSEG---------RKGPLSVIAEVFEVAPEVAVVE 404 (459)
Q Consensus 337 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~---~~~i~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~v~ 404 (459)
++.-...|+..|.+|+..|..+++.+|+.|++.+ .+.|++.-.... ....+.|.+++|++.++.+|||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 4555678889999999999999999999999876 788888632111 1134899999999999999999
Q ss_pred EEecCC----------------------ChHHHHHHhhhhhhhhc
Q 012637 405 FSKSSG----------------------DTLEYAKFCEEDVRPAL 427 (459)
Q Consensus 405 ~~k~~G----------------------d~le~~~~~~~~l~~~l 427 (459)
|+ ..| ..+.|-.+|. +|--.|
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca-~LI~eL 172 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTT-KLIMEL 172 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHH-HHHHHH
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHH-HHHHHH
Confidence 99 778 6688888887 554444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00012 Score=66.96 Aligned_cols=120 Identities=17% Similarity=0.097 Sum_probs=80.5
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-hCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccccc
Q 012637 96 ELFAKVAR--GRLREDLARKYFQQLISAVDFCH-SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQC 172 (459)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH-~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~ 172 (459)
+|.+.+.. .+++|+++|.++.|.+.+|.-+- ++.-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 67787764 79999999999999999988772 22222444567899999999998864 2111 1
Q ss_pred CCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcCC
Q 012637 173 GTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249 (459)
Q Consensus 173 Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 249 (459)
....+.|||... ...+.+.=|+|||+++|.-+--.+|= .-+..+|+++.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 223577888763 22347789999999999877533331 12345899999999999866
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0001 Score=74.85 Aligned_cols=32 Identities=16% Similarity=0.337 Sum_probs=28.5
Q ss_pred HhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 126 H~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
+...++|+|++|.|||++.++ ++|.||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 467899999999999999877 99999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00015 Score=70.98 Aligned_cols=135 Identities=13% Similarity=0.135 Sum_probs=72.0
Q ss_pred eeeecccCcEE-EEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CCcceeEEEEEeCCEEEEEEec
Q 012637 15 GRLLGKGTFAK-VYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH--PNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 15 ~~~LG~G~fg~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 91 (459)
.+.|+.|+... +|+... .+|+.+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34566665554 556642 2367787876543210 234567888877742 23566666643333 789999
Q ss_pred cCCCchHHHHhcC------------------------C---CCHHHHH-------H-HH------------HHHHHHHHH
Q 012637 92 VKGGELFAKVARG------------------------R---LREDLAR-------K-YF------------QQLISAVDF 124 (459)
Q Consensus 92 ~~gg~L~~~i~~~------------------------~---l~e~~~~-------~-~~------------~qll~~L~~ 124 (459)
+.|..+.+.+... . +...... . +. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776554332211 1 1121110 0 00 011112222
Q ss_pred H------HhCCcEeccCCCCCeEecCC----CCeEEeecCCCcc
Q 012637 125 C------HSRGVSHRDLKPENLLLDEN----EDLKISDFGLSAL 158 (459)
Q Consensus 125 L------H~~gi~HrDlkp~NILl~~~----~~lKl~DFGla~~ 158 (459)
+ +...++|+|+.|.|||++.+ +.+.|.||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 2 23579999999999999875 6799999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00018 Score=69.34 Aligned_cols=131 Identities=16% Similarity=0.158 Sum_probs=75.5
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEEecc-
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV-VELREVMATKKKIFVAMEYV- 92 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~- 92 (459)
.+.|+.|....+|++ +.+++|+...... ..-...+|+.+++.+...++ .+++.+ +...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 688999999999998 5688898764311 01112468888887743233 455544 343457899999
Q ss_pred CCCchHH------------------HHhcCC--CC-----HHHHHHHHHH--------------HHHHHHHH----H---
Q 012637 93 KGGELFA------------------KVARGR--LR-----EDLARKYFQQ--------------LISAVDFC----H--- 126 (459)
Q Consensus 93 ~gg~L~~------------------~i~~~~--l~-----e~~~~~~~~q--------------ll~~L~~L----H--- 126 (459)
+|..+.. .+.... ++ ...+..+..+ +...+..+ .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6644421 011100 10 1112222111 11111111 1
Q ss_pred -hCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 127 -SRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 127 -~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
...++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 124899999999999 5677899999998863
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00028 Score=68.50 Aligned_cols=137 Identities=12% Similarity=0.137 Sum_probs=78.0
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC--cceeEE------EEEeCCEE
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN--VVELRE------VMATKKKI 85 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~ 85 (459)
-.+.|+.|....+|++... +..+++|+..... ..+.+..|+.+++.+...+ +.+++. +....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeC--CccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 3567788888999998752 3468899886521 1134556888887773211 233331 12235678
Q ss_pred EEEEeccCCCchH--------------HHHhc--CCC--------CHHHHHHHH---------------HHHHHHHHHHH
Q 012637 86 FVAMEYVKGGELF--------------AKVAR--GRL--------REDLARKYF---------------QQLISAVDFCH 126 (459)
Q Consensus 86 ~lV~E~~~gg~L~--------------~~i~~--~~l--------~e~~~~~~~---------------~qll~~L~~LH 126 (459)
+++++|++|..+. ..+.. ..+ ....-...+ ..+...++.++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 9999999985431 11111 011 100000000 11333445554
Q ss_pred h-------CCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 127 S-------RGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 127 ~-------~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
+ .+++|+|++|.|||++.++.+.|.||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2 479999999999999987666899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0013 Score=63.74 Aligned_cols=134 Identities=16% Similarity=0.123 Sum_probs=78.5
Q ss_pred eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CCcceeEEE-----EEeCCEEEEE
Q 012637 16 RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH--PNVVELREV-----MATKKKIFVA 88 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~-----~~~~~~~~lV 88 (459)
+.|+ |....||++.. .+|+.+++|+....... ...+..|..+++.+.. -.+.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 77888998753 35668999998643221 2356678888887742 123444332 2335677899
Q ss_pred EeccCCCchH--------------HHHhc----CC------CCHHH----H------------------HHHHHHHHHHH
Q 012637 89 MEYVKGGELF--------------AKVAR----GR------LREDL----A------------------RKYFQQLISAV 122 (459)
Q Consensus 89 ~E~~~gg~L~--------------~~i~~----~~------l~e~~----~------------------~~~~~qll~~L 122 (459)
|++++|..+. ..+.. .. ++... . ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999985431 01110 00 11110 0 11112222222
Q ss_pred HHH----HhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 123 DFC----HSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 123 ~~L----H~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
.-+ ....++|+|++|.|||++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 234689999999999999 4 89999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0041 Score=59.32 Aligned_cols=80 Identities=14% Similarity=0.091 Sum_probs=56.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-C--CCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-H--PNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~ 85 (459)
..+..-.+.+|.|..+.||++.. .+|+.|.+|+......... ..+..|...|+.|. . -.+.+.+.+ +. -
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~---~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALD---GLFRAEALGLDWLGRSFGSPVPQVAGW--DD--R 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCT---THHHHHHHHHHHHTCSTTCCSCCEEEE--ET--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchh---hHHHHHHHHHHHHHhhCCCCcceEEec--cC--c
Confidence 34566788999999999999985 5789999998654332221 24678999999884 2 234555554 22 3
Q ss_pred EEEEeccCCCc
Q 012637 86 FVAMEYVKGGE 96 (459)
Q Consensus 86 ~lV~E~~~gg~ 96 (459)
++||||++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 78999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0011 Score=67.41 Aligned_cols=73 Identities=11% Similarity=0.101 Sum_probs=49.7
Q ss_pred eeeecccCcEEEEEEEEcC-------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC-cceeEEEEEeCCEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLM-------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN-VVELREVMATKKKIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 86 (459)
.+.|+.|.-..||++.... +++.+.+|+..... . .+.+.+|..+++.+...+ ..++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 5678889999999998643 35789999884321 1 123447999999885333 356666553 2 3
Q ss_pred EEEeccCCCc
Q 012637 87 VAMEYVKGGE 96 (459)
Q Consensus 87 lV~E~~~gg~ 96 (459)
+|+||++|..
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00077 Score=67.50 Aligned_cols=136 Identities=15% Similarity=0.155 Sum_probs=82.9
Q ss_pred eeeecccCcEEEEEEEEcC-------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLM-------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (459)
.+.|..|--..+|++.... +++.|.+|+.... ... ...+.+|..+++.+. +.-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQG---VDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567778888899987642 3578999986431 111 234568999999884 3334566666543 2
Q ss_pred EEEeccCCCchH--------------HHH---hcCC------C--CHHHHHHHHHHHHH-------------------HH
Q 012637 87 VAMEYVKGGELF--------------AKV---ARGR------L--REDLARKYFQQLIS-------------------AV 122 (459)
Q Consensus 87 lV~E~~~gg~L~--------------~~i---~~~~------l--~e~~~~~~~~qll~-------------------~L 122 (459)
+||||++|..|. ..+ .... . -...+..|..|+-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 999999985442 111 1111 1 13556666655432 23
Q ss_pred HHHH----h----CCcEeccCCCCCeEecCC----CCeEEeecCCCcc
Q 012637 123 DFCH----S----RGVSHRDLKPENLLLDEN----EDLKISDFGLSAL 158 (459)
Q Consensus 123 ~~LH----~----~gi~HrDlkp~NILl~~~----~~lKl~DFGla~~ 158 (459)
..|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 258999999999999876 7899999998863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0034 Score=61.63 Aligned_cols=31 Identities=26% Similarity=0.429 Sum_probs=27.9
Q ss_pred CCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 128 RGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 128 ~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
.+++|+|+.|.||+++.++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888999999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0023 Score=63.39 Aligned_cols=74 Identities=11% Similarity=0.072 Sum_probs=44.9
Q ss_pred eeeecccCcEEEEEEEEcC--------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC-cceeEEEEEeCCEE
Q 012637 15 GRLLGKGTFAKVYYGKQLM--------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN-VVELREVMATKKKI 85 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 85 (459)
.+.|+.|....+|++.... .+..+++|+....... . .....|..+++.+...+ +.+++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---L-YNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---T-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---e-ecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4678888888999998643 1368899987542110 1 12357888888884333 44666544 33
Q ss_pred EEEEeccCCCc
Q 012637 86 FVAMEYVKGGE 96 (459)
Q Consensus 86 ~lV~E~~~gg~ 96 (459)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999999853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.011 Score=60.59 Aligned_cols=75 Identities=12% Similarity=0.159 Sum_probs=48.7
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEEeccC
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV-VELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 93 (459)
.+.|+.|--..+|++.....+..+++|+...... . ... ..+|..+++.|...++ .++++++ .+ .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~--~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E--IIN-REREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S--CSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h--hcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeC
Confidence 4678889999999998754457899998754211 0 111 1479999999965444 5677665 23 25999999
Q ss_pred CCch
Q 012637 94 GGEL 97 (459)
Q Consensus 94 gg~L 97 (459)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.72 E-value=0.031 Score=56.64 Aligned_cols=75 Identities=12% Similarity=0.131 Sum_probs=48.8
Q ss_pred eeeecccCcEEEEEEEEcC-------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLM-------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (459)
.+.|..|.-..+|++.... .++.|.+++..... .... ...+|..+++.+. +.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 4677788888999998652 15789999865421 1011 2357888988884 33345566533 33 7
Q ss_pred EEEeccCCCch
Q 012637 87 VAMEYVKGGEL 97 (459)
Q Consensus 87 lV~E~~~gg~L 97 (459)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.52 E-value=0.1 Score=52.25 Aligned_cols=29 Identities=34% Similarity=0.568 Sum_probs=25.3
Q ss_pred cEeccCCCCCeEe------cCCCCeEEeecCCCcc
Q 012637 130 VSHRDLKPENLLL------DENEDLKISDFGLSAL 158 (459)
Q Consensus 130 i~HrDlkp~NILl------~~~~~lKl~DFGla~~ 158 (459)
++|+|+.+.|||+ ++++.+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999999864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.61 E-value=0.6 Score=42.41 Aligned_cols=84 Identities=11% Similarity=0.203 Sum_probs=64.1
Q ss_pred CCCCcceeEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCC
Q 012637 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENED 147 (459)
Q Consensus 68 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~ 147 (459)
.||+.+.. .+-++.+.+.+.++.-+.+.-+..+ ..++..+-++++.+|+....++++ =+|--|+|+||+++.++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~~~~ 117 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTRDGL 117 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECTTSC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcCCCC
Confidence 68998877 6777778777777765544334444 357888889999999988855554 478889999999999999
Q ss_pred eEEeecCCC
Q 012637 148 LKISDFGLS 156 (459)
Q Consensus 148 lKl~DFGla 156 (459)
+++.=.|+-
T Consensus 118 p~i~~RGik 126 (215)
T 4ann_A 118 PIAKTRGLQ 126 (215)
T ss_dssp EEESCCEET
T ss_pred EEEEEccCc
Confidence 999877654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.05 E-value=0.79 Score=41.73 Aligned_cols=83 Identities=16% Similarity=0.155 Sum_probs=64.6
Q ss_pred CCCCcceeEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCcEeccCCCCCeEecCCC
Q 012637 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVD-FCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 68 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~-~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
.||++ -..+-.+.+.+.+.++.-+++.-+..+ ..++..+.++++.+|+.... ++++ -+|-=|+|+||+++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--~~~~~~eKlrll~nl~~L~~~~~~~--r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--RKTTLLSRIRAAIHLVSKVKHHSAR--RLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--HTSCHHHHHHHHHHHHHHHSSCCSS--SEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--HhcCHHHHHHHHHHHHHHHHHhhhC--ceeEEEeCceEEEeCCC
Confidence 68888 556667888888888877666556666 35888888988888888766 5444 57888999999999999
Q ss_pred CeEEeecCCC
Q 012637 147 DLKISDFGLS 156 (459)
Q Consensus 147 ~lKl~DFGla 156 (459)
.++|.-.|+-
T Consensus 122 ~p~i~hRGi~ 131 (219)
T 4ano_A 122 EPFFLHVGVK 131 (219)
T ss_dssp CEEESCCEET
T ss_pred cEEEEEcCCc
Confidence 9999877753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.86 E-value=0.077 Score=54.33 Aligned_cols=64 Identities=8% Similarity=0.111 Sum_probs=18.6
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEE------EEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAI------KVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT 81 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAi------K~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 81 (459)
+.+.|| ||.||++.......+||+ |......... .....+.+|..+++.++|||+++.|.+...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~-e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE-KRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccc-cccccccccccccccccccccCCCcceEEe
Confidence 445666 999999987665568888 6554322222 223456789999999999999999987653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 459 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-88 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-86 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-84 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-82 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-81 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-81 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-80 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-79 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-78 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-76 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-76 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-75 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-75 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-74 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-73 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-73 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-72 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-72 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-72 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-71 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-69 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-68 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-66 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-66 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-64 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-62 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-61 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-61 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-61 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-60 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-59 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 3e-16 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (685), Expect = 3e-88
Identities = 87/259 (33%), Positives = 146/259 (56%), Gaps = 6/259 (2%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+E+GR LGKG F VY ++ + +A+KV+ K QL+K + Q++RE+ + +RHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG 129
N++ L ++++ +EY G ++ ++ + + E Y +L +A+ +CHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
V HRD+KPENLLL +LKI+DFG S T CGT Y+ PE++ + +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249
K DLWS GV+ Y L G PF+ Y+++ + EF +P +++ A+ LIS+LL
Sbjct: 183 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 250 DPERRITIQSIMRVPWFRK 268
+P +R ++ ++ PW
Sbjct: 242 NPSQRPMLREVLEHPWITA 260
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (674), Expect = 3e-86
Identities = 83/259 (32%), Positives = 144/259 (55%), Gaps = 2/259 (0%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
++ G++LG+G+F+ V ++L T AIK++ K + KE + + RE VM + HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG 129
V+L +K++ + Y K GEL + + G E R Y +++SA+++ H +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
+ HRDLKPEN+LL+E+ ++I+DFG + + ++ GT YV+PE+L +K
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249
+DLW+ G I+Y L+AG PF+ N +++K+ K E+ +P A+ L+ KLLV
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 250 DPERRITIQSIMRVPWFRK 268
D +R+ + + +
Sbjct: 248 DATKRLGCEEMEGYGPLKA 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (659), Expect = 4e-84
Identities = 92/267 (34%), Positives = 153/267 (57%), Gaps = 6/267 (2%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+++ + LG+G + +V +T E+VA+K+++ + E IK+EI + +++ H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSR 128
NVV+ ++ +EY GGELF ++ + E A+++F QL++ V + H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
G++HRD+KPENLLLDE ++LKISDFGL+ + + LL+ CGT YVAPE+L+++ +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 189 DGSKADLWSCGVILYVLLAGFLPF-QDENIMNMYRKVFKAEFVYPPW--ISTDAKRLISK 245
D+WSCG++L +LAG LP+ Q + Y + + PW I + L+ K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 246 LLVSDPERRITIQSIMRVPWFRKGFTR 272
+LV +P RITI I + W+ K +
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (646), Expect = 7e-82
Identities = 76/262 (29%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
KY +G+G VY + TG+ VAI+ +N Q K+ E I EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
PN+V + +++V MEY+ GG L V + E ++ + A++F HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
V HRD+K +N+LL + +K++DFG A T GTP ++APEV+ +K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EFVYPPWISTDAKRLISKL 246
K D+WS G++ ++ G P+ +EN + + E P +S + +++
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 247 LVSDPERRITIQSIMRVPWFRK 268
L D E+R + + +++ + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKI 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 4e-81
Identities = 77/272 (28%), Positives = 130/272 (47%), Gaps = 14/272 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+E+ LG G F KVY + T A KVI+ K E +E EI ++ HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT---KSEEELEDYMVEIDILASCDHPN 70
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRG 129
+V+L + + +++ +E+ GG + A + L E + +Q + A+++ H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR----K 185
+ HRDLK N+L + D+K++DFG+SA R + GTP ++APEV+ K
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE---FVYPPWISTDAKRL 242
KAD+WS G+ L + P + N M + K+ K+E P S++ K
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
+ K L + + R T +++ P+ +P+
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 252 bits (644), Expect = 7e-81
Identities = 82/350 (23%), Positives = 161/350 (46%), Gaps = 34/350 (9%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
++ Y++ LG G F V+ + TG K IN + +K EIS+M +
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQL 83
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFC 125
HP ++ L + K ++ + +E++ GGELF ++A ++ E Y +Q +
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 126 HSRGVSHRDLKPENLLLDENED--LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVL 183
H + H D+KPEN++ + + +KI DFGL+ +L D ++ T + APE++
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIV 200
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTDA 239
++ D+W+ GV+ YVLL+G PF E+ + + V + ++ + +S +A
Sbjct: 201 DREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTENDR 299
K I LL +P +R+T+ + PW + D T + + R
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKG------------------DHSNLTSRIPSSR 301
Query: 300 HNNQEEKVSSPKFFNAFEFISSMSSGFDLSNLFENKKKTGSMFTSRYSAR 349
+N +K+ K+ + ++ + S+L +++ + ++ S + +
Sbjct: 302 YNKIRQKI-KEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRK 350
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 250 bits (639), Expect = 3e-80
Identities = 90/275 (32%), Positives = 132/275 (48%), Gaps = 16/275 (5%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
+ HVL Y++ LG G F V+ + TG + A K + + E +++EI
Sbjct: 20 KHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQ 75
Query: 63 VMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKV--ARGRLREDLARKYFQQLIS 120
M ++RHP +V L + ++ + E++ GGELF KV ++ ED A +Y +Q+
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENED--LKISDFGLSALPEQLRNDGLLHTQCGTPAYV 178
+ H H DLKPEN++ LK+ DFGL+A L + GT +
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFA 192
Query: 179 APEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PW 234
APEV K G D+WS GV+ Y+LL+G PF EN R V ++
Sbjct: 193 APEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269
IS D K I KLL++DP R+TI + PW G
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 246 bits (628), Expect = 5e-79
Identities = 65/279 (23%), Positives = 121/279 (43%), Gaps = 11/279 (3%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+ R +G G+F VY+ + + E VAIK ++ + + I +E+ ++ +RHP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELF-AKVARGRLREDLARKYFQQLISAVDFCHSRG 129
N ++ R + ++ MEY G +V + L+E + + + HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR--KKG 187
+ HRD+K N+LL E +K+ DFG +++ ++ GTP ++APEV+ +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW--ISTDAKRLISK 245
K D+WS G+ L P + N M+ + + E S + +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 246 LLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQHDDD 284
L P+ R T + +++ + + V + Q D
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 288
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 6e-78
Identities = 71/274 (25%), Positives = 130/274 (47%), Gaps = 16/274 (5%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
L+ KY + LG+G F V+ + + ++ K + + +K+EIS++ +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIA 58
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFC 125
RH N++ L E + +++ + E++ G ++F ++ L E Y Q+ A+ F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 126 HSRGVSHRDLKPENLLLDENED--LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVL 183
HS + H D++PEN++ +KI +FG + QL+ P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 184 RKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTDA 239
+ + D+WS G ++YVLL+G PF E + + AE+ + IS +A
Sbjct: 176 QHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGFTRP 273
+ +LLV + + R+T ++ PW ++ R
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (607), Expect = 2e-76
Identities = 70/268 (26%), Positives = 132/268 (49%), Gaps = 17/268 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
YE+ +G G++ + ++ G+ + K ++ + + + + E++++R ++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 71 NVVELREVM--ATKKKIFVAMEYVKGGELF-----AKVARGRLREDLARKYFQQLISAVD 123
N+V + + T +++ MEY +GG+L R L E+ + QL A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 124 FCHSRG-----VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYV 178
CH R V HRDLKP N+ LD +++K+ DFGL+ + + GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYM 181
Query: 179 APEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWIST 237
+PE + + Y+ K+D+WS G +LY L A PF + + K+ + +F P S
Sbjct: 182 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 238 DAKRLISKLLVSDPERRITIQSIMRVPW 265
+ +I+++L R +++ I+ P
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 237 bits (606), Expect = 4e-76
Identities = 87/277 (31%), Positives = 141/277 (50%), Gaps = 20/277 (7%)
Query: 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK------EFMMEQIKREIS 62
+ YE +LG+G + V T + A+K+I+ + + E +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 63 VMRLVR-HPNVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLIS 120
++R V HPN+++L++ T F+ + +K GELF + + L E RK + L+
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
+ H + HRDLKPEN+LLD++ ++K++DFG S QL L CGTP+Y+AP
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAP 178
Query: 181 EVLRKKGYD-----GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP--- 232
E++ D G + D+WS GVI+Y LLAG PF M M R + + +
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 233 -PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
S K L+S+ LV P++R T + + P+F++
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 236 bits (604), Expect = 2e-75
Identities = 102/266 (38%), Positives = 150/266 (56%), Gaps = 14/266 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
Y+ +LG G F++V + T + VAIK I K L+ + ++ EI+V+ ++HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHP 67
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRG 129
N+V L ++ + +++ M+ V GGELF ++ +G E A + Q++ AV + H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 130 VSHRDLKPENLLL---DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
+ HRDLKPENLL DE+ + ISDFGLS + +L T CGTP YVAPEVL +K
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTDAKRL 242
Y D WS GVI Y+LL G+ PF DEN ++ ++ KAE+ + IS AK
Sbjct: 185 PYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRK 268
I L+ DPE+R T + ++ PW
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAG 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 2e-75
Identities = 88/260 (33%), Positives = 146/260 (56%), Gaps = 6/260 (2%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHP 70
+ + ++LGKG+F KV+ + T + AIK + KD + + +E E V+ L HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKV-ARGRLREDLARKYFQQLISAVDFCHSRG 129
+ + TK+ +F MEY+ GG+L + + + A Y ++I + F HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
+ +RDLK +N+LLD++ +KI+DFG+ E + D +T CGTP Y+APE+L + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249
D WS GV+LY +L G PF ++ ++ + YP W+ +AK L+ KL V
Sbjct: 182 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 250 DPERRITIQS-IMRVPWFRK 268
+PE+R+ ++ I + P FR+
Sbjct: 241 EPEKRLGVRGDIRQHPLFRE 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 232 bits (593), Expect = 9e-74
Identities = 88/263 (33%), Positives = 152/263 (57%), Gaps = 12/263 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+++ R LG G+F +V+ + G A+KV+ K+ + + +E E ++ +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFA-KVARGRLREDLARKYFQQLISAVDFCHSRGV 130
++ + ++IF+ M+Y++GGELF+ R +A+ Y ++ A+++ HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 131 SHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDG 190
+RDLKPEN+LLD+N +KI+DFG + + +T CGTP Y+APEV+ K Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYN- 179
Query: 191 SKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVSD 250
D WS G+++Y +LAG+ PF D N M Y K+ AE +PP+ + D K L+S+L+ D
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 251 PERRI-----TIQSIMRVPWFRK 268
+R+ + + PWF++
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 1e-73
Identities = 80/266 (30%), Positives = 133/266 (50%), Gaps = 18/266 (6%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMME---QIKREISVMRL 66
+Y++G LLG G F VY G ++ VAIK + KD++ + ++ E+ +++
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 67 VR--HPNVVELREVMATKKKIFVAMEYVKGGELFAKV--ARGRLREDLARKYFQQLISAV 122
V V+ L + + +E + + RG L+E+LAR +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 123 DFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181
CH+ GV HRD+K EN+L+D N +LK+ DFG AL D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKR 241
+R Y G A +WS G++LY ++ G +PF+ + ++ + + + +S++ +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 242 LISKLLVSDPERRITIQSIMRVPWFR 267
LI L P R T + I PW +
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 4e-73
Identities = 62/264 (23%), Positives = 121/264 (45%), Gaps = 15/264 (5%)
Query: 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
G+ +G+ +G G+F VY GK VA+K++N + + + K E+ V+R R
Sbjct: 7 DGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRKTR 62
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLISAVDFCH 126
H N++ T ++ + ++ +G L+ + + +Q +D+ H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR-- 184
++ + HRDLK N+ L E+ +KI DFGL+ + + G+ ++APEV+R
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV------YPPWISTD 238
K ++D+++ G++LY L+ G LP+ + N + + ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 239 AKRLISKLLVSDPERRITIQSIMR 262
KRL+++ L + R I+
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILA 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 5e-73
Identities = 90/267 (33%), Positives = 149/267 (55%), Gaps = 9/267 (3%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
V ++ +LLGKGTF KV ++ TG A+K++ K+ + + + E V++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 67 VRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARG-RLREDLARKYFQQLISAVDFC 125
RHP + L+ T ++ MEY GGELF ++R E+ AR Y +++SA+++
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK 185
HSR V +RD+K ENL+LD++ +KI+DFGL E + + + T CGTP Y+APEVL
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245
Y D W GV++Y ++ G LPF +++ ++ + E +P +S +AK L++
Sbjct: 180 NDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
Query: 246 LLVSDPERRI-----TIQSIMRVPWFR 267
LL DP++R+ + +M +F
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 1e-72
Identities = 65/313 (20%), Positives = 128/313 (40%), Gaps = 53/313 (16%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+E LG G V+ +G +A K+I+ + K + QI RE+ V+ P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSR- 128
+V + +I + ME++ GG L + + GR+ E + K +I + + +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
+ HRD+KP N+L++ ++K+ DFG+S D + ++ GT +Y++PE L+ Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDEN---IMNMYRKVFKAEFVYPPW----------- 234
++D+WS G+ L + G P + + M+ + + P
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 235 ------------------------------ISTDAKRLISKLLVSDPERRITIQSIMRVP 264
S + + ++K L+ +P R ++ +M
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 265 WFRKGFTRPVAFS 277
+ ++ V F+
Sbjct: 300 FIKRSDAEEVDFA 312
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 3e-72
Identities = 95/283 (33%), Positives = 148/283 (52%), Gaps = 16/283 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL---KKEFMMEQIKREISVMRLV 67
Y+ G LG G FA V ++ TG A K I K + ++ E I+RE+S+++ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELFA-KVARGRLREDLARKYFQQLISAVDFCH 126
+HPNV+ L EV K + + +E V GGELF + L E+ A ++ +Q+++ V + H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 127 SRGVSHRDLKPENLLLDENED----LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEV 182
S ++H DLKPEN++L + +KI DFGL+ ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 183 LRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV----YPPWISTD 238
+ + +AD+WS GVI Y+LL+G PF + V + Y S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQH 281
AK I +LLV DP++R+TIQ ++ PW + T+ S H
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 5e-72
Identities = 63/273 (23%), Positives = 126/273 (46%), Gaps = 19/273 (6%)
Query: 7 VLFGKY-EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
G++ + +G+G+F VY G T VA + +L K ++ K E +++
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLK 63
Query: 66 LVRHPNVVELREVMAT----KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLIS 120
++HPN+V + + KK I + E + G L + R ++ + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 121 AVDFCHSRG--VSHRDLKPENLLL-DENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAY 177
+ F H+R + HRDLK +N+ + +KI D GL+ L+ GTP +
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEF 179
Query: 178 VAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFKA--EFVYPPW 234
+APE+ +K YD D+++ G+ + + P+ + N +YR+V +
Sbjct: 180 MAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
+ K +I + + + R +I+ ++ +F+
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 225 bits (574), Expect = 2e-71
Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 11/271 (4%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
L +YE+G +LG G ++V+ + L VA+KV+ D + + +RE
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 67 VRHPNVVELREVMATKKK----IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISA 121
+ HP +V + + + ++ MEYV G L V G + A + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPAYVAP 180
++F H G+ HRD+KP N+++ +K+ DFG++ + + + GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWIS 236
E R D +++D++S G +LY +L G PF ++ +++ + + + + P +S
Sbjct: 184 EQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 237 TDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
D ++ K L +PE R + MR R
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 223 bits (569), Expect = 1e-69
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 16/268 (5%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR--- 68
+ + R++G+G F +VY ++ TG+ A+K ++K ++K + E ++ LV
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS 127
P +V + T K+ ++ + GG+L +++ G E R Y ++I ++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
R V +RDLKP N+LLDE+ ++ISD GL+ H GT Y+APEVL+K
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGV 181
Query: 188 YDGSKADLWSCGVILYVLLAGFLPFQDEN---IMNMYRKVFKAEFVYPPWISTDAKRLIS 244
S AD +S G +L+ LL G PF+ + R P S + + L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 245 KLLVSDPERRIT-----IQSIMRVPWFR 267
LL D RR+ Q + P+FR
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-68
Identities = 87/332 (26%), Positives = 151/332 (45%), Gaps = 32/332 (9%)
Query: 1 MEEERHVLFGKYE-MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKR 59
++ +++ + Y+ ++LG G KV T E A+K++ + +R
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARR 53
Query: 60 EISVM-RLVRHPNVVELREV----MATKKKIFVAMEYVKGGELFAKVAR---GRLREDLA 111
E+ + R + P++V + +V A +K + + ME + GGELF+++ E A
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 112 RKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQ 171
+ + + A+ + HS ++HRD+KPENLL I ++ + L T
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173
Query: 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM----NMYRKVFKA 227
C TP YVAPEVL + YD D+WS GVI+Y+LL G+ PF + + M ++
Sbjct: 174 CYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 228 EFVYP----PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPVAFSITQH-- 281
++ +P +S + K LI LL ++P +R+TI M PW + P T
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL 292
Query: 282 ----DDDGDDDQAATEKTENDRHNNQEEKVSS 309
+ D + T R + ++ K+
Sbjct: 293 KEDKERWEDVKEEMTSALATMRVDYEQIKIKK 324
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (546), Expect = 2e-66
Identities = 84/264 (31%), Positives = 141/264 (53%), Gaps = 12/264 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+++ + LG G+F +V K +G A+K+++K ++ K +E E +++ V P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG 129
+V+L +++ MEYV GGE+F+ + R GR E AR Y Q++ ++ HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
+ +RDLKPENLL+D+ ++++DFG + R G T CGTP +APE++ KGY+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLLVS 249
D W+ GV++Y + AG+ PF + + +Y K+ + +P S+D K L+ LL
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 250 DPERRI-----TIQSIMRVPWFRK 268
D +R + I WF
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 4e-66
Identities = 71/317 (22%), Positives = 128/317 (40%), Gaps = 41/317 (12%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+Y +G+G + V + VAIK I+ + + ++ REI ++ RH
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLRFRH 65
Query: 70 PNVVELREVMATK----KKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC 125
N++ + +++ K + ++ G +L+ + L D + Q++ + +
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
HS V HRDLKP NLLL+ DLKI DFGL+ + G L T Y APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP------------ 232
D+WS G IL +L+ F ++ ++ +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 233 -------------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT-- 271
P + A L+ K+L +P +RI ++ + P+ + +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
Query: 272 -RPVAFSITQHDDDGDD 287
P+A + + D + DD
Sbjct: 306 DEPIAEAPFKFDMELDD 322
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-65
Identities = 71/286 (24%), Positives = 114/286 (39%), Gaps = 33/286 (11%)
Query: 13 EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQL--KKEFMMEQIKREISVMRLVRHP 70
E LG+G FA VY + T + VAIK I K+ + REI +++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDFCHSRG 129
N++ L + K I + ++++ L + Y + +++ H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
+ HRDLKP NLLLDEN LK++DFGL+ + Q T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----------------- 232
G D+W+ G IL LL ++ ++ ++F+
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 233 -----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
D LI L + +P RIT +++ +F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-64
Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 44/302 (14%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
KYE +G+GTF +V+ + TG+ VA+K + + K+ F REI +++L++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKH 68
Query: 70 PNVVELREVMAT--------KKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLIS 120
NVV L E+ T K I++ ++ + + ++ Q L++
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 121 AVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND--GLLHTQCGTPAYV 178
+ + H + HRD+K N+L+ + LK++DFGL+ +N + T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 179 APEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWI--- 235
PE+L + G DLW G I+ + Q + + + P +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 236 -----------------------------STDAKRLISKLLVSDPERRITIQSIMRVPWF 266
A LI KLLV DP +RI + +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 267 RK 268
Sbjct: 309 WS 310
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 9e-64
Identities = 66/258 (25%), Positives = 115/258 (44%), Gaps = 19/258 (7%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+ ++ + +GKG F V G G VA+K I D + F+ E SVM +RH
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFL-----AEASVMTQLRHS 60
Query: 71 NVVELREVMA-TKKKIFVAMEYVKGGELF---AKVARGRLREDLARKYFQQLISAVDFCH 126
N+V+L V+ K +++ EY+ G L R L D K+ + A+++
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
HRDL N+L+ E+ K+SDFGL+ ++ T + APE LR+K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175
Query: 187 GYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLIS 244
+ +K+D+WS G++L+ + + G +P+ + ++ +V K P ++
Sbjct: 176 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 245 KLLVSDPERRITIQSIMR 262
D R + +
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 9e-64
Identities = 78/295 (26%), Positives = 140/295 (47%), Gaps = 35/295 (11%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
++ +G+GT+ VY + +TGE VA+K I D + + REIS+++ + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHP 61
Query: 71 NVVELREVMATKKKIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLISAVDFCHSR 128
N+V+L +V+ T+ K+++ E++ + A + L + Y QL+ + FCHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
V HRDLKP+NLL++ +K++DFGL+ + T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 189 DGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP---------------- 232
+ D+WS G I ++ F ++ ++ ++F+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 233 -------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTRPV 274
P + D + L+S++L DP +RI+ ++ + P+F + T+PV
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPV 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-62
Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 11/259 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMT---GESVAIKVINKDQLKKEFMMEQIKREISVMRLVR 68
+ LG G+F V G+ SVA+K + D L + M+ RE++ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 69 HPNVVELREVMATKKKIFVAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCH 126
H N++ L V+ T V E G L ++ +G +Y Q+ + +
Sbjct: 70 HRNLIRLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 127 SRGVSHRDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVLRK 185
S+ HRDL NLLL + +KI DFGL ALP+ + + + A+ APE L+
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 186 KGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE--FVYPPWISTDAKRL 242
+ + +D W GV L+ + G P+ N + K+ K P D +
Sbjct: 189 RTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 243 ISKLLVSDPERRITIQSIM 261
+ + PE R T ++
Sbjct: 248 MVQCWAHKPEDRPTFVALR 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 6e-62
Identities = 66/259 (25%), Positives = 109/259 (42%), Gaps = 14/259 (5%)
Query: 18 LGKGTFAKVYYGKQLMTGES--VAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVEL 75
LG G F V G M + VAIKV+ + K + E++ RE +M + +P +V L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 74
Query: 76 REVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLISAVDFCHSRGVSHR 133
V + + V ME GG L R + + Q+ + + + HR
Sbjct: 75 IGVCQAEALMLV-MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 134 DLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSK 192
DL N+LL KISDFGLS AL + APE + + + S+
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192
Query: 193 ADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLISKLLVSD 250
+D+WS GV ++ L+ G P++ + + + + + PP + L+S +
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 251 PERRITIQSI---MRVPWF 266
E R ++ MR ++
Sbjct: 253 WEDRPDFLTVEQRMRACYY 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 6e-62
Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 50/297 (16%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
Y +++G G+F VY K +GE VAIK + +D+ RE+ +MR + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCN 74
Query: 72 VVELREVMAT------KKKIFVAMEYVKGGEL----FAKVARGRLREDLARKYFQQLISA 121
+V LR + + + + ++YV A+ L + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 122 VDFCHSRGVSHRDLKPENLLLD-ENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAP 180
+ + HS G+ HRD+KP+NLLLD + LK+ DFG + +QL + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRAP 191
Query: 181 EVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------- 227
E++ S D+WS G +L LL G F ++ ++ ++ K
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 228 ----------------EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
V+ P +A L S+LL P R+T +F +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-61
Identities = 59/285 (20%), Positives = 112/285 (39%), Gaps = 36/285 (12%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGES-----VAIKVINKDQLKKEFMMEQIKREISVM- 64
E G++LG G F KV ++ VA+K++ + E E + E+ +M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMT 95
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGELF------------------------AK 100
+L H N+V L I++ EY G+L +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 101 VARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160
L + + Q+ ++F + HRDL N+L+ + +KI DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMN 219
N + ++APE L + Y K+D+WS G++L+ + + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 220 MYRKVFKAEFV--YPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
+ K+ + F P + + + ++ D +R + ++
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 200 bits (508), Expect = 1e-61
Identities = 75/288 (26%), Positives = 131/288 (45%), Gaps = 34/288 (11%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KY +G+GT+ VY + GE+ A+K I ++ + REIS+++ ++H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIP-STTIREISILKELKHS 60
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFA-KVARGRLREDLARKYFQQLISAVDFCHSRG 129
N+V+L +V+ TKK++ + E++ V G L A+ + QL++ + +CH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
V HRDLKP+NLL++ +LKI+DFGL+ + T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 190 GSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV------------------- 230
+ D+WS G I ++ G F + + ++F+
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 231 ----------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
+ + L+SK+L DP +RIT + + +F++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-61
Identities = 76/324 (23%), Positives = 136/324 (41%), Gaps = 44/324 (13%)
Query: 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV 67
+ Y + +G G + V TG VAIK + + + F ++ RE+ +++ +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHM 74
Query: 68 RHPNVVELREVMATKKK------IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISA 121
RH NV+ L +V + ++ M ++ G +L + +L ED + Q++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKG 133
Query: 122 VDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPE 181
+ + H+ G+ HRDLKP NL ++E+ +LKI DFGL+ D + T Y APE
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPE 188
Query: 182 VLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW------- 234
V+ D+WS G I+ ++ G F+ + ++ +++ K P
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 235 ------------------------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270
S A L+ K+LV D E+R+T + P+F
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 271 TRPVAFSITQHDDDGDDDQAATEK 294
+ ++DD DD ++
Sbjct: 309 DTEDEPQVQKYDDSFDDVDRTLDE 332
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 4e-61
Identities = 78/273 (28%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQL-KKEFMMEQIKREISVMRL 66
+E+ ++LG G + KV+ +++ TG+ A+KV+ K + +K E + E V+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 67 VRH-PNVVELREVMATKKKIFVAMEYVKGGELFAKVARG-RLREDLARKYFQQLISAVDF 124
+R P +V L T+ K+ + ++Y+ GGELF +++ R E + Y +++ A++
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 125 CHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLR 184
H G+ +RD+K EN+LLD N + ++DFGLS + V
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 185 KKGYDGSKADLWSCGVILYVLLAGFLPFQDEN----IMNMYRKVFKAEFVYPPWISTDAK 240
D WS GV++Y LL G PF + + R++ K+E YP +S AK
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 241 RLISKLLVSDPERRI-----TIQSIMRVPWFRK 268
LI +LL+ DP++R+ I +F+K
Sbjct: 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-61
Identities = 59/255 (23%), Positives = 108/255 (42%), Gaps = 11/255 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+ LG G F V YGK VAIK+I + + ++ + E VM + H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSED----EFIEEAKVMMNLSHEK 60
Query: 72 VVELREVMATKKKIFVAMEYVKGGELFA--KVARGRLREDLARKYFQQLISAVDFCHSRG 129
+V+L V ++ IF+ EY+ G L + R R + + + + A+++ S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
HRDL N L+++ +K+SDFGLS + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 190 GSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISKLL 247
SK+D+W+ GV+++ + + G +P++ + + P S ++
Sbjct: 180 -SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 248 VSDPERRITIQSIMR 262
+ R T + ++
Sbjct: 239 HEKADERPTFKILLS 253
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 1e-60
Identities = 56/269 (20%), Positives = 113/269 (42%), Gaps = 13/269 (4%)
Query: 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGES---VAIKVINKDQLKKEFMMEQIKREI 61
+ + ++ +++G G F +V G + G+ VAIK + +K+ E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEA 78
Query: 62 SVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLI 119
S+M HPNV+ L V+ + + E+++ G L F + G+ + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT---QCGTPA 176
+ + + HRDL N+L++ N K+SDFGLS E +D +
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPW 234
+ APE ++ + + +D+WS G++++ +++ G P+ D ++ + + P
Sbjct: 199 WTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257
Query: 235 ISTDAKRLISKLLVSDPERRITIQSIMRV 263
+ +L+ D R I+
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-60
Identities = 56/260 (21%), Positives = 108/260 (41%), Gaps = 12/260 (4%)
Query: 16 RLLGKGTFAKVYYG--KQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVV 73
+ LG G F V G + ++VA+K++ + +++ E +VM+ + +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK-DELLAEANVMQQLDNPYIV 71
Query: 74 ELREVMATKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSH 132
+ + + + V ME + G L + + +++ + Q+ + + H
Sbjct: 72 RMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 133 RDLKPENLLLDENEDLKISDFGLS-ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGS 191
RDL N+LL KISDFGLS AL + APE + + S
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 192 KADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLISKLLVS 249
K+D+WS GV+++ + G P++ + + K E + P + L++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 250 DPERRITIQSIMRV---PWF 266
D E R ++ ++
Sbjct: 250 DVENRPGFAAVELRLRNYYY 269
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 5e-60
Identities = 64/294 (21%), Positives = 121/294 (41%), Gaps = 42/294 (14%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+Y+ +G G + V TG VA+K +++ ++ RE+ +++ ++H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKHE 77
Query: 71 NVVELREVMATKKKI-----FVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC 125
NV+ L +V + + + ++ G +L V +L +D + Q++ + +
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK 185
HS + HRDLKP NL ++E+ +LKI DFGL+ + T Y APE++
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLN 192
Query: 186 KGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW----------- 234
+ D+WS G I+ LL G F + ++ + + +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 235 --------------------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
+ A L+ K+LV D ++RIT + +F +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-60
Identities = 75/295 (25%), Positives = 125/295 (42%), Gaps = 43/295 (14%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMT-GESVAIKVINKDQLKKEFMMEQIKREISVMRL--- 66
+YE +G+G + KV+ + L G VA+K + ++ M RE++V+R
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLET 66
Query: 67 VRHPNVVELREVMATKK-----KIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLI 119
HPNVV L +V + K+ + E+V KV + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 120 SAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVA 179
+DF HS V HRDLKP+N+L+ + +K++DFGL+ + + T Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV--------- 230
PEVL + Y + DLWS G I + F+ + ++ K+ +
Sbjct: 184 PEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 231 ------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
+ I K L+ K L +P +RI+ S + P+F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 59/255 (23%), Positives = 109/255 (42%), Gaps = 11/255 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN 71
+ +G G F V+ G + + VAIK I + + +E E VM + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEE----DFIEEAEVMMKLSHPK 61
Query: 72 VVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
+V+L V + I + E+++ G L + + RG + + + +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
V HRDL N L+ EN+ +K+SDFG++ + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 190 GSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISKLL 247
SK+D+WS GV+++ + + G +P+++ + + + P ST ++++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 248 VSDPERRITIQSIMR 262
PE R ++R
Sbjct: 240 KERPEDRPAFSRLLR 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 1e-59
Identities = 63/260 (24%), Positives = 114/260 (43%), Gaps = 17/260 (6%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
M LG G + +VY G +VA+K + +D ++ E + +E +VM+ ++HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHP 73
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELF---AKVARGRLREDLARKYFQQLISAVDFCHS 127
N+V+L V + ++ E++ G L + R + + Q+ SA+++
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGT---PAYVAPEVLR 184
+ HRDL N L+ EN +K++DFGLS +L G + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 185 KKGYDGSKADLWSCGVILYVLL-AGFLPFQDENIMNMYRKVFK-AEFVYPPWISTDAKRL 242
+ K+D+W+ GV+L+ + G P+ ++ +Y + K P L
Sbjct: 190 YNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248
Query: 243 ISKLLVSDPERRITIQSIMR 262
+ +P R + I +
Sbjct: 249 MRACWQWNPSDRPSFAEIHQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 3e-59
Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 13/299 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINK--DQLKKEFMMEQIKREISVMRLVRH 69
++ ++LG G F VY G + GE V I V K + ++I E VM V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 70 PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLR-EDLARKYFQQLISAVDFCHSR 128
P+V L + T + G L + Q+ +++ R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 129 GVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGY 188
+ HRDL N+L+ + +KI+DFGL+ L + ++A E + + Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 189 DGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKL 246
++D+WS GV ++ L+ G P+ + + K E PP + D ++ K
Sbjct: 191 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 247 LVSDPERRITIQSIM-------RVPWFRKGFTRPVAFSITQHDDDGDDDQAATEKTEND 298
+ D + R + ++ R P + D E+ +D
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDD 308
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-59
Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 34/289 (11%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
KYE +G+GT+ V+ K T E VA+K + D + REI +++ ++H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP-SSALREICLLKELKHK 61
Query: 71 NVVELREVMATKKKIFVAMEYVKGGEL-FAKVARGRLREDLARKYFQQLISAVDFCHSRG 129
N+V L +V+ + KK+ + E+ + G L ++ + + QL+ + FCHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 130 VSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYD 189
V HRDLKP+NLL++ N +LK+++FGL+ + T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 190 GSKADLWSCGVILYVLLAGFLP-FQDENIMNMYRKVFKAEFVYP---------------- 232
+ D+WS G I L P F ++ + +++F+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 233 -------------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268
P ++ + L+ LL +P +RI+ + ++ P+F
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-58
Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 13/258 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
++ LG G F +V+ G VA+K + + + + E ++M+ ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQ 68
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFA---KVARGRLREDLARKYFQQLISAVDFCHS 127
+V L V+ T++ I++ EY++ G L + +L + Q+ + F
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
R HRDL+ N+L+ + KI+DFGL+ L E + APE + G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAIN-YG 185
Query: 188 YDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISK 245
K+D+WS G++L ++ G +P+ + + + + V P + +L+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 246 LLVSDPERRITIQSIMRV 263
PE R T + V
Sbjct: 246 CWKERPEDRPTFDYLRSV 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-58
Identities = 63/263 (23%), Positives = 109/263 (41%), Gaps = 15/263 (5%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHP 70
+ LG+G F +V+ G T VAIK + + E +E VM+ +RH
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE----AFLQEAQVMKKLRHE 72
Query: 71 NVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLR---EDLARKYFQQLISAVDFCHS 127
+V+L V+ +++ I++ EY+ G L + + Q+ S + +
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 128 RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKG 187
HRDL+ N+L+ EN K++DFGL+ L E + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 188 YDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISK 245
+ K+D+WS G++L L G +P+ + +V + PP L+ +
Sbjct: 191 FT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 246 LLVSDPERRITIQSIMRV--PWF 266
+PE R T + + +F
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 6e-58
Identities = 55/274 (20%), Positives = 102/274 (37%), Gaps = 24/274 (8%)
Query: 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLV 67
+ + ++G+G F +V + G + + + + E+ V+ +L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGELF-----------------AKVARGRLREDL 110
HPN++ L + +++A+EY G L A L
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 111 ARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT 170
+ + +D+ + HRDL N+L+ EN KI+DFGLS E
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TM 185
Query: 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE- 228
++A E L Y +D+WS GV+L+ +++ G P+ +Y K+ +
Sbjct: 186 GRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 229 FVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
P + L+ + P R + I+
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-57
Identities = 69/259 (26%), Positives = 118/259 (45%), Gaps = 12/259 (4%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGES---VAIKVINKDQLKKEFMMEQIKREISVMRLV 67
+ E+GR +G+G F V+ G + VAIK + + E+ +E MR
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF 65
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGGEL--FAKVARGRLREDLARKYFQQLISAVDFC 125
HP++V+L V+ T+ +++ ME GEL F +V + L Y QL +A+ +
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRK 185
S+ HRD+ N+L+ N+ +K+ DFGLS E ++APE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 183
Query: 186 KGYDGSKADLWSCGVILY-VLLAGFLPFQDENIMNMYRKVFKAEFV-YPPWISTDAKRLI 243
+ + +D+W GV ++ +L+ G PFQ ++ ++ E + PP L+
Sbjct: 184 RRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242
Query: 244 SKLLVSDPERRITIQSIMR 262
+K DP RR +
Sbjct: 243 TKCWAYDPSRRPRFTELKA 261
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 187 bits (476), Expect = 2e-56
Identities = 67/299 (22%), Positives = 127/299 (42%), Gaps = 53/299 (17%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVM-RLVRH 69
Y++ R LG+G +++V+ + E V +K++ + ++IKREI ++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 89
Query: 70 PNVVELREVM--ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS 127
PN++ L +++ + + E+V + L + R Y +++ A+D+CHS
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHS 147
Query: 128 RGVSHRDLKPENLLLD-ENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKK 186
G+ HRD+KP N+++D E+ L++ D+GL+ E + + + + PE+L
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 187 GYDGSKADLWSCGVILYVLLAGFLPFQDEN----IMNMYRKVFKAEFVY----------- 231
D+WS G +L ++ PF + + KV E +Y
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 232 -----------------------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267
+S +A + KLL D + R+T + M P+F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 3e-56
Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 35/285 (12%)
Query: 11 KYEMGRLLGKGTFAKVYYGK-----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
E R +G+G F +V+ + VA+K++ ++ M +RE ++M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMA 71
Query: 66 LVRHPNVVELREVMATKKKIFVAMEYVKGGELF-------------------------AK 100
+PN+V+L V A K + + EY+ G+L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 101 VARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160
L +Q+ + + + R HRDL N L+ EN +KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFL-PFQDENIMN 219
++ PE + Y +++D+W+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 220 MYRKVFKAEFV-YPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263
+ V + P + L+ P R + SI R+
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 6e-56
Identities = 63/276 (22%), Positives = 122/276 (44%), Gaps = 17/276 (6%)
Query: 1 MEEERHVLFGKYEM----GRLLGKGTFAKVYYGKQLM---TGESVAIKVINKDQLKKEFM 53
++ +HV+ G + ++G+G F VY+G L A+K +N+ E
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-- 71
Query: 54 MEQIKREISVMRLVRHPNVVELREV-MATKKKIFVAMEYVKGGEL--FAKVARGRLREDL 110
+ Q E +M+ HPNV+ L + + ++ V + Y+K G+L F +
Sbjct: 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 131
Query: 111 ARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL--PEQLRNDGLL 168
+ Q+ + F S+ HRDL N +LDE +K++DFGL+ ++ +
Sbjct: 132 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 169 HTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA 227
++A E L+ + + +K+D+WS GV+L+ L+ G P+ D N ++ + +
Sbjct: 192 TGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250
Query: 228 E-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
+ P + ++ K E R + ++
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 7e-56
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 31/281 (11%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVM- 64
+ G+ LG G F KV +VA+K++ E E + E+ V+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLS 81
Query: 65 RLVRHPNVVELREVMATKKKIFVAMEYVKGGELF-------------------AKVARGR 105
L H N+V L V EY G+L +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 106 LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165
L + + Q+ + F S+ HRDL N+LL KI DFGL+ + N
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKV 224
+ ++APE + ++D+WS G+ L+ L + G P+ + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 225 FKAEF--VYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263
K F + P + ++ +DP +R T + I+++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 2e-55
Identities = 56/283 (19%), Positives = 102/283 (36%), Gaps = 27/283 (9%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+Y +GR +G G+F +Y G + GE VAIK+ + E + ++++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL-----HIESKIYKMMQG 61
Query: 70 PN-VVELREVMATKKKIFVAMEYVKGGELF-AKVARGRLREDLARKYFQQLISAVDFCHS 127
+ +R A + ME + + Q+IS +++ HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 128 RGVSHRDLKPENLL---LDENEDLKISDFGLS-----ALPEQLRNDGLLHTQCGTPAYVA 179
+ HRD+KP+N L + + I DFGL+ A Q GT Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 180 PEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF--------VY 231
+ DL S G +L G LP+Q +K + V
Sbjct: 182 INTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 232 PPWISTDAKRLISKLLVSDPERRIT---IQSIMRVPWFRKGFT 271
++ ++ + + ++ + R + R+GF+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-55
Identities = 54/279 (19%), Positives = 118/279 (42%), Gaps = 30/279 (10%)
Query: 11 KYEMGRLLGKGTFAKVYYGKQLMTGES-------VAIKVINKDQLKKEFMMEQIKREISV 63
+ +G+ LG+G F +V + + + VA+K++ D +K+ + + E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM 71
Query: 64 M-RLVRHPNVVELREVMATKKKIFVAMEYVKGGELF-----------------AKVARGR 105
M + +H N++ L ++V +EY G L + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 106 LREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165
L Q+ +++ S+ HRDL N+L+ E+ +KI+DFGL+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKV 224
++APE L + Y ++D+WS GV+L+ + G P+ + +++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 225 FKAEFV-YPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
+ + P + + ++ + P +R T + ++
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-53
Identities = 53/261 (20%), Positives = 108/261 (41%), Gaps = 12/261 (4%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGES----VAIKVINKDQLKKEFMMEQIKREISVMRLV 67
+++G G F +VY G + VAIK + +K+ E +M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQF 66
Query: 68 RHPNVVELREVMATKKKIFVAMEYVKGG--ELFAKVARGRLREDLARKYFQQLISAVDFC 125
H N++ L V++ K + + EY++ G + F + G + + + + +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 126 HSRGVSHRDLKPENLLLDENEDLKISDFGLSA-LPEQLRNDGLLHTQCGTPAYVAPEVLR 184
+ HRDL N+L++ N K+SDFGLS L + + APE +
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 185 KKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRL 242
+ + S +D+WS G++++ ++ G P+ + + + + + P + +L
Sbjct: 187 YRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 243 ISKLLVSDPERRITIQSIMRV 263
+ + + RR I+ +
Sbjct: 246 MMQCWQQERARRPKFADIVSI 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 177 bits (449), Expect = 9e-53
Identities = 46/286 (16%), Positives = 96/286 (33%), Gaps = 28/286 (9%)
Query: 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL 66
V+ Y++GR +G+G+F ++ G L+ + VAIK + Q++ E +L
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKL 56
Query: 67 VRH-PNVVELREVMATKKKIFVAMEYVKGGELFAKVARGR-LREDLARKYFQQLISAVDF 124
+ + + + ++ + GR +Q+++ V
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 125 CHSRGVSHRDLKPENLLLDE-----NEDLKISDFGLSAL-----PEQLRNDGLLHTQCGT 174
H + + +RD+KP+N L+ + + DFG+ +Q GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 175 PAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW 234
Y++ + + DL + G + L G LP+Q +K +
Sbjct: 177 ARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 235 --------ISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFTR 272
+ + + + + + F K R
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL--FSKVLER 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-52
Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 27/290 (9%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGK-----QLMTGESVAIKVINKDQLKKEFMMEQI 57
+E V K M R LG+G+F VY G + VAIK +N+ +E +
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEF 70
Query: 58 KREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELF-----------AKVARGRL 106
E SVM+ +VV L V++ + V ME + G+L
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 107 REDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166
+ ++ + + ++ HRDL N ++ E+ +KI DFG++ +
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGF-LPFQDENIMNMYRKVF 225
+++PE L+ + +D+WS GV+L+ + P+Q + + R V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249
Query: 226 KAEFV-YPPWISTDAKRLISKLLVSDPERRITIQSIMRV------PWFRK 268
+ + P L+ +P+ R + I+ P FR+
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (448), Expect = 6e-52
Identities = 67/316 (21%), Positives = 128/316 (40%), Gaps = 55/316 (17%)
Query: 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREIS 62
+ + +Y+ + +G G V + +VAIK +++ + ++ RE+
Sbjct: 10 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELV 68
Query: 63 VMRLVRHPNVVELREVMATKKK------IFVAMEYVKGGELFAKVARGRLREDLARKYFQ 116
+M+ V H N++ L V +K +++ ME + +V + L +
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLY 126
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
Q++ + HS G+ HRDLKP N+++ + LKI DFGL+ ++ T
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRY 183
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPW-- 234
Y APEV+ GY D+WS G I+ ++ + F + ++ + KV + P
Sbjct: 184 YRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 235 ----------------------------------------ISTDAKRLISKLLVSDPERR 254
++ A+ L+SK+LV DP +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 255 ITIQSIMRVPWFRKGF 270
I++ ++ P+ +
Sbjct: 303 ISVDDALQHPYINVWY 318
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-51
Identities = 58/278 (20%), Positives = 111/278 (39%), Gaps = 28/278 (10%)
Query: 11 KYEMGRLLGKGTFAKVYYGK-----QLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR 65
+ ++G+ LG+G F +V + T +VA+K++ + E + ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIH 72
Query: 66 LVRHPNVVELREVMA-TKKKIFVAMEYVKGGELF-----------------AKVARGRLR 107
+ H NVV L + V +E+ K G L + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 108 EDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167
+ Y Q+ ++F SR HRDL N+LL E +KI DFGL+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGF-LPFQDENIMNMYRKVFK 226
++APE + + Y ++D+WS GV+L+ + + P+ I + + K
Sbjct: 193 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 227 A--EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
P + + + + + +P +R T ++
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-50
Identities = 58/294 (19%), Positives = 116/294 (39%), Gaps = 47/294 (15%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+ +GKG F +V+ GK GE VA+K+ + + + F + EI ++RH
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFR----EAEIYQTVMLRH 56
Query: 70 PNVVELREVM----ATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFC 125
N++ T ++++ +Y + G LF + R + + K S +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 126 HS--------RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN--DGLLHTQCGTP 175
H ++HRDLK +N+L+ +N I+D GL+ + + D + + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 176 AYVAPEVLR-----KKGYDGSKADLWSCGVILYVLLAGFLPF---------------QDE 215
Y+APEVL K +AD+++ G++ + + D
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 216 NIMNMYRKVFKAEF-------VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262
++ M + V + + +++ + ++ R+T I +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 4e-43
Identities = 56/328 (17%), Positives = 113/328 (34%), Gaps = 72/328 (21%)
Query: 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH 69
+Y + R LG G F+ V+ K ++ VA+K++ D++ E + EI +++ V
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVND 68
Query: 70 PNVVELREVMA-------------TKKKIFVAMEYVKGG----ELFAKVARGRLREDLAR 112
+ + + A + V M + G L K + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 113 KYFQQLISAVDFC-HSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLRNDGLLHT 170
+ +QL+ +D+ G+ H D+KPEN+L++ + + ++ L D
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY--------- 221
T Y +PEVL + AD+WS +++ L+ G F+ + +
Sbjct: 189 SIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 222 ---------------------------------------RKVFKAEFVYPPWISTDAKRL 242
V ++ + + +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 243 ISKLLVSDPERRITIQSIMRVPWFRKGF 270
+S +L DP +R ++ PW +
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTL 335
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 1e-20
Identities = 32/209 (15%), Positives = 66/209 (31%), Gaps = 35/209 (16%)
Query: 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMM---------------EQ 56
+G+L+G+G + V+ +K + +
Sbjct: 2 DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 57 IKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQ 116
+ E ++ ++ V ++ V ME + E R+R + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKE------LYRVRVENPDEVLD 110
Query: 117 QLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPA 176
++ V + RG+ H DL N+L+ E + I DF S + +L
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDV---- 165
Query: 177 YVAPEVLRKKGYDGSKADLWSCGVILYVL 205
+ ++ D+ S I +L
Sbjct: 166 RNIITYFSRTY--RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 72.1 bits (177), Expect = 3e-16
Identities = 13/80 (16%), Positives = 28/80 (35%), Gaps = 1/80 (1%)
Query: 343 TSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVA-PEVA 401
TS +M +I V N + + F + + + EV ++ +
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 402 VVEFSKSSGDTLEYAKFCEE 421
V F + SG ++ + +
Sbjct: 76 GVRFKRISGTSIAFKNIASK 95
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 459 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.42 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.63 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.28 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.64 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.26 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.95 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.49 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-66 Score=498.04 Aligned_cols=257 Identities=34% Similarity=0.681 Sum_probs=238.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 34688999999999999999999999999999999998765544445677899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~ 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----C
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----C
Confidence 99999999999999976 789999999999999999999999999999999999999999999999999997543 2
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
......+||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..+.+..+.+..+.+|..+|+++++||.+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 334567899999999999988775 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccccc
Q 012637 246 LLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
||++||++|||++|+|+||||+.
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-66 Score=499.24 Aligned_cols=263 Identities=34% Similarity=0.630 Sum_probs=227.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
++.++|++++.||+|+||+||+|+++.+|+.||||++++....+ ..+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 46789999999999999999999999999999999998664332 3456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+|||||+||+|++++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999999876 68999999999999999999999999999999999999999999999999999876543334
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-HHHHHHHhccCCCC--CCCCHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM-NMYRKVFKAEFVYP--PWISTDAKRL 242 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~L 242 (459)
....+.+||+.|||||++.+..+++.++|||||||+||+|++|++||...+.. ..+..+.......+ ..+|+++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 45567899999999999998888778899999999999999999999775543 33333333333332 3479999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 243 ISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
|.+||++||++|||++|+++||||+++..
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 99999999999999999999999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-65 Score=497.17 Aligned_cols=259 Identities=33% Similarity=0.628 Sum_probs=232.9
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999876554444567789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..........
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999999999998876 8999999999999999999999999999999999999999999999999999987654444445
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLL 247 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 247 (459)
..+.+||+.|||||++.+..|+ .++|||||||+||+|++|..||.+.+..+++.++.+..+.+|..+|+++++||.+||
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 245 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 245 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTS
T ss_pred cccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 5677899999999999988775 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHH------HhcCccccc
Q 012637 248 VSDPERRITIQS------IMRVPWFRK 268 (459)
Q Consensus 248 ~~dP~~R~t~~e------il~hpw~~~ 268 (459)
++||++|||++| |++||||+.
T Consensus 246 ~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 246 VLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred cCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 999999999988 578888864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-64 Score=490.57 Aligned_cols=254 Identities=30% Similarity=0.498 Sum_probs=228.4
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
++|++.+.||+|+||+||+|+++.+|+.||||++.+..... .+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 58999999999999999999999999999999998665433 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 90 EYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
|||+||+|.+++.++.+++.+++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ......
T Consensus 97 Ey~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~~ 174 (293)
T d1yhwa1 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRS 174 (293)
T ss_dssp ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCBC
T ss_pred EecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cccccc
Confidence 999999999999889999999999999999999999999999999999999999999999999999986543 233445
Q ss_pred cccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc---cCCCCCCCCHHHHHHHHHh
Q 012637 170 TQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA---EFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~~ 246 (459)
..+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.......+... .+..|+.+|+++++||.+|
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred ccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 67899999999999988775 8999999999999999999999988877666555544 2344567899999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccC
Q 012637 247 LVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 247 L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
|++||++|||++|+|+||||+..
T Consensus 254 L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp TCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-64 Score=497.84 Aligned_cols=258 Identities=34% Similarity=0.627 Sum_probs=239.0
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
-+++|++++.||+|+||+||+|+++.+|+.||||++.++........+++.+|+.+|++++||||+++++++.+...+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 46789999999999999999999999999999999987655444456778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||||+||+|++++.+ +.++|+.++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~~ 160 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTC
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CCc
Confidence 9999999999999976 7899999999999999999999999999999999999999999999999999985432 233
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 246 (459)
...+.||||.|+|||++.+.+|. .++|||||||++|+|++|++||.+.+..+++..+....+.+|..+|+++++||.+|
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhh
Confidence 45678999999999999998884 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCC-----HHHHhcCccccc
Q 012637 247 LVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 247 L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
|++||.+|++ ++|+++||||+.
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ccCCchhhcccccccHHHHHcCccccc
Confidence 9999999994 899999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-63 Score=487.14 Aligned_cols=259 Identities=39% Similarity=0.707 Sum_probs=216.4
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+..-+.++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||++++++.+.+
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 44557788999999999999999999999999999999998765433 2356789999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec---CCCCeEEeecCCCccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD---ENEDLKISDFGLSALP 159 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~---~~~~lKl~DFGla~~~ 159 (459)
.+|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||+. .+|.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999999999976 7899999999999999999999999999999999999995 5789999999999854
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCC
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWI 235 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 235 (459)
. ......+.+||+.|||||++.+..|+ .++|||||||+||+|++|..||.+.+..+.+..+....+..+ +.+
T Consensus 161 ~---~~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 161 D---PGSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred c---CCCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 3 23345677899999999999988775 899999999999999999999999998888888888766544 458
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
|+++.+||.+||++||++|||++|+++||||+.
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-62 Score=485.62 Aligned_cols=254 Identities=35% Similarity=0.714 Sum_probs=235.5
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46799999999999999999999999999999999876544444467889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||||+||+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 999999999998876 6899999999999999999999999999999999999999999999999999986432 3
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKLL 247 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 247 (459)
..+.+||+.|||||++.+..|+ .++|||||||+||+|++|..||.+.+..+.+.++..+...+|+.+|+++.+||.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3467999999999999988876 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----CHHHHhcCccccc
Q 012637 248 VSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 248 ~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
.+||.+|+ |+++|++||||+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhCHHhccccchhhHHHHHcCccccc
Confidence 99999996 9999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-63 Score=480.91 Aligned_cols=254 Identities=29% Similarity=0.448 Sum_probs=225.0
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.|++.+.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 5799999999999999999999999999999999765322 2456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..... ...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 99999999998754 57999999999999999999999999999999999999999999999999999754331 123
Q ss_pred cccccCCCcccChhhHh-----hcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC---CCCCCCCHHH
Q 012637 168 LHTQCGTPAYVAPEVLR-----KKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF---VYPPWISTDA 239 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~-----~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 239 (459)
..+.+||+.|+|||++. ..+| +.++|||||||+||+|++|.+||.+.+..+.+.++..... ..|..+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 34678999999999985 3334 5899999999999999999999999888888888777653 3345689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
.+||.+||++||++|||++|+++||||+..
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=475.47 Aligned_cols=254 Identities=27% Similarity=0.534 Sum_probs=216.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--CCEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT--KKKIF 86 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 86 (459)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|++++|||||++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 468999999999999999999999999999999998765543 346778999999999999999999999864 56799
Q ss_pred EEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 87 VAMEYVKGGELFAKVAR-----GRLREDLARKYFQQLISAVDFCHSRG-----VSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~~~~qll~~L~~LH~~g-----i~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
+|||||+||+|.+++.+ +.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998853 57999999999999999999999976 999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-CCCCCC
Q 012637 157 ALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF-VYPPWI 235 (459)
Q Consensus 157 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~ 235 (459)
+.... ......+.+|||.|||||++.+..|+ .++|||||||++|+|++|..||.+.+..+++..+..+.+ ..|..+
T Consensus 162 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 86543 22334567899999999999888775 899999999999999999999999999998888887765 456679
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012637 236 STDAKRLISKLLVSDPERRITIQSIMRVPWF 266 (459)
Q Consensus 236 s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~ 266 (459)
|+++.+||.+||++||++|||++||++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=474.19 Aligned_cols=259 Identities=36% Similarity=0.617 Sum_probs=232.9
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
..+.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||++++++.+.
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3466889999999999999999999999999999999987544321 1356789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC----CeEEeecCCCc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE----DLKISDFGLSA 157 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~----~lKl~DFGla~ 157 (459)
+.+|+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999999976 7899999999999999999999999999999999999998876 59999999997
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----C
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----P 233 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 233 (459)
.... .....+.+||+.|+|||++.+..| +.++|||||||+||+|++|..||.+.+..+.+..+.......+ +
T Consensus 166 ~~~~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 166 KIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp ECTT---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hcCC---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 6432 334456789999999999988766 5899999999999999999999999999998888888776655 5
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+|+++++||.+||++||++|||++|+++||||+.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 68999999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-62 Score=478.70 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=226.5
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAME 90 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (459)
+|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999988776666667889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCccc
Q 012637 91 YVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLH 169 (459)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~ 169 (459)
||+||+|..++.. +++++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 9999999776654 7899999999999999999999999999999999999999999999999999985432 34
Q ss_pred cccCCCcccChhhHhhc--CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC--CCCCCHHHHHHHHH
Q 012637 170 TQCGTPAYVAPEVLRKK--GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY--PPWISTDAKRLISK 245 (459)
Q Consensus 170 ~~~Gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~ 245 (459)
..+||+.|||||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+....... +..+|+++.+||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 56899999999999643 223589999999999999999999999988887777776665433 34589999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccC
Q 012637 246 LLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
||++||.+|||++|+|+||||...
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-61 Score=483.80 Aligned_cols=256 Identities=34% Similarity=0.602 Sum_probs=231.6
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999997653 2345678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC--CCCeEEeecCCCccccccc
Q 012637 88 AMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE--NEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~--~~~lKl~DFGla~~~~~~~ 163 (459)
|||||+||+|++++.. +++++.+++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||+|+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~--- 177 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 177 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC---
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc---
Confidence 9999999999999853 67999999999999999999999999999999999999964 5789999999998643
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTDA 239 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (459)
......+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+....+..+ +.+|+++
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 33445678999999999999988875 899999999999999999999999999999998888776655 3589999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 240 KRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
++||.+||++||++|||++|+|+||||+...
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-62 Score=486.11 Aligned_cols=256 Identities=32% Similarity=0.629 Sum_probs=236.9
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.-+++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34689999999999999999999999999999999998765544444677899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND 165 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~ 165 (459)
+||||+.||+|...+.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 99999999999999876 7899999999999999999999999999999999999999999999999999986432
Q ss_pred CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 012637 166 GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISK 245 (459)
Q Consensus 166 ~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 245 (459)
...+.+||+.|||||++.+.+|+ .++|||||||+||+|++|+.||.+.+....+..+....+..|..+|+++.+||.+
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 33467899999999999988875 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----CHHHHhcCccccc
Q 012637 246 LLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 246 ~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
||.+||.+|+ |+++|++||||+.
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999995 9999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-61 Score=483.14 Aligned_cols=257 Identities=28% Similarity=0.560 Sum_probs=232.5
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
.+.++|++.+.||+|+||+||+|+++.+|+.||||++.+.... ....+.+|+.+|++++|||||++++++.+++.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3567899999999999999999999999999999999765422 3456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEec--CCCCeEEeecCCCcccccc
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLD--ENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~--~~~~lKl~DFGla~~~~~~ 162 (459)
+|||||+||+|++.+.. .++++.+++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+|+...
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~-- 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-- 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC--
Confidence 99999999999998865 4699999999999999999999999999999999999998 56899999999998654
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CCCCHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PWISTD 238 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (459)
......+.+||+.|+|||++.+..|+ .++|||||||+||+|++|..||.+.+..+.+..+....+.+| +.+|++
T Consensus 181 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 181 -PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp -TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred -CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 34456678999999999999988775 899999999999999999999999999999899888876655 458999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
+.+||.+||++||.+|||++|+|+||||+...
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-61 Score=465.90 Aligned_cols=256 Identities=24% Similarity=0.465 Sum_probs=221.2
Q ss_pred cccccCCE-EEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe--
Q 012637 5 RHVLFGKY-EMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-- 81 (459)
Q Consensus 5 ~~~~~~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (459)
|....+|| ++.+.||+|+||+||+|.++.+++.||+|.+....... ...+.+.+|+++|++++|||||++++++.+
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 34556777 78889999999999999999999999999998765443 345778999999999999999999999875
Q ss_pred --CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeccCCCCCeEec-CCCCeEEeecCC
Q 012637 82 --KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRG--VSHRDLKPENLLLD-ENEDLKISDFGL 155 (459)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~g--i~HrDlkp~NILl~-~~~~lKl~DFGl 155 (459)
...+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 4578999999999999999976 78999999999999999999999999 99999999999997 478999999999
Q ss_pred CcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCc-hHHHHHHHHHhccC--CCC
Q 012637 156 SALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDE-NIMNMYRKVFKAEF--VYP 232 (459)
Q Consensus 156 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~--~~p 232 (459)
|+... .....+.+|||.|||||++.+ .| +.++|||||||+||+|++|+.||.+. +...+++.+..+.. .++
T Consensus 162 a~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 162 ATLKR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235 (270)
T ss_dssp GGGCC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred ceecc----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC
Confidence 97532 234457799999999999875 45 58999999999999999999999765 44555666655432 234
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 233 PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 233 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
...++++.+||.+||++||++|||++|+|+||||+
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 55799999999999999999999999999999995
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-61 Score=478.87 Aligned_cols=257 Identities=33% Similarity=0.624 Sum_probs=233.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHH-hcCCCCcceeEEEEEeCCEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMR-LVRHPNVVELREVMATKKKIFV 87 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 87 (459)
+++|++++.||+|+||+||+|.++.+|+.||||++.++........+.+.+|+.++. .++||||+++++++.+.+.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999998765433333455667777765 6899999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 88 AMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
|||||+||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 9999999999999976 7899999999999999999999999999999999999999999999999999985433 233
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTDAKRLISKL 246 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 246 (459)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+++..+..+.+.+|..+|+++.+||.+|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 44567899999999999988875 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHH-HHhcCccccc
Q 012637 247 LVSDPERRITIQ-SIMRVPWFRK 268 (459)
Q Consensus 247 L~~dP~~R~t~~-eil~hpw~~~ 268 (459)
|++||.+|||+. ++++||||+.
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999996 8999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-60 Score=463.11 Aligned_cols=258 Identities=33% Similarity=0.590 Sum_probs=230.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc------HHHHHHHHHHHHHHHhcC-CCCcceeEEEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK------EFMMEQIKREISVMRLVR-HPNVVELREVMA 80 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~ 80 (459)
|.++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 4689999999999999999999999999999999998764322 224467889999999996 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 81 TKKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
+++.+|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999965 89999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCccccccCCCcccChhhHhhc-----CCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC-
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKK-----GYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP- 233 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~-----~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~- 233 (459)
.. .......+||+.|+|||++.+. ...+.++||||+||+||+|++|..||.+.+.......+..+.+..+.
T Consensus 161 ~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 161 DP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 43 3334567899999999999743 23367899999999999999999999999998888888887665443
Q ss_pred ---CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 234 ---WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 234 ---~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
.+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=479.16 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=217.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
+..++|++.+.||+|+||+||+|+++.+|+.||+|++.++.. ....+++.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 446789999999999999999999999999999999976532 224567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+|||||+||+|.+++.+ +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 99999999999999965 789999999999999999999997 5999999999999999999999999999986543
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHH-----------------------
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMY----------------------- 221 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~----------------------- 221 (459)
....+.+||+.|||||++.+..|+ .++||||+||++|+|++|+.||.+.+.....
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred -CccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 223467999999999999988775 8999999999999999999999765432110
Q ss_pred -------------------HHHHhcc-CCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 222 -------------------RKVFKAE-FVYP-PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 222 -------------------~~i~~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..+.... ...| ..+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0000000 1111 125889999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-61 Score=474.12 Aligned_cols=255 Identities=27% Similarity=0.525 Sum_probs=231.4
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
-+++||++++.||+|+||+||+|.++.+|+.||||++.+... ....+.+|+.+|+.++|||||++++++++.+.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 378999999999999999999999999999999999976542 2345789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC--CCeEEeecCCCcccccc
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN--EDLKISDFGLSALPEQL 162 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~--~~lKl~DFGla~~~~~~ 162 (459)
+|||||+||+|++++.. .+++|.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 99999999999999975 379999999999999999999999999999999999999854 589999999997543
Q ss_pred cCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC----CCCHH
Q 012637 163 RNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP----WISTD 238 (459)
Q Consensus 163 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 238 (459)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+.+..+....+.+|. .+|++
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 23345677899999999999887765 8999999999999999999999999999999999988877663 68999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+++||.+||.+||++|||++|+++||||+..
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-60 Score=479.45 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=222.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHH---HHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQI---KREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i---~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+ .+|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 36789999999999999999999999999999999986554332222223 345777778889999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
+|+|||||+||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999985432
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH---HHHHHHHHhccCCCCCCCCHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI---MNMYRKVFKAEFVYPPWISTDAK 240 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~ 240 (459)
....+.+||+.|+|||++.....++.++|||||||+||+|++|+.||.+.+. ..+.+.+....+..|..+|++++
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 2345678999999999997655456899999999999999999999987543 33444445556677788999999
Q ss_pred HHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012637 241 RLISKLLVSDPERRIT-----IQSIMRVPWFRK 268 (459)
Q Consensus 241 ~Li~~~L~~dP~~R~t-----~~eil~hpw~~~ 268 (459)
+||.+||++||.+||| ++||++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-61 Score=462.79 Aligned_cols=253 Identities=32% Similarity=0.593 Sum_probs=223.3
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccH---HHHHHHHHHHHHHHhcC--CCCcceeEEEEEe
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKE---FMMEQIKREISVMRLVR--HPNVVELREVMAT 81 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~ 81 (459)
++.++|++++.||+|+||+||+|+++.+|+.||||++.++..... ....++.+|+.+|++++ ||||+++++++.+
T Consensus 1 pl~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 367899999999999999999999999999999999987544321 11234668999999996 8999999999999
Q ss_pred CCEEEEEEeccCC-CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCC-CCeEEeecCCCcc
Q 012637 82 KKKIFVAMEYVKG-GELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDEN-EDLKISDFGLSAL 158 (459)
Q Consensus 82 ~~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~-~~lKl~DFGla~~ 158 (459)
.+.+|+||||+.+ +++.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999999986 577787765 789999999999999999999999999999999999999854 7999999999975
Q ss_pred cccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCCCCCHH
Q 012637 159 PEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPPWISTD 238 (459)
Q Consensus 159 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (459)
.. .....+.+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+ .+.++...+++.+|++
T Consensus 161 ~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 161 LK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 230 (273)
T ss_dssp CC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred cc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHH
Confidence 43 2344567899999999999988887788999999999999999999998743 4567778889999999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
+++||.+||++||++|||++|+++||||++.
T Consensus 231 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-59 Score=458.25 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=215.4
Q ss_pred EeeeecccCcEEEEEEEEcCCCcEEEEEEeecccccc--HHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q 012637 14 MGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKK--EFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEY 91 (459)
Q Consensus 14 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (459)
..+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999997654322 22345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCcccc
Q 012637 92 VKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGLLHT 170 (459)
Q Consensus 92 ~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~ 170 (459)
|.|+.+...... +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ......+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 999888777764 6799999999999999999999999999999999999999999999999999976443 2334456
Q ss_pred ccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCC--------------------
Q 012637 171 QCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFV-------------------- 230 (459)
Q Consensus 171 ~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------------------- 230 (459)
.+||+.|+|||++....+++.++||||+||++|+|++|.+||.+.+..+.+.++.+....
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 789999999999987666679999999999999999999999998888777666532100
Q ss_pred C--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 231 Y--------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 231 ~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
. .+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 12468899999999999999999999999999999853
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-59 Score=455.25 Aligned_cols=258 Identities=30% Similarity=0.514 Sum_probs=218.7
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.++|++.+.||+|+||+||+|+++.+|+.||||++..+... +...+++.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 36899999999999999999999999999999999765432 22356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCC
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDG 166 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~ 166 (459)
||||.++.+...... +++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 999987655444332 5799999999999999999999999999999999999999999999999999975432 333
Q ss_pred ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC-----------------
Q 012637 167 LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF----------------- 229 (459)
Q Consensus 167 ~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (459)
.....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+..+....+.+...
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 455678999999999999888888999999999999999999999998887666555432100
Q ss_pred -CCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 230 -VYP-----------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 230 -~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..+ +.+|+++.+||.+||++||++|||++|+++||||+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 011 2467899999999999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-59 Score=464.91 Aligned_cols=256 Identities=32% Similarity=0.609 Sum_probs=217.6
Q ss_pred ccccccCCEEEe-eeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCCcceeEEEEEe
Q 012637 4 ERHVLFGKYEMG-RLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRL-VRHPNVVELREVMAT 81 (459)
Q Consensus 4 ~~~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~ 81 (459)
++..+.++|++. +.||+|+||+||+|+++.+|+.||||++.+. ..+.+|+.++.+ ++|||||++++++++
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 455678899986 5699999999999999999999999999643 346789998755 489999999999976
Q ss_pred ----CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CCCeEEe
Q 012637 82 ----KKKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NEDLKIS 151 (459)
Q Consensus 82 ----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~~lKl~ 151 (459)
...+|+|||||+||+|++++.. .+++|.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 4779999999999999999975 36999999999999999999999999999999999999986 4679999
Q ss_pred ecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHH----HHHHHhc
Q 012637 152 DFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNM----YRKVFKA 227 (459)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~ 227 (459)
|||+|+.... .....+.+|||.|||||++.+..|+ .++|||||||+||+|++|++||.+.+.... ...+...
T Consensus 157 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 157 DFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp CCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred ccceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 9999986442 3345678999999999999988775 899999999999999999999987654333 3333444
Q ss_pred cCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 228 EFVYPP----WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 228 ~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
.+.+|. .+|+++.+||.+||+.||++|||++|+++||||.....
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 555553 37999999999999999999999999999999976543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.8e-58 Score=444.56 Aligned_cols=262 Identities=26% Similarity=0.457 Sum_probs=221.9
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC-
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK- 83 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~- 83 (459)
++.+.++|++.+.||+|+||+||+|+++.+|+.||||++.++...+......+.+|+.+|+.++||||+++++++...+
T Consensus 2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 4568899999999999999999999999999999999998877767767788999999999999999999999997654
Q ss_pred ---EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 84 ---KIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
.+|+|||||+||+|..++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 48999999999999998865 78999999999999999999999999999999999999999999999999998654
Q ss_pred cccc-CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCC----CC
Q 012637 160 EQLR-NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYP----PW 234 (459)
Q Consensus 160 ~~~~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 234 (459)
.... ......+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+...++.......| +.
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp C----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred ccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 3221 22344567899999999999887775 899999999999999999999999998888777776655433 45
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012637 235 ISTDAKRLISKLLVSDPERRITIQSIMRVPWFR 267 (459)
Q Consensus 235 ~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~ 267 (459)
+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 899999999999999999999555555677764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.6e-58 Score=445.42 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=218.4
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.+||++.+.||+|+||+||+|+++ +|+.||||++....... ...+++.+|+.+|++++||||+++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 379999999999999999999985 88999999997654332 2346788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||+.++.+..+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cccc
Confidence 999999888777764 7899999999999999999999999999999999999999999999999999975432 2223
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-------------------
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------------- 228 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 228 (459)
.....||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+..+.+.++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3455799999999999887777899999999999999999999999888776665554210
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 229 ----------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 229 ----------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
...++.+++++.+||++||++||++|||++|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0112347889999999999999999999999999999973
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-57 Score=451.02 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=216.8
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK---- 83 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (459)
+.++|++++.||+|+||+||+|.++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 67899999999999999999999999999999999976543 4446678999999999999999999999997654
Q ss_pred --EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 --KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.+|+||||| |++|...+..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 6688888888999999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccC------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEF------------ 229 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------ 229 (459)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+..+.....
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 2345678999999999998877777999999999999999999999998876655443322110
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 230 -------------------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 230 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..++.+++++.+||.+||..||.+|||++|+|+||||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1224578999999999999999999999999999999853
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=444.70 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=214.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCC-CcEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCCcceeEEEEEe---
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMT-GESVAIKVINKDQLKKEFMMEQIKREISVMRLV---RHPNVVELREVMAT--- 81 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~--- 81 (459)
.++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 57999999999999999999999766 66799999976433221 123455788887766 79999999999853
Q ss_pred --CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 82 --KKKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
...+|++||||.++.+...... ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3579999999999877554433 679999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc---------
Q 012637 158 LPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE--------- 228 (459)
Q Consensus 158 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------- 228 (459)
.... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+.+..+....
T Consensus 165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 6442 2344577899999999999988875 89999999999999999999999988877766654310
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 229 ------------------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 229 ------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
..++..+++++.+||.+||++||++|||++|+|+||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0123457899999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-57 Score=443.90 Aligned_cols=261 Identities=26% Similarity=0.358 Sum_probs=215.7
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------ 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (459)
-++||++++.||+|+||+||+|+++.+|+.||||++.++.... ....++.+|+.+|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 3689999999999999999999999999999999997654432 234567899999999999999999998854
Q ss_pred --CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 82 --KKKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
...+|+|||||.++.+...... +.+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 4568999999998877655544 6899999999999999999999999999999999999999999999999999975
Q ss_pred ccccc--CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCCCC---
Q 012637 159 PEQLR--NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVYPP--- 233 (459)
Q Consensus 159 ~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--- 233 (459)
..... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.......++
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 44221 2234455789999999999987755568999999999999999999999988877666555442211110
Q ss_pred -----------------------------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 234 -----------------------------WISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 234 -----------------------------~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
..++++.+||.+||++||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 036788999999999999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=447.81 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=217.3
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCCc-----EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEE
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTGE-----SVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVM 79 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 79 (459)
.+-.++|++++.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|+++ +|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 3445789999999999999999999876554 699999865432 22345788999999998 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccC
Q 012637 80 ATKKKIFVAMEYVKGGELFAKVARG------------------------RLREDLARKYFQQLISAVDFCHSRGVSHRDL 135 (459)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDl 135 (459)
.+.+.+|+|||||+||+|.+++... .+++..++.|+.||+.||+|||++||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999999998642 3899999999999999999999999999999
Q ss_pred CCCCeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCC
Q 012637 136 KPENLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQD 214 (459)
Q Consensus 136 kp~NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~ 214 (459)
||+|||++.++++||+|||+|+............+.+||+.|||||++.+..|+ .++||||+||+||+|+| |..||.+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543333344567899999999999988775 89999999999999998 8999988
Q ss_pred chHHHHHHHHHhc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 215 ENIMNMYRKVFKA--EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 215 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+....+.++... .+..|..+|+++.+||.+||+.||++|||++||++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7665555555544 345677899999999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=438.90 Aligned_cols=256 Identities=24% Similarity=0.419 Sum_probs=209.7
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
++.+-.++|++++.||+|+||+||+|+. +..||||++........ ..+.+.+|+.+|++++|||||++++++. .+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTT-HHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 4566678999999999999999999974 34699999976544433 4678899999999999999999999874 55
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.+|+|||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 68999999999999999964 5799999999999999999999999999999999999999999999999999987654
Q ss_pred ccCCCccccccCCCcccChhhHhhcC--CCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHH-HHhccC-----CCCC
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKG--YDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK-VFKAEF-----VYPP 233 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~-i~~~~~-----~~p~ 233 (459)
........+.+||+.|||||++.+.. ..+.++||||+||+||+|+||+.||.+.+....... +.++.. ..+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 43444556678999999999997532 235899999999999999999999988665544333 333321 2345
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012637 234 WISTDAKRLISKLLVSDPERRITIQSIMRVP 264 (459)
Q Consensus 234 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~hp 264 (459)
.+++++.+||.+||+.||++|||+++|+++-
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 6899999999999999999999999999873
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-56 Score=442.78 Aligned_cols=262 Identities=25% Similarity=0.430 Sum_probs=216.8
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC----
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK---- 83 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (459)
+..||++++.||+|+||+||+|.++.+|+.||||++++.. .....+++.+|+.+|+.++||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 3478999999999999999999999999999999997543 3445678899999999999999999999997653
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 84 KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
..+++++|+.||+|++++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 23444456678999999988999999999999999999999999999999999999999999999999999997644322
Q ss_pred -CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc--------------
Q 012637 164 -NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE-------------- 228 (459)
Q Consensus 164 -~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------- 228 (459)
........+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+..+.........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 22345667899999999999776666789999999999999999999998877654443332100
Q ss_pred --------C---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012637 229 --------F---------VYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGFT 271 (459)
Q Consensus 229 --------~---------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~~ 271 (459)
. ...+.+|+++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 012347889999999999999999999999999999986543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-56 Score=436.28 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=218.1
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
+.+-.++|++.+.||+|+||+||+|.++.+|+.||||++..+... .+++.+|+.+|++++|||||++++++.+.+.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 445567899999999999999999999999999999999765432 3568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
+|+|||||++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999999999864 5789999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCC-CCCCchHHHHHHHHHhc-cCCCCCCCCHHH
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFL-PFQDENIMNMYRKVFKA-EFVYPPWISTDA 239 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~-Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (459)
. .........||+.|+|||++.+..|+ .++||||+||++|+|++|.. ||.+.+...++..+..+ .+..|..+|+++
T Consensus 168 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 245 (287)
T d1opja_ 168 D-TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245 (287)
T ss_dssp S-SSEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred C-CceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence 1 11222345689999999999988875 89999999999999999655 55666666666655544 356677899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 012637 240 KRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+||.+||+.||++|||+++|++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=429.09 Aligned_cols=257 Identities=28% Similarity=0.486 Sum_probs=222.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVA 88 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (459)
.+||++.+.||+|+||+||+|+++.+|+.||||+++.+.. ......++.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 3689999999999999999999999999999999976654 333567889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 89 MEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
+|++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|..... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CCcc
Confidence 999999999888766 6899999999999999999999999999999999999999999999999999986543 2223
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCC-CCchHHHHHHHHHhcc------------------
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPF-QDENIMNMYRKVFKAE------------------ 228 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~------------------ 228 (459)
.....+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+..+.+..+....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 344567889999999988877779999999999999999999885 4555555555543210
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 229 -----------FVYPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 229 -----------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
...++.+++++.+||++||++||++|||++|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0122346889999999999999999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=430.56 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=221.1
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
+++.+-.++|++++.||+|+||+||+|.++ +++.||||++...... .+.+.+|+.+|++++|||||++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 445566789999999999999999999975 6788999999765433 2468899999999999999999998754
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALP 159 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~ 159 (459)
+.+|+|||||++|+|.+++.. .++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 567999999999999997754 36999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCH
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWIST 237 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 237 (459)
... .........||+.|||||++.+..|+ .++||||+||+||+|+| |.+||...+..+....+..+ ....|..+++
T Consensus 160 ~~~-~~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 160 EDN-EYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (272)
T ss_dssp SSS-CEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCC-ccccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChH
Confidence 431 11223456799999999999887775 89999999999999999 56677777777777777665 3556778999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc--Ccccc
Q 012637 238 DAKRLISKLLVSDPERRITIQSIMR--VPWFR 267 (459)
Q Consensus 238 ~~~~Li~~~L~~dP~~R~t~~eil~--hpw~~ 267 (459)
++.+||.+||+.||++|||+++|++ |+||.
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999999999998 78885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=432.83 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=210.4
Q ss_pred eeecccCcEEEEEEEEc--CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q 012637 16 RLLGKGTFAKVYYGKQL--MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAMEYVK 93 (459)
Q Consensus 16 ~~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (459)
+.||+|+||+||+|.+. .+++.||||++..+.. +....+.+.+|+.+|++++|||||++++++.++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999864 3567899999975543 333567899999999999999999999999654 5789999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCC-Cccccc
Q 012637 94 GGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRND-GLLHTQ 171 (459)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~-~~~~~~ 171 (459)
+|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999976 67999999999999999999999999999999999999999999999999999865432111 122345
Q ss_pred cCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHHHHHHhcCC
Q 012637 172 CGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKRLISKLLVS 249 (459)
Q Consensus 172 ~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~ 249 (459)
.||+.|||||++.+..|+ .++|||||||++|+|++ |..||.+.+..++...+..+. +..|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 789999999999987765 89999999999999998 999999988888887777653 566788999999999999999
Q ss_pred CCCCCCCHHHH---hcCcccc
Q 012637 250 DPERRITIQSI---MRVPWFR 267 (459)
Q Consensus 250 dP~~R~t~~ei---l~hpw~~ 267 (459)
||++|||+++| |+|+|+.
T Consensus 250 dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHhh
Confidence 99999999998 4666653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-56 Score=433.23 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=209.0
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCc---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGE---SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
+-.++|++.+.||+|+||+||+|+++.+|+ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 345789999999999999999999987765 58999886543 2334567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
.+|+|||||+||+|.+++.. +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999998865 5799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCc---cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCC
Q 012637 162 LRNDGL---LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWIS 236 (459)
Q Consensus 162 ~~~~~~---~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s 236 (459)
...... .....||+.|||||++.+..|+ .++|||||||+||+|+| |..||.+.+..++...+..+. ...|..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 222111 1224579999999999887775 89999999999999998 899999988888887776653 45667789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 237 TDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+++.+||.+||+.||++|||+.||+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=438.51 Aligned_cols=249 Identities=30% Similarity=0.428 Sum_probs=210.4
Q ss_pred CEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------CCE
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------KKK 84 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~~~ 84 (459)
+|+..++||+|+||+||+|+++.+|+.||||++.++... ..+|+.+|++++||||+++++++.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999765422 2379999999999999999999854 346
Q ss_pred EEEEEeccCCCchHHHH---hc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeecCCCccc
Q 012637 85 IFVAMEYVKGGELFAKV---AR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALP 159 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i---~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~ 159 (459)
+|+|||||+++.+.... .. ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999887543332 22 5799999999999999999999999999999999999999775 8999999999754
Q ss_pred ccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhc------------
Q 012637 160 EQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKA------------ 227 (459)
Q Consensus 160 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 227 (459)
.. .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||...+..+.+..+.+.
T Consensus 174 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 32 334556789999999999987666679999999999999999999999988776665554321
Q ss_pred -----cCC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 228 -----EFV------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 228 -----~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
... ..+.+++++.+||.+||..||++|||+.|+|+||||+.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 111 123478999999999999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-56 Score=430.10 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=218.7
Q ss_pred CCEEEeee-ecccCcEEEEEEEEcC--CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q 012637 10 GKYEMGRL-LGKGTFAKVYYGKQLM--TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIF 86 (459)
Q Consensus 10 ~~y~i~~~-LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (459)
++|.+.+. ||+|+||+||+|.++. ++..||||++.... .....+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 56888885 9999999999998764 44579999997543 33456788999999999999999999999865 4589
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC
Q 012637 87 VAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN 164 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~ 164 (459)
+|||||+||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999998754 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHH
Q 012637 165 -DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKR 241 (459)
Q Consensus 165 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (459)
.......+||+.|+|||++....++ .++||||+||++|+|+| |..||.+.+..++...+..+. +..|+.+|+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1223355789999999999887765 89999999999999998 999999988888877777654 5677889999999
Q ss_pred HHHHhcCCCCCCCCCHHHH---hcCcccc
Q 012637 242 LISKLLVSDPERRITIQSI---MRVPWFR 267 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~ei---l~hpw~~ 267 (459)
||.+||+.||++|||+.+| |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999888 6788875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-56 Score=425.75 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=208.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
.+|++.+.||+|+||+||+|++. +++.||||++.+..... +.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 57999999999999999999985 67889999997654433 46789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
|||++|+|.+++.. ..++++.+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...... ...
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence 99999999998865 568999999999999999999999999999999999999999999999999998654321 122
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 245 (459)
.....||+.|+|||++.+..|+ .++||||+||++|+|+| |.+||...+..+++..+..+ ....|...++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3346799999999999988875 89999999999999999 67888888887887777665 345567789999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 012637 246 LLVSDPERRITIQSIMRV 263 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~h 263 (459)
||+.||++|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=441.90 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=218.0
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC-----C
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK-----K 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 83 (459)
.+||++.+.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4799999999999999999999999999999999986543 333456788999999999999999999998643 3
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 84 KIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
..+++|+|+.||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--- 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--- 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT---
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC---
Confidence 34666777889999999988999999999999999999999999999999999999999999999999999997543
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhccCCC------------
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAEFVY------------ 231 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 231 (459)
....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 234567899999999999888777899999999999999999999999988776666554321111
Q ss_pred -------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012637 232 -------------------PPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 232 -------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~ 269 (459)
...+++++++||.+||..||.+|||++|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12478999999999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=420.76 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=220.5
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKIFVAM 89 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (459)
+.|+++++||+|+||+||+|+++ +++.||||++.++.... +.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 57899999999999999999984 78899999998765443 46789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccCCCc
Q 012637 90 EYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRNDGL 167 (459)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~~~~ 167 (459)
||+++|+|..++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 99999999988754 67999999999999999999999999999999999999999999999999999765432 2223
Q ss_pred cccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHHHHHHHHH
Q 012637 168 LHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTDAKRLISK 245 (459)
Q Consensus 168 ~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 245 (459)
....+||+.|+|||++.+..|+ .++||||+||++|+|+| |+.||.+.+..++..++..+ ....|...++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3346799999999999988875 89999999999999998 89999999988888888765 345667789999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 012637 246 LLVSDPERRITIQSIMRV 263 (459)
Q Consensus 246 ~L~~dP~~R~t~~eil~h 263 (459)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=436.54 Aligned_cols=260 Identities=32% Similarity=0.571 Sum_probs=223.9
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEc---CCCcEEEEEEeeccccc-cHHHHHHHHHHHHHHHhcCC-CCcceeEEEEEeC
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQL---MTGESVAIKVINKDQLK-KEFMMEQIKREISVMRLVRH-PNVVELREVMATK 82 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~ 82 (459)
-.++|++++.||+|+||+||+|++. .+|+.||||++++.... +....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 4578999999999999999999974 47899999999765432 22234567899999999966 8999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR-GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
..+|++|||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999999976 7899999999999999999999999999999999999999999999999999976543
Q ss_pred ccCCCccccccCCCcccChhhHhhcC-CCCCcchhhhHHHHHHHHhhCCCCCCCchH----HHHHHHHHhccCCCCCCCC
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKG-YDGSKADLWSCGVILYVLLAGFLPFQDENI----MNMYRKVFKAEFVYPPWIS 236 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s 236 (459)
. ......+.+||+.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+. ..+.+......+..|..+|
T Consensus 182 ~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 182 D-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp G-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred c-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 2 233445678999999999997654 346789999999999999999999977543 3444555566677788899
Q ss_pred HHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012637 237 TDAKRLISKLLVSDPERRI-----TIQSIMRVPWFRK 268 (459)
Q Consensus 237 ~~~~~Li~~~L~~dP~~R~-----t~~eil~hpw~~~ 268 (459)
+++.+||.+||++||.+|| |++|+++||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=423.32 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=209.2
Q ss_pred ccccCCEEEeeeecccCcEEEEEEEEcCCC---cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeC
Q 012637 6 HVLFGKYEMGRLLGKGTFAKVYYGKQLMTG---ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATK 82 (459)
Q Consensus 6 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (459)
.+..++|++++.||+|+||+||+|.+..++ ..||||.+.... .....+.+.+|+.+|++++||||+++++++. .
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 455679999999999999999999987653 468898875432 3445677899999999999999999999985 5
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 83 KKIFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
+.+|+|||||++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 679999999999999988754 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 238 (459)
.. ........+||+.|+|||++.+..|. .++|||||||++|+|++ |.+||.+.+..+++..+..+. ...|+.+|++
T Consensus 160 ~~-~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 160 DS-TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CC-cceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 32 22233456789999999999988775 89999999999999998 899999988888888877664 5677889999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+||.+||+.||++|||++||++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-54 Score=429.74 Aligned_cols=250 Identities=25% Similarity=0.469 Sum_probs=209.2
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEe--CCE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMAT--KKK 84 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 84 (459)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. .+++.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3578999999999999999999999999999999997542 346789999999995 9999999999974 456
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC-CeEEeecCCCccccccc
Q 012637 85 IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE-DLKISDFGLSALPEQLR 163 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~-~lKl~DFGla~~~~~~~ 163 (459)
+|+|||||++++|.... +.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 107 ~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~-- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT--
T ss_pred eeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC--
Confidence 99999999999997764 5799999999999999999999999999999999999998765 599999999986442
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchH-HHHHHHHH-------------hccC
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENI-MNMYRKVF-------------KAEF 229 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~-------------~~~~ 229 (459)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||..... ......+. ....
T Consensus 183 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 23445678999999999998776667999999999999999999999976432 11111111 0000
Q ss_pred C------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012637 230 V------------------------YPPWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRK 268 (459)
Q Consensus 230 ~------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~ 268 (459)
. ....+|+++.+||++||.+||++|||++|+|+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 01226889999999999999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=437.32 Aligned_cols=256 Identities=26% Similarity=0.462 Sum_probs=206.5
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe------
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT------ 81 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (459)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+.... .....++.+|+.+|++++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 458999999999999999999999999999999999876543 4456778999999999999999999999953
Q ss_pred CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccc
Q 012637 82 KKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQ 161 (459)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~ 161 (459)
...+|+|||||.|+.+. .+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 94 ~~~~~iv~Ey~~~~l~~-~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQ-VI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHHH-HH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHHH-hh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 47899999999876554 33 36799999999999999999999999999999999999999999999999999876443
Q ss_pred ccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHHHHhcc-------------
Q 012637 162 LRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRKVFKAE------------- 228 (459)
Q Consensus 162 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 228 (459)
.......+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+......++....
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 3344566899999999999987765 89999999999999999999999887665554443210
Q ss_pred ---------CCC--------------C------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012637 229 ---------FVY--------------P------PWISTDAKRLISKLLVSDPERRITIQSIMRVPWFRKGF 270 (459)
Q Consensus 229 ---------~~~--------------p------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~hpw~~~~~ 270 (459)
... + ...|+++.+||++||.+||++|||++|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000 0 01366789999999999999999999999999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=418.43 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=215.3
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
++.+-.++|++++.||+|+||+||+|+++.+ +.||||++....... +.+.+|+.+|++++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 3455578999999999999999999998655 679999997654332 468899999999999999999999854 5
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
.+|+|||||++|+|..++.. +.+++.++..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 68999999999999888753 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-CCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
.. ........+||+.|+|||++....++ .++||||+||+||+|++| .+||.+.+..+.+..+..+ ....|+.++++
T Consensus 165 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 165 DN-EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred CC-CceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHH
Confidence 32 12233446799999999999988775 899999999999999995 6666777777777776654 45677889999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc--CcccccC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMR--VPWFRKG 269 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~--hpw~~~~ 269 (459)
+.+||.+||+.||++|||+++|++ ++||...
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999988 8888653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=425.38 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=210.3
Q ss_pred CCEEEeeeecccCcEEEEEEEEcCCCc----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 10 GKYEMGRLLGKGTFAKVYYGKQLMTGE----SVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 10 ~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
..|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988887 47888775432 222356789999999999999999999999765 57
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
++++||+.+|+|.+.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788899999999888764 579999999999999999999999999999999999999999999999999998655433
Q ss_pred CCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhcc-CCCCCCCCHHHHH
Q 012637 164 NDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAE-FVYPPWISTDAKR 241 (459)
Q Consensus 164 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 241 (459)
.........||+.|+|||++.+..|+ .++||||+||+||+|+| |.+||.+.+..++...+..+. +..|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 33333445689999999999988775 89999999999999998 899999988777777776654 5667789999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCc
Q 012637 242 LISKLLVSDPERRITIQSIMRVP 264 (459)
Q Consensus 242 Li~~~L~~dP~~R~t~~eil~hp 264 (459)
||.+||..||.+|||+.||++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=413.13 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=207.3
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCC----cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTG----ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKK 84 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (459)
-..|++.+.||+|+||+||+|.++.++ ..||||.+.... .......+.+|+.+|++++|||||++++++.+...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 467999999999999999999987655 469999996543 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccc
Q 012637 85 IFVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQL 162 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~ 162 (459)
.|+|||||.+|++.+.+.. +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999999988765 57999999999999999999999999999999999999999999999999999865432
Q ss_pred cCC-CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-CCCCCCchHHHHHHHHHhc-cCCCCCCCCHHH
Q 012637 163 RND-GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMNMYRKVFKA-EFVYPPWISTDA 239 (459)
Q Consensus 163 ~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 239 (459)
... .......||+.|||||++.+..|+ .++|||||||++|+|++| .+||...+..+++..+..+ ....|..+++++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 221 122345689999999999887775 899999999999999995 5666666777777766654 345667789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 012637 240 KRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+||.+||+.||++|||+.||++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=416.74 Aligned_cols=256 Identities=21% Similarity=0.390 Sum_probs=219.8
Q ss_pred ccccccCCEEEeeeecccCcEEEEEEEEcCCC-------cEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCccee
Q 012637 4 ERHVLFGKYEMGRLLGKGTFAKVYYGKQLMTG-------ESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVEL 75 (459)
Q Consensus 4 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l 75 (459)
++.+-.++|++++.||+|+||.||+|++..++ ..||||++.++.. ......+.+|...++++ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 34556789999999999999999999976654 4799999976542 33456788899999888 89999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCC
Q 012637 76 REVMATKKKIFVAMEYVKGGELFAKVARG-----------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPE 138 (459)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~ 138 (459)
++++.++..+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999642 4899999999999999999999999999999999
Q ss_pred CeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchH
Q 012637 139 NLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENI 217 (459)
Q Consensus 139 NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~ 217 (459)
|||++.++.+||+|||+++..............+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999877654444455667899999999999988875 89999999999999998 7999999988
Q ss_pred HHHHHHHHhc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 218 MNMYRKVFKA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 218 ~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+++..+..+ .+..|.++++++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8888777654 45667889999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-54 Score=418.80 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=204.9
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 78 (459)
+.+-.++|++++.||+|+||.||+|.+.. +++.||||++..... ....+.+.+|+.++.++ +||||+.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 33456789999999999999999999754 457899999865432 22345677788887776 78999999998
Q ss_pred EEe-CCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCe
Q 012637 79 MAT-KKKIFVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENL 140 (459)
Q Consensus 79 ~~~-~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NI 140 (459)
+.. ...+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 765 4568999999999999999853 2488999999999999999999999999999999999
Q ss_pred EecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-CCCCCCchHHH
Q 012637 141 LLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMN 219 (459)
Q Consensus 141 Ll~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~ 219 (459)
|++.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||++|+|++| .+||.+.+...
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999865543333344567899999999999987774 899999999999999986 57888765444
Q ss_pred HHH-HHHhc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 220 MYR-KVFKA-EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 220 ~~~-~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+. .+..+ .+..|..+++++.+||.+||+.||++|||++||++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333 33333 455677899999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-53 Score=416.22 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=219.2
Q ss_pred cCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK 83 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (459)
.++|++.+.||+|+||+||+|+++ .+++.||||+++... .....+++.+|+.+|+.++||||+++++++.+.+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 467999999999999999999975 356789999997543 2335677899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCC
Q 012637 84 KIFVAMEYVKGGELFAKVARG-------------------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPE 138 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~ 138 (459)
..+++|||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 999999999999999988531 3889999999999999999999999999999999
Q ss_pred CeEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCC-CCCCCchH
Q 012637 139 NLLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGF-LPFQDENI 217 (459)
Q Consensus 139 NILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~-~Pf~~~~~ 217 (459)
|||++.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|. +||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999866544444445567899999999999988876 8999999999999999985 78999998
Q ss_pred HHHHHHHHhccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 218 MNMYRKVFKAEF-VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 218 ~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+....+..+.. ..|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888877654 356779999999999999999999999999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=413.10 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=206.1
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcC-CC--cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLM-TG--ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~-~~--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (459)
.++|++.+.||+|+||+||+|++.. ++ ..||||++.++........+.+.+|+.+|++++||||+++++++.+ ..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3579999999999999999998654 33 3689999987766666667889999999999999999999999965 467
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCccccccc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLR 163 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~ 163 (459)
|+|||||++|++.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999987754 679999999999999999999999999999999999999999999999999998654322
Q ss_pred CCC-ccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhccC--CCCCCCCHHH
Q 012637 164 NDG-LLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKAEF--VYPPWISTDA 239 (459)
Q Consensus 164 ~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 239 (459)
... .....+||+.|+|||++.+..++ .++|||||||++|+|+| |..||.+.+..+....+.+... ..|+.+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 222 22345678899999999987664 88999999999999998 8999999999998888877654 4456789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 012637 240 KRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 240 ~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+||.+||..||++|||+++|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=405.94 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=208.6
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-CC
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-KK 83 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~ 83 (459)
+.+-.++|++++.||+|+||.||+|++ +|+.||||+++++. ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 345577899999999999999999997 57899999997653 23568899999999999999999998854 56
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccc
Q 012637 84 KIFVAMEYVKGGELFAKVAR---GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPE 160 (459)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~ 160 (459)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 78999999999999999865 249999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHHHHHHHHHhc-cCCCCCCCCHH
Q 012637 161 QLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIMNMYRKVFKA-EFVYPPWISTD 238 (459)
Q Consensus 161 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 238 (459)
. ...+.+||+.|+|||++.+..+ +.++||||+||++|+|+| |.+||...+..+.+..+..+ .+..|+.++++
T Consensus 155 ~-----~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (262)
T d1byga_ 155 S-----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred C-----CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 2 2345678999999999998777 489999999999999998 79999998888887777653 45677889999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 239 AKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 239 ~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+.+||.+||..||.+|||+.+++++
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=412.59 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=224.3
Q ss_pred cccccccCCEEEeeeecccCcEEEEEEEEcC-----CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEE
Q 012637 3 EERHVLFGKYEMGRLLGKGTFAKVYYGKQLM-----TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELRE 77 (459)
Q Consensus 3 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 77 (459)
+++.+..++|++++.||+|+||+||+|.++. +++.||||++++.. .......+.+|+.++++++||||+++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 3455667899999999999999999998753 45789999997543 3334567899999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCC
Q 012637 78 VMATKKKIFVAMEYVKGGELFAKVAR-----------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENE 146 (459)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~ 146 (459)
++...+..++|||||++|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 99999999999999999999998753 2368899999999999999999999999999999999999999
Q ss_pred CeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-CCCCCCchHHHHHHHHH
Q 012637 147 DLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMNMYRKVF 225 (459)
Q Consensus 147 ~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~ 225 (459)
++||+|||+|+..............+||+.|+|||.+.+..+. .++||||+||++|+|+|| .+||.+.+..+.+..+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876554433344556799999999999988775 899999999999999998 58999999888888877
Q ss_pred hcc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 226 KAE-FVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 226 ~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
.+. ...|+.+++.+.+||.+||+.||++|||+++|++
T Consensus 250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 654 3456789999999999999999999999999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-53 Score=414.10 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=213.8
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcE--EEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGES--VAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREVMATKKKI 85 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (459)
.++|++.+.||+|+||+||+|.++.+|.. ||||.+.... .....+.+.+|+.+|+++ +|||||++++++.+.+.+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 46899999999999999999999988875 6777765332 222456789999999999 799999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCe
Q 012637 86 FVAMEYVKGGELFAKVAR-----------------GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDL 148 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~l 148 (459)
|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 999999999999998853 468999999999999999999999999999999999999999999
Q ss_pred EEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhC-CCCCCCchHHHHHHHHHhc
Q 012637 149 KISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAG-FLPFQDENIMNMYRKVFKA 227 (459)
Q Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~ 227 (459)
||+|||+|+..... ......+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..+++..+..+
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999754432 222456799999999999988775 899999999999999996 5689999988888887664
Q ss_pred -cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 228 -EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 228 -~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
.+..|..+++++.+||.+||+.||++|||+++|++|
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 456677899999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=410.05 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=217.5
Q ss_pred cccccCCEEEeeeecccCcEEEEEEEEc-----CCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCCcceeEEE
Q 012637 5 RHVLFGKYEMGRLLGKGTFAKVYYGKQL-----MTGESVAIKVINKDQLKKEFMMEQIKREISVMRLV-RHPNVVELREV 78 (459)
Q Consensus 5 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 78 (459)
+.+-.++|++++.||+|+||.||+|.+. .+++.||||++.+... ......+.+|+.+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4455689999999999999999999863 4677899999976542 33456788999999999 69999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCC
Q 012637 79 MATKKKIFVAMEYVKGGELFAKVARG-------------------RLREDLARKYFQQLISAVDFCHSRGVSHRDLKPEN 139 (459)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~N 139 (459)
+.+...+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 99999999999999999999998642 48999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhh-CCCCCCCchHH
Q 012637 140 LLLDENEDLKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLA-GFLPFQDENIM 218 (459)
Q Consensus 140 ILl~~~~~lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~-G~~Pf~~~~~~ 218 (459)
||++.++++||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||.+.+..
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987654333334445689999999999988766 489999999999999998 67777776665
Q ss_pred HHHHHHHhc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 219 NMYRKVFKA--EFVYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 219 ~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
+.+.++... ....|..+++++.+||.+||++||++|||+++|++
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 555544433 33455678999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=394.42 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=205.1
Q ss_pred EEeeeecccCcEEEEEEEEcCCC---cEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEe-CCEEEEE
Q 012637 13 EMGRLLGKGTFAKVYYGKQLMTG---ESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMAT-KKKIFVA 88 (459)
Q Consensus 13 ~i~~~LG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV 88 (459)
...++||+|+||+||+|.+..++ ..||||.+++. ......+++.+|+.+|++++||||+++++++.+ +...|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34689999999999999987653 36999998643 344456889999999999999999999999765 5689999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCCcccccccC--
Q 012637 89 MEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLSALPEQLRN-- 164 (459)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla~~~~~~~~-- 164 (459)
||||++|+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999998875 4578889999999999999999999999999999999999999999999999986543211
Q ss_pred CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCC-chHHHHHHHHHhc-cCCCCCCCCHHHHHH
Q 012637 165 DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQD-ENIMNMYRKVFKA-EFVYPPWISTDAKRL 242 (459)
Q Consensus 165 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 242 (459)
........||+.|+|||++....+ +.++|||||||++|+|++|..||.. .+..+....+..+ .+..|+.+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 112234568999999999998776 4899999999999999997776654 3444455555544 445677889999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcC
Q 012637 243 ISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 243 i~~~L~~dP~~R~t~~eil~h 263 (459)
|.+||..||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-50 Score=393.47 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=204.1
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC-cceeEEEEEeCCEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN-VVELREVMATKKKIF 86 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 86 (459)
+.+||++++.||+|+||+||+|++..+|+.||||++..+... +.+.+|+.+++.++|+| |+.+..++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 456899999999999999999999999999999998765432 24678999999997665 555667778899999
Q ss_pred EEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC---CCCeEEeecCCCccccc
Q 012637 87 VAMEYVKGGELFAKVA--RGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE---NEDLKISDFGLSALPEQ 161 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~--~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~---~~~lKl~DFGla~~~~~ 161 (459)
+||||+.+ +|...+. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+....
T Consensus 80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99999965 4555443 368999999999999999999999999999999999999864 45799999999987643
Q ss_pred ccCC-----CccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHHHHHHH---HHhccC----
Q 012637 162 LRND-----GLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIMNMYRK---VFKAEF---- 229 (459)
Q Consensus 162 ~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~~~---- 229 (459)
.... ....+.+||+.|||||++.+..++ .++|||||||++|+|++|..||........... ......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 2221 123456899999999999988875 899999999999999999999987554433222 111111
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCcccccCC
Q 012637 230 -VYPPWISTDAKRLISKLLVSDPERRITIQ---SIMRVPWFRKGF 270 (459)
Q Consensus 230 -~~p~~~s~~~~~Li~~~L~~dP~~R~t~~---eil~hpw~~~~~ 270 (459)
..++.+|+++.+||.+||+.||++||+++ ++|+|+|.+.+.
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 12356899999999999999999999987 457888876554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-49 Score=384.18 Aligned_cols=249 Identities=17% Similarity=0.251 Sum_probs=207.2
Q ss_pred cccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CCcceeEEEEEeCCEE
Q 012637 7 VLFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRH-PNVVELREVMATKKKI 85 (459)
Q Consensus 7 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 85 (459)
++.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+|+++++.+.| +||+.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 4568999999999999999999999999999999998654322 246789999999965 8999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecC-----CCCeEEeecCCCcc
Q 012637 86 FVAMEYVKGGELFAKVAR--GRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDE-----NEDLKISDFGLSAL 158 (459)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~-----~~~lKl~DFGla~~ 158 (459)
|+||||+ |++|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 6788888765 57999999999999999999999999999999999999974 57899999999986
Q ss_pred cccccC-----CCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCch---HHHHHHHHHhccC-
Q 012637 159 PEQLRN-----DGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDEN---IMNMYRKVFKAEF- 229 (459)
Q Consensus 159 ~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~- 229 (459)
...... .....+.+||+.|||||++.+..++ .++|||||||++|+|++|..||.+.. ....+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 543211 1233456899999999999988775 89999999999999999999997543 3333333322211
Q ss_pred ----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012637 230 ----VYPPWISTDAKRLISKLLVSDPERRITIQSIMR 262 (459)
Q Consensus 230 ----~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 262 (459)
..++.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123568899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=386.46 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=194.6
Q ss_pred cCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCcceeEEEEEeCC----E
Q 012637 9 FGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNVVELREVMATKK----K 84 (459)
Q Consensus 9 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 84 (459)
...|.+.+.||+|+||.||+|+. +|+.||||+++.+... ......|+..++.++||||+++++++.+.+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 45799999999999999999985 6899999999654321 122234666667789999999999997654 6
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 85 IFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS--------RGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~--------~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
+|+|||||++|+|.+++.+..++++....++.|++.||.|||+ +||+||||||+|||++.++++||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 8999999999999999998899999999999999999999996 59999999999999999999999999999
Q ss_pred cccccccC--CCccccccCCCcccChhhHhhcCC-----CCCcchhhhHHHHHHHHhhCCCCCCCc--------------
Q 012637 157 ALPEQLRN--DGLLHTQCGTPAYVAPEVLRKKGY-----DGSKADLWSCGVILYVLLAGFLPFQDE-------------- 215 (459)
Q Consensus 157 ~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~-----~~~~~DIwSlGvil~~ll~G~~Pf~~~-------------- 215 (459)
+....... .......+||+.|+|||++.+... .+.++|||||||+||+|+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86543221 123345789999999999876432 135799999999999999998877421
Q ss_pred -hHHHHHHHHHhccC--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012637 216 -NIMNMYRKVFKAEF--VYPPW-----ISTDAKRLISKLLVSDPERRITIQSIMRV 263 (459)
Q Consensus 216 -~~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 263 (459)
+............. ..|.. ....+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22222222222222 12221 12348899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-48 Score=385.84 Aligned_cols=255 Identities=22% Similarity=0.443 Sum_probs=199.7
Q ss_pred ccccc-CCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-----------CCCc
Q 012637 5 RHVLF-GKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-----------HPNV 72 (459)
Q Consensus 5 ~~~~~-~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----------hpnI 72 (459)
|..+. +||+++++||+|+||+||+|+++.+|+.||||+++++.. ..+.+.+|+.+++.++ |+||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 44454 689999999999999999999999999999999976532 3456778999988875 5789
Q ss_pred ceeEEEEE--eCCEEEEEEeccCCCchHHHH-h---cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeccCCCCCeEecCC
Q 012637 73 VELREVMA--TKKKIFVAMEYVKGGELFAKV-A---RGRLREDLARKYFQQLISAVDFCHS-RGVSHRDLKPENLLLDEN 145 (459)
Q Consensus 73 v~l~~~~~--~~~~~~lV~E~~~gg~L~~~i-~---~~~l~e~~~~~~~~qll~~L~~LH~-~gi~HrDlkp~NILl~~~ 145 (459)
+++++++. .....+++|+++..+...... . ...+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 99998875 456778888887665433322 1 2679999999999999999999998 899999999999999876
Q ss_pred CC------eEEeecCCCcccccccCCCccccccCCCcccChhhHhhcCCCCCcchhhhHHHHHHHHhhCCCCCCCchHH-
Q 012637 146 ED------LKISDFGLSALPEQLRNDGLLHTQCGTPAYVAPEVLRKKGYDGSKADLWSCGVILYVLLAGFLPFQDENIM- 218 (459)
Q Consensus 146 ~~------lKl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~~DIwSlGvil~~ll~G~~Pf~~~~~~- 218 (459)
+. +|++|||.|..... .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 64 99999999975432 23467899999999999988875 8999999999999999999999754321
Q ss_pred -----HHHHHHHh------------------------------------------ccCCCCCCCCHHHHHHHHHhcCCCC
Q 012637 219 -----NMYRKVFK------------------------------------------AEFVYPPWISTDAKRLISKLLVSDP 251 (459)
Q Consensus 219 -----~~~~~i~~------------------------------------------~~~~~p~~~s~~~~~Li~~~L~~dP 251 (459)
........ .....+...++++.+||.+||..||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 11110000 0011112246779999999999999
Q ss_pred CCCCCHHHHhcCcccccC
Q 012637 252 ERRITIQSIMRVPWFRKG 269 (459)
Q Consensus 252 ~~R~t~~eil~hpw~~~~ 269 (459)
.+|||++|+|+||||+..
T Consensus 317 ~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTCBCHHHHHTCGGGTTC
T ss_pred hHCcCHHHHhcCcccCCC
Confidence 999999999999999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.2e-26 Score=210.69 Aligned_cols=136 Identities=21% Similarity=0.285 Sum_probs=109.5
Q ss_pred EEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccc---------------cHHHHHHHHHHHHHHHhcCCCCcceeE
Q 012637 12 YEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLK---------------KEFMMEQIKREISVMRLVRHPNVVELR 76 (459)
Q Consensus 12 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~i~~Ei~il~~l~hpnIv~l~ 76 (459)
|.+++.||+|+||+||+|.+ .+|+.||||++...... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 57899999999999999998 47899999987532110 011124456789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeccCCCCCeEecCCCCeEEeecCCC
Q 012637 77 EVMATKKKIFVAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHSRGVSHRDLKPENLLLDENEDLKISDFGLS 156 (459)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~~gi~HrDlkp~NILl~~~~~lKl~DFGla 156 (459)
++. . .+++|||++++.+. .+++..+..++.||+.+|.|||++||+||||||+|||+++++ ++|+|||+|
T Consensus 81 ~~~--~--~~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a 149 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred Eec--C--CEEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence 764 2 27999999987543 356666788999999999999999999999999999999654 999999999
Q ss_pred ccc
Q 012637 157 ALP 159 (459)
Q Consensus 157 ~~~ 159 (459)
...
T Consensus 150 ~~~ 152 (191)
T d1zara2 150 VEV 152 (191)
T ss_dssp EET
T ss_pred ccC
Confidence 743
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.42 E-value=4.1e-13 Score=106.89 Aligned_cols=88 Identities=17% Similarity=0.206 Sum_probs=80.2
Q ss_pred ceeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEe-CceEEEEEEecCCChHHHHHH
Q 012637 340 SMFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVA-PEVAVVEFSKSSGDTLEYAKF 418 (459)
Q Consensus 340 trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~k~~Gd~le~~~~ 418 (459)
-..+|+.+|++|+..|+++++.+|+.++.++++.+++....++.++.+.|.+||+++. +++++|+|+|.+||.++|+++
T Consensus 13 v~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l 92 (102)
T d1ul7a_ 13 MKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI 92 (102)
T ss_dssp CCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHH
T ss_pred eecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHH
Confidence 4678999999999999999999999999888899999987788899999999999995 799999999999999999999
Q ss_pred hhhhhhhhcc
Q 012637 419 CEEDVRPALK 428 (459)
Q Consensus 419 ~~~~l~~~l~ 428 (459)
|. +|...|+
T Consensus 93 ~~-~il~~l~ 101 (102)
T d1ul7a_ 93 AS-KIANELK 101 (102)
T ss_dssp HH-HHHHHCC
T ss_pred HH-HHHHhcc
Confidence 99 6766553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.63 E-value=9.8e-08 Score=88.06 Aligned_cols=142 Identities=18% Similarity=0.142 Sum_probs=97.9
Q ss_pred ccCCEEEeeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeCCEEE
Q 012637 8 LFGKYEMGRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATKKKIF 86 (459)
Q Consensus 8 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (459)
+.+.|++.+..+.++.+.||+.. .+++.+.+|......... ...+.+|...++.+. +--+.+++.+..+++..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 46788888887767778999886 567778889876443222 234667888888774 444678888888999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 012637 87 VAMEYVKGGELFAKVARGRLREDLARKYFQQLISAVDFCHS--------------------------------------- 127 (459)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~~~~qll~~L~~LH~--------------------------------------- 127 (459)
+||++++|..+........- ...++.++...+..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~~~----~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQS----PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHTTTCSC----HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEEeccccccccccccccc----HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999999877544322111 11222333333333332
Q ss_pred --------------------CCcEeccCCCCCeEecCCCCeEEeecCCCcc
Q 012637 128 --------------------RGVSHRDLKPENLLLDENEDLKISDFGLSAL 158 (459)
Q Consensus 128 --------------------~gi~HrDlkp~NILl~~~~~lKl~DFGla~~ 158 (459)
..++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999776677999998863
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.28 E-value=2e-06 Score=70.80 Aligned_cols=74 Identities=14% Similarity=0.244 Sum_probs=63.2
Q ss_pred eeecCCCHHHHHHHHHHHHhhcCcEEEEecCcEEEEEeccCCCCCCeEEEEEEEEEeCceEEEEEEecCCChHH
Q 012637 341 MFTSRYSARHIMEKIEGVAKGMNFKVAKVKDFKIRLRGDSEGRKGPLSVIAEVFEVAPEVAVVEFSKSSGDTLE 414 (459)
Q Consensus 341 rf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~le 414 (459)
..-|+..|.+|+..|..+++.||+.|++.+.+.|++.-........+.|.+++|++.++.+||||+...|+-.|
T Consensus 4 GIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 4 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 35678899999999999999999999999999999976444445678999999999999999999999998655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=5.7e-06 Score=81.12 Aligned_cols=81 Identities=14% Similarity=0.105 Sum_probs=51.0
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeecc-ccc-c--HHHHHHHHHHHHHHHhcC-C--CCcceeEEEEEeCCEEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKD-QLK-K--EFMMEQIKREISVMRLVR-H--PNVVELREVMATKKKIFV 87 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~-~--~~~~~~i~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 87 (459)
.+.||.|....||++.+..+++.|++|.-... +.. + ....++...|..+|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56799999999999998777889999975321 110 0 011345567888888773 3 345556544 4555689
Q ss_pred EEeccCCCch
Q 012637 88 AMEYVKGGEL 97 (459)
Q Consensus 88 V~E~~~gg~L 97 (459)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=1.4e-05 Score=72.63 Aligned_cols=140 Identities=16% Similarity=0.150 Sum_probs=84.8
Q ss_pred CCEEEeeeecccC-cEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC--CCCcceeEEEEEeCCEEE
Q 012637 10 GKYEMGRLLGKGT-FAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR--HPNVVELREVMATKKKIF 86 (459)
Q Consensus 10 ~~y~i~~~LG~G~-fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~ 86 (459)
..++.. .+..|. -+.||+... ..+..+.+|....... ..+..|...++.+. .-.+.+++.+..+.+..|
T Consensus 11 ~g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~ 82 (255)
T d1nd4a_ 11 FGYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 82 (255)
T ss_dssp TTCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceE
Confidence 344543 344444 468998874 4566788898654432 23667888888774 334677888888888999
Q ss_pred EEEeccCCCchHHH--------------Hhc-CCCC---------HHH----HH-HHH---------------HHHHHHH
Q 012637 87 VAMEYVKGGELFAK--------------VAR-GRLR---------EDL----AR-KYF---------------QQLISAV 122 (459)
Q Consensus 87 lV~E~~~gg~L~~~--------------i~~-~~l~---------e~~----~~-~~~---------------~qll~~L 122 (459)
+||++++|-.+... +.+ ..++ ... .. .+. ......+
T Consensus 83 ~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 83 LLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp EEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred EEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 99999998654210 100 0000 000 00 000 0011122
Q ss_pred HHHHhC-------CcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 123 DFCHSR-------GVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 123 ~~LH~~-------gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
..+..+ .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 333222 37999999999999987767899999875
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.64 E-value=7.1e-05 Score=60.14 Aligned_cols=68 Identities=16% Similarity=0.201 Sum_probs=54.6
Q ss_pred cceeecCCCHHHHHHHHHHHHhhcCcEEEEecC---------cEEEEEec-----cCCCCCCeEEEEEEEEEeCceEEEE
Q 012637 339 GSMFTSRYSARHIMEKIEGVAKGMNFKVAKVKD---------FKIRLRGD-----SEGRKGPLSVIAEVFEVAPEVAVVE 404 (459)
Q Consensus 339 ~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~---------~~i~~~~~-----~~~~~~~l~~~~~i~~~~~~~~~v~ 404 (459)
--..-|+..|-+|+-.|..|++++|+.|++-++ +.|++.-. ..+....+.|.+++|++.++.+|||
T Consensus 4 hfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlD 83 (127)
T d2qrda1 4 HFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLD 83 (127)
T ss_dssp EESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEE
T ss_pred eeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEE
Confidence 345668899999999999999999999987654 67888521 1222345788999999999999999
Q ss_pred EE
Q 012637 405 FS 406 (459)
Q Consensus 405 ~~ 406 (459)
|+
T Consensus 84 FK 85 (127)
T d2qrda1 84 VK 85 (127)
T ss_dssp EE
T ss_pred Ec
Confidence 98
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.26 E-value=0.00033 Score=59.06 Aligned_cols=71 Identities=18% Similarity=0.194 Sum_probs=52.9
Q ss_pred cccceeecCCCHHHHHHHHHHHHhhcCcEEEEec---CcEEEEEeccC---------CCCCCeEEEEEEEEEeCceEEEE
Q 012637 337 KTGSMFTSRYSARHIMEKIEGVAKGMNFKVAKVK---DFKIRLRGDSE---------GRKGPLSVIAEVFEVAPEVAVVE 404 (459)
Q Consensus 337 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~---~~~i~~~~~~~---------~~~~~l~~~~~i~~~~~~~~~v~ 404 (459)
|+.-..-|+..|-+||-.|..|++.||+.|++.+ .+.|++.-..+ .....+.|.+++|++.++.+|||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 4566788999999999999999999999998764 47787752111 11134789999999999999999
Q ss_pred EEe
Q 012637 405 FSK 407 (459)
Q Consensus 405 ~~k 407 (459)
|+-
T Consensus 125 FK~ 127 (171)
T d2qlva1 125 FKF 127 (171)
T ss_dssp EEE
T ss_pred Eec
Confidence 974
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.00087 Score=63.13 Aligned_cols=127 Identities=17% Similarity=0.178 Sum_probs=75.0
Q ss_pred EEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCCc--ceeE-----EEEEeCCEEEEEEeccCCCc
Q 012637 24 AKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPNV--VELR-----EVMATKKKIFVAMEYVKGGE 96 (459)
Q Consensus 24 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~lV~E~~~gg~ 96 (459)
-.||++.. .+|+.|++|+.+...... +++..|...+..|...+| +... ..+...+..+.++++++|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 57999875 578899999986543322 456778888887742221 1111 23356788999999998743
Q ss_pred h--------------HHHHhc-----------------------------CCCCHHH---HHHHHHHHHHHHHHHH----
Q 012637 97 L--------------FAKVAR-----------------------------GRLREDL---ARKYFQQLISAVDFCH---- 126 (459)
Q Consensus 97 L--------------~~~i~~-----------------------------~~l~e~~---~~~~~~qll~~L~~LH---- 126 (459)
+ ...+.. ..++... ....+.+++..+.-+-
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 2 011100 0011111 2222233333332221
Q ss_pred hCCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 127 SRGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 127 ~~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
..+++|+|+.|.|||+++ + ..+.||+-+.
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 136899999999999974 3 4589999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.95 E-value=0.0019 Score=62.36 Aligned_cols=77 Identities=12% Similarity=0.093 Sum_probs=52.1
Q ss_pred CEEEeeeecccCcEEEEEEEEcC-------CCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCCcceeEEEEEeC
Q 012637 11 KYEMGRLLGKGTFAKVYYGKQLM-------TGESVAIKVINKDQLKKEFMMEQIKREISVMRLVR-HPNVVELREVMATK 82 (459)
Q Consensus 11 ~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 82 (459)
..+ ++.|+.|---.+|++.... ..+.|.+++..... . .. ...+|..+++.+. +.-..++++++..
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~--~i-dr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T--ES-HLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C--HH-HHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h--hh-HHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 344 4788999999999998653 34568888775321 1 12 3568999999885 4434577777642
Q ss_pred CEEEEEEeccCCCch
Q 012637 83 KKIFVAMEYVKGGEL 97 (459)
Q Consensus 83 ~~~~lV~E~~~gg~L 97 (459)
.+|+||++|..+
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 689999988543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.49 E-value=0.0087 Score=55.35 Aligned_cols=136 Identities=13% Similarity=0.082 Sum_probs=74.8
Q ss_pred eeeecccCcEEEEEEEEcCCCcEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCC--cceeE------EEEEeCCEEE
Q 012637 15 GRLLGKGTFAKVYYGKQLMTGESVAIKVINKDQLKKEFMMEQIKREISVMRLVRHPN--VVELR------EVMATKKKIF 86 (459)
Q Consensus 15 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~------~~~~~~~~~~ 86 (459)
.+.|..|---+.|+.... +..+++|++....- .+.+..|+.+|..|...+ +.... .+........
T Consensus 23 ~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eecCCCCcccCeEEEEEC--CCcEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 344556766888998743 34589999864321 234556777777774222 21111 1223456677
Q ss_pred EEEeccCCCchH--------------HHHh---c---C----------------------CCCHHHHHHHHHHHHHHHHH
Q 012637 87 VAMEYVKGGELF--------------AKVA---R---G----------------------RLREDLARKYFQQLISAVDF 124 (459)
Q Consensus 87 lV~E~~~gg~L~--------------~~i~---~---~----------------------~l~e~~~~~~~~qll~~L~~ 124 (459)
.++.+..|.... ..+. . . ..........+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 777777764320 0000 0 0 00011122223333333333
Q ss_pred HHh----CCcEeccCCCCCeEecCCCCeEEeecCCCc
Q 012637 125 CHS----RGVSHRDLKPENLLLDENEDLKISDFGLSA 157 (459)
Q Consensus 125 LH~----~gi~HrDlkp~NILl~~~~~lKl~DFGla~ 157 (459)
.+. .|++|+|+.++||+++.++..-|.||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 332 479999999999999988877899999885
|